data_2jza_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jza _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.681 0.753 . . . . 74.23 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.0 112.28 24.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.95 -1.023 . . . . 72.54 110.176 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -99.1 137.88 36.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.174 -0.466 . . . . 73.33 110.719 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -71.13 131.64 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 65.31 110.771 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 106' ' ' ILE . 38.9 t -87.42 -70.52 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.911 -0.403 . . . . 64.44 109.911 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.9 m -154.41 178.54 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 73.4 109.782 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -78.08 144.16 36.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.521 -0.548 . . . . 75.34 109.521 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 71.31 110.724 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.36 -32.93 64.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.464 -0.789 . . . . 63.11 111.157 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.49 -16.76 63.52 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.265 -0.425 . . . . 73.25 110.497 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 mm -89.69 112.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.806 -0.442 . . . . 70.11 109.806 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.12 133.67 91.66 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.489 . . . . 74.34 111.14 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.72 133.36 57.62 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.815 2.343 . . . . 74.04 112.169 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.09 28.0 51.0 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.654 -0.703 . . . . 63.23 111.766 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -150.24 177.08 10.27 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 121.014 -0.274 . . . . 74.22 110.619 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.634 ' H ' HG22 ' A' ' 17' ' ' THR . . . 174.22 130.04 1.24 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.008 -0.615 . . . . 74.3 112.197 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.718 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 27.1 m -125.03 162.35 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.717 0.259 . . . . 72.32 110.975 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 14.7 p -87.5 144.56 26.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.171 0.51 . . . . 63.4 111.307 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 148.32 50.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.587 -0.733 . . . . 74.11 109.546 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.28 94.59 4.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.708 -0.849 . . . . 64.33 108.708 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.595 HG12 HD11 ' A' ' 106' ' ' ILE . 44.9 t -95.11 94.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 70.21 110.438 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . 41.0 mm-40 64.19 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.243 -0.89 . . . . 60.23 112.28 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.402 ' NE2' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -120.26 -21.31 7.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 72.22 111.542 -176.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -127.41 146.38 50.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.557 0.217 . . . . 72.24 111.263 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.72 130.0 35.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 72.41 110.135 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.0 mt -127.74 133.3 67.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 74.54 110.331 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.78 140.83 37.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.118 -0.492 . . . . 70.15 109.741 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 101.58 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.87 -0.332 . . . . 74.04 111.534 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.764 ' HZ ' HD21 ' A' ' 44' ' ' ASN . 79.8 m-85 -73.43 118.06 15.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.018 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' HG3' HG13 ' A' ' 39' ' ' VAL . 59.2 ttt180 -111.54 103.53 55.16 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 120.072 -0.651 . . . . 74.34 110.244 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.38 -55.08 0.17 Allowed 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.731 2.288 . . . . 74.25 112.233 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -122.97 -174.95 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.466 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -79.18 12.66 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.483 0.659 . . . . 73.52 110.463 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.1 178.62 6.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 71.41 109.425 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.66 -22.78 19.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.362 -0.381 . . . . 72.43 110.229 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -72.69 99.0 2.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 73.12 110.823 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.482 HG13 ' HG3' ' A' ' 32' ' ' ARG . 28.3 m -114.99 178.92 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.324 -0.853 . . . . 63.41 110.097 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 98.0 m-85 -126.01 101.23 6.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.807 0.337 . . . . 71.12 110.495 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 97' ' ' THR . . . -102.81 96.51 6.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.087 -0.506 . . . . 70.34 110.412 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.34 171.7 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.069 -0.514 . . . . 70.21 110.562 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.551 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 69.3 m -88.62 87.22 7.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.821 0.343 . . . . 72.13 110.209 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.764 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 53.2 t30 -124.37 82.43 2.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.408 0.623 . . . . 61.44 109.885 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.11 141.57 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.423 -0.808 . . . . 62.01 109.962 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.524 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t70 -93.39 123.99 58.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.503 -0.555 . . . . 61.42 109.503 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 23.3 Cg_exo -64.37 -10.22 23.1 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.055 2.503 . . . . 63.51 113.488 -175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -95.08 -13.06 25.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 70.34 110.717 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.57 -26.45 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.703 0.261 . . . . 74.41 111.703 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 68.39 12.63 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.773 0.671 . . . . 73.1 111.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.635 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -133.23 177.01 8.0 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.137 -0.483 . . . . 71.0 110.696 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.718 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 27.0 p -81.62 47.69 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.6 -0.727 . . . . 75.54 111.594 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.22 -21.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.282 0.563 . . . . 73.03 109.899 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.529 HD13 ' HH ' ' A' ' 90' ' ' TYR . 91.0 mt -82.46 -9.15 59.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.149 -0.932 . . . . 73.24 110.116 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 14.2 m -102.62 -18.93 15.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.816 -0.629 . . . . 71.4 110.742 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -94.32 19.88 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.332 0.587 . . . . 61.42 109.967 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.99 -151.43 9.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.635 -0.712 . . . . 74.34 112.047 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 4.0 mp -90.4 103.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.213 0.53 . . . . 61.33 110.285 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -88.08 104.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.32 -0.855 . . . . 62.04 109.411 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.38 175.15 11.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.807 -0.633 . . . . 72.41 111.036 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.35 119.43 28.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.011 -0.541 . . . . 71.33 110.227 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 71.2 t60 -86.11 -33.42 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.989 0.423 . . . . 73.24 110.476 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -150.89 -65.09 0.19 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.261 0.553 . . . . 71.41 109.969 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.29 -22.84 1.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 74.25 110.917 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.68 -174.59 2.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.96 -0.563 . . . . 72.14 110.257 -171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.4 mt -94.09 120.09 33.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.439 . . . . 71.43 110.409 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.419 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 19.7 m95 -121.95 153.39 38.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.842 -0.617 . . . . 75.21 109.893 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 9.8 p -114.3 122.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.455 0.645 . . . . 73.44 110.078 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.52 114.37 22.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.74 -0.664 . . . . 71.34 109.976 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.506 ' HG ' HD21 ' A' ' 54' ' ' LEU . 48.2 t -63.48 128.03 92.05 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.099 -0.501 . . . . 62.2 110.541 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.74 -31.41 32.41 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.585 2.19 . . . . 62.54 112.221 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.86 -56.3 2.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 73.31 111.179 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -84.1 -19.88 33.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.382 -0.372 . . . . 64.12 111.449 -173.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 70' ' ' SER . 0.3 OUTLIER 72.73 -23.01 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.547 0.943 . . . . 75.42 113.547 172.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 28.1 mm-40 -50.04 145.88 5.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.619 0.247 . . . . 75.21 110.991 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -100.18 105.66 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 74.13 110.848 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.501 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 52.3 m-85 -89.55 122.29 32.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.215 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 29.3 ttp180 -76.42 122.23 24.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.018 -1.104 . . . . 75.15 108.018 171.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.41 -49.81 60.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.682 0.993 . . . . 73.21 113.682 -165.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.525 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 58.1 t80 -89.32 -2.61 58.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 74.21 111.208 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HB2' ' HE ' ' A' ' 78' ' ' ARG . 10.5 t70 -103.16 -60.86 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.861 -0.336 . . . . 75.3 110.696 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.68 -19.76 28.05 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.504 -0.855 . . . . 75.51 113.527 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.93 157.48 33.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.421 0.61 . . . . 73.53 110.36 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 10.8 m -108.65 94.67 5.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp 62.23 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.514 0.726 . . . . 74.25 112.39 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 -55.8 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.967 -0.383 . . . . 72.31 109.967 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.34 113.74 26.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 74.44 110.618 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.11 69.45 3.37 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.722 -0.672 . . . . 73.34 112.914 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.43 7.36 45.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.464 . . . . 72.11 110.852 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.529 ' HH ' HD13 ' A' ' 54' ' ' LEU . 8.9 t80 -153.33 29.7 0.49 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 72.42 109.928 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 m -63.97 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.619 -0.719 . . . . 53.24 111.292 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.5 m -103.6 -178.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 74.43 111.246 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -101.2 130.87 47.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 72.14 111.165 -177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.02 105.29 11.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.092 -0.504 . . . . 71.22 110.524 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -94.86 158.27 15.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.677 -0.692 . . . . 75.42 109.987 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -82.94 151.22 26.01 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.797 0.332 . . . . 75.3 110.788 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.983 HG21 HG21 ' A' ' 106' ' ' ILE . 28.6 p -134.07 151.23 51.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 74.01 111.256 -172.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 98' ' ' GLN . 1.7 pt20 -135.64 157.97 45.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.04 -0.355 . . . . 74.2 110.04 173.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.89 108.51 25.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.963 -0.384 . . . . 70.24 109.963 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.7 t -74.6 -75.98 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 71.52 111.294 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.798 ' H ' HG23 ' A' ' 100' ' ' THR . 53.3 m-80 -144.32 87.79 1.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.859 -0.423 . . . . 72.14 109.859 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.51 -1.1 45.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.046 -0.597 . . . . 73.24 112.907 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.0 140.86 52.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.873 -0.417 . . . . 72.44 109.873 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.88 133.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.327 -0.397 . . . . 75.02 110.716 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.38 151.59 42.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 55.02 110.053 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.983 HG21 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -122.29 155.44 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.66 0.267 . . . . 73.11 110.291 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -83.42 101.44 11.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.822 -0.807 . . . . 64.12 108.822 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 108' ' ' ILE . 24.6 pt -79.34 86.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.816 0.817 . . . . 74.54 112.471 -173.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 108.582 -0.895 . . . . 53.54 108.582 170.137 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.839 0.352 . . . . 74.22 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.414 ' CZ3' ' HG2' ' A' ' 98' ' ' GLN . 96.5 m95 -94.88 116.15 28.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 71.14 110.277 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.0 m -105.13 129.05 53.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.318 -0.401 . . . . 74.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.787 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.5 m -70.33 115.16 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 53.2 110.423 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.36 -77.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 53.11 110.747 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -146.59 172.91 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.502 . . . . 70.42 110.059 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 46.7 mtpt -84.12 141.99 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 74.12 110.004 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.616 HD11 ' HB ' ' A' ' 13' ' ' ILE . 50.5 tp -70.69 -21.53 62.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 64.15 110.841 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.95 -34.39 76.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 72.23 110.733 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.63 -12.35 42.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 72.51 110.268 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.616 ' HB ' HD11 ' A' ' 10' ' ' LEU . 65.5 mt -82.11 111.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.164 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 14' ' ' LEU . 5.6 mp -56.42 130.12 75.71 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.675 -0.693 . . . . 73.31 112.11 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 17.1 Cg_exo -67.59 121.43 8.51 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.72 2.28 . . . . 73.33 111.381 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 35.87 5.09 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.917 -0.659 . . . . 75.22 112.462 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -136.14 -171.25 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.167 0.484 . . . . 72.52 111.328 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 168.94 96.13 0.1 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.154 -0.545 . . . . 43.11 111.887 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -133.98 165.92 30.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.52 0.16 . . . . 75.11 110.969 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.684 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.6 p -80.02 120.09 23.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.917 0.389 . . . . 74.41 111.421 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -91.35 150.87 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.402 -0.592 . . . . 72.02 109.402 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.77 107.44 19.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.992 0.425 . . . . 65.4 110.532 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 106' ' ' ILE . 46.4 t -113.5 113.78 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.314 -0.624 . . . . 74.32 109.314 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 27.5 mm-40 65.81 -85.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.677 0.611 . . . . 72.52 109.753 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -154.0 18.81 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.624 0.726 . . . . 73.2 109.302 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.82 128.87 47.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.864 -1.062 . . . . 74.25 109.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.638 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 48.9 mt-30 -101.46 130.32 47.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.189 0.519 . . . . 37.85 111.243 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.2 pp -127.63 129.85 70.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.599 . . . . 72.32 110.313 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -85.73 113.7 22.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.55 . . . . 75.32 109.916 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 37.9 t -97.16 98.29 7.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.228 0.537 . . . . 73.0 110.27 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.6 126.5 31.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.185 -0.916 . . . . 73.32 110.59 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' HD2' HD12 ' A' ' 10' ' ' LEU . 77.1 ttt180 -120.04 78.51 24.81 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.8 -0.815 . . . . 74.54 108.8 170.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HB3' HG23 ' A' ' 59' ' ' VAL . 3.6 Cg_exo -76.85 -20.03 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.98 2.454 . . . . 73.3 112.165 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -104.22 153.7 20.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.567 -0.742 . . . . 72.13 109.641 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.19 5.74 9.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.551 0.691 . . . . 72.03 109.727 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 13.6 t70 -89.56 -159.9 0.63 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.038 -0.983 . . . . 74.22 108.88 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.582 ' HA ' HD21 ' A' ' 10' ' ' LEU . 28.2 mt-10 -108.36 2.53 22.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 71.22 111.329 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -75.34 103.04 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 65.1 110.0 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.4 164.04 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.01 -0.541 . . . . 71.22 111.327 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -135.61 101.94 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.693 -0.685 . . . . 70.44 110.278 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB2' ' OG1' ' A' ' 97' ' ' THR . . . -100.38 95.24 6.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.107 0.48 . . . . 74.34 110.872 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -115.24 164.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.973 -0.558 . . . . 74.33 110.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.2 m -81.67 66.92 7.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.129 0.49 . . . . 74.1 110.629 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.634 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 38.1 t-20 -92.23 92.03 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.897 -0.779 . . . . 37.85 108.897 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 27' ' ' GLN . 14.5 mt -137.55 144.8 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 64.3 110.158 -174.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.545 ' HB3' HG22 ' A' ' 53' ' ' VAL . 2.4 p-10 -88.96 140.07 29.13 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.948 -0.76 . . . . 63.31 108.948 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 1.2 Cg_endo -83.91 15.13 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.477 2.118 . . . . 73.1 112.942 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -101.37 -56.54 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.729 0.3 . . . . 71.32 110.54 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -120.49 -2.23 10.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.287 -0.415 . . . . 75.24 110.643 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.472 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 19.5 mm-40 62.99 72.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.558 -0.747 . . . . 73.32 111.94 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.684 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -152.25 173.01 15.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.39 -0.823 . . . . 63.12 109.227 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -92.58 66.55 4.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.329 0.585 . . . . 73.11 109.903 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 46' ' ' ASP . 32.8 m -85.5 -10.57 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 64.21 110.273 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.634 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 90.0 mt -86.56 9.62 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.619 -0.719 . . . . 72.43 109.766 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 57' ' ' GLY . 40.7 t -84.37 -63.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.347 -0.842 . . . . 37.85 110.11 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.567 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 58.8 ttt180 70.47 -11.67 0.59 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.185 0.594 . . . . 72.24 111.15 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 55' ' ' SER . . . 77.41 5.5 85.75 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.319 -0.467 . . . . 62.45 112.244 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.47 105.72 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.613 0.72 . . . . 75.2 110.688 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 33' ' ' PRO . 96.7 t -99.3 101.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.702 -1.135 . . . . 71.53 109.757 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.95 156.98 17.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.515 . . . . 62.45 110.436 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.14 127.04 40.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.053 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.6 -46.05 17.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.583 -0.895 . . . . 75.21 108.583 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 177.62 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.658 -1.155 . . . . 73.45 108.497 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.87 -15.14 16.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.478 -0.783 . . . . 74.4 109.898 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -109.99 149.67 29.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.649 -0.705 . . . . 73.22 110.034 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.16 131.02 57.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 73.22 110.329 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.817 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 35.7 m95 -127.74 119.12 25.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.398 -0.365 . . . . 71.14 110.791 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HB ' HD23 ' A' ' 79' ' ' LEU . 11.3 p -73.89 138.39 21.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.656 -0.498 . . . . 62.44 109.656 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.09 109.67 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 73.42 111.123 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 m -72.85 154.02 91.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 70.05 111.239 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 56' ' ' ARG . 69.6 Cg_endo -74.46 -6.0 17.69 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.044 2.496 . . . . 54.21 113.626 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.09 -75.63 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.804 0.335 . . . . 72.11 111.163 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.62 24.61 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.455 -0.339 . . . . 75.3 110.254 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 55.24 34.65 23.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.03 0.919 . . . . 75.23 109.908 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.745 ' HG3' ' HE1' ' A' ' 77' ' ' PHE . 3.8 pt20 -81.29 141.13 34.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.592 -1.185 . . . . 74.24 110.693 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 61.6 m80 -93.13 121.55 34.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.478 -0.783 . . . . 75.05 110.42 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.745 ' HE1' ' HG3' ' A' ' 75' ' ' GLN . 7.3 m-85 -96.11 -16.83 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.478 0.547 . . . . 72.04 112.478 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 67' ' ' TRP . 5.7 ttt180 72.32 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.527 0.68 . . . . 70.33 111.18 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.707 HD23 ' HB ' ' A' ' 68' ' ' VAL . 97.4 mt -96.48 5.81 50.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 73.13 112.168 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.89 -26.6 19.26 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.635 -0.426 . . . . 71.51 111.13 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.36 -69.35 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.306 . . . . 63.32 111.382 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 92' ' ' VAL . . . 159.29 12.31 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.915 -0.66 . . . . 51.4 112.621 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -82.1 96.26 7.73 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.546 -0.539 . . . . 74.21 109.546 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 87' ' ' ASP . 6.8 m -79.95 161.38 25.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.273 -0.876 . . . . 70.43 111.504 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.5 tp -90.14 -66.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.999 -0.546 . . . . 74.11 110.424 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -86.36 -1.06 57.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.401 -0.363 . . . . 74.11 111.215 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 7.7 t70 -114.1 132.85 55.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 53.2 111.401 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.21 15.14 3.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.684 -0.966 . . . . 72.44 110.684 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -112.11 -37.38 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.598 0.237 . . . . 74.32 111.231 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -89.13 -71.72 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.51 -0.314 . . . . 74.42 110.555 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.0 m 60.14 99.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.685 0.616 . . . . 65.55 111.805 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.48 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 27.2 m -77.54 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.254 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.54 178.93 4.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.093 -0.503 . . . . 71.3 110.188 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.01 118.04 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.799 0.333 . . . . 72.03 110.965 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -101.0 153.54 19.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.64 -0.709 . . . . 75.1 110.442 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.09 139.31 54.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.087 0.47 . . . . 73.22 110.973 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 41' ' ' ALA . 2.9 m -134.4 158.85 42.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.566 -0.743 . . . . 70.24 109.324 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.1 pt20 -155.91 146.1 21.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.03 0.443 . . . . 74.4 110.422 174.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.0 102.06 13.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 72.24 110.126 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.2 m -82.11 85.06 6.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.349 -0.611 . . . . 63.14 109.349 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 72.45 -66.89 0.29 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.983 -1.008 . . . . 73.01 111.298 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.32 3.9 1.96 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.915 -0.659 . . . . 71.04 112.085 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -103.17 118.19 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.493 0.187 . . . . 71.14 110.715 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.68 115.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.829 -0.434 . . . . 71.22 109.829 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.787 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 24.2 mt-30 -123.09 134.79 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 73.42 111.113 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.414 HD13 HG11 ' A' ' 23' ' ' VAL . 2.9 pp -117.7 167.18 11.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.665 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.0 m -101.58 125.27 48.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.296 -0.411 . . . . 73.21 110.447 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.17 107.02 19.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.293 0.568 . . . . 75.11 111.543 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.143 -0.48 . . . . 37.85 111.067 179.622 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 107' ' ' SER . 52.4 mt-30 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 121.155 0.502 . . . . 73.04 111.039 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -116.95 121.84 42.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.507 -0.769 . . . . 74.53 109.777 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 m -103.15 134.24 46.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.245 -0.434 . . . . 61.24 109.861 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -79.53 116.78 19.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 75.22 110.3 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.44 -65.62 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.434 . . . . 65.41 110.282 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -176.68 -166.37 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.648 -0.706 . . . . 74.24 109.15 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 11' ' ' ASP . 50.2 mtpt -67.48 151.45 47.35 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.211 0.319 . . . . 75.21 111.294 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.38 -17.26 63.66 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.777 -0.824 . . . . 75.21 108.777 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.588 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 4.9 t70 -93.84 -24.28 17.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.562 -1.199 . . . . 74.24 111.014 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 25.3 t70 -84.17 -26.27 28.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.912 -0.586 . . . . 72.13 110.391 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 30' ' ' VAL . 61.3 mt -82.25 111.64 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.839 -0.619 . . . . 72.14 109.467 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.49 145.87 99.02 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 71.42 112.31 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 153.15 30.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.878 2.385 . . . . 75.24 112.571 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.72 28.58 71.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.81 -0.632 . . . . 71.24 113.052 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 34.4 p -143.31 -177.27 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.047 0.424 . . . . 74.24 110.817 -176.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.99 104.72 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.55 -1.02 . . . . 62.35 110.55 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 31.3 m -105.27 142.14 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.488 . . . . 64.23 112.319 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.79 ' HB3' HD12 ' A' ' 45' ' ' ILE . 3.8 p -75.51 117.13 16.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.555 . . . . 64.54 110.812 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.32 143.27 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.063 -0.517 . . . . 72.32 110.429 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 25' ' ' GLN . 7.0 tt -84.93 92.71 8.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 64.33 108.964 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.68 131.09 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.309 -0.86 . . . . 75.35 109.267 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.16 16.73 10.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.895 0.855 . . . . 62.52 110.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.486 ' HA ' HD22 ' A' ' 22' ' ' LEU . 83.9 mm-40 76.3 25.91 0.97 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.258 -1.792 . . . . 74.23 111.054 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.19 167.21 21.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 75.51 109.849 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.531 ' HB3' HG13 ' A' ' 45' ' ' ILE . 24.4 mm-40 -91.87 119.35 31.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.047 0.451 . . . . 74.53 111.147 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.1 mt -135.46 129.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.725 -0.67 . . . . 75.2 109.869 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.98 134.46 34.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.496 -0.32 . . . . 64.24 110.335 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.636 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 40.4 t -110.14 111.32 35.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.986 0.422 . . . . 64.31 110.512 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.816 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 8.8 m-85 -91.74 146.95 23.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.583 -0.735 . . . . 75.51 111.386 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 46.9 mtp85 -140.66 55.07 5.39 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.045 -0.525 . . . . 74.43 111.666 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HG2' HD13 ' A' ' 79' ' ' LEU . 23.5 Cg_exo -63.45 -46.38 9.66 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.914 2.41 . . . . 74.55 113.077 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.31 -29.67 67.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.599 -0.273 . . . . 73.23 111.623 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 62.5 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.41 0.624 . . . . 73.2 110.029 -170.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 21.3 t70 -177.9 -127.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 -174.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 65.1 mt-10 -104.74 -9.02 18.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.929 0.395 . . . . 72.32 110.105 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -71.04 103.43 2.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.032 -0.531 . . . . 72.42 110.966 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 m -113.74 142.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.02 109.402 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.816 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 74.1 m-85 -128.6 104.32 7.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.948 -0.301 . . . . 72.33 110.637 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.69 103.85 13.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 74.3 110.898 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.849 HG21 ' HA ' ' A' ' 94' ' ' ALA . 34.4 pt -134.9 154.16 36.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.005 -0.543 . . . . 54.33 110.056 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.4 m -77.95 55.13 1.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.262 0.553 . . . . 75.02 111.18 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.574 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 63.4 t30 -91.29 68.88 5.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.865 -0.791 . . . . 64.1 108.865 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 20' ' ' CYS . 25.7 mm -122.89 138.06 54.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 72.14 110.619 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.25 130.5 94.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.975 -0.557 . . . . 71.0 110.886 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -87.63 13.13 2.71 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.0 2.467 . . . . 74.42 113.284 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -101.46 -54.85 2.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.591 0.234 . . . . 74.13 110.912 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.15 -0.66 11.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.062 0.458 . . . . 64.55 110.813 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 61.69 74.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.231 -0.895 . . . . 74.55 111.443 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.7 151.87 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.693 -0.685 . . . . 75.23 109.651 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 p -83.07 83.09 7.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.286 0.565 . . . . 74.43 110.737 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.507 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 26.9 m -101.5 8.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.469 0.652 . . . . 73.31 109.813 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.87 13.81 24.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.204 -0.907 . . . . 75.32 109.669 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 p -112.17 -64.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.613 -0.721 . . . . 75.42 111.659 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ptt85 -81.32 51.06 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.005 -0.543 . . . . 74.3 111.208 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.684 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -112.06 -110.55 3.1 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.253 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 62.2 mt -110.84 114.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.059 0.457 . . . . 74.31 110.346 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.54 110.87 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.748 -0.66 . . . . 51.51 109.454 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.89 116.8 32.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.559 -0.746 . . . . 51.14 111.085 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.89 121.21 38.5 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.361 -0.607 . . . . 61.45 109.361 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.15 76.68 1.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 72.5 109.189 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 66.01 -75.21 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.488 -0.778 . . . . 72.54 111.51 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -121.93 -22.75 5.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.128 0.49 . . . . 72.32 110.37 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.487 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 19.2 t0 -84.69 148.84 26.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 72.51 110.147 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.631 ' HB3' HD11 ' A' ' 79' ' ' LEU . 68.1 mt -117.34 115.34 25.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.279 0.561 . . . . 65.2 111.055 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.487 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 38.0 m95 -117.19 163.39 16.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.371 -0.831 . . . . 74.33 110.17 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 79' ' ' LEU . 13.3 p -137.56 137.39 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.09 -0.505 . . . . 70.25 110.387 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -117.17 132.22 56.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.982 -0.554 . . . . 54.35 110.452 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 43.3 t -67.89 133.37 92.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.898 -0.408 . . . . 73.33 109.898 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.684 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 39.7 Cg_endo -66.37 -32.24 41.33 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 122.341 2.027 . . . . 73.33 112.164 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -100.81 -56.84 2.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.845 -0.616 . . . . 73.32 111.111 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -79.56 -19.63 48.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 70.24 110.746 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 70' ' ' SER . 52.4 mtmt 57.37 34.8 25.21 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.505 -0.77 . . . . 74.22 112.841 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.418 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.6 mm-40 -82.82 139.65 33.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 53.21 108.908 169.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 8.7 m80 -116.17 115.83 26.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.103 -0.332 . . . . 75.31 110.103 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.57 ' HZ ' ' HB2' ' A' ' 90' ' ' TYR . 77.6 m-85 -129.86 166.89 19.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.541 0.21 . . . . 74.43 110.631 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 61.4 mtt180 -81.26 146.53 30.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.407 . . . . 72.45 109.9 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 66' ' ' LEU . 96.0 mt -67.97 -27.47 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.896 0.332 . . . . 71.21 111.896 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.59 37.22 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.81 0.3 . . . . 71.24 111.81 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.708 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 20.2 t70 -148.88 -62.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.932 -0.307 . . . . 71.05 111.195 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.46 -12.22 23.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.181 -1.009 . . . . 38.16 113.697 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -75.32 160.03 30.79 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.193 0.52 . . . . 73.42 111.253 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . 61.8 m -87.86 151.99 22.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.453 -0.794 . . . . 71.13 111.481 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 64.5 tp -88.49 -58.86 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.484 . . . . 63.4 110.324 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 16.3 mm-40 -125.53 18.84 8.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 71.24 109.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 84' ' ' CYS . 2.1 m-20 -124.07 -180.0 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.414 -0.812 . . . . 62.4 111.037 -168.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.81 23.72 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.513 -0.767 . . . . 64.23 111.277 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.34 -59.52 2.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.748 0.277 . . . . 64.44 111.748 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 40.3 m-85 -90.4 -76.35 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.621 0.23 . . . . 73.33 111.621 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 m 66.27 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.84 0.712 . . . . 73.44 110.333 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.7 176.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.445 . . . . 72.25 111.697 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.08 167.64 9.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 51.33 110.916 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.849 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -127.34 112.39 14.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.087 0.47 . . . . 63.33 110.649 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -85.98 157.31 20.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.734 -0.666 . . . . 74.22 110.082 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 107' ' ' SER . 3.9 t0 -82.47 162.93 21.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.714 -0.476 . . . . 64.13 109.714 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.784 HG23 HG21 ' A' ' 106' ' ' ILE . 3.1 p -149.12 154.01 38.59 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.342 0.257 . . . . 73.31 110.831 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -154.45 153.87 32.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.239 0.542 . . . . 63.34 111.115 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.08 83.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.735 -0.839 . . . . 74.4 108.735 173.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -97.25 -0.22 47.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.703 -0.68 . . . . 75.34 110.813 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -161.13 -164.75 1.22 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.785 -0.821 . . . . 73.22 108.785 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.01 -11.38 84.8 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.59 -0.604 . . . . 73.23 111.59 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.47 152.26 24.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.953 -0.388 . . . . 72.33 109.953 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.79 136.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 73.32 110.889 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -126.16 147.51 49.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 60.52 110.386 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -125.62 158.37 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.905 -0.589 . . . . 74.33 109.567 177.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.588 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 13.1 t -102.65 119.61 39.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.97 0.414 . . . . 75.32 109.973 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -120.85 117.36 52.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 70.24 110.446 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 73.43 111.133 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.362 0.601 . . . . 70.43 110.545 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 91.8 m95 -74.44 111.14 9.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.45 110.096 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' HD12 ' A' ' 106' ' ' ILE . 9.6 m -95.55 138.5 33.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 73.12 109.909 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -84.36 128.72 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.789 0.328 . . . . 61.25 110.837 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.92 -75.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.017 0.437 . . . . 72.31 110.081 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.0 m -151.64 -173.76 4.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 55.15 109.534 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 86.4 mttt -78.4 164.15 25.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 72.52 110.402 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 37' ' ' GLU . 65.6 tp -75.4 -19.45 59.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.682 0.753 . . . . 74.23 109.046 167.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.51 -25.38 19.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.926 -1.034 . . . . 72.43 110.761 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.662 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 35.6 t70 -75.93 -21.56 56.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.444 0.64 . . . . 71.53 109.97 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 30' ' ' VAL . 26.8 mt -97.29 104.56 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 51.31 109.469 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.84 148.88 92.53 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 75.45 111.938 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.79 119.8 7.17 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.981 2.454 . . . . 73.34 112.017 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.38 33.24 4.59 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.96 -0.564 . . . . 53.44 112.058 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -133.62 176.96 8.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.305 0.574 . . . . 71.13 111.53 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 177.14 91.83 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.272 -1.131 . . . . 74.12 110.272 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.639 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.1 m -121.0 151.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.659 0.614 . . . . 73.0 112.659 -172.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 3.4 p -77.63 99.12 5.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.743 -0.662 . . . . 64.04 111.073 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.93 127.36 32.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 74.21 109.836 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.9 112.24 17.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.051 0.453 . . . . 63.12 109.922 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.08 107.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 72.41 109.622 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 67.11 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.72 -0.673 . . . . 72.4 111.785 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -138.88 0.75 2.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.227 0.537 . . . . 75.33 110.162 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -116.02 129.83 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.886 -0.597 . . . . 75.53 111.276 -173.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.673 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 39.5 mt-30 -89.14 113.99 25.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.351 -0.611 . . . . 72.51 109.351 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.09 117.71 55.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.796 -0.638 . . . . 74.01 110.625 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -79.97 119.51 22.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 72.32 110.119 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.661 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 18.8 t -100.91 108.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.268 -0.424 . . . . 74.54 109.931 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 55' ' ' SER . 33.4 m-85 -79.48 117.98 20.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.296 -0.411 . . . . 75.24 110.598 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.577 HH11 ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -130.83 75.57 78.5 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 75.52 110.786 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.74 -34.89 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.037 2.491 . . . . 54.31 113.033 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.7 -179.67 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 70.5 111.296 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.28 18.88 18.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.757 -0.656 . . . . 72.11 109.852 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 23.3 t70 -83.13 -161.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 75.51 109.454 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.568 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 50.3 mt-10 -118.25 2.43 11.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.122 -0.361 . . . . 75.12 111.255 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 153.79 41.41 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 110.164 -0.31 . . . . 70.11 110.164 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.7 148.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.106 0.479 . . . . 65.21 111.598 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -137.92 100.2 4.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.427 -0.806 . . . . 74.03 109.913 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB2' HG21 ' A' ' 97' ' ' THR . . . -118.89 106.33 12.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.047 -0.524 . . . . 73.3 110.459 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.6 pt -132.35 164.58 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 72.45 109.757 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.556 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 56.1 m -78.41 65.72 3.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.49 . . . . 41.42 110.779 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.564 ' HA ' HG11 ' A' ' 92' ' ' VAL . 64.4 t30 -97.7 75.98 2.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 74.02 108.986 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.665 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.7 mm -125.18 137.65 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.628 -0.714 . . . . 72.21 111.128 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.91 117.98 69.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.417 -0.586 . . . . 75.43 109.417 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.86 -0.14 9.9 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.69 2.26 . . . . 73.55 113.276 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -88.85 -30.72 18.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.22 0.534 . . . . 74.35 109.737 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 -19.49 13.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.868 -0.605 . . . . 75.13 109.933 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 63.16 36.37 12.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.895 -1.048 . . . . 72.23 111.347 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.524 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -148.95 165.53 31.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 72.53 109.216 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 14.0 p -77.31 77.99 3.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.217 0.532 . . . . 62.33 111.302 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.68 -8.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 71.12 109.755 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.95 7.63 23.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.978 -1.01 . . . . 72.53 110.2 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 10.0 p -129.63 7.7 5.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.602 -0.726 . . . . 74.13 110.772 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -110.01 18.19 20.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 71.21 110.486 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.562 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -103.67 -158.93 24.71 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.527 -0.844 . . . . 71.31 112.428 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 74.1 mt -85.86 108.02 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.845 0.355 . . . . 70.23 110.389 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 68' ' ' VAL . 84.9 t -71.56 91.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.871 -0.789 . . . . 53.41 108.871 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.45 145.99 30.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.47 0.652 . . . . 64.51 111.744 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -90.41 98.2 11.64 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.305 -0.861 . . . . 74.41 108.725 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.521 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 77.5 t60 -91.64 -45.29 8.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.487 -1.233 . . . . 73.13 110.076 -169.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -123.68 -148.11 0.39 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.148 -1.427 . . . . 72.02 107.148 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.98 44.25 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.179 -0.675 . . . . 75.34 109.179 171.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.439 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 5.6 t70 -157.55 -175.44 5.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.669 -0.493 . . . . 54.24 109.669 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.85 114.8 24.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 55.42 110.312 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' A' ' 78' ' ' ARG . 46.8 m95 -122.28 127.35 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.862 -0.608 . . . . 74.42 110.243 -176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG11 HG22 ' A' ' 59' ' ' VAL . 15.9 m -89.13 126.46 42.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.363 0.601 . . . . 71.41 111.036 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -88.83 99.38 12.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.663 -0.699 . . . . 71.32 109.231 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -58.47 128.41 82.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.726 -0.67 . . . . 71.12 111.035 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.1 Cg_endo -71.01 -36.38 7.59 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 62.13 112.324 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.9 tp -89.73 -44.25 10.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 72.43 110.705 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 27.0 mmmt -81.43 -28.68 34.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 74.02 110.638 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 63.06 22.31 13.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.572 -0.74 . . . . 74.14 112.29 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.39 161.63 19.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.884 -0.598 . . . . 71.2 109.612 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -92.64 140.33 29.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.553 -0.294 . . . . 74.41 110.879 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' A' ' 90' ' ' TYR . 53.5 m-85 -128.95 139.27 52.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.079 -0.341 . . . . 71.32 110.079 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.649 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 52.6 ttt180 -96.55 127.38 42.49 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.74 -0.466 . . . . 74.52 109.74 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.45 -60.59 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.66 0.6 . . . . 74.13 111.403 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.56 77.25 2.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 74.52 109.836 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 22.6 t70 -178.2 -58.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.197 -0.91 . . . . 72.43 109.881 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . 102.97 -16.35 54.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.672 -0.775 . . . . 71.1 113.395 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.41 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 81.8 m-85 -85.83 162.42 18.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.052 0.426 . . . . 74.24 111.452 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.17 40.57 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.648 -0.705 . . . . 61.42 111.27 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.9 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.4 tp 60.5 -83.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.02 0.528 . . . . 75.23 111.859 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.9 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 43.4 mt-10 -110.73 -17.83 13.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.337 -0.392 . . . . 74.32 110.575 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -93.02 172.24 8.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 74.32 110.472 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.01 60.24 0.5 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.001 -0.84 . . . . 70.12 111.001 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.25 -27.41 15.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.997 0.369 . . . . 72.5 111.997 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.413 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 22.3 m-85 -132.58 -68.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.337 0.495 . . . . 72.1 112.337 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 27.6 m 62.25 88.28 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 73.11 109.695 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 44' ' ' ASN . 30.1 m -85.86 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.587 -0.733 . . . . 62.34 112.566 -169.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -89.95 169.18 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 72.23 111.037 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 120.17 8.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.839 0.352 . . . . 74.33 110.342 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.48 153.87 27.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.057 -0.519 . . . . 72.51 110.714 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.15 119.89 21.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 65.0 110.186 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.83 HG23 HG21 ' A' ' 106' ' ' ILE . 77.5 p -119.73 145.06 46.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.114 -0.494 . . . . 74.1 110.814 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -152.47 148.4 27.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 75.41 111.111 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 47.2 t -100.06 109.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.54 -0.755 . . . . 65.01 109.142 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.4 m -96.19 -63.26 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.176 0.512 . . . . 72.11 111.714 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -124.24 55.44 1.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.639 -0.709 . . . . 73.1 109.878 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.6 -1.31 62.15 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.031 -0.604 . . . . 72.25 112.233 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 29.9 p-10 -110.65 144.62 39.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 72.42 110.725 -177.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.1 113.31 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 70.45 110.058 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 21.5 mt-30 -106.52 135.66 47.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.529 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.83 HG21 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.42 150.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.328 -0.619 . . . . 62.53 109.328 174.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -89.08 101.88 14.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.919 0.39 . . . . 74.21 110.982 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.4 mm -95.18 96.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.25 0.548 . . . . 74.31 109.676 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.554 -0.748 . . . . 74.14 110.674 -179.465 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 107' ' ' SER . 3.9 pt20 . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 120.942 0.401 . . . . 63.4 111.798 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.445 ' CZ3' ' HG2' ' A' ' 98' ' ' GLN . 98.5 m95 -118.27 95.02 4.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.909 -0.587 . . . . 75.13 109.733 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.3 m -92.81 135.1 34.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 75.24 110.84 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 103' ' ' ASN . 85.2 m -76.49 121.35 22.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.083 -0.508 . . . . 74.22 110.585 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 23' ' ' VAL . 54.1 t -80.61 -69.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.985 -0.552 . . . . 61.13 110.128 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 p -161.55 -179.46 7.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.702 -0.681 . . . . 64.31 110.172 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.12 137.6 40.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.951 0.405 . . . . 73.13 110.953 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 37' ' ' GLU . 51.0 tp -70.94 -8.04 50.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.053 0.93 . . . . 74.44 109.354 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.33 -14.96 39.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.375 -1.284 . . . . 71.3 110.078 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -100.86 -25.4 14.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.924 -0.58 . . . . 72.5 110.513 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.22 113.5 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 52.51 110.674 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -71.61 129.52 88.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 70.13 111.661 -175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.78 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 17.0 Cg_exo -67.79 128.92 18.73 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.314 2.676 . . . . 73.15 112.48 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 27.7 15.57 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.963 -0.637 . . . . 74.43 112.098 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.73 19.86 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.574 0.226 . . . . 75.21 111.199 -176.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 130.35 2.16 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 74.03 111.445 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.51 174.72 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.963 0.382 . . . . 53.01 111.31 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.741 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.1 p -80.63 138.92 36.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.867 -0.606 . . . . 71.34 111.614 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.68 127.76 45.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.41 -0.814 . . . . 51.11 109.523 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -84.66 100.6 11.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.431 -0.581 . . . . 64.2 109.431 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.447 HG22 HG21 ' A' ' 7' ' ' VAL . 48.4 t -107.29 112.27 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 53.31 109.832 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 63.97 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.775 -0.648 . . . . 74.03 110.48 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.7 -6.51 3.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.281 0.562 . . . . 74.15 109.936 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.621 ' HB3' HD13 ' A' ' 28' ' ' ILE . 1.7 mm100 -89.97 138.78 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.685 -0.689 . . . . 73.2 112.023 -171.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.745 ' HB3' HG13 ' A' ' 45' ' ' ILE . 51.7 mt-30 -100.59 103.44 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 74.0 109.554 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.621 HD13 ' HB3' ' A' ' 26' ' ' GLN . 3.2 mp -119.21 142.15 35.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.246 -0.279 . . . . 64.02 110.246 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.47 131.63 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.473 -0.566 . . . . 73.12 109.473 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.96 99.75 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.024 0.44 . . . . 73.05 110.456 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 42.3 m-85 -75.78 125.12 28.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.725 . . . . 74.04 110.507 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -110.78 87.35 6.68 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.113 -1.069 . . . . 70.52 108.113 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.89 -13.32 13.0 Favored 'Trans proline' 0 CA--C 1.517 -0.349 0 C-N-CA 122.588 2.192 . . . . 74.21 112.933 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -117.21 163.37 16.4 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.864 -0.607 . . . . 73.31 110.213 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.78 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 m-20 -79.9 -1.92 41.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 73.55 109.562 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 37.5 t70 -92.76 178.56 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.073 -0.967 . . . . 74.52 109.534 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.776 ' HB3' HD23 ' A' ' 10' ' ' LEU . 41.9 mt-10 -86.14 46.55 1.34 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.127 0.489 . . . . 61.04 111.547 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -117.53 128.93 55.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.425 -0.583 . . . . 71.5 109.425 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.73 162.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 70.55 112.428 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 49.0 m-85 -132.66 106.73 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.245 -0.889 . . . . 75.05 110.38 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.722 ' HB2' HG23 ' A' ' 97' ' ' THR . . . -97.14 101.59 13.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.894 0.378 . . . . 73.35 111.277 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -129.87 155.06 41.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 65.23 109.956 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 m -90.81 85.99 6.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 111.94 0.348 . . . . 75.05 111.94 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.769 ' HB3' HG11 ' A' ' 92' ' ' VAL . 21.7 p30 -135.39 65.5 1.55 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.855 0.836 . . . . 74.23 111.017 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.745 HG13 ' HB3' ' A' ' 27' ' ' GLN . 10.6 mm -84.04 -15.79 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.316 -0.856 . . . . 74.55 111.282 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.611 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 10.9 t70 66.62 121.13 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.939 -1.028 . . . . 74.31 110.714 -174.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.7 Cg_exo -75.01 -4.36 15.29 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.986 2.457 . . . . 64.24 113.523 -173.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.24 -31.91 11.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.744 0.307 . . . . 75.05 110.847 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.03 -31.65 7.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.825 0.345 . . . . 72.45 110.896 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 63.71 16.61 9.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.543 -0.753 . . . . 72.5 112.412 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.9 23.85 4.97 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.159 -0.338 . . . . 54.35 111.21 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.5 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 14.9 m 61.87 58.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 74.11 111.418 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.648 HG23 HD11 ' A' ' 72' ' ' LEU . 20.6 m -79.62 -14.11 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.301 0.572 . . . . 55.11 109.901 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 49.4 mt -74.78 -23.52 58.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.749 -0.834 . . . . 73.23 108.749 172.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 1.1 m -90.59 -38.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.231 -0.895 . . . . 73.45 110.034 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -80.64 29.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.56 -0.745 . . . . 74.44 111.112 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.96 -147.2 21.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.381 -0.688 . . . . 73.24 111.381 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.45 102.18 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.143 0.497 . . . . 73.44 110.397 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.3 t -83.82 94.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.39 -0.823 . . . . 74.31 109.3 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 179.76 3.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.116 -0.493 . . . . 72.12 111.267 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG2' HD22 ' A' ' 66' ' ' LEU . 23.8 mt-10 -116.02 155.59 27.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.6 -0.727 . . . . 63.41 110.614 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -127.1 39.23 3.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.936 -1.135 . . . . 70.23 107.936 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 69.28 103.2 0.06 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.128 -1.396 . . . . 75.43 110.6 -171.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 75.8 -53.05 0.63 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.863 -1.062 . . . . 62.1 111.55 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -76.2 143.88 40.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.208 0.527 . . . . 72.1 110.969 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.412 HD22 ' HG2' ' A' ' 61' ' ' GLU . 92.6 mt -103.52 120.25 40.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 71.35 109.768 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.537 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 58.5 m95 -124.49 117.1 23.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.423 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.08 130.3 42.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.018 0.437 . . . . 63.12 110.259 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.46 116.54 32.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.903 -0.59 . . . . 72.53 110.111 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.7 p -81.2 138.16 48.98 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.951 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.03 -29.84 26.68 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.413 2.075 . . . . 65.25 112.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 53' ' ' VAL . 74.8 mt -86.83 -52.21 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 75.13 111.405 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -32.48 29.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.426 -0.352 . . . . 74.12 110.854 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt 62.24 37.75 13.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.742 -0.663 . . . . 72.31 111.215 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -115.62 146.89 41.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 71.11 109.753 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 66.0 m80 -91.42 116.35 28.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.012 -0.54 . . . . 71.1 110.604 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -105.77 121.3 43.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.243 -0.435 . . . . 75.23 110.038 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.9 ttp180 -84.58 129.99 34.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.916 -0.401 . . . . 75.41 109.916 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.07 95.34 0.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.296 0.569 . . . . 72.05 111.032 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -161.31 -58.95 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.449 -0.945 . . . . 75.54 108.449 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' HA ' ' CB ' ' A' ' 94' ' ' ALA . 7.3 m-20 -138.23 -83.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.835 -1.075 . . . . 53.3 108.985 170.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . -159.28 32.34 0.45 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.596 -0.729 . . . . 63.12 111.539 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -71.25 120.24 16.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.758 0.314 . . . . 64.41 110.731 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 8.6 m -100.83 141.74 33.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.734 -0.667 . . . . 74.13 110.099 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 53.9 tp -71.17 -64.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 73.51 111.818 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.4 pm0 -85.73 -51.84 6.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.994 0.368 . . . . 71.03 111.994 -173.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 9.9 t70 -115.8 -151.92 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . -172.14 48.38 0.18 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.865 -0.894 . . . . 74.24 110.865 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.04 -25.32 67.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.112 0.412 . . . . 63.44 112.112 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -128.54 -57.98 1.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.886 -0.326 . . . . 75.04 111.332 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 49.3 m 57.05 83.01 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.479 0.657 . . . . 75.4 109.749 -173.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' A' ' 44' ' ' ASN . 23.3 m -70.99 166.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.019 -0.991 . . . . 74.23 112.605 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.49 146.39 25.81 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 53.44 110.714 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -124.79 107.86 11.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 64.31 110.532 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 109' ' ' ALA . 91.2 m-85 -84.11 144.31 29.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.678 -0.692 . . . . 75.41 109.463 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.34 136.07 49.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.781 0.324 . . . . 63.22 110.353 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.765 HG22 HG23 ' A' ' 106' ' ' ILE . 79.2 p -127.77 144.46 51.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 64.31 110.512 -175.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 8.9 pt20 -140.11 141.8 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 74.25 110.93 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.681 HG13 HD22 ' A' ' 10' ' ' LEU . 37.5 t -110.48 98.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.566 -0.743 . . . . 70.04 109.214 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -128.02 -1.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 63.12 111.42 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 103' ' ' ASN . 8.4 t-20 -136.36 24.99 3.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.374 0.607 . . . . 71.53 110.222 -175.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.89 -23.32 2.61 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.752 -0.737 . . . . 64.24 111.516 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 6' ' ' THR . 41.6 m-80 -103.57 153.82 20.17 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.362 -0.607 . . . . 73.04 109.362 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.531 HG23 HG23 ' A' ' 99' ' ' VAL . 45.0 t -90.08 120.11 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.947 -0.39 . . . . 74.34 109.947 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -114.14 127.06 55.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 71.44 109.892 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.765 HG23 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.21 152.98 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.15 110.977 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 25.4 t -82.69 107.31 15.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.166 -0.679 . . . . 64.02 109.166 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 108' ' ' ILE . 1.7 pp -81.51 121.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.705 0.764 . . . . 73.24 112.275 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.543 ' HB2' ' HE1' ' A' ' 95' ' ' TYR . . . . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.396 -0.82 . . . . 74.34 108.875 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 15.6 mm-40 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.18 0.514 . . . . 74.25 111.395 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 96.0 m95 -116.26 96.58 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.418 -0.81 . . . . 74.12 109.437 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.4 m -77.07 119.3 20.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.354 -0.384 . . . . 74.21 110.633 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 m -68.81 113.13 5.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.058 -0.519 . . . . 62.32 109.743 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.36 -65.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.169 0.509 . . . . 63.43 111.246 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.779 ' SG ' HG12 ' A' ' 13' ' ' ILE . 34.1 t -134.11 167.56 20.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.904 -0.589 . . . . 64.35 110.874 -172.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 11' ' ' ASP . 16.0 tptm -84.93 2.96 40.46 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.978 -0.555 . . . . 63.13 110.27 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 67.5 tp 71.77 -40.49 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.855 -1.066 . . . . 71.11 111.018 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 9' ' ' LYS . 28.8 t70 -74.25 -32.56 63.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.374 -0.83 . . . . 71.25 111.231 -175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -84.67 9.9 12.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.911 -0.716 . . . . 63.24 111.342 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.779 HG12 ' SG ' ' A' ' 8' ' ' CYS . 37.2 mm -90.55 128.93 42.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.719 -0.474 . . . . 63.22 109.719 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.96 125.99 92.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 71.1 111.3 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.17 126.82 17.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.837 2.358 . . . . 45.42 112.459 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 30.86 29.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 70.3 111.553 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -150.54 173.98 13.48 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.308 . . . . 72.41 110.864 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 17' ' ' THR . . . -148.04 142.88 10.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.175 -1.17 . . . . 75.21 110.175 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 m -134.3 146.83 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 117.822 0.811 . . . . 73.11 112.605 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 3.5 p -75.54 111.94 11.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.729 -0.668 . . . . 72.22 110.713 174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.07 109.55 20.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.931 -0.577 . . . . 61.1 109.878 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.15 103.15 3.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.298 -0.63 . . . . 75.31 109.298 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 26' ' ' GLN . 16.3 t -94.22 161.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.6 -0.889 . . . . 61.53 108.6 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.81 -53.16 10.07 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.52 0.512 . . . . 75.24 112.246 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -130.36 23.02 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.614 0.245 . . . . 74.13 111.226 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 20.2 mm-40 -138.4 157.63 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.107 0.479 . . . . 74.24 112.064 -174.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.447 ' HB3' HG13 ' A' ' 45' ' ' ILE . 50.3 mt-30 -127.6 103.31 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.653 -0.703 . . . . 71.34 110.461 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.21 135.94 59.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.324 -0.398 . . . . 63.35 110.254 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -100.51 134.62 43.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.743 -0.465 . . . . 71.34 109.743 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.482 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 39.8 t -111.06 108.44 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.808 -0.357 . . . . 55.14 110.343 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.835 ' HZ ' ' HB3' ' A' ' 44' ' ' ASN . 2.8 m-85 -93.55 128.0 39.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.906 -0.588 . . . . 72.01 110.148 -178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HG3' HG12 ' A' ' 39' ' ' VAL . 55.3 ttt180 -119.74 86.67 35.92 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 108.765 -0.828 . . . . 65.11 108.765 172.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 -36.84 91.72 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.853 2.368 . . . . 74.31 112.166 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.5 mtm180 -133.24 163.96 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 65.44 109.551 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.97 56.47 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.624 0.726 . . . . 65.45 110.243 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.82 -171.61 2.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.503 -0.771 . . . . 71.43 109.72 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.6 0.04 56.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 73.54 111.09 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.99 99.33 12.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.979 0.419 . . . . 71.33 110.3 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.516 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.5 m -125.32 165.57 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 62.54 110.818 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -133.04 107.34 8.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.983 -0.553 . . . . 72.14 110.77 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' A' ' 97' ' ' THR . . . -106.79 96.43 6.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.03 0.443 . . . . 74.41 110.714 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.3 164.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 74.21 109.6 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.8 m -76.89 53.83 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.043 0.449 . . . . 74.03 111.865 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.835 ' HB3' ' HZ ' ' A' ' 31' ' ' PHE . 53.8 t30 -100.93 67.03 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.625 0.726 . . . . 73.53 109.294 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 29' ' ' ALA . 30.8 mm -97.05 -21.05 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.107 -0.951 . . . . 75.54 111.555 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.72 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 32.1 t0 63.2 96.97 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.152 -0.931 . . . . 64.43 109.259 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 90' ' ' TYR . 32.2 Cg_exo -60.31 -1.05 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.622 2.881 . . . . 64.42 113.57 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -92.4 -15.04 27.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.557 0.218 . . . . 73.32 110.822 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -129.43 -31.02 2.08 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.817 0.673 . . . . 63.01 112.817 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.7 mp0 76.35 -14.14 0.84 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.017 0.747 . . . . 75.24 113.017 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.472 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -111.3 34.53 4.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.108 0.41 . . . . 72.31 112.108 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 53.0 p 47.55 56.4 7.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.282 0.563 . . . . 73.15 111.584 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 m -76.44 -2.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.497 0.665 . . . . 72.21 110.133 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 82.9 mt -92.58 23.36 4.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.086 -0.961 . . . . 74.43 109.583 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 77.2 p -145.12 -39.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 65.52 110.858 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -81.37 59.33 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 64.13 109.685 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.4 -110.38 0.44 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.401 -0.818 . . . . 63.22 111.524 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 50.5 mm -119.74 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.159 0.504 . . . . 73.24 110.694 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.78 101.7 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.141 -1.059 . . . . 75.41 108.141 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 116.19 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.913 -0.585 . . . . 73.33 112.497 -169.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.99 103.67 3.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.043 -1.095 . . . . 74.45 108.043 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -58.96 -57.24 13.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.869 -0.605 . . . . 71.23 110.656 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -141.64 -66.81 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.731 -0.668 . . . . 73.32 109.371 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.08 -7.63 8.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.181 -0.918 . . . . 65.12 110.331 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.562 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.5 t70 -122.54 171.63 8.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.115 -173.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.98 112.48 24.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.061 0.458 . . . . 73.53 110.955 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.712 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 9.3 m95 -124.65 168.14 13.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.577 -0.897 . . . . 75.52 108.577 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.456 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 14.4 p -131.94 144.75 36.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.769 0.318 . . . . 61.14 110.541 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -103.83 127.64 51.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.537 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 47.5 t -90.77 132.94 33.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 73.15 110.427 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.9 -17.3 37.03 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.648 2.232 . . . . 71.02 112.182 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.33 -52.85 4.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 52.21 109.868 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.1 pttm -125.9 103.38 7.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.601 -0.727 . . . . 74.44 109.147 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.7 77.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 72.33 112.178 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -130.72 151.37 51.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 64.31 109.022 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -88.92 93.26 9.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.555 0.217 . . . . 74.44 110.877 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 33.4 m-85 -78.81 121.87 25.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 71.01 109.656 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 49.4 ttt180 -80.04 122.65 27.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.867 -0.333 . . . . 74.21 110.583 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 62.11 111.353 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -106.84 16.46 24.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.329 0.585 . . . . 73.41 110.558 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.542 ' CB ' ' HD3' ' A' ' 78' ' ' ARG . 9.8 t70 -147.92 -65.21 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.1 111.191 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.04 -30.03 4.22 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.037 -0.601 . . . . 73.53 111.817 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.45 153.67 42.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 64.21 110.307 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.3 m -100.41 29.49 4.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 73.15 111.702 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.712 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 56.5 tp 53.89 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.452 0.908 . . . . 75.01 113.452 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -73.15 -21.71 60.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.695 . . . . 74.54 111.782 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 3.4 t70 -166.51 -160.68 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.777 -0.823 . . . . 74.32 108.777 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -122.08 -155.14 9.33 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 110.24 -1.144 . . . . 52.13 110.24 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 88' ' ' GLY . . . 171.39 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.373 0.606 . . . . 75.4 110.018 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CD2' ' HD2' ' A' ' 47' ' ' PRO . 94.9 m-85 -147.25 108.54 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.139 -0.937 . . . . 64.33 108.687 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 m -56.87 105.59 0.23 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 74.31 110.456 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.0 m -94.35 156.07 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.277 -0.419 . . . . 60.2 110.959 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.4 121.43 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.535 . . . . 63.45 111.51 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.36 94.72 8.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 70.3 110.057 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -75.46 164.56 26.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.557 -0.747 . . . . 72.12 111.381 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 21.6 t70 -86.04 132.24 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.342 -0.614 . . . . 73.41 109.342 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.734 HG21 HG22 ' A' ' 106' ' ' ILE . 51.7 p -128.06 144.49 51.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.342 -0.39 . . . . 74.41 111.081 -173.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.42 148.77 49.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.94 0.4 . . . . 71.33 110.653 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.48 103.11 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.915 -0.584 . . . . 71.02 109.504 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 m -83.32 77.99 9.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.832 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 71.83 -44.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.84 0.856 . . . . 64.33 112.348 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.06 -49.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.059 -0.591 . . . . 71.3 112.039 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -80.4 151.73 29.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.028 0.442 . . . . 73.42 110.855 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.94 127.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 75.4 110.457 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 23.6 mt-30 -120.47 137.22 54.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 74.1 110.483 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.734 HG22 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -113.82 149.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.107 -0.331 . . . . 75.13 110.107 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -84.99 105.05 15.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.62 . . . . 74.1 109.327 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 pt -82.85 147.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.089 0.471 . . . . 74.5 111.288 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 41.25 109.691 175.647 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.39 0.615 . . . . 75.32 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.563 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 57.4 m95 -129.14 125.38 36.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.132 -0.94 . . . . 75.31 109.041 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -112.62 136.18 52.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 74.41 111.732 -177.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.501 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 25.9 m -67.55 114.37 6.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.656 -0.702 . . . . 73.31 110.873 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.491 ' CG2' HD13 ' A' ' 106' ' ' ILE . 46.4 t -89.38 -78.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 75.42 111.171 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.428 ' SG ' HG11 ' A' ' 7' ' ' VAL . 86.0 m -143.44 177.8 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 72.24 110.677 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' ILE . 43.3 mtmt -84.29 117.68 23.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.582 -0.735 . . . . 72.3 110.384 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . 56.9 tp -66.34 -21.13 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.408 0.623 . . . . 74.52 110.429 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.97 -13.27 56.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.437 -0.801 . . . . 72.31 109.794 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.47 -29.94 10.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.172 -0.922 . . . . 73.32 110.412 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 9' ' ' LYS . 77.4 mt -68.67 122.03 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 74.54 110.741 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 6.3 mp -68.92 142.01 92.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 70.54 111.258 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.72 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 15.3 Cg_exo -69.16 142.01 49.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.872 2.382 . . . . 73.54 111.571 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.76 29.54 38.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.214 -0.517 . . . . 71.22 111.9 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 18' ' ' GLY . 2.0 m -139.54 177.81 7.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.057 -0.349 . . . . 74.03 110.057 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 17' ' ' THR . . . 178.0 118.97 0.57 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.657 -0.577 . . . . 42.14 111.657 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.545 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 28.1 m -129.45 156.0 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.926 0.363 . . . . 71.31 111.712 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 4.7 p -80.42 107.95 13.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 73.13 110.895 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 138.15 31.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.534 . . . . 75.43 110.058 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -82.75 100.36 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 70.22 109.86 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.32 97.85 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.941 -0.572 . . . . 63.31 109.52 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 64.84 -76.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.817 0.698 . . . . 65.2 111.719 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.88 6.04 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.612 0.244 . . . . 74.55 111.132 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -115.73 145.46 42.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.464 -0.335 . . . . 75.2 111.155 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -105.47 126.63 52.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.532 . . . . 74.51 109.562 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.96 130.35 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 64.24 109.189 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.83 113.95 21.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.03 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.541 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.1 t -97.16 98.44 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.045 -0.525 . . . . 63.22 110.416 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.452 ' HZ ' HG23 ' A' ' 68' ' ' VAL . 18.6 m-85 -76.21 138.74 40.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.339 -0.846 . . . . 72.13 111.313 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -123.41 76.14 53.44 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 109.121 -0.696 . . . . 74.45 109.121 164.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.39 -24.37 19.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.735 2.29 . . . . 75.24 111.267 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 3.4 mmp_? -94.74 137.11 34.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.077 -0.965 . . . . 74.11 110.251 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.72 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 31.4 p-10 -86.94 14.04 8.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 73.24 109.982 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 3.4 p-10 -113.75 -93.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.457 -0.792 . . . . 72.41 111.352 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 49.0 mt-10 -121.27 -52.64 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.963 0.727 . . . . 74.25 112.963 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -55.72 130.92 45.23 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.267 0.84 . . . . 71.44 113.267 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.4 m -128.72 170.23 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.207 -0.906 . . . . 72.13 109.846 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -144.72 111.31 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.769 0.319 . . . . 72.13 111.686 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.19 103.61 15.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.873 0.368 . . . . 63.35 110.258 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' A' ' 94' ' ' ALA . 34.1 pt -122.39 161.85 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.788 0.328 . . . . 71.32 111.353 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -76.88 46.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 61.2 111.126 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.401 ' N ' HD13 ' A' ' 45' ' ' ILE . 65.9 t30 -95.5 61.43 2.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.619 0.724 . . . . 73.32 110.776 -171.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.2 mp -123.12 129.64 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.299 -0.864 . . . . 72.23 110.024 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.3 t70 -87.6 123.91 68.59 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 74.32 109.691 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 25.4 Cg_exo -63.84 -22.22 69.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.299 2.666 . . . . 73.21 113.806 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.76 -22.22 37.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.333 0.587 . . . . 74.43 110.465 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.01 -20.14 13.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 71.21 109.851 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 59.2 28.65 18.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.82 -1.082 . . . . 62.43 109.99 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.776 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -150.83 165.52 33.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.136 -0.938 . . . . 75.31 109.864 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.936 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 3.8 p -80.75 56.93 2.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 65.3 111.258 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.12 -9.72 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.618 . . . . 74.42 110.368 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -95.0 -1.46 52.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.321 -0.854 . . . . 74.4 109.25 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.936 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 25.9 t -113.12 -52.46 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.205 -0.907 . . . . 71.44 110.862 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -83.78 59.97 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 64.43 109.696 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.65 -91.26 0.53 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 114.835 -1.075 . . . . 36.88 111.963 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 58.9 mt -129.09 132.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 74.43 110.247 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.23 121.22 58.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.215 -0.661 . . . . 72.05 109.215 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.77 162.51 34.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.08 0.466 . . . . 65.35 111.185 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -87.15 157.15 19.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.707 -0.679 . . . . 72.41 110.263 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 82.8 t60 -131.36 96.19 3.94 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.691 -0.485 . . . . 74.33 109.691 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 73.79 -55.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.857 -1.065 . . . . 72.15 111.792 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.88 -36.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.966 0.412 . . . . 73.35 110.828 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.401 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 1.3 m-20 -89.24 169.84 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 73.44 111.542 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.8 mt -108.93 123.79 49.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.492 -0.776 . . . . 73.11 109.898 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.487 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 11.8 m95 -130.84 174.94 9.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.204 -0.665 . . . . 65.44 109.204 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.4 p -120.09 145.28 26.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.955 -0.387 . . . . 71.12 109.955 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -110.02 103.54 12.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.173 0.511 . . . . 51.1 110.539 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -73.89 124.68 90.37 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 65.31 110.36 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.0 -32.45 92.36 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.792 2.328 . . . . 65.14 112.874 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.3 -63.65 1.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.388 -0.369 . . . . 74.14 111.425 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.803 ' HE3' ' HE2' ' A' ' 90' ' ' TYR . 73.2 mmtt -71.87 -26.55 62.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.32 112.022 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 62.69 15.88 8.45 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.065 0.546 . . . . 73.43 111.733 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 79.6 mt-30 -80.3 141.81 35.12 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.959 -0.564 . . . . 74.31 109.625 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 29.1 m80 -104.57 96.44 6.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 74.3 110.246 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.441 ' HB2' HG11 ' A' ' 68' ' ' VAL . 58.9 m-85 -82.42 121.22 26.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.767 -0.457 . . . . 71.43 109.767 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -71.5 127.59 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.747 -0.834 . . . . 71.31 108.747 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.427 HD22 ' HB ' ' A' ' 68' ' ' VAL . 87.5 mt -72.72 67.46 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 60.13 113.059 -167.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 t80 168.68 -52.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.975 0.91 . . . . 71.01 109.592 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.95 -44.0 61.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 73.4 111.587 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.77 -15.37 44.97 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.474 -0.87 . . . . 54.34 113.183 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.26 135.65 57.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.108 -0.331 . . . . 72.13 110.108 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 2.5 m -90.54 22.59 3.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.022 -0.536 . . . . 72.11 111.476 -172.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp 59.41 -73.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.716 0.806 . . . . 62.32 112.277 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -81.6 -49.99 9.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.289 0.566 . . . . 74.23 110.724 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -105.51 -175.53 2.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.513 -0.767 . . . . 70.21 110.419 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.48 32.71 0.77 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.824 -0.91 . . . . 43.35 110.824 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.04 -48.25 18.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.039 0.447 . . . . 74.53 110.874 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.803 ' HE2' ' HE3' ' A' ' 73' ' ' LYS . 56.5 m-85 -102.58 79.56 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.265 0.555 . . . . 63.45 110.037 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -73.18 82.72 1.32 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.627 -0.715 . . . . 61.45 109.695 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -78.69 149.69 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.596 -0.729 . . . . 73.21 111.753 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.32 165.58 11.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.849 -0.614 . . . . 73.01 110.187 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.582 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -122.27 105.06 9.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.062 0.458 . . . . 61.11 110.343 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.66 129.83 34.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.865 -0.607 . . . . 62.21 110.201 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.9 153.89 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.766 -0.652 . . . . 74.13 110.76 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.795 HG21 HG22 ' A' ' 106' ' ' ILE . 30.8 p -133.54 133.66 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.293 -0.412 . . . . 73.12 110.931 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -114.86 150.67 35.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.388 . . . . 75.22 110.024 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 t -102.98 96.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.99 -0.55 . . . . 72.3 109.922 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.0 m -66.99 -63.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.994 -0.548 . . . . 74.32 111.014 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -173.75 95.67 0.1 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.607 -0.724 . . . . 75.1 109.781 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.13 -40.86 2.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.152 -0.547 . . . . 71.1 112.369 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -104.21 151.64 23.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 73.42 110.604 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 47.9 t -101.47 135.99 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 60.14 110.661 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 75.8 mt-30 -118.2 127.06 53.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 74.24 110.151 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.795 HG22 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -100.25 155.17 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 63.44 110.83 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -77.02 124.07 27.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.709 -0.678 . . . . 74.14 110.407 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 pt -116.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.259 0.552 . . . . 74.23 110.935 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.444 0.64 . . . . 74.15 110.481 177.461 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.142 -0.318 . . . . 61.42 110.142 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.49 136.59 52.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.375 . . . . 75.22 110.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -118.74 128.47 54.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.222 -0.445 . . . . 63.3 110.353 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.595 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.6 m -78.14 113.7 16.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.77 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.11 -75.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.07 0.462 . . . . 75.24 109.848 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.3 m -144.34 168.44 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 72.12 109.189 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 9.8 mtmp? -91.17 165.81 13.28 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.992 -0.283 . . . . 64.14 110.578 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 tp -71.27 -7.59 47.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.496 0.665 . . . . 74.04 110.124 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.65 -20.29 21.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.216 -0.902 . . . . 72.11 110.002 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 18.4 m-20 -83.47 -27.18 29.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 73.54 110.694 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.87 136.99 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.87 -0.604 . . . . 73.24 110.572 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' A' ' 17' ' ' THR . 5.2 mp -91.53 149.04 38.7 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.621 -0.263 . . . . 74.04 110.977 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.98 121.41 8.89 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.562 2.175 . . . . 74.42 111.696 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 45.72 6.24 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.93 -0.577 . . . . 74.43 112.198 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 14' ' ' LEU . 72.5 p -141.61 174.9 10.13 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.954 0.377 . . . . 63.53 111.073 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -164.22 110.83 0.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.266 -1.134 . . . . 74.05 110.266 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -125.78 135.8 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 117.265 0.533 . . . . 73.43 112.43 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 8.7 p -79.72 104.22 10.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.86 -0.609 . . . . 72.35 110.082 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.06 147.46 23.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.108 -0.496 . . . . 73.2 110.236 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.57 113.35 22.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.897 -0.779 . . . . 73.22 108.897 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.33 93.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.872 -0.603 . . . . 73.33 110.082 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 67.23 -75.57 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.238 -0.892 . . . . 72.41 111.854 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -132.26 -8.49 3.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.446 -0.343 . . . . 73.42 111.223 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.871 ' HA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -122.9 163.53 20.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 75.42 111.46 -175.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.21 128.84 51.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 54.33 109.912 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -127.13 119.04 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.765 -0.457 . . . . 74.15 109.765 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.651 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -88.96 125.47 34.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.933 -0.576 . . . . 75.34 110.262 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.522 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.1 t -107.87 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.166 -0.47 . . . . 73.2 110.081 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.401 ' CZ ' HG23 ' A' ' 59' ' ' VAL . 63.1 t80 -91.8 130.25 37.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.716 -0.675 . . . . 71.34 110.352 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HG3' HG13 ' A' ' 39' ' ' VAL . 64.2 ttt180 -131.31 100.37 16.85 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 75.21 110.009 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.45 -32.76 6.0 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.672 2.248 . . . . 74.24 113.293 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -128.73 166.13 19.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.52 -0.309 . . . . 75.12 110.684 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.77 26.47 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 72.21 111.255 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 16.5 m-20 -113.56 -155.04 0.56 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.745 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.404 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 24.4 mt-10 -84.4 -13.04 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.916 -0.583 . . . . 74.55 111.61 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -73.07 100.23 2.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.097 0.475 . . . . 72.53 110.992 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.579 HG13 ' HG3' ' A' ' 32' ' ' ARG . 27.0 m -129.95 156.4 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 72.4 110.159 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.36 102.84 6.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.698 0.285 . . . . 71.12 110.667 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 97' ' ' THR . . . -102.94 96.91 7.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.01 0.433 . . . . 62.33 110.682 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.578 HG13 ' HB2' ' A' ' 44' ' ' ASN . 49.3 pt -134.56 -179.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.083 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -79.29 60.73 3.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 73.32 109.911 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' HB2' HG13 ' A' ' 42' ' ' ILE . 2.0 t-20 -93.0 46.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.457 0.646 . . . . 54.44 110.644 -174.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.7 mp -103.05 131.25 51.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.512 -0.767 . . . . 75.41 110.04 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 10.0 t70 -82.52 120.94 77.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.101 -0.703 . . . . 73.22 109.101 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.455 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 43.4 Cg_exo -57.35 -23.71 56.39 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.227 2.618 . . . . 61.25 113.678 -175.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -84.14 -20.35 32.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 65.45 111.08 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.78 -20.57 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.99 -0.284 . . . . 71.24 111.195 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 64.49 19.19 11.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.692 -0.685 . . . . 72.42 111.096 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -137.1 169.7 17.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 63.24 109.927 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -81.42 50.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.682 -0.69 . . . . 74.53 111.291 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.66 -19.05 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.115 0.484 . . . . 62.01 109.91 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.45 HD21 ' HG ' ' A' ' 70' ' ' SER . 70.6 mt -62.23 -43.45 98.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.62 -0.718 . . . . 75.12 109.38 173.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -71.3 -23.15 61.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.441 -0.8 . . . . 71.54 111.09 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -98.37 20.23 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.267 0.556 . . . . 73.14 110.429 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.51 -149.29 24.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.745 -0.661 . . . . 62.3 111.636 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.26 116.32 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 75.4 109.759 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 68' ' ' VAL . 60.2 t -112.37 112.93 42.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.672 -0.695 . . . . 71.51 110.301 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.6 159.07 30.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 53.51 110.237 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.07 163.32 27.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.992 0.425 . . . . 72.24 110.251 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -122.09 46.54 2.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.727 -0.67 . . . . 74.34 109.264 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 55.85 25.31 8.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.087 -0.961 . . . . 64.43 111.697 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -164.15 -55.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 63.44 110.777 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.547 ' HB3' ' NE1' ' A' ' 67' ' ' TRP . 2.3 t0 -135.83 -173.0 3.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.086 -0.506 . . . . 74.15 110.116 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 79.2 mt -107.34 110.02 21.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 73.14 109.98 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.561 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 61.3 m95 -122.89 128.69 50.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.38 . . . . 71.55 111.062 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.572 HG21 HG22 ' A' ' 59' ' ' VAL . 13.2 p -103.56 145.69 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.339 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.21 117.68 30.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.499 -0.318 . . . . 63.23 110.771 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 27.3 t -73.34 147.27 87.48 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 65.4 111.29 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.36 -20.53 24.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.437 2.091 . . . . 63.11 112.021 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.33 -67.98 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 72.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.58 -39.23 93.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 73.01 111.416 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 70' ' ' SER . 70.6 tttt 62.06 11.94 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.635 -0.711 . . . . 73.43 111.374 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.51 ' HG3' ' HB2' ' A' ' 87' ' ' ASP . 21.9 mm-40 -88.65 150.04 23.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.386 -0.598 . . . . 64.34 109.386 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.4 m80 -89.86 121.66 32.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.914 0.388 . . . . 72.0 110.737 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -117.54 143.42 46.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.002 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.758 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 46.6 mtm180 -79.61 119.68 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.732 -0.47 . . . . 75.41 109.732 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.526 HD21 ' HB ' ' A' ' 68' ' ' VAL . 92.3 mt -52.1 -55.82 18.37 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.811 0.671 . . . . 73.25 112.811 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -90.22 15.94 9.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.735 0.302 . . . . 74.3 111.44 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 29.5 t70 -122.52 -60.69 1.52 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 45.42 111.365 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.26 -22.8 14.92 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.298 -0.954 . . . . 52.31 113.289 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.36 166.21 18.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.997 0.398 . . . . 74.22 110.924 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -112.7 166.2 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.853 -0.612 . . . . 71.15 111.634 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.561 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 62.1 tp -94.89 -69.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 53.44 110.276 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -87.1 -19.51 28.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 74.14 110.985 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.51 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 5.1 t70 -96.59 -152.37 0.38 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.931 -0.396 . . . . 74.42 109.931 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.27 -33.34 0.29 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.962 -0.855 . . . . 74.01 110.962 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.25 66.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.461 . . . . 54.43 110.803 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 94.7 m-85 -107.44 61.45 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 70.43 110.893 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.24 121.63 33.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.467 -0.788 . . . . 72.04 109.385 174.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.88 163.73 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 71.2 112.124 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.53 131.22 37.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.65 -0.704 . . . . 70.43 110.961 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -110.9 98.73 7.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.88 -0.6 . . . . 71.14 110.369 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.63 150.88 34.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 75.14 110.475 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.24 122.74 23.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.54 -0.541 . . . . 74.42 109.54 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.907 HG23 HG21 ' A' ' 106' ' ' ILE . 69.3 p -124.7 160.88 27.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.247 -0.433 . . . . 74.03 110.589 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -168.9 151.38 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 73.12 110.715 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 60.4 t -94.01 106.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.547 -0.751 . . . . 54.34 108.978 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.2 t -104.34 -34.24 8.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -133.03 30.81 3.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 54.52 110.369 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.25 -0.25 85.51 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.113 -0.795 . . . . 70.12 111.113 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.0 p30 -115.09 151.47 34.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.568 . . . . 60.02 110.318 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 99' ' ' VAL . 46.0 t -94.66 113.2 28.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 74.21 109.963 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 23.7 mt-30 -115.3 140.77 48.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.091 -0.504 . . . . 53.43 110.746 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.907 HG21 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -111.32 151.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.691 -0.686 . . . . 74.34 109.815 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 t -87.67 104.02 16.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.597 -0.89 . . . . 74.3 108.597 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.49 ' O ' HD13 ' A' ' 108' ' ' ILE . 2.3 pp -74.12 135.91 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.588 0.709 . . . . 71.12 112.439 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.098 -0.955 . . . . 74.51 109.037 173.527 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.656 0.265 . . . . 74.03 110.831 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 98' ' ' GLN . 59.7 m95 -109.14 109.78 20.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.49 -0.323 . . . . 75.32 110.858 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -99.01 141.49 31.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.5 -0.318 . . . . 63.43 110.858 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 m -80.32 122.87 27.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.541 -0.299 . . . . 72.41 110.276 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.5 -81.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.883 -0.414 . . . . 74.42 109.883 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -145.17 -84.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 64.32 109.796 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 60.3 mttp -151.35 151.44 31.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.018 0.437 . . . . 74.44 111.128 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.3 tp -84.39 -13.56 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.091 0.948 . . . . 65.52 109.138 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -88.39 -28.34 21.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.585 -1.188 . . . . 75.34 110.199 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 -18.75 43.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 74.34 111.3 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CG2' ' HB2' ' A' ' 32' ' ' ARG . 48.6 mm -76.1 118.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 62.21 110.898 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.66 163.72 42.93 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.57 . . . . 54.43 111.684 -175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.79 125.19 16.04 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.165 2.577 . . . . 73.11 112.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 17' ' ' THR . . . 59.45 40.47 96.2 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.08 -0.509 . . . . 54.11 111.923 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.639 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.7 m -148.68 174.29 12.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.842 0.353 . . . . 74.13 110.422 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.689 ' HA3' ' O ' ' A' ' 30' ' ' VAL . . . 166.16 165.38 23.43 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.745 -0.942 . . . . 63.15 110.745 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.511 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 30.7 m -129.57 164.6 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 74.03 111.652 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.764 ' HB3' HD11 ' A' ' 45' ' ' ILE . 2.8 p -83.44 129.27 34.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.913 -0.585 . . . . 72.21 111.084 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.92 125.41 51.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.797 -0.638 . . . . 74.34 109.921 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.06 89.57 5.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 74.35 109.403 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.8 104.39 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.296 -0.411 . . . . 64.32 111.151 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 61.38 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.031 0.832 . . . . 65.12 112.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.73 3.69 3.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.743 0.306 . . . . 75.23 111.061 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.459 ' HB3' HG13 ' A' ' 28' ' ' ILE . 58.0 mm-40 -102.28 129.22 48.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 73.12 111.329 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -102.73 88.2 3.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.926 -0.768 . . . . 74.13 108.926 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.459 HG13 ' HB3' ' A' ' 26' ' ' GLN . 60.3 mt -105.33 135.76 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.88 -0.6 . . . . 72.53 110.825 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 44' ' ' ASN . . . -117.99 137.16 53.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.128 -0.323 . . . . 71.55 110.128 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.689 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 26.2 t -95.38 146.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.534 -0.543 . . . . 75.41 109.534 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -140.65 129.41 23.02 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 70.51 109.629 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.537 ' HG3' HG13 ' A' ' 39' ' ' VAL . 46.8 ttt180 -111.71 91.15 14.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.01 -0.276 . . . . 74.52 110.825 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.13 -55.09 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.452 2.102 . . . . 73.23 113.668 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.668 ' HB2' ' OD1' ' A' ' 36' ' ' ASP . 34.3 mtm180 -89.58 -0.15 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.65 0.262 . . . . 63.41 110.926 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 64.5 t30 62.12 28.14 16.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.545 0.688 . . . . 70.51 110.895 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.668 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 6.4 p-10 -111.81 -166.71 1.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.254 -0.43 . . . . 64.42 110.324 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.75 -28.3 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 71.23 111.633 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.33 104.24 11.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.371 0.605 . . . . 73.34 111.433 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG13 ' HG3' ' A' ' 32' ' ' ARG . 30.9 m -105.77 158.56 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.459 -0.791 . . . . 73.12 109.596 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -113.28 96.3 5.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 72.22 110.258 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 93.6 8.15 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.747 -0.661 . . . . 65.34 109.429 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.799 HG23 ' HA ' ' A' ' 94' ' ' ALA . 38.3 pt -126.43 -172.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.001 -0.545 . . . . 74.13 110.678 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.49 47.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 62.3 110.284 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.684 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 33.8 t30 -83.12 40.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.271 0.558 . . . . 62.15 111.175 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.764 HD11 ' HB3' ' A' ' 20' ' ' CYS . 33.4 mm -114.38 123.5 70.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 62.32 111.037 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.97 120.85 71.75 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.011 -0.737 . . . . 75.0 109.011 173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' HE2' ' A' ' 90' ' ' TYR . 52.4 Cg_exo -56.34 -26.03 60.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.18 2.587 . . . . 41.01 113.406 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -78.15 -13.79 59.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 74.23 110.666 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.44 -34.85 4.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.902 0.382 . . . . 73.33 110.494 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.9 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 66.37 17.56 10.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.325 -0.852 . . . . 65.44 111.027 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.41 171.06 14.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 55.02 109.311 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.511 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 6.5 p -76.97 80.24 3.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.477 0.656 . . . . 55.12 111.282 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.0 m -90.97 -20.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 73.14 110.171 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.437 HD13 ' HZ ' ' A' ' 77' ' ' PHE . 61.0 mt -86.08 -17.74 34.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.45 -0.795 . . . . 52.42 110.222 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 49.6 m -81.56 10.66 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 54.13 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -149.5 31.97 0.72 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.291 0.567 . . . . 75.21 109.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.67 -145.58 19.25 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.293 -0.867 . . . . 75.1 112.485 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.5 mp -97.83 123.94 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.106 0.479 . . . . 64.25 110.992 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -88.85 102.2 12.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.699 -0.682 . . . . 70.13 109.905 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 109.02 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 64.11 110.952 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.16 116.87 23.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.998 -0.546 . . . . 71.1 110.196 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -102.96 90.25 3.71 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.851 -0.426 . . . . 72.2 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 63.8 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.465 -0.789 . . . . 73.13 111.787 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -114.19 -22.91 9.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.352 0.596 . . . . 73.52 110.301 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.481 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 5.9 m-20 -91.64 154.14 19.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 72.32 111.712 -173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.22 116.2 29.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.595 -0.73 . . . . 70.02 110.486 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.481 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 16.2 m95 -119.81 151.14 39.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 74.22 109.7 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.94 129.17 66.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.347 0.594 . . . . 75.0 109.724 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.767 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -87.94 114.27 24.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.626 -0.716 . . . . 71.31 110.216 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.4 t -62.42 116.22 21.48 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 71.41 109.867 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD2' HD23 ' A' ' 54' ' ' LEU . 45.8 Cg_endo -69.25 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.491 2.127 . . . . 71.24 112.16 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -112.82 -50.65 2.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 72.35 111.198 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -92.64 -4.61 53.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.485 -0.325 . . . . 75.1 111.447 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 32.2 ttmt 66.09 11.12 7.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.849 -0.614 . . . . 73.22 112.278 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.648 HE22 ' HB2' ' A' ' 89' ' ' ALA . 3.3 pt20 -102.36 150.71 23.07 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.133 -0.355 . . . . 74.05 110.697 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.38 107.31 18.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 74.14 110.189 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.735 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 16.2 p90 -111.29 142.38 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.289 0.566 . . . . 75.42 110.981 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 38.6 ttp180 -85.82 123.56 31.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 72.02 110.315 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.8 mt -50.66 -57.07 9.14 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.821 0.7 . . . . 75.13 112.497 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -87.08 37.08 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.468 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 26.4 t0 -149.92 -50.84 0.14 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.346 . . . . 75.01 110.649 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.93 -25.83 25.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.944 -0.646 . . . . 75.33 113.146 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -85.51 147.74 26.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.774 0.321 . . . . 74.12 110.955 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.2 m -102.04 47.16 0.91 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.992 -0.549 . . . . 62.13 111.749 -171.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.585 ' HG ' ' HG2' ' A' ' 86' ' ' GLU . 49.5 tp 57.41 -95.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 72.42 112.123 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.585 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 6.5 mm-40 -107.23 -27.87 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 74.22 111.386 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 39.0 t70 -111.16 75.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.203 -0.666 . . . . 73.32 109.203 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -89.06 63.55 3.45 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.407 -0.815 . . . . 74.34 113.283 -171.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.648 ' HB2' HE22 ' A' ' 75' ' ' GLN . . . -80.45 -59.03 2.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.893 0.378 . . . . 71.2 110.576 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.424 ' HE2' ' CD ' ' A' ' 47' ' ' PRO . 29.3 m-85 -90.04 74.19 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 65.13 110.323 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 100.3 3.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.497 -0.774 . . . . 62.41 109.638 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.76 167.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 62.2 111.125 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 135.89 51.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 62.12 110.53 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.799 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -96.86 92.33 6.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.935 -0.575 . . . . 45.11 109.578 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -67.2 155.87 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.432 -0.804 . . . . 73.54 110.754 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.66 142.8 29.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.543 -0.54 . . . . 72.0 109.543 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.843 HG23 HG22 ' A' ' 106' ' ' ILE . 26.0 p -134.47 138.08 44.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.404 . . . . 65.53 111.082 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 48.2 mt-30 -104.85 144.13 32.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.864 0.364 . . . . 63.04 110.561 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.1 t -99.6 76.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.206 -1.035 . . . . 74.1 108.206 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.5 p -75.46 -32.58 60.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.27 -0.877 . . . . 65.11 111.789 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 103' ' ' ASN . 7.2 t-20 -164.52 -146.99 0.1 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.145 . . . . 72.41 107.907 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.07 36.81 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 60.1 111.239 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 20.4 p30 -145.74 163.25 35.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.96 0.504 . . . . 74.15 110.092 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 74.23 110.464 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -117.27 117.64 30.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 74.33 110.218 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.843 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.4 152.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.342 -0.39 . . . . 65.51 110.235 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -87.81 125.37 34.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.496 -0.557 . . . . 75.41 109.496 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.07 96.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.092 -0.503 . . . . 44.41 111.029 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.627 0 N-CA-C 108.478 -0.934 . . . . 65.23 108.478 169.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.457 -0.093 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.447 ' HH2' ' OD2' ' A' ' 96' ' ' ASP . 73.9 m95 -59.81 117.22 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.71 -1.132 . . . . 63.24 110.393 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -89.61 131.83 35.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.121 -0.491 . . . . 74.54 110.192 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.1 m -74.47 118.9 17.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 62.42 110.48 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.98 -70.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.091 -0.504 . . . . 70.43 111.064 -177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -161.29 -177.33 5.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.666 . . . . 74.43 109.212 -174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -86.65 143.89 27.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.557 0.218 . . . . 74.1 110.592 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -67.28 -12.71 60.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.561 0.696 . . . . 74.35 110.139 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.09 -17.02 53.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.998 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.96 -9.08 16.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.31 0.576 . . . . 63.34 110.471 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -75.59 126.9 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.541 . . . . 71.12 110.686 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.8 mt -70.14 137.48 86.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 72.5 111.604 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -79.46 127.78 7.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.241 2.627 . . . . 71.42 112.639 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.84 23.77 44.53 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.932 -0.576 . . . . 71.01 112.573 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.35 167.34 29.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.064 0.432 . . . . 75.21 111.624 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -127.56 142.1 13.21 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.333 -0.707 . . . . 43.24 111.333 177.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.488 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 21.3 m -127.41 139.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.049 0.425 . . . . 72.23 111.821 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 7.4 p -70.64 99.0 1.59 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 64.53 110.479 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 132.04 34.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.112 -0.495 . . . . 71.53 110.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -86.99 100.47 12.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.377 -0.601 . . . . 72.22 109.377 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 106' ' ' ILE . 34.3 t -120.76 112.79 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.823 -0.626 . . . . 72.54 110.103 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 31.1 mt-10 61.78 19.41 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.269 0.557 . . . . 74.44 111.892 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 73.8 mm-40 81.47 19.72 0.39 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.176 -1.375 . . . . 73.34 111.27 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -113.47 137.99 50.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.845 -0.798 . . . . 62.42 108.845 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -99.33 108.88 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 74.14 111.151 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.53 130.5 64.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.735 -0.666 . . . . 71.1 109.298 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 113.63 21.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 74.03 110.192 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.551 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 29.1 t -95.77 102.34 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.093 -0.503 . . . . 72.33 110.307 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.81 128.51 33.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.639 -0.709 . . . . 71.52 110.077 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 70.6 ttt180 -112.8 84.21 6.48 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.874 -0.788 . . . . 75.43 108.874 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.21 -31.75 53.14 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.672 2.248 . . . . 73.2 112.108 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.619 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 99.9 mtt180 -109.39 164.47 12.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.754 -0.657 . . . . 73.44 109.997 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -91.59 10.3 28.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.093 0.949 . . . . 74.4 108.647 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.25 -109.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.657 -1.156 . . . . 72.4 112.008 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.25 -67.06 1.02 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.455 0.539 . . . . 74.51 112.455 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.15 131.27 50.3 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.078 0.77 . . . . 71.31 113.078 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.4 m -124.74 169.18 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.872 -1.058 . . . . 72.11 109.861 175.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -137.8 104.4 5.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.565 -0.289 . . . . 74.42 111.298 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -97.14 108.28 20.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.153 0.501 . . . . 61.14 110.928 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.579 HD11 HG22 ' A' ' 92' ' ' VAL . 34.4 pt -129.34 161.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.667 -0.697 . . . . 74.22 109.625 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.2 m -74.56 75.75 1.98 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.478 . . . . 74.11 111.096 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.504 HD21 HG13 ' A' ' 92' ' ' VAL . 26.8 t-20 -110.49 72.71 0.8 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.69 0.757 . . . . 75.33 109.487 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -127.82 133.16 68.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.268 -0.878 . . . . 74.45 109.829 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.04 125.8 63.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.769 -0.456 . . . . 64.31 109.769 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.94 -11.08 25.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.2 2.6 . . . . 65.21 113.392 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -87.64 -16.22 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.002 -0.279 . . . . 71.21 111.0 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.47 -26.67 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.283 0.475 . . . . 71.11 112.283 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.53 34.84 17.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 71.14 111.153 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -143.9 169.81 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 54.32 109.263 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 13.6 p -80.81 51.09 1.46 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.248 0.547 . . . . 72.25 110.973 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -18.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 75.13 110.196 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.448 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 72.5 mt -83.74 -17.07 42.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.345 -0.843 . . . . 74.53 109.745 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 m -89.96 -13.21 36.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.751 . . . . 75.13 111.6 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -104.96 30.32 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 71.53 111.339 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -94.66 -129.25 5.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.485 -0.864 . . . . 64.14 111.974 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.74 108.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.071 0.462 . . . . 75.24 110.215 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 108.53 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.502 -0.772 . . . . 50.04 110.073 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.85 166.01 27.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 64.13 111.569 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.95 120.94 33.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.525 -0.761 . . . . 73.3 109.718 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.603 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 63.7 t-80 -62.43 -76.88 0.05 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.728 -0.669 . . . . 70.11 110.024 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -130.97 -44.95 1.04 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.412 -0.813 . . . . 55.31 108.93 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -132.36 -21.45 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.275 -0.875 . . . . 72.24 110.574 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.52 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 1.6 t70 -109.92 175.15 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 72.22 111.203 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.76 124.57 49.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 50.32 110.359 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.603 ' CD1' ' HB2' ' A' ' 62' ' ' HIS . 40.1 m95 -124.63 143.84 50.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.164 -0.471 . . . . 73.44 110.594 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.43 117.44 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.617 0.722 . . . . 73.13 110.118 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -90.69 116.2 28.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.797 -0.638 . . . . 73.12 110.17 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -60.09 136.59 91.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.492 -0.322 . . . . 72.01 110.653 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.01 -31.53 55.39 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.695 2.263 . . . . 74.32 112.765 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.89 -56.83 2.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.595 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -90.93 -13.81 32.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 74.22 111.671 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 mttm 64.02 8.56 4.04 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.161 0.8 . . . . 74.23 113.161 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.52 127.12 30.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.094 -0.706 . . . . 72.35 109.094 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.725 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 41.9 m80 -90.87 99.45 12.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.037 -0.528 . . . . 75.23 110.371 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -84.71 120.45 26.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.933 0.397 . . . . 70.12 110.158 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 61.4 ttt180 -78.71 121.28 24.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.986 -0.552 . . . . 72.55 109.805 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.63 -36.22 78.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -80.29 -20.09 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.404 -0.362 . . . . 72.15 111.575 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 10.0 t70 -115.15 -74.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.023 -0.271 . . . . 73.51 111.586 -170.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 92' ' ' VAL . . . 140.36 -27.12 2.53 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.802 -0.713 . . . . 75.32 112.124 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -63.31 151.68 40.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.178 0.514 . . . . 74.12 111.258 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 4.4 m -103.39 50.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.63 -0.714 . . . . 75.33 110.643 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.725 ' HB2' ' HB2' ' A' ' 76' ' ' HIS . 38.6 tp 66.74 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.954 0.502 . . . . 74.11 111.363 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 36.6 mt-10 -109.08 -4.57 16.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 73.23 110.341 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.82 160.03 20.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.555 . . . . 72.53 110.917 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.39 27.67 2.49 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.978 -0.849 . . . . 75.3 110.978 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.3 42.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 54.22 110.745 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -117.27 62.39 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.11 -0.496 . . . . 74.53 110.299 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 2.5 p -65.88 107.19 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 75.3 109.784 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.645 HG21 ' HA2' ' A' ' 82' ' ' GLY . 28.0 m -68.01 136.78 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 75.01 111.295 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.59 106.42 4.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.006 -0.543 . . . . 52.32 109.907 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.547 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -79.26 88.21 4.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.796 -0.638 . . . . 73.41 110.854 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -80.19 175.92 10.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.755 . . . . 74.44 109.811 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 20.0 t70 -114.32 147.29 39.33 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.992 -0.373 . . . . 73.21 109.992 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 HG23 ' A' ' 106' ' ' ILE . 1.3 m -129.0 157.16 42.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.62 -0.718 . . . . 75.25 109.606 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -153.34 143.26 22.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 74.2 111.112 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.86 98.27 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.39 -0.823 . . . . 73.15 108.783 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.413 HG23 HD21 ' A' ' 101' ' ' ASN . 7.4 t -94.3 -34.58 12.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.54 0.571 . . . . 71.35 112.54 -170.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.413 HD21 HG23 ' A' ' 100' ' ' THR . 61.3 m-80 -136.99 31.61 2.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.047 0.451 . . . . 37.42 110.599 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.62 -11.91 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 62.15 111.387 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.89 150.65 22.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.536 . . . . 74.35 110.127 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -97.12 120.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.305 -0.861 . . . . 75.32 111.05 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -115.59 142.33 46.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.101 -0.333 . . . . 74.01 110.101 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.645 HD11 HG13 ' A' ' 23' ' ' VAL . 2.8 pp -122.13 154.48 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.459 . . . . 75.33 110.633 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 t -113.38 102.01 9.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.778 -0.453 . . . . 55.31 109.778 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.503 HG23 HD12 ' A' ' 106' ' ' ILE . 16.4 pt -109.04 110.96 34.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.187 -0.461 . . . . 74.43 111.124 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.66 0.743 . . . . 71.33 110.485 175.911 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.176 0.513 . . . . 73.31 111.398 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -81.19 112.11 18.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.811 -0.631 . . . . 74.43 110.072 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 106' ' ' ILE . 6.0 m -95.93 126.72 41.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.679 . . . . 74.44 110.184 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 27.4 m -73.61 132.26 42.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.894 0.378 . . . . 72.43 110.994 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.14 -67.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.562 . . . . 74.3 109.514 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -169.92 -167.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 62.52 108.991 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.92 154.49 33.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.732 -0.213 . . . . 74.44 110.471 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 37' ' ' GLU . 56.9 tp -75.41 -27.07 58.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.37 -32.07 69.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.13 -1.395 . . . . 72.45 110.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.12 -14.27 59.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.422 -0.808 . . . . 74.41 110.186 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.0 mt -93.08 116.34 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 75.32 110.236 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.63 128.84 93.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 70.43 111.45 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.26 124.16 12.16 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.857 2.371 . . . . 65.23 112.16 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.62 28.62 8.28 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.814 -0.63 . . . . 52.41 112.141 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.27 170.46 17.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.608 0.242 . . . . 72.04 111.41 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -138.11 144.69 16.0 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.218 -0.753 . . . . 72.11 111.218 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.07 145.91 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.205 0.503 . . . . 71.32 112.18 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.2 p -86.79 133.08 33.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.101 -0.5 . . . . 72.21 111.213 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.38 125.9 41.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.092 -0.503 . . . . 71.43 110.419 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.97 99.9 2.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.773 -0.825 . . . . 72.52 108.773 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 106' ' ' ILE . 46.0 t -109.52 103.08 14.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 73.13 110.738 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 70.26 -53.72 0.64 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.285 -0.87 . . . . 75.11 112.771 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.6 -50.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.603 0.594 . . . . 74.42 112.603 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.576 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 27.8 mt-30 -109.39 167.38 10.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.743 0.306 . . . . 74.14 110.84 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -95.49 127.04 41.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.906 -0.588 . . . . 62.2 109.832 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.86 134.53 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.367 -0.605 . . . . 75.03 109.367 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -94.14 122.04 36.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.665 -0.494 . . . . 74.42 109.665 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.412 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 26.1 t -105.41 104.36 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.082 0.468 . . . . 70.45 110.18 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.667 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 79.5 m-85 -79.91 134.68 36.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.396 -0.82 . . . . 71.24 111.342 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -119.71 82.12 26.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.871 -1.159 . . . . 72.22 107.871 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.92 -25.63 19.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.649 2.233 . . . . 63.43 112.791 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 34' ' ' ARG . 61.8 mtt180 -111.57 167.72 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.684 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -84.5 2.88 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.153 0.501 . . . . 73.24 110.212 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 19.3 t70 -98.68 -150.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.894 -0.594 . . . . 54.21 110.041 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.56 ' HA ' HD22 ' A' ' 10' ' ' LEU . 40.7 mt-10 -105.83 21.62 16.97 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.892 0.701 . . . . 65.43 112.892 -169.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.4 123.21 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.593 -0.443 . . . . 70.31 110.337 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.45 167.3 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.983 -0.553 . . . . 75.43 110.967 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.667 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 78.3 m-85 -138.95 105.57 5.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 73.51 110.107 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.1 101.93 12.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.062 0.458 . . . . 63.22 110.651 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 94' ' ' ALA . 38.7 pt -131.63 173.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.979 -0.555 . . . . 72.14 110.352 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.483 ' HG ' ' HB ' ' A' ' 92' ' ' VAL . 89.9 p -83.09 67.82 9.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.347 0.594 . . . . 72.12 109.69 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.551 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.9 t-20 -98.27 35.96 1.68 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.228 1.013 . . . . 71.3 109.517 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 20' ' ' CYS . 35.6 mm -107.01 109.14 27.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 75.4 110.483 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.71 115.95 42.94 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.129 -0.693 . . . . 64.41 109.129 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD2' ' OH ' ' A' ' 90' ' ' TYR . 47.5 Cg_exo -57.51 -17.19 26.75 Favored 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.358 2.705 . . . . 71.44 113.445 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.09 -15.53 59.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 74.05 110.553 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.92 -29.89 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 61.34 111.645 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.68 37.99 12.34 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.328 0.585 . . . . 63.34 111.663 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.26 170.52 21.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.318 -0.856 . . . . 75.12 108.868 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 73.4 m -77.02 61.84 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.436 0.636 . . . . 74.31 110.895 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -80.42 -22.36 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.59 -0.732 . . . . 64.51 110.373 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.635 HD21 ' HG ' ' A' ' 70' ' ' SER . 32.2 mt -81.06 -20.01 42.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.245 -0.65 . . . . 65.24 109.245 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 11.2 m -79.82 -15.6 57.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.225 -0.898 . . . . 75.44 110.904 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 18.71 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 71.11 109.759 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.78 -156.67 20.99 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.877 -0.678 . . . . 62.2 112.379 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 57.7 mt -100.01 125.09 53.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.875 0.369 . . . . 71.23 110.413 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.49 101.14 2.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.264 0.554 . . . . 72.42 109.83 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.56 95.37 5.7 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.536 -0.756 . . . . 54.01 109.616 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.48 137.71 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.784 -0.644 . . . . 74.51 110.244 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 41.1 t-80 -79.17 -169.93 2.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.647 -0.706 . . . . 73.34 109.288 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.521 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -54.99 -37.73 66.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.778 -0.823 . . . . 73.42 108.778 175.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.19 60.62 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.253 -0.885 . . . . 72.41 109.888 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.605 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 1.5 t70 -156.52 173.29 17.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 63.55 109.674 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 79' ' ' LEU . 96.7 mt -119.16 118.11 30.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.554 0.216 . . . . 74.11 111.36 -171.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 39.5 m95 -136.25 125.52 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.817 -0.438 . . . . 74.3 109.817 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.87 130.64 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.974 0.416 . . . . 75.43 110.589 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -85.0 114.96 22.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.093 -0.503 . . . . 54.33 111.148 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.751 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . 29.1 t -62.08 126.8 88.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.563 -0.744 . . . . 72.33 111.086 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.2 -4.18 14.52 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.419 2.079 . . . . 73.23 112.079 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.7 mt -109.74 -55.93 2.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.119 -0.491 . . . . 75.14 111.207 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 48.3 mmtm -91.55 -16.26 27.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.951 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 54.76 70.01 0.67 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.68 0.753 . . . . 72.11 111.214 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -141.32 152.04 44.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.211 -0.904 . . . . 72.55 109.091 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 74.2 m80 -93.97 100.43 12.57 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.236 0.335 . . . . 75.02 110.162 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.751 ' HE2' ' HB2' ' A' ' 70' ' ' SER . 96.9 m-85 -85.88 124.53 32.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.221 -0.445 . . . . 75.2 110.487 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 81' ' ' ASP . 33.4 ttt180 -73.81 122.58 22.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.657 -0.497 . . . . 71.54 109.657 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 66' ' ' LEU . 3.3 mm? -70.57 1.47 5.15 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.908 1.077 . . . . 71.33 113.908 -168.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HH ' ' CG ' ' A' ' 65' ' ' ASP . 39.9 p90 -153.65 28.29 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.711 -0.396 . . . . 74.44 111.412 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 7.9 t70 -145.3 -71.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.026 -0.27 . . . . 71.51 111.327 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.82 -20.3 3.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.201 -0.999 . . . . 73.24 113.287 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.51 157.21 37.59 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.123 0.461 . . . . 72.42 111.569 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 8.8 m -109.87 20.88 17.53 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.415 -0.811 . . . . 75.21 110.516 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.7 tp 69.68 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.34 -0.845 . . . . 75.1 111.774 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.69 -63.02 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.725 0.298 . . . . 65.13 111.388 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.57 92.31 6.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.853 -0.425 . . . . 70.23 109.853 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.93 74.1 2.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.656 -0.783 . . . . 73.33 112.441 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.58 -1.13 13.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.617 0.246 . . . . 54.32 111.504 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.582 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -134.1 50.84 2.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 70.32 110.24 -176.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 m -64.75 116.63 6.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.818 -0.628 . . . . 75.31 111.546 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.483 ' HB ' ' HG ' ' A' ' 43' ' ' SER . 33.3 m -102.87 168.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.52 . . . . 70.41 110.565 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.26 154.82 18.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 73.05 111.218 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -121.95 109.1 14.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.971 -0.559 . . . . 74.2 109.495 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -84.96 -177.79 6.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 70.01 110.718 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.58 137.17 51.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.407 -0.59 . . . . 75.4 109.407 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.713 HG23 HG23 ' A' ' 106' ' ' ILE . 3.2 m -134.5 161.26 35.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.709 0.29 . . . . 73.12 111.005 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -138.56 153.21 48.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.237 0.542 . . . . 72.42 110.635 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.19 123.52 60.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 64.12 107.927 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 101' ' ' ASN . 3.7 t -131.59 -63.51 0.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.966 0.728 . . . . 74.44 112.966 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.527 ' H ' HG23 ' A' ' 100' ' ' THR . 92.0 m-20 -101.41 28.21 5.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.098 0.475 . . . . 75.41 110.774 -174.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.96 3.22 85.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.662 -0.78 . . . . 72.15 111.2 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -113.31 158.33 20.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.32 109.797 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.92 122.75 65.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.013 -0.54 . . . . 70.13 110.545 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 16.5 mt-30 -127.02 136.19 51.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.643 -0.503 . . . . 74.43 109.643 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.713 HG23 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.39 153.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.079 0.466 . . . . 62.23 110.686 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -103.57 96.79 6.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.164 -0.68 . . . . 71.05 109.164 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.5 pt -112.12 78.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 72.14 110.735 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 121.951 0.881 . . . . 74.34 109.921 178.31 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.991 0.901 . . . . 73.24 108.6 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -117.07 117.46 29.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.28 -1.327 . . . . 75.41 109.402 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -88.54 138.13 31.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 73.22 109.619 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 13.4 m -79.59 122.79 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.031 -0.532 . . . . 73.01 110.858 -174.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.3 t -85.6 -81.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.974 0.416 . . . . 74.01 110.707 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.6 m -155.43 -178.75 7.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 71.52 109.411 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -71.14 147.6 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 72.33 110.667 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 tp -66.48 -27.12 67.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.677 -0.692 . . . . 75.32 110.943 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -98.05 -8.05 28.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.685 . . . . 72.1 110.715 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 -29.72 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.864 -0.791 . . . . 74.33 108.864 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.45 127.22 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.77 -1.104 . . . . 63.14 109.97 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.56 144.98 30.39 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.288 -0.415 . . . . 74.41 111.176 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 Cg_exo -58.55 147.94 84.0 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.56 . . . . 75.42 112.389 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.71 26.34 56.58 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.002 -0.618 . . . . 72.11 111.854 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.62 HG21 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -141.22 178.55 7.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.135 -0.32 . . . . 74.31 110.135 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.62 ' H ' HG21 ' A' ' 17' ' ' THR . . . 175.25 105.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.839 -0.696 . . . . 60.22 111.865 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.09 170.77 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.691 0.281 . . . . 75.42 111.116 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.639 ' HB3' HD12 ' A' ' 45' ' ' ILE . 8.0 p -83.05 134.33 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 74.35 111.557 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.94 143.51 42.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 74.11 109.651 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.43 100.06 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.689 -0.486 . . . . 73.04 109.689 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' A' ' 28' ' ' ILE . 21.7 t -101.31 81.3 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.092 -0.503 . . . . 63.44 109.938 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.77 -74.91 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.134 -0.939 . . . . 72.41 112.223 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -116.82 -35.43 4.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.597 0.237 . . . . 74.14 111.524 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -103.84 153.78 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.068 0.461 . . . . 73.4 111.833 -174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.88 116.94 29.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.636 -0.711 . . . . 63.34 109.095 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mp -112.93 127.93 69.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -86.44 131.01 34.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.206 -0.452 . . . . 71.32 109.837 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.8 t -110.0 97.29 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.02 0.438 . . . . 72.02 110.042 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.815 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 89.7 m-85 -72.71 141.32 48.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.492 -0.776 . . . . 72.3 110.741 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.661 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 6.4 tpt180 -132.69 59.39 42.87 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.878 -0.601 . . . . 73.12 110.495 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 6.2 Cg_exo -79.39 -22.31 8.25 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.491 2.127 . . . . 72.43 111.011 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -82.06 150.74 27.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.986 -1.006 . . . . 73.25 109.81 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -75.49 77.13 2.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.095 0.474 . . . . 71.43 109.888 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.624 ' HA ' ' HE ' ' A' ' 32' ' ' ARG . 41.1 t0 63.16 179.6 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.753 -1.112 . . . . 70.32 111.409 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 36.1 mt-10 66.46 -22.91 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.746 1.218 . . . . 74.1 114.006 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 36' ' ' ASP . 30.2 tp60 -134.62 114.14 12.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.02 0.438 . . . . 75.1 110.364 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.582 HG13 ' HD3' ' A' ' 32' ' ' ARG . 27.1 m -110.99 163.37 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.898 -0.592 . . . . 72.31 110.507 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.815 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 73.2 m-85 -127.28 86.69 2.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.132 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -91.15 98.35 11.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 94' ' ' ALA . 41.0 pt -131.95 175.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 72.21 111.118 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 15.1 m -83.94 75.46 10.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.178 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -130.8 85.88 2.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.461 0.648 . . . . 74.42 110.08 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.2 mm -120.42 -124.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.782 -0.822 . . . . 55.5 108.782 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.512 ' HB3' HG23 ' A' ' 53' ' ' VAL . 4.1 p30 -175.35 141.61 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.296 -1.001 . . . . 63.52 108.296 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -94.7 30.22 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.352 2.035 . . . . 74.53 112.802 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -117.56 -48.06 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 71.42 110.417 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.44 6.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.279 -0.418 . . . . 64.55 111.472 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 58.44 61.82 2.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.559 0.537 . . . . 71.24 111.167 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.69 16.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.583 0.216 . . . . 75.12 111.583 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 72.4 m 61.74 57.98 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.461 0.648 . . . . 62.45 110.8 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 46' ' ' ASP . 19.7 m -73.68 -9.67 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 71.5 110.309 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 94.3 mt -87.59 -9.69 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.468 -0.787 . . . . 70.31 110.25 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 5.1 m -103.03 -43.83 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.303 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -81.08 50.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 75.44 111.86 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.42 -115.52 2.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.491 -0.861 . . . . 53.41 112.92 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 83.2 mt -108.19 120.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.003 0.43 . . . . 74.2 110.853 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -85.34 96.58 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.35 -0.611 . . . . 75.32 109.35 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.18 118.14 35.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.153 0.501 . . . . 71.24 111.204 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -92.84 121.44 34.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.311 -0.626 . . . . 74.43 109.311 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -117.5 102.97 9.63 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.781 -0.451 . . . . 72.24 109.781 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.12 -81.95 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.352 -0.84 . . . . 73.52 111.222 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -124.39 -30.2 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.903 0.383 . . . . 75.53 110.72 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.66 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 35.1 m-20 -85.21 161.02 19.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.301 0.572 . . . . 74.4 111.206 -172.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 33' ' ' PRO . 94.6 mt -108.32 112.9 25.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.443 -0.799 . . . . 65.31 109.642 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.66 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 30.5 m95 -110.66 107.82 17.53 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.466 HG23 ' HE2' ' A' ' 31' ' ' PHE . 14.4 p -78.1 133.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.699 -0.482 . . . . 74.13 109.699 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 75' ' ' GLN . . . -118.91 134.02 55.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.434 . . . . 74.03 110.532 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.638 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 1.2 p -74.86 145.14 80.96 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.176 -0.465 . . . . 70.55 110.338 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.86 -53.14 5.42 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.965 2.443 . . . . 72.03 113.214 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.97 -47.08 7.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 73.14 111.518 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 71.4 mmtt -65.71 -33.46 75.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.343 -0.39 . . . . 75.3 110.77 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 60.82 28.96 18.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.685 -0.688 . . . . 55.05 111.022 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 79.0 mt-30 -91.86 137.12 32.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.645 -0.707 . . . . 70.22 110.563 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.527 ' H ' ' CG ' ' A' ' 87' ' ' ASP . 26.5 m80 -101.91 126.11 48.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.658 -0.701 . . . . 61.24 110.885 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.15 125.09 45.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.486 -0.324 . . . . 75.34 110.158 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.55 111.22 8.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.048 0.451 . . . . 75.3 110.446 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.94 82.8 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.746 . . . . 74.11 110.784 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -172.52 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.442 -0.799 . . . . 74.03 108.944 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -121.98 -11.82 8.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.51 -0.768 . . . . 73.25 110.726 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.59 59.29 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.94 -0.648 . . . . 74.42 112.341 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -62.68 123.13 17.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 74.11 111.157 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.4 145.59 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.797 -0.816 . . . . 74.4 108.797 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.87 -62.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.369 -0.604 . . . . 75.43 109.369 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.66 13.99 1.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.913 -1.143 . . . . 75.22 107.913 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 76' ' ' HIS . 1.1 m-20 -95.38 31.29 2.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.619 -1.628 . . . . 74.5 110.892 -167.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.15 44.37 2.38 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.014 -0.612 . . . . 75.03 113.117 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.42 -21.62 27.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.268 0.556 . . . . 71.25 110.08 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.64 91.34 3.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.49 -0.777 . . . . 75.13 109.057 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -61.16 100.89 0.13 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.51 -0.768 . . . . 71.34 111.593 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.1 m -122.13 161.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 75.15 110.286 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.84 173.17 11.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 70.22 110.349 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.575 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -101.92 -158.84 0.7 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.984 0.421 . . . . 72.04 109.987 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -157.24 169.88 23.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.105 -0.952 . . . . 73.51 109.839 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.68 126.7 35.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.989 -0.745 . . . . 71.14 108.989 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.581 HG23 HG23 ' A' ' 106' ' ' ILE . 80.6 p -128.75 131.98 47.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.568 0.223 . . . . 74.43 110.953 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 141.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 71.4 110.253 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.4 92.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.711 -0.677 . . . . 62.23 109.812 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.46 83.57 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.616 -0.72 . . . . 62.43 111.375 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 71.06 -82.4 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.181 -0.918 . . . . 54.13 111.831 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 8.17 7.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.802 -0.713 . . . . 63.42 112.931 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -138.53 152.07 47.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.973 0.387 . . . . 71.34 110.46 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.0 t -107.21 131.91 56.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.274 -0.421 . . . . 75.4 110.807 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 68.0 mt-30 -127.51 128.23 45.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.939 -0.393 . . . . 73.23 109.939 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.581 HG23 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -117.32 156.16 18.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 73.04 110.985 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -98.14 106.76 19.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.345 -0.613 . . . . 71.02 109.345 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 pt -80.6 142.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.037 0.446 . . . . 65.44 110.962 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.965 -0.562 . . . . 62.21 110.936 -177.015 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 107' ' ' SER . 14.2 mm100 . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 108.411 -0.959 . . . . 74.13 108.411 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 84.0 m95 -86.31 110.69 19.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.915 -1.493 . . . . 75.23 109.482 175.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.692 HG23 HG12 ' A' ' 23' ' ' VAL . 19.1 m -100.22 136.79 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.618 -0.512 . . . . 73.04 109.618 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.736 HG21 ' H ' ' A' ' 8' ' ' CYS . 8.5 m -81.12 126.67 31.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.975 0.417 . . . . 75.14 111.974 -173.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.71 -1.2 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.6 0.714 . . . . 64.11 109.476 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.736 ' H ' HG21 ' A' ' 6' ' ' THR . 61.1 m 87.49 -60.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.566 -1.197 . . . . 62.33 111.581 169.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.843 ' HE3' ' HB2' ' A' ' 12' ' ' ASP . 44.1 mtmt -145.34 146.41 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.974 0.416 . . . . 64.55 111.893 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.449 HD23 ' OE1' ' A' ' 37' ' ' GLU . 35.6 tp -84.12 -25.92 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.717 -1.216 . . . . 74.54 107.717 165.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -60.61 -39.37 87.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.168 -1.378 . . . . 71.43 111.349 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.843 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -77.67 -10.16 59.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 72.0 110.175 -176.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.4 mt -93.78 113.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.839 -0.619 . . . . 71.43 109.782 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.5 mt -69.7 139.16 88.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.316 -0.402 . . . . 73.5 111.381 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 16.5 Cg_exo -68.2 128.17 17.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.096 2.531 . . . . 72.13 112.178 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.07 19.33 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.949 -0.569 . . . . 72.3 112.19 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 172.47 16.86 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.816 0.308 . . . . 72.12 111.41 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.16 138.01 5.05 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.734 -0.546 . . . . 72.04 111.734 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.09 167.59 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.937 0.368 . . . . 71.03 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.72 ' HB3' HD13 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.79 109.42 11.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.979 0.419 . . . . 71.1 111.401 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.34 106.84 6.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.831 -0.622 . . . . 74.15 109.342 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.13 105.48 9.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.07 -0.514 . . . . 75.13 109.709 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.692 HG12 HG23 ' A' ' 5' ' ' THR . 48.5 t -118.6 92.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.759 -0.655 . . . . 63.12 110.016 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 61.64 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.578 -0.737 . . . . 70.43 112.035 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -118.82 -2.14 10.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.807 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -109.29 139.45 44.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.399 -0.364 . . . . 75.11 111.222 -174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -128.92 113.16 14.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.934 -0.576 . . . . 75.14 109.805 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.509 ' HA ' HD11 ' A' ' 45' ' ' ILE . 1.4 pp -132.71 142.82 41.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.935 0.398 . . . . 73.42 110.588 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.49 120.79 28.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 65.2 109.94 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.26 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 64.24 110.619 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.594 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 55.7 m-85 -72.45 134.62 45.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.623 -0.717 . . . . 75.45 111.156 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -120.43 81.53 31.01 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 165.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.01 -32.54 53.55 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.848 2.366 . . . . 74.4 112.733 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.92 -166.71 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 74.13 111.459 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -79.98 -18.88 49.2 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.202 0.816 . . . . 74.34 113.202 -165.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.456 ' OD2' ' HG2' ' A' ' 38' ' ' GLN . 11.5 p-10 -110.81 -165.69 1.01 Allowed 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.335 0.495 . . . . 45.4 112.335 -168.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' OE1' HD23 ' A' ' 10' ' ' LEU . 6.5 mm-40 -69.52 6.62 1.03 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.152 0.797 . . . . 74.23 113.152 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 15.8 mm100 -74.42 83.27 1.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 70.13 110.757 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.441 HG23 HG21 ' A' ' 97' ' ' THR . 20.6 m -108.79 159.53 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.885 -0.598 . . . . 72.05 110.79 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.594 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 94.7 m-85 -135.67 109.16 7.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.464 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.87 95.78 7.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 71.22 110.623 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 44' ' ' ASN . 37.7 pt -121.85 168.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.016 -0.538 . . . . 63.14 111.255 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -78.87 48.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.4 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.513 ' HB2' HG13 ' A' ' 42' ' ' ILE . 53.9 t30 -98.35 46.42 1.0 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.357 0.599 . . . . 72.15 110.242 -173.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.72 HD13 ' HB3' ' A' ' 20' ' ' CYS . 10.9 mm -83.52 -23.5 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.551 -0.749 . . . . 71.43 111.098 -175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.848 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 7.5 t70 68.6 123.05 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 O-C-N 124.367 1.042 . . . . 72.34 111.631 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.6 Cg_endo -80.99 18.86 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.17 2.58 . . . . 75.24 112.951 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 85.0 t80 -111.28 -36.04 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.636 -0.256 . . . . 72.44 111.094 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.42 -20.98 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.108 0.41 . . . . 72.55 112.108 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 64.84 19.18 11.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.387 0.514 . . . . 74.13 112.387 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.55 22.98 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.889 0.329 . . . . 72.32 111.889 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 38.2 m 58.62 39.62 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.279 0.561 . . . . 62.32 110.785 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.54 -18.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 74.53 111.275 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.848 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 59.0 mt -75.11 -18.06 60.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 74.4 110.11 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -86.78 1.23 52.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.073 -0.512 . . . . 72.14 110.536 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -102.13 11.75 37.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.946 -0.761 . . . . 61.02 108.946 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.96 -151.31 12.08 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.353 -0.84 . . . . 71.5 112.825 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 3.7 mp -97.44 129.82 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 64.25 110.898 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.95 99.1 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.917 -0.772 . . . . 72.33 108.917 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.5 97.93 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.611 . . . . 75.02 110.843 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.52 110.93 19.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 74.12 109.49 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -89.89 92.24 8.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.534 -0.543 . . . . 61.12 109.534 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 66.52 -74.86 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.706 -0.679 . . . . 73.24 111.145 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -126.99 -24.86 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.828 -0.624 . . . . 65.24 110.185 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -81.4 165.41 21.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 73.21 110.556 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.5 mt -123.75 108.69 12.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.208 0.528 . . . . 73.14 111.12 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 37.0 m95 -117.56 144.49 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 74.4 109.88 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 7.1 p -102.12 125.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.158 0.504 . . . . 73.3 109.79 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.607 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -84.55 109.46 17.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.974 -0.557 . . . . 75.41 109.82 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.553 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 46.5 t -60.86 122.82 71.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.784 -0.643 . . . . 75.13 110.846 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 61.1 Cg_endo -73.34 -8.6 22.1 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.442 2.095 . . . . 65.21 112.138 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.22 -49.37 2.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 74.42 111.219 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB3' ' HG2' ' A' ' 75' ' ' GLN . 29.6 mmtm -94.85 -6.62 42.35 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.197 0.443 . . . . 75.33 112.197 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 73.47 -35.89 0.33 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.241 0.616 . . . . 74.13 112.65 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.554 ' OE1' ' HB3' ' A' ' 87' ' ' ASP . 21.0 pt20 -59.29 159.14 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.626 0.727 . . . . 71.25 112.604 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 80.6 m80 -99.21 123.55 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.946 -1.024 . . . . 71.11 110.66 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 81.1 m-85 -99.12 124.67 44.32 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.755 -0.831 . . . . 72.53 108.755 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 10.3 ttp180 -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.28 -0.568 . . . . 73.44 109.508 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.69 -52.75 63.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.637 -0.71 . . . . 75.03 112.728 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.73 32.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 75.25 110.591 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 11.4 t70 -145.23 -56.79 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.324 -0.398 . . . . 73.4 111.322 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.23 -32.09 6.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.631 -0.795 . . . . 51.53 113.109 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -78.42 166.91 22.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.195 0.521 . . . . 72.33 111.335 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 20.2 m -106.03 159.5 16.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.56 -0.745 . . . . 74.24 110.487 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 63.3 tp -83.56 -65.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 62.32 111.72 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.34 -11.22 35.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.331 -0.395 . . . . 72.33 111.711 -174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.554 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 9.2 t70 -135.64 -161.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.059 -0.719 . . . . 75.22 109.059 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . 173.56 27.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.387 -0.911 . . . . 60.15 113.075 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 3.0 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.726 0.298 . . . . 54.41 111.432 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.86 -78.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.18 -0.208 . . . . 64.14 111.331 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 m 66.55 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.839 0.712 . . . . 73.03 110.949 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.51 164.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 72.34 111.313 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 167.24 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 72.34 109.696 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -141.61 120.09 12.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.369 . . . . 64.42 110.065 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.44 148.44 24.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.812 -0.631 . . . . 74.43 111.171 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.624 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 m-20 -66.72 140.64 57.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 65.21 109.917 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.655 HG23 HG22 ' A' ' 106' ' ' ILE . 12.1 p -116.7 124.89 50.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.879 0.371 . . . . 74.12 110.637 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -106.4 139.43 40.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.404 0.621 . . . . 64.35 110.936 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.68 97.9 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.602 -1.181 . . . . 74.23 108.661 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' HE21 ' A' ' 105' ' ' GLN . 13.3 t -86.71 -17.05 34.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.117 -0.492 . . . . 71.03 111.645 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.41 -77.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.042 -0.725 . . . . 72.12 109.042 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.22 24.03 1.4 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.316 -1.514 . . . . 73.54 109.316 173.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -135.49 153.69 51.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.953 -1.124 . . . . 75.02 108.35 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.08 139.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 121.098 -0.241 . . . . 75.14 111.043 -171.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 36.0 mt-30 -129.69 131.93 46.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.932 -0.396 . . . . 71.44 109.932 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.655 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.34 144.5 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 71.11 110.85 178.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 49.7 m -78.47 106.82 10.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 63.41 110.208 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 pp -80.52 143.83 11.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.915 0.388 . . . . 75.54 110.409 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.439 0.637 . . . . 62.11 110.275 -179.654 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.569 0.223 . . . . 72.34 111.305 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -81.44 114.59 20.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.927 0.394 . . . . 72.34 110.225 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -122.98 136.17 54.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 75.04 110.638 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 m -81.99 137.55 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.354 . . . . 74.13 110.262 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.45 HG12 ' HB1' ' A' ' 21' ' ' ALA . 25.7 t -99.61 -75.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.099 0.475 . . . . 52.51 110.008 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.87 -173.39 4.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.81 -0.632 . . . . 73.31 109.495 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -70.05 139.75 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 63.11 110.709 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.9 tt -83.65 -27.5 29.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.122 -1.066 . . . . 72.12 108.122 171.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -67.5 -25.32 65.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.526 -1.216 . . . . 71.41 110.563 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.9 -5.72 56.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 52.33 110.23 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 10' ' ' LEU . 71.2 mt -78.58 129.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 74.24 109.822 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mt -74.37 138.8 74.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.105 -0.498 . . . . 75.22 111.584 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 14.3 Cg_exo -69.35 123.62 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.878 2.385 . . . . 73.32 111.88 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.19 28.18 10.12 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.773 -0.649 . . . . 74.34 112.601 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.6 p -139.18 -178.81 5.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 117.207 0.503 . . . . 73.21 111.607 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -158.02 127.16 1.84 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.237 -1.145 . . . . 51.25 110.237 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.11 146.02 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.252 0.834 . . . . 73.23 113.252 -172.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.97 108.73 6.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.202 -0.908 . . . . 70.33 110.176 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 7' ' ' VAL . . . -103.86 128.27 51.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.119 -0.491 . . . . 72.33 110.548 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.14 106.19 17.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.861 -0.792 . . . . 74.11 108.861 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.567 HG13 HD11 ' A' ' 108' ' ' ILE . 13.5 t -105.76 90.12 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.347 -0.388 . . . . 74.11 110.448 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 67.61 -67.14 0.19 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.214 -0.903 . . . . 72.04 112.103 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.635 ' HA ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -136.84 -18.15 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.792 0.293 . . . . 63.12 111.792 -175.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.516 ' HG3' HD13 ' A' ' 28' ' ' ILE . 3.6 pt20 -117.12 151.96 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 64.15 111.75 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -103.43 125.58 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.739 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 26' ' ' GLN . 5.1 mp -129.17 143.45 41.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 60.11 110.056 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.1 36.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 73.2 109.584 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 45.6 t -105.93 104.97 17.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.895 0.379 . . . . 75.25 110.332 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.795 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.7 m-85 -81.88 131.02 35.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.734 . . . . 73.35 111.312 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB2' HG12 ' A' ' 39' ' ' VAL . 75.6 ttt180 -131.06 76.35 76.9 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.81 -0.811 . . . . 70.2 108.81 165.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.47 -19.37 13.17 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.574 2.182 . . . . 62.33 111.963 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -100.13 164.62 11.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 74.33 109.899 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 2.2 p-10 -80.92 -10.23 59.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 62.33 109.904 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.93 171.76 14.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.442 -0.799 . . . . 72.14 110.94 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.498 ' HG2' HD21 ' A' ' 10' ' ' LEU . 29.2 mt-10 -85.52 30.89 0.6 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 75.13 111.253 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -100.57 103.33 14.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.144 -0.48 . . . . 74.44 109.755 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 19.1 m -104.92 163.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.002 -0.544 . . . . 75.42 111.298 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 48.9 m-85 -124.19 102.77 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 73.25 109.951 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.01 95.23 9.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.16 0.505 . . . . 64.4 110.741 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.58 162.65 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.576 . . . . 72.01 110.057 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 92' ' ' VAL . 20.7 m -78.71 82.87 4.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.15 0.5 . . . . 74.02 110.589 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.26 17.96 21.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.066 0.936 . . . . 73.51 109.556 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.27 107.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.721 -1.127 . . . . 74.52 109.909 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.2 t70 -60.95 131.67 91.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.251 -0.431 . . . . 62.22 110.221 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 18.7 Cg_exo -67.39 -4.64 12.23 Favored 'Trans proline' 0 N--CA 1.472 0.26 0 C-N-CA 123.393 2.729 . . . . 64.12 113.482 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -113.16 3.96 16.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.296 0.57 . . . . 73.23 109.923 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.41 -35.83 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.91 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 64.66 21.52 12.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.941 0.401 . . . . 73.1 111.658 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.25 170.56 16.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.57 . . . . 63.43 110.082 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.8 m -81.61 59.91 4.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.53 0.681 . . . . 74.21 111.057 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -78.53 -23.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.65 -0.705 . . . . 72.4 110.312 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 70' ' ' SER . 57.8 mt -81.79 -21.79 37.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 73.45 109.948 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 m -74.56 -22.57 58.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.369 -0.832 . . . . 72.43 111.244 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -96.61 27.1 4.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.192 0.52 . . . . 75.43 110.675 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.47 -152.0 26.76 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 62.12 112.056 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 53.8 mt -86.44 103.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.043 0.449 . . . . 71.12 110.8 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -75.58 96.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.815 -0.63 . . . . 62.31 109.759 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.43 137.17 46.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.995 -0.548 . . . . 75.35 111.416 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 72.12 109.482 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.673 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 56.2 t60 -107.52 114.43 28.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.113 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 69.76 -84.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.054 -0.975 . . . . 72.01 111.413 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.65 -9.31 2.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.511 . . . . 73.13 110.999 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.522 ' HB2' ' NE1' ' A' ' 67' ' ' TRP . 3.6 m-20 -115.16 -179.2 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.04 0.447 . . . . 65.12 110.873 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.0 mt -112.6 118.46 35.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 74.54 109.449 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.673 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 26.8 m95 -122.5 115.8 22.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.637 . . . . 74.31 109.991 -174.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.8 p -85.16 127.31 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.146 0.498 . . . . 64.4 110.605 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -89.9 101.94 14.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.917 -0.583 . . . . 71.45 109.463 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.662 ' HB2' HD22 ' A' ' 54' ' ' LEU . 12.8 p -64.89 136.5 96.81 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.642 -0.708 . . . . 75.11 111.028 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.7 -32.12 31.02 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.392 2.061 . . . . 71.14 112.51 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.78 -49.42 9.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 72.15 111.683 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 4.3 mmpt? -84.18 -27.14 28.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 72.32 110.157 -175.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 62.07 27.11 16.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.152 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.03 151.9 25.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 63.35 110.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 79.7 m80 -92.8 126.33 37.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.471 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -115.29 132.76 56.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.064 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 ttp180 -81.75 119.97 24.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.536 -0.542 . . . . 74.3 109.536 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.413 HD22 ' CG1' ' A' ' 68' ' ' VAL . 75.1 mt -78.81 23.92 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.679 0.622 . . . . 74.21 112.679 -170.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.49 24.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.257 -0.646 . . . . 73.03 109.257 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 25.2 t70 -136.65 -71.26 0.45 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.83 -0.623 . . . . 62.01 110.898 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.61 -26.78 4.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.759 -0.734 . . . . 45.41 112.225 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.63 169.49 12.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.312 0.577 . . . . 73.25 111.067 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 4.2 m -109.14 149.93 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.479 -0.782 . . . . 75.1 110.351 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.3 tp -98.73 20.26 13.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.247 0.546 . . . . 75.41 110.184 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -135.44 -68.11 0.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.618 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.33 136.27 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.548 -0.296 . . . . 63.41 110.348 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.35 49.04 3.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.031 -0.604 . . . . 74.31 112.801 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.15 -5.59 16.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 74.33 110.904 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.5 ' CE2' ' HD3' ' A' ' 73' ' ' LYS . 80.5 m-85 -136.14 32.38 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.134 -0.485 . . . . 74.02 110.816 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -78.27 117.35 19.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.159 -0.473 . . . . 60.33 110.045 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 43' ' ' SER . 30.3 m -116.05 -170.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 62.33 111.476 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.01 168.19 9.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 74.04 111.075 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.47 109.53 13.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.61 -0.723 . . . . 53.43 109.376 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -82.26 147.42 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.757 -0.656 . . . . 75.44 111.232 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.616 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 12.5 m-20 -66.24 122.11 16.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 74.54 110.068 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 106' ' ' ILE . 1.6 m -117.51 153.77 32.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.85 -0.426 . . . . 72.53 109.85 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -144.41 153.01 41.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.445 -0.343 . . . . 64.45 110.261 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -124.9 105.39 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 72.5 109.138 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 101' ' ' ASN . 5.2 t -112.72 -63.6 1.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.986 0.736 . . . . 75.15 112.986 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.451 ' H ' HG21 ' A' ' 100' ' ' THR . 32.6 m-20 -106.33 29.2 7.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 71.54 110.403 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.13 90.28 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.875 -0.89 . . . . 73.24 110.875 -172.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -111.34 159.4 18.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.956 -0.622 . . . . 74.34 109.758 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.412 HG23 HD13 ' A' ' 10' ' ' LEU . 22.0 t -103.69 125.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.256 -0.429 . . . . 71.33 110.565 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.52 131.41 53.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.42 . . . . 63.12 110.389 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.533 HG13 HG22 ' A' ' 97' ' ' THR . 3.8 mp -113.71 142.04 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 73.1 110.005 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.616 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 47.0 t -80.53 99.21 7.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.285 -0.635 . . . . 71.41 109.285 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.567 HD11 HG13 ' A' ' 23' ' ' VAL . 44.3 mm -77.0 94.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.668 -0.696 . . . . 71.22 111.142 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 109.248 -0.649 . . . . 73.21 109.248 173.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 107' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.066 0.46 . . . . 70.23 110.861 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -85.13 118.21 24.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 75.13 110.131 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -121.08 152.27 38.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 74.15 110.555 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.944 0.402 . . . . 75.2 111.543 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 30' ' ' VAL . 93.3 t -80.84 -68.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 75.42 109.498 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.1 t -179.22 -163.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.052 -1.092 . . . . 70.21 108.052 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 13.7 mtpt -79.15 136.24 37.06 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.896 -0.409 . . . . 72.41 109.896 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.71 -30.49 69.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.356 0.598 . . . . 73.21 110.104 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.57 -17.57 51.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.479 -176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 t70 -84.81 -19.63 32.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.77 -0.65 . . . . 71.11 109.347 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.97 125.03 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.616 -0.72 . . . . 75.14 110.679 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 94.1 mt -77.13 133.47 68.76 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.205 -0.452 . . . . 70.03 111.665 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 12.7 Cg_exo -70.24 144.8 52.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.324 2.683 . . . . 74.44 112.555 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.61 56.1 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.935 -0.575 . . . . 41.42 112.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.548 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -156.48 158.06 36.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.779 0.323 . . . . 64.3 111.737 -172.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -122.58 138.74 12.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.797 -0.921 . . . . 72.14 110.797 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.78 142.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.459 0.54 . . . . 70.44 112.459 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.624 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.1 p -75.19 105.91 6.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.448 . . . . 64.22 111.44 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.72 132.92 35.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.911 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.17 98.14 8.88 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.48 -0.563 . . . . 73.42 109.48 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG23 HD12 ' A' ' 106' ' ' ILE . 21.2 t -108.74 70.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.957 -0.565 . . . . 73.33 109.629 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 8.1 pt-20 42.2 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.938 1.295 . . . . 74.11 114.191 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.703 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 3.9 pt20 -80.87 -13.05 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.564 0.579 . . . . 72.22 112.564 -172.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -143.92 153.72 42.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.288 0.566 . . . . 64.32 111.951 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -115.33 117.86 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 65.11 109.054 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 106' ' ' ILE . 66.1 mt -122.01 132.32 71.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -88.65 125.6 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.292 -0.413 . . . . 71.12 110.641 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 7' ' ' VAL . 39.0 t -105.54 105.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.074 0.464 . . . . 74.14 110.126 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.444 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 74.7 m-85 -78.37 128.39 33.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.501 -0.772 . . . . 74.1 110.76 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 13.0 tpt180 -109.16 84.67 2.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.196 -1.038 . . . . 72.21 108.196 168.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 31' ' ' PHE . 16.9 Cg_exo -66.65 -48.03 2.46 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.621 2.214 . . . . 55.24 112.353 -174.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -116.92 166.75 11.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.048 -0.524 . . . . 65.21 110.111 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -81.77 72.65 8.82 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.092 -1.077 . . . . 75.21 108.092 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.19 179.04 8.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.896 -1.047 . . . . 75.14 109.082 -174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -79.27 -9.04 59.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.724 0.297 . . . . 74.53 111.33 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.08 129.27 35.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.6 . . . . 74.52 111.605 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.74 155.17 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.794 . . . . 53.53 110.021 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.94 108.01 8.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.684 0.278 . . . . 71.41 111.005 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.24 108.29 19.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.878 0.37 . . . . 73.13 111.109 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.16 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.146 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 55.0 m -81.82 89.91 6.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.796 0.332 . . . . 61.34 110.167 178.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -129.08 43.99 3.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.583 0.706 . . . . 75.13 109.223 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.624 HD13 ' HB3' ' A' ' 20' ' ' CYS . 46.8 mm -107.98 128.98 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.585 -0.734 . . . . 62.1 110.532 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 t70 -85.91 118.07 69.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.259 -0.645 . . . . 74.21 109.259 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 19.2 Cg_exo -66.97 -12.18 35.12 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.225 2.617 . . . . 75.11 113.25 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -93.94 -18.69 21.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.951 0.405 . . . . 73.33 110.37 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.41 -22.27 13.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 70.21 109.639 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 66.22 28.81 9.93 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.909 -1.041 . . . . 65.23 111.782 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.557 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -159.17 173.74 15.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 72.33 110.561 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -79.65 52.27 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.919 -0.582 . . . . 72.25 110.94 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.75 -18.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.784 -0.644 . . . . 63.23 110.702 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.49 -6.43 49.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.624 -0.716 . . . . 73.13 109.666 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 5.1 m -100.61 -35.16 9.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.388 -0.824 . . . . 64.05 110.362 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.548 ' HG3' HG22 ' A' ' 17' ' ' THR . 72.5 ttt180 -88.18 61.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.797 0.808 . . . . 73.52 109.665 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.72 -153.81 9.34 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.865 -1.061 . . . . 64.01 111.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.5 mp -94.75 120.69 44.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.892 0.377 . . . . 60.25 110.012 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.4 99.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.726 . . . . 64.32 109.832 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.73 119.98 31.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.474 -0.785 . . . . 60.23 110.454 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -95.45 132.48 40.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.078 -0.51 . . . . 73.32 110.639 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -94.76 -155.78 0.48 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.921 -1.14 . . . . 72.21 107.921 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -78.08 -30.91 49.86 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.878 -0.514 . . . . 72.31 110.275 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -128.59 -39.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.982 -0.554 . . . . 74.21 111.0 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.551 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 11.8 m-20 -93.74 158.94 15.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 73.1 112.289 -170.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.41 121.77 43.77 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.024 -0.989 . . . . 63.22 109.621 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.551 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 24.0 m95 -119.4 165.81 13.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.244 -0.434 . . . . 75.54 110.33 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' A' ' 79' ' ' LEU . 11.3 p -122.93 129.13 75.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.204 0.526 . . . . 73.32 110.08 173.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.19 107.99 19.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.868 -0.606 . . . . 74.35 110.012 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 21.1 p -74.55 134.69 75.87 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.979 -0.555 . . . . 72.44 110.448 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.38 -39.67 12.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.527 2.152 . . . . 64.43 112.562 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.61 -58.08 3.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 63.55 111.387 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.6 -31.42 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.436 -0.347 . . . . 73.21 110.965 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' SER . 56.2 mttm 65.78 17.78 10.96 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.514 -0.766 . . . . 60.32 110.782 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -85.99 138.46 31.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.436 -0.802 . . . . 75.05 108.948 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -97.12 105.98 18.23 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.857 0.36 . . . . 72.15 110.214 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -96.72 128.59 43.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.912 -0.585 . . . . 64.43 110.02 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.401 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 35.2 ttp180 -74.21 117.05 15.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.35 -0.611 . . . . 71.34 109.35 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 68' ' ' VAL . 88.7 mt -48.13 -58.06 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.113 0.883 . . . . 75.45 113.306 -168.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 65' ' ' ASP . 5.9 p90 -95.84 24.82 5.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.049 0.389 . . . . 75.13 112.049 -172.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 83' ' ' PHE . 8.1 t70 -142.03 -59.01 0.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.028 0.381 . . . . 75.33 112.028 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.28 -16.13 10.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.454 -0.879 . . . . 61.33 113.46 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.494 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 10.7 t80 -56.34 126.28 25.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.955 0.378 . . . . 75.21 110.068 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 22.5 m -97.08 37.15 1.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 72.1 111.029 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.747 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 52.3 tp 66.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.4 111.479 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.747 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 45.4 mt-10 -137.38 -33.13 0.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 55.21 110.599 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.43 93.17 5.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.606 . . . . 61.54 110.985 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.05 21.75 40.24 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.953 -0.567 . . . . 53.41 112.011 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.45 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.888 0.375 . . . . 74.11 111.384 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.26 -47.73 4.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.405 -0.361 . . . . 74.31 111.718 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.473 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 23.9 p 49.84 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.334 0.654 . . . . 71.52 112.188 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 43' ' ' SER . 34.1 m -76.21 161.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.932 -0.577 . . . . 71.33 111.316 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.25 154.51 19.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 64.44 110.861 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.09 106.01 8.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.923 0.392 . . . . 75.32 110.393 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.5 -177.61 3.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.089 -0.505 . . . . 73.41 110.875 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.39 158.18 17.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 73.34 111.166 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.667 HG22 HG22 ' A' ' 106' ' ' ILE . 3.9 m -148.36 159.62 43.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.77 -0.65 . . . . 74.4 109.317 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -161.71 155.69 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.024 0.44 . . . . 61.33 111.126 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.413 HG21 HG23 ' A' ' 104' ' ' VAL . 29.2 t -132.19 127.35 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.607 -0.886 . . . . 72.35 108.607 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -135.67 -28.22 1.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.631 0.604 . . . . 70.32 112.631 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -139.55 32.62 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.051 0.453 . . . . 62.42 110.625 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.47 -37.31 3.35 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.593 -0.813 . . . . 73.34 111.865 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.0 140.34 34.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.975 0.417 . . . . 62.32 110.034 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 99' ' ' VAL . 41.3 t -96.53 131.57 42.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.829 -0.623 . . . . 70.04 110.211 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' THR . 40.0 mt-30 -116.61 141.77 47.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.77 -0.196 . . . . 75.22 110.596 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -123.9 161.93 25.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.292 -0.413 . . . . 72.31 110.271 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 37.3 m -101.88 101.07 11.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.375 -0.375 . . . . 61.01 110.982 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 pt -80.54 119.04 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.274 -0.421 . . . . 73.53 109.968 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 72.24 111.697 -174.56 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 112.114 0.413 . . . . 71.21 112.114 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -128.45 135.78 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.326 . . . . 71.21 110.474 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 m -119.79 132.04 55.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.102 -0.499 . . . . 72.35 110.203 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.801 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.7 m -71.49 117.52 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.098 0.475 . . . . 75.3 111.58 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 106' ' ' ILE . 41.4 t -86.9 -67.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.293 0.568 . . . . 72.05 110.644 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.51 -177.6 6.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.781 . . . . 73.3 108.975 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 47.3 mtpt -84.2 157.16 21.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.85 0.357 . . . . 75.41 110.546 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.8 tp -79.16 -2.38 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.415 0.626 . . . . 75.23 110.142 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.48 -40.74 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.745 . . . . 62.33 112.202 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 p30 -88.6 -6.74 57.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 74.14 112.395 -172.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.38 129.85 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.882 0.372 . . . . 70.34 110.164 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 91.7 mt -61.22 124.52 80.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.153 -0.476 . . . . 74.11 111.708 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 14.8 Cg_exo -68.47 131.91 24.26 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 123.232 2.621 . . . . 60.32 112.646 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 84.55 18.51 61.88 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.792 -0.64 . . . . 55.41 112.77 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -153.13 162.32 41.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 117.096 0.448 . . . . 75.51 111.444 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -118.27 124.32 6.03 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.478 -0.649 . . . . 71.33 111.478 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.42 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -111.95 141.45 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.953 0.377 . . . . 75.41 111.482 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.736 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 6.9 p -82.32 92.91 7.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.086 0.47 . . . . 74.31 111.025 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -82.65 143.19 31.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 60.25 109.93 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.02 97.44 6.8 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.28 -0.637 . . . . 73.14 109.28 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.525 HG11 HD12 ' A' ' 106' ' ' ILE . 19.2 t -91.24 79.65 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.894 -0.594 . . . . 72.35 109.997 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 65.15 -68.56 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 74.24 112.437 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -118.94 -19.41 8.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.903 0.334 . . . . 73.11 111.903 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -138.35 140.32 39.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.807 -0.357 . . . . 75.33 111.444 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 49.0 mt-30 -88.41 132.0 34.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.787 -0.449 . . . . 72.14 109.787 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.4 mt -130.37 136.44 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.186 -0.672 . . . . 71.23 109.186 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.24 108.41 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.385 -0.37 . . . . 64.02 110.225 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.6 t -101.0 110.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.91 -0.586 . . . . 73.35 109.907 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.607 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 89.8 m-85 -77.9 137.4 38.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.54 -0.755 . . . . 74.12 111.432 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -124.29 57.89 14.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.925 -0.768 . . . . 74.14 108.925 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.666 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 98.5 Cg_endo -77.65 -25.54 7.85 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.545 2.163 . . . . 75.23 112.871 -166.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -97.96 1.05 47.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.281 -0.418 . . . . 63.34 110.141 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.54 31.17 18.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 74.03 110.147 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.7 t70 -144.23 -158.71 0.91 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.191 -0.913 . . . . 74.44 109.674 -171.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 37.8 mt-10 -70.41 -25.82 63.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.226 0.454 . . . . 72.3 112.226 -172.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.58 91.38 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.102 0.477 . . . . 62.43 111.522 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.16 157.64 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.266 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -140.25 115.54 9.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 72.01 110.424 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 106.27 16.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.312 -0.404 . . . . 63.23 111.274 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 44' ' ' ASN . 38.5 pt -123.98 153.9 30.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 63.05 109.986 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.476 ' OG ' ' HE1' ' A' ' 95' ' ' TYR . 44.9 m -77.23 59.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.128 0.49 . . . . 62.2 110.596 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 42' ' ' ILE . 64.9 t30 -105.1 63.54 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.621 0.724 . . . . 72.3 110.378 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 HG13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mp -114.36 132.05 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.088 -0.96 . . . . 72.34 109.77 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.0 t70 -81.24 117.12 66.83 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 71.24 109.396 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 9.0 Cg_exo -72.32 -5.6 17.44 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.143 2.562 . . . . 73.41 113.576 -174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -89.46 -32.09 17.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.136 -0.32 . . . . 74.31 110.136 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -13.81 14.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.191 0.519 . . . . 55.52 110.066 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 57.98 59.68 3.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.862 -1.063 . . . . 73.44 110.914 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.736 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -167.32 158.44 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.028 -0.987 . . . . 71.42 109.587 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 16.7 p -81.34 50.29 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.862 -0.608 . . . . 72.13 110.515 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.59 -20.74 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.376 0.608 . . . . 65.24 110.058 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.4 mt -75.57 -14.6 60.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.3 -0.864 . . . . 73.35 109.848 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 19.5 m -117.05 4.93 12.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 61.14 110.749 -176.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -107.68 9.06 29.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.535 . . . . 74.15 110.198 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.499 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -90.79 -114.92 1.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.895 -0.669 . . . . 72.12 112.53 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.0 mt -121.24 113.81 40.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.917 0.389 . . . . 70.45 110.874 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.79 93.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.653 . . . . 75.34 109.287 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.72 157.29 16.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.718 -0.674 . . . . 73.12 111.426 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -117.88 122.99 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.738 -0.665 . . . . 75.4 110.061 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -65.38 -59.67 3.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.653 -0.703 . . . . 75.01 110.169 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -173.34 -58.52 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.774 -1.103 . . . . 73.12 108.439 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -125.96 11.37 7.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.34 -0.846 . . . . 74.14 109.489 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.568 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.3 t0 -132.53 166.48 21.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.446 -0.797 . . . . 71.33 109.526 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.62 117.43 21.99 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.462 0.305 . . . . 65.22 110.663 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.568 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 20.4 m95 -130.01 112.58 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 72.1 110.376 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 13.8 p -79.85 141.39 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.847 -0.427 . . . . 72.5 109.847 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.46 54.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.971 0.415 . . . . 74.22 111.583 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 28.2 t -74.66 127.44 87.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 74.41 110.552 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.499 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 55.5 Cg_endo -70.86 -34.05 11.5 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.635 2.223 . . . . 73.42 113.021 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.62 -63.2 1.33 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.85 0.357 . . . . 74.33 111.825 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.579 ' HG3' ' HE2' ' A' ' 90' ' ' TYR . 41.4 mmtm -73.69 -25.57 60.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 74.22 110.874 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.4 tttm 56.15 95.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 73.14 112.357 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.441 ' OE1' ' HB3' ' A' ' 89' ' ' ALA . 2.5 pt20 -166.64 155.41 10.6 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.006 -0.997 . . . . 74.14 109.454 170.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.776 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 75.5 m80 -90.35 143.57 26.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.709 -0.678 . . . . 72.53 110.183 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.437 ' HB2' ' CG1' ' A' ' 68' ' ' VAL . 86.2 m-85 -130.58 121.1 25.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.401 -0.592 . . . . 73.14 109.401 173.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.07 133.79 45.44 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.333 -0.547 . . . . 75.51 109.74 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.63 11.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.06 4.9 5.88 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.675 -0.41 . . . . 74.44 111.075 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.87 -77.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.581 -0.281 . . . . 62.45 111.164 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.49 22.66 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.608 -0.806 . . . . 54.14 113.056 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -68.26 146.28 53.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.86 -0.422 . . . . 74.55 109.86 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 53.9 m -99.28 0.96 44.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.646 0.61 . . . . 54.54 112.646 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.505 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.0 tp 63.58 -74.73 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.241 0.617 . . . . 74.13 112.537 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 27.0 mt-10 -109.95 -40.71 4.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.474 0.654 . . . . 60.54 109.969 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.31 -171.01 3.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.852 -1.067 . . . . 71.23 110.386 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.33 118.43 0.75 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.574 -0.822 . . . . 64.34 112.522 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . . . -168.01 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.524 0.202 . . . . 71.52 110.884 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.579 ' HE2' ' HG3' ' A' ' 73' ' ' LYS . 75.1 m-85 -83.91 80.44 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 73.23 110.756 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -74.83 97.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.004 -0.543 . . . . 70.22 109.581 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.51 -175.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.171 -0.468 . . . . 72.2 111.725 -172.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.09 173.52 8.66 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.964 -0.562 . . . . 74.13 110.403 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -134.11 116.4 15.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.806 0.336 . . . . 74.51 111.179 -173.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . 0.476 ' HE1' ' OG ' ' A' ' 43' ' ' SER . 80.0 m-85 -80.42 151.51 29.3 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.788 -0.642 . . . . 63.32 109.42 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -81.5 160.84 23.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.224 -0.658 . . . . 71.54 109.224 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.808 HG21 HG22 ' A' ' 106' ' ' ILE . 4.8 p -136.08 142.86 44.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.779 0.324 . . . . 74.34 111.366 -171.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -125.45 138.25 54.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.22 0.533 . . . . 75.43 110.116 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.92 103.72 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.597 -0.89 . . . . 53.51 108.597 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.4 m -89.62 -68.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.317 0.58 . . . . 73.23 110.69 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -116.35 -133.02 0.33 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.359 -0.978 . . . . 71.31 108.359 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.78 35.4 2.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.421 -0.895 . . . . 61.21 111.139 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.7 p30 -141.65 155.13 45.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.496 . . . . 73.32 110.958 -175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.59 128.06 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.627 -0.715 . . . . 74.23 110.322 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.801 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -121.76 127.0 50.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.33 -0.395 . . . . 53.12 110.23 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.808 HG22 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -101.72 165.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.08 -0.341 . . . . 74.1 110.08 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -92.09 96.82 10.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.041 0.448 . . . . 73.42 110.235 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mm -73.79 102.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.2 0.524 . . . . 64.43 110.073 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 71.44 110.148 178.489 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 107' ' ' SER . 51.3 mt-30 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.054 0.454 . . . . 74.51 110.611 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.491 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 85.0 m95 -133.7 100.24 4.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.417 -0.811 . . . . 72.51 110.03 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -88.45 135.44 33.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.509 -0.314 . . . . 74.43 111.21 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.2 m -72.41 111.85 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 75.11 110.165 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 30' ' ' VAL . 50.2 t -81.97 -73.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.827 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.2 m -150.44 175.91 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 63.31 109.688 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 2.8 mptp? -79.36 142.18 36.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.973 -0.381 . . . . 72.42 109.973 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.645 HD13 HG23 ' A' ' 99' ' ' VAL . 7.9 tt -62.63 -23.47 67.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 70.21 109.61 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.87 -21.21 26.5 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 72.55 110.264 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.55 -24.96 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 71.51 110.723 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 32' ' ' ARG . 73.1 mt -77.59 116.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 75.12 111.161 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.05 132.83 90.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 60.4 111.474 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 44.1 Cg_endo -68.4 145.12 64.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.073 2.515 . . . . 63.21 113.153 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.04 64.41 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.676 -0.693 . . . . 74.34 112.856 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 166.73 32.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.084 0.442 . . . . 63.4 111.932 -175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -146.17 142.7 10.77 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.578 -0.609 . . . . 41.23 111.578 177.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.534 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 26.2 m -127.21 144.5 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.07 0.435 . . . . 52.24 112.013 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.539 ' HB3' HD11 ' A' ' 45' ' ' ILE . 7.5 p -74.0 105.3 5.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.851 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 131.27 41.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.02 -0.536 . . . . 71.35 110.391 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.27 101.33 13.75 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.331 -0.618 . . . . 63.24 109.331 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -111.45 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.594 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 66.09 -72.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.351 -0.84 . . . . 72.42 111.697 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.2 11.32 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 74.05 110.973 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -119.08 137.73 53.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.245 -0.434 . . . . 64.44 111.014 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -99.6 112.8 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 75.34 109.878 173.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.3 mt -118.18 135.65 57.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.087 -0.506 . . . . 75.53 110.453 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.91 114.81 26.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 74.43 109.989 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.544 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.9 t -98.54 101.63 12.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.376 -0.374 . . . . 64.04 110.747 -176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' HE2' HG22 ' A' ' 68' ' ' VAL . 66.8 m-85 -80.05 141.99 35.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.659 . . . . 75.45 111.089 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.55 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 14.0 tpt180 -112.7 80.72 3.9 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.302 -0.999 . . . . 72.43 108.302 165.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.683 ' HG2' HE22 ' A' ' 38' ' ' GLN . 18.2 Cg_exo -65.95 -43.32 9.49 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.568 2.179 . . . . 72.53 112.962 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -114.08 156.79 23.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.707 0.289 . . . . 74.54 110.284 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.18 71.09 3.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.816 -1.179 . . . . 75.4 107.816 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 26.7 t70 -160.07 -175.9 5.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.91 -1.041 . . . . 62.32 109.08 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 29.0 mt-10 -78.71 -10.75 59.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 71.01 110.236 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.683 HE22 ' HG2' ' A' ' 33' ' ' PRO . 22.2 tm0? -73.52 124.2 25.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.291 -0.868 . . . . 71.24 110.885 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 ' HD2' ' A' ' 32' ' ' ARG . 28.5 m -132.74 168.22 24.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 75.41 110.425 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.92 103.02 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.657 0.244 . . . . 75.12 111.657 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.95 109.64 21.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.857 0.361 . . . . 71.3 110.245 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 43.7 pt -130.51 179.16 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.976 0.417 . . . . 73.24 111.149 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.481 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 5.2 m -82.29 80.11 8.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.501 -0.555 . . . . 72.04 109.501 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.56 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.0 t-20 -123.84 70.57 1.08 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.713 0.768 . . . . 73.33 110.243 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 20' ' ' CYS . 37.3 mm -126.69 131.97 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.166 -0.924 . . . . 72.35 109.368 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.1 t70 -83.72 121.74 76.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.764 -0.458 . . . . 54.12 109.764 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 29.1 Cg_exo -62.54 -17.62 59.18 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.13 2.553 . . . . 50.11 113.248 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.1 5.77 44.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 75.44 110.597 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.33 -29.84 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 74.04 111.645 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 69.0 19.85 7.99 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.345 0.593 . . . . 74.51 110.816 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -142.19 168.19 20.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.757 -0.656 . . . . 73.02 109.88 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.534 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 22.0 p -81.62 55.83 2.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.933 -0.576 . . . . 64.14 110.938 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.01 -21.5 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.494 0.664 . . . . 62.3 109.901 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.56 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 50.0 mt -77.47 -19.68 55.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.264 -0.88 . . . . 61.41 109.636 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.0 m -90.62 -19.43 23.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.667 -0.697 . . . . 70.3 111.503 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -98.8 27.4 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.603 0.716 . . . . 73.12 109.847 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.502 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -95.93 -122.94 4.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.575 -0.739 . . . . 74.11 111.971 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 61.5 mt -112.34 104.27 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.205 0.526 . . . . 62.24 110.606 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 33' ' ' PRO . 93.6 t -91.64 105.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.396 -0.82 . . . . 74.34 109.077 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.27 179.38 8.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.135 0.493 . . . . 73.43 111.344 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 166.52 10.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.851 -0.613 . . . . 74.2 109.9 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -126.37 77.35 1.69 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.22 -0.659 . . . . 64.2 109.22 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 68.02 -59.78 0.42 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.441 -0.8 . . . . 74.11 111.77 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -117.84 -57.77 2.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.217 -0.447 . . . . 61.53 111.458 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.602 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.3 t0 -90.61 179.01 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 62.01 110.989 -173.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.66 123.19 43.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 74.34 110.742 -173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.602 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 46.4 m95 -137.83 128.26 26.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 73.31 110.893 -173.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 31' ' ' PHE . 10.6 p -94.95 127.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.603 . . . . 55.3 110.029 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -97.41 120.04 37.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.908 -0.587 . . . . 62.1 110.918 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 41.1 t -64.55 141.32 98.22 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 72.41 110.391 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.502 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 61.1 Cg_endo -78.11 -41.18 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.163 1.909 . . . . 53.44 111.706 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.694 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -76.99 -69.09 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.601 -0.727 . . . . 73.1 110.986 -178.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.694 ' HD2' ' HB3' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -80.95 -19.11 44.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.36 -0.382 . . . . 73.43 111.181 -175.196 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.6 mttp 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.82 -0.627 . . . . 73.31 112.594 176.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -78.3 143.31 37.1 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 73.33 109.477 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -100.62 115.36 30.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.307 -0.406 . . . . 73.33 110.328 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 68' ' ' VAL . 70.3 m-85 -106.12 124.75 50.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.114 -0.328 . . . . 73.34 110.114 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 42.9 ttp180 -72.97 121.99 20.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.821 0.343 . . . . 75.22 110.436 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 99.0 mt -76.39 78.0 3.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 74.13 110.263 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -174.56 -63.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 73.2 109.752 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -111.81 -23.08 10.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.736 -0.665 . . . . 73.04 111.046 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 19.29 27.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.742 . . . . 72.34 112.391 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.77 134.22 48.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.603 0.24 . . . . 74.41 110.539 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 46.0 m -88.31 26.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.157 0.428 . . . . 72.15 112.157 -174.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.2 tp 63.2 -79.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 73.2 112.308 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -126.93 -7.27 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.039 0.447 . . . . 75.52 110.56 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.59 -176.52 3.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.153 -0.684 . . . . 63.32 109.153 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 22.54 0.15 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.789 -0.719 . . . . 64.43 112.169 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -58.06 6.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.077 0.465 . . . . 60.03 110.799 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -130.61 92.38 3.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.471 . . . . 73.2 110.729 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -74.44 130.13 39.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.587 . . . . 73.41 109.414 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' SER . 32.4 m -95.88 -176.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.509 -0.314 . . . . 72.41 111.291 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -129.63 179.55 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 72.2 110.728 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.77 124.63 15.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.0 0.429 . . . . 75.23 110.664 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -89.51 169.6 11.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.651 -0.704 . . . . 74.54 109.704 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -99.73 138.53 36.68 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.474 -0.565 . . . . 74.4 109.474 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.889 HG21 HG22 ' A' ' 106' ' ' ILE . 44.6 p -127.24 156.38 41.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.303 -0.408 . . . . 70.24 111.104 -173.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.447 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.0 pt20 -155.44 140.77 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.169 0.509 . . . . 65.44 110.851 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.645 HG23 HD13 ' A' ' 10' ' ' LEU . 39.8 t -109.29 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.79 -0.819 . . . . 71.12 108.79 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -113.64 -5.04 13.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.47 . . . . 73.14 111.396 -171.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -141.63 25.09 2.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 74.11 110.842 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.28 17.48 Favored Glycine 0 C--O 1.234 0.139 0 C-N-CA 120.843 -0.694 . . . . 52.22 111.544 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 40.5 m-80 -106.56 157.14 17.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.3 -0.63 . . . . 72.24 109.3 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.55 HG23 HG22 ' A' ' 99' ' ' VAL . 44.8 t -94.76 117.22 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.994 0.426 . . . . 74.34 110.297 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -102.29 139.08 38.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.529 . . . . 74.05 110.095 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.889 HG22 HG21 ' A' ' 97' ' ' THR . 2.9 pp -114.47 149.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.105 -0.498 . . . . 72.51 110.012 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 8.5 t -85.8 128.0 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.714 -0.476 . . . . 75.14 109.714 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.2 mm -65.43 105.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.923 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.636 -0.711 . . . . 73.01 110.08 177.936 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.269 0.557 . . . . 71.43 110.293 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -102.4 116.71 33.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 75.15 109.772 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 m -98.91 131.78 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.073 0.463 . . . . 74.4 111.226 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.767 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 5.2 m -67.47 119.42 12.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.478 -0.783 . . . . 75.32 111.036 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 t -95.53 -84.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.52 110.46 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.1 m -142.25 161.15 38.75 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.979 -0.378 . . . . 74.45 109.979 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 89.8 mttt -65.6 145.15 56.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.047 -0.353 . . . . 75.34 110.047 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 37' ' ' GLU . 10.4 tt -65.57 -28.19 68.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.532 0.682 . . . . 75.12 109.565 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.85 -25.44 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.277 -0.874 . . . . 74.32 110.848 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 26.6 t0 -72.67 -15.94 61.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 53.34 109.817 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.4 mt -96.02 133.57 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.463 -0.79 . . . . 51.45 109.983 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.92 150.35 88.17 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.988 0.423 . . . . 72.0 111.784 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.97 123.68 11.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.69 2.26 . . . . 72.54 111.803 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.51 11.35 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.64 -0.709 . . . . 44.13 112.484 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -136.3 179.44 6.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.387 0.594 . . . . 71.24 111.023 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -175.42 101.42 0.16 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.069 -0.812 . . . . 45.14 111.069 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -117.63 150.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.21 0.448 . . . . 74.4 112.21 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB3' HD11 ' A' ' 45' ' ' ILE . 7.0 p -78.6 128.68 33.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.73 -0.668 . . . . 74.42 111.65 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.05 137.42 50.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.417 -0.586 . . . . 72.33 109.417 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -83.71 107.65 16.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.565 -0.531 . . . . 72.43 109.565 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.99 92.48 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.094 -0.503 . . . . 73.01 110.084 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 65.45 -75.06 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.271 -0.877 . . . . 75.41 113.113 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.68 10.58 3.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.194 0.442 . . . . 73.33 112.194 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -142.24 144.22 33.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.937 0.399 . . . . 73.43 111.314 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 45' ' ' ILE . 52.3 mt-30 -95.48 120.16 35.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.269 -0.641 . . . . 75.55 109.269 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.85 120.83 62.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 110.056 -0.349 . . . . 65.54 110.056 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.0 123.71 34.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.602 . . . . 64.35 109.373 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.624 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 15.0 t -107.87 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.952 0.406 . . . . 73.1 111.043 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.1 m-85 -77.34 136.17 38.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.567 -0.742 . . . . 72.12 110.726 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -127.77 73.99 78.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.131 -0.692 . . . . 72.52 109.131 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.53 -36.72 52.32 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.017 2.478 . . . . 71.13 112.215 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -111.92 149.77 31.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.56 -0.746 . . . . 71.4 109.807 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -81.26 56.8 2.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.311 1.053 . . . . 71.44 109.231 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -136.92 -176.1 4.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.564 -1.198 . . . . 72.54 108.448 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HA ' HD12 ' A' ' 10' ' ' LEU . 35.7 mt-10 -82.76 47.6 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.622 0.725 . . . . 71.24 110.274 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -126.7 99.04 5.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.107 -0.952 . . . . 74.3 109.413 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.56 162.19 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 63.13 111.078 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 99.7 m-85 -134.31 102.07 5.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.965 -0.562 . . . . 75.03 110.3 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.68 96.97 6.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.879 0.371 . . . . 75.12 111.045 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 pt -131.18 175.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.924 -0.58 . . . . 73.14 110.15 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.2 m -80.63 56.62 2.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.175 0.512 . . . . 65.4 110.793 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 20.2 t-20 -87.05 71.5 10.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.72 0.771 . . . . 73.5 109.675 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 20' ' ' CYS . 16.8 mm -124.55 142.96 39.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 74.31 109.992 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 9.9 t70 -90.55 116.65 66.87 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.022 -0.733 . . . . 63.42 109.022 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.19 -16.9 53.76 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 123.121 2.547 . . . . 75.14 113.108 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -101.36 -3.41 28.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.003 0.43 . . . . 73.34 110.509 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 46' ' ' ASP . . . -117.96 -24.92 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 51.43 110.897 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 69.11 19.49 7.99 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.727 -0.669 . . . . 65.21 110.601 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.604 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -153.1 169.1 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 74.12 109.709 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -84.23 83.87 7.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 72.21 110.791 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -96.97 -10.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.41 0.624 . . . . 75.23 109.787 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 43.6 mt -70.26 -28.52 65.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.315 -0.857 . . . . 70.02 109.608 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 p -88.81 5.86 41.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.06 -0.973 . . . . 74.02 111.841 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.922 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -108.6 15.38 23.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.276 0.56 . . . . 72.03 110.481 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.477 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -96.55 -147.61 22.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.717 -0.754 . . . . 73.32 112.299 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.75 118.03 42.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.02 0.438 . . . . 74.04 110.472 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.37 101.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.743 . . . . 42.35 109.531 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.85 109.01 21.42 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.254 -0.884 . . . . 63.34 110.641 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.32 129.01 35.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.305 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -108.1 45.44 1.02 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.581 -0.736 . . . . 64.44 109.523 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 69.29 -67.03 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.131 -0.94 . . . . 71.22 111.117 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.34 -43.9 7.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.965 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 3.2 t70 -98.52 174.58 6.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.287 . . . . 73.21 110.39 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HB3' HD11 ' A' ' 79' ' ' LEU . 89.3 mt -132.28 118.7 19.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 74.23 109.883 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.461 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 35.8 m95 -124.14 165.53 17.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.93 0.395 . . . . 73.43 110.585 -175.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.7 p -135.06 132.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.191 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -94.35 106.03 18.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 73.53 109.985 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.539 ' HG ' HD23 ' A' ' 54' ' ' LEU . 30.6 t -68.85 133.68 90.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.127 -0.488 . . . . 64.34 111.124 -177.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.8 Cg_endo -71.14 -30.02 16.7 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.486 2.124 . . . . 65.41 111.941 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.86 -37.65 14.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.978 -0.555 . . . . 73.3 111.099 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.792 ' HD3' ' HE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -88.41 -28.16 21.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.164 -0.471 . . . . 71.31 111.379 -175.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 65.19 22.95 12.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.534 0.521 . . . . 65.12 111.018 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.86 155.81 35.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.29 -0.413 . . . . 73.12 110.712 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 76.6 m80 -95.32 117.0 29.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.667 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -100.78 137.41 39.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.179 -0.464 . . . . 73.21 110.7 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -78.42 123.89 27.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.036 -0.529 . . . . 75.12 110.19 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 66' ' ' LEU . 84.4 mt -74.31 -30.44 62.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.454 0.538 . . . . 72.23 112.454 -172.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HD1' ' HE1' ' A' ' 40' ' ' TYR . 48.6 t80 -81.73 -19.13 42.06 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.797 -0.361 . . . . 73.43 111.566 -174.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -140.52 -78.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 74.21 111.037 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.36 0.46 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.681 -0.771 . . . . 71.44 112.123 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -55.37 108.32 0.41 Allowed 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 109.83 -0.434 . . . . 71.11 109.83 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.2 m -76.16 155.92 34.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.003 0.43 . . . . 71.43 111.418 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 24.7 tp -86.59 -20.45 27.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 70.51 110.001 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -82.97 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.799 -0.637 . . . . 72.12 110.715 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -144.16 160.65 40.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.106 -0.497 . . . . 72.03 109.954 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.13 65.78 3.73 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.971 -0.851 . . . . 74.15 110.971 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.34 -66.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.77 0.285 . . . . 74.03 111.77 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.792 ' HE2' ' HD3' ' A' ' 73' ' ' LYS . 60.1 m-85 -100.04 -28.21 13.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.833 -0.347 . . . . 72.21 111.501 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m 59.73 84.53 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.744 0.653 . . . . 74.34 110.234 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.9 m -79.2 155.83 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 71.51 110.975 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.11 142.79 26.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.008 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.78 97.71 6.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.916 -0.584 . . . . 71.43 110.153 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -81.96 136.43 35.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.987 -0.551 . . . . 75.43 110.042 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -66.44 136.63 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 73.12 109.357 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.57 HG22 HG21 ' A' ' 106' ' ' ILE . 76.0 p -115.52 143.43 45.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 65.33 111.214 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -134.72 137.27 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.617 . . . . 75.35 110.413 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 t -111.03 62.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.037 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -85.12 -29.35 24.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.247 -0.888 . . . . 72.4 111.397 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -103.59 -6.73 21.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.499 0.666 . . . . 75.24 110.835 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.02 -33.14 6.36 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.692 -1.363 . . . . 63.52 109.692 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.711 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 46.7 m-80 -81.39 139.84 35.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.566 -0.901 . . . . 75.44 108.566 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -81.78 123.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.409 -0.589 . . . . 73.12 109.409 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.767 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 21.5 mt-30 -117.55 121.1 40.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.656 . . . . 73.33 110.591 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 97' ' ' THR . 2.1 pp -96.38 153.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.813 -0.63 . . . . 71.52 111.345 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -81.4 114.74 20.36 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.128 -0.693 . . . . 45.21 109.128 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.69 109.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.344 0.592 . . . . 74.12 111.745 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 108.258 -1.015 . . . . 72.11 108.258 168.626 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.228 0.537 . . . . 74.2 109.818 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.58 139.12 54.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.57 -0.741 . . . . 74.25 110.173 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.649 HG21 HG11 ' A' ' 23' ' ' VAL . 21.1 m -126.15 124.3 40.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.235 -0.439 . . . . 72.34 110.841 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.3 m -67.32 119.57 12.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.286 -0.416 . . . . 74.31 110.394 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 30' ' ' VAL . 61.6 t -68.27 -60.91 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 62.34 109.673 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.513 ' SG ' HD13 ' A' ' 13' ' ' ILE . 5.0 p -172.33 -90.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.024 -0.989 . . . . 71.31 109.414 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.821 ' HD2' ' HB2' ' A' ' 12' ' ' ASP . 47.0 mttp -145.08 170.68 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.597 -0.52 . . . . 73.03 109.597 177.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.642 HD23 HG12 ' A' ' 99' ' ' VAL . 53.8 tp -91.23 -49.96 6.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.203 0.525 . . . . 74.41 110.396 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.44 -30.08 53.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.717 -0.674 . . . . 75.35 110.701 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.821 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 29.3 t0 -72.48 -13.68 61.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.293 -0.867 . . . . 75.44 110.334 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.513 HD13 ' SG ' ' A' ' 8' ' ' CYS . 34.7 mm -88.4 117.67 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 74.21 109.803 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.63 123.33 76.39 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 74.23 111.174 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.54 146.15 84.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.572 2.181 . . . . 71.45 111.874 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.82 30.17 36.43 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.448 -0.661 . . . . 70.44 111.448 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.1 m -147.97 174.16 12.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.738 0.304 . . . . 74.1 110.95 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.42 107.9 0.33 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.706 -0.958 . . . . 75.35 110.706 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.497 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.3 m -124.7 153.96 31.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 112.427 0.529 . . . . 71.2 112.427 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.681 ' HB3' HD13 ' A' ' 45' ' ' ILE . 5.2 p -79.87 118.23 21.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.578 -0.737 . . . . 73.24 111.275 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.14 169.94 9.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 71.45 110.358 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.09 117.54 29.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.236 0.541 . . . . 72.11 110.828 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.688 ' HB ' ' O ' ' A' ' 26' ' ' GLN . 57.3 t -124.77 154.03 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.385 -0.969 . . . . 73.04 108.385 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -45.68 -48.18 15.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.333 0.864 . . . . 73.52 113.333 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -114.65 -4.68 12.76 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.266 0.839 . . . . 71.32 113.266 -167.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.688 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 10.3 tt0 -172.37 143.49 1.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.821 -0.352 . . . . 63.42 110.524 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -75.64 137.45 40.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.28 -0.637 . . . . 73.52 109.28 173.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 20.6 tt -115.8 138.05 47.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.628 0.251 . . . . 63.2 110.502 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -97.43 124.8 41.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 72.2 110.281 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.61 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 38.9 t -106.19 99.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.974 0.416 . . . . 75.4 110.949 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.762 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 57.6 m-85 -75.21 113.83 13.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 73.41 110.75 176.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -118.59 82.69 20.19 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.528 -0.916 . . . . 71.54 108.528 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.507 ' HB3' HG23 ' A' ' 59' ' ' VAL . 10.4 Cg_exo -71.11 -31.75 14.24 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 122.72 2.28 . . . . 74.25 112.758 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -121.48 -179.74 4.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.48 -0.327 . . . . 75.13 110.278 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -93.24 23.9 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.881 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.77 -174.8 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.381 0.61 . . . . 71.44 111.429 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -98.66 31.64 2.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.308 -0.86 . . . . 71.24 110.712 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.94 153.23 52.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.09 -0.505 . . . . 64.24 111.028 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.82 165.98 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.114 -0.493 . . . . 72.05 110.488 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.762 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.3 m-85 -122.14 92.15 3.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.063 -0.517 . . . . 73.33 110.401 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -94.04 100.48 12.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.982 0.42 . . . . 65.02 110.323 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.71 173.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 72.33 110.795 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 m -78.51 87.08 4.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.08 0.467 . . . . 62.42 109.87 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.421 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 25.7 t-20 -133.5 67.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.678 0.751 . . . . 52.44 109.584 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.681 HD13 ' HB3' ' A' ' 20' ' ' CYS . 38.7 mm -118.79 143.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.431 -0.804 . . . . 75.13 109.384 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 48' ' ' PHE . 27.0 t70 -99.36 114.44 65.57 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.327 -0.397 . . . . 65.44 109.941 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.19 -12.99 35.3 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.187 2.591 . . . . 43.05 112.773 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.491 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 82.7 t80 -82.82 -22.13 34.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 75.14 110.983 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.7 -13.78 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 72.35 111.426 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 63.62 29.44 15.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.801 -0.636 . . . . 73.01 111.018 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -147.95 170.35 17.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.166 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 12.2 p -83.95 58.83 4.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.249 0.547 . . . . 74.14 110.702 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.476 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 31.2 m -79.73 3.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.704 . . . . 74.32 110.208 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.402 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 64.1 mt -104.78 -2.54 24.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.99 -1.004 . . . . 74.14 109.248 174.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 34.9 t -102.04 -48.7 4.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.648 -0.705 . . . . 71.14 111.362 -174.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -84.17 62.65 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.89 0.852 . . . . 72.41 109.892 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.51 -156.06 11.39 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.748 -1.115 . . . . 63.32 111.741 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mm -93.9 125.21 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.74 -0.467 . . . . 71.31 109.74 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 33' ' ' PRO . 93.4 t -86.48 97.79 6.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.023 -0.535 . . . . 74.1 110.097 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 133.13 51.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.667 -0.697 . . . . 72.35 110.374 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.67 151.24 20.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.116 0.484 . . . . 73.04 110.78 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -134.54 103.77 5.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.008 -0.738 . . . . 64.43 109.008 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 70.38 -61.45 0.46 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.07 0.857 . . . . 75.31 110.532 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -157.19 -23.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 73.52 110.826 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.64 171.56 14.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.98 -0.378 . . . . 74.0 109.98 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.6 mt -127.58 117.78 22.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.054 0.454 . . . . 72.14 110.668 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.434 ' CZ2' ' HD3' ' A' ' 78' ' ' ARG . 20.7 m95 -111.56 127.35 55.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.508 -0.769 . . . . 73.45 109.655 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 8.5 p -92.25 129.19 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.983 0.421 . . . . 71.55 110.496 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.28 108.09 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 70.52 110.813 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 29.9 t -56.31 138.34 74.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 72.43 111.407 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 53' ' ' VAL . 60.9 Cg_endo -73.67 -25.6 14.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.566 2.177 . . . . 62.41 112.768 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.94 -49.56 3.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 74.31 111.364 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -19.18 28.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.359 . . . . 64.31 110.903 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 70' ' ' SER . 57.2 tttm 62.62 22.66 13.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.437 0.636 . . . . 74.23 111.278 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.647 ' HG3' ' HB2' ' A' ' 86' ' ' GLU . 8.2 tt0 -95.61 150.8 19.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.857 -0.611 . . . . 75.11 110.387 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.0 m80 -99.32 124.32 44.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.895 -0.593 . . . . 75.12 110.439 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HD2' ' HG ' ' A' ' 84' ' ' CYS . 84.4 m-85 -119.3 134.86 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.317 -0.401 . . . . 73.41 110.793 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.703 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 49.1 mmm-85 -63.18 131.52 48.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.691 -0.485 . . . . 73.3 109.691 170.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.468 HD23 ' HB ' ' A' ' 68' ' ' VAL . 59.6 mt -70.42 -67.6 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.972 0.36 . . . . 75.23 111.972 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 34.0 p90 -101.08 25.68 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.433 . . . . 74.43 111.546 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . 0.703 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 8.0 t70 -118.27 -67.57 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.106 -0.497 . . . . 72.02 110.454 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.48 -21.69 5.07 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.131 -1.033 . . . . 54.0 113.511 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.4 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 41.0 m-85 -74.08 162.97 28.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.331 0.586 . . . . 74.31 111.606 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 90' ' ' TYR . 21.3 m -124.89 153.83 42.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 61.21 109.76 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.94 -68.34 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.705 0.288 . . . . 74.34 110.555 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 30.3 mp0 -64.47 -51.75 61.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 74.01 111.925 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.27 102.08 6.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 73.12 110.99 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -82.48 25.99 4.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.985 -0.626 . . . . 44.52 112.985 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 -14.72 46.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.069 0.462 . . . . 63.04 110.871 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.504 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 99.6 m-85 -80.91 -59.72 2.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.987 -0.551 . . . . 75.02 110.859 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 p 45.55 73.72 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.606 0.717 . . . . 74.42 110.742 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.58 157.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 75.24 111.751 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.71 116.38 29.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.506 -0.77 . . . . 71.43 110.825 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.37 86.89 3.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 73.2 110.046 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -71.75 170.27 13.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.822 -0.626 . . . . 74.52 111.202 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -83.48 135.29 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.146 -0.479 . . . . 52.15 110.367 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.971 HG21 HG21 ' A' ' 106' ' ' ILE . 63.9 p -124.82 127.19 46.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.281 -0.872 . . . . 72.15 109.535 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 4.5 pt20 -118.5 139.19 51.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.524 0.678 . . . . 74.23 111.102 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.642 HG12 HD23 ' A' ' 10' ' ' LEU . 45.4 t -108.6 88.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.027 -0.988 . . . . 73.02 109.133 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -88.31 -23.44 23.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 73.44 110.562 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.71 -154.8 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.802 -0.814 . . . . 72.22 108.802 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.03 -1.34 59.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.835 -0.698 . . . . 72.34 112.288 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 3.8 m-20 -113.61 158.82 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.087 -0.338 . . . . 74.51 110.087 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.57 128.44 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 72.4 111.698 -176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . 18.7 mm-40 -106.19 127.57 53.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.745 -0.661 . . . . 64.43 110.414 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.971 HG21 HG21 ' A' ' 97' ' ' THR . 2.7 pp -115.49 146.47 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.203 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -91.25 125.63 36.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 70.03 110.799 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.6 pt -98.17 102.15 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.968 -0.56 . . . . 64.23 110.224 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 73.43 111.037 -178.621 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.987 0.422 . . . . 73.31 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -67.76 105.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 74.33 109.546 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 p -96.01 146.04 24.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.886 -0.597 . . . . 71.04 110.679 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.1 m -83.61 119.94 25.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.301 -0.409 . . . . 73.11 110.507 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.438 HG13 HG21 ' A' ' 23' ' ' VAL . 46.6 t -84.91 -83.38 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 65.41 110.314 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.6 m -158.75 174.55 14.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 73.12 109.688 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -75.69 133.77 40.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.656 -0.498 . . . . 65.51 109.656 173.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.5 tp -66.74 -20.41 65.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.04 0.448 . . . . 62.05 110.994 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.1 -29.19 67.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 72.05 110.278 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.5 -25.78 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.545 -0.752 . . . . 72.24 109.8 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.77 107.89 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 74.54 110.147 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 95.3 mt -68.42 145.86 97.52 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.417 . . . . 73.33 111.8 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.1 Cg_exo -64.41 125.98 16.09 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.525 2.15 . . . . 74.21 111.656 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.72 42.86 4.98 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.864 -0.607 . . . . 71.31 112.139 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.8 p -137.95 -179.47 5.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.099 0.476 . . . . 63.43 111.632 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -166.81 81.19 0.11 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.058 -1.217 . . . . 74.01 110.058 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.485 ' HA ' ' HG ' ' A' ' 52' ' ' SER . 35.7 m -111.39 150.68 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.743 0.646 . . . . 73.14 112.743 -169.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.563 ' HB3' HD13 ' A' ' 45' ' ' ILE . 5.6 p -70.07 114.42 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.452 -0.795 . . . . 74.22 110.736 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.35 148.38 25.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 74.2 110.384 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -89.31 103.58 16.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 63.03 109.605 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.438 HG21 HG13 ' A' ' 7' ' ' VAL . 14.5 t -116.24 99.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 71.42 110.269 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 62.72 -85.68 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.649 0.593 . . . . 75.53 111.059 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -130.13 2.66 4.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.148 0.499 . . . . 75.32 109.961 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 14.5 mm100 -105.49 137.13 43.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 73.13 111.478 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -105.07 97.83 7.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 72.13 109.679 171.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.48 HG22 ' HB1' ' A' ' 41' ' ' ALA . 1.7 mp -110.26 135.9 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 74.32 110.541 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.12 114.44 21.77 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.597 -0.52 . . . . 53.41 109.597 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.9 t -99.89 106.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.005 0.431 . . . . 73.43 110.179 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 96.6 m-85 -81.24 127.25 32.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.598 -0.728 . . . . 74.54 110.687 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -118.97 80.39 18.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.54 -0.911 . . . . 70.44 108.54 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 38' ' ' GLN . 92.7 Cg_endo -79.25 -10.72 14.89 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.77 2.313 . . . . 72.4 112.351 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -121.44 163.01 19.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.428 -0.806 . . . . 73.25 110.119 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.31 -15.56 61.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.209 0.528 . . . . 72.34 111.15 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.8 t70 -97.42 -156.99 0.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.348 -0.387 . . . . 75.13 110.263 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 23.7 mt-10 -89.34 13.15 14.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.599 0.36 . . . . 74.41 111.929 -171.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' A' ' 36' ' ' ASP . 2.5 mp0 -74.31 94.25 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.882 -0.414 . . . . 73.44 109.882 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 27.5 m -113.74 151.92 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.99 -0.55 . . . . 73.21 111.65 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.747 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 89.4 m-85 -122.46 99.83 6.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 72.43 109.559 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 28' ' ' ILE . . . -97.02 100.79 12.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.952 0.406 . . . . 64.23 110.816 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 92' ' ' VAL . 31.3 pt -132.16 156.08 42.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.894 -0.594 . . . . 64.42 110.195 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 m -76.06 52.24 0.71 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.512 -0.313 . . . . 54.52 111.622 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.442 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 65.8 t30 -90.17 78.86 6.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.514 0.673 . . . . 75.42 110.072 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -126.75 142.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.17 -0.923 . . . . 74.23 109.67 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 12.7 t70 -80.94 125.83 78.99 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.755 -0.461 . . . . 71.3 109.755 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 24.3 Cg_exo -64.1 -12.58 33.07 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.323 2.682 . . . . 53.43 113.27 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -113.44 15.07 19.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.491 0.186 . . . . 72.22 111.365 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -134.75 -33.94 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.85 0.315 . . . . 43.13 111.85 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 63.41 23.09 13.56 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.312 0.577 . . . . 54.02 110.772 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -139.31 159.32 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.131 -0.941 . . . . 65.23 108.843 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.636 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -80.83 65.44 5.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.309 0.576 . . . . 71.21 111.321 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.43 -10.61 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.524 0.678 . . . . 71.14 109.806 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 87.3 mt -86.37 6.2 31.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.968 -1.015 . . . . 70.33 108.989 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.771 ' HA ' HG23 ' A' ' 68' ' ' VAL . 4.5 m -138.94 30.3 2.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.807 -1.088 . . . . 63.22 108.302 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.581 ' HD3' ' HG3' ' A' ' 71' ' ' PRO . 18.7 ttt180 -77.85 61.07 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.421 -0.809 . . . . 75.53 111.284 -170.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.58 -44.95 3.42 Favored Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.654 -1.157 . . . . 75.14 114.311 167.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -69.14 103.36 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.319 0.58 . . . . 73.54 111.293 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.69 118.1 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 115.105 -0.952 . . . . 62.53 109.478 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.56 55.67 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.544 -0.753 . . . . 71.33 111.001 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.73 95.52 4.03 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.63 -0.878 . . . . 71.42 108.63 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' HIS . . . . . 0.69 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 32.1 t60 -84.35 89.01 7.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.985 -0.552 . . . . 75.13 109.548 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.12 -64.17 0.34 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.766 -1.106 . . . . 74.24 112.749 176.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -121.3 -33.17 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.389 0.515 . . . . 73.13 112.389 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -128.78 -172.2 2.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.655 -0.418 . . . . 62.45 111.141 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.53 117.29 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 71.44 110.213 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TRP . . . . . 0.862 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 30.3 m95 -122.48 119.8 32.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.901 -0.59 . . . . 75.01 110.297 -176.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 55' ' ' SER . 12.8 p -84.15 149.77 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.282 -0.417 . . . . 72.31 110.143 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 130.68 54.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 62.45 110.526 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.675 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 57.3 p -102.76 143.4 26.54 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.291 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HG3' ' HD3' ' A' ' 56' ' ' ARG . 60.3 Cg_endo -73.19 -2.91 12.76 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.442 2.095 . . . . 65.21 112.188 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.81 -55.82 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 73.53 110.928 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.48 -24.75 21.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.438 -0.346 . . . . 74.04 110.638 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 74.35 -31.77 0.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.252 0.834 . . . . 74.44 113.252 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -71.59 168.18 18.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 74.1 111.081 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.862 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 35.5 m80 -96.5 128.5 43.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 75.34 111.385 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.672 ' HE1' ' HG ' ' A' ' 70' ' ' SER . 54.6 m-85 -98.09 122.66 41.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.389 -0.597 . . . . 75.22 109.389 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -72.69 117.46 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.62 -0.511 . . . . 75.14 109.62 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.626 HD21 ' HB ' ' A' ' 68' ' ' VAL . 50.1 mt -61.5 -25.33 67.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 71.42 112.149 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -89.43 -0.52 57.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.639 0.257 . . . . 73.14 111.525 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.05 -65.67 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.54 -0.464 . . . . 71.14 112.011 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' HG23 ' A' ' 92' ' ' VAL . . . 132.62 -25.79 3.73 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.731 -0.747 . . . . 73.23 112.667 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -55.61 144.03 28.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.508 0.67 . . . . 75.14 111.784 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.8 65.04 1.8 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.0 -1.0 . . . . 73.44 110.89 -171.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.498 ' HA ' ' CZ3' ' A' ' 67' ' ' TRP . 35.5 tp 65.53 -87.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.719 -0.673 . . . . 74.41 111.477 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.74 -12.37 17.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 70.4 110.934 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -117.12 176.19 5.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.373 -0.376 . . . . 70.34 110.569 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.5 41.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.908 -0.877 . . . . 72.34 110.908 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.91 -45.8 78.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 55.34 111.22 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.61 80.24 1.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.167 0.508 . . . . 73.24 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -76.65 96.98 4.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.969 -0.559 . . . . 74.42 109.558 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.572 HG21 HD12 ' A' ' 42' ' ' ILE . 20.0 m -82.82 165.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.719 -0.673 . . . . 64.35 110.782 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.69 125.6 45.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.706 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -94.21 96.57 9.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 75.33 109.783 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -82.91 152.0 25.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.554 -0.748 . . . . 73.24 109.681 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.74 128.75 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.236 0.541 . . . . 65.34 109.73 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.579 HG22 HG12 ' A' ' 106' ' ' ILE . 3.5 m -122.96 158.39 30.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.63 -0.714 . . . . 65.15 109.376 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -156.46 141.76 17.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.225 0.536 . . . . 74.1 110.591 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 104' ' ' VAL . 34.5 t -110.21 105.68 19.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.12 -0.945 . . . . 62.53 108.797 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.69 HG21 ' H ' ' A' ' 101' ' ' ASN . 1.2 t -86.6 -76.31 0.36 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.371 -0.377 . . . . 72.42 111.568 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.69 ' H ' HG21 ' A' ' 100' ' ' THR . 1.0 OUTLIER -120.87 70.46 0.91 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.678 0.275 . . . . 73.2 110.638 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.67 -31.34 2.2 Favored Glycine 0 C--O 1.229 -0.184 0 C-N-CA 120.701 -0.762 . . . . 64.0 112.748 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -89.0 146.86 24.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.957 0.408 . . . . 71.21 110.123 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 99' ' ' VAL . 39.8 t -105.51 133.22 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.798 -0.637 . . . . 73.41 109.918 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -129.32 146.8 51.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.707 0.289 . . . . 72.51 111.072 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.579 HG12 HG22 ' A' ' 97' ' ' THR . 70.9 mt -121.38 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 73.51 109.81 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.5 p -90.88 112.94 24.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.177 0.513 . . . . 65.3 110.224 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 pt -126.06 155.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.381 -0.372 . . . . 61.04 110.792 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.882 -0.599 . . . . 71.5 109.664 173.973 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.828 0.347 . . . . 74.41 110.626 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.546 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 32.7 t -115.82 -71.35 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 74.43 110.329 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.06 22.02 16.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.681 0.753 . . . . 74.23 110.006 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.546 ' HD1' ' H ' ' A' ' 2' ' ' SER . 71.6 m95 -98.0 112.28 24.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.95 -1.023 . . . . 72.54 110.176 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -99.1 137.88 36.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.174 -0.466 . . . . 73.33 110.719 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -71.13 131.64 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 65.31 110.771 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.407 HG23 HD13 ' A' ' 106' ' ' ILE . 38.9 t -87.42 -70.52 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.911 -0.403 . . . . 64.44 109.911 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.9 m -154.41 178.54 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 73.4 109.782 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -78.08 144.16 36.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.521 -0.548 . . . . 75.34 109.521 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 71.31 110.724 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.36 -32.93 64.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.464 -0.789 . . . . 63.11 111.157 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.49 -16.76 63.52 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.265 -0.425 . . . . 73.25 110.497 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 mm -89.69 112.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.806 -0.442 . . . . 70.11 109.806 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.12 133.67 91.66 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.489 . . . . 74.34 111.14 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.72 133.36 57.62 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.815 2.343 . . . . 74.04 112.169 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.09 28.0 51.0 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.654 -0.703 . . . . 63.23 111.766 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.634 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -150.24 177.08 10.27 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 121.014 -0.274 . . . . 74.22 110.619 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.634 ' H ' HG22 ' A' ' 17' ' ' THR . . . 174.22 130.04 1.24 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.008 -0.615 . . . . 74.3 112.197 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.718 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 27.1 m -125.03 162.35 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.717 0.259 . . . . 72.32 110.975 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 14.7 p -87.5 144.56 26.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.171 0.51 . . . . 63.4 111.307 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 148.32 50.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.587 -0.733 . . . . 74.11 109.546 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.28 94.59 4.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.708 -0.849 . . . . 64.33 108.708 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.595 HG12 HD11 ' A' ' 106' ' ' ILE . 44.9 t -95.11 94.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 70.21 110.438 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . 41.0 mm-40 64.19 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.243 -0.89 . . . . 60.23 112.28 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.402 ' NE2' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -120.26 -21.31 7.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 72.22 111.542 -176.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -127.41 146.38 50.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.557 0.217 . . . . 72.24 111.263 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.72 130.0 35.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 72.41 110.135 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.0 mt -127.74 133.3 67.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 74.54 110.331 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.78 140.83 37.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.118 -0.492 . . . . 70.15 109.741 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 101.58 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.87 -0.332 . . . . 74.04 111.534 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.764 ' HZ ' HD21 ' A' ' 44' ' ' ASN . 79.8 m-85 -73.43 118.06 15.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.018 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' HG3' HG13 ' A' ' 39' ' ' VAL . 59.2 ttt180 -111.54 103.53 55.16 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 120.072 -0.651 . . . . 74.34 110.244 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.38 -55.08 0.17 Allowed 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.731 2.288 . . . . 74.25 112.233 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -122.97 -174.95 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.466 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -79.18 12.66 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.483 0.659 . . . . 73.52 110.463 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.1 178.62 6.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 71.41 109.425 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.66 -22.78 19.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.362 -0.381 . . . . 72.43 110.229 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -72.69 99.0 2.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 73.12 110.823 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.482 HG13 ' HG3' ' A' ' 32' ' ' ARG . 28.3 m -114.99 178.92 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.324 -0.853 . . . . 63.41 110.097 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.658 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 98.0 m-85 -126.01 101.23 6.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.807 0.337 . . . . 71.12 110.495 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 97' ' ' THR . . . -102.81 96.51 6.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.087 -0.506 . . . . 70.34 110.412 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.34 171.7 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.069 -0.514 . . . . 70.21 110.562 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.551 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 69.3 m -88.62 87.22 7.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.821 0.343 . . . . 72.13 110.209 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.764 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 53.2 t30 -124.37 82.43 2.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.408 0.623 . . . . 61.44 109.885 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.11 141.57 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.423 -0.808 . . . . 62.01 109.962 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.524 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t70 -93.39 123.99 58.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.503 -0.555 . . . . 61.42 109.503 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 23.3 Cg_exo -64.37 -10.22 23.1 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.055 2.503 . . . . 63.51 113.488 -175.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -95.08 -13.06 25.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 70.34 110.717 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.57 -26.45 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.703 0.261 . . . . 74.41 111.703 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 68.39 12.63 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.773 0.671 . . . . 73.1 111.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.635 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -133.23 177.01 8.0 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.137 -0.483 . . . . 71.0 110.696 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.718 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 27.0 p -81.62 47.69 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.6 -0.727 . . . . 75.54 111.594 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.22 -21.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.282 0.563 . . . . 73.03 109.899 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.529 HD13 ' HH ' ' A' ' 90' ' ' TYR . 91.0 mt -82.46 -9.15 59.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.149 -0.932 . . . . 73.24 110.116 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.617 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 14.2 m -102.62 -18.93 15.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.816 -0.629 . . . . 71.4 110.742 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -94.32 19.88 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.332 0.587 . . . . 61.42 109.967 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.99 -151.43 9.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.635 -0.712 . . . . 74.34 112.047 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 4.0 mp -90.4 103.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.213 0.53 . . . . 61.33 110.285 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -88.08 104.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.32 -0.855 . . . . 62.04 109.411 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.38 175.15 11.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.807 -0.633 . . . . 72.41 111.036 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.35 119.43 28.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.011 -0.541 . . . . 71.33 110.227 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.419 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 71.2 t60 -86.11 -33.42 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.989 0.423 . . . . 73.24 110.476 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -150.89 -65.09 0.19 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.261 0.553 . . . . 71.41 109.969 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.29 -22.84 1.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 74.25 110.917 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.68 -174.59 2.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.96 -0.563 . . . . 72.14 110.257 -171.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.4 mt -94.09 120.09 33.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.439 . . . . 71.43 110.409 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.419 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 19.7 m95 -121.95 153.39 38.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.842 -0.617 . . . . 75.21 109.893 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 9.8 p -114.3 122.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.455 0.645 . . . . 73.44 110.078 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.52 114.37 22.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.74 -0.664 . . . . 71.34 109.976 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.506 ' HG ' HD21 ' A' ' 54' ' ' LEU . 48.2 t -63.48 128.03 92.05 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.099 -0.501 . . . . 62.2 110.541 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.74 -31.41 32.41 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.585 2.19 . . . . 62.54 112.221 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.86 -56.3 2.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 73.31 111.179 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -84.1 -19.88 33.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.382 -0.372 . . . . 64.12 111.449 -173.63 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 70' ' ' SER . 0.3 OUTLIER 72.73 -23.01 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.547 0.943 . . . . 75.42 113.547 172.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.64 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 28.1 mm-40 -50.04 145.88 5.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.619 0.247 . . . . 75.21 110.991 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 19.0 m170 -100.18 105.66 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 74.13 110.848 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.501 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 52.3 m-85 -89.55 122.29 32.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.215 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.466 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 29.3 ttp180 -76.42 122.23 24.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.018 -1.104 . . . . 75.15 108.018 171.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.41 -49.81 60.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.682 0.993 . . . . 73.21 113.682 -165.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.525 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 58.1 t80 -89.32 -2.61 58.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 74.21 111.208 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HB2' ' HE ' ' A' ' 78' ' ' ARG . 10.5 t70 -103.16 -60.86 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.861 -0.336 . . . . 75.3 110.696 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.68 -19.76 28.05 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.504 -0.855 . . . . 75.51 113.527 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.93 157.48 33.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.421 0.61 . . . . 73.53 110.36 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.64 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 10.8 m -108.65 94.67 5.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp 62.23 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.514 0.726 . . . . 74.25 112.39 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 -55.8 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.967 -0.383 . . . . 72.31 109.967 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.34 113.74 26.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 74.44 110.618 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.11 69.45 3.37 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.722 -0.672 . . . . 73.34 112.914 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.43 7.36 45.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.464 . . . . 72.11 110.852 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.529 ' HH ' HD13 ' A' ' 54' ' ' LEU . 8.9 t80 -153.33 29.7 0.49 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 72.42 109.928 -177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 m -63.97 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.619 -0.719 . . . . 53.24 111.292 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.551 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.5 m -103.6 -178.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 74.43 111.246 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -101.2 130.87 47.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 72.14 111.165 -177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.02 105.29 11.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.092 -0.504 . . . . 71.22 110.524 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -94.86 158.27 15.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.677 -0.692 . . . . 75.42 109.987 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -82.94 151.22 26.01 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.797 0.332 . . . . 75.3 110.788 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.983 HG21 HG21 ' A' ' 106' ' ' ILE . 28.6 p -134.07 151.23 51.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 74.01 111.256 -172.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.406 HE21 ' HB2' ' A' ' 98' ' ' GLN . 1.7 pt20 -135.64 157.97 45.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.04 -0.355 . . . . 74.2 110.04 173.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.89 108.51 25.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.963 -0.384 . . . . 70.24 109.963 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.7 t -74.6 -75.98 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 71.52 111.294 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.798 ' H ' HG23 ' A' ' 100' ' ' THR . 53.3 m-80 -144.32 87.79 1.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.859 -0.423 . . . . 72.14 109.859 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.51 -1.1 45.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.046 -0.597 . . . . 73.24 112.907 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.0 140.86 52.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.873 -0.417 . . . . 72.44 109.873 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.88 133.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.327 -0.397 . . . . 75.02 110.716 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.38 151.59 42.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 55.02 110.053 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.983 HG21 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -122.29 155.44 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.66 0.267 . . . . 73.11 110.291 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -83.42 101.44 11.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.822 -0.807 . . . . 64.12 108.822 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 108' ' ' ILE . 24.6 pt -79.34 86.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.816 0.817 . . . . 74.54 112.471 -173.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.67 93.76 6.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.582 -0.895 . . . . 53.54 108.582 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.29 122.86 17.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.374 0.607 . . . . 72.33 111.147 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.4 m -104.79 -54.46 2.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.411 -0.813 . . . . 62.33 110.643 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -136.42 108.57 7.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.22 -0.445 . . . . 73.42 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -104.82 128.7 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.09 -0.505 . . . . 54.22 110.728 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -116.78 165.87 12.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.061 -0.518 . . . . 71.31 110.721 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 147.89 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.379 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.92 147.48 53.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 74.12 110.664 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 119' ' ' GLN . 9.8 p30 -85.13 148.86 25.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 75.52 110.962 -173.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.4 t -107.04 74.72 0.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.162 -0.681 . . . . 73.43 109.162 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.438 ' HB2' ' OD1' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -98.13 143.71 26.76 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.229 -0.896 . . . . 75.43 110.22 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 23.3 Cg_exo -63.78 121.89 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.265 1.977 . . . . 71.54 111.147 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 162.06 42.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 65.55 111.113 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.96 125.11 12.49 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.096 2.531 . . . . 74.35 112.577 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 tp -97.0 129.94 44.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.672 -0.695 . . . . 75.35 110.138 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -70.01 135.18 49.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 63.42 111.132 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -85.01 97.63 9.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.936 -0.575 . . . . 75.3 109.701 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -70.12 127.96 34.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 65.23 110.339 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -56.04 130.04 42.36 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.45 -0.795 . . . . 70.45 111.908 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -98.76 119.86 38.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.59 -0.732 . . . . 72.24 109.316 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 70.15 148.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 72.12 111.244 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.39 -0.814 . . . . 71.44 109.561 174.04 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.813 ' HA ' ' HD1' ' A' ' 4' ' ' TRP . 75.8 mtp . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.104 0.478 . . . . 75.05 111.152 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.3 t -102.14 -51.87 3.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 74.04 109.752 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -109.39 22.56 15.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.073 -0.512 . . . . 74.22 111.122 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.813 ' HD1' ' HA ' ' A' ' 1' ' ' MET . 96.5 m95 -94.88 116.15 28.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 71.14 110.277 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.0 m -105.13 129.05 53.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.318 -0.401 . . . . 74.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.787 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.5 m -70.33 115.16 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 53.2 110.423 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.36 -77.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 53.11 110.747 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -146.59 172.91 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.502 . . . . 70.42 110.059 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 46.7 mtpt -84.12 141.99 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 74.12 110.004 174.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.616 HD11 ' HB ' ' A' ' 13' ' ' ILE . 50.5 tp -70.69 -21.53 62.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 64.15 110.841 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.95 -34.39 76.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 72.23 110.733 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.63 -12.35 42.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 72.51 110.268 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.616 ' HB ' HD11 ' A' ' 10' ' ' LEU . 65.5 mt -82.11 111.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.164 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 14' ' ' LEU . 5.6 mp -56.42 130.12 75.71 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.675 -0.693 . . . . 73.31 112.11 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 17.1 Cg_exo -67.59 121.43 8.51 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.72 2.28 . . . . 73.33 111.381 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 35.87 5.09 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.917 -0.659 . . . . 75.22 112.462 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -136.14 -171.25 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.167 0.484 . . . . 72.52 111.328 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 168.94 96.13 0.1 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.154 -0.545 . . . . 43.11 111.887 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -133.98 165.92 30.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.52 0.16 . . . . 75.11 110.969 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.684 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.6 p -80.02 120.09 23.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.917 0.389 . . . . 74.41 111.421 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -91.35 150.87 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.402 -0.592 . . . . 72.02 109.402 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.77 107.44 19.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.992 0.425 . . . . 65.4 110.532 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.414 HG11 HD13 ' A' ' 106' ' ' ILE . 46.4 t -113.5 113.78 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.314 -0.624 . . . . 74.32 109.314 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 27.5 mm-40 65.81 -85.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.677 0.611 . . . . 72.52 109.753 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -154.0 18.81 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.624 0.726 . . . . 73.2 109.302 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.82 128.87 47.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.864 -1.062 . . . . 74.25 109.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.638 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 48.9 mt-30 -101.46 130.32 47.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.189 0.519 . . . . 37.85 111.243 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 28' ' ' ILE . 1.2 pp -127.63 129.85 70.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.599 . . . . 72.32 110.313 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -85.73 113.7 22.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.55 . . . . 75.32 109.916 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 37.9 t -97.16 98.29 7.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.228 0.537 . . . . 73.0 110.27 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -81.6 126.5 31.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.185 -0.916 . . . . 73.32 110.59 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' HD2' HD12 ' A' ' 10' ' ' LEU . 77.1 ttt180 -120.04 78.51 24.81 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.8 -0.815 . . . . 74.54 108.8 170.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HB3' HG23 ' A' ' 59' ' ' VAL . 3.6 Cg_exo -76.85 -20.03 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.98 2.454 . . . . 73.3 112.165 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -104.22 153.7 20.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.567 -0.742 . . . . 72.13 109.641 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.19 5.74 9.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.551 0.691 . . . . 72.03 109.727 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 13.6 t70 -89.56 -159.9 0.63 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.038 -0.983 . . . . 74.22 108.88 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.582 ' HA ' HD21 ' A' ' 10' ' ' LEU . 28.2 mt-10 -108.36 2.53 22.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 71.22 111.329 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -75.34 103.04 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 65.1 110.0 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.4 164.04 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.01 -0.541 . . . . 71.22 111.327 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -135.61 101.94 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.693 -0.685 . . . . 70.44 110.278 177.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HB2' ' OG1' ' A' ' 97' ' ' THR . . . -100.38 95.24 6.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.107 0.48 . . . . 74.34 110.872 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -115.24 164.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.973 -0.558 . . . . 74.33 110.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 33.2 m -81.67 66.92 7.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.129 0.49 . . . . 74.1 110.629 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.634 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 38.1 t-20 -92.23 92.03 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.897 -0.779 . . . . 37.85 108.897 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 27' ' ' GLN . 14.5 mt -137.55 144.8 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 64.3 110.158 -174.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.545 ' HB3' HG22 ' A' ' 53' ' ' VAL . 2.4 p-10 -88.96 140.07 29.13 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.948 -0.76 . . . . 63.31 108.948 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 1.2 Cg_endo -83.91 15.13 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.477 2.118 . . . . 73.1 112.942 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -101.37 -56.54 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.729 0.3 . . . . 71.32 110.54 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -120.49 -2.23 10.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.287 -0.415 . . . . 75.24 110.643 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.472 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 19.5 mm-40 62.99 72.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.558 -0.747 . . . . 73.32 111.94 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.684 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -152.25 173.01 15.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.39 -0.823 . . . . 63.12 109.227 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -92.58 66.55 4.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.329 0.585 . . . . 73.11 109.903 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 46' ' ' ASP . 32.8 m -85.5 -10.57 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 64.21 110.273 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.634 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 90.0 mt -86.56 9.62 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.619 -0.719 . . . . 72.43 109.766 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.467 ' C ' ' H ' ' A' ' 57' ' ' GLY . 40.7 t -84.37 -63.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.347 -0.842 . . . . 37.85 110.11 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.567 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 58.8 ttt180 70.47 -11.67 0.59 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.185 0.594 . . . . 72.24 111.15 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 55' ' ' SER . . . 77.41 5.5 85.75 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.319 -0.467 . . . . 62.45 112.244 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.47 105.72 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.613 0.72 . . . . 75.2 110.688 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.697 HG23 ' HB3' ' A' ' 33' ' ' PRO . 96.7 t -99.3 101.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.702 -1.135 . . . . 71.53 109.757 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.95 156.98 17.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.515 . . . . 62.45 110.436 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.14 127.04 40.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.053 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.6 -46.05 17.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.583 -0.895 . . . . 75.21 108.583 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 177.62 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.658 -1.155 . . . . 73.45 108.497 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.87 -15.14 16.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.478 -0.783 . . . . 74.4 109.898 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -109.99 149.67 29.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.649 -0.705 . . . . 73.22 110.034 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.16 131.02 57.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 73.22 110.329 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.817 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 35.7 m95 -127.74 119.12 25.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.398 -0.365 . . . . 71.14 110.791 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.707 ' HB ' HD23 ' A' ' 79' ' ' LEU . 11.3 p -73.89 138.39 21.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.656 -0.498 . . . . 62.44 109.656 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.09 109.67 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 73.42 111.123 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 m -72.85 154.02 91.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 70.05 111.239 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 56' ' ' ARG . 69.6 Cg_endo -74.46 -6.0 17.69 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.044 2.496 . . . . 54.21 113.626 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.09 -75.63 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.804 0.335 . . . . 72.11 111.163 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.62 24.61 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.455 -0.339 . . . . 75.3 110.254 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 55.24 34.65 23.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.03 0.919 . . . . 75.23 109.908 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.745 ' HG3' ' HE1' ' A' ' 77' ' ' PHE . 3.8 pt20 -81.29 141.13 34.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.592 -1.185 . . . . 74.24 110.693 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.817 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 61.6 m80 -93.13 121.55 34.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.478 -0.783 . . . . 75.05 110.42 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.745 ' HE1' ' HG3' ' A' ' 75' ' ' GLN . 7.3 m-85 -96.11 -16.83 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.478 0.547 . . . . 72.04 112.478 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 67' ' ' TRP . 5.7 ttt180 72.32 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.527 0.68 . . . . 70.33 111.18 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.707 HD23 ' HB ' ' A' ' 68' ' ' VAL . 97.4 mt -96.48 5.81 50.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 73.13 112.168 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.89 -26.6 19.26 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.635 -0.426 . . . . 71.51 111.13 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.36 -69.35 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.306 . . . . 63.32 111.382 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 92' ' ' VAL . . . 159.29 12.31 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.915 -0.66 . . . . 51.4 112.621 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -82.1 96.26 7.73 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.546 -0.539 . . . . 74.21 109.546 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 87' ' ' ASP . 6.8 m -79.95 161.38 25.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.273 -0.876 . . . . 70.43 111.504 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.514 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.5 tp -90.14 -66.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.999 -0.546 . . . . 74.11 110.424 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -86.36 -1.06 57.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.401 -0.363 . . . . 74.11 111.215 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 7.7 t70 -114.1 132.85 55.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 53.2 111.401 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.21 15.14 3.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.684 -0.966 . . . . 72.44 110.684 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -112.11 -37.38 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.598 0.237 . . . . 74.32 111.231 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -89.13 -71.72 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.51 -0.314 . . . . 74.42 110.555 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.0 m 60.14 99.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.685 0.616 . . . . 65.55 111.805 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.48 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 27.2 m -77.54 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.254 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -118.54 178.93 4.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.093 -0.503 . . . . 71.3 110.188 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.01 118.04 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.799 0.333 . . . . 72.03 110.965 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -101.0 153.54 19.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.64 -0.709 . . . . 75.1 110.442 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.09 139.31 54.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.087 0.47 . . . . 73.22 110.973 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 41' ' ' ALA . 2.9 m -134.4 158.85 42.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.566 -0.743 . . . . 70.24 109.324 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.414 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.1 pt20 -155.91 146.1 21.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.03 0.443 . . . . 74.4 110.422 174.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.0 102.06 13.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 72.24 110.126 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.2 m -82.11 85.06 6.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.349 -0.611 . . . . 63.14 109.349 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 72.45 -66.89 0.29 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.983 -1.008 . . . . 73.01 111.298 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.32 3.9 1.96 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.915 -0.659 . . . . 71.04 112.085 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -103.17 118.19 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.493 0.187 . . . . 71.14 110.715 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.68 115.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.829 -0.434 . . . . 71.22 109.829 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.787 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 24.2 mt-30 -123.09 134.79 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 73.42 111.113 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.414 HD13 HG11 ' A' ' 23' ' ' VAL . 2.9 pp -117.7 167.18 11.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.665 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.0 m -101.58 125.27 48.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.296 -0.411 . . . . 73.21 110.447 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.17 107.02 19.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.293 0.568 . . . . 75.11 111.543 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.96 89.04 2.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.143 -0.48 . . . . 37.85 111.067 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -159.29 142.33 14.33 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.438 -0.578 . . . . 75.43 109.438 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.5 m -94.34 -10.59 32.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.157 -0.474 . . . . 55.1 111.34 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.58 93.3 9.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 74.3 110.207 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.23 123.77 61.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.616 . . . . 73.13 110.546 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.09 22.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 65.31 110.575 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.14 135.18 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 75.4 110.381 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -137.75 151.41 48.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.34 110.755 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -147.81 31.06 0.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.065 -0.516 . . . . 73.33 109.967 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 t -58.63 -53.66 55.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.781 -0.645 . . . . 71.24 111.601 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.48 165.02 33.0 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 121.115 -0.234 . . . . 75.35 110.765 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.1 137.57 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.169 1.913 . . . . 50.03 110.852 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.47 151.36 97.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 73.0 110.323 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.0 135.8 23.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.834 2.356 . . . . 63.42 111.972 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.03 97.81 3.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.111 0.481 . . . . 62.44 110.642 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -101.57 125.44 48.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.933 -0.576 . . . . 74.35 110.129 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -130.18 36.27 4.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.152 0.501 . . . . 73.13 109.658 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -61.84 106.91 0.75 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.456 -0.793 . . . . 73.22 110.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -152.99 102.32 2.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 72.14 109.704 -176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.55 147.87 26.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.974 -0.557 . . . . 71.32 111.799 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -103.32 -17.04 15.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.081 -1.081 . . . . 60.45 108.081 165.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 64.33 109.02 174.72 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' HB3' ' HZ2' ' A' ' 4' ' ' TRP . 65.2 mtt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 63.43 109.934 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -122.34 -177.25 3.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.352 -0.386 . . . . 60.1 111.092 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.587 ' O ' ' HA ' ' A' ' 107' ' ' SER . 52.4 mt-30 64.36 71.53 0.47 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.614 -0.721 . . . . 73.04 111.039 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.488 ' HZ2' ' HB3' ' A' ' 1' ' ' MET . 83.0 m95 -116.95 121.84 42.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.507 -0.769 . . . . 74.53 109.777 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 m -103.15 134.24 46.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.245 -0.434 . . . . 61.24 109.861 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -79.53 116.78 19.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 75.22 110.3 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.44 -65.62 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.434 . . . . 65.41 110.282 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -176.68 -166.37 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.648 -0.706 . . . . 74.24 109.15 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HB3' ' A' ' 11' ' ' ASP . 50.2 mtpt -67.48 151.45 47.35 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.211 0.319 . . . . 75.21 111.294 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.38 -17.26 63.66 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.777 -0.824 . . . . 75.21 108.777 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.588 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 4.9 t70 -93.84 -24.28 17.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.562 -1.199 . . . . 74.24 111.014 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.429 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 25.3 t70 -84.17 -26.27 28.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.912 -0.586 . . . . 72.13 110.391 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.482 HD12 HG13 ' A' ' 30' ' ' VAL . 61.3 mt -82.25 111.64 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.839 -0.619 . . . . 72.14 109.467 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.49 145.87 99.02 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 71.42 112.31 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.4 153.15 30.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.878 2.385 . . . . 75.24 112.571 177.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.72 28.58 71.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.81 -0.632 . . . . 71.24 113.052 176.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 34.4 p -143.31 -177.27 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.047 0.424 . . . . 74.24 110.817 -176.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.636 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.99 104.72 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.55 -1.02 . . . . 62.35 110.55 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 31.3 m -105.27 142.14 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.488 . . . . 64.23 112.319 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.79 ' HB3' HD12 ' A' ' 45' ' ' ILE . 3.8 p -75.51 117.13 16.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.555 . . . . 64.54 110.812 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.32 143.27 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.063 -0.517 . . . . 72.32 110.429 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 25' ' ' GLN . 7.0 tt -84.93 92.71 8.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 64.33 108.964 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.68 131.09 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.309 -0.86 . . . . 75.35 109.267 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.16 16.73 10.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.895 0.855 . . . . 62.52 110.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.486 ' HA ' HD22 ' A' ' 22' ' ' LEU . 83.9 mm-40 76.3 25.91 0.97 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.258 -1.792 . . . . 74.23 111.054 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -136.19 167.21 21.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 75.51 109.849 177.054 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.531 ' HB3' HG13 ' A' ' 45' ' ' ILE . 24.4 mm-40 -91.87 119.35 31.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.047 0.451 . . . . 74.53 111.147 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.1 mt -135.46 129.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.725 -0.67 . . . . 75.2 109.869 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.98 134.46 34.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.496 -0.32 . . . . 64.24 110.335 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.636 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 40.4 t -110.14 111.32 35.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.986 0.422 . . . . 64.31 110.512 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.816 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 8.8 m-85 -91.74 146.95 23.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.583 -0.735 . . . . 75.51 111.386 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.474 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 46.9 mtp85 -140.66 55.07 5.39 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.045 -0.525 . . . . 74.43 111.666 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.511 ' HG2' HD13 ' A' ' 79' ' ' LEU . 23.5 Cg_exo -63.45 -46.38 9.66 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.914 2.41 . . . . 74.55 113.077 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.31 -29.67 67.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.599 -0.273 . . . . 73.23 111.623 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 62.5 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.41 0.624 . . . . 73.2 110.029 -170.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 21.3 t70 -177.9 -127.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 -174.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.408 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 65.1 mt-10 -104.74 -9.02 18.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.929 0.395 . . . . 72.32 110.105 170.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -71.04 103.43 2.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.032 -0.531 . . . . 72.42 110.966 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 m -113.74 142.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.02 109.402 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.816 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 74.1 m-85 -128.6 104.32 7.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.948 -0.301 . . . . 72.33 110.637 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.69 103.85 13.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 74.3 110.898 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.849 HG21 ' HA ' ' A' ' 94' ' ' ALA . 34.4 pt -134.9 154.16 36.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.005 -0.543 . . . . 54.33 110.056 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.4 m -77.95 55.13 1.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.262 0.553 . . . . 75.02 111.18 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.574 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 63.4 t30 -91.29 68.88 5.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.865 -0.791 . . . . 64.1 108.865 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.79 HD12 ' HB3' ' A' ' 20' ' ' CYS . 25.7 mm -122.89 138.06 54.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 72.14 110.619 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.25 130.5 94.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.975 -0.557 . . . . 71.0 110.886 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -87.63 13.13 2.71 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.0 2.467 . . . . 74.42 113.284 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -101.46 -54.85 2.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.591 0.234 . . . . 74.13 110.912 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.15 -0.66 11.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.062 0.458 . . . . 64.55 110.813 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 61.69 74.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.231 -0.895 . . . . 74.55 111.443 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.7 151.87 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.693 -0.685 . . . . 75.23 109.651 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 p -83.07 83.09 7.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.286 0.565 . . . . 74.43 110.737 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.507 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 26.9 m -101.5 8.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.469 0.652 . . . . 73.31 109.813 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.87 13.81 24.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.204 -0.907 . . . . 75.32 109.669 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 p -112.17 -64.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.613 -0.721 . . . . 75.42 111.659 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ptt85 -81.32 51.06 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.005 -0.543 . . . . 74.3 111.208 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.684 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -112.06 -110.55 3.1 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.253 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 62.2 mt -110.84 114.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.059 0.457 . . . . 74.31 110.346 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.54 110.87 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.748 -0.66 . . . . 51.51 109.454 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.89 116.8 32.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.559 -0.746 . . . . 51.14 111.085 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.89 121.21 38.5 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.361 -0.607 . . . . 61.45 109.361 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.15 76.68 1.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 72.5 109.189 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 66.01 -75.21 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.488 -0.778 . . . . 72.54 111.51 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -121.93 -22.75 5.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.128 0.49 . . . . 72.32 110.37 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.487 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 19.2 t0 -84.69 148.84 26.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 72.51 110.147 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.631 ' HB3' HD11 ' A' ' 79' ' ' LEU . 68.1 mt -117.34 115.34 25.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.279 0.561 . . . . 65.2 111.055 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.487 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 38.0 m95 -117.19 163.39 16.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.371 -0.831 . . . . 74.33 110.17 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.534 ' HB ' HD21 ' A' ' 79' ' ' LEU . 13.3 p -137.56 137.39 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.09 -0.505 . . . . 70.25 110.387 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.586 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -117.17 132.22 56.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.982 -0.554 . . . . 54.35 110.452 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 43.3 t -67.89 133.37 92.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.898 -0.408 . . . . 73.33 109.898 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.684 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 39.7 Cg_endo -66.37 -32.24 41.33 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 122.341 2.027 . . . . 73.33 112.164 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -100.81 -56.84 2.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.845 -0.616 . . . . 73.32 111.111 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -79.56 -19.63 48.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 70.24 110.746 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 70' ' ' SER . 52.4 mtmt 57.37 34.8 25.21 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.505 -0.77 . . . . 74.22 112.841 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.418 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.6 mm-40 -82.82 139.65 33.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 53.21 108.908 169.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 8.7 m80 -116.17 115.83 26.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.103 -0.332 . . . . 75.31 110.103 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.57 ' HZ ' ' HB2' ' A' ' 90' ' ' TYR . 77.6 m-85 -129.86 166.89 19.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.541 0.21 . . . . 74.43 110.631 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.708 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 61.4 mtt180 -81.26 146.53 30.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.407 . . . . 72.45 109.9 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 66' ' ' LEU . 96.0 mt -67.97 -27.47 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.896 0.332 . . . . 71.21 111.896 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.59 37.22 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.81 0.3 . . . . 71.24 111.81 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.708 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 20.2 t70 -148.88 -62.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.932 -0.307 . . . . 71.05 111.195 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.46 -12.22 23.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.181 -1.009 . . . . 38.16 113.697 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -75.32 160.03 30.79 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.193 0.52 . . . . 73.42 111.253 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . 61.8 m -87.86 151.99 22.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.453 -0.794 . . . . 71.13 111.481 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.602 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 64.5 tp -88.49 -58.86 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.484 . . . . 63.4 110.324 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 16.3 mm-40 -125.53 18.84 8.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 71.24 109.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 84' ' ' CYS . 2.1 m-20 -124.07 -180.0 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.414 -0.812 . . . . 62.4 111.037 -168.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.81 23.72 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.513 -0.767 . . . . 64.23 111.277 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.34 -59.52 2.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.748 0.277 . . . . 64.44 111.748 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 40.3 m-85 -90.4 -76.35 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.621 0.23 . . . . 73.33 111.621 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 m 66.27 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.84 0.712 . . . . 73.44 110.333 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.7 176.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.445 . . . . 72.25 111.697 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.08 167.64 9.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 51.33 110.916 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.849 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -127.34 112.39 14.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.087 0.47 . . . . 63.33 110.649 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -85.98 157.31 20.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.734 -0.666 . . . . 74.22 110.082 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' A' ' 107' ' ' SER . 3.9 t0 -82.47 162.93 21.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.714 -0.476 . . . . 64.13 109.714 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.784 HG23 HG21 ' A' ' 106' ' ' ILE . 3.1 p -149.12 154.01 38.59 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.342 0.257 . . . . 73.31 110.831 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -154.45 153.87 32.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.239 0.542 . . . . 63.34 111.115 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.08 83.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.735 -0.839 . . . . 74.4 108.735 173.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -97.25 -0.22 47.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.703 -0.68 . . . . 75.34 110.813 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -161.13 -164.75 1.22 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.785 -0.821 . . . . 73.22 108.785 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.01 -11.38 84.8 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.59 -0.604 . . . . 73.23 111.59 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.47 152.26 24.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.953 -0.388 . . . . 72.33 109.953 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.79 136.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 73.32 110.889 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -126.16 147.51 49.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 60.52 110.386 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.784 HG21 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -125.62 158.37 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.905 -0.589 . . . . 74.33 109.567 177.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.588 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 13.1 t -102.65 119.61 39.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.97 0.414 . . . . 75.32 109.973 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -120.85 117.36 52.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 70.24 110.446 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.33 17.67 15.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 73.43 111.133 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -172.67 141.91 1.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.44 -0.8 . . . . 70.23 109.353 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.573 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 50.0 m -121.19 -72.28 0.7 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.256 0.465 . . . . 62.51 112.256 -173.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.45 ' HB3' ' O ' ' A' ' 111' ' ' SER . 30.4 t70 73.43 112.73 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.059 0.849 . . . . 72.13 109.27 -166.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.47 116.61 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.393 0.616 . . . . 70.13 111.805 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.05 94.53 5.22 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.325 -0.852 . . . . 70.5 109.182 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.32 103.39 14.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.084 0.945 . . . . 65.52 112.053 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -132.2 122.93 26.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.363 -1.289 . . . . 61.05 108.228 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.91 124.52 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.544 0.688 . . . . 72.34 111.01 -173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 m -114.85 80.77 1.46 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.64 -0.709 . . . . 52.25 110.003 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -72.55 117.2 57.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 73.31 109.594 178.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.67 111.11 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.653 2.236 . . . . 74.51 111.719 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 92.9 mt -75.91 121.65 85.44 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.213 -0.448 . . . . 74.42 110.562 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 35.1 Cg_exo -60.2 118.8 5.72 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.733 2.289 . . . . 74.41 111.455 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 tt -130.54 111.79 12.58 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.559 -0.534 . . . . 75.24 109.559 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -119.36 141.91 48.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.106 -0.497 . . . . 71.1 110.137 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -124.71 84.49 2.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.269 -0.641 . . . . 74.53 109.269 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -97.57 121.0 38.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 70.23 109.757 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -107.6 78.67 1.22 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.517 0.675 . . . . 62.51 109.466 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -118.89 86.68 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.227 -0.897 . . . . 75.34 109.43 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -132.14 133.11 43.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.476 . . . . 75.01 110.156 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.672 -0.68 . . . . 74.52 109.821 176.334 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.927 0.394 . . . . 70.22 110.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -75.02 -75.03 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 73.24 110.614 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 21.71 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.362 0.601 . . . . 70.43 110.545 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.477 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 91.8 m95 -74.44 111.14 9.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.45 110.096 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' HD12 ' A' ' 106' ' ' ILE . 9.6 m -95.55 138.5 33.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 73.12 109.909 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -84.36 128.72 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.789 0.328 . . . . 61.25 110.837 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.92 -75.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.017 0.437 . . . . 72.31 110.081 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.0 m -151.64 -173.76 4.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 55.15 109.534 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.662 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 86.4 mttt -78.4 164.15 25.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 72.52 110.402 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.556 HD23 ' HA ' ' A' ' 37' ' ' GLU . 65.6 tp -75.4 -19.45 59.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.682 0.753 . . . . 74.23 109.046 167.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.51 -25.38 19.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.926 -1.034 . . . . 72.43 110.761 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.662 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 35.6 t70 -75.93 -21.56 56.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.444 0.64 . . . . 71.53 109.97 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.539 HD12 HG12 ' A' ' 30' ' ' VAL . 26.8 mt -97.29 104.56 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 51.31 109.469 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.4 mt -71.84 148.88 92.53 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 75.45 111.938 -173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.79 119.8 7.17 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.981 2.454 . . . . 73.34 112.017 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.38 33.24 4.59 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.96 -0.564 . . . . 53.44 112.058 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -133.62 176.96 8.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.305 0.574 . . . . 71.13 111.53 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.661 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 177.14 91.83 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.272 -1.131 . . . . 74.12 110.272 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.639 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.1 m -121.0 151.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.659 0.614 . . . . 73.0 112.659 -172.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.673 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 3.4 p -77.63 99.12 5.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.743 -0.662 . . . . 64.04 111.073 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.93 127.36 32.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 74.21 109.836 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.9 112.24 17.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.051 0.453 . . . . 63.12 109.922 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.08 107.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 72.41 109.622 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 67.11 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.72 -0.673 . . . . 72.4 111.785 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -138.88 0.75 2.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.227 0.537 . . . . 75.33 110.162 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -116.02 129.83 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.886 -0.597 . . . . 75.53 111.276 -173.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.673 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 39.5 mt-30 -89.14 113.99 25.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.351 -0.611 . . . . 72.51 109.351 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.09 117.71 55.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.796 -0.638 . . . . 74.01 110.625 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.404 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -79.97 119.51 22.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 72.32 110.119 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.661 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 18.8 t -100.91 108.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.268 -0.424 . . . . 74.54 109.931 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.499 ' HE1' ' HB3' ' A' ' 55' ' ' SER . 33.4 m-85 -79.48 117.98 20.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.296 -0.411 . . . . 75.24 110.598 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.577 HH11 ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -130.83 75.57 78.5 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 75.52 110.786 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.74 -34.89 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.037 2.491 . . . . 54.31 113.033 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.7 -179.67 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 70.5 111.296 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.28 18.88 18.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.757 -0.656 . . . . 72.11 109.852 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.568 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 23.3 t70 -83.13 -161.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 75.51 109.454 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.568 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 50.3 mt-10 -118.25 2.43 11.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.122 -0.361 . . . . 75.12 111.255 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 153.79 41.41 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 110.164 -0.31 . . . . 70.11 110.164 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.7 148.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.106 0.479 . . . . 65.21 111.598 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -137.92 100.2 4.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.427 -0.806 . . . . 74.03 109.913 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.682 ' HB2' HG21 ' A' ' 97' ' ' THR . . . -118.89 106.33 12.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.047 -0.524 . . . . 73.3 110.459 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.6 pt -132.35 164.58 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 72.45 109.757 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.556 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 56.1 m -78.41 65.72 3.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.49 . . . . 41.42 110.779 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.564 ' HA ' HG11 ' A' ' 92' ' ' VAL . 64.4 t30 -97.7 75.98 2.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 74.02 108.986 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.665 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.7 mm -125.18 137.65 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.628 -0.714 . . . . 72.21 111.128 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.91 117.98 69.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.417 -0.586 . . . . 75.43 109.417 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.86 -0.14 9.9 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.69 2.26 . . . . 73.55 113.276 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -88.85 -30.72 18.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.22 0.534 . . . . 74.35 109.737 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 -19.49 13.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.868 -0.605 . . . . 75.13 109.933 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 63.16 36.37 12.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.895 -1.048 . . . . 72.23 111.347 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.524 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -148.95 165.53 31.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 72.53 109.216 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.639 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 14.0 p -77.31 77.99 3.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.217 0.532 . . . . 62.33 111.302 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.68 -8.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 71.12 109.755 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.95 7.63 23.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.978 -1.01 . . . . 72.53 110.2 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.499 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 10.0 p -129.63 7.7 5.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.602 -0.726 . . . . 74.13 110.772 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -110.01 18.19 20.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 71.21 110.486 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.562 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -103.67 -158.93 24.71 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.527 -0.844 . . . . 71.31 112.428 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.457 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 74.1 mt -85.86 108.02 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.845 0.355 . . . . 70.23 110.389 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.474 HG22 HG11 ' A' ' 68' ' ' VAL . 84.9 t -71.56 91.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.871 -0.789 . . . . 53.41 108.871 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.45 145.99 30.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.47 0.652 . . . . 64.51 111.744 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -90.41 98.2 11.64 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.305 -0.861 . . . . 74.41 108.725 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.521 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 77.5 t60 -91.64 -45.29 8.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.487 -1.233 . . . . 73.13 110.076 -169.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -123.68 -148.11 0.39 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.148 -1.427 . . . . 72.02 107.148 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.98 44.25 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.179 -0.675 . . . . 75.34 109.179 171.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.439 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 5.6 t70 -157.55 -175.44 5.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.669 -0.493 . . . . 54.24 109.669 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.85 114.8 24.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 55.42 110.312 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.604 ' CZ3' ' HB2' ' A' ' 78' ' ' ARG . 46.8 m95 -122.28 127.35 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.862 -0.608 . . . . 74.42 110.243 -176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG11 HG22 ' A' ' 59' ' ' VAL . 15.9 m -89.13 126.46 42.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.363 0.601 . . . . 71.41 111.036 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -88.83 99.38 12.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.663 -0.699 . . . . 71.32 109.231 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -58.47 128.41 82.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.726 -0.67 . . . . 71.12 111.035 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.562 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.1 Cg_endo -71.01 -36.38 7.59 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 62.13 112.324 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.9 tp -89.73 -44.25 10.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 72.43 110.705 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 27.0 mmmt -81.43 -28.68 34.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 74.02 110.638 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 63.06 22.31 13.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.572 -0.74 . . . . 74.14 112.29 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.39 161.63 19.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.884 -0.598 . . . . 71.2 109.612 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -92.64 140.33 29.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.553 -0.294 . . . . 74.41 110.879 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' A' ' 90' ' ' TYR . 53.5 m-85 -128.95 139.27 52.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.079 -0.341 . . . . 71.32 110.079 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.649 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 52.6 ttt180 -96.55 127.38 42.49 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.74 -0.466 . . . . 74.52 109.74 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.45 -60.59 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.66 0.6 . . . . 74.13 111.403 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.56 77.25 2.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 74.52 109.836 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 22.6 t70 -178.2 -58.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.197 -0.91 . . . . 72.43 109.881 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . 102.97 -16.35 54.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.672 -0.775 . . . . 71.1 113.395 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.41 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 81.8 m-85 -85.83 162.42 18.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.052 0.426 . . . . 74.24 111.452 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.17 40.57 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.648 -0.705 . . . . 61.42 111.27 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.9 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.4 tp 60.5 -83.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.02 0.528 . . . . 75.23 111.859 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.9 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 43.4 mt-10 -110.73 -17.83 13.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.337 -0.392 . . . . 74.32 110.575 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -93.02 172.24 8.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 74.32 110.472 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.01 60.24 0.5 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.001 -0.84 . . . . 70.12 111.001 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.25 -27.41 15.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.997 0.369 . . . . 72.5 111.997 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.413 ' HD2' ' HZ ' ' A' ' 77' ' ' PHE . 22.3 m-85 -132.58 -68.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.337 0.495 . . . . 72.1 112.337 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 27.6 m 62.25 88.28 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 73.11 109.695 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.564 HG11 ' HA ' ' A' ' 44' ' ' ASN . 30.1 m -85.86 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.587 -0.733 . . . . 62.34 112.566 -169.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -89.95 169.18 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 72.23 111.037 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 120.17 8.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.839 0.352 . . . . 74.33 110.342 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.48 153.87 27.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.057 -0.519 . . . . 72.51 110.714 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.15 119.89 21.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 65.0 110.186 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.83 HG23 HG21 ' A' ' 106' ' ' ILE . 77.5 p -119.73 145.06 46.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.114 -0.494 . . . . 74.1 110.814 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -152.47 148.4 27.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 75.41 111.111 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 47.2 t -100.06 109.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.54 -0.755 . . . . 65.01 109.142 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.4 m -96.19 -63.26 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.176 0.512 . . . . 72.11 111.714 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -124.24 55.44 1.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.639 -0.709 . . . . 73.1 109.878 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.6 -1.31 62.15 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.031 -0.604 . . . . 72.25 112.233 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 29.9 p-10 -110.65 144.62 39.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 72.42 110.725 -177.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.1 113.31 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 70.45 110.058 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 21.5 mt-30 -106.52 135.66 47.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.171 -0.468 . . . . 75.31 110.529 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.83 HG21 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.42 150.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.328 -0.619 . . . . 62.53 109.328 174.019 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -89.08 101.88 14.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.919 0.39 . . . . 74.21 110.982 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.4 mm -95.18 96.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.25 0.548 . . . . 74.31 109.676 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.13 157.14 19.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.554 -0.748 . . . . 74.14 110.674 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.13 145.08 35.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.13 0.491 . . . . 63.15 110.774 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.4 m -150.63 -85.87 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.696 -0.684 . . . . 75.22 109.889 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -177.27 -146.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.036 -1.098 . . . . 60.52 108.036 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t 53.72 58.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.125 0.964 . . . . 62.41 110.928 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.1 83.57 1.8 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.098 -0.956 . . . . 60.15 110.24 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.07 167.27 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.004 -0.544 . . . . 70.12 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -124.23 110.34 14.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.942 -0.572 . . . . 72.15 109.674 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.23 158.73 42.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.81 -0.441 . . . . 70.22 109.81 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 m 65.69 95.66 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.935 0.772 . . . . 71.1 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 61.32 78.44 0.31 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.307 -0.861 . . . . 74.23 111.725 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.81 153.22 42.64 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.493 2.129 . . . . 74.23 111.975 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.59 92.74 48.75 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.748 0.309 . . . . 64.01 111.667 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.445 ' HD2' ' CE1' ' A' ' 125' ' ' HIS . 74.4 Cg_endo -76.53 175.63 11.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.415 2.077 . . . . 73.2 111.459 172.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.41 -51.19 54.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.974 0.416 . . . . 70.42 110.93 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.9 136.58 32.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.207 0.527 . . . . 74.14 111.614 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.445 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 92.8 m-70 -136.73 122.84 20.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.493 -0.776 . . . . 71.44 108.908 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -76.56 71.96 3.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.253 0.549 . . . . 72.24 110.813 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -103.22 153.93 19.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -145.53 113.68 6.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.296 0.569 . . . . 75.4 110.644 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -86.69 148.6 25.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.391 -0.822 . . . . 74.34 109.638 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.457 -0.783 . . . . 64.14 108.908 174.409 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -61.79 -60.97 2.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.671 0.619 . . . . 73.34 112.671 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.567 ' O ' ' HA ' ' A' ' 107' ' ' SER . 3.9 pt20 -89.48 -0.86 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 63.4 111.798 -173.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.511 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 98.5 m95 -118.27 95.02 4.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.909 -0.587 . . . . 75.13 109.733 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.3 m -92.81 135.1 34.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 75.24 110.84 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.521 HG21 ' HB3' ' A' ' 103' ' ' ASN . 85.2 m -76.49 121.35 22.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.083 -0.508 . . . . 74.22 110.585 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.447 HG21 HG22 ' A' ' 23' ' ' VAL . 54.1 t -80.61 -69.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.985 -0.552 . . . . 61.13 110.128 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 p -161.55 -179.46 7.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.702 -0.681 . . . . 64.31 110.172 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.12 137.6 40.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.951 0.405 . . . . 73.13 110.953 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.776 HD23 ' HB3' ' A' ' 37' ' ' GLU . 51.0 tp -70.94 -8.04 50.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.053 0.93 . . . . 74.44 109.354 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.33 -14.96 39.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.375 -1.284 . . . . 71.3 110.078 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -100.86 -25.4 14.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.924 -0.58 . . . . 72.5 110.513 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.22 113.5 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 52.51 110.674 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -71.61 129.52 88.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 70.13 111.661 -175.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.78 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 17.0 Cg_exo -67.79 128.92 18.73 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.314 2.676 . . . . 73.15 112.48 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 27.7 15.57 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.963 -0.637 . . . . 74.43 112.098 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.73 19.86 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.574 0.226 . . . . 75.21 111.199 -176.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 130.35 2.16 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 74.03 111.445 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.51 174.72 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.963 0.382 . . . . 53.01 111.31 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.741 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.1 p -80.63 138.92 36.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.867 -0.606 . . . . 71.34 111.614 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.68 127.76 45.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.41 -0.814 . . . . 51.11 109.523 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -84.66 100.6 11.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.431 -0.581 . . . . 64.2 109.431 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.447 HG22 HG21 ' A' ' 7' ' ' VAL . 48.4 t -107.29 112.27 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 53.31 109.832 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 63.97 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.775 -0.648 . . . . 74.03 110.48 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.7 -6.51 3.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.281 0.562 . . . . 74.15 109.936 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.621 ' HB3' HD13 ' A' ' 28' ' ' ILE . 1.7 mm100 -89.97 138.78 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.685 -0.689 . . . . 73.2 112.023 -171.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.745 ' HB3' HG13 ' A' ' 45' ' ' ILE . 51.7 mt-30 -100.59 103.44 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 74.0 109.554 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.621 HD13 ' HB3' ' A' ' 26' ' ' GLN . 3.2 mp -119.21 142.15 35.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.246 -0.279 . . . . 64.02 110.246 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.47 131.63 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.473 -0.566 . . . . 73.12 109.473 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.96 99.75 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.024 0.44 . . . . 73.05 110.456 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.448 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 42.3 m-85 -75.78 125.12 28.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.725 . . . . 74.04 110.507 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -110.78 87.35 6.68 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.113 -1.069 . . . . 70.52 108.113 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.89 -13.32 13.0 Favored 'Trans proline' 0 CA--C 1.517 -0.349 0 C-N-CA 122.588 2.192 . . . . 74.21 112.933 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -117.21 163.37 16.4 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.864 -0.607 . . . . 73.31 110.213 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.78 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 m-20 -79.9 -1.92 41.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 73.55 109.562 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.484 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 37.5 t70 -92.76 178.56 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.073 -0.967 . . . . 74.52 109.534 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.776 ' HB3' HD23 ' A' ' 10' ' ' LEU . 41.9 mt-10 -86.14 46.55 1.34 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.127 0.489 . . . . 61.04 111.547 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -117.53 128.93 55.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.425 -0.583 . . . . 71.5 109.425 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.73 162.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 70.55 112.428 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.448 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 49.0 m-85 -132.66 106.73 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.245 -0.889 . . . . 75.05 110.38 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.722 ' HB2' HG23 ' A' ' 97' ' ' THR . . . -97.14 101.59 13.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.894 0.378 . . . . 73.35 111.277 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -129.87 155.06 41.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 65.23 109.956 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 m -90.81 85.99 6.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 111.94 0.348 . . . . 75.05 111.94 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.769 ' HB3' HG11 ' A' ' 92' ' ' VAL . 21.7 p30 -135.39 65.5 1.55 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.855 0.836 . . . . 74.23 111.017 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.745 HG13 ' HB3' ' A' ' 27' ' ' GLN . 10.6 mm -84.04 -15.79 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.316 -0.856 . . . . 74.55 111.282 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.611 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 10.9 t70 66.62 121.13 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.939 -1.028 . . . . 74.31 110.714 -174.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.7 Cg_exo -75.01 -4.36 15.29 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.986 2.457 . . . . 64.24 113.523 -173.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.24 -31.91 11.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.744 0.307 . . . . 75.05 110.847 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.03 -31.65 7.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.825 0.345 . . . . 72.45 110.896 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 63.71 16.61 9.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.543 -0.753 . . . . 72.5 112.412 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.9 23.85 4.97 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.159 -0.338 . . . . 54.35 111.21 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.5 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 14.9 m 61.87 58.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 74.11 111.418 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.648 HG23 HD11 ' A' ' 72' ' ' LEU . 20.6 m -79.62 -14.11 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.301 0.572 . . . . 55.11 109.901 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.611 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 49.4 mt -74.78 -23.52 58.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.749 -0.834 . . . . 73.23 108.749 172.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.5 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 1.1 m -90.59 -38.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.231 -0.895 . . . . 73.45 110.034 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -80.64 29.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.56 -0.745 . . . . 74.44 111.112 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.96 -147.2 21.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.381 -0.688 . . . . 73.24 111.381 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.45 102.18 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.143 0.497 . . . . 73.44 110.397 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.3 t -83.82 94.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.39 -0.823 . . . . 74.31 109.3 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 179.76 3.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.116 -0.493 . . . . 72.12 111.267 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' HG2' HD22 ' A' ' 66' ' ' LEU . 23.8 mt-10 -116.02 155.59 27.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.6 -0.727 . . . . 63.41 110.614 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -127.1 39.23 3.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.936 -1.135 . . . . 70.23 107.936 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 69.28 103.2 0.06 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.128 -1.396 . . . . 75.43 110.6 -171.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.3 t70 75.8 -53.05 0.63 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.863 -1.062 . . . . 62.1 111.55 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -76.2 143.88 40.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.208 0.527 . . . . 72.1 110.969 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.412 HD22 ' HG2' ' A' ' 61' ' ' GLU . 92.6 mt -103.52 120.25 40.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 71.35 109.768 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.537 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 58.5 m95 -124.49 117.1 23.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 74.12 110.423 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.08 130.3 42.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.018 0.437 . . . . 63.12 110.259 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.46 116.54 32.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.903 -0.59 . . . . 72.53 110.111 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.7 p -81.2 138.16 48.98 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.951 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.03 -29.84 26.68 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.413 2.075 . . . . 65.25 112.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.648 HD11 HG23 ' A' ' 53' ' ' VAL . 74.8 mt -86.83 -52.21 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 75.13 111.405 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -32.48 29.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.426 -0.352 . . . . 74.12 110.854 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt 62.24 37.75 13.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.742 -0.663 . . . . 72.31 111.215 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -115.62 146.89 41.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 71.11 109.753 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.435 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 66.0 m80 -91.42 116.35 28.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.012 -0.54 . . . . 71.1 110.604 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -105.77 121.3 43.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.243 -0.435 . . . . 75.23 110.038 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.462 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.9 ttp180 -84.58 129.99 34.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.916 -0.401 . . . . 75.41 109.916 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.07 95.34 0.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.296 0.569 . . . . 72.05 111.032 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -161.31 -58.95 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.449 -0.945 . . . . 75.54 108.449 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.476 ' HA ' ' CB ' ' A' ' 94' ' ' ALA . 7.3 m-20 -138.23 -83.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.835 -1.075 . . . . 53.3 108.985 170.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . -159.28 32.34 0.45 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.596 -0.729 . . . . 63.12 111.539 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -71.25 120.24 16.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.758 0.314 . . . . 64.41 110.731 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 8.6 m -100.83 141.74 33.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.734 -0.667 . . . . 74.13 110.099 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.537 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 53.9 tp -71.17 -64.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 73.51 111.818 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.4 pm0 -85.73 -51.84 6.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.994 0.368 . . . . 71.03 111.994 -173.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 9.9 t70 -115.8 -151.92 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.461 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . -172.14 48.38 0.18 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.865 -0.894 . . . . 74.24 110.865 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.04 -25.32 67.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.112 0.412 . . . . 63.44 112.112 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -128.54 -57.98 1.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.886 -0.326 . . . . 75.04 111.332 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 49.3 m 57.05 83.01 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.479 0.657 . . . . 75.4 109.749 -173.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.769 HG11 ' HB3' ' A' ' 44' ' ' ASN . 23.3 m -70.99 166.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.019 -0.991 . . . . 74.23 112.605 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.49 146.39 25.81 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 53.44 110.714 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -124.79 107.86 11.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 64.31 110.532 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.543 ' HE1' ' HB2' ' A' ' 109' ' ' ALA . 91.2 m-85 -84.11 144.31 29.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.678 -0.692 . . . . 75.41 109.463 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.34 136.07 49.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.781 0.324 . . . . 63.22 110.353 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.765 HG22 HG23 ' A' ' 106' ' ' ILE . 79.2 p -127.77 144.46 51.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 64.31 110.512 -175.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 8.9 pt20 -140.11 141.8 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 74.25 110.93 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.681 HG13 HD22 ' A' ' 10' ' ' LEU . 37.5 t -110.48 98.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.566 -0.743 . . . . 70.04 109.214 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -128.02 -1.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 63.12 111.42 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.506 ' C ' ' H ' ' A' ' 103' ' ' ASN . 8.4 t-20 -136.36 24.99 3.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.374 0.607 . . . . 71.53 110.222 -175.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.89 -23.32 2.61 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.752 -0.737 . . . . 64.24 111.516 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 6' ' ' THR . 41.6 m-80 -103.57 153.82 20.17 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.362 -0.607 . . . . 73.04 109.362 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.531 HG23 HG23 ' A' ' 99' ' ' VAL . 45.0 t -90.08 120.11 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.947 -0.39 . . . . 74.34 109.947 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -114.14 127.06 55.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 71.44 109.892 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.765 HG23 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.21 152.98 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.15 110.977 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 25.4 t -82.69 107.31 15.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.166 -0.679 . . . . 64.02 109.166 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.522 HD11 ' O ' ' A' ' 108' ' ' ILE . 1.7 pp -81.51 121.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.705 0.764 . . . . 73.24 112.275 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.543 ' HB2' ' HE1' ' A' ' 95' ' ' TYR . . . -110.29 24.41 13.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.396 -0.82 . . . . 74.34 108.875 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.57 141.93 44.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.423 -1.262 . . . . 74.0 111.212 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.7 m -123.75 -77.17 0.59 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.906 -0.588 . . . . 74.41 110.009 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -150.37 113.26 4.79 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.44 -0.346 . . . . 62.32 110.604 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.66 132.97 41.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.007 0.432 . . . . 74.05 110.104 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.16 95.98 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.333 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.3 m -78.74 168.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.657 -0.701 . . . . 73.1 111.103 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -84.47 -169.41 2.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.984 -0.747 . . . . 74.04 108.984 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -79.7 115.33 19.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.384 0.612 . . . . 74.32 110.337 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -68.97 -42.08 77.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.627 -0.715 . . . . 61.32 109.498 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.422 ' CD ' ' H ' ' A' ' 119' ' ' GLN . 5.1 pm0 -89.0 128.78 50.63 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.385 -0.825 . . . . 64.43 109.988 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 4.7 Cg_exo -75.73 176.77 9.57 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.976 2.451 . . . . 72.35 112.372 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.42 137.12 26.16 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.581 . . . . 75.03 109.935 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.44 117.77 4.72 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.534 2.156 . . . . 72.05 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.75 165.99 14.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.988 -0.551 . . . . 74.21 110.665 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -118.89 135.95 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 74.11 110.501 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -139.4 109.03 6.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.192 -0.669 . . . . 75.54 109.192 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -58.26 123.46 16.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.06 -0.518 . . . . 72.45 111.489 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -60.31 126.68 28.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.522 -0.763 . . . . 72.15 110.195 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -96.78 109.78 22.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.4 0.619 . . . . 73.13 111.221 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -147.13 142.1 26.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.033 -0.985 . . . . 63.23 108.948 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.633 -0.698 . . . . 74.21 109.786 177.927 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.97 0.414 . . . . 62.13 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -85.52 -158.31 0.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.006 -0.543 . . . . 73.11 110.168 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 15.6 mm-40 -70.56 77.42 0.58 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.18 0.514 . . . . 74.25 111.395 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 96.0 m95 -116.26 96.58 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.418 -0.81 . . . . 74.12 109.437 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.4 m -77.07 119.3 20.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.354 -0.384 . . . . 74.21 110.633 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 21.2 m -68.81 113.13 5.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.058 -0.519 . . . . 62.32 109.743 175.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.36 -65.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.169 0.509 . . . . 63.43 111.246 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.779 ' SG ' HG12 ' A' ' 13' ' ' ILE . 34.1 t -134.11 167.56 20.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.904 -0.589 . . . . 64.35 110.874 -172.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.508 ' C ' ' H ' ' A' ' 11' ' ' ASP . 16.0 tptm -84.93 2.96 40.46 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.978 -0.555 . . . . 63.13 110.27 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 67.5 tp 71.77 -40.49 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.855 -1.066 . . . . 71.11 111.018 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' H ' ' C ' ' A' ' 9' ' ' LYS . 28.8 t70 -74.25 -32.56 63.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.374 -0.83 . . . . 71.25 111.231 -175.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -84.67 9.9 12.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.911 -0.716 . . . . 63.24 111.342 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.779 HG12 ' SG ' ' A' ' 8' ' ' CYS . 37.2 mm -90.55 128.93 42.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.719 -0.474 . . . . 63.22 109.719 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.96 125.99 92.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 71.1 111.3 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.17 126.82 17.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.837 2.358 . . . . 45.42 112.459 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 30.86 29.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 70.3 111.553 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.504 HG23 ' H ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -150.54 173.98 13.48 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.308 . . . . 72.41 110.864 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' H ' HG23 ' A' ' 17' ' ' THR . . . -148.04 142.88 10.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.175 -1.17 . . . . 75.21 110.175 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 m -134.3 146.83 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 117.822 0.811 . . . . 73.11 112.605 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 3.5 p -75.54 111.94 11.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.729 -0.668 . . . . 72.22 110.713 174.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.07 109.55 20.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.931 -0.577 . . . . 61.1 109.878 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.15 103.15 3.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.298 -0.63 . . . . 75.31 109.298 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.412 ' HB ' ' HB2' ' A' ' 26' ' ' GLN . 16.3 t -94.22 161.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.6 -0.889 . . . . 61.53 108.6 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.81 -53.16 10.07 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.52 0.512 . . . . 75.24 112.246 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -130.36 23.02 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.614 0.245 . . . . 74.13 111.226 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.412 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 20.2 mm-40 -138.4 157.63 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.107 0.479 . . . . 74.24 112.064 -174.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.447 ' HB3' HG13 ' A' ' 45' ' ' ILE . 50.3 mt-30 -127.6 103.31 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.653 -0.703 . . . . 71.34 110.461 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -121.21 135.94 59.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.324 -0.398 . . . . 63.35 110.254 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.711 ' HB2' HD12 ' A' ' 45' ' ' ILE . . . -100.51 134.62 43.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.743 -0.465 . . . . 71.34 109.743 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.482 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 39.8 t -111.06 108.44 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.808 -0.357 . . . . 55.14 110.343 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.835 ' HZ ' ' HB3' ' A' ' 44' ' ' ASN . 2.8 m-85 -93.55 128.0 39.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.906 -0.588 . . . . 72.01 110.148 -178.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.516 ' HG3' HG12 ' A' ' 39' ' ' VAL . 55.3 ttt180 -119.74 86.67 35.92 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 108.765 -0.828 . . . . 65.11 108.765 172.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 -36.84 91.72 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.853 2.368 . . . . 74.31 112.166 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.486 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.5 mtm180 -133.24 163.96 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 65.44 109.551 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.97 56.47 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.624 0.726 . . . . 65.45 110.243 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.82 -171.61 2.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.503 -0.771 . . . . 71.43 109.72 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.6 0.04 56.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 73.54 111.09 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.99 99.33 12.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.979 0.419 . . . . 71.33 110.3 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.516 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.5 m -125.32 165.57 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 62.54 110.818 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -133.04 107.34 8.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.983 -0.553 . . . . 72.14 110.77 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' HB2' HG22 ' A' ' 97' ' ' THR . . . -106.79 96.43 6.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.03 0.443 . . . . 74.41 110.714 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.3 164.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 74.21 109.6 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.8 m -76.89 53.83 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.043 0.449 . . . . 74.03 111.865 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.835 ' HB3' ' HZ ' ' A' ' 31' ' ' PHE . 53.8 t30 -100.93 67.03 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.625 0.726 . . . . 73.53 109.294 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.711 HD12 ' HB2' ' A' ' 29' ' ' ALA . 30.8 mm -97.05 -21.05 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.107 -0.951 . . . . 75.54 111.555 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.72 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 32.1 t0 63.2 96.97 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.152 -0.931 . . . . 64.43 109.259 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.449 ' HD2' ' CD2' ' A' ' 90' ' ' TYR . 32.2 Cg_exo -60.31 -1.05 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.622 2.881 . . . . 64.42 113.57 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -92.4 -15.04 27.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.557 0.218 . . . . 73.32 110.822 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -129.43 -31.02 2.08 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.817 0.673 . . . . 63.01 112.817 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.7 mp0 76.35 -14.14 0.84 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.017 0.747 . . . . 75.24 113.017 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -111.3 34.53 4.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.108 0.41 . . . . 72.31 112.108 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 53.0 p 47.55 56.4 7.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.282 0.563 . . . . 73.15 111.584 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 m -76.44 -2.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.497 0.665 . . . . 72.21 110.133 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 82.9 mt -92.58 23.36 4.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.086 -0.961 . . . . 74.43 109.583 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.552 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 77.2 p -145.12 -39.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 65.52 110.858 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -81.37 59.33 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 64.13 109.685 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.4 -110.38 0.44 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.401 -0.818 . . . . 63.22 111.524 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.474 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 50.5 mm -119.74 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.159 0.504 . . . . 73.24 110.694 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.78 101.7 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.141 -1.059 . . . . 75.41 108.141 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 116.19 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.913 -0.585 . . . . 73.33 112.497 -169.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.99 103.67 3.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.043 -1.095 . . . . 74.45 108.043 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -58.96 -57.24 13.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.869 -0.605 . . . . 71.23 110.656 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -141.64 -66.81 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.731 -0.668 . . . . 73.32 109.371 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.08 -7.63 8.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.181 -0.918 . . . . 65.12 110.331 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.562 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.5 t70 -122.54 171.63 8.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 74.42 110.115 -173.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.98 112.48 24.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.061 0.458 . . . . 73.53 110.955 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.712 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 9.3 m95 -124.65 168.14 13.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.577 -0.897 . . . . 75.52 108.577 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.456 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 14.4 p -131.94 144.75 36.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.769 0.318 . . . . 61.14 110.541 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -103.83 127.64 51.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.537 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.567 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 47.5 t -90.77 132.94 33.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 73.15 110.427 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.9 -17.3 37.03 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.648 2.232 . . . . 71.02 112.182 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.33 -52.85 4.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 52.21 109.868 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.567 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.1 pttm -125.9 103.38 7.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.601 -0.727 . . . . 74.44 109.147 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.7 77.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 72.33 112.178 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -130.72 151.37 51.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 64.31 109.022 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -88.92 93.26 9.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.555 0.217 . . . . 74.44 110.877 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.6 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 33.4 m-85 -78.81 121.87 25.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 71.01 109.656 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 49.4 ttt180 -80.04 122.65 27.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.867 -0.333 . . . . 74.21 110.583 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 62.11 111.353 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -106.84 16.46 24.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.329 0.585 . . . . 73.41 110.558 -177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.542 ' CB ' ' HD3' ' A' ' 78' ' ' ARG . 9.8 t70 -147.92 -65.21 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.1 111.191 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.04 -30.03 4.22 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.037 -0.601 . . . . 73.53 111.817 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.45 153.67 42.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 64.21 110.307 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.3 m -100.41 29.49 4.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 73.15 111.702 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.712 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 56.5 tp 53.89 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.452 0.908 . . . . 75.01 113.452 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -73.15 -21.71 60.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.695 . . . . 74.54 111.782 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.423 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 3.4 t70 -166.51 -160.68 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.777 -0.823 . . . . 74.32 108.777 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 89' ' ' ALA . . . -122.08 -155.14 9.33 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 110.24 -1.144 . . . . 52.13 110.24 174.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 88' ' ' GLY . . . 171.39 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.373 0.606 . . . . 75.4 110.018 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CD2' ' HD2' ' A' ' 47' ' ' PRO . 94.9 m-85 -147.25 108.54 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.139 -0.937 . . . . 64.33 108.687 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 m -56.87 105.59 0.23 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 74.31 110.456 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.0 m -94.35 156.07 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.277 -0.419 . . . . 60.2 110.959 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.4 121.43 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.535 . . . . 63.45 111.51 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.36 94.72 8.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 70.3 110.057 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -75.46 164.56 26.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.557 -0.747 . . . . 72.12 111.381 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 21.6 t70 -86.04 132.24 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.342 -0.614 . . . . 73.41 109.342 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.734 HG21 HG22 ' A' ' 106' ' ' ILE . 51.7 p -128.06 144.49 51.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.342 -0.39 . . . . 74.41 111.081 -173.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.42 148.77 49.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.94 0.4 . . . . 71.33 110.653 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.48 103.11 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.915 -0.584 . . . . 71.02 109.504 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 m -83.32 77.99 9.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.832 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 71.83 -44.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.84 0.856 . . . . 64.33 112.348 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.06 -49.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.059 -0.591 . . . . 71.3 112.039 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -80.4 151.73 29.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.028 0.442 . . . . 73.42 110.855 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.94 127.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 75.4 110.457 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 23.6 mt-30 -120.47 137.22 54.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 74.1 110.483 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.734 HG22 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -113.82 149.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.107 -0.331 . . . . 75.13 110.107 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -84.99 105.05 15.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.62 . . . . 74.1 109.327 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 pt -82.85 147.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.089 0.471 . . . . 74.5 111.288 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.71 151.84 22.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 41.25 109.691 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.91 172.61 13.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.051 -0.351 . . . . 71.42 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 t -152.18 -60.34 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.748 -0.381 . . . . 75.21 111.327 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t70 65.54 100.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.257 0.551 . . . . 74.43 110.448 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 p -156.88 149.31 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.087 -0.506 . . . . 74.32 110.274 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 126.73 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.837 0.351 . . . . 63.33 110.538 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.18 155.25 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 75.53 111.493 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.03 125.24 29.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.577 -0.738 . . . . 74.24 109.954 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.84 128.09 34.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.336 0.588 . . . . 72.12 111.685 -178.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 t -118.16 -1.92 11.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.051 -0.522 . . . . 73.41 110.926 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.55 96.2 45.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 121.135 -0.226 . . . . 75.14 111.023 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.499 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 3.8 Cg_exo -77.67 125.33 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.583 2.189 . . . . 64.14 110.532 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.97 105.5 24.32 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.812 0.339 . . . . 75.55 110.935 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 95.3 Cg_endo -91.48 20.55 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.124 2.549 . . . . 45.53 112.18 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' O ' HD11 ' A' ' 123' ' ' LEU . 2.6 pp -77.42 145.77 36.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.308 -0.86 . . . . 74.34 109.437 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.21 168.38 18.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.454 0.645 . . . . 75.55 112.419 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -159.04 74.86 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.69 -1.141 . . . . 64.41 109.177 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -76.84 112.68 13.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.9 -0.591 . . . . 75.52 109.962 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -104.13 137.06 42.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.918 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -72.45 130.95 41.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.948 -0.39 . . . . 74.1 109.948 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -91.3 -48.47 6.9 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.117 -0.697 . . . . 71.4 109.117 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.298 -0.865 . . . . 73.43 108.689 174.149 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.686 ' H2 ' ' HB2' ' A' ' 4' ' ' TRP . 47.2 ttm . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.516 0.198 . . . . 54.44 110.828 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 67.6 -75.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.242 0.617 . . . . 74.02 112.181 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -85.9 14.34 6.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.39 0.615 . . . . 75.32 110.348 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.686 ' HB2' ' H2 ' ' A' ' 1' ' ' MET . 57.4 m95 -129.14 125.38 36.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.132 -0.94 . . . . 75.31 109.041 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -112.62 136.18 52.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 74.41 111.732 -177.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.501 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 25.9 m -67.55 114.37 6.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.656 -0.702 . . . . 73.31 110.873 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.491 ' CG2' HD13 ' A' ' 106' ' ' ILE . 46.4 t -89.38 -78.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 75.42 111.171 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.428 ' SG ' HG11 ' A' ' 7' ' ' VAL . 86.0 m -143.44 177.8 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 72.24 110.677 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' ILE . 43.3 mtmt -84.29 117.68 23.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.582 -0.735 . . . . 72.3 110.384 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . 56.9 tp -66.34 -21.13 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.408 0.623 . . . . 74.52 110.429 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.97 -13.27 56.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.437 -0.801 . . . . 72.31 109.794 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.47 -29.94 10.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.172 -0.922 . . . . 73.32 110.412 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 9' ' ' LYS . 77.4 mt -68.67 122.03 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 74.54 110.741 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 6.3 mp -68.92 142.01 92.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 70.54 111.258 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.72 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 15.3 Cg_exo -69.16 142.01 49.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.872 2.382 . . . . 73.54 111.571 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.76 29.54 38.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.214 -0.517 . . . . 71.22 111.9 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.688 HG22 ' H ' ' A' ' 18' ' ' GLY . 2.0 m -139.54 177.81 7.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.057 -0.349 . . . . 74.03 110.057 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.688 ' H ' HG22 ' A' ' 17' ' ' THR . . . 178.0 118.97 0.57 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.657 -0.577 . . . . 42.14 111.657 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.545 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 28.1 m -129.45 156.0 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.926 0.363 . . . . 71.31 111.712 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.776 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 4.7 p -80.42 107.95 13.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 73.13 110.895 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 138.15 31.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.534 . . . . 75.43 110.058 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -82.75 100.36 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 70.22 109.86 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.32 97.85 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.941 -0.572 . . . . 63.31 109.52 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 64.84 -76.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.817 0.698 . . . . 65.2 111.719 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.88 6.04 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.612 0.244 . . . . 74.55 111.132 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -115.73 145.46 42.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.464 -0.335 . . . . 75.2 111.155 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -105.47 126.63 52.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.532 . . . . 74.51 109.562 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 5.0 mp -130.96 130.35 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 64.24 109.189 177.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.83 113.95 21.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.246 -0.434 . . . . 75.43 110.03 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.541 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.1 t -97.16 98.44 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.045 -0.525 . . . . 63.22 110.416 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.452 ' HZ ' HG23 ' A' ' 68' ' ' VAL . 18.6 m-85 -76.21 138.74 40.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.339 -0.846 . . . . 72.13 111.313 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -123.41 76.14 53.44 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 109.121 -0.696 . . . . 74.45 109.121 164.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.39 -24.37 19.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.735 2.29 . . . . 75.24 111.267 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 3.4 mmp_? -94.74 137.11 34.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.077 -0.965 . . . . 74.11 110.251 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.72 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 31.4 p-10 -86.94 14.04 8.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 73.24 109.982 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 3.4 p-10 -113.75 -93.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.457 -0.792 . . . . 72.41 111.352 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.431 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 49.0 mt-10 -121.27 -52.64 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.963 0.727 . . . . 74.25 112.963 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 -55.72 130.92 45.23 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.267 0.84 . . . . 71.44 113.267 -169.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.4 m -128.72 170.23 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.207 -0.906 . . . . 72.13 109.846 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -144.72 111.31 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.769 0.319 . . . . 72.13 111.686 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.19 103.61 15.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.873 0.368 . . . . 63.35 110.258 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' A' ' 94' ' ' ALA . 34.1 pt -122.39 161.85 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.788 0.328 . . . . 71.32 111.353 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -76.88 46.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 61.2 111.126 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.401 ' N ' HD13 ' A' ' 45' ' ' ILE . 65.9 t30 -95.5 61.43 2.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.619 0.724 . . . . 73.32 110.776 -171.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.485 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.2 mp -123.12 129.64 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.299 -0.864 . . . . 72.23 110.024 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.3 t70 -87.6 123.91 68.59 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 74.32 109.691 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 25.4 Cg_exo -63.84 -22.22 69.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.299 2.666 . . . . 73.21 113.806 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.76 -22.22 37.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.333 0.587 . . . . 74.43 110.465 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.01 -20.14 13.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 71.21 109.851 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 59.2 28.65 18.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.82 -1.082 . . . . 62.43 109.99 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.776 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -150.83 165.52 33.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.136 -0.938 . . . . 75.31 109.864 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.936 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 3.8 p -80.75 56.93 2.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 65.3 111.258 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.12 -9.72 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.618 . . . . 74.42 110.368 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -95.0 -1.46 52.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.321 -0.854 . . . . 74.4 109.25 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.936 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 25.9 t -113.12 -52.46 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.205 -0.907 . . . . 71.44 110.862 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -83.78 59.97 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 64.43 109.696 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.65 -91.26 0.53 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 114.835 -1.075 . . . . 36.88 111.963 177.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.744 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 58.9 mt -129.09 132.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 74.43 110.247 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.23 121.22 58.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.215 -0.661 . . . . 72.05 109.215 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.77 162.51 34.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.08 0.466 . . . . 65.35 111.185 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.454 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -87.15 157.15 19.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.707 -0.679 . . . . 72.41 110.263 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.487 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 82.8 t60 -131.36 96.19 3.94 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.691 -0.485 . . . . 74.33 109.691 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 73.79 -55.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.857 -1.065 . . . . 72.15 111.792 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.88 -36.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.966 0.412 . . . . 73.35 110.828 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.401 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 1.3 m-20 -89.24 169.84 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 73.44 111.542 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.8 mt -108.93 123.79 49.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.492 -0.776 . . . . 73.11 109.898 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.487 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 11.8 m95 -130.84 174.94 9.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.204 -0.665 . . . . 65.44 109.204 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.4 p -120.09 145.28 26.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.955 -0.387 . . . . 71.12 109.955 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.744 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -110.02 103.54 12.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.173 0.511 . . . . 51.1 110.539 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -73.89 124.68 90.37 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 65.31 110.36 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -61.0 -32.45 92.36 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.792 2.328 . . . . 65.14 112.874 -177.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.3 -63.65 1.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.388 -0.369 . . . . 74.14 111.425 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.803 ' HE3' ' HE2' ' A' ' 90' ' ' TYR . 73.2 mmtt -71.87 -26.55 62.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.32 112.022 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 62.69 15.88 8.45 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.065 0.546 . . . . 73.43 111.733 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 79.6 mt-30 -80.3 141.81 35.12 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.959 -0.564 . . . . 74.31 109.625 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.59 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 29.1 m80 -104.57 96.44 6.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 74.3 110.246 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.441 ' HB2' HG11 ' A' ' 68' ' ' VAL . 58.9 m-85 -82.42 121.22 26.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.767 -0.457 . . . . 71.43 109.767 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 23.8 ttp85 -71.5 127.59 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.747 -0.834 . . . . 71.31 108.747 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.427 HD22 ' HB ' ' A' ' 68' ' ' VAL . 87.5 mt -72.72 67.46 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 60.13 113.059 -167.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 t80 168.68 -52.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.975 0.91 . . . . 71.01 109.592 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.95 -44.0 61.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 73.4 111.587 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.77 -15.37 44.97 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.474 -0.87 . . . . 54.34 113.183 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.26 135.65 57.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.108 -0.331 . . . . 72.13 110.108 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 2.5 m -90.54 22.59 3.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.022 -0.536 . . . . 72.11 111.476 -172.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp 59.41 -73.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.716 0.806 . . . . 62.32 112.277 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -81.6 -49.99 9.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.289 0.566 . . . . 74.23 110.724 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -105.51 -175.53 2.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.513 -0.767 . . . . 70.21 110.419 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.48 32.71 0.77 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.824 -0.91 . . . . 43.35 110.824 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.04 -48.25 18.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.039 0.447 . . . . 74.53 110.874 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.803 ' HE2' ' HE3' ' A' ' 73' ' ' LYS . 56.5 m-85 -102.58 79.56 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.265 0.555 . . . . 63.45 110.037 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -73.18 82.72 1.32 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.627 -0.715 . . . . 61.45 109.695 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -78.69 149.69 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.596 -0.729 . . . . 73.21 111.753 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.32 165.58 11.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.849 -0.614 . . . . 73.01 110.187 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.582 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -122.27 105.06 9.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.062 0.458 . . . . 61.11 110.343 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.66 129.83 34.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.865 -0.607 . . . . 62.21 110.201 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.9 153.89 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.766 -0.652 . . . . 74.13 110.76 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.795 HG21 HG22 ' A' ' 106' ' ' ILE . 30.8 p -133.54 133.66 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.293 -0.412 . . . . 73.12 110.931 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -114.86 150.67 35.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.388 . . . . 75.22 110.024 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 t -102.98 96.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.99 -0.55 . . . . 72.3 109.922 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.0 m -66.99 -63.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.994 -0.548 . . . . 74.32 111.014 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -173.75 95.67 0.1 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.607 -0.724 . . . . 75.1 109.781 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.13 -40.86 2.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.152 -0.547 . . . . 71.1 112.369 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -104.21 151.64 23.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 73.42 110.604 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 47.9 t -101.47 135.99 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 60.14 110.661 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 75.8 mt-30 -118.2 127.06 53.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 74.24 110.151 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.795 HG22 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -100.25 155.17 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 63.44 110.83 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -77.02 124.07 27.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.709 -0.678 . . . . 74.14 110.407 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 pt -116.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.259 0.552 . . . . 74.23 110.935 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.61 19.54 7.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.444 0.64 . . . . 74.15 110.481 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.6 150.92 21.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.145 -0.934 . . . . 63.52 108.644 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 t -137.13 17.2 2.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.116 0.26 . . . . 74.24 110.762 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 53.88 84.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.288 0.566 . . . . 72.14 109.637 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.8 m -67.49 133.56 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.656 -0.702 . . . . 73.14 112.437 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.33 -175.0 5.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.146 -0.934 . . . . 51.55 108.812 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.14 70.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 122.821 1.296 . . . . 43.03 110.683 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 117' ' ' ASN . 25.1 t70 55.03 -158.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.224 -1.807 . . . . 74.34 110.084 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.517 ' H ' ' CG ' ' A' ' 116' ' ' ASP . 6.9 p30 -165.59 167.96 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.053 -0.404 . . . . 54.32 110.467 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.2 t -117.25 79.45 1.34 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.099 -0.704 . . . . 65.45 109.099 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.8 114.82 13.49 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.584 -0.735 . . . . 64.11 111.061 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.444 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 3.8 Cg_endo -85.49 106.63 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.844 2.363 . . . . 71.43 110.457 173.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.56 107.6 2.4 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.384 -0.371 . . . . 74.35 111.106 -174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 93.1 Cg_endo -88.77 146.99 5.82 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.867 2.378 . . . . 65.45 111.84 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 pp -91.31 135.61 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.23 0.538 . . . . 71.33 110.178 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -100.05 176.81 5.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.376 -0.972 . . . . 75.05 108.376 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.471 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 41.4 m80 -72.01 76.94 0.92 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.31 -0.996 . . . . 74.22 108.31 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -75.51 95.14 3.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 73.14 110.736 -171.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -86.03 85.02 7.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.768 -0.651 . . . . 71.03 110.757 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -98.02 89.94 4.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.91 -0.586 . . . . 74.33 109.774 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -95.01 -49.01 5.73 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.983 -0.747 . . . . 53.24 108.983 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.1 p80 . . . . . 0 C--O 1.244 0.794 0 CA-C-N 115.456 -0.793 . . . . 73.23 109.078 173.483 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.78 0.324 . . . . 73.32 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 t -89.14 -171.49 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.852 -0.613 . . . . 74.33 110.272 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -83.91 104.24 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.987 -0.551 . . . . 61.42 110.142 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.49 136.59 52.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.375 . . . . 75.22 110.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -118.74 128.47 54.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.222 -0.445 . . . . 63.3 110.353 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.595 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.6 m -78.14 113.7 16.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.175 -0.466 . . . . 74.52 110.77 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.11 -75.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.07 0.462 . . . . 75.24 109.848 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.3 m -144.34 168.44 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 72.12 109.189 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 9.8 mtmp? -91.17 165.81 13.28 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.992 -0.283 . . . . 64.14 110.578 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 tp -71.27 -7.59 47.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.496 0.665 . . . . 74.04 110.124 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.65 -20.29 21.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.216 -0.902 . . . . 72.11 110.002 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.404 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 18.4 m-20 -83.47 -27.18 29.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 73.54 110.694 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.87 136.99 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.87 -0.604 . . . . 73.24 110.572 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.42 ' HB2' HG21 ' A' ' 17' ' ' THR . 5.2 mp -91.53 149.04 38.7 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.621 -0.263 . . . . 74.04 110.977 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.98 121.41 8.89 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.562 2.175 . . . . 74.42 111.696 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 45.72 6.24 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.93 -0.577 . . . . 74.43 112.198 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.42 HG21 ' HB2' ' A' ' 14' ' ' LEU . 72.5 p -141.61 174.9 10.13 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.954 0.377 . . . . 63.53 111.073 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -164.22 110.83 0.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.266 -1.134 . . . . 74.05 110.266 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -125.78 135.8 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 117.265 0.533 . . . . 73.43 112.43 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.682 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 8.7 p -79.72 104.22 10.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.86 -0.609 . . . . 72.35 110.082 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.06 147.46 23.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.108 -0.496 . . . . 73.2 110.236 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.57 113.35 22.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.897 -0.779 . . . . 73.22 108.897 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.33 93.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.872 -0.603 . . . . 73.33 110.082 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 67.23 -75.57 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.238 -0.892 . . . . 72.41 111.854 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.583 ' HG2' HG11 ' A' ' 115' ' ' VAL . 18.7 mt-30 -132.26 -8.49 3.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.446 -0.343 . . . . 73.42 111.223 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.871 ' HA ' HE21 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -122.9 163.53 20.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 75.42 111.46 -175.523 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.21 128.84 51.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 54.33 109.912 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -127.13 119.04 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.765 -0.457 . . . . 74.15 109.765 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.651 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -88.96 125.47 34.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.933 -0.576 . . . . 75.34 110.262 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.522 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.1 t -107.87 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.166 -0.47 . . . . 73.2 110.081 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.401 ' CZ ' HG23 ' A' ' 59' ' ' VAL . 63.1 t80 -91.8 130.25 37.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.716 -0.675 . . . . 71.34 110.352 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' HG3' HG13 ' A' ' 39' ' ' VAL . 64.2 ttt180 -131.31 100.37 16.85 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 75.21 110.009 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.45 -32.76 6.0 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.672 2.248 . . . . 74.24 113.293 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -128.73 166.13 19.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.52 -0.309 . . . . 75.12 110.684 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.77 26.47 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 72.21 111.255 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 16.5 m-20 -113.56 -155.04 0.56 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.745 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.404 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 24.4 mt-10 -84.4 -13.04 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.916 -0.583 . . . . 74.55 111.61 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -73.07 100.23 2.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.097 0.475 . . . . 72.53 110.992 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.579 HG13 ' HG3' ' A' ' 32' ' ' ARG . 27.0 m -129.95 156.4 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 72.4 110.159 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -131.36 102.84 6.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.698 0.285 . . . . 71.12 110.667 178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HG21 ' A' ' 97' ' ' THR . . . -102.94 96.91 7.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.01 0.433 . . . . 62.33 110.682 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.578 HG13 ' HB2' ' A' ' 44' ' ' ASN . 49.3 pt -134.56 -179.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.083 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -79.29 60.73 3.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 73.32 109.911 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' HB2' HG13 ' A' ' 42' ' ' ILE . 2.0 t-20 -93.0 46.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.457 0.646 . . . . 54.44 110.644 -174.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.7 mp -103.05 131.25 51.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.512 -0.767 . . . . 75.41 110.04 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 10.0 t70 -82.52 120.94 77.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.101 -0.703 . . . . 73.22 109.101 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.455 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 43.4 Cg_exo -57.35 -23.71 56.39 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.227 2.618 . . . . 61.25 113.678 -175.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -84.14 -20.35 32.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 65.45 111.08 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.78 -20.57 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.99 -0.284 . . . . 71.24 111.195 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 64.49 19.19 11.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.692 -0.685 . . . . 72.42 111.096 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.682 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -137.1 169.7 17.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 63.24 109.927 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -81.42 50.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.682 -0.69 . . . . 74.53 111.291 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.66 -19.05 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.115 0.484 . . . . 62.01 109.91 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.45 HD21 ' HG ' ' A' ' 70' ' ' SER . 70.6 mt -62.23 -43.45 98.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.62 -0.718 . . . . 75.12 109.38 173.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -71.3 -23.15 61.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.441 -0.8 . . . . 71.54 111.09 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -98.37 20.23 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.267 0.556 . . . . 73.14 110.429 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.51 -149.29 24.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.745 -0.661 . . . . 62.3 111.636 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.6 mp -90.26 116.32 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 75.4 109.759 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.572 HG22 HG21 ' A' ' 68' ' ' VAL . 60.2 t -112.37 112.93 42.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.672 -0.695 . . . . 71.51 110.301 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.6 159.07 30.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 53.51 110.237 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -76.07 163.32 27.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.992 0.425 . . . . 72.24 110.251 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -122.09 46.54 2.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.727 -0.67 . . . . 74.34 109.264 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 55.85 25.31 8.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.087 -0.961 . . . . 64.43 111.697 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -164.15 -55.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 63.44 110.777 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.547 ' HB3' ' NE1' ' A' ' 67' ' ' TRP . 2.3 t0 -135.83 -173.0 3.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.086 -0.506 . . . . 74.15 110.116 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.428 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 79.2 mt -107.34 110.02 21.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 73.14 109.98 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.561 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 61.3 m95 -122.89 128.69 50.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.38 . . . . 71.55 111.062 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.572 HG21 HG22 ' A' ' 59' ' ' VAL . 13.2 p -103.56 145.69 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.22 -0.445 . . . . 72.21 110.339 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.21 117.68 30.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.499 -0.318 . . . . 63.23 110.771 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.571 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 27.3 t -73.34 147.27 87.48 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 65.4 111.29 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.36 -20.53 24.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.437 2.091 . . . . 63.11 112.021 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -98.33 -67.98 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 72.0 110.499 179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -64.58 -39.23 93.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 73.01 111.416 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 70' ' ' SER . 70.6 tttt 62.06 11.94 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.635 -0.711 . . . . 73.43 111.374 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.51 ' HG3' ' HB2' ' A' ' 87' ' ' ASP . 21.9 mm-40 -88.65 150.04 23.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.386 -0.598 . . . . 64.34 109.386 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.497 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.4 m80 -89.86 121.66 32.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.914 0.388 . . . . 72.0 110.737 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -117.54 143.42 46.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.002 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.758 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 46.6 mtm180 -79.61 119.68 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.732 -0.47 . . . . 75.41 109.732 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.526 HD21 ' HB ' ' A' ' 68' ' ' VAL . 92.3 mt -52.1 -55.82 18.37 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.811 0.671 . . . . 73.25 112.811 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -90.22 15.94 9.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.735 0.302 . . . . 74.3 111.44 -173.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.758 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 29.5 t70 -122.52 -60.69 1.52 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 45.42 111.365 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.26 -22.8 14.92 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.298 -0.954 . . . . 52.31 113.289 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.36 166.21 18.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.997 0.398 . . . . 74.22 110.924 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -112.7 166.2 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.853 -0.612 . . . . 71.15 111.634 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.561 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 62.1 tp -94.89 -69.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 53.44 110.276 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -87.1 -19.51 28.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 74.14 110.985 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.51 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 5.1 t70 -96.59 -152.37 0.38 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.931 -0.396 . . . . 74.42 109.931 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.27 -33.34 0.29 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.962 -0.855 . . . . 74.01 110.962 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.25 66.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.461 . . . . 54.43 110.803 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 94.7 m-85 -107.44 61.45 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 70.43 110.893 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.24 121.63 33.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.467 -0.788 . . . . 72.04 109.385 174.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.88 163.73 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 71.2 112.124 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.53 131.22 37.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.65 -0.704 . . . . 70.43 110.961 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -110.9 98.73 7.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.88 -0.6 . . . . 71.14 110.369 179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.63 150.88 34.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 75.14 110.475 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.24 122.74 23.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.54 -0.541 . . . . 74.42 109.54 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.907 HG23 HG21 ' A' ' 106' ' ' ILE . 69.3 p -124.7 160.88 27.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.247 -0.433 . . . . 74.03 110.589 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -168.9 151.38 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 73.12 110.715 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 60.4 t -94.01 106.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.547 -0.751 . . . . 54.34 108.978 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.2 t -104.34 -34.24 8.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -133.03 30.81 3.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 54.52 110.369 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.25 -0.25 85.51 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.113 -0.795 . . . . 70.12 111.113 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.718 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.0 p30 -115.09 151.47 34.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.568 . . . . 60.02 110.318 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.441 HG23 HG22 ' A' ' 99' ' ' VAL . 46.0 t -94.66 113.2 28.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 74.21 109.963 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.595 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 23.7 mt-30 -115.3 140.77 48.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.091 -0.504 . . . . 53.43 110.746 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.907 HG21 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -111.32 151.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.691 -0.686 . . . . 74.34 109.815 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 t -87.67 104.02 16.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.597 -0.89 . . . . 74.3 108.597 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.49 ' O ' HD13 ' A' ' 108' ' ' ILE . 2.3 pp -74.12 135.91 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.588 0.709 . . . . 71.12 112.439 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.92 87.64 2.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.098 -0.955 . . . . 74.51 109.037 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -76.76 136.78 39.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.682 -0.69 . . . . 74.52 111.174 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.7 m -104.96 -81.81 0.53 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 73.54 109.927 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.04 100.6 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.148 -0.315 . . . . 52.2 110.148 174.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.45 133.06 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 74.05 109.896 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.15 166.47 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.274 -0.421 . . . . 65.52 110.644 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.583 HG11 ' HG2' ' A' ' 25' ' ' GLN . 12.1 m -88.33 111.91 23.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.274 0.559 . . . . 62.23 111.548 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -95.22 105.84 17.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.258 -0.428 . . . . 73.02 109.944 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -112.71 33.43 4.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 71.14 109.714 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.7 m -59.06 -34.11 71.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 71.44 110.05 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -88.05 117.44 68.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.157 -0.683 . . . . 54.44 109.157 171.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -60.03 146.69 95.45 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.844 2.363 . . . . 64.24 112.793 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 146.09 96.98 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.756 -0.656 . . . . 61.35 110.523 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.06 129.46 35.42 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.816 2.344 . . . . 73.14 112.478 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.44 -64.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.445 -0.576 . . . . 74.13 109.445 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.85 28.02 3.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.379 -0.828 . . . . 71.1 112.833 174.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -95.83 20.82 9.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.602 0.715 . . . . 74.53 109.219 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -59.21 -63.03 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.368 -1.287 . . . . 72.13 110.243 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.3 m170 64.0 177.7 0.17 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.493 -0.776 . . . . 74.52 112.106 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -100.95 122.01 42.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.031 -0.531 . . . . 74.21 110.689 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -86.62 84.34 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.464 -0.569 . . . . 75.52 109.464 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.722 -0.656 . . . . 70.51 109.689 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.127 -0.323 . . . . 71.25 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -137.23 -33.55 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.303 -0.408 . . . . 74.41 111.199 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -86.82 16.84 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.421 -0.354 . . . . 74.03 110.831 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CZ3' ' HG3' ' A' ' 98' ' ' GLN . 59.7 m95 -109.14 109.78 20.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.49 -0.323 . . . . 75.32 110.858 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -99.01 141.49 31.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.5 -0.318 . . . . 63.43 110.858 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 m -80.32 122.87 27.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.541 -0.299 . . . . 72.41 110.276 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.5 -81.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.883 -0.414 . . . . 74.42 109.883 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -145.17 -84.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 64.32 109.796 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 60.3 mttp -151.35 151.44 31.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.018 0.437 . . . . 74.44 111.128 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.3 tp -84.39 -13.56 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.091 0.948 . . . . 65.52 109.138 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -88.39 -28.34 21.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.585 -1.188 . . . . 75.34 110.199 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 -18.75 43.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 74.34 111.3 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.439 ' CG2' ' HB2' ' A' ' 32' ' ' ARG . 48.6 mm -76.1 118.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 62.21 110.898 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.66 163.72 42.93 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.57 . . . . 54.43 111.684 -175.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.79 125.19 16.04 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.165 2.577 . . . . 73.11 112.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' C ' ' HG1' ' A' ' 17' ' ' THR . . . 59.45 40.47 96.2 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.08 -0.509 . . . . 54.11 111.923 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.639 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.7 m -148.68 174.29 12.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.842 0.353 . . . . 74.13 110.422 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.689 ' HA3' ' O ' ' A' ' 30' ' ' VAL . . . 166.16 165.38 23.43 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.745 -0.942 . . . . 63.15 110.745 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.511 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 30.7 m -129.57 164.6 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 74.03 111.652 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.764 ' HB3' HD11 ' A' ' 45' ' ' ILE . 2.8 p -83.44 129.27 34.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.913 -0.585 . . . . 72.21 111.084 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.92 125.41 51.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.797 -0.638 . . . . 74.34 109.921 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.06 89.57 5.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 74.35 109.403 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.8 104.39 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.296 -0.411 . . . . 64.32 111.151 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 61.38 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.031 0.832 . . . . 65.12 112.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.73 3.69 3.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.743 0.306 . . . . 75.23 111.061 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.459 ' HB3' HG13 ' A' ' 28' ' ' ILE . 58.0 mm-40 -102.28 129.22 48.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 73.12 111.329 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -102.73 88.2 3.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.926 -0.768 . . . . 74.13 108.926 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.459 HG13 ' HB3' ' A' ' 26' ' ' GLN . 60.3 mt -105.33 135.76 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.88 -0.6 . . . . 72.53 110.825 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.684 ' HB1' ' HB3' ' A' ' 44' ' ' ASN . . . -117.99 137.16 53.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.128 -0.323 . . . . 71.55 110.128 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.689 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 26.2 t -95.38 146.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.534 -0.543 . . . . 75.41 109.534 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -140.65 129.41 23.02 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 70.51 109.629 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.537 ' HG3' HG13 ' A' ' 39' ' ' VAL . 46.8 ttt180 -111.71 91.15 14.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.01 -0.276 . . . . 74.52 110.825 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.13 -55.09 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.452 2.102 . . . . 73.23 113.668 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.668 ' HB2' ' OD1' ' A' ' 36' ' ' ASP . 34.3 mtm180 -89.58 -0.15 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.65 0.262 . . . . 63.41 110.926 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.447 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 64.5 t30 62.12 28.14 16.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.545 0.688 . . . . 70.51 110.895 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.668 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 6.4 p-10 -111.81 -166.71 1.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.254 -0.43 . . . . 64.42 110.324 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.75 -28.3 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 71.23 111.633 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.33 104.24 11.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.371 0.605 . . . . 73.34 111.433 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG13 ' HG3' ' A' ' 32' ' ' ARG . 30.9 m -105.77 158.56 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.459 -0.791 . . . . 73.12 109.596 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -113.28 96.3 5.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 72.22 110.258 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 93.6 8.15 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.747 -0.661 . . . . 65.34 109.429 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.799 HG23 ' HA ' ' A' ' 94' ' ' ALA . 38.3 pt -126.43 -172.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.001 -0.545 . . . . 74.13 110.678 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.49 47.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 62.3 110.284 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.684 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 33.8 t30 -83.12 40.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.271 0.558 . . . . 62.15 111.175 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.764 HD11 ' HB3' ' A' ' 20' ' ' CYS . 33.4 mm -114.38 123.5 70.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 62.32 111.037 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.97 120.85 71.75 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.011 -0.737 . . . . 75.0 109.011 173.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.424 ' CD ' ' HE2' ' A' ' 90' ' ' TYR . 52.4 Cg_exo -56.34 -26.03 60.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.18 2.587 . . . . 41.01 113.406 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -78.15 -13.79 59.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 74.23 110.666 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.44 -34.85 4.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.902 0.382 . . . . 73.33 110.494 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.9 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 66.37 17.56 10.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.325 -0.852 . . . . 65.44 111.027 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.41 171.06 14.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 55.02 109.311 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.511 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 6.5 p -76.97 80.24 3.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.477 0.656 . . . . 55.12 111.282 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.0 m -90.97 -20.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 73.14 110.171 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.437 HD13 ' HZ ' ' A' ' 77' ' ' PHE . 61.0 mt -86.08 -17.74 34.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.45 -0.795 . . . . 52.42 110.222 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.48 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 49.6 m -81.56 10.66 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 54.13 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -149.5 31.97 0.72 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.291 0.567 . . . . 75.21 109.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.67 -145.58 19.25 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.293 -0.867 . . . . 75.1 112.485 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.767 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.5 mp -97.83 123.94 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.106 0.479 . . . . 64.25 110.992 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -88.85 102.2 12.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.699 -0.682 . . . . 70.13 109.905 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 109.02 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 64.11 110.952 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.16 116.87 23.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.998 -0.546 . . . . 71.1 110.196 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -102.96 90.25 3.71 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.851 -0.426 . . . . 72.2 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 63.8 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.465 -0.789 . . . . 73.13 111.787 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -114.19 -22.91 9.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.352 0.596 . . . . 73.52 110.301 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.481 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 5.9 m-20 -91.64 154.14 19.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 72.32 111.712 -173.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.22 116.2 29.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.595 -0.73 . . . . 70.02 110.486 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.481 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 16.2 m95 -119.81 151.14 39.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 74.22 109.7 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.94 129.17 66.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.347 0.594 . . . . 75.0 109.724 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.767 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -87.94 114.27 24.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.626 -0.716 . . . . 71.31 110.216 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.4 t -62.42 116.22 21.48 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 71.41 109.867 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.406 ' HD2' HD23 ' A' ' 54' ' ' LEU . 45.8 Cg_endo -69.25 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.491 2.127 . . . . 71.24 112.16 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -112.82 -50.65 2.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 72.35 111.198 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -92.64 -4.61 53.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.485 -0.325 . . . . 75.1 111.447 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 32.2 ttmt 66.09 11.12 7.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.849 -0.614 . . . . 73.22 112.278 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.648 HE22 ' HB2' ' A' ' 89' ' ' ALA . 3.3 pt20 -102.36 150.71 23.07 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.133 -0.355 . . . . 74.05 110.697 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.38 107.31 18.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 74.14 110.189 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.735 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 16.2 p90 -111.29 142.38 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.289 0.566 . . . . 75.42 110.981 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.418 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 38.6 ttp180 -85.82 123.56 31.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 72.02 110.315 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.8 mt -50.66 -57.07 9.14 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.821 0.7 . . . . 75.13 112.497 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -87.08 37.08 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 75.41 111.468 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 26.4 t0 -149.92 -50.84 0.14 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.346 . . . . 75.01 110.649 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.93 -25.83 25.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.944 -0.646 . . . . 75.33 113.146 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -85.51 147.74 26.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.774 0.321 . . . . 74.12 110.955 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.2 m -102.04 47.16 0.91 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.992 -0.549 . . . . 62.13 111.749 -171.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.585 ' HG ' ' HG2' ' A' ' 86' ' ' GLU . 49.5 tp 57.41 -95.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 72.42 112.123 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.585 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 6.5 mm-40 -107.23 -27.87 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 74.22 111.386 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 39.0 t70 -111.16 75.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.203 -0.666 . . . . 73.32 109.203 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -89.06 63.55 3.45 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.407 -0.815 . . . . 74.34 113.283 -171.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.648 ' HB2' HE22 ' A' ' 75' ' ' GLN . . . -80.45 -59.03 2.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.893 0.378 . . . . 71.2 110.576 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.424 ' HE2' ' CD ' ' A' ' 47' ' ' PRO . 29.3 m-85 -90.04 74.19 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 65.13 110.323 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 100.3 3.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.497 -0.774 . . . . 62.41 109.638 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.76 167.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 62.2 111.125 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 135.89 51.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 62.12 110.53 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.799 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -96.86 92.33 6.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.935 -0.575 . . . . 45.11 109.578 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -67.2 155.87 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.432 -0.804 . . . . 73.54 110.754 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.66 142.8 29.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.543 -0.54 . . . . 72.0 109.543 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.843 HG23 HG22 ' A' ' 106' ' ' ILE . 26.0 p -134.47 138.08 44.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.404 . . . . 65.53 111.082 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.45 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 48.2 mt-30 -104.85 144.13 32.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.864 0.364 . . . . 63.04 110.561 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.1 t -99.6 76.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.206 -1.035 . . . . 74.1 108.206 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.5 p -75.46 -32.58 60.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.27 -0.877 . . . . 65.11 111.789 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.457 ' C ' ' H ' ' A' ' 103' ' ' ASN . 7.2 t-20 -164.52 -146.99 0.1 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.145 . . . . 72.41 107.907 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.07 36.81 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 60.1 111.239 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 20.4 p30 -145.74 163.25 35.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.96 0.504 . . . . 74.15 110.092 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 74.23 110.464 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -117.27 117.64 30.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 74.33 110.218 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.843 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.4 152.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.342 -0.39 . . . . 65.51 110.235 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -87.81 125.37 34.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.496 -0.557 . . . . 75.41 109.496 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.07 96.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.092 -0.503 . . . . 44.41 111.029 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.71 140.97 35.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.478 -0.934 . . . . 65.23 108.478 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.98 139.28 42.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.415 0.626 . . . . 72.55 109.947 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.0 m -151.87 91.73 1.66 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.305 -0.862 . . . . 73.54 108.895 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.21 100.18 0.59 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 73.22 109.605 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.6 t -47.87 128.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.397 -1.274 . . . . 73.44 111.946 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.65 116.78 18.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.537 -0.756 . . . . 72.33 109.014 175.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.6 m -88.47 120.95 38.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.572 0.701 . . . . 74.53 112.278 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.416 ' CG ' ' H ' ' A' ' 117' ' ' ASN . 9.5 t70 -105.87 -153.3 0.49 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.326 -0.99 . . . . 70.31 108.326 174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.472 HD21 ' N ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -142.49 94.07 2.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 73.53 112.362 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m 68.17 111.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.919 -1.037 . . . . 62.23 113.414 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -115.13 102.44 54.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.025 -0.732 . . . . 75.51 109.025 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.37 143.31 47.54 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.784 2.322 . . . . 63.14 113.015 -174.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.7 mt -109.42 106.41 58.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.755 -0.657 . . . . 71.23 110.13 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.13 94.39 0.57 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.589 2.192 . . . . 72.43 112.227 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mp -115.86 93.05 4.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.264 -0.425 . . . . 73.51 111.134 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -120.02 129.48 54.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.133 -0.691 . . . . 72.12 109.133 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -132.84 94.69 3.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.737 0.304 . . . . 75.01 111.096 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -109.67 132.63 53.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.473 -0.566 . . . . 72.34 109.473 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -143.6 113.22 7.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.277 -0.42 . . . . 75.44 110.022 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -92.92 122.09 34.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.191 -0.459 . . . . 73.22 110.101 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -91.71 -57.69 2.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.212 -0.662 . . . . 74.35 109.212 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.1 p80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.358 -0.829 . . . . 74.14 109.96 172.343 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.538 0.208 . . . . 64.33 110.835 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p 176.4 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.545 0.738 . . . . 75.21 109.019 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -132.09 16.3 4.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.447 ' HH2' ' OD2' ' A' ' 96' ' ' ASP . 73.9 m95 -59.81 117.22 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.71 -1.132 . . . . 63.24 110.393 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -89.61 131.83 35.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.121 -0.491 . . . . 74.54 110.192 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.1 m -74.47 118.9 17.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 62.42 110.48 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.7 t -87.98 -70.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.091 -0.504 . . . . 70.43 111.064 -177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -161.29 -177.33 5.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.666 . . . . 74.43 109.212 -174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -86.65 143.89 27.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.557 0.218 . . . . 74.1 110.592 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -67.28 -12.71 60.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.561 0.696 . . . . 74.35 110.139 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.09 -17.02 53.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.998 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.96 -9.08 16.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.31 0.576 . . . . 63.34 110.471 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 46.3 mm -75.59 126.9 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.541 . . . . 71.12 110.686 -179.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.507 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.8 mt -70.14 137.48 86.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 72.5 111.604 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -79.46 127.78 7.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.241 2.627 . . . . 71.42 112.639 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.84 23.77 44.53 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.932 -0.576 . . . . 71.01 112.573 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.35 167.34 29.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.064 0.432 . . . . 75.21 111.624 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.551 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -127.56 142.1 13.21 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.333 -0.707 . . . . 43.24 111.333 177.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.488 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 21.3 m -127.41 139.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.049 0.425 . . . . 72.23 111.821 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.434 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 7.4 p -70.64 99.0 1.59 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 64.53 110.479 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 132.04 34.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.112 -0.495 . . . . 71.53 110.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -86.99 100.47 12.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.377 -0.601 . . . . 72.22 109.377 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.645 HG13 HD11 ' A' ' 106' ' ' ILE . 34.3 t -120.76 112.79 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.823 -0.626 . . . . 72.54 110.103 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 31.1 mt-10 61.78 19.41 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.269 0.557 . . . . 74.44 111.892 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 73.8 mm-40 81.47 19.72 0.39 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.176 -1.375 . . . . 73.34 111.27 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -113.47 137.99 50.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.845 -0.798 . . . . 62.42 108.845 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -99.33 108.88 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 74.14 111.151 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.53 130.5 64.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.735 -0.666 . . . . 71.1 109.298 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 113.63 21.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 74.03 110.192 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.551 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 29.1 t -95.77 102.34 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.093 -0.503 . . . . 72.33 110.307 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.81 128.51 33.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.639 -0.709 . . . . 71.52 110.077 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 70.6 ttt180 -112.8 84.21 6.48 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.874 -0.788 . . . . 75.43 108.874 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.21 -31.75 53.14 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.672 2.248 . . . . 73.2 112.108 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.619 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 99.9 mtt180 -109.39 164.47 12.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.754 -0.657 . . . . 73.44 109.997 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -91.59 10.3 28.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.093 0.949 . . . . 74.4 108.647 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.25 -109.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.657 -1.156 . . . . 72.4 112.008 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.25 -67.06 1.02 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.455 0.539 . . . . 74.51 112.455 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.15 131.27 50.3 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.078 0.77 . . . . 71.31 113.078 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.4 m -124.74 169.18 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.872 -1.058 . . . . 72.11 109.861 175.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -137.8 104.4 5.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.565 -0.289 . . . . 74.42 111.298 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -97.14 108.28 20.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.153 0.501 . . . . 61.14 110.928 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.579 HD11 HG22 ' A' ' 92' ' ' VAL . 34.4 pt -129.34 161.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.667 -0.697 . . . . 74.22 109.625 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 62.2 m -74.56 75.75 1.98 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.478 . . . . 74.11 111.096 178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.504 HD21 HG13 ' A' ' 92' ' ' VAL . 26.8 t-20 -110.49 72.71 0.8 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.69 0.757 . . . . 75.33 109.487 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.431 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -127.82 133.16 68.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.268 -0.878 . . . . 74.45 109.829 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.04 125.8 63.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.769 -0.456 . . . . 64.31 109.769 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.94 -11.08 25.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.2 2.6 . . . . 65.21 113.392 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -87.64 -16.22 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.002 -0.279 . . . . 71.21 111.0 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.47 -26.67 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.283 0.475 . . . . 71.11 112.283 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.53 34.84 17.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 71.14 111.153 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -143.9 169.81 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 54.32 109.263 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 13.6 p -80.81 51.09 1.46 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.248 0.547 . . . . 72.25 110.973 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -18.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 75.13 110.196 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.448 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 72.5 mt -83.74 -17.07 42.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.345 -0.843 . . . . 74.53 109.745 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 m -89.96 -13.21 36.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.751 . . . . 75.13 111.6 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -104.96 30.32 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 71.53 111.339 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -94.66 -129.25 5.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.485 -0.864 . . . . 64.14 111.974 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 57.1 mt -104.74 108.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.071 0.462 . . . . 75.24 110.215 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.37 108.53 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.502 -0.772 . . . . 50.04 110.073 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.85 166.01 27.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 64.13 111.569 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.95 120.94 33.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.525 -0.761 . . . . 73.3 109.718 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.603 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 63.7 t-80 -62.43 -76.88 0.05 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.728 -0.669 . . . . 70.11 110.024 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -130.97 -44.95 1.04 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.412 -0.813 . . . . 55.31 108.93 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -132.36 -21.45 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.275 -0.875 . . . . 72.24 110.574 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.52 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 1.6 t70 -109.92 175.15 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 72.22 111.203 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.76 124.57 49.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 50.32 110.359 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.603 ' CD1' ' HB2' ' A' ' 62' ' ' HIS . 40.1 m95 -124.63 143.84 50.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.164 -0.471 . . . . 73.44 110.594 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.43 117.44 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.617 0.722 . . . . 73.13 110.118 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -90.69 116.2 28.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.797 -0.638 . . . . 73.12 110.17 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -60.09 136.59 91.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.492 -0.322 . . . . 72.01 110.653 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.01 -31.53 55.39 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.695 2.263 . . . . 74.32 112.765 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.89 -56.83 2.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.595 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -90.93 -13.81 32.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 74.22 111.671 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 mttm 64.02 8.56 4.04 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.161 0.8 . . . . 74.23 113.161 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.52 127.12 30.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.094 -0.706 . . . . 72.35 109.094 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.725 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 41.9 m80 -90.87 99.45 12.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.037 -0.528 . . . . 75.23 110.371 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -84.71 120.45 26.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.933 0.397 . . . . 70.12 110.158 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 61.4 ttt180 -78.71 121.28 24.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.986 -0.552 . . . . 72.55 109.805 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.63 -36.22 78.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -80.29 -20.09 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.404 -0.362 . . . . 72.15 111.575 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.488 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 10.0 t70 -115.15 -74.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.023 -0.271 . . . . 73.51 111.586 -170.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.645 ' HA2' HG21 ' A' ' 92' ' ' VAL . . . 140.36 -27.12 2.53 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.802 -0.713 . . . . 75.32 112.124 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -63.31 151.68 40.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.178 0.514 . . . . 74.12 111.258 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 4.4 m -103.39 50.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.63 -0.714 . . . . 75.33 110.643 -174.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.725 ' HB2' ' HB2' ' A' ' 76' ' ' HIS . 38.6 tp 66.74 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.954 0.502 . . . . 74.11 111.363 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 36.6 mt-10 -109.08 -4.57 16.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 73.23 110.341 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -115.82 160.03 20.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.555 . . . . 72.53 110.917 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.39 27.67 2.49 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.978 -0.849 . . . . 75.3 110.978 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.3 42.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 54.22 110.745 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -117.27 62.39 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.11 -0.496 . . . . 74.53 110.299 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 2.5 p -65.88 107.19 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 75.3 109.784 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.645 HG21 ' HA2' ' A' ' 82' ' ' GLY . 28.0 m -68.01 136.78 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 75.01 111.295 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.59 106.42 4.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.006 -0.543 . . . . 52.32 109.907 176.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.547 ' HA ' HG23 ' A' ' 42' ' ' ILE . . . -79.26 88.21 4.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.796 -0.638 . . . . 73.41 110.854 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -80.19 175.92 10.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.755 . . . . 74.44 109.811 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 20.0 t70 -114.32 147.29 39.33 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.992 -0.373 . . . . 73.21 109.992 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 HG23 ' A' ' 106' ' ' ILE . 1.3 m -129.0 157.16 42.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.62 -0.718 . . . . 75.25 109.606 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -153.34 143.26 22.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 74.2 111.112 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.86 98.27 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.39 -0.823 . . . . 73.15 108.783 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.413 HG23 HD21 ' A' ' 101' ' ' ASN . 7.4 t -94.3 -34.58 12.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.54 0.571 . . . . 71.35 112.54 -170.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.413 HD21 HG23 ' A' ' 100' ' ' THR . 61.3 m-80 -136.99 31.61 2.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.047 0.451 . . . . 37.42 110.599 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.62 -11.91 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 62.15 111.387 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.89 150.65 22.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.536 . . . . 74.35 110.127 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -97.12 120.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.305 -0.861 . . . . 75.32 111.05 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -115.59 142.33 46.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.101 -0.333 . . . . 74.01 110.101 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.645 HD11 HG13 ' A' ' 23' ' ' VAL . 2.8 pp -122.13 154.48 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.459 . . . . 75.33 110.633 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 t -113.38 102.01 9.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.778 -0.453 . . . . 55.31 109.778 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.503 HG23 HD12 ' A' ' 106' ' ' ILE . 16.4 pt -109.04 110.96 34.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.187 -0.461 . . . . 74.43 111.124 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.47 13.29 28.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.66 0.743 . . . . 71.33 110.485 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -153.21 134.47 14.19 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.858 -1.065 . . . . 75.41 109.535 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 m -113.02 19.43 17.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.958 -0.564 . . . . 71.1 110.733 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.71 -92.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.648 0.779 . . . . 61.54 110.999 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.36 119.75 14.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.732 -1.122 . . . . 74.02 108.136 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.08 123.4 22.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.0 -0.545 . . . . 54.44 111.814 -174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.13 124.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.683 -0.69 . . . . 65.22 109.229 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HA ' ' CD ' ' A' ' 25' ' ' GLN . 13.5 t70 -89.05 130.74 35.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.241 0.543 . . . . 71.02 111.957 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -127.11 136.78 52.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.338 -0.846 . . . . 75.04 108.887 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.3 m -103.24 -12.62 17.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.658 0.614 . . . . 65.24 112.658 -172.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -87.16 117.24 68.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 74.42 111.504 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -93.22 178.97 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.203 2.602 . . . . 72.25 111.997 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -124.52 106.27 30.05 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.77 0.319 . . . . 64.02 110.628 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -91.4 -170.92 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.075 2.517 . . . . 62.54 112.63 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.5 165.74 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 73.11 109.597 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.42 124.75 41.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.317 0.58 . . . . 73.2 111.01 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -112.22 131.22 55.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.903 -0.59 . . . . 71.5 109.574 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -153.51 120.58 5.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.979 -0.555 . . . . 71.21 110.942 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -88.5 158.25 18.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 72.12 111.265 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -132.21 171.95 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.747 -0.661 . . . . 71.34 110.344 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -155.01 164.68 38.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.074 -0.512 . . . . 73.04 109.644 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.6 p80 . . . . . 0 C--O 1.246 0.885 0 N-CA-C 109.209 -0.663 . . . . 74.45 109.209 174.241 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 2.0 mpt? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.26 -0.274 . . . . 72.21 110.26 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 p -86.05 -70.45 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.956 -0.297 . . . . 64.13 111.139 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.11 8.25 42.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.176 0.513 . . . . 73.31 111.398 -176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.756 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 97.0 m95 -81.19 112.11 18.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.811 -0.631 . . . . 74.43 110.072 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 106' ' ' ILE . 6.0 m -95.93 126.72 41.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.679 . . . . 74.44 110.184 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.556 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 27.4 m -73.61 132.26 42.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.894 0.378 . . . . 72.43 110.994 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.14 -67.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.562 . . . . 74.3 109.514 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -169.92 -167.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 62.52 108.991 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -76.92 154.49 33.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.732 -0.213 . . . . 74.44 110.471 178.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.56 HD22 ' HA ' ' A' ' 37' ' ' GLU . 56.9 tp -75.41 -27.07 58.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.51 -0.922 . . . . 74.11 108.51 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.37 -32.07 69.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.13 -1.395 . . . . 72.45 110.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.12 -14.27 59.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.422 -0.808 . . . . 74.41 110.186 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.0 mt -93.08 116.34 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 75.32 110.236 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.63 128.84 93.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 70.43 111.45 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.26 124.16 12.16 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.857 2.371 . . . . 65.23 112.16 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.62 28.62 8.28 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.814 -0.63 . . . . 52.41 112.141 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.27 170.46 17.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.608 0.242 . . . . 72.04 111.41 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.412 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -138.11 144.69 16.0 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.218 -0.753 . . . . 72.11 111.218 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.07 145.91 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.205 0.503 . . . . 71.32 112.18 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.2 p -86.79 133.08 33.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.101 -0.5 . . . . 72.21 111.213 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.38 125.9 41.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.092 -0.503 . . . . 71.43 110.419 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.97 99.9 2.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.773 -0.825 . . . . 72.52 108.773 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.569 HG13 HD11 ' A' ' 106' ' ' ILE . 46.0 t -109.52 103.08 14.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 73.13 110.738 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 70.26 -53.72 0.64 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.285 -0.87 . . . . 75.11 112.771 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.576 ' NE2' ' H ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.6 -50.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.603 0.594 . . . . 74.42 112.603 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.576 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 27.8 mt-30 -109.39 167.38 10.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.743 0.306 . . . . 74.14 110.84 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -95.49 127.04 41.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.906 -0.588 . . . . 62.2 109.832 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.86 134.53 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.367 -0.605 . . . . 75.03 109.367 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -94.14 122.04 36.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.665 -0.494 . . . . 74.42 109.665 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.412 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 26.1 t -105.41 104.36 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.082 0.468 . . . . 70.45 110.18 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.667 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 79.5 m-85 -79.91 134.68 36.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.396 -0.82 . . . . 71.24 111.342 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -119.71 82.12 26.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.871 -1.159 . . . . 72.22 107.871 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.92 -25.63 19.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.649 2.233 . . . . 63.43 112.791 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 34' ' ' ARG . 61.8 mtt180 -111.57 167.72 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.684 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -84.5 2.88 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.153 0.501 . . . . 73.24 110.212 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 19.3 t70 -98.68 -150.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.894 -0.594 . . . . 54.21 110.041 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.56 ' HA ' HD22 ' A' ' 10' ' ' LEU . 40.7 mt-10 -105.83 21.62 16.97 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.892 0.701 . . . . 65.43 112.892 -169.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.4 123.21 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.593 -0.443 . . . . 70.31 110.337 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.45 167.3 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.983 -0.553 . . . . 75.43 110.967 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.667 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 78.3 m-85 -138.95 105.57 5.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 73.51 110.107 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -102.1 101.93 12.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.062 0.458 . . . . 63.22 110.651 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.621 HG21 ' HA ' ' A' ' 94' ' ' ALA . 38.7 pt -131.63 173.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.979 -0.555 . . . . 72.14 110.352 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.483 ' HG ' ' HB ' ' A' ' 92' ' ' VAL . 89.9 p -83.09 67.82 9.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.347 0.594 . . . . 72.12 109.69 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.551 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.9 t-20 -98.27 35.96 1.68 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.228 1.013 . . . . 71.3 109.517 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.503 HD12 ' HB3' ' A' ' 20' ' ' CYS . 35.6 mm -107.01 109.14 27.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 75.4 110.483 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.71 115.95 42.94 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.129 -0.693 . . . . 64.41 109.129 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.458 ' HD2' ' OH ' ' A' ' 90' ' ' TYR . 47.5 Cg_exo -57.51 -17.19 26.75 Favored 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.358 2.705 . . . . 71.44 113.445 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.09 -15.53 59.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 74.05 110.553 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.92 -29.89 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 61.34 111.645 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.68 37.99 12.34 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.328 0.585 . . . . 63.34 111.663 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.67 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.26 170.52 21.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.318 -0.856 . . . . 75.12 108.868 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.418 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 73.4 m -77.02 61.84 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.436 0.636 . . . . 74.31 110.895 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -80.42 -22.36 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.59 -0.732 . . . . 64.51 110.373 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.635 HD21 ' HG ' ' A' ' 70' ' ' SER . 32.2 mt -81.06 -20.01 42.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.245 -0.65 . . . . 65.24 109.245 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 11.2 m -79.82 -15.6 57.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.225 -0.898 . . . . 75.44 110.904 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 18.71 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 71.11 109.759 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.78 -156.67 20.99 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.877 -0.678 . . . . 62.2 112.379 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.425 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 57.7 mt -100.01 125.09 53.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.875 0.369 . . . . 71.23 110.413 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.49 101.14 2.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.264 0.554 . . . . 72.42 109.83 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.56 95.37 5.7 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.536 -0.756 . . . . 54.01 109.616 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.48 137.71 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.784 -0.644 . . . . 74.51 110.244 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.598 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 41.1 t-80 -79.17 -169.93 2.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.647 -0.706 . . . . 73.34 109.288 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.521 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -54.99 -37.73 66.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.778 -0.823 . . . . 73.42 108.778 175.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.19 60.62 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.253 -0.885 . . . . 72.41 109.888 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.605 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 1.5 t70 -156.52 173.29 17.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 63.55 109.674 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' HB3' HD21 ' A' ' 79' ' ' LEU . 96.7 mt -119.16 118.11 30.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.554 0.216 . . . . 74.11 111.36 -171.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.767 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 39.5 m95 -136.25 125.52 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.817 -0.438 . . . . 74.3 109.817 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.87 130.64 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.974 0.416 . . . . 75.43 110.589 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.425 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -85.0 114.96 22.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.093 -0.503 . . . . 54.33 111.148 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.751 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . 29.1 t -62.08 126.8 88.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.563 -0.744 . . . . 72.33 111.086 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.2 -4.18 14.52 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.419 2.079 . . . . 73.23 112.079 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.7 mt -109.74 -55.93 2.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.119 -0.491 . . . . 75.14 111.207 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 48.3 mmtm -91.55 -16.26 27.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.171 -0.468 . . . . 75.43 110.951 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 54.76 70.01 0.67 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.68 0.753 . . . . 72.11 111.214 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -141.32 152.04 44.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.211 -0.904 . . . . 72.55 109.091 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 74.2 m80 -93.97 100.43 12.57 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.236 0.335 . . . . 75.02 110.162 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.751 ' HE2' ' HB2' ' A' ' 70' ' ' SER . 96.9 m-85 -85.88 124.53 32.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.221 -0.445 . . . . 75.2 110.487 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 81' ' ' ASP . 33.4 ttt180 -73.81 122.58 22.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.657 -0.497 . . . . 71.54 109.657 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 66' ' ' LEU . 3.3 mm? -70.57 1.47 5.15 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.908 1.077 . . . . 71.33 113.908 -168.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.426 ' HH ' ' CG ' ' A' ' 65' ' ' ASP . 39.9 p90 -153.65 28.29 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.711 -0.396 . . . . 74.44 111.412 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.594 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 7.9 t70 -145.3 -71.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.026 -0.27 . . . . 71.51 111.327 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.82 -20.3 3.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.201 -0.999 . . . . 73.24 113.287 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.51 157.21 37.59 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.123 0.461 . . . . 72.42 111.569 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 8.8 m -109.87 20.88 17.53 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.415 -0.811 . . . . 75.21 110.516 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.7 tp 69.68 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.34 -0.845 . . . . 75.1 111.774 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.69 -63.02 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.725 0.298 . . . . 65.13 111.388 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.57 92.31 6.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.853 -0.425 . . . . 70.23 109.853 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.93 74.1 2.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.656 -0.783 . . . . 73.33 112.441 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.58 -1.13 13.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.617 0.246 . . . . 54.32 111.504 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.582 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -134.1 50.84 2.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 70.32 110.24 -176.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 m -64.75 116.63 6.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.818 -0.628 . . . . 75.31 111.546 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.483 ' HB ' ' HG ' ' A' ' 43' ' ' SER . 33.3 m -102.87 168.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.52 . . . . 70.41 110.565 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.26 154.82 18.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 73.05 111.218 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.621 ' HA ' HG21 ' A' ' 42' ' ' ILE . . . -121.95 109.1 14.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.971 -0.559 . . . . 74.2 109.495 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -84.96 -177.79 6.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 70.01 110.718 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.58 137.17 51.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.407 -0.59 . . . . 75.4 109.407 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.713 HG23 HG23 ' A' ' 106' ' ' ILE . 3.2 m -134.5 161.26 35.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.709 0.29 . . . . 73.12 111.005 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -138.56 153.21 48.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.237 0.542 . . . . 72.42 110.635 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.19 123.52 60.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 64.12 107.927 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.527 HG23 ' H ' ' A' ' 101' ' ' ASN . 3.7 t -131.59 -63.51 0.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.966 0.728 . . . . 74.44 112.966 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.527 ' H ' HG23 ' A' ' 100' ' ' THR . 92.0 m-20 -101.41 28.21 5.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.098 0.475 . . . . 75.41 110.774 -174.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.96 3.22 85.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.662 -0.78 . . . . 72.15 111.2 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -113.31 158.33 20.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.32 109.797 178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.92 122.75 65.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.013 -0.54 . . . . 70.13 110.545 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.556 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 16.5 mt-30 -127.02 136.19 51.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.643 -0.503 . . . . 74.43 109.643 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.713 HG23 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.39 153.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.079 0.466 . . . . 62.23 110.686 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -103.57 96.79 6.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.164 -0.68 . . . . 71.05 109.164 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.5 pt -112.12 78.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 72.14 110.735 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.91 -21.58 50.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.951 0.881 . . . . 74.34 109.921 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -148.04 132.07 17.23 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.993 -1.458 . . . . 74.45 110.863 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 m -158.2 -77.91 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.308 -0.997 . . . . 72.42 108.308 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -150.39 119.02 6.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.941 -1.133 . . . . 75.3 107.941 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 t -55.29 119.49 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.241 0.543 . . . . 72.2 111.553 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' A' ' 25' ' ' GLN . . . -85.08 87.53 7.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.412 -0.813 . . . . 63.43 111.176 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.17 94.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.734 -0.839 . . . . 73.23 108.734 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.429 ' CG ' ' H ' ' A' ' 117' ' ' ASN . 8.2 t70 -153.11 -148.96 0.27 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.169 -0.923 . . . . 71.5 108.745 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.429 ' H ' ' CG ' ' A' ' 116' ' ' ASP . 37.5 m-80 -69.48 137.09 52.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.77 0.319 . . . . 74.44 110.999 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.8 t -64.71 -44.36 90.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.319 -0.623 . . . . 63.15 109.319 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.444 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 11.2 pt20 -122.22 126.67 26.18 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.587 -0.733 . . . . 73.44 109.48 172.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 16.6 Cg_exo -68.49 174.96 7.59 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.466 2.111 . . . . 44.02 111.799 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 154.85 76.48 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.169 -0.469 . . . . 75.54 109.771 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.03 106.3 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.012 2.475 . . . . 74.02 112.584 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 123' ' ' LEU . 3.8 pp -101.48 136.41 41.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.877 -0.601 . . . . 72.4 109.968 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.56 104.7 2.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.844 -0.616 . . . . 70.03 110.894 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -110.48 94.14 4.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.55 -0.75 . . . . 73.43 109.454 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -103.47 103.67 13.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.736 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -178.26 147.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.498 -0.927 . . . . 70.14 108.498 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -52.73 102.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.52 0.512 . . . . 73.02 110.445 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -89.04 135.73 33.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 73.43 111.359 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.645 -0.693 . . . . 72.45 109.58 172.625 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 110.116 -0.328 . . . . 75.13 110.116 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HB2' ' H ' ' A' ' 3' ' ' GLN . 5.0 m -126.44 -84.23 0.62 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 62.4 109.998 175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.423 ' H ' ' HB2' ' A' ' 2' ' ' SER . 13.9 pt20 -102.61 19.14 19.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.991 0.901 . . . . 73.24 108.6 172.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.491 ' O ' ' HG2' ' A' ' 1' ' ' MET . 21.5 m95 -117.07 117.46 29.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.28 -1.327 . . . . 75.41 109.402 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -88.54 138.13 31.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 73.22 109.619 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.431 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 13.4 m -79.59 122.79 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.031 -0.532 . . . . 73.01 110.858 -174.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.3 t -85.6 -81.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.974 0.416 . . . . 74.01 110.707 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.6 m -155.43 -178.75 7.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 71.52 109.411 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -71.14 147.6 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 72.33 110.667 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 tp -66.48 -27.12 67.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.677 -0.692 . . . . 75.32 110.943 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -98.05 -8.05 28.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.685 . . . . 72.1 110.715 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 -29.72 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.864 -0.791 . . . . 74.33 108.864 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.45 127.22 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.77 -1.104 . . . . 63.14 109.97 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.56 144.98 30.39 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.288 -0.415 . . . . 74.41 111.176 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.661 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 Cg_exo -58.55 147.94 84.0 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.56 . . . . 75.42 112.389 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.71 26.34 56.58 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.002 -0.618 . . . . 72.11 111.854 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.62 HG21 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -141.22 178.55 7.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.135 -0.32 . . . . 74.31 110.135 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.62 ' H ' HG21 ' A' ' 17' ' ' THR . . . 175.25 105.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.839 -0.696 . . . . 60.22 111.865 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.09 170.77 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.691 0.281 . . . . 75.42 111.116 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.639 ' HB3' HD12 ' A' ' 45' ' ' ILE . 8.0 p -83.05 134.33 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 74.35 111.557 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.94 143.51 42.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 74.11 109.651 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.43 100.06 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.689 -0.486 . . . . 73.04 109.689 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.4 ' HB ' HD13 ' A' ' 28' ' ' ILE . 21.7 t -101.31 81.3 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.092 -0.503 . . . . 63.44 109.938 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.77 -74.91 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.134 -0.939 . . . . 72.41 112.223 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -116.82 -35.43 4.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.597 0.237 . . . . 74.14 111.524 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -103.84 153.78 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.068 0.461 . . . . 73.4 111.833 -174.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.88 116.94 29.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.636 -0.711 . . . . 63.34 109.095 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mp -112.93 127.93 69.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.485 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -86.44 131.01 34.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.206 -0.452 . . . . 71.32 109.837 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.8 t -110.0 97.29 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.02 0.438 . . . . 72.02 110.042 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.815 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 89.7 m-85 -72.71 141.32 48.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.492 -0.776 . . . . 72.3 110.741 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.661 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 6.4 tpt180 -132.69 59.39 42.87 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.878 -0.601 . . . . 73.12 110.495 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 6.2 Cg_exo -79.39 -22.31 8.25 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.491 2.127 . . . . 72.43 111.011 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -82.06 150.74 27.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.986 -1.006 . . . . 73.25 109.81 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -75.49 77.13 2.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.095 0.474 . . . . 71.43 109.888 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.624 ' HA ' ' HE ' ' A' ' 32' ' ' ARG . 41.1 t0 63.16 179.6 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.753 -1.112 . . . . 70.32 111.409 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.422 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 36.1 mt-10 66.46 -22.91 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.746 1.218 . . . . 74.1 114.006 176.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.439 ' H ' ' C ' ' A' ' 36' ' ' ASP . 30.2 tp60 -134.62 114.14 12.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.02 0.438 . . . . 75.1 110.364 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.582 HG13 ' HD3' ' A' ' 32' ' ' ARG . 27.1 m -110.99 163.37 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.898 -0.592 . . . . 72.31 110.507 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.815 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 73.2 m-85 -127.28 86.69 2.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.132 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -91.15 98.35 11.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 74.23 110.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.575 ' HB ' ' HA ' ' A' ' 94' ' ' ALA . 41.0 pt -131.95 175.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 72.21 111.118 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.449 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 15.1 m -83.94 75.46 10.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.178 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -130.8 85.88 2.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.461 0.648 . . . . 74.42 110.08 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.639 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.2 mm -120.42 -124.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.782 -0.822 . . . . 55.5 108.782 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.512 ' HB3' HG23 ' A' ' 53' ' ' VAL . 4.1 p30 -175.35 141.61 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.296 -1.001 . . . . 63.52 108.296 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -94.7 30.22 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.352 2.035 . . . . 74.53 112.802 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -117.56 -48.06 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 71.42 110.417 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.44 6.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.279 -0.418 . . . . 64.55 111.472 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 58.44 61.82 2.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.559 0.537 . . . . 71.24 111.167 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.69 16.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.583 0.216 . . . . 75.12 111.583 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.515 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 72.4 m 61.74 57.98 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.461 0.648 . . . . 62.45 110.8 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.512 HG23 ' HB3' ' A' ' 46' ' ' ASP . 19.7 m -73.68 -9.67 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 71.5 110.309 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 94.3 mt -87.59 -9.69 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.468 -0.787 . . . . 70.31 110.25 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.417 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 5.1 m -103.03 -43.83 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.303 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -81.08 50.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 75.44 111.86 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.42 -115.52 2.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.491 -0.861 . . . . 53.41 112.92 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 83.2 mt -108.19 120.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.003 0.43 . . . . 74.2 110.853 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -85.34 96.58 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.35 -0.611 . . . . 75.32 109.35 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.18 118.14 35.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.153 0.501 . . . . 71.24 111.204 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -92.84 121.44 34.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.311 -0.626 . . . . 74.43 109.311 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -117.5 102.97 9.63 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.781 -0.451 . . . . 72.24 109.781 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.12 -81.95 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.352 -0.84 . . . . 73.52 111.222 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -124.39 -30.2 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.903 0.383 . . . . 75.53 110.72 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.66 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 35.1 m-20 -85.21 161.02 19.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.301 0.572 . . . . 74.4 111.206 -172.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.448 HD12 ' HB2' ' A' ' 33' ' ' PRO . 94.6 mt -108.32 112.9 25.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.443 -0.799 . . . . 65.31 109.642 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.66 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 30.5 m95 -110.66 107.82 17.53 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.466 HG23 ' HE2' ' A' ' 31' ' ' PHE . 14.4 p -78.1 133.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.699 -0.482 . . . . 74.13 109.699 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 75' ' ' GLN . . . -118.91 134.02 55.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.434 . . . . 74.03 110.532 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.638 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 1.2 p -74.86 145.14 80.96 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.176 -0.465 . . . . 70.55 110.338 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.86 -53.14 5.42 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.965 2.443 . . . . 72.03 113.214 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.97 -47.08 7.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 73.14 111.518 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 71.4 mmtt -65.71 -33.46 75.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.343 -0.39 . . . . 75.3 110.77 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 60.82 28.96 18.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.685 -0.688 . . . . 55.05 111.022 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.562 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 79.0 mt-30 -91.86 137.12 32.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.645 -0.707 . . . . 70.22 110.563 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.527 ' H ' ' CG ' ' A' ' 87' ' ' ASP . 26.5 m80 -101.91 126.11 48.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.658 -0.701 . . . . 61.24 110.885 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.15 125.09 45.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.486 -0.324 . . . . 75.34 110.158 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.55 111.22 8.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.048 0.451 . . . . 75.3 110.446 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.94 82.8 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.746 . . . . 74.11 110.784 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -172.52 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.442 -0.799 . . . . 74.03 108.944 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -121.98 -11.82 8.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.51 -0.768 . . . . 73.25 110.726 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.59 59.29 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.94 -0.648 . . . . 74.42 112.341 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -62.68 123.13 17.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 74.11 111.157 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.4 145.59 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.797 -0.816 . . . . 74.4 108.797 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.87 -62.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.369 -0.604 . . . . 75.43 109.369 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.66 13.99 1.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.913 -1.143 . . . . 75.22 107.913 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 76' ' ' HIS . 1.1 m-20 -95.38 31.29 2.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.619 -1.628 . . . . 74.5 110.892 -167.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.15 44.37 2.38 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.014 -0.612 . . . . 75.03 113.117 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.42 -21.62 27.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.268 0.556 . . . . 71.25 110.08 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.64 91.34 3.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.49 -0.777 . . . . 75.13 109.057 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -61.16 100.89 0.13 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.51 -0.768 . . . . 71.34 111.593 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.1 m -122.13 161.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 75.15 110.286 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.84 173.17 11.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 70.22 110.349 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.575 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -101.92 -158.84 0.7 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.984 0.421 . . . . 72.04 109.987 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -157.24 169.88 23.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.105 -0.952 . . . . 73.51 109.839 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -88.68 126.7 35.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.989 -0.745 . . . . 71.14 108.989 170.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.581 HG23 HG23 ' A' ' 106' ' ' ILE . 80.6 p -128.75 131.98 47.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.568 0.223 . . . . 74.43 110.953 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 141.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 71.4 110.253 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.4 92.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.711 -0.677 . . . . 62.23 109.812 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.46 83.57 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.616 -0.72 . . . . 62.43 111.375 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 71.06 -82.4 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.181 -0.918 . . . . 54.13 111.831 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 8.17 7.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.802 -0.713 . . . . 63.42 112.931 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -138.53 152.07 47.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.973 0.387 . . . . 71.34 110.46 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.0 t -107.21 131.91 56.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.274 -0.421 . . . . 75.4 110.807 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.431 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 68.0 mt-30 -127.51 128.23 45.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.939 -0.393 . . . . 73.23 109.939 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.581 HG23 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -117.32 156.16 18.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 73.04 110.985 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 13.5 t -98.14 106.76 19.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.345 -0.613 . . . . 71.02 109.345 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 pt -80.6 142.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.037 0.446 . . . . 65.44 110.962 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.79 22.0 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.965 -0.562 . . . . 62.21 110.936 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.88 -178.08 5.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.712 -0.676 . . . . 72.1 109.972 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.3 m -137.86 -2.54 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 73.25 110.474 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.3 t70 61.34 95.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.543 -0.753 . . . . 74.34 111.146 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -101.36 112.6 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 70.24 109.463 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.67 158.59 43.96 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.969 -0.56 . . . . 72.33 110.386 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.83 140.97 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.226 -0.443 . . . . 61.22 110.232 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -73.29 147.72 44.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.236 -0.438 . . . . 74.01 110.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -85.73 92.65 8.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.91 0.862 . . . . 75.21 109.146 172.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 m -63.46 -21.0 66.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.753 -1.112 . . . . 74.14 111.686 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -122.54 93.22 48.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 71.05 110.091 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.4 167.19 23.27 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.176 2.584 . . . . 74.13 111.801 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 82.3 mt -97.68 138.42 21.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.232 -0.44 . . . . 71.21 110.108 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 31.6 Cg_exo -59.47 113.12 1.47 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.748 2.299 . . . . 73.52 112.145 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 pp -78.35 -12.07 59.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.108 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.94 132.31 37.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 72.53 111.458 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -86.83 99.63 11.95 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.276 -1.379 . . . . 70.41 107.276 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.75 -79.22 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 74.13 111.004 -168.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -166.07 143.86 5.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.399 -0.593 . . . . 75.24 109.399 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.73 131.49 46.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.523 -0.547 . . . . 73.2 109.523 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -70.58 -45.99 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 74.13 109.99 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 117.958 -1.02 . . . . 75.41 108.849 170.378 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 25.2 ttt . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.604 0.24 . . . . 64.14 110.637 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 p -130.12 -82.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.618 -0.512 . . . . 45.53 109.618 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.423 ' O ' ' HA ' ' A' ' 107' ' ' SER . 14.2 mm100 -106.55 -3.38 20.86 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.411 -0.959 . . . . 74.13 108.411 166.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 84.0 m95 -86.31 110.69 19.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.915 -1.493 . . . . 75.23 109.482 175.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.692 HG23 HG12 ' A' ' 23' ' ' VAL . 19.1 m -100.22 136.79 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.618 -0.512 . . . . 73.04 109.618 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.736 HG21 ' H ' ' A' ' 8' ' ' CYS . 8.5 m -81.12 126.67 31.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.975 0.417 . . . . 75.14 111.974 -173.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.71 -1.2 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.6 0.714 . . . . 64.11 109.476 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.736 ' H ' HG21 ' A' ' 6' ' ' THR . 61.1 m 87.49 -60.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.566 -1.197 . . . . 62.33 111.581 169.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.843 ' HE3' ' HB2' ' A' ' 12' ' ' ASP . 44.1 mtmt -145.34 146.41 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.974 0.416 . . . . 64.55 111.893 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD23 ' OE1' ' A' ' 37' ' ' GLU . 35.6 tp -84.12 -25.92 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.717 -1.216 . . . . 74.54 107.717 165.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -60.61 -39.37 87.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.168 -1.378 . . . . 71.43 111.349 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.843 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -77.67 -10.16 59.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 72.0 110.175 -176.399 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.4 mt -93.78 113.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.839 -0.619 . . . . 71.43 109.782 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.471 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.5 mt -69.7 139.16 88.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.316 -0.402 . . . . 73.5 111.381 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 16.5 Cg_exo -68.2 128.17 17.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.096 2.531 . . . . 72.13 112.178 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.07 19.33 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.949 -0.569 . . . . 72.3 112.19 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 172.47 16.86 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.816 0.308 . . . . 72.12 111.41 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.16 138.01 5.05 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.734 -0.546 . . . . 72.04 111.734 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.09 167.59 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.937 0.368 . . . . 71.03 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.72 ' HB3' HD13 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.79 109.42 11.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.979 0.419 . . . . 71.1 111.401 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.34 106.84 6.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.831 -0.622 . . . . 74.15 109.342 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -78.13 105.48 9.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.07 -0.514 . . . . 75.13 109.709 -178.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.692 HG12 HG23 ' A' ' 5' ' ' THR . 48.5 t -118.6 92.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.759 -0.655 . . . . 63.12 110.016 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 61.64 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.578 -0.737 . . . . 70.43 112.035 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -118.82 -2.14 10.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.807 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -109.29 139.45 44.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.399 -0.364 . . . . 75.11 111.222 -174.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -128.92 113.16 14.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.934 -0.576 . . . . 75.14 109.805 173.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.509 ' HA ' HD11 ' A' ' 45' ' ' ILE . 1.4 pp -132.71 142.82 41.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.935 0.398 . . . . 73.42 110.588 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.49 120.79 28.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 65.2 109.94 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.26 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 64.24 110.619 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.594 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 55.7 m-85 -72.45 134.62 45.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.623 -0.717 . . . . 75.45 111.156 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -120.43 81.53 31.01 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 165.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.01 -32.54 53.55 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.848 2.366 . . . . 74.4 112.733 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.92 -166.71 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 74.13 111.459 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -79.98 -18.88 49.2 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.202 0.816 . . . . 74.34 113.202 -165.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.456 ' OD2' ' HG2' ' A' ' 38' ' ' GLN . 11.5 p-10 -110.81 -165.69 1.01 Allowed 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.335 0.495 . . . . 45.4 112.335 -168.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' OE1' HD23 ' A' ' 10' ' ' LEU . 6.5 mm-40 -69.52 6.62 1.03 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.152 0.797 . . . . 74.23 113.152 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.456 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 15.8 mm100 -74.42 83.27 1.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 70.13 110.757 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.441 HG23 HG21 ' A' ' 97' ' ' THR . 20.6 m -108.79 159.53 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.885 -0.598 . . . . 72.05 110.79 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.594 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 94.7 m-85 -135.67 109.16 7.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.464 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.87 95.78 7.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 71.22 110.623 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 44' ' ' ASN . 37.7 pt -121.85 168.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.016 -0.538 . . . . 63.14 111.255 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -78.87 48.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.4 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.513 ' HB2' HG13 ' A' ' 42' ' ' ILE . 53.9 t30 -98.35 46.42 1.0 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.357 0.599 . . . . 72.15 110.242 -173.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.72 HD13 ' HB3' ' A' ' 20' ' ' CYS . 10.9 mm -83.52 -23.5 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.551 -0.749 . . . . 71.43 111.098 -175.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.848 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 7.5 t70 68.6 123.05 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 O-C-N 124.367 1.042 . . . . 72.34 111.631 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.6 Cg_endo -80.99 18.86 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.17 2.58 . . . . 75.24 112.951 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.413 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 85.0 t80 -111.28 -36.04 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.636 -0.256 . . . . 72.44 111.094 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.42 -20.98 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.108 0.41 . . . . 72.55 112.108 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 64.84 19.18 11.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.387 0.514 . . . . 74.13 112.387 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.55 22.98 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.889 0.329 . . . . 72.32 111.889 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 38.2 m 58.62 39.62 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.279 0.561 . . . . 62.32 110.785 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.54 -18.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 74.53 111.275 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.848 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 59.0 mt -75.11 -18.06 60.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 74.4 110.11 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -86.78 1.23 52.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.073 -0.512 . . . . 72.14 110.536 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -102.13 11.75 37.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.946 -0.761 . . . . 61.02 108.946 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.96 -151.31 12.08 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.353 -0.84 . . . . 71.5 112.825 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 3.7 mp -97.44 129.82 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 64.25 110.898 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.95 99.1 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.917 -0.772 . . . . 72.33 108.917 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.5 97.93 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.611 . . . . 75.02 110.843 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.52 110.93 19.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 74.12 109.49 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -89.89 92.24 8.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.534 -0.543 . . . . 61.12 109.534 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 66.52 -74.86 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.706 -0.679 . . . . 73.24 111.145 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -126.99 -24.86 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.828 -0.624 . . . . 65.24 110.185 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -81.4 165.41 21.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 73.21 110.556 -174.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.5 mt -123.75 108.69 12.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.208 0.528 . . . . 73.14 111.12 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.521 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 37.0 m95 -117.56 144.49 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 74.4 109.88 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 7.1 p -102.12 125.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.158 0.504 . . . . 73.3 109.79 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.607 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -84.55 109.46 17.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.974 -0.557 . . . . 75.41 109.82 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.553 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 46.5 t -60.86 122.82 71.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.784 -0.643 . . . . 75.13 110.846 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 61.1 Cg_endo -73.34 -8.6 22.1 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.442 2.095 . . . . 65.21 112.138 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.22 -49.37 2.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 74.42 111.219 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HB3' ' HG2' ' A' ' 75' ' ' GLN . 29.6 mmtm -94.85 -6.62 42.35 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.197 0.443 . . . . 75.33 112.197 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 73.47 -35.89 0.33 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.241 0.616 . . . . 74.13 112.65 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.554 ' OE1' ' HB3' ' A' ' 87' ' ' ASP . 21.0 pt20 -59.29 159.14 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.626 0.727 . . . . 71.25 112.604 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 80.6 m80 -99.21 123.55 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.946 -1.024 . . . . 71.11 110.66 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 81.1 m-85 -99.12 124.67 44.32 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.755 -0.831 . . . . 72.53 108.755 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 10.3 ttp180 -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.28 -0.568 . . . . 73.44 109.508 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.69 -52.75 63.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.637 -0.71 . . . . 75.03 112.728 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.73 32.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 75.25 110.591 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 11.4 t70 -145.23 -56.79 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.324 -0.398 . . . . 73.4 111.322 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.23 -32.09 6.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.631 -0.795 . . . . 51.53 113.109 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -78.42 166.91 22.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.195 0.521 . . . . 72.33 111.335 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 20.2 m -106.03 159.5 16.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.56 -0.745 . . . . 74.24 110.487 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.463 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 63.3 tp -83.56 -65.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 62.32 111.72 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -92.34 -11.22 35.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.331 -0.395 . . . . 72.33 111.711 -174.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.554 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 9.2 t70 -135.64 -161.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.059 -0.719 . . . . 75.22 109.059 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . 173.56 27.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.387 -0.911 . . . . 60.15 113.075 179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 3.0 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.726 0.298 . . . . 54.41 111.432 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.86 -78.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.18 -0.208 . . . . 64.14 111.331 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 m 66.55 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.839 0.712 . . . . 73.03 110.949 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.51 164.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 72.34 111.313 -176.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 167.24 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 72.34 109.696 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -141.61 120.09 12.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.369 . . . . 64.42 110.065 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.44 148.44 24.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.812 -0.631 . . . . 74.43 111.171 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.624 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 m-20 -66.72 140.64 57.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 65.21 109.917 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.655 HG23 HG22 ' A' ' 106' ' ' ILE . 12.1 p -116.7 124.89 50.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.879 0.371 . . . . 74.12 110.637 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -106.4 139.43 40.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.404 0.621 . . . . 64.35 110.936 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.68 97.9 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.602 -1.181 . . . . 74.23 108.661 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.485 ' HB ' HE21 ' A' ' 105' ' ' GLN . 13.3 t -86.71 -17.05 34.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.117 -0.492 . . . . 71.03 111.645 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.41 -77.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.042 -0.725 . . . . 72.12 109.042 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.22 24.03 1.4 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.316 -1.514 . . . . 73.54 109.316 173.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -135.49 153.69 51.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.953 -1.124 . . . . 75.02 108.35 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.08 139.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 121.098 -0.241 . . . . 75.14 111.043 -171.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.507 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 36.0 mt-30 -129.69 131.93 46.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.932 -0.396 . . . . 71.44 109.932 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.655 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.34 144.5 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 71.11 110.85 178.088 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 49.7 m -78.47 106.82 10.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 63.41 110.208 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 pp -80.52 143.83 11.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.915 0.388 . . . . 75.54 110.409 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.3 -46.08 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.439 0.637 . . . . 62.11 110.275 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.6 t70 70.42 130.37 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.615 -1.63 . . . . 62.43 112.072 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.1 m -101.55 -84.48 0.44 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.416 -0.811 . . . . 64.33 109.978 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -146.52 104.45 3.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.305 -0.407 . . . . 73.41 110.756 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.6 t -113.36 142.82 24.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.814 -0.63 . . . . 72.25 109.484 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 120.96 18.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 62.2 110.385 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.99 138.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.031 -0.531 . . . . 65.34 110.17 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.11 167.63 11.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 74.21 110.993 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -121.57 87.77 2.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 64.24 110.115 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.1 t -79.6 63.96 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.619 . . . . 74.11 109.479 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -62.63 131.49 94.2 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 74.43 111.023 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.49 -175.11 2.41 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.827 2.351 . . . . 61.21 112.227 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.49 122.71 81.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 72.42 111.043 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.29 42.59 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.427 2.752 . . . . 72.31 111.569 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.58 164.92 3.21 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.767 -0.651 . . . . 64.41 111.406 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.2 122.72 10.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.818 -0.628 . . . . 73.45 111.746 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.37 121.31 1.37 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.0 -1.0 . . . . 74.11 108.477 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -67.76 140.93 56.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.346 0.593 . . . . 55.53 111.683 -173.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -163.02 131.12 3.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.057 -0.974 . . . . 74.43 108.491 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -63.37 140.47 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.109 -0.33 . . . . 74.54 110.109 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -91.4 -174.05 3.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.331 -0.395 . . . . 74.53 110.055 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.3 p80 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.346 -0.835 . . . . 73.34 110.095 179.742 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.635 0.255 . . . . 75.41 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -86.78 173.91 9.14 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.03 -0.359 . . . . 53.25 110.03 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -80.63 81.38 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.569 0.223 . . . . 72.34 111.305 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -81.44 114.59 20.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.927 0.394 . . . . 72.34 110.225 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -122.98 136.17 54.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 75.04 110.638 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 40.8 m -81.99 137.55 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.354 . . . . 74.13 110.262 178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.45 HG12 ' HB1' ' A' ' 21' ' ' ALA . 25.7 t -99.61 -75.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.099 0.475 . . . . 52.51 110.008 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.87 -173.39 4.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.81 -0.632 . . . . 73.31 109.495 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -70.05 139.75 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 63.11 110.709 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.51 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.9 tt -83.65 -27.5 29.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.122 -1.066 . . . . 72.12 108.122 171.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -67.5 -25.32 65.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.526 -1.216 . . . . 71.41 110.563 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.9 -5.72 56.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 52.33 110.23 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 10' ' ' LEU . 71.2 mt -78.58 129.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 74.24 109.822 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mt -74.37 138.8 74.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.105 -0.498 . . . . 75.22 111.584 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.518 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 14.3 Cg_exo -69.35 123.62 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.878 2.385 . . . . 73.32 111.88 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.19 28.18 10.12 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.773 -0.649 . . . . 74.34 112.601 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.6 p -139.18 -178.81 5.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 117.207 0.503 . . . . 73.21 111.607 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -158.02 127.16 1.84 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.237 -1.145 . . . . 51.25 110.237 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.11 146.02 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.252 0.834 . . . . 73.23 113.252 -172.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.9 t -73.97 108.73 6.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.202 -0.908 . . . . 70.33 110.176 173.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.45 ' HB1' HG12 ' A' ' 7' ' ' VAL . . . -103.86 128.27 51.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.119 -0.491 . . . . 72.33 110.548 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.14 106.19 17.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.861 -0.792 . . . . 74.11 108.861 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.567 HG13 HD11 ' A' ' 108' ' ' ILE . 13.5 t -105.76 90.12 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.347 -0.388 . . . . 74.11 110.448 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 67.61 -67.14 0.19 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.214 -0.903 . . . . 72.04 112.103 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.635 ' HA ' HE21 ' A' ' 25' ' ' GLN . 0.0 OUTLIER -136.84 -18.15 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.792 0.293 . . . . 63.12 111.792 -175.442 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.516 ' HG3' HD13 ' A' ' 28' ' ' ILE . 3.6 pt20 -117.12 151.96 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 64.15 111.75 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -103.43 125.58 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.739 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 HD13 ' HG3' ' A' ' 26' ' ' GLN . 5.1 mp -129.17 143.45 41.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 60.11 110.056 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.1 36.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 73.2 109.584 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.485 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 45.6 t -105.93 104.97 17.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.895 0.379 . . . . 75.25 110.332 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.795 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.7 m-85 -81.88 131.02 35.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.734 . . . . 73.35 111.312 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.413 ' HB2' HG12 ' A' ' 39' ' ' VAL . 75.6 ttt180 -131.06 76.35 76.9 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.81 -0.811 . . . . 70.2 108.81 165.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.47 -19.37 13.17 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.574 2.182 . . . . 62.33 111.963 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -100.13 164.62 11.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 74.33 109.899 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 2.2 p-10 -80.92 -10.23 59.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 62.33 109.904 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.93 171.76 14.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.442 -0.799 . . . . 72.14 110.94 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.498 ' HG2' HD21 ' A' ' 10' ' ' LEU . 29.2 mt-10 -85.52 30.89 0.6 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 75.13 111.253 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -100.57 103.33 14.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.144 -0.48 . . . . 74.44 109.755 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 19.1 m -104.92 163.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.002 -0.544 . . . . 75.42 111.298 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.795 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 48.9 m-85 -124.19 102.77 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 73.25 109.951 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.01 95.23 9.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.16 0.505 . . . . 64.4 110.741 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.58 162.65 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.576 . . . . 72.01 110.057 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.42 ' HB2' ' HB ' ' A' ' 92' ' ' VAL . 20.7 m -78.71 82.87 4.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.15 0.5 . . . . 74.02 110.589 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.26 17.96 21.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.066 0.936 . . . . 73.51 109.556 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.27 107.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.721 -1.127 . . . . 74.52 109.909 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.444 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.2 t70 -60.95 131.67 91.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.251 -0.431 . . . . 62.22 110.221 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 18.7 Cg_exo -67.39 -4.64 12.23 Favored 'Trans proline' 0 N--CA 1.472 0.26 0 C-N-CA 123.393 2.729 . . . . 64.12 113.482 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -113.16 3.96 16.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.296 0.57 . . . . 73.23 109.923 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.41 -35.83 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.91 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 64.66 21.52 12.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.941 0.401 . . . . 73.1 111.658 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -146.25 170.56 16.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.57 . . . . 63.43 110.082 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.8 m -81.61 59.91 4.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.53 0.681 . . . . 74.21 111.057 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -78.53 -23.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.65 -0.705 . . . . 72.4 110.312 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 70' ' ' SER . 57.8 mt -81.79 -21.79 37.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 73.45 109.948 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 m -74.56 -22.57 58.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.369 -0.832 . . . . 72.43 111.244 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -96.61 27.1 4.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.192 0.52 . . . . 75.43 110.675 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.47 -152.0 26.76 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 62.12 112.056 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.763 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 53.8 mt -86.44 103.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.043 0.449 . . . . 71.12 110.8 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -75.58 96.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.815 -0.63 . . . . 62.31 109.759 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.43 137.17 46.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.995 -0.548 . . . . 75.35 111.416 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 72.12 109.482 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.673 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 56.2 t60 -107.52 114.43 28.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.113 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 69.76 -84.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.054 -0.975 . . . . 72.01 111.413 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.65 -9.31 2.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.511 . . . . 73.13 110.999 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.522 ' HB2' ' NE1' ' A' ' 67' ' ' TRP . 3.6 m-20 -115.16 -179.2 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.04 0.447 . . . . 65.12 110.873 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.0 mt -112.6 118.46 35.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 74.54 109.449 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.673 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 26.8 m95 -122.5 115.8 22.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.637 . . . . 74.31 109.991 -174.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.8 p -85.16 127.31 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.146 0.498 . . . . 64.4 110.605 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.763 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -89.9 101.94 14.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.917 -0.583 . . . . 71.45 109.463 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.662 ' HB2' HD22 ' A' ' 54' ' ' LEU . 12.8 p -64.89 136.5 96.81 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.642 -0.708 . . . . 75.11 111.028 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.7 -32.12 31.02 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.392 2.061 . . . . 71.14 112.51 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.78 -49.42 9.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 72.15 111.683 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.5 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 4.3 mmpt? -84.18 -27.14 28.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 72.32 110.157 -175.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 62.07 27.11 16.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.152 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.03 151.9 25.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 63.35 110.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.503 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 79.7 m80 -92.8 126.33 37.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.471 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -115.29 132.76 56.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.064 177.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.489 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 ttp180 -81.75 119.97 24.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.536 -0.542 . . . . 74.3 109.536 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.413 HD22 ' CG1' ' A' ' 68' ' ' VAL . 75.1 mt -78.81 23.92 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.679 0.622 . . . . 74.21 112.679 -170.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.49 24.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.257 -0.646 . . . . 73.03 109.257 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 25.2 t70 -136.65 -71.26 0.45 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.83 -0.623 . . . . 62.01 110.898 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.61 -26.78 4.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.759 -0.734 . . . . 45.41 112.225 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.63 169.49 12.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.312 0.577 . . . . 73.25 111.067 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 4.2 m -109.14 149.93 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.479 -0.782 . . . . 75.1 110.351 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.3 tp -98.73 20.26 13.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.247 0.546 . . . . 75.41 110.184 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -135.44 -68.11 0.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.618 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.33 136.27 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.548 -0.296 . . . . 63.41 110.348 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.35 49.04 3.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.031 -0.604 . . . . 74.31 112.801 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.15 -5.59 16.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 74.33 110.904 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.5 ' CE2' ' HD3' ' A' ' 73' ' ' LYS . 80.5 m-85 -136.14 32.38 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.134 -0.485 . . . . 74.02 110.816 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -78.27 117.35 19.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.159 -0.473 . . . . 60.33 110.045 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' A' ' 43' ' ' SER . 30.3 m -116.05 -170.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 62.33 111.476 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.01 168.19 9.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 74.04 111.075 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.47 109.53 13.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.61 -0.723 . . . . 53.43 109.376 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -82.26 147.42 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.757 -0.656 . . . . 75.44 111.232 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.616 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 12.5 m-20 -66.24 122.11 16.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 74.54 110.068 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.533 HG22 HG13 ' A' ' 106' ' ' ILE . 1.6 m -117.51 153.77 32.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.85 -0.426 . . . . 72.53 109.85 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -144.41 153.01 41.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.445 -0.343 . . . . 64.45 110.261 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -124.9 105.39 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 72.5 109.138 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 101' ' ' ASN . 5.2 t -112.72 -63.6 1.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.986 0.736 . . . . 75.15 112.986 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.451 ' H ' HG21 ' A' ' 100' ' ' THR . 32.6 m-20 -106.33 29.2 7.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 71.54 110.403 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.13 90.28 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.875 -0.89 . . . . 73.24 110.875 -172.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -111.34 159.4 18.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.956 -0.622 . . . . 74.34 109.758 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.412 HG23 HD13 ' A' ' 10' ' ' LEU . 22.0 t -103.69 125.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.256 -0.429 . . . . 71.33 110.565 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -124.52 131.41 53.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.42 . . . . 63.12 110.389 176.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.533 HG13 HG22 ' A' ' 97' ' ' THR . 3.8 mp -113.71 142.04 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 73.1 110.005 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.616 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 47.0 t -80.53 99.21 7.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.285 -0.635 . . . . 71.41 109.285 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.567 HD11 HG13 ' A' ' 23' ' ' VAL . 44.3 mm -77.0 94.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.668 -0.696 . . . . 71.22 111.142 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.0 134.6 34.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.248 -0.649 . . . . 73.21 109.248 173.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.8 121.83 18.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.662 0.744 . . . . 61.31 111.157 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 m -84.99 -69.71 0.63 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.013 -0.994 . . . . 73.32 109.356 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.48 97.61 3.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.369 -0.832 . . . . 64.43 109.396 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -111.69 135.84 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.888 -0.596 . . . . 75.52 110.517 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.05 175.13 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.919 -0.582 . . . . 72.3 109.592 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 m -67.52 104.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.384 0.611 . . . . 63.43 110.598 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.53 144.33 54.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 74.33 110.699 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -63.44 137.58 58.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 74.22 110.125 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 m -82.55 76.76 9.39 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.631 0.729 . . . . 74.35 111.359 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -82.54 151.84 65.88 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.071 -0.968 . . . . 74.24 109.662 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 119.81 7.18 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.3 2.0 . . . . 70.24 111.598 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.07 144.98 93.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 75.14 110.751 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.71 168.63 4.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.832 2.354 . . . . 73.31 112.063 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.35 45.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.337 0.495 . . . . 73.32 112.337 -174.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.72 139.6 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.93 -1.137 . . . . 74.25 107.93 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -67.05 -50.05 63.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.657 0.243 . . . . 73.21 111.657 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 63.31 179.31 0.15 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 71.32 111.183 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -125.93 101.72 6.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.313 -0.995 . . . . 74.24 108.313 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -103.39 118.46 36.81 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.419 -0.512 . . . . 74.44 111.37 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.0 135.19 8.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 75.12 109.089 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.616 -0.707 . . . . 72.12 109.546 177.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.956 0.408 . . . . 75.13 110.592 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.418 ' HB2' ' NE1' ' A' ' 4' ' ' TRP . 4.0 m -69.03 153.53 43.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 75.43 110.313 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -75.57 76.01 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.066 0.46 . . . . 70.23 110.861 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.418 ' NE1' ' HB2' ' A' ' 2' ' ' SER . 98.4 m95 -85.13 118.21 24.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 75.13 110.131 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -121.08 152.27 38.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 74.15 110.555 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.944 0.402 . . . . 75.2 111.543 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG13 HG23 ' A' ' 30' ' ' VAL . 93.3 t -80.84 -68.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 75.42 109.498 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.1 t -179.22 -163.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.052 -1.092 . . . . 70.21 108.052 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.684 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 13.7 mtpt -79.15 136.24 37.06 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.896 -0.409 . . . . 72.41 109.896 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.71 -30.49 69.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.356 0.598 . . . . 73.21 110.104 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.57 -17.57 51.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.479 -176.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.684 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 t70 -84.81 -19.63 32.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.77 -0.65 . . . . 71.11 109.347 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.97 125.03 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.616 -0.72 . . . . 75.14 110.679 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.466 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 94.1 mt -77.13 133.47 68.76 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.205 -0.452 . . . . 70.03 111.665 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 12.7 Cg_exo -70.24 144.8 52.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.324 2.683 . . . . 74.44 112.555 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.61 56.1 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.935 -0.575 . . . . 41.42 112.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.548 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -156.48 158.06 36.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.779 0.323 . . . . 64.3 111.737 -172.676 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -122.58 138.74 12.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.797 -0.921 . . . . 72.14 110.797 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.78 142.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.459 0.54 . . . . 70.44 112.459 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.624 ' HB3' HD13 ' A' ' 45' ' ' ILE . 2.1 p -75.19 105.91 6.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.448 . . . . 64.22 111.44 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.72 132.92 35.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.911 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 118' ' ' SER . 2.9 tm? -100.17 98.14 8.88 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.48 -0.563 . . . . 73.42 109.48 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG23 HD12 ' A' ' 106' ' ' ILE . 21.2 t -108.74 70.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.957 -0.565 . . . . 73.33 109.629 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 8.1 pt-20 42.2 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.938 1.295 . . . . 74.11 114.191 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.703 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 3.9 pt20 -80.87 -13.05 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.564 0.579 . . . . 72.22 112.564 -172.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.514 ' NE2' ' HB3' ' A' ' 110' ' ' ASP . 19.6 mt-30 -143.92 153.72 42.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.288 0.566 . . . . 64.32 111.951 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -115.33 117.86 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 65.11 109.054 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.561 HD13 HG13 ' A' ' 106' ' ' ILE . 66.1 mt -122.01 132.32 71.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' HD11 ' A' ' 45' ' ' ILE . . . -88.65 125.6 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.292 -0.413 . . . . 71.12 110.641 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.471 HG23 HG13 ' A' ' 7' ' ' VAL . 39.0 t -105.54 105.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.074 0.464 . . . . 74.14 110.126 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.444 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 74.7 m-85 -78.37 128.39 33.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.501 -0.772 . . . . 74.1 110.76 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 13.0 tpt180 -109.16 84.67 2.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.196 -1.038 . . . . 72.21 108.196 168.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 31' ' ' PHE . 16.9 Cg_exo -66.65 -48.03 2.46 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.621 2.214 . . . . 55.24 112.353 -174.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -116.92 166.75 11.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.048 -0.524 . . . . 65.21 110.111 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -81.77 72.65 8.82 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.092 -1.077 . . . . 75.21 108.092 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -150.19 179.04 8.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.896 -1.047 . . . . 75.14 109.082 -174.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -79.27 -9.04 59.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.724 0.297 . . . . 74.53 111.33 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.08 129.27 35.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.6 . . . . 74.52 111.605 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.74 155.17 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.794 . . . . 53.53 110.021 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -132.94 108.01 8.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.684 0.278 . . . . 71.41 111.005 -179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.24 108.29 19.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.878 0.37 . . . . 73.13 111.109 178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -132.16 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 74.14 110.146 178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 55.0 m -81.82 89.91 6.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.796 0.332 . . . . 61.34 110.167 178.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -129.08 43.99 3.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.583 0.706 . . . . 75.13 109.223 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.624 HD13 ' HB3' ' A' ' 20' ' ' CYS . 46.8 mm -107.98 128.98 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.585 -0.734 . . . . 62.1 110.532 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 t70 -85.91 118.07 69.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.259 -0.645 . . . . 74.21 109.259 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 19.2 Cg_exo -66.97 -12.18 35.12 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.225 2.617 . . . . 75.11 113.25 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -93.94 -18.69 21.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.951 0.405 . . . . 73.33 110.37 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.41 -22.27 13.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 70.21 109.639 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 66.22 28.81 9.93 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.909 -1.041 . . . . 65.23 111.782 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.557 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -159.17 173.74 15.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 72.33 110.561 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -79.65 52.27 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.919 -0.582 . . . . 72.25 110.94 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.75 -18.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.784 -0.644 . . . . 63.23 110.702 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.49 -6.43 49.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.624 -0.716 . . . . 73.13 109.666 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.678 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 5.1 m -100.61 -35.16 9.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.388 -0.824 . . . . 64.05 110.362 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.548 ' HG3' HG22 ' A' ' 17' ' ' THR . 72.5 ttt180 -88.18 61.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.797 0.808 . . . . 73.52 109.665 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.72 -153.81 9.34 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.865 -1.061 . . . . 64.01 111.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.5 mp -94.75 120.69 44.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.892 0.377 . . . . 60.25 110.012 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.4 99.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.726 . . . . 64.32 109.832 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.73 119.98 31.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.474 -0.785 . . . . 60.23 110.454 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -95.45 132.48 40.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.078 -0.51 . . . . 73.32 110.639 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -94.76 -155.78 0.48 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.921 -1.14 . . . . 72.21 107.921 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -78.08 -30.91 49.86 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.878 -0.514 . . . . 72.31 110.275 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -128.59 -39.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.982 -0.554 . . . . 74.21 111.0 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.551 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 11.8 m-20 -93.74 158.94 15.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 73.1 112.289 -170.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.41 121.77 43.77 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.024 -0.989 . . . . 63.22 109.621 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.551 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 24.0 m95 -119.4 165.81 13.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.244 -0.434 . . . . 75.54 110.33 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.642 ' HB ' HD23 ' A' ' 79' ' ' LEU . 11.3 p -122.93 129.13 75.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.204 0.526 . . . . 73.32 110.08 173.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.19 107.99 19.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.868 -0.606 . . . . 74.35 110.012 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 21.1 p -74.55 134.69 75.87 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.979 -0.555 . . . . 72.44 110.448 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.38 -39.67 12.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.527 2.152 . . . . 64.43 112.562 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.61 -58.08 3.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 63.55 111.387 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.6 -31.42 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.436 -0.347 . . . . 73.21 110.965 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 70' ' ' SER . 56.2 mttm 65.78 17.78 10.96 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.514 -0.766 . . . . 60.32 110.782 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -85.99 138.46 31.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.436 -0.802 . . . . 75.05 108.948 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -97.12 105.98 18.23 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.857 0.36 . . . . 72.15 110.214 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -96.72 128.59 43.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.912 -0.585 . . . . 64.43 110.02 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.401 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 35.2 ttp180 -74.21 117.05 15.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.35 -0.611 . . . . 71.34 109.35 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.642 HD23 ' HB ' ' A' ' 68' ' ' VAL . 88.7 mt -48.13 -58.06 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.113 0.883 . . . . 75.45 113.306 -168.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.482 ' OH ' ' HA ' ' A' ' 65' ' ' ASP . 5.9 p90 -95.84 24.82 5.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.049 0.389 . . . . 75.13 112.049 -172.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 83' ' ' PHE . 8.1 t70 -142.03 -59.01 0.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.028 0.381 . . . . 75.33 112.028 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.28 -16.13 10.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.454 -0.879 . . . . 61.33 113.46 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.494 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 10.7 t80 -56.34 126.28 25.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.955 0.378 . . . . 75.21 110.068 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.473 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 22.5 m -97.08 37.15 1.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 72.1 111.029 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.747 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 52.3 tp 66.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.4 111.479 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.747 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 45.4 mt-10 -137.38 -33.13 0.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 55.21 110.599 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.43 93.17 5.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.606 . . . . 61.54 110.985 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.05 21.75 40.24 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.953 -0.567 . . . . 53.41 112.011 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.45 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.888 0.375 . . . . 74.11 111.384 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.26 -47.73 4.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.405 -0.361 . . . . 74.31 111.718 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.473 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 23.9 p 49.84 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.334 0.654 . . . . 71.52 112.188 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 43' ' ' SER . 34.1 m -76.21 161.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.932 -0.577 . . . . 71.33 111.316 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.25 154.51 19.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 64.44 110.861 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.09 106.01 8.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.923 0.392 . . . . 75.32 110.393 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.5 -177.61 3.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.089 -0.505 . . . . 73.41 110.875 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.39 158.18 17.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 73.34 111.166 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.667 HG22 HG22 ' A' ' 106' ' ' ILE . 3.9 m -148.36 159.62 43.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.77 -0.65 . . . . 74.4 109.317 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -161.71 155.69 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.024 0.44 . . . . 61.33 111.126 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.413 HG21 HG23 ' A' ' 104' ' ' VAL . 29.2 t -132.19 127.35 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.607 -0.886 . . . . 72.35 108.607 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -135.67 -28.22 1.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.631 0.604 . . . . 70.32 112.631 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -139.55 32.62 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.051 0.453 . . . . 62.42 110.625 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.47 -37.31 3.35 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.593 -0.813 . . . . 73.34 111.865 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.0 140.34 34.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.975 0.417 . . . . 62.32 110.034 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.413 HG23 HG21 ' A' ' 99' ' ' VAL . 41.3 t -96.53 131.57 42.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.829 -0.623 . . . . 70.04 110.211 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 5' ' ' THR . 40.0 mt-30 -116.61 141.77 47.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.77 -0.196 . . . . 75.22 110.596 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.667 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -123.9 161.93 25.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.292 -0.413 . . . . 72.31 110.271 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 37.3 m -101.88 101.07 11.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.375 -0.375 . . . . 61.01 110.982 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 pt -80.54 119.04 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.274 -0.421 . . . . 73.53 109.968 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.08 22.42 7.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 72.24 111.697 -174.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.514 ' HB3' ' NE2' ' A' ' 26' ' ' GLN . 21.7 t70 -160.7 178.48 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.843 -0.617 . . . . 64.41 109.414 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 25' ' ' GLN . 32.5 t -165.9 23.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.733 0.302 . . . . 65.34 110.591 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.83 82.88 3.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.53 0.681 . . . . 63.22 110.983 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.85 128.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.326 -0.852 . . . . 75.01 109.699 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.66 102.58 14.39 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.047 -0.524 . . . . 71.44 111.188 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t 70.32 125.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.454 -0.794 . . . . 74.53 112.216 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.18 157.39 23.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.48 -0.782 . . . . 74.34 110.16 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -132.9 19.06 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.016 0.436 . . . . 73.11 110.636 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.511 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 2.5 m -106.45 77.64 1.22 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 73.34 110.948 -173.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.401 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 5.3 pm0 -66.33 137.65 95.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 75.13 110.503 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 24.6 Cg_exo -64.61 168.17 13.75 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.029 2.486 . . . . 65.21 112.985 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.485 HD21 ' H ' ' A' ' 121' ' ' LEU . 2.3 pt? -129.14 145.32 56.2 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 71.31 110.38 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 3.3 Cg_exo -80.35 179.88 5.78 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.937 2.424 . . . . 70.3 111.322 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.6 tp -134.94 93.77 3.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.858 0.361 . . . . 63.35 110.514 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.86 122.02 34.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.17 -0.468 . . . . 63.13 109.932 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -126.66 87.06 2.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.936 -0.394 . . . . 73.11 109.936 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -99.18 132.21 44.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 71.23 110.042 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -153.84 108.25 3.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 74.3 110.476 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -114.27 158.58 21.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.87 -0.605 . . . . 71.52 109.538 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.0 t60 72.33 132.41 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 124.046 0.841 . . . . 75.41 111.103 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.0 p80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.561 -0.733 . . . . 60.02 109.888 178.855 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 ttp . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.09 -0.337 . . . . 50.21 110.09 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.0 t -145.39 -46.18 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.365 -0.38 . . . . 72.03 111.261 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -83.95 27.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.114 0.413 . . . . 71.21 112.114 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -128.45 135.78 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.326 . . . . 71.21 110.474 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 m -119.79 132.04 55.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.102 -0.499 . . . . 72.35 110.203 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.801 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.7 m -71.49 117.52 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.098 0.475 . . . . 75.3 111.58 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 106' ' ' ILE . 41.4 t -86.9 -67.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.293 0.568 . . . . 72.05 110.644 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.51 -177.6 6.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.781 . . . . 73.3 108.975 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 47.3 mtpt -84.2 157.16 21.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.85 0.357 . . . . 75.41 110.546 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.8 tp -79.16 -2.38 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.415 0.626 . . . . 75.23 110.142 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.48 -40.74 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.745 . . . . 62.33 112.202 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 p30 -88.6 -6.74 57.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 74.14 112.395 -172.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.38 129.85 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.882 0.372 . . . . 70.34 110.164 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.489 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 91.7 mt -61.22 124.52 80.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.153 -0.476 . . . . 74.11 111.708 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 14.8 Cg_exo -68.47 131.91 24.26 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 123.232 2.621 . . . . 60.32 112.646 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 84.55 18.51 61.88 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.792 -0.64 . . . . 55.41 112.77 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -153.13 162.32 41.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 117.096 0.448 . . . . 75.51 111.444 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -118.27 124.32 6.03 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.478 -0.649 . . . . 71.33 111.478 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.42 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -111.95 141.45 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.953 0.377 . . . . 75.41 111.482 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.736 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 6.9 p -82.32 92.91 7.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.086 0.47 . . . . 74.31 111.025 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.483 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -82.65 143.19 31.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 60.25 109.93 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -80.02 97.44 6.8 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.28 -0.637 . . . . 73.14 109.28 -179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.525 HG11 HD12 ' A' ' 106' ' ' ILE . 19.2 t -91.24 79.65 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.894 -0.594 . . . . 72.35 109.997 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 65.15 -68.56 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 74.24 112.437 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -118.94 -19.41 8.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.903 0.334 . . . . 73.11 111.903 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -138.35 140.32 39.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.807 -0.357 . . . . 75.33 111.444 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 49.0 mt-30 -88.41 132.0 34.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.787 -0.449 . . . . 72.14 109.787 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 59.4 mt -130.37 136.44 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.186 -0.672 . . . . 71.23 109.186 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.24 108.41 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.385 -0.37 . . . . 64.02 110.225 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.467 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.6 t -101.0 110.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.91 -0.586 . . . . 73.35 109.907 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.607 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 89.8 m-85 -77.9 137.4 38.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.54 -0.755 . . . . 74.12 111.432 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -124.29 57.89 14.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.925 -0.768 . . . . 74.14 108.925 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.666 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 98.5 Cg_endo -77.65 -25.54 7.85 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.545 2.163 . . . . 75.23 112.871 -166.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -97.96 1.05 47.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.281 -0.418 . . . . 63.34 110.141 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.54 31.17 18.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 74.03 110.147 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.7 t70 -144.23 -158.71 0.91 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.191 -0.913 . . . . 74.44 109.674 -171.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.542 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 37.8 mt-10 -70.41 -25.82 63.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.226 0.454 . . . . 72.3 112.226 -172.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.58 91.38 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.102 0.477 . . . . 62.43 111.522 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.16 157.64 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.266 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -140.25 115.54 9.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 72.01 110.424 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 106.27 16.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.312 -0.404 . . . . 63.23 111.274 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.452 HG13 ' HB2' ' A' ' 44' ' ' ASN . 38.5 pt -123.98 153.9 30.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 63.05 109.986 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.476 ' OG ' ' HE1' ' A' ' 95' ' ' TYR . 44.9 m -77.23 59.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.128 0.49 . . . . 62.2 110.596 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.452 ' HB2' HG13 ' A' ' 42' ' ' ILE . 64.9 t30 -105.1 63.54 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.621 0.724 . . . . 72.3 110.378 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 HG13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mp -114.36 132.05 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.088 -0.96 . . . . 72.34 109.77 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.0 t70 -81.24 117.12 66.83 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 71.24 109.396 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 9.0 Cg_exo -72.32 -5.6 17.44 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.143 2.562 . . . . 73.41 113.576 -174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -89.46 -32.09 17.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.136 -0.32 . . . . 74.31 110.136 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -13.81 14.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.191 0.519 . . . . 55.52 110.066 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 57.98 59.68 3.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.862 -1.063 . . . . 73.44 110.914 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.736 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -167.32 158.44 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.028 -0.987 . . . . 71.42 109.587 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 16.7 p -81.34 50.29 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.862 -0.608 . . . . 72.13 110.515 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.59 -20.74 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.376 0.608 . . . . 65.24 110.058 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.4 mt -75.57 -14.6 60.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.3 -0.864 . . . . 73.35 109.848 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.503 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 19.5 m -117.05 4.93 12.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 61.14 110.749 -176.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -107.68 9.06 29.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.535 . . . . 74.15 110.198 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.499 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -90.79 -114.92 1.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.895 -0.669 . . . . 72.12 112.53 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.0 mt -121.24 113.81 40.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.917 0.389 . . . . 70.45 110.874 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -74.79 93.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.653 . . . . 75.34 109.287 173.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.72 157.29 16.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.718 -0.674 . . . . 73.12 111.426 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -117.88 122.99 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.738 -0.665 . . . . 75.4 110.061 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -65.38 -59.67 3.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.653 -0.703 . . . . 75.01 110.169 178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -173.34 -58.52 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.774 -1.103 . . . . 73.12 108.439 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -125.96 11.37 7.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.34 -0.846 . . . . 74.14 109.489 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.568 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.3 t0 -132.53 166.48 21.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.446 -0.797 . . . . 71.33 109.526 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.62 117.43 21.99 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.462 0.305 . . . . 65.22 110.663 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.568 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 20.4 m95 -130.01 112.58 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 72.1 110.376 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 13.8 p -79.85 141.39 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.847 -0.427 . . . . 72.5 109.847 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.46 54.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.971 0.415 . . . . 74.22 111.583 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 28.2 t -74.66 127.44 87.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 74.41 110.552 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.499 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 55.5 Cg_endo -70.86 -34.05 11.5 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.635 2.223 . . . . 73.42 113.021 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.62 -63.2 1.33 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.85 0.357 . . . . 74.33 111.825 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.579 ' HG3' ' HE2' ' A' ' 90' ' ' TYR . 41.4 mmtm -73.69 -25.57 60.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 74.22 110.874 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.4 tttm 56.15 95.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 73.14 112.357 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.441 ' OE1' ' HB3' ' A' ' 89' ' ' ALA . 2.5 pt20 -166.64 155.41 10.6 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.006 -0.997 . . . . 74.14 109.454 170.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.776 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 75.5 m80 -90.35 143.57 26.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.709 -0.678 . . . . 72.53 110.183 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.437 ' HB2' ' CG1' ' A' ' 68' ' ' VAL . 86.2 m-85 -130.58 121.1 25.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.401 -0.592 . . . . 73.14 109.401 173.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.07 133.79 45.44 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.333 -0.547 . . . . 75.51 109.74 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.63 11.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -128.06 4.9 5.88 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.675 -0.41 . . . . 74.44 111.075 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.87 -77.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.581 -0.281 . . . . 62.45 111.164 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.49 22.66 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.608 -0.806 . . . . 54.14 113.056 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -68.26 146.28 53.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.86 -0.422 . . . . 74.55 109.86 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 53.9 m -99.28 0.96 44.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.646 0.61 . . . . 54.54 112.646 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.505 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.0 tp 63.58 -74.73 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.241 0.617 . . . . 74.13 112.537 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 27.0 mt-10 -109.95 -40.71 4.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.474 0.654 . . . . 60.54 109.969 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.31 -171.01 3.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.852 -1.067 . . . . 71.23 110.386 -173.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.33 118.43 0.75 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.574 -0.822 . . . . 64.34 112.522 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . . . -168.01 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.524 0.202 . . . . 71.52 110.884 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.579 ' HE2' ' HG3' ' A' ' 73' ' ' LYS . 75.1 m-85 -83.91 80.44 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 73.23 110.756 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -74.83 97.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.004 -0.543 . . . . 70.22 109.581 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.51 -175.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.171 -0.468 . . . . 72.2 111.725 -172.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.09 173.52 8.66 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.964 -0.562 . . . . 74.13 110.403 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.428 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -134.11 116.4 15.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.806 0.336 . . . . 74.51 111.179 -173.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.476 ' HE1' ' OG ' ' A' ' 43' ' ' SER . 80.0 m-85 -80.42 151.51 29.3 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.788 -0.642 . . . . 63.32 109.42 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -81.5 160.84 23.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.224 -0.658 . . . . 71.54 109.224 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.808 HG21 HG22 ' A' ' 106' ' ' ILE . 4.8 p -136.08 142.86 44.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.779 0.324 . . . . 74.34 111.366 -171.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -125.45 138.25 54.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.22 0.533 . . . . 75.43 110.116 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.92 103.72 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.597 -0.89 . . . . 53.51 108.597 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.4 m -89.62 -68.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.317 0.58 . . . . 73.23 110.69 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -116.35 -133.02 0.33 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.359 -0.978 . . . . 71.31 108.359 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.78 35.4 2.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.421 -0.895 . . . . 61.21 111.139 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.7 p30 -141.65 155.13 45.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.496 . . . . 73.32 110.958 -175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.59 128.06 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.627 -0.715 . . . . 74.23 110.322 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.801 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -121.76 127.0 50.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.33 -0.395 . . . . 53.12 110.23 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.808 HG22 HG21 ' A' ' 97' ' ' THR . 0.2 OUTLIER -101.72 165.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.08 -0.341 . . . . 74.1 110.08 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -92.09 96.82 10.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.041 0.448 . . . . 73.42 110.235 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mm -73.79 102.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.2 0.524 . . . . 64.43 110.073 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.95 100.85 4.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 71.44 110.148 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' HB2' HG23 ' A' ' 113' ' ' VAL . 6.2 p-10 -99.35 143.98 28.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.966 -0.561 . . . . 74.22 109.939 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.1 t -56.69 -63.49 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.348 -0.612 . . . . 73.14 109.348 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -170.97 80.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.618 -0.719 . . . . 74.43 109.586 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.473 HG23 ' HB2' ' A' ' 110' ' ' ASP . 40.4 t -97.84 124.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.675 -0.693 . . . . 72.22 110.065 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.55 111.95 3.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.707 . . . . 43.31 110.398 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.05 127.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.508 -0.552 . . . . 72.4 109.508 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -118.03 106.86 13.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.157 0.504 . . . . 70.1 111.173 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -145.46 -38.51 0.25 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.26 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.403 ' O ' ' HD3' ' A' ' 120' ' ' PRO . 28.6 p -99.35 78.95 2.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.642 -0.708 . . . . 72.54 110.864 -175.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.14 111.7 11.79 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.736 -0.665 . . . . 75.21 109.996 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.479 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 87.9 Cg_endo -93.23 173.51 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.917 2.411 . . . . 65.45 112.269 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.54 90.4 8.66 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.384 -0.598 . . . . 75.1 109.384 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 5.9 Cg_endo -85.88 125.94 2.83 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.98 2.453 . . . . 74.15 112.07 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 tp -83.64 94.79 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.179 0.514 . . . . 62.33 109.861 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.596 ' OE1' ' HA ' ' A' ' 127' ' ' HIS . 44.2 tt0 -97.74 103.65 15.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.518 -0.765 . . . . 54.34 109.191 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -64.8 -41.79 95.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.379 -0.373 . . . . 74.53 111.039 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -108.62 94.26 4.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.774 -0.824 . . . . 65.21 108.774 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.596 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 51.1 m80 -68.71 129.62 40.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.426 -0.806 . . . . 72.44 112.61 -172.011 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -79.89 125.03 29.2 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.723 -1.214 . . . . 75.41 107.723 169.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -127.21 142.88 51.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.112 0.482 . . . . 73.22 111.632 -165.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.298 -0.858 . . . . 74.14 109.651 176.046 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.876 0.37 . . . . 73.21 110.772 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -114.25 -75.96 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.198 -0.456 . . . . 73.54 110.537 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 107' ' ' SER . 51.3 mt-30 -91.38 80.51 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 74.51 110.611 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.491 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 85.0 m95 -133.7 100.24 4.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.417 -0.811 . . . . 72.51 110.03 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -88.45 135.44 33.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.509 -0.314 . . . . 74.43 111.21 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.2 m -72.41 111.85 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 75.11 110.165 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.463 HG11 HG23 ' A' ' 30' ' ' VAL . 50.2 t -81.97 -73.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.827 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.2 m -150.44 175.91 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 63.31 109.688 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 2.8 mptp? -79.36 142.18 36.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.973 -0.381 . . . . 72.42 109.973 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.645 HD13 HG23 ' A' ' 99' ' ' VAL . 7.9 tt -62.63 -23.47 67.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 70.21 109.61 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.87 -21.21 26.5 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 72.55 110.264 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.55 -24.96 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 71.51 110.723 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.491 HG21 ' HB2' ' A' ' 32' ' ' ARG . 73.1 mt -77.59 116.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 75.12 111.161 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.05 132.83 90.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 60.4 111.474 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.55 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 44.1 Cg_endo -68.4 145.12 64.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.073 2.515 . . . . 63.21 113.153 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.04 64.41 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.676 -0.693 . . . . 74.34 112.856 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 166.73 32.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.084 0.442 . . . . 63.4 111.932 -175.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -146.17 142.7 10.77 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.578 -0.609 . . . . 41.23 111.578 177.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.534 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 26.2 m -127.21 144.5 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.07 0.435 . . . . 52.24 112.013 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.539 ' HB3' HD11 ' A' ' 45' ' ' ILE . 7.5 p -74.0 105.3 5.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.162 -0.472 . . . . 73.13 110.851 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 131.27 41.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.02 -0.536 . . . . 71.35 110.391 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.27 101.33 13.75 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.331 -0.618 . . . . 63.24 109.331 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -111.45 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.594 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 66.09 -72.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.351 -0.84 . . . . 72.42 111.697 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -155.2 11.32 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 74.05 110.973 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -119.08 137.73 53.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.245 -0.434 . . . . 64.44 111.014 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -99.6 112.8 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 75.34 109.878 173.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.3 mt -118.18 135.65 57.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.087 -0.506 . . . . 75.53 110.453 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.91 114.81 26.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 74.43 109.989 179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.544 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.9 t -98.54 101.63 12.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.376 -0.374 . . . . 64.04 110.747 -176.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' HE2' HG22 ' A' ' 68' ' ' VAL . 66.8 m-85 -80.05 141.99 35.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.659 . . . . 75.45 111.089 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.55 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 14.0 tpt180 -112.7 80.72 3.9 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.302 -0.999 . . . . 72.43 108.302 165.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.683 ' HG2' HE22 ' A' ' 38' ' ' GLN . 18.2 Cg_exo -65.95 -43.32 9.49 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.568 2.179 . . . . 72.53 112.962 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -114.08 156.79 23.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.707 0.289 . . . . 74.54 110.284 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.18 71.09 3.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.816 -1.179 . . . . 75.4 107.816 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.467 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 26.7 t70 -160.07 -175.9 5.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.91 -1.041 . . . . 62.32 109.08 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.467 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 29.0 mt-10 -78.71 -10.75 59.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 71.01 110.236 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.683 HE22 ' HG2' ' A' ' 33' ' ' PRO . 22.2 tm0? -73.52 124.2 25.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.291 -0.868 . . . . 71.24 110.885 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.504 HG13 ' HD2' ' A' ' 32' ' ' ARG . 28.5 m -132.74 168.22 24.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 75.41 110.425 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.92 103.02 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.657 0.244 . . . . 75.12 111.657 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -103.95 109.64 21.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.857 0.361 . . . . 71.3 110.245 175.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 43.7 pt -130.51 179.16 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.976 0.417 . . . . 73.24 111.149 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.481 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 5.2 m -82.29 80.11 8.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.501 -0.555 . . . . 72.04 109.501 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.56 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.0 t-20 -123.84 70.57 1.08 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.713 0.768 . . . . 73.33 110.243 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.539 HD11 ' HB3' ' A' ' 20' ' ' CYS . 37.3 mm -126.69 131.97 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.166 -0.924 . . . . 72.35 109.368 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.451 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.1 t70 -83.72 121.74 76.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.764 -0.458 . . . . 54.12 109.764 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 29.1 Cg_exo -62.54 -17.62 59.18 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.13 2.553 . . . . 50.11 113.248 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.1 5.77 44.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 75.44 110.597 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.33 -29.84 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 74.04 111.645 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 69.0 19.85 7.99 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.345 0.593 . . . . 74.51 110.816 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -142.19 168.19 20.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.757 -0.656 . . . . 73.02 109.88 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.534 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 22.0 p -81.62 55.83 2.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.933 -0.576 . . . . 64.14 110.938 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.01 -21.5 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.494 0.664 . . . . 62.3 109.901 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.56 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 50.0 mt -77.47 -19.68 55.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.264 -0.88 . . . . 61.41 109.636 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 6.0 m -90.62 -19.43 23.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.667 -0.697 . . . . 70.3 111.503 -175.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -98.8 27.4 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.603 0.716 . . . . 73.12 109.847 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.502 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -95.93 -122.94 4.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.575 -0.739 . . . . 74.11 111.971 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.641 ' HB ' ' HB2' ' A' ' 69' ' ' ALA . 61.5 mt -112.34 104.27 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.205 0.526 . . . . 62.24 110.606 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 33' ' ' PRO . 93.6 t -91.64 105.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.396 -0.82 . . . . 74.34 109.077 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.27 179.38 8.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.135 0.493 . . . . 73.43 111.344 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 166.52 10.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.851 -0.613 . . . . 74.2 109.9 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -126.37 77.35 1.69 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.22 -0.659 . . . . 64.2 109.22 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 68.02 -59.78 0.42 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.441 -0.8 . . . . 74.11 111.77 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -117.84 -57.77 2.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.217 -0.447 . . . . 61.53 111.458 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.602 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.3 t0 -90.61 179.01 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 62.01 110.989 -173.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.66 123.19 43.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 74.34 110.742 -173.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.602 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 46.4 m95 -137.83 128.26 26.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 73.31 110.893 -173.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.437 HG22 ' HE2' ' A' ' 31' ' ' PHE . 10.6 p -94.95 127.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.603 . . . . 55.3 110.029 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB2' ' HB ' ' A' ' 58' ' ' ILE . . . -97.41 120.04 37.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.908 -0.587 . . . . 62.1 110.918 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.68 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 41.1 t -64.55 141.32 98.22 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 72.41 110.391 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.502 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 61.1 Cg_endo -78.11 -41.18 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.163 1.909 . . . . 53.44 111.706 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.694 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -76.99 -69.09 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.601 -0.727 . . . . 73.1 110.986 -178.063 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.694 ' HD2' ' HB3' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -80.95 -19.11 44.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.36 -0.382 . . . . 73.43 111.181 -175.196 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.68 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.6 mttp 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.82 -0.627 . . . . 73.31 112.594 176.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -78.3 143.31 37.1 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 73.33 109.477 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -100.62 115.36 30.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.307 -0.406 . . . . 73.33 110.328 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 68' ' ' VAL . 70.3 m-85 -106.12 124.75 50.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.114 -0.328 . . . . 73.34 110.114 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.424 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 42.9 ttp180 -72.97 121.99 20.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.821 0.343 . . . . 75.22 110.436 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 99.0 mt -76.39 78.0 3.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 74.13 110.263 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -174.56 -63.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 73.2 109.752 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -111.81 -23.08 10.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.736 -0.665 . . . . 73.04 111.046 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 19.29 27.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.742 . . . . 72.34 112.391 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.77 134.22 48.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.603 0.24 . . . . 74.41 110.539 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 46.0 m -88.31 26.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.157 0.428 . . . . 72.15 112.157 -174.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.2 tp 63.2 -79.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 73.2 112.308 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -126.93 -7.27 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.039 0.447 . . . . 75.52 110.56 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.59 -176.52 3.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.153 -0.684 . . . . 63.32 109.153 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 22.54 0.15 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.789 -0.719 . . . . 64.43 112.169 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -58.06 6.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.077 0.465 . . . . 60.03 110.799 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -130.61 92.38 3.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.471 . . . . 73.2 110.729 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.4 m -74.44 130.13 39.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.587 . . . . 73.41 109.414 173.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 43' ' ' SER . 32.4 m -95.88 -176.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.509 -0.314 . . . . 72.41 111.291 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.55 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -129.63 179.55 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 72.2 110.728 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.77 124.63 15.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.0 0.429 . . . . 75.23 110.664 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -89.51 169.6 11.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.651 -0.704 . . . . 74.54 109.704 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -99.73 138.53 36.68 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.474 -0.565 . . . . 74.4 109.474 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.889 HG21 HG22 ' A' ' 106' ' ' ILE . 44.6 p -127.24 156.38 41.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.303 -0.408 . . . . 70.24 111.104 -173.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.447 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.0 pt20 -155.44 140.77 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.169 0.509 . . . . 65.44 110.851 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.645 HG23 HD13 ' A' ' 10' ' ' LEU . 39.8 t -109.29 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.79 -0.819 . . . . 71.12 108.79 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -113.64 -5.04 13.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.47 . . . . 73.14 111.396 -171.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -141.63 25.09 2.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 74.11 110.842 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.28 17.48 Favored Glycine 0 C--O 1.234 0.139 0 C-N-CA 120.843 -0.694 . . . . 52.22 111.544 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.491 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 40.5 m-80 -106.56 157.14 17.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.3 -0.63 . . . . 72.24 109.3 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.55 HG23 HG22 ' A' ' 99' ' ' VAL . 44.8 t -94.76 117.22 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.994 0.426 . . . . 74.34 110.297 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -102.29 139.08 38.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.529 . . . . 74.05 110.095 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.889 HG22 HG21 ' A' ' 97' ' ' THR . 2.9 pp -114.47 149.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.105 -0.498 . . . . 72.51 110.012 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 8.5 t -85.8 128.0 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.714 -0.476 . . . . 75.14 109.714 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 50.2 mm -65.43 105.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.923 -179.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.66 150.77 37.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.636 -0.711 . . . . 73.01 110.08 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.94 149.43 41.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 75.24 111.273 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 m -149.05 -71.08 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.856 -0.611 . . . . 73.35 109.515 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -179.42 107.05 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.016 -0.538 . . . . 75.45 110.037 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 t -84.88 116.26 28.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.173 -0.677 . . . . 74.42 109.173 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.88 -174.29 2.79 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.833 -0.621 . . . . 64.54 110.577 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.72 106.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.846 0.831 . . . . 61.43 109.369 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.24 158.86 15.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.106 -0.952 . . . . 63.35 111.682 -170.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.83 104.53 7.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.924 -1.035 . . . . 74.43 108.727 171.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 p -64.18 -53.07 55.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 71.21 111.509 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 64.82 107.9 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.191 0 O-C-N 123.707 0.63 . . . . 75.21 111.317 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.64 104.98 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.341 2.028 . . . . 36.62 110.762 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.96 134.18 41.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 54.41 110.471 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.32 105.12 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.448 2.099 . . . . 72.03 111.089 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.486 HD13 ' O ' ' A' ' 123' ' ' LEU . 1.6 pp -68.35 134.93 51.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.18 0.514 . . . . 64.12 110.815 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.58 -170.92 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.611 -0.722 . . . . 74.33 109.91 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.5 125.97 54.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.379 . . . . 75.32 111.054 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.01 104.48 14.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.803 -0.814 . . . . 74.24 108.803 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -64.75 137.73 57.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.512 -0.313 . . . . 72.13 110.224 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -66.37 131.78 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 72.34 110.07 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -70.93 125.33 26.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 73.52 110.975 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.169 -0.92 . . . . 63.44 109.917 178.403 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.917 0.389 . . . . 61.03 110.732 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.876 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 15.0 p -133.91 -73.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.104 -0.498 . . . . 73.22 110.371 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -90.73 21.26 4.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 71.43 110.293 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.876 ' HD1' ' H ' ' A' ' 2' ' ' SER . 54.9 m95 -102.4 116.71 33.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 75.15 109.772 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 m -98.91 131.78 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.073 0.463 . . . . 74.4 111.226 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.767 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 5.2 m -67.47 119.42 12.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.478 -0.783 . . . . 75.32 111.036 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 t -95.53 -84.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.52 110.46 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.1 m -142.25 161.15 38.75 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.979 -0.378 . . . . 74.45 109.979 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.711 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 89.8 mttt -65.6 145.15 56.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.047 -0.353 . . . . 75.34 110.047 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.436 HD12 ' HA ' ' A' ' 37' ' ' GLU . 10.4 tt -65.57 -28.19 68.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.532 0.682 . . . . 75.12 109.565 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.85 -25.44 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.277 -0.874 . . . . 74.32 110.848 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 26.6 t0 -72.67 -15.94 61.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 53.34 109.817 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.4 mt -96.02 133.57 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.463 -0.79 . . . . 51.45 109.983 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.92 150.35 88.17 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.988 0.423 . . . . 72.0 111.784 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.97 123.68 11.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.69 2.26 . . . . 72.54 111.803 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.51 11.35 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.64 -0.709 . . . . 44.13 112.484 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -136.3 179.44 6.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.387 0.594 . . . . 71.24 111.023 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.624 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -175.42 101.42 0.16 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.069 -0.812 . . . . 45.14 111.069 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.45 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -117.63 150.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.21 0.448 . . . . 74.4 112.21 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.666 ' HB3' HD11 ' A' ' 45' ' ' ILE . 7.0 p -78.6 128.68 33.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.73 -0.668 . . . . 74.42 111.65 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.05 137.42 50.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.417 -0.586 . . . . 72.33 109.417 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -83.71 107.65 16.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.565 -0.531 . . . . 72.43 109.565 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.99 92.48 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.094 -0.503 . . . . 73.01 110.084 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 65.45 -75.06 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.271 -0.877 . . . . 75.41 113.113 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.68 10.58 3.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.194 0.442 . . . . 73.33 112.194 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -142.24 144.22 33.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.937 0.399 . . . . 73.43 111.314 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 45' ' ' ILE . 52.3 mt-30 -95.48 120.16 35.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.269 -0.641 . . . . 75.55 109.269 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.85 120.83 62.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 110.056 -0.349 . . . . 65.54 110.056 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.0 123.71 34.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.602 . . . . 64.35 109.373 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.624 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 15.0 t -107.87 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.952 0.406 . . . . 73.1 111.043 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.635 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.1 m-85 -77.34 136.17 38.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.567 -0.742 . . . . 72.12 110.726 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -127.77 73.99 78.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.131 -0.692 . . . . 72.52 109.131 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.53 -36.72 52.32 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.017 2.478 . . . . 71.13 112.215 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -111.92 149.77 31.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.56 -0.746 . . . . 71.4 109.807 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -81.26 56.8 2.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.311 1.053 . . . . 71.44 109.231 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -136.92 -176.1 4.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.564 -1.198 . . . . 72.54 108.448 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.436 ' HA ' HD12 ' A' ' 10' ' ' LEU . 35.7 mt-10 -82.76 47.6 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.622 0.725 . . . . 71.24 110.274 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -126.7 99.04 5.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.107 -0.952 . . . . 74.3 109.413 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.56 162.19 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 63.13 111.078 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.635 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 99.7 m-85 -134.31 102.07 5.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.965 -0.562 . . . . 75.03 110.3 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.68 96.97 6.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.879 0.371 . . . . 75.12 111.045 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 pt -131.18 175.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.924 -0.58 . . . . 73.14 110.15 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.2 m -80.63 56.62 2.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.175 0.512 . . . . 65.4 110.793 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 20.2 t-20 -87.05 71.5 10.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.72 0.771 . . . . 73.5 109.675 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.666 HD11 ' HB3' ' A' ' 20' ' ' CYS . 16.8 mm -124.55 142.96 39.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 74.31 109.992 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.483 ' HB3' ' HB1' ' A' ' 49' ' ' ALA . 9.9 t70 -90.55 116.65 66.87 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.022 -0.733 . . . . 63.42 109.022 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.19 -16.9 53.76 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 123.121 2.547 . . . . 75.14 113.108 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -101.36 -3.41 28.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.003 0.43 . . . . 73.34 110.509 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 46' ' ' ASP . . . -117.96 -24.92 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 51.43 110.897 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 69.11 19.49 7.99 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.727 -0.669 . . . . 65.21 110.601 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.604 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -153.1 169.1 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 74.12 109.709 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -84.23 83.87 7.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 72.21 110.791 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -96.97 -10.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.41 0.624 . . . . 75.23 109.787 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 43.6 mt -70.26 -28.52 65.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.315 -0.857 . . . . 70.02 109.608 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 p -88.81 5.86 41.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.06 -0.973 . . . . 74.02 111.841 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.922 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -108.6 15.38 23.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.276 0.56 . . . . 72.03 110.481 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.477 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -96.55 -147.61 22.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.717 -0.754 . . . . 73.32 112.299 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.75 118.03 42.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.02 0.438 . . . . 74.04 110.472 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.37 101.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.743 . . . . 42.35 109.531 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.85 109.01 21.42 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.254 -0.884 . . . . 63.34 110.641 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.32 129.01 35.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.305 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -108.1 45.44 1.02 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.581 -0.736 . . . . 64.44 109.523 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 69.29 -67.03 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.131 -0.94 . . . . 71.22 111.117 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.34 -43.9 7.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.177 -0.465 . . . . 65.13 110.965 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 3.2 t70 -98.52 174.58 6.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.287 . . . . 73.21 110.39 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.493 ' HB3' HD11 ' A' ' 79' ' ' LEU . 89.3 mt -132.28 118.7 19.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 74.23 109.883 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.461 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 35.8 m95 -124.14 165.53 17.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.93 0.395 . . . . 73.43 110.585 -175.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.7 p -135.06 132.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.191 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.474 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -94.35 106.03 18.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 73.53 109.985 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.539 ' HG ' HD23 ' A' ' 54' ' ' LEU . 30.6 t -68.85 133.68 90.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.127 -0.488 . . . . 64.34 111.124 -177.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.477 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.8 Cg_endo -71.14 -30.02 16.7 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.486 2.124 . . . . 65.41 111.941 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.86 -37.65 14.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.978 -0.555 . . . . 73.3 111.099 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.792 ' HD3' ' HE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -88.41 -28.16 21.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.164 -0.471 . . . . 71.31 111.379 -175.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 65.19 22.95 12.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.534 0.521 . . . . 65.12 111.018 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.86 155.81 35.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.29 -0.413 . . . . 73.12 110.712 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.629 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 76.6 m80 -95.32 117.0 29.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.667 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -100.78 137.41 39.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.179 -0.464 . . . . 73.21 110.7 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -78.42 123.89 27.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.036 -0.529 . . . . 75.12 110.19 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' A' ' 66' ' ' LEU . 84.4 mt -74.31 -30.44 62.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.454 0.538 . . . . 72.23 112.454 -172.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HD1' ' HE1' ' A' ' 40' ' ' TYR . 48.6 t80 -81.73 -19.13 42.06 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.797 -0.361 . . . . 73.43 111.566 -174.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -140.52 -78.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 74.21 111.037 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.36 0.46 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.681 -0.771 . . . . 71.44 112.123 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -55.37 108.32 0.41 Allowed 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 109.83 -0.434 . . . . 71.11 109.83 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.2 m -76.16 155.92 34.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.003 0.43 . . . . 71.43 111.418 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.629 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 24.7 tp -86.59 -20.45 27.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 70.51 110.001 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -82.97 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.799 -0.637 . . . . 72.12 110.715 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -144.16 160.65 40.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.106 -0.497 . . . . 72.03 109.954 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.13 65.78 3.73 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.971 -0.851 . . . . 74.15 110.971 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.34 -66.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.77 0.285 . . . . 74.03 111.77 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.792 ' HE2' ' HD3' ' A' ' 73' ' ' LYS . 60.1 m-85 -100.04 -28.21 13.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.833 -0.347 . . . . 72.21 111.501 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m 59.73 84.53 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.744 0.653 . . . . 74.34 110.234 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.9 m -79.2 155.83 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 71.51 110.975 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.11 142.79 26.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.008 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.78 97.71 6.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.916 -0.584 . . . . 71.43 110.153 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -81.96 136.43 35.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.987 -0.551 . . . . 75.43 110.042 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -66.44 136.63 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 73.12 109.357 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.57 HG22 HG21 ' A' ' 106' ' ' ILE . 76.0 p -115.52 143.43 45.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 65.33 111.214 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -134.72 137.27 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.617 . . . . 75.35 110.413 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 t -111.03 62.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.037 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -85.12 -29.35 24.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.247 -0.888 . . . . 72.4 111.397 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -103.59 -6.73 21.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.499 0.666 . . . . 75.24 110.835 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.02 -33.14 6.36 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.692 -1.363 . . . . 63.52 109.692 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.711 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 46.7 m-80 -81.39 139.84 35.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.566 -0.901 . . . . 75.44 108.566 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -81.78 123.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.409 -0.589 . . . . 73.12 109.409 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.767 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 21.5 mt-30 -117.55 121.1 40.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.656 . . . . 73.33 110.591 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 97' ' ' THR . 2.1 pp -96.38 153.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.813 -0.63 . . . . 71.52 111.345 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -81.4 114.74 20.36 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.128 -0.693 . . . . 45.21 109.128 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.69 109.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.344 0.592 . . . . 74.12 111.745 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.11 7.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.258 -1.015 . . . . 72.11 108.258 168.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.51 136.21 54.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 70.21 111.053 -173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -86.89 -12.78 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.791 -0.64 . . . . 73.04 111.076 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 54.4 78.37 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.852 0.72 . . . . 72.34 111.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 115' ' ' VAL . 10.7 p -152.13 142.34 15.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.995 -0.548 . . . . 71.53 110.543 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.66 86.95 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 42.13 111.25 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.528 HG21 HG21 ' A' ' 113' ' ' VAL . 40.1 t -112.9 144.74 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 73.2 109.641 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.46 82.42 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.209 0.528 . . . . 64.02 111.652 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -161.3 173.87 14.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 75.44 108.553 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.4 m 56.31 38.96 30.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.154 0.502 . . . . 72.22 110.537 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.2 pt20 -61.23 140.74 94.36 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.515 -0.766 . . . . 71.03 111.448 -175.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -64.63 118.81 5.75 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.834 2.356 . . . . 72.32 111.212 176.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.55 77.48 0.42 Allowed Pre-proline 0 N--CA 1.463 0.217 0 O-C-N 123.732 0.645 . . . . 53.13 111.251 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.02 106.62 2.06 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.832 2.355 . . . . 72.32 111.424 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 124' ' ' GLU . 2.5 tm? 66.74 103.02 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.907 0.755 . . . . 61.43 109.919 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -74.06 -166.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 73.01 111.278 -175.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.466 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 8.8 t-160 70.73 26.5 3.82 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.516 -0.92 . . . . 73.42 108.516 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -79.49 79.03 5.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.936 -1.029 . . . . 72.0 110.395 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -129.41 153.24 48.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.368 -0.604 . . . . 74.31 109.368 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -160.51 146.23 14.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.425 -0.352 . . . . 71.25 110.169 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.62 134.0 35.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 71.03 109.707 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 . . . . . 0 C--O 1.241 0.634 0 CA-C-O 118.553 -0.737 . . . . 74.32 109.921 178.87 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.947 0.403 . . . . 75.42 110.668 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.49 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 25.6 p -111.22 -72.05 0.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.373 -0.376 . . . . 65.12 110.029 175.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.85 61.57 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.228 0.537 . . . . 74.2 109.818 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.49 ' HD1' ' H ' ' A' ' 2' ' ' SER . 82.3 m95 -124.58 139.12 54.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.57 -0.741 . . . . 74.25 110.173 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.649 HG21 HG11 ' A' ' 23' ' ' VAL . 21.1 m -126.15 124.3 40.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.235 -0.439 . . . . 72.34 110.841 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.3 m -67.32 119.57 12.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.286 -0.416 . . . . 74.31 110.394 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.446 HG12 HG23 ' A' ' 30' ' ' VAL . 61.6 t -68.27 -60.91 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 62.34 109.673 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.513 ' SG ' HD13 ' A' ' 13' ' ' ILE . 5.0 p -172.33 -90.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.024 -0.989 . . . . 71.31 109.414 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.821 ' HD2' ' HB2' ' A' ' 12' ' ' ASP . 47.0 mttp -145.08 170.68 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.597 -0.52 . . . . 73.03 109.597 177.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.642 HD23 HG12 ' A' ' 99' ' ' VAL . 53.8 tp -91.23 -49.96 6.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.203 0.525 . . . . 74.41 110.396 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.44 -30.08 53.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.717 -0.674 . . . . 75.35 110.701 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.821 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 29.3 t0 -72.48 -13.68 61.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.293 -0.867 . . . . 75.44 110.334 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.513 HD13 ' SG ' ' A' ' 8' ' ' CYS . 34.7 mm -88.4 117.67 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 74.21 109.803 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.63 123.33 76.39 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 74.23 111.174 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -65.54 146.15 84.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.572 2.181 . . . . 71.45 111.874 -179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.82 30.17 36.43 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.448 -0.661 . . . . 70.44 111.448 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.608 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.1 m -147.97 174.16 12.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.738 0.304 . . . . 74.1 110.95 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.61 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.42 107.9 0.33 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.706 -0.958 . . . . 75.35 110.706 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.497 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.3 m -124.7 153.96 31.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 112.427 0.529 . . . . 71.2 112.427 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.681 ' HB3' HD13 ' A' ' 45' ' ' ILE . 5.2 p -79.87 118.23 21.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.578 -0.737 . . . . 73.24 111.275 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.14 169.94 9.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 71.45 110.358 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.09 117.54 29.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.236 0.541 . . . . 72.11 110.828 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.688 ' HB ' ' O ' ' A' ' 26' ' ' GLN . 57.3 t -124.77 154.03 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.385 -0.969 . . . . 73.04 108.385 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -45.68 -48.18 15.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.333 0.864 . . . . 73.52 113.333 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HB2' HG22 ' A' ' 113' ' ' VAL . 10.0 pt20 -114.65 -4.68 12.76 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.266 0.839 . . . . 71.32 113.266 -167.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.688 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 10.3 tt0 -172.37 143.49 1.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.821 -0.352 . . . . 63.42 110.524 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -75.64 137.45 40.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.28 -0.637 . . . . 73.52 109.28 173.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.462 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 20.6 tt -115.8 138.05 47.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.628 0.251 . . . . 63.2 110.502 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.428 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -97.43 124.8 41.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 72.2 110.281 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.61 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 38.9 t -106.19 99.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.974 0.416 . . . . 75.4 110.949 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.762 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 57.6 m-85 -75.21 113.83 13.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 73.41 110.75 176.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -118.59 82.69 20.19 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.528 -0.916 . . . . 71.54 108.528 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.507 ' HB3' HG23 ' A' ' 59' ' ' VAL . 10.4 Cg_exo -71.11 -31.75 14.24 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 122.72 2.28 . . . . 74.25 112.758 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -121.48 -179.74 4.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.48 -0.327 . . . . 75.13 110.278 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -93.24 23.9 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.881 -176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.77 -174.8 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.381 0.61 . . . . 71.44 111.429 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -98.66 31.64 2.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.308 -0.86 . . . . 71.24 110.712 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.94 153.23 52.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.09 -0.505 . . . . 64.24 111.028 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.82 165.98 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.114 -0.493 . . . . 72.05 110.488 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.762 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.3 m-85 -122.14 92.15 3.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.063 -0.517 . . . . 73.33 110.401 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -94.04 100.48 12.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.982 0.42 . . . . 65.02 110.323 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.71 173.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 72.33 110.795 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 m -78.51 87.08 4.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.08 0.467 . . . . 62.42 109.87 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.421 ' HB3' ' HB1' ' A' ' 29' ' ' ALA . 25.7 t-20 -133.5 67.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.678 0.751 . . . . 52.44 109.584 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.681 HD13 ' HB3' ' A' ' 20' ' ' CYS . 38.7 mm -118.79 143.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.431 -0.804 . . . . 75.13 109.384 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.491 ' OD2' ' HB3' ' A' ' 48' ' ' PHE . 27.0 t70 -99.36 114.44 65.57 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.327 -0.397 . . . . 65.44 109.941 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.19 -12.99 35.3 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.187 2.591 . . . . 43.05 112.773 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 82.7 t80 -82.82 -22.13 34.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 75.14 110.983 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.7 -13.78 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 72.35 111.426 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 63.62 29.44 15.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.801 -0.636 . . . . 73.01 111.018 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -147.95 170.35 17.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.166 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.497 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 12.2 p -83.95 58.83 4.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.249 0.547 . . . . 74.14 110.702 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.476 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 31.2 m -79.73 3.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.704 . . . . 74.32 110.208 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 64.1 mt -104.78 -2.54 24.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.99 -1.004 . . . . 74.14 109.248 174.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.501 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 34.9 t -102.04 -48.7 4.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.648 -0.705 . . . . 71.14 111.362 -174.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -84.17 62.65 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.89 0.852 . . . . 72.41 109.892 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -114.51 -156.06 11.39 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.748 -1.115 . . . . 63.32 111.741 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mm -93.9 125.21 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.74 -0.467 . . . . 71.31 109.74 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG23 ' HB3' ' A' ' 33' ' ' PRO . 93.4 t -86.48 97.79 6.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.023 -0.535 . . . . 74.1 110.097 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 133.13 51.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.667 -0.697 . . . . 72.35 110.374 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.67 151.24 20.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.116 0.484 . . . . 73.04 110.78 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -134.54 103.77 5.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.008 -0.738 . . . . 64.43 109.008 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 70.38 -61.45 0.46 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.07 0.857 . . . . 75.31 110.532 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -157.19 -23.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 73.52 110.826 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.64 171.56 14.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.98 -0.378 . . . . 74.0 109.98 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.6 mt -127.58 117.78 22.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.054 0.454 . . . . 72.14 110.668 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.434 ' CZ2' ' HD3' ' A' ' 78' ' ' ARG . 20.7 m95 -111.56 127.35 55.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.508 -0.769 . . . . 73.45 109.655 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 8.5 p -92.25 129.19 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.983 0.421 . . . . 71.55 110.496 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -99.28 108.09 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 70.52 110.813 178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 29.9 t -56.31 138.34 74.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 72.43 111.407 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.476 ' HD2' ' O ' ' A' ' 53' ' ' VAL . 60.9 Cg_endo -73.67 -25.6 14.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.566 2.177 . . . . 62.41 112.768 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.94 -49.56 3.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 74.31 111.364 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -19.18 28.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.359 . . . . 64.31 110.903 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 70' ' ' SER . 57.2 tttm 62.62 22.66 13.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.437 0.636 . . . . 74.23 111.278 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.647 ' HG3' ' HB2' ' A' ' 86' ' ' GLU . 8.2 tt0 -95.61 150.8 19.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.857 -0.611 . . . . 75.11 110.387 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.471 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.0 m80 -99.32 124.32 44.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.895 -0.593 . . . . 75.12 110.439 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.442 ' HD2' ' HG ' ' A' ' 84' ' ' CYS . 84.4 m-85 -119.3 134.86 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.317 -0.401 . . . . 73.41 110.793 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.703 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 49.1 mmm-85 -63.18 131.52 48.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.691 -0.485 . . . . 73.3 109.691 170.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.468 HD23 ' HB ' ' A' ' 68' ' ' VAL . 59.6 mt -70.42 -67.6 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.972 0.36 . . . . 75.23 111.972 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 34.0 p90 -101.08 25.68 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.433 . . . . 74.43 111.546 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.703 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 8.0 t70 -118.27 -67.57 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.106 -0.497 . . . . 72.02 110.454 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 129.48 -21.69 5.07 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.131 -1.033 . . . . 54.0 113.511 175.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.4 ' HD2' ' OD2' ' A' ' 81' ' ' ASP . 41.0 m-85 -74.08 162.97 28.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.331 0.586 . . . . 74.31 111.606 -179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 90' ' ' TYR . 21.3 m -124.89 153.83 42.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 61.21 109.76 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.94 -68.34 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.705 0.288 . . . . 74.34 110.555 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 30.3 mp0 -64.47 -51.75 61.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 74.01 111.925 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.27 102.08 6.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 73.12 110.99 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -82.48 25.99 4.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.985 -0.626 . . . . 44.52 112.985 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 -14.72 46.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.069 0.462 . . . . 63.04 110.871 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.504 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 99.6 m-85 -80.91 -59.72 2.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.987 -0.551 . . . . 75.02 110.859 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 p 45.55 73.72 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.606 0.717 . . . . 74.42 110.742 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.58 157.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 75.24 111.751 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.71 116.38 29.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.506 -0.77 . . . . 71.43 110.825 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.37 86.89 3.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 73.2 110.046 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -71.75 170.27 13.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.822 -0.626 . . . . 74.52 111.202 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -83.48 135.29 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.146 -0.479 . . . . 52.15 110.367 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.971 HG21 HG21 ' A' ' 106' ' ' ILE . 63.9 p -124.82 127.19 46.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.281 -0.872 . . . . 72.15 109.535 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.407 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 4.5 pt20 -118.5 139.19 51.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.524 0.678 . . . . 74.23 111.102 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.642 HG12 HD23 ' A' ' 10' ' ' LEU . 45.4 t -108.6 88.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.027 -0.988 . . . . 73.02 109.133 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -88.31 -23.44 23.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 73.44 110.562 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -145.71 -154.8 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.802 -0.814 . . . . 72.22 108.802 179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -74.03 -1.34 59.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.835 -0.698 . . . . 72.34 112.288 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.721 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 3.8 m-20 -113.61 158.82 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.087 -0.338 . . . . 74.51 110.087 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.57 128.44 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 72.4 111.698 -176.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . 18.7 mm-40 -106.19 127.57 53.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.745 -0.661 . . . . 64.43 110.414 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.971 HG21 HG21 ' A' ' 97' ' ' THR . 2.7 pp -115.49 146.47 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.203 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -91.25 125.63 36.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 70.03 110.799 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.6 pt -98.17 102.15 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.968 -0.56 . . . . 64.23 110.224 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.22 17.43 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 73.43 111.037 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.82 122.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.961 -1.018 . . . . 74.31 111.264 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 m -90.4 -75.07 0.47 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.083 -0.962 . . . . 72.13 109.958 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -173.83 35.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.924 -1.139 . . . . 64.41 107.924 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.433 HG22 ' HB2' ' A' ' 25' ' ' GLN . 7.9 p -81.35 139.71 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.982 -1.008 . . . . 71.12 112.333 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.47 112.08 24.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.847 -1.168 . . . . 64.32 107.847 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.05 95.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.679 0.752 . . . . 73.03 111.771 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.15 -161.2 0.74 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.009 -1.478 . . . . 45.32 107.009 172.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.62 114.83 27.19 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.647 -0.821 . . . . 71.34 109.308 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 119' ' ' GLN . 17.6 m -93.01 11.86 26.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.959 -0.564 . . . . 73.22 110.332 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 118' ' ' SER . 30.0 mm-40 69.33 119.67 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.126 0 O-C-N 124.027 0.829 . . . . 62.12 111.177 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . 0.476 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 15.8 Cg_exo -68.78 90.39 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.322 2.015 . . . . 55.23 110.366 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 97.9 mt -96.88 108.41 43.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.931 -0.577 . . . . 62.25 111.075 -174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 57.4 Cg_endo -96.97 70.91 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.489 2.792 . . . . 72.51 111.955 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.52 113.84 11.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 71.33 109.291 176.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.25 127.0 31.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.092 0.473 . . . . 72.13 110.382 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -74.04 73.04 1.69 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.733 -0.667 . . . . 75.41 109.806 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -78.51 83.87 4.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.544 -0.753 . . . . 73.4 111.207 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -97.97 93.22 6.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.919 -1.141 . . . . 74.33 107.919 171.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -59.81 125.08 22.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.475 -0.784 . . . . 64.41 110.889 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -135.7 -177.13 4.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.479 -0.782 . . . . 71.21 110.517 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 . . . . . 0 C--O 1.247 0.939 0 N-CA-C 108.816 -0.809 . . . . 74.33 108.816 173.773 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.747 -0.464 . . . . 75.15 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -114.39 93.16 4.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.965 -0.754 . . . . 74.23 108.965 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -71.03 114.42 9.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.638 -0.71 . . . . 73.31 111.165 -172.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -67.76 105.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 74.33 109.546 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 p -96.01 146.04 24.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.886 -0.597 . . . . 71.04 110.679 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.1 m -83.61 119.94 25.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.301 -0.409 . . . . 73.11 110.507 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.438 HG13 HG21 ' A' ' 23' ' ' VAL . 46.6 t -84.91 -83.38 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 65.41 110.314 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.6 m -158.75 174.55 14.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 73.12 109.688 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -75.69 133.77 40.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.656 -0.498 . . . . 65.51 109.656 173.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.5 tp -66.74 -20.41 65.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.04 0.448 . . . . 62.05 110.994 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.1 -29.19 67.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 72.05 110.278 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.5 -25.78 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.545 -0.752 . . . . 72.24 109.8 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.77 107.89 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 74.54 110.147 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 95.3 mt -68.42 145.86 97.52 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.417 . . . . 73.33 111.8 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.1 Cg_exo -64.41 125.98 16.09 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.525 2.15 . . . . 74.21 111.656 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.72 42.86 4.98 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.864 -0.607 . . . . 71.31 112.139 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.8 p -137.95 -179.47 5.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.099 0.476 . . . . 63.43 111.632 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.404 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -166.81 81.19 0.11 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.058 -1.217 . . . . 74.01 110.058 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.485 ' HA ' ' HG ' ' A' ' 52' ' ' SER . 35.7 m -111.39 150.68 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.743 0.646 . . . . 73.14 112.743 -169.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.563 ' HB3' HD13 ' A' ' 45' ' ' ILE . 5.6 p -70.07 114.42 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.452 -0.795 . . . . 74.22 110.736 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.35 148.38 25.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 74.2 110.384 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -89.31 103.58 16.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 63.03 109.605 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.438 HG21 HG13 ' A' ' 7' ' ' VAL . 14.5 t -116.24 99.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 71.42 110.269 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 62.72 -85.68 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.649 0.593 . . . . 75.53 111.059 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -130.13 2.66 4.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.148 0.499 . . . . 75.32 109.961 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.405 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 14.5 mm100 -105.49 137.13 43.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 73.13 111.478 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -105.07 97.83 7.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 72.13 109.679 171.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.48 HG22 ' HB1' ' A' ' 41' ' ' ALA . 1.7 mp -110.26 135.9 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 74.32 110.541 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.12 114.44 21.77 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.597 -0.52 . . . . 53.41 109.597 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.9 t -99.89 106.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.005 0.431 . . . . 73.43 110.179 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 96.6 m-85 -81.24 127.25 32.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.598 -0.728 . . . . 74.54 110.687 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -118.97 80.39 18.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.54 -0.911 . . . . 70.44 108.54 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 38' ' ' GLN . 92.7 Cg_endo -79.25 -10.72 14.89 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.77 2.313 . . . . 72.4 112.351 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -121.44 163.01 19.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.428 -0.806 . . . . 73.25 110.119 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.31 -15.56 61.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.209 0.528 . . . . 72.34 111.15 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.8 t70 -97.42 -156.99 0.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.348 -0.387 . . . . 75.13 110.263 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 23.7 mt-10 -89.34 13.15 14.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.599 0.36 . . . . 74.41 111.929 -171.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.492 ' OE1' ' HB3' ' A' ' 36' ' ' ASP . 2.5 mp0 -74.31 94.25 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.882 -0.414 . . . . 73.44 109.882 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 27.5 m -113.74 151.92 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.99 -0.55 . . . . 73.21 111.65 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.747 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 89.4 m-85 -122.46 99.83 6.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 72.43 109.559 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB1' HG22 ' A' ' 28' ' ' ILE . . . -97.02 100.79 12.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.952 0.406 . . . . 64.23 110.816 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.572 HD12 HG21 ' A' ' 92' ' ' VAL . 31.3 pt -132.16 156.08 42.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.894 -0.594 . . . . 64.42 110.195 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 m -76.06 52.24 0.71 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.512 -0.313 . . . . 54.52 111.622 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.442 HD21 ' HZ ' ' A' ' 31' ' ' PHE . 65.8 t30 -90.17 78.86 6.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.514 0.673 . . . . 75.42 110.072 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -126.75 142.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.17 -0.923 . . . . 74.23 109.67 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 12.7 t70 -80.94 125.83 78.99 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.755 -0.461 . . . . 71.3 109.755 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 24.3 Cg_exo -64.1 -12.58 33.07 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.323 2.682 . . . . 53.43 113.27 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -113.44 15.07 19.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.491 0.186 . . . . 72.22 111.365 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -134.75 -33.94 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.85 0.315 . . . . 43.13 111.85 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 63.41 23.09 13.56 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.312 0.577 . . . . 54.02 110.772 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -139.31 159.32 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.131 -0.941 . . . . 65.23 108.843 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.636 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -80.83 65.44 5.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.309 0.576 . . . . 71.21 111.321 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.43 -10.61 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.524 0.678 . . . . 71.14 109.806 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 87.3 mt -86.37 6.2 31.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.968 -1.015 . . . . 70.33 108.989 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.771 ' HA ' HG23 ' A' ' 68' ' ' VAL . 4.5 m -138.94 30.3 2.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.807 -1.088 . . . . 63.22 108.302 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.581 ' HD3' ' HG3' ' A' ' 71' ' ' PRO . 18.7 ttt180 -77.85 61.07 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.421 -0.809 . . . . 75.53 111.284 -170.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.58 -44.95 3.42 Favored Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.654 -1.157 . . . . 75.14 114.311 167.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -69.14 103.36 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.319 0.58 . . . . 73.54 111.293 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.69 118.1 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 115.105 -0.952 . . . . 62.53 109.478 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.56 55.67 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.544 -0.753 . . . . 71.33 111.001 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.73 95.52 4.03 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.63 -0.878 . . . . 71.42 108.63 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.69 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 32.1 t60 -84.35 89.01 7.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.985 -0.552 . . . . 75.13 109.548 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.12 -64.17 0.34 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.766 -1.106 . . . . 74.24 112.749 176.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -121.3 -33.17 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.389 0.515 . . . . 73.13 112.389 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -128.78 -172.2 2.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.655 -0.418 . . . . 62.45 111.141 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.53 117.29 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 71.44 110.213 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TRP . . . . . 0.862 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 30.3 m95 -122.48 119.8 32.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.901 -0.59 . . . . 75.01 110.297 -176.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.771 HG23 ' HA ' ' A' ' 55' ' ' SER . 12.8 p -84.15 149.77 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.282 -0.417 . . . . 72.31 110.143 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 130.68 54.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 62.45 110.526 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.675 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 57.3 p -102.76 143.4 26.54 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.291 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HG3' ' HD3' ' A' ' 56' ' ' ARG . 60.3 Cg_endo -73.19 -2.91 12.76 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.442 2.095 . . . . 65.21 112.188 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.81 -55.82 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 73.53 110.928 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.48 -24.75 21.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.438 -0.346 . . . . 74.04 110.638 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 74.35 -31.77 0.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.252 0.834 . . . . 74.44 113.252 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -71.59 168.18 18.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 74.1 111.081 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.862 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 35.5 m80 -96.5 128.5 43.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 75.34 111.385 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.672 ' HE1' ' HG ' ' A' ' 70' ' ' SER . 54.6 m-85 -98.09 122.66 41.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.389 -0.597 . . . . 75.22 109.389 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -72.69 117.46 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.62 -0.511 . . . . 75.14 109.62 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.626 HD21 ' HB ' ' A' ' 68' ' ' VAL . 50.1 mt -61.5 -25.33 67.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 71.42 112.149 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -89.43 -0.52 57.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.639 0.257 . . . . 73.14 111.525 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.05 -65.67 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.54 -0.464 . . . . 71.14 112.011 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.469 ' HA3' HG23 ' A' ' 92' ' ' VAL . . . 132.62 -25.79 3.73 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.731 -0.747 . . . . 73.23 112.667 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -55.61 144.03 28.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.508 0.67 . . . . 75.14 111.784 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.8 65.04 1.8 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.0 -1.0 . . . . 73.44 110.89 -171.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.498 ' HA ' ' CZ3' ' A' ' 67' ' ' TRP . 35.5 tp 65.53 -87.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.719 -0.673 . . . . 74.41 111.477 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.74 -12.37 17.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 70.4 110.934 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -117.12 176.19 5.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.373 -0.376 . . . . 70.34 110.569 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.5 41.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.908 -0.877 . . . . 72.34 110.908 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.91 -45.8 78.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 55.34 111.22 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.61 80.24 1.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.167 0.508 . . . . 73.24 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -76.65 96.98 4.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.969 -0.559 . . . . 74.42 109.558 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.572 HG21 HD12 ' A' ' 42' ' ' ILE . 20.0 m -82.82 165.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.719 -0.673 . . . . 64.35 110.782 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.69 125.6 45.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.706 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.541 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -94.21 96.57 9.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 75.33 109.783 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -82.91 152.0 25.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.554 -0.748 . . . . 73.24 109.681 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.74 128.75 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.236 0.541 . . . . 65.34 109.73 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.579 HG22 HG12 ' A' ' 106' ' ' ILE . 3.5 m -122.96 158.39 30.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.63 -0.714 . . . . 65.15 109.376 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -156.46 141.76 17.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.225 0.536 . . . . 74.1 110.591 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.552 HG23 HG22 ' A' ' 104' ' ' VAL . 34.5 t -110.21 105.68 19.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.12 -0.945 . . . . 62.53 108.797 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.69 HG21 ' H ' ' A' ' 101' ' ' ASN . 1.2 t -86.6 -76.31 0.36 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.371 -0.377 . . . . 72.42 111.568 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.69 ' H ' HG21 ' A' ' 100' ' ' THR . 1.0 OUTLIER -120.87 70.46 0.91 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.678 0.275 . . . . 73.2 110.638 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.67 -31.34 2.2 Favored Glycine 0 C--O 1.229 -0.184 0 C-N-CA 120.701 -0.762 . . . . 64.0 112.748 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -89.0 146.86 24.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.957 0.408 . . . . 71.21 110.123 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.552 HG22 HG23 ' A' ' 99' ' ' VAL . 39.8 t -105.51 133.22 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.798 -0.637 . . . . 73.41 109.918 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -129.32 146.8 51.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.707 0.289 . . . . 72.51 111.072 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.579 HG12 HG22 ' A' ' 97' ' ' THR . 70.9 mt -121.38 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 73.51 109.81 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.5 p -90.88 112.94 24.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.177 0.513 . . . . 65.3 110.224 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 pt -126.06 155.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.381 -0.372 . . . . 61.04 110.792 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.49 173.86 10.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.882 -0.599 . . . . 71.5 109.664 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -65.04 132.48 49.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.646 0.736 . . . . 73.13 110.993 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -117.31 33.14 5.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.04 -0.982 . . . . 74.21 108.786 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -73.1 84.49 1.32 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.866 -1.061 . . . . 72.33 110.758 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.07 152.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.734 -0.839 . . . . 73.03 108.734 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.87 82.71 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.19 0.519 . . . . 72.51 111.062 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.4 t -121.51 125.32 73.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.531 -0.759 . . . . 61.11 109.941 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -91.35 174.28 7.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.859 -0.423 . . . . 73.3 109.859 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.78 132.15 56.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.936 0.398 . . . . 73.32 110.268 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -100.58 -16.12 17.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.952 -0.567 . . . . 74.11 110.141 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -121.46 124.33 27.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 62.51 109.95 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -62.53 138.02 67.96 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.898 2.398 . . . . 74.11 112.098 178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 3.1 mm? -64.22 139.56 97.72 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 4.2 Cg_exo -74.3 97.95 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.829 2.353 . . . . 72.43 112.286 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -91.87 99.1 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.612 -0.884 . . . . 72.43 108.612 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.69 124.18 51.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.96 -0.564 . . . . 74.41 109.588 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -78.11 101.29 6.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.9 0.381 . . . . 74.55 111.095 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -75.24 132.19 40.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.715 -0.675 . . . . 74.12 110.799 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -56.08 132.28 49.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.271 -0.877 . . . . 75.54 111.984 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -142.37 112.88 7.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 73.12 110.361 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -94.73 136.98 34.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 74.44 111.215 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.431 -0.795 . . . . 71.34 109.551 179.202 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.681 0.753 . . . . 73.01 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.0 112.28 24.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.95 -1.023 . . . . 72.54 110.176 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -99.1 137.88 36.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.174 -0.466 . . . . 73.33 110.719 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -71.13 131.64 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 62.43 110.771 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 106' ' ' ILE . 38.9 t -87.42 -70.52 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.911 -0.403 . . . . 62.12 109.911 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.9 m -154.41 178.54 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 73.4 109.782 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -78.08 144.16 36.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.521 -0.548 . . . . 75.34 109.521 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 71.31 110.724 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.36 -32.93 64.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.464 -0.789 . . . . 63.11 111.157 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.49 -16.76 63.52 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.265 -0.425 . . . . 72.24 110.497 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 mm -89.69 112.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.806 -0.442 . . . . 70.11 109.806 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.12 133.67 91.66 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.489 . . . . 74.34 111.14 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.72 133.36 57.62 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.815 2.343 . . . . 74.04 112.169 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.09 28.0 51.0 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.654 -0.703 . . . . 63.23 111.766 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -150.24 177.08 10.27 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 121.014 -0.274 . . . . 74.22 110.619 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 17' ' ' THR . . . 174.22 130.04 1.24 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.008 -0.615 . . . . 74.3 112.197 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.721 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 27.1 m -125.03 162.35 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.717 0.259 . . . . 72.32 110.975 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 14.7 p -87.5 144.56 26.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.171 0.51 . . . . 63.4 111.307 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 148.32 50.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.587 -0.733 . . . . 74.11 109.546 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.28 94.59 4.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.708 -0.849 . . . . 64.33 108.708 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 106' ' ' ILE . 44.9 t -95.11 94.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 70.21 110.438 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 64.19 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.243 -0.89 . . . . 54.52 112.28 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -120.26 -21.31 7.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 70.24 111.542 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -127.41 146.38 50.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.557 0.217 . . . . 72.24 111.263 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.72 130.0 35.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 72.41 110.135 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.0 mt -127.74 133.3 67.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 62.24 110.331 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -103.78 140.83 37.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.118 -0.492 . . . . 70.15 109.741 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 101.58 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.87 -0.332 . . . . 74.02 111.534 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.811 ' HZ ' HD22 ' A' ' 44' ' ' ASN . 79.8 m-85 -73.43 118.06 15.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.018 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HG3' HG12 ' A' ' 39' ' ' VAL . 59.2 ttt180 -111.54 103.53 55.16 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 120.072 -0.651 . . . . 74.34 110.244 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.38 -55.08 0.17 Allowed 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.731 2.288 . . . . 74.25 112.233 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -122.97 -174.95 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.466 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -79.18 12.66 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.483 0.659 . . . . 73.52 110.463 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.1 178.62 6.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 71.41 109.425 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.66 -22.78 19.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.362 -0.381 . . . . 72.43 110.229 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -72.69 99.0 2.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 73.12 110.823 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' ARG . 28.3 m -114.99 178.92 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.324 -0.853 . . . . 61.43 110.097 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.669 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 98.0 m-85 -126.01 101.23 6.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.807 0.337 . . . . 65.43 110.495 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.81 96.51 6.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.087 -0.506 . . . . 70.34 110.412 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.34 171.7 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.069 -0.514 . . . . 61.44 110.562 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.555 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 69.3 m -88.62 87.22 7.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.821 0.343 . . . . 54.21 110.209 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.811 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 53.2 t30 -124.37 82.43 2.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.408 0.623 . . . . 61.44 109.885 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.11 141.57 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.423 -0.808 . . . . 62.01 109.962 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t70 -93.39 123.99 58.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.503 -0.555 . . . . 61.42 109.503 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 23.3 Cg_exo -64.37 -10.22 23.1 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.055 2.503 . . . . 63.51 113.488 -175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -95.08 -13.06 25.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 61.33 110.717 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.57 -26.45 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.703 0.261 . . . . 74.41 111.703 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 68.39 12.63 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.773 0.671 . . . . 52.31 111.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.635 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -133.23 177.01 8.0 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.137 -0.483 . . . . 71.0 110.696 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.721 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 27.0 p -81.62 47.69 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.6 -0.727 . . . . 35.24 111.594 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.22 -21.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.282 0.563 . . . . 73.03 109.899 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 91.0 mt -82.46 -9.15 59.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.149 -0.932 . . . . 72.32 110.116 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 14.2 m -102.62 -18.93 15.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.816 -0.629 . . . . 71.4 110.742 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -94.32 19.88 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.332 0.587 . . . . 44.0 109.967 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.99 -151.43 9.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.635 -0.712 . . . . 74.34 112.047 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 4.0 mp -90.4 103.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.213 0.53 . . . . 61.33 110.285 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -88.08 104.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.32 -0.855 . . . . 62.04 109.411 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.38 175.15 11.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.807 -0.633 . . . . 72.01 111.036 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.35 119.43 28.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.011 -0.541 . . . . 71.33 110.227 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 71.2 t60 -86.11 -33.42 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.989 0.423 . . . . 73.24 110.476 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -150.89 -65.09 0.19 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.261 0.553 . . . . 51.14 109.969 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.29 -22.84 1.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 74.22 110.917 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.68 -174.59 2.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.96 -0.563 . . . . 63.43 110.257 -171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.4 mt -94.09 120.09 33.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.439 . . . . 71.43 110.409 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 19.7 m95 -121.95 153.39 38.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.842 -0.617 . . . . 75.21 109.893 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 9.8 p -114.3 122.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.455 0.645 . . . . 73.44 110.078 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.52 114.37 22.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.74 -0.664 . . . . 71.34 109.976 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.521 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 48.2 t -63.48 128.03 92.05 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.099 -0.501 . . . . 33.53 110.541 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.74 -31.41 32.41 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.585 2.19 . . . . 62.54 112.221 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.86 -56.3 2.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 53.21 111.179 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -84.1 -19.88 33.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.382 -0.372 . . . . 64.12 111.449 -173.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 70' ' ' SER . 0.3 OUTLIER 72.73 -23.01 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.547 0.943 . . . . 75.42 113.547 172.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.648 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 28.1 mm-40 -50.04 145.88 5.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.619 0.247 . . . . 75.21 110.991 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 19.0 m170 -100.18 105.66 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 74.13 110.848 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 52.3 m-85 -89.55 122.29 32.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.215 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 29.3 ttp180 -76.42 122.23 24.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.018 -1.104 . . . . 75.15 108.018 171.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.41 -49.81 60.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.682 0.993 . . . . 73.21 113.682 -165.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.533 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 58.1 t80 -89.32 -2.61 58.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 74.21 111.208 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HB2' ' HE ' ' A' ' 78' ' ' ARG . 10.5 t70 -103.16 -60.86 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.861 -0.336 . . . . 64.13 110.696 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.68 -19.76 28.05 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.504 -0.855 . . . . 70.11 113.527 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.93 157.48 33.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.421 0.61 . . . . 73.53 110.36 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 10.8 m -108.65 94.67 5.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp 62.23 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.514 0.726 . . . . 74.25 112.39 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 -55.8 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.967 -0.383 . . . . 72.31 109.967 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.34 113.74 26.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 74.44 110.618 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.11 69.45 3.37 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.722 -0.672 . . . . 73.34 112.914 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.43 7.36 45.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.464 . . . . 63.42 110.852 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -153.33 29.7 0.49 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 72.42 109.928 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 m -63.97 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.619 -0.719 . . . . 44.54 111.292 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.5 m -103.6 -178.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 74.43 111.246 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -101.2 130.87 47.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 50.32 111.165 -177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.02 105.29 11.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.092 -0.504 . . . . 71.22 110.524 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -94.86 158.27 15.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.677 -0.692 . . . . 73.21 109.987 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -82.94 151.22 26.01 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.797 0.332 . . . . 75.2 110.788 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 1.015 HG22 HG22 ' A' ' 106' ' ' ILE . 28.6 p -134.07 151.23 51.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 65.22 111.256 -172.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -135.64 157.97 45.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.04 -0.355 . . . . 74.2 110.04 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.89 108.51 25.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.963 -0.384 . . . . 70.24 109.963 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.7 t -74.6 -75.98 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 71.52 111.294 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.798 ' H ' HG23 ' A' ' 100' ' ' THR . 53.3 m-80 -144.32 87.79 1.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.859 -0.423 . . . . 71.54 109.859 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.51 -1.1 45.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.046 -0.597 . . . . 73.24 112.907 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.0 140.86 52.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.873 -0.417 . . . . 44.12 109.873 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.88 133.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.327 -0.397 . . . . 72.52 110.716 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.38 151.59 42.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 55.02 110.053 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.015 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -122.29 155.44 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.66 0.267 . . . . 61.33 110.291 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -83.42 101.44 11.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.822 -0.807 . . . . 62.11 108.822 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . 24.6 pt -79.34 86.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.816 0.817 . . . . 64.33 112.471 -173.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 108.582 -0.895 . . . . 53.54 108.582 170.137 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.839 0.352 . . . . 74.22 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.412 ' CZ3' ' HG2' ' A' ' 98' ' ' GLN . 96.5 m95 -94.88 116.15 28.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 71.14 110.277 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.0 m -105.13 129.05 53.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.318 -0.401 . . . . 74.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.809 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.5 m -70.33 115.16 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 53.2 110.423 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.36 -77.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 53.11 110.747 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -146.59 172.91 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.502 . . . . 70.3 110.059 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -84.12 141.99 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 74.12 110.004 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.641 HD12 ' HB ' ' A' ' 13' ' ' ILE . 50.5 tp -70.69 -21.53 62.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 64.15 110.841 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.95 -34.39 76.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 63.32 110.733 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.63 -12.35 42.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 72.51 110.268 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.641 ' HB ' HD12 ' A' ' 10' ' ' LEU . 65.5 mt -82.11 111.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.164 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.642 ' H ' HD12 ' A' ' 14' ' ' LEU . 5.6 mp -56.42 130.12 75.71 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.675 -0.693 . . . . 73.31 112.11 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 17.1 Cg_exo -67.59 121.43 8.51 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.72 2.28 . . . . 73.33 111.381 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 35.87 5.09 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.917 -0.659 . . . . 75.22 112.462 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -136.14 -171.25 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.167 0.484 . . . . 72.0 111.328 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 168.94 96.13 0.1 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.154 -0.545 . . . . 43.11 111.887 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -133.98 165.92 30.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.52 0.16 . . . . 73.41 110.969 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.6 p -80.02 120.09 23.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.917 0.389 . . . . 74.41 111.421 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -91.35 150.87 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.402 -0.592 . . . . 72.02 109.402 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.77 107.44 19.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.992 0.425 . . . . 65.4 110.532 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 106' ' ' ILE . 46.4 t -113.5 113.78 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.314 -0.624 . . . . 74.32 109.314 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 27.5 mm-40 65.81 -85.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.677 0.611 . . . . 71.11 109.753 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -154.0 18.81 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.624 0.726 . . . . 73.2 109.302 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.82 128.87 47.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.864 -1.062 . . . . 74.25 109.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 48.9 mt-30 -101.46 130.32 47.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.189 0.519 . . . . 34.51 111.243 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.426 ' O ' HD12 ' A' ' 28' ' ' ILE . 1.2 pp -127.63 129.85 70.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.599 . . . . 72.32 110.313 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -85.73 113.7 22.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.55 . . . . 74.31 109.916 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 37.9 t -97.16 98.29 7.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.228 0.537 . . . . 73.0 110.27 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 69.9 m-85 -81.6 126.5 31.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.185 -0.916 . . . . 72.21 110.59 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 10' ' ' LEU . 77.1 ttt180 -120.04 78.51 24.81 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.8 -0.815 . . . . 74.54 108.8 170.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.6 Cg_exo -76.85 -20.03 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.98 2.454 . . . . 73.3 112.165 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -104.22 153.7 20.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.567 -0.742 . . . . 52.33 109.641 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.19 5.74 9.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.551 0.691 . . . . 63.43 109.727 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 13.6 t70 -89.56 -159.9 0.63 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.038 -0.983 . . . . 72.23 108.88 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.6 ' HA ' HD21 ' A' ' 10' ' ' LEU . 28.2 mt-10 -108.36 2.53 22.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 71.22 111.329 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -75.34 103.04 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.33 110.0 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.4 164.04 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.01 -0.541 . . . . 71.22 111.327 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 96.5 m-85 -135.61 101.94 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.693 -0.685 . . . . 65.05 110.278 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -100.38 95.24 6.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.107 0.48 . . . . 74.34 110.872 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -115.24 164.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.973 -0.558 . . . . 74.33 110.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 33.2 m -81.67 66.92 7.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.129 0.49 . . . . 74.1 110.629 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.645 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 38.1 t-20 -92.23 92.03 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.897 -0.779 . . . . 33.24 108.897 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.581 HD11 ' O ' ' A' ' 27' ' ' GLN . 14.5 mt -137.55 144.8 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 64.3 110.158 -174.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' HG22 ' A' ' 53' ' ' VAL . 2.4 p-10 -88.96 140.07 29.13 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.948 -0.76 . . . . 63.31 108.948 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 1.2 Cg_endo -83.91 15.13 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.477 2.118 . . . . 73.1 112.942 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -101.37 -56.54 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.729 0.3 . . . . 71.32 110.54 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -120.49 -2.23 10.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.287 -0.415 . . . . 75.24 110.643 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 19.5 mm-40 62.99 72.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.558 -0.747 . . . . 73.32 111.94 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.685 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -152.25 173.01 15.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.39 -0.823 . . . . 63.12 109.227 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -92.58 66.55 4.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.329 0.585 . . . . 73.11 109.903 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 46' ' ' ASP . 32.8 m -85.5 -10.57 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 63.22 110.273 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 90.0 mt -86.56 9.62 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.619 -0.719 . . . . 72.43 109.766 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 40.7 t -84.37 -63.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.347 -0.842 . . . . 33.33 110.11 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.565 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 58.8 ttt180 70.47 -11.67 0.59 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.185 0.594 . . . . 72.24 111.15 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' SER . . . 77.41 5.5 85.75 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.319 -0.467 . . . . 62.45 112.244 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.47 105.72 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.613 0.72 . . . . 65.31 110.688 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 33' ' ' PRO . 96.7 t -99.3 101.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.702 -1.135 . . . . 71.53 109.757 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.95 156.98 17.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.515 . . . . 62.45 110.436 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.14 127.04 40.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.015 -0.539 . . . . 71.32 110.053 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.6 -46.05 17.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.583 -0.895 . . . . 72.23 108.583 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 177.62 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.658 -1.155 . . . . 73.45 108.497 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.87 -15.14 16.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.478 -0.783 . . . . 74.4 109.898 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -109.99 149.67 29.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.649 -0.705 . . . . 73.22 110.034 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.16 131.02 57.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 73.22 110.329 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.845 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 35.7 m95 -127.74 119.12 25.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.398 -0.365 . . . . 64.13 110.791 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -73.89 138.39 21.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.656 -0.498 . . . . 62.44 109.656 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.09 109.67 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 73.42 111.123 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 m -72.85 154.02 91.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 61.34 111.239 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 56' ' ' ARG . 69.6 Cg_endo -74.46 -6.0 17.69 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.044 2.496 . . . . 54.21 113.626 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.09 -75.63 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.804 0.335 . . . . 72.11 111.163 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.62 24.61 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.455 -0.339 . . . . 75.3 110.254 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 55.24 34.65 23.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.03 0.919 . . . . 75.23 109.908 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.745 ' HG3' ' HE1' ' A' ' 77' ' ' PHE . 3.8 pt20 -81.29 141.13 34.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.592 -1.185 . . . . 74.24 110.693 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.845 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 61.6 m80 -93.13 121.55 34.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.478 -0.783 . . . . 71.5 110.42 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.745 ' HE1' ' HG3' ' A' ' 75' ' ' GLN . 7.3 m-85 -96.11 -16.83 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.478 0.547 . . . . 72.04 112.478 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 67' ' ' TRP . 5.7 ttt180 72.32 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.527 0.68 . . . . 70.33 111.18 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' A' ' 68' ' ' VAL . 97.4 mt -96.48 5.81 50.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 73.13 112.168 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.89 -26.6 19.26 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.635 -0.426 . . . . 63.33 111.13 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.36 -69.35 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.306 . . . . 63.32 111.382 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 92' ' ' VAL . . . 159.29 12.31 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.915 -0.66 . . . . 51.4 112.621 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -82.1 96.26 7.73 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.546 -0.539 . . . . 73.5 109.546 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 87' ' ' ASP . 6.8 m -79.95 161.38 25.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.273 -0.876 . . . . 70.43 111.504 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.5 tp -90.14 -66.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.999 -0.546 . . . . 74.11 110.424 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -86.36 -1.06 57.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.401 -0.363 . . . . 62.21 111.215 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 7.7 t70 -114.1 132.85 55.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 41.41 111.401 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.21 15.14 3.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.684 -0.966 . . . . 72.44 110.684 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -112.11 -37.38 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.598 0.237 . . . . 74.32 111.231 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -89.13 -71.72 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.51 -0.314 . . . . 74.42 110.555 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.0 m 60.14 99.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.685 0.616 . . . . 65.55 111.805 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 27.2 m -77.54 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.254 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -118.54 178.93 4.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.093 -0.503 . . . . 71.3 110.188 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.01 118.04 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.799 0.333 . . . . 72.03 110.965 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -101.0 153.54 19.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.64 -0.709 . . . . 72.41 110.442 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.09 139.31 54.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.087 0.47 . . . . 73.22 110.973 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 41' ' ' ALA . 2.9 m -134.4 158.85 42.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.566 -0.743 . . . . 70.24 109.324 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 12.6 pt20 -155.91 146.1 21.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.03 0.443 . . . . 74.4 110.422 174.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.0 102.06 13.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 72.24 110.126 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.2 m -82.11 85.06 6.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.349 -0.611 . . . . 63.14 109.349 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 72.45 -66.89 0.29 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.983 -1.008 . . . . 73.01 111.298 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.32 3.9 1.96 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.915 -0.659 . . . . 71.04 112.085 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -103.17 118.19 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.493 0.187 . . . . 62.44 110.715 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.68 115.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.829 -0.434 . . . . 71.22 109.829 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.809 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 96.2 mt-30 -123.09 134.79 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 73.42 111.113 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 23' ' ' VAL . 2.9 pp -117.7 167.18 11.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.665 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.0 m -101.58 125.27 48.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.296 -0.411 . . . . 73.21 110.447 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.17 107.02 19.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.293 0.568 . . . . 75.11 111.543 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.143 -0.48 . . . . 35.42 111.067 179.622 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 107' ' ' SER . 52.4 mt-30 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 121.155 0.502 . . . . 70.41 111.039 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -116.95 121.84 42.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.507 -0.769 . . . . 72.35 109.777 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 m -103.15 134.24 46.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.245 -0.434 . . . . 61.24 109.861 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -79.53 116.78 19.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 75.22 110.3 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.44 -65.62 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.434 . . . . 34.2 110.282 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -176.68 -166.37 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.648 -0.706 . . . . 74.24 109.15 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HE2' ' HB3' ' A' ' 11' ' ' ASP . 50.2 mtpt -67.48 151.45 47.35 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.211 0.319 . . . . 75.21 111.294 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.38 -17.26 63.66 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.777 -0.824 . . . . 74.23 108.777 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.597 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 4.9 t70 -93.84 -24.28 17.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.562 -1.199 . . . . 74.24 111.014 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 25.3 t70 -84.17 -26.27 28.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.912 -0.586 . . . . 71.13 110.391 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.497 HD13 HG11 ' A' ' 30' ' ' VAL . 61.3 mt -82.25 111.64 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.839 -0.619 . . . . 72.14 109.467 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.49 145.87 99.02 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 54.24 112.31 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HB3' ' OD1' ' A' ' 35' ' ' ASN . 72.5 Cg_endo -77.4 153.15 30.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.878 2.385 . . . . 75.24 112.571 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 62.72 28.58 71.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.81 -0.632 . . . . 71.24 113.052 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 34.4 p -143.31 -177.27 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.047 0.424 . . . . 74.24 110.817 -176.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.99 104.72 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.55 -1.02 . . . . 62.35 110.55 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 31.3 m -105.27 142.14 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.488 . . . . 64.23 112.319 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.821 ' HB3' HD12 ' A' ' 45' ' ' ILE . 3.8 p -75.51 117.13 16.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.555 . . . . 64.54 110.812 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.32 143.27 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.063 -0.517 . . . . 72.32 110.429 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 25' ' ' GLN . 7.0 tt -84.93 92.71 8.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 64.33 108.964 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.68 131.09 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.309 -0.86 . . . . 73.44 109.267 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.16 16.73 10.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.895 0.855 . . . . 62.52 110.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.473 ' HA ' HD21 ' A' ' 22' ' ' LEU . 83.9 mm-40 76.3 25.91 0.97 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.258 -1.792 . . . . 74.23 111.054 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.19 167.21 21.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 75.51 109.849 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 45' ' ' ILE . 24.4 mm-40 -91.87 119.35 31.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.047 0.451 . . . . 54.12 111.147 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.1 mt -135.46 129.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.725 -0.67 . . . . 72.33 109.869 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.98 134.46 34.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.496 -0.32 . . . . 63.25 110.335 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 40.4 t -110.14 111.32 35.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.986 0.422 . . . . 53.53 110.512 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 8.8 m-85 -91.74 146.95 23.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.583 -0.735 . . . . 75.51 111.386 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 46.9 mtp85 -140.66 55.07 5.39 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.045 -0.525 . . . . 74.43 111.666 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HG2' HD13 ' A' ' 79' ' ' LEU . 23.5 Cg_exo -63.45 -46.38 9.66 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.914 2.41 . . . . 74.55 113.077 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.31 -29.67 67.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.599 -0.273 . . . . 63.23 111.623 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 62.5 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.41 0.624 . . . . 73.2 110.029 -170.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -177.9 -127.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 -174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -104.74 -9.02 18.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.929 0.395 . . . . 71.52 110.105 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -71.04 103.43 2.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.032 -0.531 . . . . 72.42 110.966 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 m -113.74 142.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.02 109.402 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.832 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 74.1 m-85 -128.6 104.32 7.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.948 -0.301 . . . . 70.23 110.637 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.69 103.85 13.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 74.3 110.898 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.829 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.4 pt -134.9 154.16 36.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.005 -0.543 . . . . 54.33 110.056 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.4 m -77.95 55.13 1.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.262 0.553 . . . . 62.44 111.18 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -91.29 68.88 5.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.865 -0.791 . . . . 53.24 108.865 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 20' ' ' CYS . 25.7 mm -122.89 138.06 54.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 72.14 110.619 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.25 130.5 94.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.975 -0.557 . . . . 71.0 110.886 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -87.63 13.13 2.71 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.0 2.467 . . . . 74.42 113.284 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -101.46 -54.85 2.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.591 0.234 . . . . 64.04 110.912 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.15 -0.66 11.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.062 0.458 . . . . 53.44 110.813 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 61.69 74.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.231 -0.895 . . . . 64.22 111.443 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.7 151.87 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.693 -0.685 . . . . 75.23 109.651 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 p -83.07 83.09 7.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.286 0.565 . . . . 74.42 110.737 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 26.9 m -101.5 8.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.469 0.652 . . . . 73.31 109.813 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.87 13.81 24.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.204 -0.907 . . . . 75.32 109.669 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 p -112.17 -64.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.613 -0.721 . . . . 73.11 111.659 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ptt85 -81.32 51.06 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.005 -0.543 . . . . 74.3 111.208 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -112.06 -110.55 3.1 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.253 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 62.2 mt -110.84 114.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.059 0.457 . . . . 74.31 110.346 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.54 110.87 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.748 -0.66 . . . . 51.51 109.454 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.89 116.8 32.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.559 -0.746 . . . . 51.14 111.085 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.89 121.21 38.5 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.361 -0.607 . . . . 61.45 109.361 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.15 76.68 1.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 72.5 109.189 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 66.01 -75.21 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.488 -0.778 . . . . 72.54 111.51 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -121.93 -22.75 5.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.128 0.49 . . . . 72.32 110.37 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 19.2 t0 -84.69 148.84 26.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 72.51 110.147 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 79' ' ' LEU . 68.1 mt -117.34 115.34 25.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.279 0.561 . . . . 65.2 111.055 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 38.0 m95 -117.19 163.39 16.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.371 -0.831 . . . . 73.32 110.17 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.545 ' HB ' HD21 ' A' ' 79' ' ' LEU . 13.3 p -137.56 137.39 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.09 -0.505 . . . . 70.25 110.387 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.17 132.22 56.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.982 -0.554 . . . . 54.35 110.452 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 43.3 t -67.89 133.37 92.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.898 -0.408 . . . . 73.33 109.898 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.7 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 39.7 Cg_endo -66.37 -32.24 41.33 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 122.341 2.027 . . . . 73.33 112.164 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -100.81 -56.84 2.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.845 -0.616 . . . . 73.32 111.111 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -79.56 -19.63 48.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 55.12 110.746 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 70' ' ' SER . 52.4 mtmt 57.37 34.8 25.21 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.505 -0.77 . . . . 74.22 112.841 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.6 mm-40 -82.82 139.65 33.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 53.21 108.908 169.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 8.7 m80 -116.17 115.83 26.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.103 -0.332 . . . . 75.31 110.103 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HZ ' ' HB2' ' A' ' 90' ' ' TYR . 77.6 m-85 -129.86 166.89 19.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.541 0.21 . . . . 73.11 110.631 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 61.4 mtt180 -81.26 146.53 30.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.407 . . . . 71.23 109.9 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 66' ' ' LEU . 96.0 mt -67.97 -27.47 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.896 0.332 . . . . 63.15 111.896 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.59 37.22 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.81 0.3 . . . . 71.24 111.81 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 20.2 t70 -148.88 -62.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.932 -0.307 . . . . 71.05 111.195 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.46 -12.22 23.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.181 -1.009 . . . . 22.33 113.697 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -75.32 160.03 30.79 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.193 0.52 . . . . 65.22 111.253 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . 61.8 m -87.86 151.99 22.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.453 -0.794 . . . . 60.44 111.481 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 64.5 tp -88.49 -58.86 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.484 . . . . 63.4 110.324 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 16.3 mm-40 -125.53 18.84 8.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 71.24 109.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 84' ' ' CYS . 2.1 m-20 -124.07 -180.0 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.414 -0.812 . . . . 62.4 111.037 -168.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.81 23.72 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.513 -0.767 . . . . 64.23 111.277 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.34 -59.52 2.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.748 0.277 . . . . 51.53 111.748 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.571 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 40.3 m-85 -90.4 -76.35 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.621 0.23 . . . . 73.33 111.621 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 m 66.27 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.84 0.712 . . . . 73.44 110.333 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.7 176.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.445 . . . . 72.25 111.697 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.08 167.64 9.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 51.33 110.916 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -127.34 112.39 14.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.087 0.47 . . . . 63.33 110.649 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -85.98 157.31 20.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.734 -0.666 . . . . 74.22 110.082 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 107' ' ' SER . 3.9 t0 -82.47 162.93 21.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.714 -0.476 . . . . 64.13 109.714 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.788 HG22 HG22 ' A' ' 106' ' ' ILE . 3.1 p -149.12 154.01 38.59 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.342 0.257 . . . . 72.33 110.831 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -154.45 153.87 32.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.239 0.542 . . . . 63.34 111.115 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.08 83.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.735 -0.839 . . . . 73.04 108.735 173.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -97.25 -0.22 47.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.703 -0.68 . . . . 75.34 110.813 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -161.13 -164.75 1.22 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.785 -0.821 . . . . 73.22 108.785 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.01 -11.38 84.8 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.59 -0.604 . . . . 73.23 111.59 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.47 152.26 24.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.953 -0.388 . . . . 72.33 109.953 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.79 136.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 73.32 110.889 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -126.16 147.51 49.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 60.52 110.386 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.788 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -125.62 158.37 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.905 -0.589 . . . . 74.33 109.567 177.127 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 13.1 t -102.65 119.61 39.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.97 0.414 . . . . 51.33 109.973 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -120.85 117.36 52.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 70.24 110.446 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 73.43 111.133 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.362 0.601 . . . . 70.43 110.545 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 91.8 m95 -74.44 111.14 9.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.45 110.096 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 106' ' ' ILE . 9.6 m -95.55 138.5 33.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 73.12 109.909 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -84.36 128.72 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.789 0.328 . . . . 54.42 110.837 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.92 -75.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.017 0.437 . . . . 53.2 110.081 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.0 m -151.64 -173.76 4.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 55.15 109.534 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.717 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 86.4 mttt -78.4 164.15 25.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 71.4 110.402 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 37' ' ' GLU . 65.6 tp -75.4 -19.45 59.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.682 0.753 . . . . 74.23 109.046 167.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.51 -25.38 19.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.926 -1.034 . . . . 72.43 110.761 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.717 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 35.6 t70 -75.93 -21.56 56.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.444 0.64 . . . . 71.53 109.97 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.528 HD13 HG11 ' A' ' 30' ' ' VAL . 26.8 mt -97.29 104.56 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 51.31 109.469 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.4 mt -71.84 148.88 92.53 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 75.45 111.938 -173.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 31.2 Cg_exo -60.79 119.8 7.17 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.981 2.454 . . . . 73.34 112.017 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.38 33.24 4.59 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.96 -0.564 . . . . 53.44 112.058 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -133.62 176.96 8.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.305 0.574 . . . . 54.23 111.53 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 177.14 91.83 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.272 -1.131 . . . . 74.12 110.272 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.659 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.1 m -121.0 151.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.659 0.614 . . . . 73.0 112.659 -172.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 3.4 p -77.63 99.12 5.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.743 -0.662 . . . . 53.45 111.073 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.93 127.36 32.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 53.04 109.836 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.9 112.24 17.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.051 0.453 . . . . 53.22 109.922 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.08 107.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 72.41 109.622 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 67.11 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.72 -0.673 . . . . 72.11 111.785 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -138.88 0.75 2.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.227 0.537 . . . . 75.33 110.162 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -116.02 129.83 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.886 -0.597 . . . . 75.53 111.276 -173.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 39.5 mt-30 -89.14 113.99 25.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.351 -0.611 . . . . 72.51 109.351 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.09 117.71 55.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.796 -0.638 . . . . 74.01 110.625 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -79.97 119.51 22.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 72.32 110.119 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.674 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 18.8 t -100.91 108.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.268 -0.424 . . . . 74.54 109.931 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HE1' ' HB3' ' A' ' 55' ' ' SER . 33.4 m-85 -79.48 117.98 20.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.296 -0.411 . . . . 75.24 110.598 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.609 HH11 ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -130.83 75.57 78.5 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 72.21 110.786 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.74 -34.89 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.037 2.491 . . . . 54.31 113.033 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.7 -179.67 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 70.5 111.296 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.28 18.88 18.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.757 -0.656 . . . . 72.11 109.852 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 23.3 t70 -83.13 -161.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 75.51 109.454 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 10' ' ' LEU . 50.3 mt-10 -118.25 2.43 11.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.122 -0.361 . . . . 75.12 111.255 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 153.79 41.41 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 110.164 -0.31 . . . . 70.11 110.164 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.7 148.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.106 0.479 . . . . 62.34 111.598 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -137.92 100.2 4.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.427 -0.806 . . . . 74.03 109.913 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -118.89 106.33 12.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.047 -0.524 . . . . 63.1 110.459 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.6 pt -132.35 164.58 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 72.45 109.757 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 56.1 m -78.41 65.72 3.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.49 . . . . 35.43 110.779 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.582 ' HA ' HG11 ' A' ' 92' ' ' VAL . 64.4 t30 -97.7 75.98 2.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 74.02 108.986 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.7 mm -125.18 137.65 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.628 -0.714 . . . . 64.5 111.128 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.91 117.98 69.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.417 -0.586 . . . . 70.31 109.417 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.86 -0.14 9.9 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.69 2.26 . . . . 73.43 113.276 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -88.85 -30.72 18.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.22 0.534 . . . . 74.23 109.737 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 -19.49 13.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.868 -0.605 . . . . 75.13 109.933 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 63.16 36.37 12.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.895 -1.048 . . . . 72.23 111.347 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -148.95 165.53 31.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 72.53 109.216 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.659 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 14.0 p -77.31 77.99 3.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.217 0.532 . . . . 53.31 111.302 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.68 -8.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 62.21 109.755 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.95 7.63 23.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.978 -1.01 . . . . 72.13 110.2 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 10.0 p -129.63 7.7 5.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.602 -0.726 . . . . 74.13 110.772 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -110.01 18.19 20.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 71.21 110.486 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -103.67 -158.93 24.71 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.527 -0.844 . . . . 71.31 112.428 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 74.1 mt -85.86 108.02 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.845 0.355 . . . . 70.23 110.389 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 68' ' ' VAL . 84.9 t -71.56 91.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.871 -0.789 . . . . 53.41 108.871 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.45 145.99 30.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.47 0.652 . . . . 53.35 111.744 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -90.41 98.2 11.64 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.305 -0.861 . . . . 74.41 108.725 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.544 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 77.5 t60 -91.64 -45.29 8.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.487 -1.233 . . . . 73.13 110.076 -169.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -123.68 -148.11 0.39 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.148 -1.427 . . . . 70.02 107.148 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.98 44.25 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.179 -0.675 . . . . 75.34 109.179 171.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 5.6 t70 -157.55 -175.44 5.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.669 -0.493 . . . . 54.24 109.669 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.85 114.8 24.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 54.22 110.312 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.614 ' CZ3' ' HB2' ' A' ' 78' ' ' ARG . 46.8 m95 -122.28 127.35 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.862 -0.608 . . . . 74.2 110.243 -176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 HG22 ' A' ' 59' ' ' VAL . 15.9 m -89.13 126.46 42.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.363 0.601 . . . . 71.41 111.036 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -88.83 99.38 12.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.663 -0.699 . . . . 62.01 109.231 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -58.47 128.41 82.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.726 -0.67 . . . . 71.12 111.035 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.1 Cg_endo -71.01 -36.38 7.59 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 62.13 112.324 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.9 tp -89.73 -44.25 10.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 72.43 110.705 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 27.0 mmmt -81.43 -28.68 34.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 74.02 110.638 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 63.06 22.31 13.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.572 -0.74 . . . . 74.14 112.29 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.39 161.63 19.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.884 -0.598 . . . . 71.2 109.612 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -92.64 140.33 29.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.553 -0.294 . . . . 74.41 110.879 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' A' ' 90' ' ' TYR . 53.5 m-85 -128.95 139.27 52.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.079 -0.341 . . . . 71.32 110.079 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 52.6 ttt180 -96.55 127.38 42.49 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.74 -0.466 . . . . 74.52 109.74 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.45 -60.59 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.66 0.6 . . . . 64.13 111.403 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.56 77.25 2.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 74.52 109.836 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 22.6 t70 -178.2 -58.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.197 -0.91 . . . . 72.43 109.881 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . 102.97 -16.35 54.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.672 -0.775 . . . . 71.1 113.395 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 81.8 m-85 -85.83 162.42 18.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.052 0.426 . . . . 74.24 111.452 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.17 40.57 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.648 -0.705 . . . . 61.42 111.27 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.914 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.4 tp 60.5 -83.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.02 0.528 . . . . 74.15 111.859 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.914 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 43.4 mt-10 -110.73 -17.83 13.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.337 -0.392 . . . . 63.44 110.575 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -93.02 172.24 8.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 74.32 110.472 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.01 60.24 0.5 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.001 -0.84 . . . . 70.12 111.001 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.25 -27.41 15.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.997 0.369 . . . . 72.5 111.997 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.423 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 22.3 m-85 -132.58 -68.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.337 0.495 . . . . 72.1 112.337 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 27.6 m 62.25 88.28 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 73.11 109.695 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 44' ' ' ASN . 30.1 m -85.86 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.587 -0.733 . . . . 62.34 112.566 -169.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -89.95 169.18 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 72.23 111.037 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 120.17 8.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.839 0.352 . . . . 65.15 110.342 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.48 153.87 27.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.057 -0.519 . . . . 72.51 110.714 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.15 119.89 21.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 65.0 110.186 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 106' ' ' ILE . 77.5 p -119.73 145.06 46.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.114 -0.494 . . . . 74.1 110.814 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -152.47 148.4 27.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 75.41 111.111 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 47.2 t -100.06 109.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.54 -0.755 . . . . 65.01 109.142 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.4 m -96.19 -63.26 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.176 0.512 . . . . 72.11 111.714 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -124.24 55.44 1.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.639 -0.709 . . . . 73.1 109.878 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.6 -1.31 62.15 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.031 -0.604 . . . . 72.25 112.233 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 29.9 p-10 -110.65 144.62 39.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 72.42 110.725 -177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.1 113.31 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 70.45 110.058 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 21.5 mt-30 -106.52 135.66 47.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.171 -0.468 . . . . 73.05 110.529 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.845 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.42 150.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.328 -0.619 . . . . 62.53 109.328 174.019 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -89.08 101.88 14.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.919 0.39 . . . . 74.21 110.982 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.4 mm -95.18 96.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.25 0.548 . . . . 74.31 109.676 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.554 -0.748 . . . . 74.14 110.674 -179.465 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' SER . 26.8 pt20 . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 120.942 0.401 . . . . 54.24 111.798 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 98' ' ' GLN . 98.5 m95 -118.27 95.02 4.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.909 -0.587 . . . . 75.13 109.733 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.3 m -92.81 135.1 34.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 72.12 110.84 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 103' ' ' ASN . 85.2 m -76.49 121.35 22.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.083 -0.508 . . . . 71.44 110.585 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 23' ' ' VAL . 54.1 t -80.61 -69.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.985 -0.552 . . . . 61.13 110.128 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 p -161.55 -179.46 7.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.702 -0.681 . . . . 64.31 110.172 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.12 137.6 40.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.951 0.405 . . . . 73.13 110.953 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' A' ' 37' ' ' GLU . 51.0 tp -70.94 -8.04 50.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.053 0.93 . . . . 74.44 109.354 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.33 -14.96 39.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.375 -1.284 . . . . 71.3 110.078 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -100.86 -25.4 14.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.924 -0.58 . . . . 72.5 110.513 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.22 113.5 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 52.51 110.674 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 93.3 mt -71.61 129.52 88.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 70.13 111.661 -175.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 17.0 Cg_exo -67.79 128.92 18.73 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.314 2.676 . . . . 73.15 112.48 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 27.7 15.57 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.963 -0.637 . . . . 74.43 112.098 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.73 19.86 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.574 0.226 . . . . 75.11 111.199 -176.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 130.35 2.16 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 74.03 111.445 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.51 174.72 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.963 0.382 . . . . 53.01 111.31 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -80.63 138.92 36.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.867 -0.606 . . . . 71.34 111.614 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.68 127.76 45.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.41 -0.814 . . . . 44.13 109.523 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tm? -84.66 100.6 11.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.431 -0.581 . . . . 64.2 109.431 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 7' ' ' VAL . 48.4 t -107.29 112.27 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 42.53 109.832 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 63.97 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.775 -0.648 . . . . 74.03 110.48 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.7 -6.51 3.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.281 0.562 . . . . 74.15 109.936 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.674 ' HB3' HD11 ' A' ' 28' ' ' ILE . 6.7 mm-40 -89.97 138.78 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.685 -0.689 . . . . 65.24 112.023 -171.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.772 ' HB3' HG13 ' A' ' 45' ' ' ILE . 51.7 mt-30 -100.59 103.44 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 74.0 109.554 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 26' ' ' GLN . 3.2 mp -119.21 142.15 35.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.246 -0.279 . . . . 64.02 110.246 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.47 131.63 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.473 -0.566 . . . . 73.12 109.473 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.96 99.75 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.024 0.44 . . . . 73.05 110.456 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 42.3 m-85 -75.78 125.12 28.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.725 . . . . 60.23 110.507 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -110.78 87.35 6.68 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.113 -1.069 . . . . 70.52 108.113 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.89 -13.32 13.0 Favored 'Trans proline' 0 CA--C 1.517 -0.349 0 C-N-CA 122.588 2.192 . . . . 63.33 112.933 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -117.21 163.37 16.4 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.864 -0.607 . . . . 73.31 110.213 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.811 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 m-20 -79.9 -1.92 41.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 73.12 109.562 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 37.5 t70 -92.76 178.56 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.073 -0.967 . . . . 74.52 109.534 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.774 ' HB3' HD21 ' A' ' 10' ' ' LEU . 41.9 mt-10 -86.14 46.55 1.34 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.127 0.489 . . . . 61.04 111.547 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -117.53 128.93 55.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.425 -0.583 . . . . 71.05 109.425 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.73 162.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 64.51 112.428 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 49.0 m-85 -132.66 106.73 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.245 -0.889 . . . . 75.05 110.38 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -97.14 101.59 13.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.894 0.378 . . . . 73.35 111.277 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -129.87 155.06 41.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 64.35 109.956 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 m -90.81 85.99 6.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 111.94 0.348 . . . . 75.05 111.94 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.789 ' HB3' HG11 ' A' ' 92' ' ' VAL . 21.7 p30 -135.39 65.5 1.55 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.855 0.836 . . . . 74.23 111.017 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.772 HG13 ' HB3' ' A' ' 27' ' ' GLN . 10.6 mm -84.04 -15.79 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.316 -0.856 . . . . 73.14 111.282 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.622 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 10.9 t70 66.62 121.13 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.939 -1.028 . . . . 74.31 110.714 -174.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.7 Cg_exo -75.01 -4.36 15.29 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.986 2.457 . . . . 64.24 113.523 -173.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.24 -31.91 11.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.744 0.307 . . . . 72.12 110.847 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.03 -31.65 7.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.825 0.345 . . . . 71.32 110.896 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 63.71 16.61 9.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.543 -0.753 . . . . 64.52 112.412 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.9 23.85 4.97 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.159 -0.338 . . . . 54.35 111.21 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 14.9 m 61.87 58.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 74.11 111.418 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 72' ' ' LEU . 20.6 m -79.62 -14.11 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.301 0.572 . . . . 55.11 109.901 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 49.4 mt -74.78 -23.52 58.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.749 -0.834 . . . . 71.0 108.749 172.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 1.1 m -90.59 -38.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.231 -0.895 . . . . 71.34 110.034 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -80.64 29.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.56 -0.745 . . . . 74.44 111.112 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.96 -147.2 21.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.381 -0.688 . . . . 73.24 111.381 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.45 102.18 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.143 0.497 . . . . 73.44 110.397 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.3 t -83.82 94.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.39 -0.823 . . . . 74.31 109.3 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 179.76 3.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.116 -0.493 . . . . 50.01 111.267 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG2' HD23 ' A' ' 66' ' ' LEU . 23.8 mt-10 -116.02 155.59 27.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.6 -0.727 . . . . 63.41 110.614 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -127.1 39.23 3.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.936 -1.135 . . . . 63.22 107.936 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 78.7 mt-30 69.28 103.2 0.06 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.128 -1.396 . . . . 75.43 110.6 -171.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 63' ' ' GLN . 29.3 t70 75.8 -53.05 0.63 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.863 -1.062 . . . . 62.1 111.55 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 78' ' ' ARG . 23.9 m-20 -76.2 143.88 40.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.208 0.527 . . . . 72.1 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 ' HG2' ' A' ' 61' ' ' GLU . 92.6 mt -103.52 120.25 40.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 65.12 109.768 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 58.5 m95 -124.49 117.1 23.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 65.12 110.423 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.08 130.3 42.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.018 0.437 . . . . 63.12 110.259 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.46 116.54 32.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.903 -0.59 . . . . 63.11 110.111 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.7 p -81.2 138.16 48.98 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.951 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.03 -29.84 26.68 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.413 2.075 . . . . 65.25 112.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 53' ' ' VAL . 74.8 mt -86.83 -52.21 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 74.12 111.405 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -32.48 29.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.426 -0.352 . . . . 74.12 110.854 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt 62.24 37.75 13.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.742 -0.663 . . . . 72.31 111.215 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -115.62 146.89 41.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 71.11 109.753 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 66.0 m80 -91.42 116.35 28.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.012 -0.54 . . . . 71.1 110.604 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -105.77 121.3 43.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.038 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.9 ttp180 -84.58 129.99 34.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.916 -0.401 . . . . 70.44 109.916 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.07 95.34 0.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.296 0.569 . . . . 63.42 111.032 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -161.31 -58.95 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.449 -0.945 . . . . 73.23 108.449 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 94' ' ' ALA . 7.3 m-20 -138.23 -83.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.835 -1.075 . . . . 44.42 108.985 170.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . -159.28 32.34 0.45 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.596 -0.729 . . . . 55.13 111.539 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -71.25 120.24 16.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.758 0.314 . . . . 64.41 110.731 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 8.6 m -100.83 141.74 33.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.734 -0.667 . . . . 73.33 110.099 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 53.9 tp -71.17 -64.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 73.51 111.818 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 1.4 pm0 -85.73 -51.84 6.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.994 0.368 . . . . 71.03 111.994 -173.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 9.9 t70 -115.8 -151.92 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . -172.14 48.38 0.18 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.865 -0.894 . . . . 74.24 110.865 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.04 -25.32 67.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.112 0.412 . . . . 21.3 112.112 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -128.54 -57.98 1.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.886 -0.326 . . . . 74.42 111.332 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 49.3 m 57.05 83.01 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.479 0.657 . . . . 75.4 109.749 -173.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.789 HG11 ' HB3' ' A' ' 44' ' ' ASN . 23.3 m -70.99 166.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.019 -0.991 . . . . 74.23 112.605 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.49 146.39 25.81 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 53.44 110.714 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -124.79 107.86 11.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 64.31 110.532 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.556 ' HE1' ' HB3' ' A' ' 109' ' ' ALA . 91.2 m-85 -84.11 144.31 29.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.678 -0.692 . . . . 75.41 109.463 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.34 136.07 49.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.781 0.324 . . . . 63.22 110.353 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.801 HG22 HG22 ' A' ' 106' ' ' ILE . 79.2 p -127.77 144.46 51.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 64.31 110.512 -175.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 8.9 pt20 -140.11 141.8 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 74.25 110.93 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 10' ' ' LEU . 37.5 t -110.48 98.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.566 -0.743 . . . . 70.04 109.214 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -128.02 -1.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 63.12 111.42 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 103' ' ' ASN . 8.4 t-20 -136.36 24.99 3.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.374 0.607 . . . . 71.53 110.222 -175.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.89 -23.32 2.61 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.752 -0.737 . . . . 63.11 111.516 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.55 ' HB3' HG23 ' A' ' 6' ' ' THR . 41.6 m-80 -103.57 153.82 20.17 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.362 -0.607 . . . . 73.04 109.362 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' VAL . 45.0 t -90.08 120.11 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.947 -0.39 . . . . 74.34 109.947 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -114.14 127.06 55.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 62.41 109.892 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.801 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.21 152.98 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.15 110.977 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 25.4 t -82.69 107.31 15.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.166 -0.679 . . . . 64.02 109.166 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 108' ' ' ILE . 1.7 pp -81.51 121.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.705 0.764 . . . . 73.24 112.275 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . . . . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.396 -0.82 . . . . 74.34 108.875 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 15.6 mm-40 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.18 0.514 . . . . 74.25 111.395 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 96.0 m95 -116.26 96.58 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.418 -0.81 . . . . 74.02 109.437 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.4 m -77.07 119.3 20.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.354 -0.384 . . . . 74.21 110.633 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.416 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 21.2 m -68.81 113.13 5.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.058 -0.519 . . . . 62.32 109.743 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.36 -65.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.169 0.509 . . . . 63.43 111.246 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.781 ' SG ' HG12 ' A' ' 13' ' ' ILE . 34.1 t -134.11 167.56 20.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.904 -0.589 . . . . 64.35 110.874 -172.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' ASP . 16.0 tptm -84.93 2.96 40.46 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.978 -0.555 . . . . 63.13 110.27 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 67.5 tp 71.77 -40.49 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.855 -1.066 . . . . 71.11 111.018 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' LYS . 28.8 t70 -74.25 -32.56 63.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.374 -0.83 . . . . 71.04 111.231 -175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -84.67 9.9 12.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.911 -0.716 . . . . 55.22 111.342 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.781 HG12 ' SG ' ' A' ' 8' ' ' CYS . 37.2 mm -90.55 128.93 42.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.719 -0.474 . . . . 63.22 109.719 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.96 125.99 92.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 71.1 111.3 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.17 126.82 17.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.837 2.358 . . . . 45.42 112.459 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 30.86 29.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 70.3 111.553 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -150.54 173.98 13.48 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.308 . . . . 70.24 110.864 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.503 ' H ' HG22 ' A' ' 17' ' ' THR . . . -148.04 142.88 10.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.175 -1.17 . . . . 75.21 110.175 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 m -134.3 146.83 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 117.822 0.811 . . . . 73.11 112.605 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 3.5 p -75.54 111.94 11.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.729 -0.668 . . . . 62.31 110.713 174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.07 109.55 20.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.931 -0.577 . . . . 61.1 109.878 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.15 103.15 3.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.298 -0.63 . . . . 75.31 109.298 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 26' ' ' GLN . 16.3 t -94.22 161.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.6 -0.889 . . . . 61.53 108.6 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.81 -53.16 10.07 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.52 0.512 . . . . 75.24 112.246 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -130.36 23.02 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.614 0.245 . . . . 74.13 111.226 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 20.2 mm-40 -138.4 157.63 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.107 0.479 . . . . 74.24 112.064 -174.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.47 ' HB3' HG13 ' A' ' 45' ' ' ILE . 50.3 mt-30 -127.6 103.31 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.653 -0.703 . . . . 71.34 110.461 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 26' ' ' GLN . 2.8 mp -121.21 135.94 59.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.324 -0.398 . . . . 63.35 110.254 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -100.51 134.62 43.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.743 -0.465 . . . . 71.34 109.743 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 39.8 t -111.06 108.44 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.808 -0.357 . . . . 55.14 110.343 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.847 ' HZ ' ' HB3' ' A' ' 44' ' ' ASN . 2.8 m-85 -93.55 128.0 39.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.906 -0.588 . . . . 72.01 110.148 -178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.522 ' HG3' HG12 ' A' ' 39' ' ' VAL . 55.3 ttt180 -119.74 86.67 35.92 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 108.765 -0.828 . . . . 62.34 108.765 172.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 -36.84 91.72 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.853 2.368 . . . . 73.45 112.166 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.5 mtm180 -133.24 163.96 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 62.4 109.551 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.97 56.47 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.624 0.726 . . . . 65.45 110.243 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.82 -171.61 2.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.503 -0.771 . . . . 71.43 109.72 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.6 0.04 56.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 73.54 111.09 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.99 99.33 12.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.979 0.419 . . . . 71.33 110.3 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.522 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.5 m -125.32 165.57 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 62.54 110.818 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -133.04 107.34 8.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.983 -0.553 . . . . 72.14 110.77 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -106.79 96.43 6.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.03 0.443 . . . . 74.41 110.714 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.3 164.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 74.21 109.6 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.8 m -76.89 53.83 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.043 0.449 . . . . 74.02 111.865 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.847 ' HB3' ' HZ ' ' A' ' 31' ' ' PHE . 53.8 t30 -100.93 67.03 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.625 0.726 . . . . 73.53 109.294 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 29' ' ' ALA . 30.8 mm -97.05 -21.05 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.107 -0.951 . . . . 75.54 111.555 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 32.1 t0 63.2 96.97 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.152 -0.931 . . . . 64.43 109.259 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 90' ' ' TYR . 32.2 Cg_exo -60.31 -1.05 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.622 2.881 . . . . 64.42 113.57 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -92.4 -15.04 27.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.557 0.218 . . . . 61.1 110.822 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -129.43 -31.02 2.08 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.817 0.673 . . . . 63.01 112.817 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.7 mp0 76.35 -14.14 0.84 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.017 0.747 . . . . 75.24 113.017 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -111.3 34.53 4.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.108 0.41 . . . . 72.31 112.108 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 53.0 p 47.55 56.4 7.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.282 0.563 . . . . 73.15 111.584 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 m -76.44 -2.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.497 0.665 . . . . 43.44 110.133 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 82.9 mt -92.58 23.36 4.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.086 -0.961 . . . . 74.43 109.583 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 77.2 p -145.12 -39.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 55.33 110.858 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -81.37 59.33 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 63.23 109.685 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.4 -110.38 0.44 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.401 -0.818 . . . . 63.22 111.524 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 50.5 mm -119.74 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.159 0.504 . . . . 73.24 110.694 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.78 101.7 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.141 -1.059 . . . . 75.41 108.141 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 116.19 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.913 -0.585 . . . . 73.33 112.497 -169.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.99 103.67 3.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.043 -1.095 . . . . 61.3 108.043 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -58.96 -57.24 13.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.869 -0.605 . . . . 54.12 110.656 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -141.64 -66.81 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.731 -0.668 . . . . 73.32 109.371 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.08 -7.63 8.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.181 -0.918 . . . . 65.12 110.331 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.594 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.5 t70 -122.54 171.63 8.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.4 110.115 -173.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.98 112.48 24.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.061 0.458 . . . . 73.53 110.955 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.715 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 9.3 m95 -124.65 168.14 13.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.577 -0.897 . . . . 75.31 108.577 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 14.4 p -131.94 144.75 36.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.769 0.318 . . . . 61.14 110.541 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -103.83 127.64 51.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.537 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 47.5 t -90.77 132.94 33.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 73.15 110.427 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.9 -17.3 37.03 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.648 2.232 . . . . 71.02 112.182 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.33 -52.85 4.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 52.21 109.868 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.1 pttm -125.9 103.38 7.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.601 -0.727 . . . . 74.44 109.147 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.7 77.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 64.34 112.178 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -130.72 151.37 51.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 64.31 109.022 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -88.92 93.26 9.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.555 0.217 . . . . 73.01 110.877 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 33.4 m-85 -78.81 121.87 25.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 71.01 109.656 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 49.4 ttt180 -80.04 122.65 27.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.867 -0.333 . . . . 74.21 110.583 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 62.11 111.353 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 49.4 t80 -106.84 16.46 24.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.329 0.585 . . . . 73.33 110.558 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.542 ' CB ' ' HD3' ' A' ' 78' ' ' ARG . 9.8 t70 -147.92 -65.21 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.1 111.191 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.04 -30.03 4.22 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.037 -0.601 . . . . 41.01 111.817 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.45 153.67 42.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 64.21 110.307 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.3 m -100.41 29.49 4.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 73.15 111.702 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 56.5 tp 53.89 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.452 0.908 . . . . 71.02 113.452 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -73.15 -21.71 60.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.695 . . . . 74.23 111.782 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 3.4 t70 -166.51 -160.68 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.777 -0.823 . . . . 74.32 108.777 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.08 -155.14 9.33 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 110.24 -1.144 . . . . 52.11 110.24 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 171.39 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.373 0.606 . . . . 75.4 110.018 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD2' ' HD2' ' A' ' 47' ' ' PRO . 94.9 m-85 -147.25 108.54 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.139 -0.937 . . . . 64.33 108.687 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 m -56.87 105.59 0.23 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 74.31 110.456 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.0 m -94.35 156.07 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.277 -0.419 . . . . 60.2 110.959 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.4 121.43 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.535 . . . . 63.45 111.51 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.36 94.72 8.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 70.3 110.057 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -75.46 164.56 26.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.557 -0.747 . . . . 72.12 111.381 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 21.6 t70 -86.04 132.24 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.342 -0.614 . . . . 73.04 109.342 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.762 HG22 HG22 ' A' ' 106' ' ' ILE . 51.7 p -128.06 144.49 51.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.342 -0.39 . . . . 53.24 111.081 -173.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -135.42 148.77 49.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.94 0.4 . . . . 45.01 110.653 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.48 103.11 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.915 -0.584 . . . . 71.02 109.504 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 m -83.32 77.99 9.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.832 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 71.83 -44.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.84 0.856 . . . . 64.33 112.348 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.06 -49.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.059 -0.591 . . . . 71.3 112.039 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -80.4 151.73 29.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.028 0.442 . . . . 73.42 110.855 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.94 127.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 42.51 110.457 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 90.4 mt-30 -120.47 137.22 54.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 74.1 110.483 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -113.82 149.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.107 -0.331 . . . . 74.44 110.107 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -84.99 105.05 15.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.62 . . . . 74.1 109.327 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 pt -82.85 147.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.089 0.471 . . . . 74.5 111.288 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 34.43 109.691 175.647 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.39 0.615 . . . . 75.32 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 57.4 m95 -129.14 125.38 36.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.132 -0.94 . . . . 62.34 109.041 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -112.62 136.18 52.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 71.12 111.732 -177.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.53 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 25.9 m -67.55 114.37 6.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.656 -0.702 . . . . 73.31 110.873 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 106' ' ' ILE . 46.4 t -89.38 -78.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 75.42 111.171 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' HD11 ' A' ' 13' ' ' ILE . 86.0 m -143.44 177.8 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 71.25 110.677 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 13' ' ' ILE . 43.3 mtmt -84.29 117.68 23.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.582 -0.735 . . . . 72.3 110.384 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . 56.9 tp -66.34 -21.13 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.408 0.623 . . . . 61.21 110.429 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.97 -13.27 56.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.437 -0.801 . . . . 72.31 109.794 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.47 -29.94 10.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.172 -0.922 . . . . 73.32 110.412 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 9' ' ' LYS . 77.4 mt -68.67 122.03 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 74.2 110.741 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 6.3 mp -68.92 142.01 92.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 70.03 111.258 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.756 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 15.3 Cg_exo -69.16 142.01 49.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.872 2.382 . . . . 73.54 111.571 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.76 29.54 38.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.214 -0.517 . . . . 71.22 111.9 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 18' ' ' GLY . 2.0 m -139.54 177.81 7.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.057 -0.349 . . . . 64.12 110.057 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 17' ' ' THR . . . 178.0 118.97 0.57 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.657 -0.577 . . . . 40.22 111.657 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.545 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 28.1 m -129.45 156.0 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.926 0.363 . . . . 54.32 111.712 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 4.7 p -80.42 107.95 13.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 73.13 110.895 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 138.15 31.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.534 . . . . 75.43 110.058 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 22' ' ' LEU . 2.4 tm? -82.75 100.36 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 70.22 109.86 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.32 97.85 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.941 -0.572 . . . . 52.02 109.52 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 64.84 -76.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.817 0.698 . . . . 65.2 111.719 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -142.88 6.04 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.612 0.244 . . . . 74.55 111.132 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -115.73 145.46 42.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.464 -0.335 . . . . 75.2 111.155 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -105.47 126.63 52.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.532 . . . . 74.51 109.562 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 5.0 mp -130.96 130.35 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 43.44 109.189 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.83 113.95 21.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.246 -0.434 . . . . 63.12 110.03 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.557 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.1 t -97.16 98.44 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.045 -0.525 . . . . 63.22 110.416 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HZ ' HG21 ' A' ' 68' ' ' VAL . 18.6 m-85 -76.21 138.74 40.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.339 -0.846 . . . . 72.13 111.313 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -123.41 76.14 53.44 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 109.121 -0.696 . . . . 74.45 109.121 164.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.39 -24.37 19.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.735 2.29 . . . . 75.24 111.267 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 3.4 mmp_? -94.74 137.11 34.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.077 -0.965 . . . . 74.11 110.251 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 31.4 p-10 -86.94 14.04 8.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 73.24 109.982 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 3.4 p-10 -113.75 -93.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.457 -0.792 . . . . 72.41 111.352 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 49.0 mt-10 -121.27 -52.64 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.963 0.727 . . . . 73.23 112.963 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.419 ' HB3' ' HG3' ' A' ' 34' ' ' ARG . 57.8 tp60 -55.72 130.92 45.23 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.267 0.84 . . . . 71.44 113.267 -169.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.4 m -128.72 170.23 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.207 -0.906 . . . . 52.0 109.846 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -144.72 111.31 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.769 0.319 . . . . 72.13 111.686 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.19 103.61 15.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.873 0.368 . . . . 62.1 110.258 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.1 pt -122.39 161.85 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.788 0.328 . . . . 65.55 111.353 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -76.88 46.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 34.31 111.126 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 45' ' ' ILE . 65.9 t30 -95.5 61.43 2.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.619 0.724 . . . . 73.32 110.776 -171.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 45' ' ' ILE . 4.2 mp -123.12 129.64 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.299 -0.864 . . . . 72.23 110.024 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.3 t70 -87.6 123.91 68.59 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 74.32 109.691 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 25.4 Cg_exo -63.84 -22.22 69.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.299 2.666 . . . . 73.21 113.806 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.76 -22.22 37.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.333 0.587 . . . . 74.43 110.465 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.01 -20.14 13.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 71.21 109.851 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 59.2 28.65 18.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.82 -1.082 . . . . 62.43 109.99 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.775 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -150.83 165.52 33.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.136 -0.938 . . . . 75.31 109.864 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.946 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 3.8 p -80.75 56.93 2.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 63.35 111.258 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.12 -9.72 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.618 . . . . 74.42 110.368 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -95.0 -1.46 52.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.321 -0.854 . . . . 74.4 109.25 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.946 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 25.9 t -113.12 -52.46 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.205 -0.907 . . . . 55.34 110.862 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -83.78 59.97 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 64.43 109.696 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -131.65 -91.26 0.53 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 114.835 -1.075 . . . . 30.54 111.963 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.74 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 58.9 mt -129.09 132.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 74.43 110.247 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.23 121.22 58.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.215 -0.661 . . . . 72.05 109.215 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.77 162.51 34.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.08 0.466 . . . . 65.35 111.185 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -87.15 157.15 19.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.707 -0.679 . . . . 72.41 110.263 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 82.8 t60 -131.36 96.19 3.94 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.691 -0.485 . . . . 74.33 109.691 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 73.79 -55.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.857 -1.065 . . . . 70.23 111.792 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.88 -36.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.966 0.412 . . . . 73.35 110.828 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 1.3 m-20 -89.24 169.84 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 73.44 111.542 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.8 mt -108.93 123.79 49.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.492 -0.776 . . . . 73.11 109.898 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.507 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 11.8 m95 -130.84 174.94 9.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.204 -0.665 . . . . 63.41 109.204 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.4 p -120.09 145.28 26.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.955 -0.387 . . . . 51.22 109.955 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -110.02 103.54 12.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.173 0.511 . . . . 51.1 110.539 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -73.89 124.68 90.37 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 65.31 110.36 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 24.3 Cg_endo -61.0 -32.45 92.36 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.792 2.328 . . . . 65.14 112.874 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.3 -63.65 1.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.388 -0.369 . . . . 74.14 111.425 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.817 ' HE3' ' HE2' ' A' ' 90' ' ' TYR . 73.2 mmtt -71.87 -26.55 62.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.32 112.022 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 62.69 15.88 8.45 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.065 0.546 . . . . 73.43 111.733 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 79.6 mt-30 -80.3 141.81 35.12 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.959 -0.564 . . . . 74.31 109.625 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 29.1 m80 -104.57 96.44 6.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 51.22 110.246 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' HG12 ' A' ' 68' ' ' VAL . 58.9 m-85 -82.42 121.22 26.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.767 -0.457 . . . . 71.43 109.767 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 65' ' ' ASP . 23.8 ttp85 -71.5 127.59 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.747 -0.834 . . . . 54.44 108.747 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 68' ' ' VAL . 87.5 mt -72.72 67.46 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 44.31 113.059 -167.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 t80 168.68 -52.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.975 0.91 . . . . 63.31 109.592 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.95 -44.0 61.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 73.24 111.587 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.77 -15.37 44.97 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.474 -0.87 . . . . 23.43 113.183 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.26 135.65 57.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.108 -0.331 . . . . 72.13 110.108 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 2.5 m -90.54 22.59 3.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.022 -0.536 . . . . 72.11 111.476 -172.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp 59.41 -73.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.716 0.806 . . . . 62.32 112.277 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -81.6 -49.99 9.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.289 0.566 . . . . 74.11 110.724 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -105.51 -175.53 2.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.513 -0.767 . . . . 70.21 110.419 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.48 32.71 0.77 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.824 -0.91 . . . . 43.35 110.824 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.04 -48.25 18.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.039 0.447 . . . . 74.53 110.874 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.817 ' HE2' ' HE3' ' A' ' 73' ' ' LYS . 56.5 m-85 -102.58 79.56 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.265 0.555 . . . . 55.43 110.037 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -73.18 82.72 1.32 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.627 -0.715 . . . . 61.45 109.695 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -78.69 149.69 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.596 -0.729 . . . . 73.21 111.753 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.32 165.58 11.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.849 -0.614 . . . . 73.01 110.187 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -122.27 105.06 9.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.062 0.458 . . . . 61.11 110.343 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.66 129.83 34.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.865 -0.607 . . . . 62.21 110.201 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.9 153.89 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.766 -0.652 . . . . 74.13 110.76 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.813 HG22 HG22 ' A' ' 106' ' ' ILE . 30.8 p -133.54 133.66 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.293 -0.412 . . . . 73.12 110.931 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 21.8 pt20 -114.86 150.67 35.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.388 . . . . 75.22 110.024 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 t -102.98 96.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.99 -0.55 . . . . 72.3 109.922 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.0 m -66.99 -63.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.994 -0.548 . . . . 74.32 111.014 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -173.75 95.67 0.1 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.607 -0.724 . . . . 73.21 109.781 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.13 -40.86 2.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.152 -0.547 . . . . 71.1 112.369 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -104.21 151.64 23.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 73.42 110.604 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 47.9 t -101.47 135.99 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 60.14 110.661 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 75.8 mt-30 -118.2 127.06 53.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 64.34 110.151 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.813 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -100.25 155.17 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 63.44 110.83 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -77.02 124.07 27.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.709 -0.678 . . . . 54.44 110.407 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 pt -116.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.259 0.552 . . . . 74.23 110.935 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.444 0.64 . . . . 74.15 110.481 177.461 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.142 -0.318 . . . . 61.42 110.142 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.49 136.59 52.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.375 . . . . 75.22 110.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -118.74 128.47 54.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.222 -0.445 . . . . 63.3 110.353 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.611 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.6 m -78.14 113.7 16.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.175 -0.466 . . . . 54.21 110.77 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.11 -75.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.07 0.462 . . . . 75.24 109.848 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.3 m -144.34 168.44 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 72.12 109.189 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 9.8 mtmp? -91.17 165.81 13.28 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.992 -0.283 . . . . 64.14 110.578 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 tp -71.27 -7.59 47.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.496 0.665 . . . . 74.04 110.124 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.65 -20.29 21.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.216 -0.902 . . . . 72.11 110.002 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 18.4 m-20 -83.47 -27.18 29.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 73.54 110.694 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.87 136.99 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.87 -0.604 . . . . 73.24 110.572 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HB2' HG21 ' A' ' 17' ' ' THR . 5.2 mp -91.53 149.04 38.7 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.621 -0.263 . . . . 74.04 110.977 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.98 121.41 8.89 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.562 2.175 . . . . 74.42 111.696 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 45.72 6.24 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.93 -0.577 . . . . 73.03 112.198 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 14' ' ' LEU . 72.5 p -141.61 174.9 10.13 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.954 0.377 . . . . 63.53 111.073 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -164.22 110.83 0.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.266 -1.134 . . . . 74.05 110.266 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -125.78 135.8 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 117.265 0.533 . . . . 73.43 112.43 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 8.7 p -79.72 104.22 10.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.86 -0.609 . . . . 72.12 110.082 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.06 147.46 23.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.108 -0.496 . . . . 73.2 110.236 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.57 113.35 22.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.897 -0.779 . . . . 73.22 108.897 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.33 93.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.872 -0.603 . . . . 73.33 110.082 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 67.23 -75.57 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.238 -0.892 . . . . 72.41 111.854 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -132.26 -8.49 3.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.446 -0.343 . . . . 73.42 111.223 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -122.9 163.53 20.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 75.42 111.46 -175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.21 128.84 51.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 54.33 109.912 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -127.13 119.04 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.765 -0.457 . . . . 64.33 109.765 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -88.96 125.47 34.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.933 -0.576 . . . . 43.43 110.262 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.528 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.1 t -107.87 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.166 -0.47 . . . . 73.2 110.081 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 63.1 t80 -91.8 130.25 37.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.716 -0.675 . . . . 71.34 110.352 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HG3' HG12 ' A' ' 39' ' ' VAL . 64.2 ttt180 -131.31 100.37 16.85 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.009 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.45 -32.76 6.0 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.672 2.248 . . . . 54.32 113.293 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -128.73 166.13 19.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.52 -0.309 . . . . 75.12 110.684 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.77 26.47 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 63.33 111.255 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 16.5 m-20 -113.56 -155.04 0.56 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.745 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 24.4 mt-10 -84.4 -13.04 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.916 -0.583 . . . . 74.55 111.61 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -73.07 100.23 2.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.097 0.475 . . . . 72.53 110.992 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 32' ' ' ARG . 27.0 m -129.95 156.4 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 60.51 110.159 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 80' ' ' TYR . 93.7 m-85 -131.36 102.84 6.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.698 0.285 . . . . 64.14 110.667 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.94 96.91 7.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.01 0.433 . . . . 62.33 110.682 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 44' ' ' ASN . 49.3 pt -134.56 -179.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.461 . . . . 51.12 110.083 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -79.29 60.73 3.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 73.32 109.911 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 42' ' ' ILE . 50.5 t30 -93.0 46.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.457 0.646 . . . . 54.44 110.644 -174.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.7 mp -103.05 131.25 51.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.512 -0.767 . . . . 65.33 110.04 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 10.0 t70 -82.52 120.94 77.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.101 -0.703 . . . . 73.22 109.101 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 43.4 Cg_exo -57.35 -23.71 56.39 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.227 2.618 . . . . 61.25 113.678 -175.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -84.14 -20.35 32.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 65.45 111.08 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.78 -20.57 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.99 -0.284 . . . . 71.24 111.195 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 64.49 19.19 11.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.692 -0.685 . . . . 71.41 111.096 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.687 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -137.1 169.7 17.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 42.23 109.927 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -81.42 50.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.682 -0.69 . . . . 74.53 111.291 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.66 -19.05 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.115 0.484 . . . . 31.23 109.91 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.23 -43.45 98.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.62 -0.718 . . . . 51.13 109.38 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -71.3 -23.15 61.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.441 -0.8 . . . . 71.54 111.09 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -98.37 20.23 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.267 0.556 . . . . 73.14 110.429 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.51 -149.29 24.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.745 -0.661 . . . . 61.02 111.636 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.6 mp -90.26 116.32 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 75.4 109.759 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 68' ' ' VAL . 60.2 t -112.37 112.93 42.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.672 -0.695 . . . . 71.51 110.301 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.6 159.07 30.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 53.11 110.237 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HG3' HD23 ' A' ' 66' ' ' LEU . 2.1 mp0 -76.07 163.32 27.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.992 0.425 . . . . 72.24 110.251 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -122.09 46.54 2.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.727 -0.67 . . . . 74.34 109.264 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 55.85 25.31 8.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.087 -0.961 . . . . 64.43 111.697 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -164.15 -55.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 55.31 110.777 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.566 ' HB3' ' NE1' ' A' ' 67' ' ' TRP . 2.3 t0 -135.83 -173.0 3.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.086 -0.506 . . . . 71.42 110.116 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 79.2 mt -107.34 110.02 21.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 73.14 109.98 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.566 ' NE1' ' HB3' ' A' ' 65' ' ' ASP . 61.3 m95 -122.89 128.69 50.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.38 . . . . 71.55 111.062 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG23 HG22 ' A' ' 59' ' ' VAL . 13.2 p -103.56 145.69 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.22 -0.445 . . . . 72.03 110.339 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.21 117.68 30.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.499 -0.318 . . . . 44.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 27.3 t -73.34 147.27 87.48 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 65.4 111.29 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.36 -20.53 24.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.437 2.091 . . . . 63.11 112.021 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 72' ' ' LEU . 4.0 mm? -98.33 -67.98 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 72.0 110.499 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -64.58 -39.23 93.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 73.01 111.416 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 70' ' ' SER . 70.6 tttt 62.06 11.94 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.635 -0.711 . . . . 64.34 111.374 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 87' ' ' ASP . 21.9 mm-40 -88.65 150.04 23.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.386 -0.598 . . . . 64.21 109.386 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.4 m80 -89.86 121.66 32.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.914 0.388 . . . . 72.0 110.737 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -117.54 143.42 46.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.002 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 46.6 mtm180 -79.61 119.68 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.732 -0.47 . . . . 75.41 109.732 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 68' ' ' VAL . 92.3 mt -52.1 -55.82 18.37 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.811 0.671 . . . . 62.21 112.811 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 46.9 p90 -90.22 15.94 9.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.735 0.302 . . . . 74.3 111.44 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.794 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 29.5 t70 -122.52 -60.69 1.52 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 45.02 111.365 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.26 -22.8 14.92 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.298 -0.954 . . . . 52.31 113.289 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.36 166.21 18.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.997 0.398 . . . . 74.22 110.924 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -112.7 166.2 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.853 -0.612 . . . . 71.15 111.634 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 62.1 tp -94.89 -69.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 44.41 110.276 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -87.1 -19.51 28.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 74.14 110.985 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 5.1 t70 -96.59 -152.37 0.38 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.931 -0.396 . . . . 52.22 109.931 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.27 -33.34 0.29 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.962 -0.855 . . . . 74.01 110.962 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.25 66.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.461 . . . . 54.43 110.803 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 94.7 m-85 -107.44 61.45 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 70.43 110.893 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.24 121.63 33.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.467 -0.788 . . . . 71.33 109.385 174.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.88 163.73 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 71.2 112.124 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.53 131.22 37.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.65 -0.704 . . . . 70.43 110.961 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.9 98.73 7.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.88 -0.6 . . . . 71.14 110.369 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.63 150.88 34.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 63.45 110.475 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.24 122.74 23.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.54 -0.541 . . . . 74.42 109.54 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.92 HG22 HG22 ' A' ' 106' ' ' ILE . 69.3 p -124.7 160.88 27.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.247 -0.433 . . . . 74.03 110.589 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -168.9 151.38 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 73.12 110.715 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 60.4 t -94.01 106.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.547 -0.751 . . . . 52.25 108.978 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.2 t -104.34 -34.24 8.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -133.03 30.81 3.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 54.52 110.369 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.25 -0.25 85.51 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.113 -0.795 . . . . 70.12 111.113 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.0 p30 -115.09 151.47 34.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.568 . . . . 60.02 110.318 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 99' ' ' VAL . 46.0 t -94.66 113.2 28.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 74.21 109.963 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 23.7 mt-30 -115.3 140.77 48.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.091 -0.504 . . . . 52.13 110.746 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.92 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -111.32 151.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.691 -0.686 . . . . 74.34 109.815 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 t -87.67 104.02 16.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.597 -0.89 . . . . 70.14 108.597 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.3 pp -74.12 135.91 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.588 0.709 . . . . 71.12 112.439 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.098 -0.955 . . . . 74.51 109.037 173.527 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.68 HE21 ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.656 0.265 . . . . 73.25 110.831 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.465 ' CZ3' ' HG3' ' A' ' 98' ' ' GLN . 59.7 m95 -109.14 109.78 20.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.49 -0.323 . . . . 75.32 110.858 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -99.01 141.49 31.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.5 -0.318 . . . . 63.33 110.858 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 m -80.32 122.87 27.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.541 -0.299 . . . . 72.41 110.276 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.5 -81.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.883 -0.414 . . . . 73.11 109.883 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -145.17 -84.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 60.33 109.796 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 60.3 mttp -151.35 151.44 31.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.018 0.437 . . . . 71.12 111.128 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.3 tp -84.39 -13.56 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.091 0.948 . . . . 65.52 109.138 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -88.39 -28.34 21.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.585 -1.188 . . . . 75.34 110.199 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 -18.75 43.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 73.13 111.3 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 32' ' ' ARG . 48.6 mm -76.1 118.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 62.21 110.898 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.66 163.72 42.93 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.57 . . . . 54.43 111.684 -175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.79 125.19 16.04 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.165 2.577 . . . . 73.11 112.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.45 40.47 96.2 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.08 -0.509 . . . . 54.11 111.923 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.7 m -148.68 174.29 12.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.842 0.353 . . . . 74.13 110.422 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 30' ' ' VAL . . . 166.16 165.38 23.43 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.745 -0.942 . . . . 63.15 110.745 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.528 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 30.7 m -129.57 164.6 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 74.03 111.652 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD11 ' A' ' 45' ' ' ILE . 2.8 p -83.44 129.27 34.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.913 -0.585 . . . . 72.21 111.084 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.92 125.41 51.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.797 -0.638 . . . . 74.34 109.921 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.06 89.57 5.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 74.35 109.403 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.8 104.39 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.296 -0.411 . . . . 64.32 111.151 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 61.38 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.031 0.832 . . . . 65.12 112.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.73 3.69 3.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.743 0.306 . . . . 75.23 111.061 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' HG13 ' A' ' 28' ' ' ILE . 58.0 mm-40 -102.28 129.22 48.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 73.12 111.329 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -102.73 88.2 3.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.926 -0.768 . . . . 74.13 108.926 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 26' ' ' GLN . 60.3 mt -105.33 135.76 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.88 -0.6 . . . . 72.53 110.825 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -117.99 137.16 53.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.128 -0.323 . . . . 71.55 110.128 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.69 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 26.2 t -95.38 146.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.534 -0.543 . . . . 65.23 109.534 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -140.65 129.41 23.02 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 70.51 109.629 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' HG3' HG12 ' A' ' 39' ' ' VAL . 46.8 ttt180 -111.71 91.15 14.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.01 -0.276 . . . . 74.52 110.825 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.13 -55.09 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.452 2.102 . . . . 73.23 113.668 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.677 ' HB2' ' OD1' ' A' ' 36' ' ' ASP . 34.3 mtm180 -89.58 -0.15 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.65 0.262 . . . . 63.41 110.926 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 64.5 t30 62.12 28.14 16.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.545 0.688 . . . . 70.51 110.895 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.677 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 6.4 p-10 -111.81 -166.71 1.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.254 -0.43 . . . . 64.42 110.324 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.75 -28.3 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 71.23 111.633 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.33 104.24 11.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.371 0.605 . . . . 70.12 111.433 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG12 ' HG3' ' A' ' 32' ' ' ARG . 30.9 m -105.77 158.56 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.459 -0.791 . . . . 73.12 109.596 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -113.28 96.3 5.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 72.22 110.258 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 93.6 8.15 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.747 -0.661 . . . . 64.54 109.429 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.3 pt -126.43 -172.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.001 -0.545 . . . . 74.13 110.678 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.49 47.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 53.32 110.284 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 33.8 t30 -83.12 40.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.271 0.558 . . . . 62.15 111.175 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 20' ' ' CYS . 33.4 mm -114.38 123.5 70.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 62.32 111.037 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.97 120.85 71.75 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.011 -0.737 . . . . 75.0 109.011 173.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD2' ' HE2' ' A' ' 90' ' ' TYR . 52.4 Cg_exo -56.34 -26.03 60.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.18 2.587 . . . . 41.01 113.406 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -78.15 -13.79 59.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 73.11 110.666 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.44 -34.85 4.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.902 0.382 . . . . 65.23 110.494 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 50' ' ' GLN . 5.7 tp60 66.37 17.56 10.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.325 -0.852 . . . . 65.44 111.027 177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.41 171.06 14.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 55.02 109.311 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 6.5 p -76.97 80.24 3.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.477 0.656 . . . . 55.12 111.282 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.0 m -90.97 -20.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 72.22 110.171 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.449 HD13 ' HZ ' ' A' ' 77' ' ' PHE . 61.0 mt -86.08 -17.74 34.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.45 -0.795 . . . . 52.42 110.222 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 49.6 m -81.56 10.66 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 53.5 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -149.5 31.97 0.72 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.291 0.567 . . . . 75.21 109.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.67 -145.58 19.25 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.293 -0.867 . . . . 75.1 112.485 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.5 mp -97.83 123.94 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.106 0.479 . . . . 64.25 110.992 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -88.85 102.2 12.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.699 -0.682 . . . . 70.13 109.905 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 109.02 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 64.11 110.952 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.16 116.87 23.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.998 -0.546 . . . . 70.03 110.196 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -102.96 90.25 3.71 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.851 -0.426 . . . . 72.2 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 63.8 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.465 -0.789 . . . . 73.13 111.787 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -114.19 -22.91 9.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.352 0.596 . . . . 73.52 110.301 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 5.9 m-20 -91.64 154.14 19.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 72.32 111.712 -173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.22 116.2 29.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.595 -0.73 . . . . 70.02 110.486 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.539 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 16.2 m95 -119.81 151.14 39.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 73.0 109.7 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.94 129.17 66.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.347 0.594 . . . . 75.0 109.724 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -87.94 114.27 24.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.626 -0.716 . . . . 71.31 110.216 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.4 t -62.42 116.22 21.48 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 71.41 109.867 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HD2' HD23 ' A' ' 54' ' ' LEU . 45.8 Cg_endo -69.25 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.491 2.127 . . . . 71.24 112.16 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -112.82 -50.65 2.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 72.35 111.198 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -92.64 -4.61 53.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.485 -0.325 . . . . 75.1 111.447 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 32.2 ttmt 66.09 11.12 7.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.849 -0.614 . . . . 70.22 112.278 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.747 HE22 ' HB3' ' A' ' 89' ' ' ALA . 3.3 pt20 -102.36 150.71 23.07 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.133 -0.355 . . . . 74.05 110.697 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.38 107.31 18.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 74.05 110.189 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 16.2 p90 -111.29 142.38 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.289 0.566 . . . . 75.42 110.981 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 38.6 ttp180 -85.82 123.56 31.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 62.35 110.315 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.8 mt -50.66 -57.07 9.14 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.821 0.7 . . . . 74.31 112.497 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -87.08 37.08 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 71.21 111.468 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 26.4 t0 -149.92 -50.84 0.14 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.346 . . . . 75.01 110.649 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.93 -25.83 25.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.944 -0.646 . . . . 75.33 113.146 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -85.51 147.74 26.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.774 0.321 . . . . 74.12 110.955 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.2 m -102.04 47.16 0.91 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.992 -0.549 . . . . 41.52 111.749 -171.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HG ' ' HG2' ' A' ' 86' ' ' GLU . 49.5 tp 57.41 -95.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 50.23 112.123 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 6.5 mm-40 -107.23 -27.87 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 74.22 111.386 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 39.0 t70 -111.16 75.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.203 -0.666 . . . . 73.32 109.203 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -89.06 63.55 3.45 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.407 -0.815 . . . . 74.34 113.283 -171.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' HE22 ' A' ' 75' ' ' GLN . . . -80.45 -59.03 2.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.893 0.378 . . . . 51.53 110.576 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HE2' ' HD2' ' A' ' 47' ' ' PRO . 29.3 m-85 -90.04 74.19 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 65.13 110.323 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 100.3 3.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.497 -0.774 . . . . 62.41 109.638 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.76 167.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 53.11 111.125 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 135.89 51.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 40.41 110.53 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -96.86 92.33 6.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.935 -0.575 . . . . 45.11 109.578 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -67.2 155.87 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.432 -0.804 . . . . 73.54 110.754 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.66 142.8 29.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.543 -0.54 . . . . 72.0 109.543 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 106' ' ' ILE . 26.0 p -134.47 138.08 44.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.404 . . . . 65.44 111.082 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 48.2 mt-30 -104.85 144.13 32.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.864 0.364 . . . . 63.04 110.561 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.1 t -99.6 76.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.206 -1.035 . . . . 74.1 108.206 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.5 p -75.46 -32.58 60.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.27 -0.877 . . . . 63.14 111.789 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 103' ' ' ASN . 7.2 t-20 -164.52 -146.99 0.1 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.145 . . . . 72.41 107.907 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.07 36.81 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 42.12 111.239 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 20.4 p30 -145.74 163.25 35.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.96 0.504 . . . . 74.15 110.092 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 72.14 110.464 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.27 117.64 30.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 74.33 110.218 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.4 152.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.342 -0.39 . . . . 44.14 110.235 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 4' ' ' TRP . 9.0 t -87.81 125.37 34.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.496 -0.557 . . . . 74.33 109.496 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.07 96.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.092 -0.503 . . . . 44.41 111.029 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.627 0 N-CA-C 108.478 -0.934 . . . . 54.54 108.478 169.871 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.457 -0.093 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.45 ' HH2' ' OD2' ' A' ' 96' ' ' ASP . 73.9 m95 -59.81 117.22 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.71 -1.132 . . . . 61.42 110.393 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -89.61 131.83 35.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.121 -0.491 . . . . 64.44 110.192 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.1 m -74.47 118.9 17.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 62.42 110.48 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 23' ' ' VAL . 40.7 t -87.98 -70.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.091 -0.504 . . . . 70.43 111.064 -177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -161.29 -177.33 5.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.666 . . . . 74.43 109.212 -174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' ILE . 58.3 mtpt -86.65 143.89 27.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.557 0.218 . . . . 74.1 110.592 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -67.28 -12.71 60.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.561 0.696 . . . . 74.35 110.139 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.09 -17.02 53.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.998 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.96 -9.08 16.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.31 0.576 . . . . 63.34 110.471 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' LYS . 46.3 mm -75.59 126.9 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.541 . . . . 61.02 110.686 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.8 mt -70.14 137.48 86.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 64.32 111.604 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -79.46 127.78 7.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.241 2.627 . . . . 71.42 112.639 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.84 23.77 44.53 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.932 -0.576 . . . . 71.01 112.573 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.35 167.34 29.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.064 0.432 . . . . 63.15 111.624 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -127.56 142.1 13.21 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.333 -0.707 . . . . 43.24 111.333 177.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.502 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 21.3 m -127.41 139.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.049 0.425 . . . . 72.23 111.821 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.4 p -70.64 99.0 1.59 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 53.21 110.479 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 132.04 34.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.112 -0.495 . . . . 52.34 110.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -86.99 100.47 12.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.377 -0.601 . . . . 72.22 109.377 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 106' ' ' ILE . 34.3 t -120.76 112.79 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.823 -0.626 . . . . 54.25 110.103 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 31.1 mt-10 61.78 19.41 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.269 0.557 . . . . 71.13 111.892 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 73.8 mm-40 81.47 19.72 0.39 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.176 -1.375 . . . . 70.55 111.27 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -113.47 137.99 50.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.845 -0.798 . . . . 62.42 108.845 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -99.33 108.88 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 74.14 111.151 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.53 130.5 64.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.735 -0.666 . . . . 71.1 109.298 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 113.63 21.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 74.03 110.192 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 29.1 t -95.77 102.34 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.093 -0.503 . . . . 72.33 110.307 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.81 128.51 33.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.639 -0.709 . . . . 62.11 110.077 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 70.6 ttt180 -112.8 84.21 6.48 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.874 -0.788 . . . . 75.43 108.874 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.21 -31.75 53.14 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.672 2.248 . . . . 73.2 112.108 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 99.9 mtt180 -109.39 164.47 12.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.754 -0.657 . . . . 73.44 109.997 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -91.59 10.3 28.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.093 0.949 . . . . 63.14 108.647 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.25 -109.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.657 -1.156 . . . . 72.4 112.008 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.25 -67.06 1.02 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.455 0.539 . . . . 74.51 112.455 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.15 131.27 50.3 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.078 0.77 . . . . 71.31 113.078 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.4 m -124.74 169.18 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.872 -1.058 . . . . 72.11 109.861 175.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -137.8 104.4 5.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.565 -0.289 . . . . 74.42 111.298 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -97.14 108.28 20.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.153 0.501 . . . . 61.14 110.928 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 92' ' ' VAL . 34.4 pt -129.34 161.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.667 -0.697 . . . . 74.22 109.625 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 62.2 m -74.56 75.75 1.98 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.478 . . . . 74.11 111.096 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.55 HD22 HG11 ' A' ' 92' ' ' VAL . 26.8 t-20 -110.49 72.71 0.8 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.69 0.757 . . . . 63.13 109.487 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -127.82 133.16 68.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.268 -0.878 . . . . 74.45 109.829 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.04 125.8 63.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.769 -0.456 . . . . 64.31 109.769 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.94 -11.08 25.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.2 2.6 . . . . 65.21 113.392 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -87.64 -16.22 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.002 -0.279 . . . . 63.14 111.0 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.47 -26.67 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.283 0.475 . . . . 61.32 112.283 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.53 34.84 17.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 71.13 111.153 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -143.9 169.81 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 53.25 109.263 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 13.6 p -80.81 51.09 1.46 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.248 0.547 . . . . 72.25 110.973 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -18.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 75.13 110.196 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.464 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 72.5 mt -83.74 -17.07 42.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.345 -0.843 . . . . 61.43 109.745 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 m -89.96 -13.21 36.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.751 . . . . 70.21 111.6 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -104.96 30.32 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 71.53 111.339 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -94.66 -129.25 5.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.485 -0.864 . . . . 64.14 111.974 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.1 mt -104.74 108.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.071 0.462 . . . . 75.24 110.215 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 59' ' ' VAL . 7.2 p -103.37 108.53 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.502 -0.772 . . . . 50.04 110.073 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.85 166.01 27.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 64.13 111.569 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.95 120.94 33.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.525 -0.761 . . . . 73.3 109.718 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 63.7 t-80 -62.43 -76.88 0.05 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.728 -0.669 . . . . 62.43 110.024 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -130.97 -44.95 1.04 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.412 -0.813 . . . . 55.31 108.93 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -132.36 -21.45 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.275 -0.875 . . . . 71.32 110.574 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.543 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 1.6 t70 -109.92 175.15 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 72.22 111.203 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.76 124.57 49.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 45.54 110.359 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.621 ' CD1' ' HB2' ' A' ' 62' ' ' HIS . 40.1 m95 -124.63 143.84 50.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.164 -0.471 . . . . 65.12 110.594 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.43 117.44 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.617 0.722 . . . . 72.31 110.118 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -90.69 116.2 28.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.797 -0.638 . . . . 73.12 110.17 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -60.09 136.59 91.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.492 -0.322 . . . . 72.01 110.653 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.01 -31.53 55.39 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.695 2.263 . . . . 74.32 112.765 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.89 -56.83 2.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.595 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -90.93 -13.81 32.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.671 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 mttm 64.02 8.56 4.04 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.161 0.8 . . . . 74.23 113.161 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.52 127.12 30.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.094 -0.706 . . . . 72.35 109.094 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.756 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 41.9 m80 -90.87 99.45 12.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.037 -0.528 . . . . 64.34 110.371 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -84.71 120.45 26.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.933 0.397 . . . . 65.13 110.158 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 61.4 ttt180 -78.71 121.28 24.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.986 -0.552 . . . . 72.55 109.805 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.63 -36.22 78.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -80.29 -20.09 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.404 -0.362 . . . . 72.15 111.575 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 10.0 t70 -115.15 -74.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.023 -0.271 . . . . 73.51 111.586 -170.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' HG22 ' A' ' 92' ' ' VAL . . . 140.36 -27.12 2.53 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.802 -0.713 . . . . 75.32 112.124 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -63.31 151.68 40.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.178 0.514 . . . . 72.42 111.258 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . 4.4 m -103.39 50.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.63 -0.714 . . . . 75.01 110.643 -174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 76' ' ' HIS . 38.6 tp 66.74 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.954 0.502 . . . . 74.11 111.363 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 36.6 mt-10 -109.08 -4.57 16.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 73.23 110.341 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 84' ' ' CYS . 6.9 m-20 -115.82 160.03 20.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.555 . . . . 72.53 110.917 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.39 27.67 2.49 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.978 -0.849 . . . . 75.3 110.978 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.3 42.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 54.22 110.745 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -117.27 62.39 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.11 -0.496 . . . . 74.53 110.299 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 2.5 p -65.88 107.19 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 75.3 109.784 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG22 ' HA2' ' A' ' 82' ' ' GLY . 28.0 m -68.01 136.78 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 75.01 111.295 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . -71.59 106.42 4.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.006 -0.543 . . . . 43.32 109.907 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -79.26 88.21 4.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.796 -0.638 . . . . 60.31 110.854 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -80.19 175.92 10.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.755 . . . . 74.42 109.811 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.45 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 20.0 t70 -114.32 147.29 39.33 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.992 -0.373 . . . . 73.21 109.992 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.486 HG23 HG22 ' A' ' 106' ' ' ILE . 1.3 m -129.0 157.16 42.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.62 -0.718 . . . . 75.25 109.606 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -153.34 143.26 22.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 74.2 111.112 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.86 98.27 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.39 -0.823 . . . . 73.15 108.783 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -94.3 -34.58 12.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.54 0.571 . . . . 70.23 112.54 -170.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -136.99 31.61 2.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.047 0.451 . . . . 34.41 110.599 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.62 -11.91 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 62.15 111.387 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.89 150.65 22.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.536 . . . . 74.34 110.127 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -97.12 120.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.305 -0.861 . . . . 75.32 111.05 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 36.2 mt-30 -115.59 142.33 46.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.101 -0.333 . . . . 62.22 110.101 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.632 HD11 HG11 ' A' ' 23' ' ' VAL . 2.8 pp -122.13 154.48 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.459 . . . . 75.33 110.633 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 t -113.38 102.01 9.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.778 -0.453 . . . . 41.25 109.778 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 106' ' ' ILE . 16.4 pt -109.04 110.96 34.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.187 -0.461 . . . . 74.43 111.124 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.66 0.743 . . . . 71.33 110.485 175.911 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.176 0.513 . . . . 73.31 111.398 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -81.19 112.11 18.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.811 -0.631 . . . . 74.43 110.072 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.482 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.0 m -95.93 126.72 41.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.679 . . . . 74.44 110.184 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.554 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 27.4 m -73.61 132.26 42.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.894 0.378 . . . . 72.43 110.994 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.14 -67.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.562 . . . . 74.3 109.514 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -169.92 -167.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 62.52 108.991 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 95.1 mttt -76.92 154.49 33.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.732 -0.213 . . . . 74.44 110.471 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 37' ' ' GLU . 56.9 tp -75.41 -27.07 58.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.51 -0.922 . . . . 60.41 108.51 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.37 -32.07 69.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.13 -1.395 . . . . 72.45 110.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.12 -14.27 59.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.422 -0.808 . . . . 74.41 110.186 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.0 mt -93.08 116.34 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 65.25 110.236 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.63 128.84 93.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 70.23 111.45 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.26 124.16 12.16 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.857 2.371 . . . . 65.23 112.16 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.62 28.62 8.28 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.814 -0.63 . . . . 52.41 112.141 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.27 170.46 17.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.608 0.242 . . . . 72.04 111.41 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -138.11 144.69 16.0 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.218 -0.753 . . . . 72.11 111.218 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.07 145.91 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.205 0.503 . . . . 71.32 112.18 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.677 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.2 p -86.79 133.08 33.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.101 -0.5 . . . . 72.21 111.213 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.38 125.9 41.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.092 -0.503 . . . . 71.43 110.419 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.97 99.9 2.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.773 -0.825 . . . . 72.52 108.773 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 106' ' ' ILE . 46.0 t -109.52 103.08 14.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 73.13 110.738 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 70.26 -53.72 0.64 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.285 -0.87 . . . . 73.1 112.771 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.6 -50.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.603 0.594 . . . . 74.42 112.603 -175.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -109.39 167.38 10.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.743 0.306 . . . . 74.14 110.84 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -95.49 127.04 41.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.906 -0.588 . . . . 62.2 109.832 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.86 134.53 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.367 -0.605 . . . . 75.03 109.367 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -94.14 122.04 36.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.665 -0.494 . . . . 74.42 109.665 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 26.1 t -105.41 104.36 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.082 0.468 . . . . 70.45 110.18 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 79.5 m-85 -79.91 134.68 36.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.396 -0.82 . . . . 65.12 111.342 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -119.71 82.12 26.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.871 -1.159 . . . . 70.14 107.871 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.92 -25.63 19.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.649 2.233 . . . . 63.43 112.791 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 34' ' ' ARG . 61.8 mtt180 -111.57 167.72 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.684 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -84.5 2.88 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.153 0.501 . . . . 73.24 110.212 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 19.3 t70 -98.68 -150.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.894 -0.594 . . . . 54.21 110.041 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.561 ' HA ' HD21 ' A' ' 10' ' ' LEU . 40.7 mt-10 -105.83 21.62 16.97 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.892 0.701 . . . . 65.43 112.892 -169.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.4 123.21 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.593 -0.443 . . . . 62.33 110.337 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.45 167.3 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.983 -0.553 . . . . 75.43 110.967 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.696 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 78.3 m-85 -138.95 105.57 5.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 72.33 110.107 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -102.1 101.93 12.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.062 0.458 . . . . 63.22 110.651 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.7 pt -131.63 173.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.979 -0.555 . . . . 72.14 110.352 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.9 p -83.09 67.82 9.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.347 0.594 . . . . 72.12 109.69 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.562 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.9 t-20 -98.27 35.96 1.68 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.228 1.013 . . . . 71.3 109.517 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 20' ' ' CYS . 35.6 mm -107.01 109.14 27.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 71.42 110.483 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.71 115.95 42.94 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.129 -0.693 . . . . 64.41 109.129 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 90' ' ' TYR . 47.5 Cg_exo -57.51 -17.19 26.75 Favored 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.358 2.705 . . . . 71.44 113.445 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.09 -15.53 59.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 64.21 110.553 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.92 -29.89 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 61.34 111.645 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.68 37.99 12.34 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.328 0.585 . . . . 53.41 111.663 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.677 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.26 170.52 21.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.318 -0.856 . . . . 75.12 108.868 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 73.4 m -77.02 61.84 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.436 0.636 . . . . 74.31 110.895 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -80.42 -22.36 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.59 -0.732 . . . . 64.51 110.373 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.562 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 32.2 mt -81.06 -20.01 42.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.245 -0.65 . . . . 65.24 109.245 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 11.2 m -79.82 -15.6 57.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.225 -0.898 . . . . 75.44 110.904 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 18.71 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 63.44 109.759 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.78 -156.67 20.99 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.877 -0.678 . . . . 62.2 112.379 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.7 mt -100.01 125.09 53.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.875 0.369 . . . . 71.23 110.413 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.49 101.14 2.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.264 0.554 . . . . 65.52 109.83 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.56 95.37 5.7 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.536 -0.756 . . . . 54.01 109.616 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.48 137.71 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.784 -0.644 . . . . 74.51 110.244 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 41.1 t-80 -79.17 -169.93 2.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.647 -0.706 . . . . 72.23 109.288 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.491 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 24.0 tm0? -54.99 -37.73 66.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.778 -0.823 . . . . 73.42 108.778 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.19 60.62 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.253 -0.885 . . . . 72.41 109.888 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.64 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 1.5 t70 -156.52 173.29 17.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 63.55 109.674 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB3' HD23 ' A' ' 79' ' ' LEU . 96.7 mt -119.16 118.11 30.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.554 0.216 . . . . 74.11 111.36 -171.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 39.5 m95 -136.25 125.52 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.817 -0.438 . . . . 72.41 109.817 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.87 130.64 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.974 0.416 . . . . 75.43 110.589 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.0 114.96 22.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.093 -0.503 . . . . 54.33 111.148 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.77 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . 29.1 t -62.08 126.8 88.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.563 -0.744 . . . . 65.55 111.086 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.2 -4.18 14.52 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.419 2.079 . . . . 73.23 112.079 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.7 mt -109.74 -55.93 2.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.119 -0.491 . . . . 61.31 111.207 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.593 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 48.3 mmtm -91.55 -16.26 27.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.171 -0.468 . . . . 55.34 110.951 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 54.76 70.01 0.67 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.68 0.753 . . . . 72.11 111.214 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -141.32 152.04 44.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.211 -0.904 . . . . 72.55 109.091 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 95.5 m-70 -93.97 100.43 12.57 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.236 0.335 . . . . 75.02 110.162 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.77 ' HE2' ' HB2' ' A' ' 70' ' ' SER . 96.9 m-85 -85.88 124.53 32.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.221 -0.445 . . . . 75.2 110.487 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HD3' ' HB3' ' A' ' 81' ' ' ASP . 33.4 ttt180 -73.81 122.58 22.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.657 -0.497 . . . . 71.54 109.657 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 66' ' ' LEU . 3.3 mm? -70.57 1.47 5.15 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.908 1.077 . . . . 55.45 113.908 -168.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -153.65 28.29 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.711 -0.396 . . . . 72.23 111.412 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 7.9 t70 -145.3 -71.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.026 -0.27 . . . . 71.51 111.327 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.82 -20.3 3.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.201 -0.999 . . . . 73.24 113.287 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.51 157.21 37.59 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.123 0.461 . . . . 63.23 111.569 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 8.8 m -109.87 20.88 17.53 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.415 -0.811 . . . . 75.21 110.516 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.7 tp 69.68 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.34 -0.845 . . . . 75.1 111.774 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.69 -63.02 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.725 0.298 . . . . 65.13 111.388 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.57 92.31 6.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.853 -0.425 . . . . 70.23 109.853 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.93 74.1 2.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.656 -0.783 . . . . 73.33 112.441 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.58 -1.13 13.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.617 0.246 . . . . 54.32 111.504 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.593 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -134.1 50.84 2.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 65.22 110.24 -176.364 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 m -64.75 116.63 6.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.818 -0.628 . . . . 75.31 111.546 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.87 168.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.52 . . . . 70.41 110.565 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.26 154.82 18.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 73.05 111.218 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -121.95 109.1 14.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.971 -0.559 . . . . 74.2 109.495 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -84.96 -177.79 6.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 64.33 110.718 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.58 137.17 51.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.407 -0.59 . . . . 75.4 109.407 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.706 HG23 HG22 ' A' ' 106' ' ' ILE . 3.2 m -134.5 161.26 35.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.709 0.29 . . . . 73.12 111.005 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -138.56 153.21 48.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.237 0.542 . . . . 72.42 110.635 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.19 123.52 60.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 64.12 107.927 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 101' ' ' ASN . 3.7 t -131.59 -63.51 0.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.966 0.728 . . . . 61.41 112.966 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.524 ' H ' HG23 ' A' ' 100' ' ' THR . 92.0 m-20 -101.41 28.21 5.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.098 0.475 . . . . 74.41 110.774 -174.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.96 3.22 85.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.662 -0.78 . . . . 54.14 111.2 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 27.9 p-10 -113.31 158.33 20.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.32 109.797 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.92 122.75 65.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.013 -0.54 . . . . 70.13 110.545 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 16.5 mt-30 -127.02 136.19 51.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.643 -0.503 . . . . 74.43 109.643 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.706 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.39 153.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.079 0.466 . . . . 62.23 110.686 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -103.57 96.79 6.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.164 -0.68 . . . . 71.05 109.164 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.5 pt -112.12 78.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 63.11 110.735 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 121.951 0.881 . . . . 74.34 109.921 178.31 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.991 0.901 . . . . 73.24 108.6 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -117.07 117.46 29.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.28 -1.327 . . . . 75.41 109.402 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -88.54 138.13 31.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 71.24 109.619 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 13.4 m -79.59 122.79 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.031 -0.532 . . . . 73.01 110.858 -174.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 23' ' ' VAL . 36.3 t -85.6 -81.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.974 0.416 . . . . 74.01 110.707 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.6 m -155.43 -178.75 7.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 71.52 109.411 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -71.14 147.6 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 72.33 110.667 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 tp -66.48 -27.12 67.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.677 -0.692 . . . . 75.32 110.943 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -98.05 -8.05 28.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.685 . . . . 72.1 110.715 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 -29.72 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.864 -0.791 . . . . 74.33 108.864 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.45 127.22 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.77 -1.104 . . . . 55.12 109.97 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.56 144.98 30.39 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.288 -0.415 . . . . 74.41 111.176 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.648 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 Cg_exo -58.55 147.94 84.0 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.56 . . . . 75.42 112.389 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.71 26.34 56.58 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.002 -0.618 . . . . 72.11 111.854 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -141.22 178.55 7.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.135 -0.32 . . . . 74.31 110.135 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 17' ' ' THR . . . 175.25 105.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.839 -0.696 . . . . 60.22 111.865 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.09 170.77 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.691 0.281 . . . . 73.13 111.116 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD12 ' A' ' 45' ' ' ILE . 8.0 p -83.05 134.33 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 74.35 111.557 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.94 143.51 42.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 74.11 109.651 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.43 100.06 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.689 -0.486 . . . . 73.04 109.689 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 7' ' ' VAL . 21.7 t -101.31 81.3 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.092 -0.503 . . . . 35.03 109.938 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.77 -74.91 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.134 -0.939 . . . . 72.41 112.223 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -116.82 -35.43 4.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.597 0.237 . . . . 74.14 111.524 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -103.84 153.78 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.068 0.461 . . . . 71.41 111.833 -174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.88 116.94 29.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.636 -0.711 . . . . 60.22 109.095 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mp -112.93 127.93 69.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -86.44 131.01 34.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.206 -0.452 . . . . 71.32 109.837 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 29.8 t -110.0 97.29 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.02 0.438 . . . . 72.02 110.042 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.857 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 89.7 m-85 -72.71 141.32 48.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.492 -0.776 . . . . 72.3 110.741 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.67 ' HE ' ' HA ' ' A' ' 36' ' ' ASP . 6.4 tpt180 -132.69 59.39 42.87 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.878 -0.601 . . . . 72.4 110.495 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 6.2 Cg_exo -79.39 -22.31 8.25 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.491 2.127 . . . . 65.33 111.011 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -82.06 150.74 27.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.986 -1.006 . . . . 64.11 109.81 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -75.49 77.13 2.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.095 0.474 . . . . 71.43 109.888 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.67 ' HA ' ' HE ' ' A' ' 32' ' ' ARG . 41.1 t0 63.16 179.6 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.753 -1.112 . . . . 70.32 111.409 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 66.46 -22.91 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.746 1.218 . . . . 73.2 114.006 176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 36' ' ' ASP . 30.2 tp60 -134.62 114.14 12.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.02 0.438 . . . . 75.1 110.364 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG12 ' HD3' ' A' ' 32' ' ' ARG . 27.1 m -110.99 163.37 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.898 -0.592 . . . . 72.31 110.507 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.857 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 73.2 m-85 -127.28 86.69 2.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.132 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -91.15 98.35 11.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 94' ' ' ALA . 41.0 pt -131.95 175.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 72.21 111.118 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.452 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 15.1 m -83.94 75.46 10.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.163 -0.471 . . . . 60.21 110.178 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -130.8 85.88 2.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.461 0.648 . . . . 74.42 110.08 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.2 mm -120.42 -124.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.782 -0.822 . . . . 54.24 108.782 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.522 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.1 p30 -175.35 141.61 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.296 -1.001 . . . . 51.33 108.296 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -94.7 30.22 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.352 2.035 . . . . 74.53 112.802 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -117.56 -48.06 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 70.43 110.417 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.44 6.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.279 -0.418 . . . . 64.55 111.472 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 58.44 61.82 2.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.559 0.537 . . . . 71.24 111.167 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.69 16.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.583 0.216 . . . . 75.12 111.583 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 72.4 m 61.74 57.98 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.461 0.648 . . . . 62.45 110.8 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 46' ' ' ASP . 19.7 m -73.68 -9.67 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 64.42 110.309 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 94.3 mt -87.59 -9.69 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.468 -0.787 . . . . 64.04 110.25 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 5.1 m -103.03 -43.83 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.303 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -81.08 50.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 71.51 111.86 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.42 -115.52 2.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.491 -0.861 . . . . 53.41 112.92 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 83.2 mt -108.19 120.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.003 0.43 . . . . 74.2 110.853 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -85.34 96.58 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.35 -0.611 . . . . 65.52 109.35 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.18 118.14 35.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.153 0.501 . . . . 70.22 111.204 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -92.84 121.44 34.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.311 -0.626 . . . . 74.43 109.311 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -117.5 102.97 9.63 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.781 -0.451 . . . . 72.24 109.781 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.12 -81.95 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.352 -0.84 . . . . 73.52 111.222 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -124.39 -30.2 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.903 0.383 . . . . 75.53 110.72 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.688 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 35.1 m-20 -85.21 161.02 19.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.301 0.572 . . . . 74.4 111.206 -172.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 33' ' ' PRO . 94.6 mt -108.32 112.9 25.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.443 -0.799 . . . . 65.31 109.642 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.688 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 30.5 m95 -110.66 107.82 17.53 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 31' ' ' PHE . 14.4 p -78.1 133.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.699 -0.482 . . . . 71.45 109.699 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 75' ' ' GLN . . . -118.91 134.02 55.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.434 . . . . 74.03 110.532 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 1.2 p -74.86 145.14 80.96 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.176 -0.465 . . . . 70.55 110.338 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.86 -53.14 5.42 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.965 2.443 . . . . 72.03 113.214 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.97 -47.08 7.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 73.14 111.518 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 71.4 mmtt -65.71 -33.46 75.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.343 -0.39 . . . . 71.52 110.77 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 60.82 28.96 18.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.685 -0.688 . . . . 55.05 111.022 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 79.0 mt-30 -91.86 137.12 32.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.645 -0.707 . . . . 70.22 110.563 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.567 ' H ' ' CG ' ' A' ' 87' ' ' ASP . 26.5 m80 -101.91 126.11 48.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.658 -0.701 . . . . 60.12 110.885 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.15 125.09 45.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.486 -0.324 . . . . 70.32 110.158 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.55 111.22 8.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.048 0.451 . . . . 75.3 110.446 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.94 82.8 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.746 . . . . 74.11 110.784 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -172.52 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.442 -0.799 . . . . 74.03 108.944 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -121.98 -11.82 8.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.51 -0.768 . . . . 73.25 110.726 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.59 59.29 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.94 -0.648 . . . . 71.44 112.341 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -62.68 123.13 17.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 74.11 111.157 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.4 145.59 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.797 -0.816 . . . . 65.05 108.797 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.87 -62.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.369 -0.604 . . . . 74.02 109.369 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.66 13.99 1.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.913 -1.143 . . . . 75.22 107.913 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 76' ' ' HIS . 1.1 m-20 -95.38 31.29 2.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.619 -1.628 . . . . 74.5 110.892 -167.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.15 44.37 2.38 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.014 -0.612 . . . . 75.03 113.117 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.42 -21.62 27.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.268 0.556 . . . . 71.25 110.08 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.64 91.34 3.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.49 -0.777 . . . . 75.13 109.057 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -61.16 100.89 0.13 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.51 -0.768 . . . . 65.22 111.593 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.1 m -122.13 161.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 75.15 110.286 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.84 173.17 11.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 44.53 110.349 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.576 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -101.92 -158.84 0.7 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.984 0.421 . . . . 72.04 109.987 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -157.24 169.88 23.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.105 -0.952 . . . . 71.23 109.839 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 9.2 m-20 -88.68 126.7 35.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.989 -0.745 . . . . 63.24 108.989 170.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.595 HG22 HG22 ' A' ' 106' ' ' ILE . 80.6 p -128.75 131.98 47.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.568 0.223 . . . . 74.43 110.953 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -121.24 141.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 71.22 110.253 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.4 92.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.711 -0.677 . . . . 62.23 109.812 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.46 83.57 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.616 -0.72 . . . . 62.43 111.375 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 71.06 -82.4 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.181 -0.918 . . . . 54.13 111.831 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 8.17 7.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.802 -0.713 . . . . 63.42 112.931 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -138.53 152.07 47.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.973 0.387 . . . . 71.34 110.46 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.0 t -107.21 131.91 56.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.274 -0.421 . . . . 73.01 110.807 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 68.0 mt-30 -127.51 128.23 45.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.939 -0.393 . . . . 73.23 109.939 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.595 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -117.32 156.16 18.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 73.04 110.985 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 13.5 t -98.14 106.76 19.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.345 -0.613 . . . . 71.02 109.345 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 pt -80.6 142.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.037 0.446 . . . . 65.44 110.962 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.965 -0.562 . . . . 62.21 110.936 -177.015 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 107' ' ' SER . 14.2 mm100 . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 108.411 -0.959 . . . . 74.13 108.411 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 84.0 m95 -86.31 110.69 19.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.915 -1.493 . . . . 75.23 109.482 175.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.696 HG21 HG11 ' A' ' 23' ' ' VAL . 19.1 m -100.22 136.79 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.618 -0.512 . . . . 73.04 109.618 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 8' ' ' CYS . 8.5 m -81.12 126.67 31.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.975 0.417 . . . . 73.22 111.974 -173.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.71 -1.2 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.6 0.714 . . . . 64.11 109.476 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.839 ' H ' HG22 ' A' ' 6' ' ' THR . 61.1 m 87.49 -60.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.566 -1.197 . . . . 62.33 111.581 169.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.85 ' HE3' ' HB2' ' A' ' 12' ' ' ASP . 44.1 mtmt -145.34 146.41 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.974 0.416 . . . . 64.55 111.893 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 37' ' ' GLU . 35.6 tp -84.12 -25.92 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.717 -1.216 . . . . 74.54 107.717 165.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -60.61 -39.37 87.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.168 -1.378 . . . . 64.23 111.349 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.85 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -77.67 -10.16 59.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 72.0 110.175 -176.399 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.4 mt -93.78 113.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.839 -0.619 . . . . 71.43 109.782 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.5 mt -69.7 139.16 88.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.316 -0.402 . . . . 73.5 111.381 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 16.5 Cg_exo -68.2 128.17 17.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.096 2.531 . . . . 72.13 112.178 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.07 19.33 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.949 -0.569 . . . . 72.3 112.19 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 172.47 16.86 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.816 0.308 . . . . 72.12 111.41 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.16 138.01 5.05 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.734 -0.546 . . . . 52.24 111.734 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.09 167.59 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.937 0.368 . . . . 43.45 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.79 109.42 11.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.979 0.419 . . . . 43.24 111.401 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.34 106.84 6.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.831 -0.622 . . . . 74.15 109.342 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 27' ' ' GLN . 3.2 tm? -78.13 105.48 9.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.07 -0.514 . . . . 64.33 109.709 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 5' ' ' THR . 48.5 t -118.6 92.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.759 -0.655 . . . . 63.12 110.016 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 61.64 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.578 -0.737 . . . . 70.43 112.035 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -118.82 -2.14 10.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.807 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -109.29 139.45 44.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.399 -0.364 . . . . 75.11 111.222 -174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HG2' HD23 ' A' ' 22' ' ' LEU . 52.7 mt-30 -128.92 113.16 14.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.934 -0.576 . . . . 75.14 109.805 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HA ' HD11 ' A' ' 45' ' ' ILE . 1.4 pp -132.71 142.82 41.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.935 0.398 . . . . 73.42 110.588 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.49 120.79 28.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 64.11 109.94 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.26 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 53.45 110.619 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 55.7 m-85 -72.45 134.62 45.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.623 -0.717 . . . . 75.45 111.156 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -120.43 81.53 31.01 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 165.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.01 -32.54 53.55 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.848 2.366 . . . . 74.4 112.733 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.92 -166.71 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 74.13 111.459 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -79.98 -18.88 49.2 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.202 0.816 . . . . 74.34 113.202 -165.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 38' ' ' GLN . 11.5 p-10 -110.81 -165.69 1.01 Allowed 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.335 0.495 . . . . 45.4 112.335 -168.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE1' HD22 ' A' ' 10' ' ' LEU . 6.5 mm-40 -69.52 6.62 1.03 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.152 0.797 . . . . 74.23 113.152 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 15.8 mm100 -74.42 83.27 1.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 70.13 110.757 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 HG21 ' A' ' 97' ' ' THR . 20.6 m -108.79 159.53 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.885 -0.598 . . . . 64.44 110.79 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 94.7 m-85 -135.67 109.16 7.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.464 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.87 95.78 7.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 71.22 110.623 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 44' ' ' ASN . 37.7 pt -121.85 168.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.016 -0.538 . . . . 63.14 111.255 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -78.87 48.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.4 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.527 ' HB2' HG13 ' A' ' 42' ' ' ILE . 53.9 t30 -98.35 46.42 1.0 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.357 0.599 . . . . 72.15 110.242 -173.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 20' ' ' CYS . 10.9 mm -83.52 -23.5 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.551 -0.749 . . . . 71.43 111.098 -175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.861 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 7.5 t70 68.6 123.05 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 O-C-N 124.367 1.042 . . . . 72.34 111.631 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.6 Cg_endo -80.99 18.86 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.17 2.58 . . . . 75.24 112.951 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 85.0 t80 -111.28 -36.04 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.636 -0.256 . . . . 72.44 111.094 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.42 -20.98 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.108 0.41 . . . . 72.55 112.108 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 64.84 19.18 11.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.387 0.514 . . . . 74.13 112.387 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.55 22.98 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.889 0.329 . . . . 72.32 111.889 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 38.2 m 58.62 39.62 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.279 0.561 . . . . 62.32 110.785 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.54 -18.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 74.53 111.275 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 59.0 mt -75.11 -18.06 60.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 74.4 110.11 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -86.78 1.23 52.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.073 -0.512 . . . . 72.14 110.536 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -102.13 11.75 37.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.946 -0.761 . . . . 61.02 108.946 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.96 -151.31 12.08 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.353 -0.84 . . . . 71.5 112.825 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 mp -97.44 129.82 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 63.44 110.898 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.95 99.1 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.917 -0.772 . . . . 72.33 108.917 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.5 97.93 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.611 . . . . 75.02 110.843 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.52 110.93 19.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 74.12 109.49 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -89.89 92.24 8.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.534 -0.543 . . . . 61.12 109.534 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 66.52 -74.86 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.706 -0.679 . . . . 73.24 111.145 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -126.99 -24.86 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.828 -0.624 . . . . 65.24 110.185 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.9 t0 -81.4 165.41 21.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 73.21 110.556 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.5 mt -123.75 108.69 12.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.208 0.528 . . . . 63.14 111.12 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 37.0 m95 -117.56 144.49 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 74.4 109.88 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 7.1 p -102.12 125.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.158 0.504 . . . . 73.3 109.79 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -84.55 109.46 17.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.974 -0.557 . . . . 71.11 109.82 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.552 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 46.5 t -60.86 122.82 71.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.784 -0.643 . . . . 75.13 110.846 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 61.1 Cg_endo -73.34 -8.6 22.1 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.442 2.095 . . . . 65.21 112.138 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.22 -49.37 2.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 74.42 111.219 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 75' ' ' GLN . 29.6 mmtm -94.85 -6.62 42.35 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.197 0.443 . . . . 63.13 112.197 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 73.47 -35.89 0.33 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.241 0.616 . . . . 74.13 112.65 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.563 ' OE1' ' HB3' ' A' ' 87' ' ' ASP . 21.0 pt20 -59.29 159.14 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.626 0.727 . . . . 71.25 112.604 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 80.6 m80 -99.21 123.55 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.946 -1.024 . . . . 71.11 110.66 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 81.1 m-85 -99.12 124.67 44.32 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.755 -0.831 . . . . 71.24 108.755 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 10.3 ttp180 -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.28 -0.568 . . . . 73.44 109.508 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.69 -52.75 63.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.637 -0.71 . . . . 74.35 112.728 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.73 32.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 74.22 110.591 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 11.4 t70 -145.23 -56.79 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.324 -0.398 . . . . 73.4 111.322 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.23 -32.09 6.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.631 -0.795 . . . . 51.53 113.109 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -78.42 166.91 22.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.195 0.521 . . . . 63.35 111.335 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 20.2 m -106.03 159.5 16.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.56 -0.745 . . . . 74.24 110.487 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.469 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 63.3 tp -83.56 -65.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 45.33 111.72 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.1 pm0 -92.34 -11.22 35.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.331 -0.395 . . . . 72.33 111.711 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 9.2 t70 -135.64 -161.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.059 -0.719 . . . . 75.22 109.059 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.56 27.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.387 -0.911 . . . . 60.15 113.075 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 3.0 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.726 0.298 . . . . 54.41 111.432 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.86 -78.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.18 -0.208 . . . . 64.14 111.331 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 m 66.55 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.839 0.712 . . . . 73.03 110.949 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 42' ' ' ILE . 33.9 m -95.51 164.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 72.34 111.313 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 167.24 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 72.34 109.696 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -141.61 120.09 12.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.369 . . . . 40.51 110.065 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.44 148.44 24.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.812 -0.631 . . . . 74.43 111.171 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 m-20 -66.72 140.64 57.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 65.21 109.917 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.652 HG22 HG22 ' A' ' 106' ' ' ILE . 12.1 p -116.7 124.89 50.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.879 0.371 . . . . 74.12 110.637 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -106.4 139.43 40.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.404 0.621 . . . . 64.35 110.936 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.68 97.9 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.602 -1.181 . . . . 74.23 108.661 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.3 t -86.71 -17.05 34.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.117 -0.492 . . . . 51.1 111.645 -173.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.41 -77.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.042 -0.725 . . . . 54.41 109.042 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.22 24.03 1.4 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.316 -1.514 . . . . 73.54 109.316 173.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -135.49 153.69 51.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.953 -1.124 . . . . 61.53 108.35 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.08 139.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 121.098 -0.241 . . . . 75.14 111.043 -171.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 36.2 mt-30 -129.69 131.93 46.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.932 -0.396 . . . . 71.44 109.932 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.654 HD13 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -112.34 144.5 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 71.11 110.85 178.088 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 49.7 m -78.47 106.82 10.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 63.41 110.208 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 pp -80.52 143.83 11.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.915 0.388 . . . . 75.54 110.409 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.439 0.637 . . . . 40.43 110.275 -179.654 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.569 0.223 . . . . 72.01 111.305 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -81.44 114.59 20.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.927 0.394 . . . . 72.34 110.225 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -122.98 136.17 54.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 75.04 110.638 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 40.8 m -81.99 137.55 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.354 . . . . 74.12 110.262 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.461 HG11 ' HB1' ' A' ' 21' ' ' ALA . 25.7 t -99.61 -75.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.099 0.475 . . . . 52.14 110.008 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.87 -173.39 4.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.81 -0.632 . . . . 64.13 109.495 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -70.05 139.75 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 63.11 110.709 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.9 tt -83.65 -27.5 29.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.122 -1.066 . . . . 72.12 108.122 171.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -67.5 -25.32 65.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.526 -1.216 . . . . 71.41 110.563 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.9 -5.72 56.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 41.1 110.23 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 10' ' ' LEU . 71.2 mt -78.58 129.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 64.24 109.822 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mt -74.37 138.8 74.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.105 -0.498 . . . . 75.22 111.584 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 14.3 Cg_exo -69.35 123.62 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.878 2.385 . . . . 73.32 111.88 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.19 28.18 10.12 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.773 -0.649 . . . . 74.34 112.601 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.6 p -139.18 -178.81 5.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 117.207 0.503 . . . . 73.21 111.607 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -158.02 127.16 1.84 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.237 -1.145 . . . . 51.25 110.237 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.11 146.02 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.252 0.834 . . . . 70.41 113.252 -172.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.9 t -73.97 108.73 6.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.202 -0.908 . . . . 70.33 110.176 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 7' ' ' VAL . . . -103.86 128.27 51.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.119 -0.491 . . . . 70.4 110.548 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.14 106.19 17.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.861 -0.792 . . . . 74.11 108.861 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 108' ' ' ILE . 13.5 t -105.76 90.12 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.347 -0.388 . . . . 72.04 110.448 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 67.61 -67.14 0.19 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.214 -0.903 . . . . 72.04 112.103 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -136.84 -18.15 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.792 0.293 . . . . 63.12 111.792 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.52 ' HG3' HD11 ' A' ' 28' ' ' ILE . 3.6 pt20 -117.12 151.96 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 64.15 111.75 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -103.43 125.58 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.739 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 ' HG3' ' A' ' 26' ' ' GLN . 5.1 mp -129.17 143.45 41.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 53.31 110.056 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.1 36.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 73.2 109.584 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 45.6 t -105.93 104.97 17.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.895 0.379 . . . . 75.25 110.332 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.7 m-85 -81.88 131.02 35.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.734 . . . . 73.35 111.312 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB2' HG12 ' A' ' 39' ' ' VAL . 75.6 ttt180 -131.06 76.35 76.9 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.81 -0.811 . . . . 70.2 108.81 165.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.47 -19.37 13.17 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.574 2.182 . . . . 62.33 111.963 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -100.13 164.62 11.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 74.33 109.899 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 2.2 p-10 -80.92 -10.23 59.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 51.11 109.904 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.93 171.76 14.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.442 -0.799 . . . . 53.02 110.94 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HG2' HD22 ' A' ' 10' ' ' LEU . 29.2 mt-10 -85.52 30.89 0.6 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 70.45 111.253 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -100.57 103.33 14.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.144 -0.48 . . . . 74.44 109.755 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 32' ' ' ARG . 19.1 m -104.92 163.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.002 -0.544 . . . . 65.35 111.298 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.784 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 48.9 m-85 -124.19 102.77 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 73.25 109.951 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.01 95.23 9.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.16 0.505 . . . . 64.4 110.741 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.58 162.65 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.576 . . . . 72.01 110.057 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 92' ' ' VAL . 20.7 m -78.71 82.87 4.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.15 0.5 . . . . 72.55 110.589 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.26 17.96 21.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.066 0.936 . . . . 73.51 109.556 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.27 107.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.721 -1.127 . . . . 74.52 109.909 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.2 t70 -60.95 131.67 91.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.251 -0.431 . . . . 62.22 110.221 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 18.7 Cg_exo -67.39 -4.64 12.23 Favored 'Trans proline' 0 N--CA 1.472 0.26 0 C-N-CA 123.393 2.729 . . . . 64.12 113.482 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -113.16 3.96 16.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.296 0.57 . . . . 73.21 109.923 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.41 -35.83 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.91 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 64.66 21.52 12.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.941 0.401 . . . . 73.1 111.658 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -146.25 170.56 16.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.57 . . . . 63.43 110.082 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.8 m -81.61 59.91 4.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.53 0.681 . . . . 74.21 111.057 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -78.53 -23.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.65 -0.705 . . . . 70.21 110.312 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 70' ' ' SER . 57.8 mt -81.79 -21.79 37.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 73.45 109.948 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 m -74.56 -22.57 58.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.369 -0.832 . . . . 72.43 111.244 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -96.61 27.1 4.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.192 0.52 . . . . 75.43 110.675 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.47 -152.0 26.76 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 62.12 112.056 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.792 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 53.8 mt -86.44 103.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.043 0.449 . . . . 71.12 110.8 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -75.58 96.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.815 -0.63 . . . . 62.31 109.759 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.43 137.17 46.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.995 -0.548 . . . . 75.35 111.416 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 72.12 109.482 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.689 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 57.5 t-80 -107.52 114.43 28.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.113 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 69.76 -84.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.054 -0.975 . . . . 72.01 111.413 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.65 -9.31 2.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.511 . . . . 73.13 110.999 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' HB2' ' NE1' ' A' ' 67' ' ' TRP . 3.6 m-20 -115.16 -179.2 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.04 0.447 . . . . 65.12 110.873 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.0 mt -112.6 118.46 35.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 74.54 109.449 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 26.8 m95 -122.5 115.8 22.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.637 . . . . 64.44 109.991 -174.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.8 p -85.16 127.31 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.146 0.498 . . . . 60.05 110.605 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -89.9 101.94 14.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.917 -0.583 . . . . 71.45 109.463 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 54' ' ' LEU . 12.8 p -64.89 136.5 96.81 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.642 -0.708 . . . . 75.11 111.028 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 38.1 Cg_endo -67.7 -32.12 31.02 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.392 2.061 . . . . 71.14 112.51 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.78 -49.42 9.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 72.15 111.683 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 4.3 mmpt? -84.18 -27.14 28.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 72.32 110.157 -175.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 62.07 27.11 16.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.152 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.03 151.9 25.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 63.35 110.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 79.7 m80 -92.8 126.33 37.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.471 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HE1' ' HG ' ' A' ' 84' ' ' CYS . 85.3 m-85 -115.29 132.76 56.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.064 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 ttp180 -81.75 119.97 24.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.536 -0.542 . . . . 74.3 109.536 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' CG1' ' A' ' 68' ' ' VAL . 75.1 mt -78.81 23.92 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.679 0.622 . . . . 74.21 112.679 -170.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.49 24.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.257 -0.646 . . . . 61.43 109.257 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 25.2 t70 -136.65 -71.26 0.45 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.83 -0.623 . . . . 62.01 110.898 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.61 -26.78 4.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.759 -0.734 . . . . 45.41 112.225 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.63 169.49 12.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.312 0.577 . . . . 71.55 111.067 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 4.2 m -109.14 149.93 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.479 -0.782 . . . . 75.1 110.351 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.3 tp -98.73 20.26 13.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.247 0.546 . . . . 75.41 110.184 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -135.44 -68.11 0.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.618 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.33 136.27 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.548 -0.296 . . . . 63.41 110.348 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.35 49.04 3.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.031 -0.604 . . . . 74.31 112.801 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.15 -5.59 16.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 74.33 110.904 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.515 ' CE2' ' HD3' ' A' ' 73' ' ' LYS . 80.5 m-85 -136.14 32.38 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.134 -0.485 . . . . 74.02 110.816 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -78.27 117.35 19.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.159 -0.473 . . . . 51.3 110.045 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 43' ' ' SER . 30.3 m -116.05 -170.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 62.33 111.476 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.01 168.19 9.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 74.04 111.075 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.47 109.53 13.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.61 -0.723 . . . . 53.43 109.376 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -82.26 147.42 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.757 -0.656 . . . . 75.44 111.232 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 12.5 m-20 -66.24 122.11 16.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 73.22 110.068 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.537 HG23 HG13 ' A' ' 106' ' ' ILE . 1.6 m -117.51 153.77 32.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.85 -0.426 . . . . 72.53 109.85 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -144.41 153.01 41.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.445 -0.343 . . . . 64.45 110.261 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -124.9 105.39 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 72.5 109.138 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 101' ' ' ASN . 5.2 t -112.72 -63.6 1.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.986 0.736 . . . . 75.15 112.986 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.489 ' H ' HG23 ' A' ' 100' ' ' THR . 32.6 m-20 -106.33 29.2 7.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 71.54 110.403 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.13 90.28 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.875 -0.89 . . . . 73.24 110.875 -172.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -111.34 159.4 18.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.956 -0.622 . . . . 74.34 109.758 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 10' ' ' LEU . 22.0 t -103.69 125.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.256 -0.429 . . . . 63.12 110.565 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -124.52 131.41 53.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.42 . . . . 63.12 110.389 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 97' ' ' THR . 3.8 mp -113.71 142.04 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 63.1 110.005 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 47.0 t -80.53 99.21 7.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.285 -0.635 . . . . 71.41 109.285 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 23' ' ' VAL . 44.3 mm -77.0 94.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.668 -0.696 . . . . 64.34 111.142 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 109.248 -0.649 . . . . 73.21 109.248 173.927 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 107' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.066 0.46 . . . . 70.23 110.861 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -85.13 118.21 24.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 75.13 110.131 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -121.08 152.27 38.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 63.43 110.555 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.944 0.402 . . . . 75.2 111.543 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 30' ' ' VAL . 93.3 t -80.84 -68.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 61.32 109.498 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.1 t -179.22 -163.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.052 -1.092 . . . . 70.21 108.052 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 13.7 mtpt -79.15 136.24 37.06 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.896 -0.409 . . . . 72.41 109.896 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.71 -30.49 69.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.356 0.598 . . . . 73.21 110.104 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.57 -17.57 51.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.479 -176.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 t70 -84.81 -19.63 32.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.77 -0.65 . . . . 71.11 109.347 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.97 125.03 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.616 -0.72 . . . . 75.05 110.679 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 94.1 mt -77.13 133.47 68.76 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.205 -0.452 . . . . 64.3 111.665 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 12.7 Cg_exo -70.24 144.8 52.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.324 2.683 . . . . 74.44 112.555 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.61 56.1 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.935 -0.575 . . . . 12.52 112.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -156.48 158.06 36.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.779 0.323 . . . . 64.3 111.737 -172.676 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -122.58 138.74 12.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.797 -0.921 . . . . 72.14 110.797 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.78 142.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.459 0.54 . . . . 70.44 112.459 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -75.19 105.91 6.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.448 . . . . 64.22 111.44 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.72 132.92 35.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.911 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.17 98.14 8.88 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.48 -0.563 . . . . 73.42 109.48 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 106' ' ' ILE . 21.2 t -108.74 70.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.957 -0.565 . . . . 73.33 109.629 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 8.1 pt-20 42.2 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.938 1.295 . . . . 60.45 114.191 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.703 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 3.9 pt20 -80.87 -13.05 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.564 0.579 . . . . 72.22 112.564 -172.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -143.92 153.72 42.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.288 0.566 . . . . 64.32 111.951 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -115.33 117.86 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 65.11 109.054 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 106' ' ' ILE . 66.1 mt -122.01 132.32 71.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 45' ' ' ILE . . . -88.65 125.6 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.292 -0.413 . . . . 53.34 110.641 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 7' ' ' VAL . 39.0 t -105.54 105.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.074 0.464 . . . . 74.14 110.126 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 74.7 m-85 -78.37 128.39 33.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.501 -0.772 . . . . 71.44 110.76 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.463 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 13.0 tpt180 -109.16 84.67 2.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.196 -1.038 . . . . 64.3 108.196 168.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' PHE . 16.9 Cg_exo -66.65 -48.03 2.46 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.621 2.214 . . . . 55.24 112.353 -174.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -116.92 166.75 11.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.048 -0.524 . . . . 63.13 110.111 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -81.77 72.65 8.82 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.092 -1.077 . . . . 75.21 108.092 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' A' ' 38' ' ' GLN . 19.0 t70 -150.19 179.04 8.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.896 -1.047 . . . . 75.14 109.082 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -79.27 -9.04 59.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.724 0.297 . . . . 74.53 111.33 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -78.08 129.27 35.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.6 . . . . 74.52 111.605 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.74 155.17 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.794 . . . . 53.35 110.021 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 55.3 m-85 -132.94 108.01 8.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.684 0.278 . . . . 71.41 111.005 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.24 108.29 19.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.878 0.37 . . . . 73.13 111.109 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.3 pt -132.16 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.146 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 55.0 m -81.82 89.91 6.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.796 0.332 . . . . 61.12 110.167 178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -129.08 43.99 3.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.583 0.706 . . . . 75.13 109.223 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 20' ' ' CYS . 46.8 mm -107.98 128.98 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.585 -0.734 . . . . 62.1 110.532 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 t70 -85.91 118.07 69.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.259 -0.645 . . . . 74.21 109.259 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 19.2 Cg_exo -66.97 -12.18 35.12 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.225 2.617 . . . . 75.11 113.25 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -93.94 -18.69 21.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.951 0.405 . . . . 72.05 110.37 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.41 -22.27 13.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 70.21 109.639 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.22 28.81 9.93 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.909 -1.041 . . . . 61.31 111.782 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -159.17 173.74 15.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 72.33 110.561 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -79.65 52.27 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.919 -0.582 . . . . 62.52 110.94 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.75 -18.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.784 -0.644 . . . . 63.13 110.702 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.49 -6.43 49.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.624 -0.716 . . . . 73.13 109.666 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 5.1 m -100.61 -35.16 9.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.388 -0.824 . . . . 64.05 110.362 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HG3' HG22 ' A' ' 17' ' ' THR . 72.5 ttt180 -88.18 61.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.797 0.808 . . . . 73.52 109.665 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.72 -153.81 9.34 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.865 -1.061 . . . . 64.01 111.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.5 mp -94.75 120.69 44.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.892 0.377 . . . . 52.23 110.012 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.4 99.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.726 . . . . 64.32 109.832 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.73 119.98 31.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.474 -0.785 . . . . 41.2 110.454 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -95.45 132.48 40.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.078 -0.51 . . . . 63.54 110.639 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -94.76 -155.78 0.48 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.921 -1.14 . . . . 72.21 107.921 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -78.08 -30.91 49.86 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.878 -0.514 . . . . 72.31 110.275 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -128.59 -39.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.982 -0.554 . . . . 74.21 111.0 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 11.8 m-20 -93.74 158.94 15.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 73.1 112.289 -170.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.41 121.77 43.77 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.024 -0.989 . . . . 63.22 109.621 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.604 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 24.0 m95 -119.4 165.81 13.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.244 -0.434 . . . . 75.54 110.33 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -122.93 129.13 75.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.204 0.526 . . . . 73.32 110.08 173.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.19 107.99 19.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.868 -0.606 . . . . 74.35 110.012 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 21.1 p -74.55 134.69 75.87 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.979 -0.555 . . . . 72.44 110.448 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.38 -39.67 12.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.527 2.152 . . . . 64.43 112.562 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.61 -58.08 3.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 63.55 111.387 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.6 -31.42 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.436 -0.347 . . . . 73.21 110.965 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 70' ' ' SER . 56.2 mttm 65.78 17.78 10.96 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.514 -0.766 . . . . 60.32 110.782 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -85.99 138.46 31.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.436 -0.802 . . . . 75.05 108.948 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -97.12 105.98 18.23 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.857 0.36 . . . . 64.4 110.214 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -96.72 128.59 43.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.912 -0.585 . . . . 63.42 110.02 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 35.2 ttp180 -74.21 117.05 15.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.35 -0.611 . . . . 71.34 109.35 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.647 HD21 ' HB ' ' A' ' 68' ' ' VAL . 88.7 mt -48.13 -58.06 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.113 0.883 . . . . 75.45 113.306 -168.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' OH ' ' HA ' ' A' ' 65' ' ' ASP . 5.9 p90 -95.84 24.82 5.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.049 0.389 . . . . 75.13 112.049 -172.062 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 83' ' ' PHE . 8.1 t70 -142.03 -59.01 0.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.028 0.381 . . . . 75.33 112.028 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.28 -16.13 10.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.454 -0.879 . . . . 61.33 113.46 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.518 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 10.7 t80 -56.34 126.28 25.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.955 0.378 . . . . 75.21 110.068 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 22.5 m -97.08 37.15 1.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 72.1 111.029 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.762 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 52.3 tp 66.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.4 111.479 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.762 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 45.4 mt-10 -137.38 -33.13 0.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 54.24 110.599 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.43 93.17 5.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.606 . . . . 61.54 110.985 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.05 21.75 40.24 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.953 -0.567 . . . . 53.41 112.011 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.45 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.888 0.375 . . . . 74.11 111.384 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.26 -47.73 4.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.405 -0.361 . . . . 74.31 111.718 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.481 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 23.9 p 49.84 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.334 0.654 . . . . 64.42 112.188 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 43' ' ' SER . 34.1 m -76.21 161.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.932 -0.577 . . . . 71.33 111.316 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -103.25 154.51 19.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 64.44 110.861 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.09 106.01 8.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.923 0.392 . . . . 71.11 110.393 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.5 -177.61 3.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.089 -0.505 . . . . 73.41 110.875 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.39 158.18 17.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 73.34 111.166 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 106' ' ' ILE . 3.9 m -148.36 159.62 43.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.77 -0.65 . . . . 53.12 109.317 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -161.71 155.69 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.024 0.44 . . . . 61.33 111.126 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 104' ' ' VAL . 29.2 t -132.19 127.35 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.607 -0.886 . . . . 60.04 108.607 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -135.67 -28.22 1.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.631 0.604 . . . . 64.3 112.631 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -139.55 32.62 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.051 0.453 . . . . 62.42 110.625 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.47 -37.31 3.35 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.593 -0.813 . . . . 73.34 111.865 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.0 140.34 34.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.975 0.417 . . . . 53.41 110.034 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 99' ' ' VAL . 41.3 t -96.53 131.57 42.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.829 -0.623 . . . . 63.4 110.211 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' THR . 40.0 mt-30 -116.61 141.77 47.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.77 -0.196 . . . . 71.03 110.596 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.689 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -123.9 161.93 25.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.292 -0.413 . . . . 72.31 110.271 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 37.3 m -101.88 101.07 11.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.375 -0.375 . . . . 61.01 110.982 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 pt -80.54 119.04 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.274 -0.421 . . . . 73.53 109.968 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 72.24 111.697 -174.56 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 112.114 0.413 . . . . 71.21 112.114 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -128.45 135.78 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.326 . . . . 71.21 110.474 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 m -119.79 132.04 55.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.102 -0.499 . . . . 72.35 110.203 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.813 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.7 m -71.49 117.52 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.098 0.475 . . . . 75.3 111.58 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG2' HD12 ' A' ' 106' ' ' ILE . 41.4 t -86.9 -67.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.293 0.568 . . . . 72.05 110.644 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.51 -177.6 6.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.781 . . . . 73.3 108.975 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 47.3 mtpt -84.2 157.16 21.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.85 0.357 . . . . 75.41 110.546 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.8 tp -79.16 -2.38 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.415 0.626 . . . . 55.12 110.142 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.48 -40.74 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.745 . . . . 62.33 112.202 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 p30 -88.6 -6.74 57.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 72.34 112.395 -172.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.38 129.85 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.882 0.372 . . . . 63.21 110.164 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 91.7 mt -61.22 124.52 80.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.153 -0.476 . . . . 74.11 111.708 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 14.8 Cg_exo -68.47 131.91 24.26 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 123.232 2.621 . . . . 43.53 112.646 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 84.55 18.51 61.88 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.792 -0.64 . . . . 55.41 112.77 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -153.13 162.32 41.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 117.096 0.448 . . . . 61.01 111.444 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -118.27 124.32 6.03 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.478 -0.649 . . . . 71.33 111.478 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -111.95 141.45 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.953 0.377 . . . . 70.23 111.482 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 6.9 p -82.32 92.91 7.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.086 0.47 . . . . 74.31 111.025 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -82.65 143.19 31.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 53.32 109.93 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 27' ' ' GLN . 3.2 tm? -80.02 97.44 6.8 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.28 -0.637 . . . . 73.14 109.28 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 HD11 ' A' ' 106' ' ' ILE . 19.2 t -91.24 79.65 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.894 -0.594 . . . . 72.35 109.997 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 65.15 -68.56 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 74.24 112.437 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -118.94 -19.41 8.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.903 0.334 . . . . 73.11 111.903 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -138.35 140.32 39.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.807 -0.357 . . . . 75.33 111.444 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 49.0 mt-30 -88.41 132.0 34.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.787 -0.449 . . . . 65.22 109.787 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 59.4 mt -130.37 136.44 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.186 -0.672 . . . . 33.42 109.186 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.24 108.41 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.385 -0.37 . . . . 64.02 110.225 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.6 t -101.0 110.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.91 -0.586 . . . . 65.33 109.907 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 89.8 m-85 -77.9 137.4 38.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.54 -0.755 . . . . 71.52 111.432 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -124.29 57.89 14.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.925 -0.768 . . . . 54.33 108.925 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.703 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 98.5 Cg_endo -77.65 -25.54 7.85 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.545 2.163 . . . . 75.23 112.871 -166.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -97.96 1.05 47.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.281 -0.418 . . . . 63.34 110.141 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.54 31.17 18.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 74.03 110.147 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.7 t70 -144.23 -158.71 0.91 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.191 -0.913 . . . . 74.44 109.674 -171.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.505 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 37.8 mt-10 -70.41 -25.82 63.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.226 0.454 . . . . 72.3 112.226 -172.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.58 91.38 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.102 0.477 . . . . 62.42 111.522 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.16 157.64 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.266 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -140.25 115.54 9.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 71.34 110.424 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 106.27 16.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.312 -0.404 . . . . 63.23 111.274 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 44' ' ' ASN . 38.5 pt -123.98 153.9 30.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 63.05 109.986 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 95' ' ' TYR . 44.9 m -77.23 59.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.128 0.49 . . . . 62.2 110.596 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 42' ' ' ILE . 64.9 t30 -105.1 63.54 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.621 0.724 . . . . 72.24 110.378 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mp -114.36 132.05 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.088 -0.96 . . . . 72.34 109.77 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.0 t70 -81.24 117.12 66.83 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 71.24 109.396 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 9.0 Cg_exo -72.32 -5.6 17.44 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.143 2.562 . . . . 73.41 113.576 -174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -89.46 -32.09 17.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.136 -0.32 . . . . 62.11 110.136 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -13.81 14.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.191 0.519 . . . . 55.52 110.066 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 57.98 59.68 3.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.862 -1.063 . . . . 73.44 110.914 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -167.32 158.44 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.028 -0.987 . . . . 51.55 109.587 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 16.7 p -81.34 50.29 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.862 -0.608 . . . . 72.13 110.515 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.59 -20.74 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.376 0.608 . . . . 63.44 110.058 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.4 mt -75.57 -14.6 60.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.3 -0.864 . . . . 73.35 109.848 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 19.5 m -117.05 4.93 12.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 61.14 110.749 -176.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -107.68 9.06 29.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.535 . . . . 61.0 110.198 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -90.79 -114.92 1.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.895 -0.669 . . . . 72.12 112.53 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.0 mt -121.24 113.81 40.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.917 0.389 . . . . 70.45 110.874 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.1 t -74.79 93.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.653 . . . . 54.14 109.287 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.72 157.29 16.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.718 -0.674 . . . . 62.42 111.426 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -117.88 122.99 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.738 -0.665 . . . . 75.4 110.061 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 50.2 t-80 -65.38 -59.67 3.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.653 -0.703 . . . . 75.01 110.169 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -173.34 -58.52 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.774 -1.103 . . . . 73.12 108.439 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -125.96 11.37 7.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.34 -0.846 . . . . 62.45 109.489 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.596 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.3 t0 -132.53 166.48 21.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.446 -0.797 . . . . 71.33 109.526 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.62 117.43 21.99 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.462 0.305 . . . . 63.2 110.663 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 20.4 m95 -130.01 112.58 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 72.1 110.376 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 13.8 p -79.85 141.39 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.847 -0.427 . . . . 72.5 109.847 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.46 54.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.971 0.415 . . . . 74.22 111.583 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 28.2 t -74.66 127.44 87.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 74.41 110.552 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 55.5 Cg_endo -70.86 -34.05 11.5 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.635 2.223 . . . . 73.42 113.021 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.62 -63.2 1.33 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.85 0.357 . . . . 60.05 111.825 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 90' ' ' TYR . 41.4 mmtm -73.69 -25.57 60.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 74.22 110.874 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.4 tttm 56.15 95.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 71.43 112.357 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.437 ' OE1' ' HB3' ' A' ' 89' ' ' ALA . 2.5 pt20 -166.64 155.41 10.6 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.006 -0.997 . . . . 74.14 109.454 170.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.783 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 75.5 m80 -90.35 143.57 26.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.709 -0.678 . . . . 72.05 110.183 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.444 ' HB2' ' CG1' ' A' ' 68' ' ' VAL . 86.2 m-85 -130.58 121.1 25.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.401 -0.592 . . . . 62.11 109.401 173.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.07 133.79 45.44 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.333 -0.547 . . . . 75.51 109.74 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.63 11.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -128.06 4.9 5.88 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.675 -0.41 . . . . 74.44 111.075 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.87 -77.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.581 -0.281 . . . . 62.45 111.164 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.49 22.66 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.608 -0.806 . . . . 54.14 113.056 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -68.26 146.28 53.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.86 -0.422 . . . . 73.33 109.86 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 53.9 m -99.28 0.96 44.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.646 0.61 . . . . 52.32 112.646 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.0 tp 63.58 -74.73 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.241 0.617 . . . . 74.13 112.537 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 27.0 mt-10 -109.95 -40.71 4.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.474 0.654 . . . . 55.11 109.969 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' CG ' ' HA ' ' A' ' 75' ' ' GLN . 1.7 m-20 -82.31 -171.01 3.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.852 -1.067 . . . . 71.23 110.386 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.33 118.43 0.75 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.574 -0.822 . . . . 64.34 112.522 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . . . -168.01 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.524 0.202 . . . . 54.53 110.884 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.583 ' HE2' ' HG3' ' A' ' 73' ' ' LYS . 75.1 m-85 -83.91 80.44 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 63.54 110.756 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -74.83 97.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.004 -0.543 . . . . 70.22 109.581 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.51 -175.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.171 -0.468 . . . . 62.22 111.725 -172.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.09 173.52 8.66 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.964 -0.562 . . . . 74.13 110.403 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -134.11 116.4 15.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.806 0.336 . . . . 74.51 111.179 -173.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HE1' ' OG ' ' A' ' 43' ' ' SER . 80.0 m-85 -80.42 151.51 29.3 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.788 -0.642 . . . . 63.32 109.42 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -81.5 160.84 23.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.224 -0.658 . . . . 54.1 109.224 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.829 HG22 HG22 ' A' ' 106' ' ' ILE . 4.8 p -136.08 142.86 44.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.779 0.324 . . . . 74.34 111.366 -171.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -125.45 138.25 54.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.22 0.533 . . . . 75.43 110.116 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.92 103.72 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.597 -0.89 . . . . 53.51 108.597 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.4 m -89.62 -68.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.317 0.58 . . . . 73.23 110.69 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -116.35 -133.02 0.33 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.359 -0.978 . . . . 71.31 108.359 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.78 35.4 2.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.421 -0.895 . . . . 24.45 111.139 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.7 p30 -141.65 155.13 45.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.496 . . . . 73.32 110.958 -175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.59 128.06 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.627 -0.715 . . . . 74.23 110.322 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.813 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -121.76 127.0 50.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.33 -0.395 . . . . 53.12 110.23 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.829 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -101.72 165.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.08 -0.341 . . . . 73.41 110.08 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -92.09 96.82 10.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.041 0.448 . . . . 73.42 110.235 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mm -73.79 102.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.2 0.524 . . . . 64.43 110.073 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 64.42 110.148 178.489 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 107' ' ' SER . 51.3 mt-30 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.054 0.454 . . . . 72.34 110.611 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 85.0 m95 -133.7 100.24 4.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.417 -0.811 . . . . 71.3 110.03 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -88.45 135.44 33.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.509 -0.314 . . . . 64.24 111.21 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.2 m -72.41 111.85 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 75.11 110.165 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 30' ' ' VAL . 50.2 t -81.97 -73.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.827 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.2 m -150.44 175.91 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 63.31 109.688 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 2.8 mptp? -79.36 142.18 36.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.973 -0.381 . . . . 72.42 109.973 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 99' ' ' VAL . 7.9 tt -62.63 -23.47 67.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 53.12 109.61 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.87 -21.21 26.5 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 72.55 110.264 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.55 -24.96 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 71.51 110.723 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 32' ' ' ARG . 73.1 mt -77.59 116.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 75.12 111.161 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.05 132.83 90.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 60.11 111.474 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 44.1 Cg_endo -68.4 145.12 64.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.073 2.515 . . . . 63.21 113.153 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.04 64.41 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.676 -0.693 . . . . 74.34 112.856 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 166.73 32.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.084 0.442 . . . . 63.4 111.932 -175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -146.17 142.7 10.77 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.578 -0.609 . . . . 40.14 111.578 177.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.549 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 26.2 m -127.21 144.5 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.07 0.435 . . . . 52.24 112.013 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.55 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.5 p -74.0 105.3 5.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.162 -0.472 . . . . 71.4 110.851 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 131.27 41.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.02 -0.536 . . . . 71.35 110.391 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.27 101.33 13.75 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.331 -0.618 . . . . 63.24 109.331 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -111.45 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.594 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 66.09 -72.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.351 -0.84 . . . . 72.42 111.697 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -155.2 11.32 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 74.05 110.973 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -119.08 137.73 53.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.245 -0.434 . . . . 64.44 111.014 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -99.6 112.8 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 62.42 109.878 173.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.3 mt -118.18 135.65 57.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.087 -0.506 . . . . 75.53 110.453 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -89.91 114.81 26.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 74.43 109.989 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.9 t -98.54 101.63 12.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.376 -0.374 . . . . 54.54 110.747 -176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HE2' HG21 ' A' ' 68' ' ' VAL . 66.8 m-85 -80.05 141.99 35.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.659 . . . . 75.45 111.089 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 39' ' ' VAL . 14.0 tpt180 -112.7 80.72 3.9 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.302 -0.999 . . . . 72.43 108.302 165.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.716 ' HG2' HE22 ' A' ' 38' ' ' GLN . 18.2 Cg_exo -65.95 -43.32 9.49 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.568 2.179 . . . . 61.43 112.962 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -114.08 156.79 23.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.707 0.289 . . . . 74.54 110.284 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.18 71.09 3.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.816 -1.179 . . . . 33.14 107.816 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 26.7 t70 -160.07 -175.9 5.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.91 -1.041 . . . . 62.32 109.08 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.5 ' HA ' HD11 ' A' ' 10' ' ' LEU . 29.0 mt-10 -78.71 -10.75 59.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 35.44 110.236 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.716 HE22 ' HG2' ' A' ' 33' ' ' PRO . 22.2 tm0? -73.52 124.2 25.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.291 -0.868 . . . . 71.24 110.885 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' HD2' ' A' ' 32' ' ' ARG . 28.5 m -132.74 168.22 24.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 51.1 110.425 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.92 103.02 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.657 0.244 . . . . 62.23 111.657 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -103.95 109.64 21.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.857 0.361 . . . . 42.22 110.245 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 43.7 pt -130.51 179.16 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.976 0.417 . . . . 73.24 111.149 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.48 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 5.2 m -82.29 80.11 8.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.501 -0.555 . . . . 62.43 109.501 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.0 t-20 -123.84 70.57 1.08 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.713 0.768 . . . . 73.33 110.243 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' HB3' ' A' ' 20' ' ' CYS . 37.3 mm -126.69 131.97 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.166 -0.924 . . . . 71.33 109.368 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.1 t70 -83.72 121.74 76.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.764 -0.458 . . . . 54.12 109.764 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 29.1 Cg_exo -62.54 -17.62 59.18 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.13 2.553 . . . . 50.11 113.248 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.1 5.77 44.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 73.01 110.597 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.33 -29.84 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 62.03 111.645 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 69.0 19.85 7.99 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.345 0.593 . . . . 74.51 110.816 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -142.19 168.19 20.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.757 -0.656 . . . . 73.02 109.88 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 22.0 p -81.62 55.83 2.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.933 -0.576 . . . . 64.14 110.938 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.01 -21.5 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.494 0.664 . . . . 62.3 109.901 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 50.0 mt -77.47 -19.68 55.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.264 -0.88 . . . . 61.41 109.636 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 6.0 m -90.62 -19.43 23.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.667 -0.697 . . . . 70.3 111.503 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -98.8 27.4 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.603 0.716 . . . . 63.33 109.847 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -95.93 -122.94 4.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.575 -0.739 . . . . 74.11 111.971 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 61.5 mt -112.34 104.27 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.205 0.526 . . . . 62.24 110.606 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 33' ' ' PRO . 93.6 t -91.64 105.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.396 -0.82 . . . . 74.34 109.077 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.27 179.38 8.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.135 0.493 . . . . 73.43 111.344 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 166.52 10.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.851 -0.613 . . . . 74.2 109.9 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -126.37 77.35 1.69 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.22 -0.659 . . . . 64.2 109.22 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 68.02 -59.78 0.42 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.441 -0.8 . . . . 74.11 111.77 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -117.84 -57.77 2.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.217 -0.447 . . . . 61.53 111.458 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.626 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.3 t0 -90.61 179.01 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 62.01 110.989 -173.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.66 123.19 43.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 52.4 110.742 -173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.626 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 46.4 m95 -137.83 128.26 26.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 73.31 110.893 -173.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.453 HG21 ' HE2' ' A' ' 31' ' ' PHE . 10.6 p -94.95 127.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.603 . . . . 55.3 110.029 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -97.41 120.04 37.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.908 -0.587 . . . . 62.1 110.918 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 41.1 t -64.55 141.32 98.22 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 53.45 110.391 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.512 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 61.1 Cg_endo -78.11 -41.18 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.163 1.909 . . . . 35.11 111.706 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -76.99 -69.09 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.601 -0.727 . . . . 73.1 110.986 -178.063 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.72 ' HD2' ' HB3' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -80.95 -19.11 44.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.36 -0.382 . . . . 73.43 111.181 -175.196 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.6 mttp 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.82 -0.627 . . . . 73.31 112.594 176.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -78.3 143.31 37.1 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 73.33 109.477 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -100.62 115.36 30.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.307 -0.406 . . . . 62.35 110.328 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 68' ' ' VAL . 70.3 m-85 -106.12 124.75 50.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.114 -0.328 . . . . 64.14 110.114 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 42.9 ttp180 -72.97 121.99 20.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.821 0.343 . . . . 75.22 110.436 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 99.0 mt -76.39 78.0 3.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 74.13 110.263 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -174.56 -63.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 65.54 109.752 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -111.81 -23.08 10.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.736 -0.665 . . . . 73.04 111.046 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 19.29 27.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.742 . . . . 72.34 112.391 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.77 134.22 48.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.603 0.24 . . . . 74.41 110.539 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 46.0 m -88.31 26.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.157 0.428 . . . . 72.15 112.157 -174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.2 tp 63.2 -79.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 73.2 112.308 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -126.93 -7.27 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.039 0.447 . . . . 75.52 110.56 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.59 -176.52 3.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.153 -0.684 . . . . 63.32 109.153 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 22.54 0.15 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.789 -0.719 . . . . 64.43 112.169 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -58.06 6.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.077 0.465 . . . . 60.03 110.799 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -130.61 92.38 3.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.471 . . . . 73.2 110.729 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.4 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 20.4 m -74.44 130.13 39.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.587 . . . . 54.41 109.414 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' SER . 32.4 m -95.88 -176.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.509 -0.314 . . . . 60.23 111.291 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -129.63 179.55 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 72.2 110.728 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.77 124.63 15.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.0 0.429 . . . . 75.23 110.664 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -89.51 169.6 11.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.651 -0.704 . . . . 74.54 109.704 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -99.73 138.53 36.68 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.474 -0.565 . . . . 74.4 109.474 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.906 HG22 HG22 ' A' ' 106' ' ' ILE . 44.6 p -127.24 156.38 41.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.303 -0.408 . . . . 55.22 111.104 -173.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.446 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 11.0 pt20 -155.44 140.77 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.169 0.509 . . . . 65.44 110.851 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.654 HG21 HD12 ' A' ' 10' ' ' LEU . 39.8 t -109.29 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.79 -0.819 . . . . 71.12 108.79 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -113.64 -5.04 13.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.47 . . . . 73.14 111.396 -171.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -141.63 25.09 2.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 74.11 110.842 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.28 17.48 Favored Glycine 0 C--O 1.234 0.139 0 C-N-CA 120.843 -0.694 . . . . 52.22 111.544 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 40.5 m-80 -106.56 157.14 17.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.3 -0.63 . . . . 72.24 109.3 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 99' ' ' VAL . 44.8 t -94.76 117.22 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.994 0.426 . . . . 74.34 110.297 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 93.1 mt-30 -102.29 139.08 38.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.529 . . . . 71.54 110.095 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.906 HG22 HG22 ' A' ' 97' ' ' THR . 2.9 pp -114.47 149.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.105 -0.498 . . . . 72.51 110.012 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 8.5 t -85.8 128.0 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.714 -0.476 . . . . 65.4 109.714 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 3' ' ' GLN . 50.2 mm -65.43 105.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.923 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.636 -0.711 . . . . 73.01 110.08 177.936 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.269 0.557 . . . . 71.43 110.293 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -102.4 116.71 33.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 74.42 109.772 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 m -98.91 131.78 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.073 0.463 . . . . 74.4 111.226 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.781 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 5.2 m -67.47 119.42 12.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.478 -0.783 . . . . 75.32 111.036 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 t -95.53 -84.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.52 110.46 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.1 m -142.25 161.15 38.75 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.979 -0.378 . . . . 74.45 109.979 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 89.8 mttt -65.6 145.15 56.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.047 -0.353 . . . . 70.02 110.047 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 37' ' ' GLU . 10.4 tt -65.57 -28.19 68.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.532 0.682 . . . . 75.12 109.565 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.85 -25.44 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.277 -0.874 . . . . 74.32 110.848 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 26.6 t0 -72.67 -15.94 61.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 53.34 109.817 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.4 mt -96.02 133.57 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.463 -0.79 . . . . 51.45 109.983 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.92 150.35 88.17 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.988 0.423 . . . . 62.22 111.784 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.97 123.68 11.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.69 2.26 . . . . 72.54 111.803 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.51 11.35 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.64 -0.709 . . . . 44.13 112.484 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -136.3 179.44 6.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.387 0.594 . . . . 63.33 111.023 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -175.42 101.42 0.16 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.069 -0.812 . . . . 45.14 111.069 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.465 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -117.63 150.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.21 0.448 . . . . 74.4 112.21 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.686 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.0 p -78.6 128.68 33.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.73 -0.668 . . . . 74.42 111.65 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.05 137.42 50.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.417 -0.586 . . . . 72.33 109.417 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -83.71 107.65 16.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.565 -0.531 . . . . 72.24 109.565 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.99 92.48 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.094 -0.503 . . . . 71.11 110.084 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 65.45 -75.06 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.271 -0.877 . . . . 75.41 113.113 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.68 10.58 3.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.194 0.442 . . . . 73.33 112.194 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -142.24 144.22 33.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.937 0.399 . . . . 73.43 111.314 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.493 ' HB2' HG13 ' A' ' 45' ' ' ILE . 52.3 mt-30 -95.48 120.16 35.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.269 -0.641 . . . . 75.55 109.269 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.85 120.83 62.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 110.056 -0.349 . . . . 65.54 110.056 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.0 123.71 34.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.602 . . . . 64.35 109.373 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 15.0 t -107.87 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.952 0.406 . . . . 73.1 111.043 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.1 m-85 -77.34 136.17 38.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.567 -0.742 . . . . 72.12 110.726 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -127.77 73.99 78.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.131 -0.692 . . . . 72.52 109.131 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.53 -36.72 52.32 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.017 2.478 . . . . 71.13 112.215 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -111.92 149.77 31.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.56 -0.746 . . . . 71.4 109.807 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -81.26 56.8 2.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.311 1.053 . . . . 71.44 109.231 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -136.92 -176.1 4.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.564 -1.198 . . . . 44.21 108.448 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 10' ' ' LEU . 35.7 mt-10 -82.76 47.6 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.622 0.725 . . . . 63.53 110.274 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -126.7 99.04 5.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.107 -0.952 . . . . 71.24 109.413 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.56 162.19 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 63.13 111.078 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 99.7 m-85 -134.31 102.07 5.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.965 -0.562 . . . . 75.03 110.3 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.68 96.97 6.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.879 0.371 . . . . 70.51 111.045 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 pt -131.18 175.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.924 -0.58 . . . . 71.41 110.15 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.2 m -80.63 56.62 2.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.175 0.512 . . . . 64.03 110.793 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.592 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 20.2 t-20 -87.05 71.5 10.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.72 0.771 . . . . 73.5 109.675 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 20' ' ' CYS . 16.8 mm -124.55 142.96 39.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 61.32 109.992 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 9.9 t70 -90.55 116.65 66.87 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.022 -0.733 . . . . 63.42 109.022 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.19 -16.9 53.76 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 123.121 2.547 . . . . 75.14 113.108 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -101.36 -3.41 28.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.003 0.43 . . . . 73.34 110.509 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -117.96 -24.92 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 43.45 110.897 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 69.11 19.49 7.99 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.727 -0.669 . . . . 65.21 110.601 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -153.1 169.1 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 64.11 109.709 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -84.23 83.87 7.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 71.12 110.791 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -96.97 -10.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.41 0.624 . . . . 74.45 109.787 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 43.6 mt -70.26 -28.52 65.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.315 -0.857 . . . . 70.02 109.608 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 p -88.81 5.86 41.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.06 -0.973 . . . . 33.31 111.841 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.946 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -108.6 15.38 23.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.276 0.56 . . . . 72.03 110.481 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -96.55 -147.61 22.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.717 -0.754 . . . . 73.32 112.299 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.75 118.03 42.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.02 0.438 . . . . 74.04 110.472 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.37 101.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.743 . . . . 42.35 109.531 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.85 109.01 21.42 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.254 -0.884 . . . . 63.34 110.641 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.32 129.01 35.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.305 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -108.1 45.44 1.02 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.581 -0.736 . . . . 64.21 109.523 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 69.29 -67.03 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.131 -0.94 . . . . 71.22 111.117 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.34 -43.9 7.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.177 -0.465 . . . . 60.34 110.965 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.488 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 3.2 t70 -98.52 174.58 6.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.287 . . . . 73.21 110.39 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 79' ' ' LEU . 89.3 mt -132.28 118.7 19.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 71.34 109.883 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.488 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 35.8 m95 -124.14 165.53 17.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.93 0.395 . . . . 73.43 110.585 -175.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.7 p -135.06 132.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.191 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -94.35 106.03 18.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 73.53 109.985 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.6 t -68.85 133.68 90.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.127 -0.488 . . . . 54.02 111.124 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.8 Cg_endo -71.14 -30.02 16.7 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.486 2.124 . . . . 65.41 111.941 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.86 -37.65 14.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.978 -0.555 . . . . 62.21 111.099 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.813 ' HD3' ' HE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -88.41 -28.16 21.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.164 -0.471 . . . . 71.31 111.379 -175.788 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 65.19 22.95 12.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.534 0.521 . . . . 65.12 111.018 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.86 155.81 35.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.29 -0.413 . . . . 73.12 110.712 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 76.6 m80 -95.32 117.0 29.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.667 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -100.78 137.41 39.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.179 -0.464 . . . . 72.34 110.7 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -78.42 123.89 27.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.036 -0.529 . . . . 75.12 110.19 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 84.4 mt -74.31 -30.44 62.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.454 0.538 . . . . 72.23 112.454 -172.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HD1' ' HE1' ' A' ' 40' ' ' TYR . 48.6 t80 -81.73 -19.13 42.06 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.797 -0.361 . . . . 73.43 111.566 -174.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -140.52 -78.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 74.21 111.037 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.36 0.46 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.681 -0.771 . . . . 71.44 112.123 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -55.37 108.32 0.41 Allowed 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 109.83 -0.434 . . . . 65.13 109.83 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.2 m -76.16 155.92 34.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.003 0.43 . . . . 43.43 111.418 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 24.7 tp -86.59 -20.45 27.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 70.51 110.001 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -82.97 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.799 -0.637 . . . . 72.12 110.715 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -144.16 160.65 40.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.106 -0.497 . . . . 72.03 109.954 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.13 65.78 3.73 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.971 -0.851 . . . . 62.32 110.971 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.34 -66.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.77 0.285 . . . . 74.03 111.77 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.813 ' HE2' ' HD3' ' A' ' 73' ' ' LYS . 60.1 m-85 -100.04 -28.21 13.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.833 -0.347 . . . . 71.22 111.501 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m 59.73 84.53 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.744 0.653 . . . . 74.34 110.234 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.9 m -79.2 155.83 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 61.11 110.975 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.11 142.79 26.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.008 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.78 97.71 6.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.916 -0.584 . . . . 71.43 110.153 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -81.96 136.43 35.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.987 -0.551 . . . . 75.43 110.042 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -66.44 136.63 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 73.12 109.357 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.577 HG22 HG22 ' A' ' 106' ' ' ILE . 76.0 p -115.52 143.43 45.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 65.33 111.214 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -134.72 137.27 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.617 . . . . 75.35 110.413 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 t -111.03 62.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.037 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -85.12 -29.35 24.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.247 -0.888 . . . . 64.43 111.397 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -103.59 -6.73 21.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.499 0.666 . . . . 54.54 110.835 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.02 -33.14 6.36 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.692 -1.363 . . . . 63.52 109.692 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 46.7 m-80 -81.39 139.84 35.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.566 -0.901 . . . . 45.22 108.566 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -81.78 123.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.409 -0.589 . . . . 62.12 109.409 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 87.9 mt-30 -117.55 121.1 40.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.656 . . . . 73.33 110.591 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.577 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -96.38 153.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.813 -0.63 . . . . 71.52 111.345 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -81.4 114.74 20.36 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.128 -0.693 . . . . 45.21 109.128 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.69 109.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.344 0.592 . . . . 73.11 111.745 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 108.258 -1.015 . . . . 72.11 108.258 168.626 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.228 0.537 . . . . 71.21 109.818 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.58 139.12 54.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.57 -0.741 . . . . 73.12 110.173 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.646 HG21 HG13 ' A' ' 23' ' ' VAL . 21.1 m -126.15 124.3 40.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.235 -0.439 . . . . 72.34 110.841 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.3 m -67.32 119.57 12.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.286 -0.416 . . . . 74.31 110.394 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 30' ' ' VAL . 61.6 t -68.27 -60.91 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 62.34 109.673 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 13' ' ' ILE . 5.0 p -172.33 -90.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.024 -0.989 . . . . 71.31 109.414 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.84 ' HD2' ' HB2' ' A' ' 12' ' ' ASP . 47.0 mttp -145.08 170.68 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.597 -0.52 . . . . 73.03 109.597 177.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 99' ' ' VAL . 53.8 tp -91.23 -49.96 6.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.203 0.525 . . . . 74.31 110.396 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.44 -30.08 53.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.717 -0.674 . . . . 75.35 110.701 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.84 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 29.3 t0 -72.48 -13.68 61.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.293 -0.867 . . . . 75.44 110.334 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 8' ' ' CYS . 34.7 mm -88.4 117.67 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 74.21 109.803 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.63 123.33 76.39 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 74.23 111.174 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 36.6 Cg_endo -65.54 146.15 84.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.572 2.181 . . . . 54.51 111.874 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.82 30.17 36.43 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.448 -0.661 . . . . 45.3 111.448 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.1 m -147.97 174.16 12.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.738 0.304 . . . . 74.1 110.95 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.42 107.9 0.33 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.706 -0.958 . . . . 75.35 110.706 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.3 m -124.7 153.96 31.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 112.427 0.529 . . . . 65.45 112.427 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.2 p -79.87 118.23 21.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.578 -0.737 . . . . 73.24 111.275 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.14 169.94 9.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 71.45 110.358 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.09 117.54 29.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.236 0.541 . . . . 72.11 110.828 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 26' ' ' GLN . 57.3 t -124.77 154.03 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.385 -0.969 . . . . 73.04 108.385 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -45.68 -48.18 15.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.333 0.864 . . . . 73.52 113.333 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -114.65 -4.68 12.76 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.266 0.839 . . . . 71.32 113.266 -167.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 62.6 tt0 -172.37 143.49 1.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.821 -0.352 . . . . 63.3 110.524 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -75.64 137.45 40.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.28 -0.637 . . . . 73.52 109.28 173.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 20.6 tt -115.8 138.05 47.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.628 0.251 . . . . 61.54 110.502 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -97.43 124.8 41.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 72.2 110.281 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.625 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 38.9 t -106.19 99.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.974 0.416 . . . . 74.32 110.949 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.806 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 57.6 m-85 -75.21 113.83 13.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 52.34 110.75 176.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -118.59 82.69 20.19 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.528 -0.916 . . . . 71.54 108.528 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 59' ' ' VAL . 10.4 Cg_exo -71.11 -31.75 14.24 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 122.72 2.28 . . . . 72.21 112.758 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -121.48 -179.74 4.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.48 -0.327 . . . . 75.13 110.278 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 15' ' ' PRO . 80.8 m-20 -93.24 23.9 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.881 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.77 -174.8 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.381 0.61 . . . . 71.44 111.429 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -98.66 31.64 2.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.308 -0.86 . . . . 71.24 110.712 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.94 153.23 52.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.09 -0.505 . . . . 62.55 111.028 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.82 165.98 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.114 -0.493 . . . . 61.3 110.488 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.806 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.3 m-85 -122.14 92.15 3.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.063 -0.517 . . . . 73.33 110.401 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -94.04 100.48 12.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.982 0.42 . . . . 43.15 110.323 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.71 173.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 72.33 110.795 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 m -78.51 87.08 4.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.08 0.467 . . . . 62.42 109.87 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 25.7 t-20 -133.5 67.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.678 0.751 . . . . 52.44 109.584 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.68 HD12 ' HB3' ' A' ' 20' ' ' CYS . 38.7 mm -118.79 143.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.431 -0.804 . . . . 75.13 109.384 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 48' ' ' PHE . 27.0 t70 -99.36 114.44 65.57 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.327 -0.397 . . . . 53.22 109.941 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.19 -12.99 35.3 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.187 2.591 . . . . 43.05 112.773 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 82.7 t80 -82.82 -22.13 34.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 75.14 110.983 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.7 -13.78 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 72.35 111.426 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 63.62 29.44 15.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.801 -0.636 . . . . 73.01 111.018 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -147.95 170.35 17.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.166 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 12.2 p -83.95 58.83 4.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.249 0.547 . . . . 64.42 110.702 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.482 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 31.2 m -79.73 3.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.704 . . . . 64.2 110.208 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 64.1 mt -104.78 -2.54 24.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.99 -1.004 . . . . 74.14 109.248 174.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.513 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 34.9 t -102.04 -48.7 4.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.648 -0.705 . . . . 71.0 111.362 -174.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -84.17 62.65 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.89 0.852 . . . . 72.41 109.892 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -114.51 -156.06 11.39 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.748 -1.115 . . . . 63.32 111.741 176.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mm -93.9 125.21 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.74 -0.467 . . . . 71.31 109.74 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.4 t -86.48 97.79 6.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.023 -0.535 . . . . 74.1 110.097 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 133.13 51.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.667 -0.697 . . . . 72.35 110.374 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.67 151.24 20.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.116 0.484 . . . . 73.04 110.78 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -134.54 103.77 5.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.008 -0.738 . . . . 64.43 109.008 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 70.38 -61.45 0.46 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.07 0.857 . . . . 75.31 110.532 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -157.19 -23.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 73.52 110.826 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.64 171.56 14.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.98 -0.378 . . . . 74.0 109.98 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.6 mt -127.58 117.78 22.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.054 0.454 . . . . 71.15 110.668 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' A' ' 78' ' ' ARG . 20.7 m95 -111.56 127.35 55.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.508 -0.769 . . . . 73.45 109.655 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 79' ' ' LEU . 8.5 p -92.25 129.19 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.983 0.421 . . . . 71.55 110.496 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -99.28 108.09 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 70.52 110.813 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 29.9 t -56.31 138.34 74.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 64.43 111.407 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 53' ' ' VAL . 60.9 Cg_endo -73.67 -25.6 14.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.566 2.177 . . . . 62.41 112.768 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.94 -49.56 3.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 62.35 111.364 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -19.18 28.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.359 . . . . 64.31 110.903 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 70' ' ' SER . 57.2 tttm 62.62 22.66 13.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.437 0.636 . . . . 74.23 111.278 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.64 ' HG3' ' HB2' ' A' ' 86' ' ' GLU . 8.2 tt0 -95.61 150.8 19.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.857 -0.611 . . . . 75.11 110.387 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.0 m80 -99.32 124.32 44.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.895 -0.593 . . . . 75.12 110.439 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -119.3 134.86 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.317 -0.401 . . . . 60.3 110.793 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 49.1 mmm-85 -63.18 131.52 48.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.691 -0.485 . . . . 73.3 109.691 170.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 68' ' ' VAL . 59.6 mt -70.42 -67.6 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.972 0.36 . . . . 75.23 111.972 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 34.0 p90 -101.08 25.68 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.433 . . . . 74.43 111.546 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.741 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 8.0 t70 -118.27 -67.57 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.106 -0.497 . . . . 53.03 110.454 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 78' ' ' ARG . . . 129.48 -21.69 5.07 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.131 -1.033 . . . . 54.0 113.511 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -74.08 162.97 28.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.331 0.586 . . . . 74.31 111.606 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 90' ' ' TYR . 21.3 m -124.89 153.83 42.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 44.35 109.76 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.94 -68.34 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.705 0.288 . . . . 52.41 110.555 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 30.3 mp0 -64.47 -51.75 61.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 74.01 111.925 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.27 102.08 6.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 73.12 110.99 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -82.48 25.99 4.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.985 -0.626 . . . . 44.52 112.985 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 -14.72 46.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.069 0.462 . . . . 54.45 110.871 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 99.6 m-85 -80.91 -59.72 2.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.987 -0.551 . . . . 75.02 110.859 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 p 45.55 73.72 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.606 0.717 . . . . 74.42 110.742 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.58 157.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 75.24 111.751 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.71 116.38 29.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.506 -0.77 . . . . 63.34 110.825 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.37 86.89 3.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 73.2 110.046 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -71.75 170.27 13.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.822 -0.626 . . . . 72.42 111.202 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -83.48 135.29 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.146 -0.479 . . . . 33.22 110.367 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.996 HG22 HG22 ' A' ' 106' ' ' ILE . 63.9 p -124.82 127.19 46.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.281 -0.872 . . . . 72.15 109.535 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 29.2 pt20 -118.5 139.19 51.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.524 0.678 . . . . 74.23 111.102 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 10' ' ' LEU . 45.4 t -108.6 88.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.027 -0.988 . . . . 73.02 109.133 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -88.31 -23.44 23.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 73.44 110.562 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.452 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 68.8 m-20 -145.71 -154.8 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.802 -0.814 . . . . 72.22 108.802 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 101' ' ' ASN . . . -74.03 -1.34 59.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.835 -0.698 . . . . 72.34 112.288 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 3.8 m-20 -113.61 158.82 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.087 -0.338 . . . . 74.51 110.087 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.57 128.44 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 64.31 111.698 -176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . 18.7 mm-40 -106.19 127.57 53.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.745 -0.661 . . . . 64.42 110.414 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.996 HG22 HG22 ' A' ' 97' ' ' THR . 2.7 pp -115.49 146.47 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.203 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -91.25 125.63 36.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 60.42 110.799 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.6 pt -98.17 102.15 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.968 -0.56 . . . . 64.23 110.224 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 73.43 111.037 -178.621 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.987 0.422 . . . . 73.31 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -67.76 105.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 74.33 109.546 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 p -96.01 146.04 24.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.886 -0.597 . . . . 71.04 110.679 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.1 m -83.61 119.94 25.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.301 -0.409 . . . . 73.11 110.507 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 23' ' ' VAL . 46.6 t -84.91 -83.38 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 65.41 110.314 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.6 m -158.75 174.55 14.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 64.12 109.688 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -75.69 133.77 40.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.656 -0.498 . . . . 65.51 109.656 173.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.5 tp -66.74 -20.41 65.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.04 0.448 . . . . 62.05 110.994 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.1 -29.19 67.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 72.05 110.278 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.5 -25.78 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.545 -0.752 . . . . 72.24 109.8 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.77 107.89 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 72.33 110.147 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 95.3 mt -68.42 145.86 97.52 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.417 . . . . 73.33 111.8 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.1 Cg_exo -64.41 125.98 16.09 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.525 2.15 . . . . 74.21 111.656 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.72 42.86 4.98 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.864 -0.607 . . . . 71.31 112.139 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.8 p -137.95 -179.47 5.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.099 0.476 . . . . 51.25 111.632 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 31' ' ' PHE . . . -166.81 81.19 0.11 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.058 -1.217 . . . . 74.01 110.058 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 35.7 m -111.39 150.68 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.743 0.646 . . . . 63.34 112.743 -169.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.557 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.6 p -70.07 114.42 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.452 -0.795 . . . . 74.22 110.736 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.35 148.38 25.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 74.2 110.384 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -89.31 103.58 16.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 63.03 109.605 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 7' ' ' VAL . 14.5 t -116.24 99.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 71.42 110.269 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 62.72 -85.68 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.649 0.593 . . . . 75.53 111.059 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -130.13 2.66 4.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.148 0.499 . . . . 75.32 109.961 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 14.5 mm100 -105.49 137.13 43.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 73.13 111.478 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -105.07 97.83 7.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 53.22 109.679 171.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.495 HG21 ' HB1' ' A' ' 41' ' ' ALA . 1.7 mp -110.26 135.9 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 74.32 110.541 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.12 114.44 21.77 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.597 -0.52 . . . . 53.41 109.597 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.9 t -99.89 106.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.005 0.431 . . . . 73.43 110.179 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 96.6 m-85 -81.24 127.25 32.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.598 -0.728 . . . . 73.45 110.687 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -118.97 80.39 18.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.54 -0.911 . . . . 53.13 108.54 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 38' ' ' GLN . 92.7 Cg_endo -79.25 -10.72 14.89 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.77 2.313 . . . . 72.4 112.351 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -121.44 163.01 19.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.428 -0.806 . . . . 73.25 110.119 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.31 -15.56 61.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.209 0.528 . . . . 72.34 111.15 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 16.8 t70 -97.42 -156.99 0.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.348 -0.387 . . . . 75.13 110.263 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.497 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 23.7 mt-10 -89.34 13.15 14.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.599 0.36 . . . . 72.21 111.929 -171.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 36' ' ' ASP . 2.5 mp0 -74.31 94.25 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.882 -0.414 . . . . 73.44 109.882 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 27.5 m -113.74 151.92 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.99 -0.55 . . . . 73.21 111.65 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 89.4 m-85 -122.46 99.83 6.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 71.43 109.559 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -97.02 100.79 12.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.952 0.406 . . . . 64.23 110.816 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 92' ' ' VAL . 31.3 pt -132.16 156.08 42.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.894 -0.594 . . . . 64.42 110.195 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 m -76.06 52.24 0.71 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.512 -0.313 . . . . 52.52 111.622 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.17 78.86 6.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.514 0.673 . . . . 75.42 110.072 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -126.75 142.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.17 -0.923 . . . . 74.23 109.67 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 12.7 t70 -80.94 125.83 78.99 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.755 -0.461 . . . . 71.3 109.755 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 24.3 Cg_exo -64.1 -12.58 33.07 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.323 2.682 . . . . 53.43 113.27 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -113.44 15.07 19.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.491 0.186 . . . . 64.22 111.365 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -134.75 -33.94 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.85 0.315 . . . . 43.13 111.85 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 63.41 23.09 13.56 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.312 0.577 . . . . 54.02 110.772 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -139.31 159.32 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.131 -0.941 . . . . 65.23 108.843 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -80.83 65.44 5.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.309 0.576 . . . . 71.21 111.321 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.43 -10.61 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.524 0.678 . . . . 71.14 109.806 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 87.3 mt -86.37 6.2 31.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.968 -1.015 . . . . 70.33 108.989 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.764 ' HA ' HG21 ' A' ' 68' ' ' VAL . 4.5 m -138.94 30.3 2.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.807 -1.088 . . . . 63.22 108.302 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.602 ' HD3' ' HG3' ' A' ' 71' ' ' PRO . 18.7 ttt180 -77.85 61.07 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.421 -0.809 . . . . 75.53 111.284 -170.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.58 -44.95 3.42 Favored Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.654 -1.157 . . . . 75.14 114.311 167.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -69.14 103.36 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.319 0.58 . . . . 73.54 111.293 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.69 118.1 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 115.105 -0.952 . . . . 62.53 109.478 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.56 55.67 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.544 -0.753 . . . . 71.33 111.001 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.73 95.52 4.03 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.63 -0.878 . . . . 71.42 108.63 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' HIS . . . . . 0.704 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 32.1 t60 -84.35 89.01 7.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.985 -0.552 . . . . 75.13 109.548 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.12 -64.17 0.34 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.766 -1.106 . . . . 74.24 112.749 176.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -121.3 -33.17 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.389 0.515 . . . . 73.13 112.389 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -128.78 -172.2 2.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.655 -0.418 . . . . 62.45 111.141 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.53 117.29 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 71.44 110.213 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TRP . . . . . 0.872 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 30.3 m95 -122.48 119.8 32.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.901 -0.59 . . . . 75.01 110.297 -176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 55' ' ' SER . 12.8 p -84.15 149.77 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.282 -0.417 . . . . 72.31 110.143 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 130.68 54.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 61.43 110.526 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 57.3 p -102.76 143.4 26.54 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.291 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HG3' ' HD3' ' A' ' 56' ' ' ARG . 60.3 Cg_endo -73.19 -2.91 12.76 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.442 2.095 . . . . 65.21 112.188 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.81 -55.82 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 73.53 110.928 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.48 -24.75 21.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.438 -0.346 . . . . 73.33 110.638 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 74.35 -31.77 0.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.252 0.834 . . . . 74.44 113.252 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -71.59 168.18 18.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 74.1 111.081 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.872 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 35.5 m80 -96.5 128.5 43.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 75.34 111.385 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 68' ' ' VAL . 54.6 m-85 -98.09 122.66 41.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.389 -0.597 . . . . 75.22 109.389 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -72.69 117.46 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.62 -0.511 . . . . 75.14 109.62 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 68' ' ' VAL . 50.1 mt -61.5 -25.33 67.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 71.42 112.149 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -89.43 -0.52 57.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.639 0.257 . . . . 73.14 111.525 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.05 -65.67 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.54 -0.464 . . . . 64.12 112.011 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 92' ' ' VAL . . . 132.62 -25.79 3.73 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.731 -0.747 . . . . 63.12 112.667 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -55.61 144.03 28.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.508 0.67 . . . . 75.14 111.784 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.8 65.04 1.8 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.0 -1.0 . . . . 73.44 110.89 -171.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 67' ' ' TRP . 35.5 tp 65.53 -87.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.719 -0.673 . . . . 74.41 111.477 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.74 -12.37 17.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 70.4 110.934 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -117.12 176.19 5.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.373 -0.376 . . . . 45.41 110.569 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.5 41.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.908 -0.877 . . . . 72.34 110.908 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.91 -45.8 78.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 53.32 111.22 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.61 80.24 1.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.167 0.508 . . . . 73.24 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -76.65 96.98 4.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.969 -0.559 . . . . 74.42 109.558 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 42' ' ' ILE . 20.0 m -82.82 165.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.719 -0.673 . . . . 64.35 110.782 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.69 125.6 45.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.706 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -94.21 96.57 9.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 61.11 109.783 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -82.91 152.0 25.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.554 -0.748 . . . . 73.24 109.681 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.74 128.75 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.236 0.541 . . . . 65.34 109.73 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.61 HG23 HG12 ' A' ' 106' ' ' ILE . 3.5 m -122.96 158.39 30.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.63 -0.714 . . . . 54.21 109.376 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -156.46 141.76 17.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.225 0.536 . . . . 74.1 110.591 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 104' ' ' VAL . 34.5 t -110.21 105.68 19.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.12 -0.945 . . . . 62.53 108.797 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.2 t -86.6 -76.31 0.36 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.371 -0.377 . . . . 72.42 111.568 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 100' ' ' THR . 4.1 m-20 -120.87 70.46 0.91 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.678 0.275 . . . . 60.43 110.638 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.67 -31.34 2.2 Favored Glycine 0 C--O 1.229 -0.184 0 C-N-CA 120.701 -0.762 . . . . 64.0 112.748 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -89.0 146.86 24.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.957 0.408 . . . . 55.13 110.123 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 99' ' ' VAL . 39.8 t -105.51 133.22 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.798 -0.637 . . . . 73.41 109.918 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -129.32 146.8 51.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.707 0.289 . . . . 72.51 111.072 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 97' ' ' THR . 70.9 mt -121.38 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 73.51 109.81 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.5 p -90.88 112.94 24.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.177 0.513 . . . . 31.22 110.224 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 pt -126.06 155.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.381 -0.372 . . . . 61.04 110.792 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.882 -0.599 . . . . 71.5 109.664 173.973 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.828 0.347 . . . . 74.41 110.626 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.597 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 32.7 t -115.82 -71.35 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 74.43 110.329 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.06 22.02 16.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.681 0.753 . . . . 73.01 110.006 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.597 ' HD1' ' H ' ' A' ' 2' ' ' SER . 71.6 m95 -98.0 112.28 24.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.95 -1.023 . . . . 72.54 110.176 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -99.1 137.88 36.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.174 -0.466 . . . . 73.33 110.719 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -71.13 131.64 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 62.43 110.771 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 106' ' ' ILE . 38.9 t -87.42 -70.52 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.911 -0.403 . . . . 62.12 109.911 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.9 m -154.41 178.54 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 73.4 109.782 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -78.08 144.16 36.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.521 -0.548 . . . . 75.34 109.521 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 71.31 110.724 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.36 -32.93 64.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.464 -0.789 . . . . 63.11 111.157 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.49 -16.76 63.52 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.265 -0.425 . . . . 72.24 110.497 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 mm -89.69 112.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.806 -0.442 . . . . 70.11 109.806 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.12 133.67 91.66 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.489 . . . . 74.34 111.14 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.72 133.36 57.62 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.815 2.343 . . . . 74.04 112.169 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.09 28.0 51.0 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.654 -0.703 . . . . 63.23 111.766 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -150.24 177.08 10.27 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 121.014 -0.274 . . . . 74.22 110.619 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 17' ' ' THR . . . 174.22 130.04 1.24 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.008 -0.615 . . . . 74.3 112.197 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.721 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 27.1 m -125.03 162.35 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.717 0.259 . . . . 72.32 110.975 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 14.7 p -87.5 144.56 26.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.171 0.51 . . . . 63.4 111.307 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 148.32 50.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.587 -0.733 . . . . 74.11 109.546 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.28 94.59 4.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.708 -0.849 . . . . 64.33 108.708 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 106' ' ' ILE . 44.9 t -95.11 94.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 70.21 110.438 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.0 mm-40 64.19 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.243 -0.89 . . . . 54.52 112.28 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -120.26 -21.31 7.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 70.24 111.542 -176.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -127.41 146.38 50.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.557 0.217 . . . . 72.24 111.263 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.72 130.0 35.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 72.41 110.135 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.0 mt -127.74 133.3 67.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 62.24 110.331 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -103.78 140.83 37.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.118 -0.492 . . . . 70.15 109.741 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 101.58 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.87 -0.332 . . . . 74.02 111.534 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.811 ' HZ ' HD22 ' A' ' 44' ' ' ASN . 79.8 m-85 -73.43 118.06 15.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 74.34 110.018 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HG3' HG12 ' A' ' 39' ' ' VAL . 59.2 ttt180 -111.54 103.53 55.16 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 120.072 -0.651 . . . . 74.34 110.244 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.38 -55.08 0.17 Allowed 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.731 2.288 . . . . 74.25 112.233 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -122.97 -174.95 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.33 110.466 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -79.18 12.66 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.483 0.659 . . . . 73.52 110.463 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.1 178.62 6.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 71.41 109.425 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.66 -22.78 19.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.362 -0.381 . . . . 72.43 110.229 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -72.69 99.0 2.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 73.12 110.823 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' ARG . 28.3 m -114.99 178.92 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.324 -0.853 . . . . 61.43 110.097 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.669 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 98.0 m-85 -126.01 101.23 6.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.807 0.337 . . . . 65.43 110.495 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.81 96.51 6.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.087 -0.506 . . . . 70.34 110.412 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.34 171.7 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.069 -0.514 . . . . 61.44 110.562 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.555 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 69.3 m -88.62 87.22 7.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.821 0.343 . . . . 54.21 110.209 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.811 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 53.2 t30 -124.37 82.43 2.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.408 0.623 . . . . 61.44 109.885 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.11 141.57 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.423 -0.808 . . . . 62.01 109.962 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t70 -93.39 123.99 58.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.503 -0.555 . . . . 61.42 109.503 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 23.3 Cg_exo -64.37 -10.22 23.1 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.055 2.503 . . . . 63.51 113.488 -175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -95.08 -13.06 25.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 61.33 110.717 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.57 -26.45 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.703 0.261 . . . . 74.41 111.703 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 68.39 12.63 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.773 0.671 . . . . 52.31 111.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.635 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -133.23 177.01 8.0 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.137 -0.483 . . . . 71.0 110.696 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.721 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 27.0 p -81.62 47.69 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.6 -0.727 . . . . 35.24 111.594 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.22 -21.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.282 0.563 . . . . 73.03 109.899 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 91.0 mt -82.46 -9.15 59.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.149 -0.932 . . . . 72.32 110.116 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 14.2 m -102.62 -18.93 15.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.816 -0.629 . . . . 71.4 110.742 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -94.32 19.88 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.332 0.587 . . . . 44.0 109.967 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.99 -151.43 9.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.635 -0.712 . . . . 74.34 112.047 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 4.0 mp -90.4 103.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.213 0.53 . . . . 61.33 110.285 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -88.08 104.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.32 -0.855 . . . . 62.04 109.411 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.38 175.15 11.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.807 -0.633 . . . . 72.01 111.036 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.35 119.43 28.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.011 -0.541 . . . . 71.33 110.227 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 71.2 t60 -86.11 -33.42 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.989 0.423 . . . . 73.24 110.476 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -150.89 -65.09 0.19 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.261 0.553 . . . . 51.14 109.969 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.29 -22.84 1.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 74.22 110.917 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.68 -174.59 2.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.96 -0.563 . . . . 63.43 110.257 -171.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.4 mt -94.09 120.09 33.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.439 . . . . 71.43 110.409 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 19.7 m95 -121.95 153.39 38.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.842 -0.617 . . . . 75.21 109.893 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 9.8 p -114.3 122.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.455 0.645 . . . . 73.44 110.078 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.52 114.37 22.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.74 -0.664 . . . . 71.34 109.976 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.521 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 48.2 t -63.48 128.03 92.05 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.099 -0.501 . . . . 33.53 110.541 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.74 -31.41 32.41 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.585 2.19 . . . . 62.54 112.221 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.86 -56.3 2.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 53.21 111.179 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -84.1 -19.88 33.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.382 -0.372 . . . . 64.12 111.449 -173.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 70' ' ' SER . 0.3 OUTLIER 72.73 -23.01 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.547 0.943 . . . . 75.42 113.547 172.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.648 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 28.1 mm-40 -50.04 145.88 5.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.619 0.247 . . . . 75.21 110.991 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 19.0 m170 -100.18 105.66 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 74.13 110.848 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 52.3 m-85 -89.55 122.29 32.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.238 -0.437 . . . . 72.54 110.215 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 29.3 ttp180 -76.42 122.23 24.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.018 -1.104 . . . . 75.15 108.018 171.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.41 -49.81 60.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.682 0.993 . . . . 73.21 113.682 -165.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.533 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 58.1 t80 -89.32 -2.61 58.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 74.21 111.208 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HB2' ' HE ' ' A' ' 78' ' ' ARG . 10.5 t70 -103.16 -60.86 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.861 -0.336 . . . . 64.13 110.696 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.68 -19.76 28.05 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.504 -0.855 . . . . 70.11 113.527 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.93 157.48 33.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.421 0.61 . . . . 73.53 110.36 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 10.8 m -108.65 94.67 5.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.248 0.462 . . . . 74.21 112.248 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp 62.23 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.514 0.726 . . . . 74.25 112.39 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 -55.8 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.967 -0.383 . . . . 72.31 109.967 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.34 113.74 26.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 74.44 110.618 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.11 69.45 3.37 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.722 -0.672 . . . . 73.34 112.914 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.43 7.36 45.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.464 . . . . 63.42 110.852 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -153.33 29.7 0.49 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 72.42 109.928 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 m -63.97 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.619 -0.719 . . . . 44.54 111.292 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.5 m -103.6 -178.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 74.43 111.246 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -101.2 130.87 47.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 50.32 111.165 -177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.02 105.29 11.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.092 -0.504 . . . . 71.22 110.524 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -94.86 158.27 15.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.677 -0.692 . . . . 73.21 109.987 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -82.94 151.22 26.01 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.797 0.332 . . . . 75.2 110.788 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 1.015 HG22 HG22 ' A' ' 106' ' ' ILE . 28.6 p -134.07 151.23 51.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 65.22 111.256 -172.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -135.64 157.97 45.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.04 -0.355 . . . . 74.2 110.04 173.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.89 108.51 25.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.963 -0.384 . . . . 70.24 109.963 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.7 t -74.6 -75.98 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 71.52 111.294 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.798 ' H ' HG23 ' A' ' 100' ' ' THR . 53.3 m-80 -144.32 87.79 1.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.859 -0.423 . . . . 71.54 109.859 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.51 -1.1 45.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.046 -0.597 . . . . 73.24 112.907 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.0 140.86 52.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.873 -0.417 . . . . 44.12 109.873 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.88 133.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.327 -0.397 . . . . 72.52 110.716 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.38 151.59 42.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 55.02 110.053 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.015 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -122.29 155.44 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.66 0.267 . . . . 61.33 110.291 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -83.42 101.44 11.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.822 -0.807 . . . . 62.11 108.822 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . 24.6 pt -79.34 86.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.816 0.817 . . . . 64.33 112.471 -173.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.67 93.76 6.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.582 -0.895 . . . . 53.54 108.582 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.29 122.86 17.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.374 0.607 . . . . 72.33 111.147 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.4 m -104.79 -54.46 2.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.411 -0.813 . . . . 62.33 110.643 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -136.42 108.57 7.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.22 -0.445 . . . . 73.42 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -104.82 128.7 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.09 -0.505 . . . . 54.22 110.728 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -116.78 165.87 12.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.061 -0.518 . . . . 71.31 110.721 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 147.89 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.3 -0.409 . . . . 62.34 110.379 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.92 147.48 53.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 74.12 110.664 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 119' ' ' GLN . 9.8 p30 -85.13 148.86 25.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 75.15 110.962 -173.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.4 t -107.04 74.72 0.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.162 -0.681 . . . . 43.42 109.162 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.445 ' HB2' ' OD1' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -98.13 143.71 26.76 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.229 -0.896 . . . . 74.12 110.22 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 23.3 Cg_exo -63.78 121.89 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.265 1.977 . . . . 71.54 111.147 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 162.06 42.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 65.55 111.113 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.96 125.11 12.49 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.096 2.531 . . . . 70.53 112.577 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 tp -97.0 129.94 44.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.672 -0.695 . . . . 75.35 110.138 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -70.01 135.18 49.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 63.42 111.132 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -85.01 97.63 9.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.936 -0.575 . . . . 75.3 109.701 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -70.12 127.96 34.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 65.23 110.339 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -56.04 130.04 42.36 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.45 -0.795 . . . . 55.32 111.908 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -98.76 119.86 38.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.59 -0.732 . . . . 72.24 109.316 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 70.15 148.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 72.12 111.244 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.39 -0.814 . . . . 71.32 109.561 174.04 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.818 ' HA ' ' HD1' ' A' ' 4' ' ' TRP . 75.8 mtp . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.104 0.478 . . . . 75.05 111.152 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.3 t -102.14 -51.87 3.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 74.04 109.752 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -109.39 22.56 15.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.073 -0.512 . . . . 74.22 111.122 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.818 ' HD1' ' HA ' ' A' ' 1' ' ' MET . 96.5 m95 -94.88 116.15 28.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 71.14 110.277 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.0 m -105.13 129.05 53.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.318 -0.401 . . . . 74.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.809 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.5 m -70.33 115.16 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 53.2 110.423 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.36 -77.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 53.11 110.747 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -146.59 172.91 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.502 . . . . 70.3 110.059 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -84.12 141.99 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 74.12 110.004 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.641 HD12 ' HB ' ' A' ' 13' ' ' ILE . 50.5 tp -70.69 -21.53 62.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 64.15 110.841 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.95 -34.39 76.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 63.32 110.733 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.63 -12.35 42.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 72.51 110.268 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.641 ' HB ' HD12 ' A' ' 10' ' ' LEU . 65.5 mt -82.11 111.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 71.2 110.164 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.642 ' H ' HD12 ' A' ' 14' ' ' LEU . 5.6 mp -56.42 130.12 75.71 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.675 -0.693 . . . . 73.31 112.11 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 17.1 Cg_exo -67.59 121.43 8.51 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.72 2.28 . . . . 73.33 111.381 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 35.87 5.09 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.917 -0.659 . . . . 75.22 112.462 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -136.14 -171.25 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.167 0.484 . . . . 72.0 111.328 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 168.94 96.13 0.1 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.154 -0.545 . . . . 43.11 111.887 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -133.98 165.92 30.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.52 0.16 . . . . 73.41 110.969 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.6 p -80.02 120.09 23.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.917 0.389 . . . . 74.41 111.421 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -91.35 150.87 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.402 -0.592 . . . . 72.02 109.402 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.77 107.44 19.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.992 0.425 . . . . 65.4 110.532 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 106' ' ' ILE . 46.4 t -113.5 113.78 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.314 -0.624 . . . . 74.32 109.314 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 27.5 mm-40 65.81 -85.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.677 0.611 . . . . 71.11 109.753 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -154.0 18.81 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.624 0.726 . . . . 73.2 109.302 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.82 128.87 47.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.864 -1.062 . . . . 74.25 109.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 48.9 mt-30 -101.46 130.32 47.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.189 0.519 . . . . 34.51 111.243 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.426 ' O ' HD12 ' A' ' 28' ' ' ILE . 1.2 pp -127.63 129.85 70.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.599 . . . . 72.32 110.313 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -85.73 113.7 22.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.55 . . . . 74.31 109.916 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 37.9 t -97.16 98.29 7.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.228 0.537 . . . . 73.0 110.27 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 69.9 m-85 -81.6 126.5 31.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.185 -0.916 . . . . 72.21 110.59 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 10' ' ' LEU . 77.1 ttt180 -120.04 78.51 24.81 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.8 -0.815 . . . . 74.54 108.8 170.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.6 Cg_exo -76.85 -20.03 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.98 2.454 . . . . 73.3 112.165 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -104.22 153.7 20.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.567 -0.742 . . . . 52.33 109.641 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.19 5.74 9.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.551 0.691 . . . . 63.43 109.727 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 13.6 t70 -89.56 -159.9 0.63 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.038 -0.983 . . . . 72.23 108.88 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.6 ' HA ' HD21 ' A' ' 10' ' ' LEU . 28.2 mt-10 -108.36 2.53 22.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 71.22 111.329 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -75.34 103.04 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.33 110.0 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.4 164.04 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.01 -0.541 . . . . 71.22 111.327 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 96.5 m-85 -135.61 101.94 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.693 -0.685 . . . . 65.05 110.278 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -100.38 95.24 6.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.107 0.48 . . . . 74.34 110.872 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -115.24 164.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.973 -0.558 . . . . 74.33 110.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 33.2 m -81.67 66.92 7.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.129 0.49 . . . . 74.1 110.629 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.645 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 38.1 t-20 -92.23 92.03 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.897 -0.779 . . . . 33.24 108.897 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.581 HD11 ' O ' ' A' ' 27' ' ' GLN . 14.5 mt -137.55 144.8 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 64.3 110.158 -174.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' HG22 ' A' ' 53' ' ' VAL . 2.4 p-10 -88.96 140.07 29.13 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.948 -0.76 . . . . 63.31 108.948 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 1.2 Cg_endo -83.91 15.13 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.477 2.118 . . . . 73.1 112.942 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -101.37 -56.54 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.729 0.3 . . . . 71.32 110.54 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -120.49 -2.23 10.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.287 -0.415 . . . . 75.24 110.643 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 19.5 mm-40 62.99 72.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.558 -0.747 . . . . 73.32 111.94 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.685 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -152.25 173.01 15.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.39 -0.823 . . . . 63.12 109.227 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -92.58 66.55 4.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.329 0.585 . . . . 73.11 109.903 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 46' ' ' ASP . 32.8 m -85.5 -10.57 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 63.22 110.273 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 90.0 mt -86.56 9.62 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.619 -0.719 . . . . 72.43 109.766 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 40.7 t -84.37 -63.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.347 -0.842 . . . . 33.33 110.11 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.565 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 58.8 ttt180 70.47 -11.67 0.59 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.185 0.594 . . . . 72.24 111.15 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' SER . . . 77.41 5.5 85.75 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.319 -0.467 . . . . 62.45 112.244 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.47 105.72 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.613 0.72 . . . . 65.31 110.688 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 33' ' ' PRO . 96.7 t -99.3 101.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.702 -1.135 . . . . 71.53 109.757 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.95 156.98 17.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.515 . . . . 62.45 110.436 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.14 127.04 40.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.015 -0.539 . . . . 71.32 110.053 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.6 -46.05 17.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.583 -0.895 . . . . 72.23 108.583 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 177.62 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.658 -1.155 . . . . 73.45 108.497 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.87 -15.14 16.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.478 -0.783 . . . . 74.4 109.898 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -109.99 149.67 29.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.649 -0.705 . . . . 73.22 110.034 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.16 131.02 57.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 73.22 110.329 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.845 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 35.7 m95 -127.74 119.12 25.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.398 -0.365 . . . . 64.13 110.791 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -73.89 138.39 21.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.656 -0.498 . . . . 62.44 109.656 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.09 109.67 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 73.42 111.123 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 m -72.85 154.02 91.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 61.34 111.239 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 56' ' ' ARG . 69.6 Cg_endo -74.46 -6.0 17.69 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.044 2.496 . . . . 54.21 113.626 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.09 -75.63 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.804 0.335 . . . . 72.11 111.163 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.62 24.61 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.455 -0.339 . . . . 75.3 110.254 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 55.24 34.65 23.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.03 0.919 . . . . 75.23 109.908 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.745 ' HG3' ' HE1' ' A' ' 77' ' ' PHE . 3.8 pt20 -81.29 141.13 34.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.592 -1.185 . . . . 74.24 110.693 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.845 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 61.6 m80 -93.13 121.55 34.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.478 -0.783 . . . . 71.5 110.42 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.745 ' HE1' ' HG3' ' A' ' 75' ' ' GLN . 7.3 m-85 -96.11 -16.83 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.478 0.547 . . . . 72.04 112.478 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 67' ' ' TRP . 5.7 ttt180 72.32 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.527 0.68 . . . . 70.33 111.18 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' A' ' 68' ' ' VAL . 97.4 mt -96.48 5.81 50.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 73.13 112.168 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.89 -26.6 19.26 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.635 -0.426 . . . . 63.33 111.13 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.36 -69.35 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.306 . . . . 63.32 111.382 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 92' ' ' VAL . . . 159.29 12.31 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.915 -0.66 . . . . 51.4 112.621 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -82.1 96.26 7.73 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.546 -0.539 . . . . 73.5 109.546 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 87' ' ' ASP . 6.8 m -79.95 161.38 25.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.273 -0.876 . . . . 70.43 111.504 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.5 tp -90.14 -66.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.999 -0.546 . . . . 74.11 110.424 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -86.36 -1.06 57.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.401 -0.363 . . . . 62.21 111.215 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 7.7 t70 -114.1 132.85 55.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 41.41 111.401 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.21 15.14 3.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.684 -0.966 . . . . 72.44 110.684 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -112.11 -37.38 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.598 0.237 . . . . 74.32 111.231 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -89.13 -71.72 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.51 -0.314 . . . . 74.42 110.555 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.0 m 60.14 99.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.685 0.616 . . . . 65.55 111.805 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 27.2 m -77.54 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 73.31 111.254 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -118.54 178.93 4.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.093 -0.503 . . . . 71.3 110.188 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.01 118.04 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.799 0.333 . . . . 72.03 110.965 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -101.0 153.54 19.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.64 -0.709 . . . . 72.41 110.442 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.09 139.31 54.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.087 0.47 . . . . 73.22 110.973 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 41' ' ' ALA . 2.9 m -134.4 158.85 42.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.566 -0.743 . . . . 70.24 109.324 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 12.6 pt20 -155.91 146.1 21.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.03 0.443 . . . . 74.4 110.422 174.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.0 102.06 13.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 72.24 110.126 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.2 m -82.11 85.06 6.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.349 -0.611 . . . . 63.14 109.349 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 72.45 -66.89 0.29 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.983 -1.008 . . . . 73.01 111.298 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.32 3.9 1.96 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.915 -0.659 . . . . 71.04 112.085 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -103.17 118.19 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.493 0.187 . . . . 62.44 110.715 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.68 115.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.829 -0.434 . . . . 71.22 109.829 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.809 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 96.2 mt-30 -123.09 134.79 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 73.42 111.113 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 23' ' ' VAL . 2.9 pp -117.7 167.18 11.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.851 -0.613 . . . . 73.54 110.665 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.0 m -101.58 125.27 48.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.296 -0.411 . . . . 73.21 110.447 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.17 107.02 19.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.293 0.568 . . . . 75.11 111.543 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.96 89.04 2.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.143 -0.48 . . . . 35.42 111.067 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -159.29 142.33 14.33 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.438 -0.578 . . . . 75.43 109.438 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.5 m -94.34 -10.59 32.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.157 -0.474 . . . . 53.33 111.34 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.58 93.3 9.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 61.2 110.207 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.23 123.77 61.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.616 . . . . 73.13 110.546 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.09 22.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 61.43 110.575 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.14 135.18 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 75.4 110.381 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -137.75 151.41 48.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.34 110.755 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -147.81 31.06 0.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.065 -0.516 . . . . 73.33 109.967 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 t -58.63 -53.66 55.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.781 -0.645 . . . . 41.31 111.601 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.48 165.02 33.0 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 121.115 -0.234 . . . . 75.35 110.765 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.1 137.57 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.169 1.913 . . . . 50.03 110.852 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.47 151.36 97.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 42.4 110.323 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.0 135.8 23.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.834 2.356 . . . . 63.42 111.972 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.03 97.81 3.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.111 0.481 . . . . 62.44 110.642 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -101.57 125.44 48.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.933 -0.576 . . . . 74.35 110.129 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -130.18 36.27 4.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.152 0.501 . . . . 73.13 109.658 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -61.84 106.91 0.75 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.456 -0.793 . . . . 73.22 110.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -152.99 102.32 2.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 70.42 109.704 -176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.55 147.87 26.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.974 -0.557 . . . . 71.32 111.799 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -103.32 -17.04 15.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.081 -1.081 . . . . 60.45 108.081 165.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 64.33 109.02 174.72 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' ' HZ2' ' A' ' 4' ' ' TRP . 65.2 mtt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 45.11 109.934 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -122.34 -177.25 3.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.352 -0.386 . . . . 60.1 111.092 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 107' ' ' SER . 52.4 mt-30 64.36 71.53 0.47 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.614 -0.721 . . . . 70.41 111.039 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.51 ' HZ2' ' HB3' ' A' ' 1' ' ' MET . 83.0 m95 -116.95 121.84 42.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.507 -0.769 . . . . 72.35 109.777 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 m -103.15 134.24 46.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.245 -0.434 . . . . 61.24 109.861 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -79.53 116.78 19.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 75.22 110.3 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.44 -65.62 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.434 . . . . 34.2 110.282 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -176.68 -166.37 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.648 -0.706 . . . . 74.24 109.15 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HE2' ' HB3' ' A' ' 11' ' ' ASP . 50.2 mtpt -67.48 151.45 47.35 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.211 0.319 . . . . 75.21 111.294 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.38 -17.26 63.66 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.777 -0.824 . . . . 74.23 108.777 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.597 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 4.9 t70 -93.84 -24.28 17.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.562 -1.199 . . . . 74.24 111.014 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 25.3 t70 -84.17 -26.27 28.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.912 -0.586 . . . . 71.13 110.391 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.497 HD13 HG11 ' A' ' 30' ' ' VAL . 61.3 mt -82.25 111.64 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.839 -0.619 . . . . 72.14 109.467 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.49 145.87 99.02 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 54.24 112.31 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HB3' ' OD1' ' A' ' 35' ' ' ASN . 72.5 Cg_endo -77.4 153.15 30.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.878 2.385 . . . . 75.24 112.571 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 62.72 28.58 71.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.81 -0.632 . . . . 71.24 113.052 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 34.4 p -143.31 -177.27 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.047 0.424 . . . . 74.24 110.817 -176.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.99 104.72 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.55 -1.02 . . . . 62.35 110.55 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 31.3 m -105.27 142.14 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.488 . . . . 64.23 112.319 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.821 ' HB3' HD12 ' A' ' 45' ' ' ILE . 3.8 p -75.51 117.13 16.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.555 . . . . 64.54 110.812 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.32 143.27 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.063 -0.517 . . . . 72.32 110.429 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 25' ' ' GLN . 7.0 tt -84.93 92.71 8.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 64.33 108.964 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.68 131.09 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.309 -0.86 . . . . 73.44 109.267 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.16 16.73 10.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.895 0.855 . . . . 62.52 110.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.473 ' HA ' HD21 ' A' ' 22' ' ' LEU . 83.9 mm-40 76.3 25.91 0.97 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.258 -1.792 . . . . 74.23 111.054 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -136.19 167.21 21.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 75.51 109.849 177.054 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 45' ' ' ILE . 24.4 mm-40 -91.87 119.35 31.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.047 0.451 . . . . 54.12 111.147 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.1 mt -135.46 129.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.725 -0.67 . . . . 72.33 109.869 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.98 134.46 34.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.496 -0.32 . . . . 63.25 110.335 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 40.4 t -110.14 111.32 35.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.986 0.422 . . . . 53.53 110.512 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 8.8 m-85 -91.74 146.95 23.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.583 -0.735 . . . . 75.51 111.386 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 46.9 mtp85 -140.66 55.07 5.39 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.045 -0.525 . . . . 74.43 111.666 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HG2' HD13 ' A' ' 79' ' ' LEU . 23.5 Cg_exo -63.45 -46.38 9.66 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.914 2.41 . . . . 74.55 113.077 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.31 -29.67 67.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.599 -0.273 . . . . 63.23 111.623 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 62.5 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.41 0.624 . . . . 73.2 110.029 -170.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -177.9 -127.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.421 -0.955 . . . . 74.34 108.421 -174.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -104.74 -9.02 18.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.929 0.395 . . . . 71.52 110.105 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -71.04 103.43 2.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.032 -0.531 . . . . 72.42 110.966 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 m -113.74 142.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.02 109.402 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.832 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 74.1 m-85 -128.6 104.32 7.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.948 -0.301 . . . . 70.23 110.637 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.69 103.85 13.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 74.3 110.898 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.829 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.4 pt -134.9 154.16 36.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.005 -0.543 . . . . 54.33 110.056 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.4 m -77.95 55.13 1.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.262 0.553 . . . . 62.44 111.18 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -91.29 68.88 5.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.865 -0.791 . . . . 53.24 108.865 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 20' ' ' CYS . 25.7 mm -122.89 138.06 54.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 72.14 110.619 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.25 130.5 94.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.975 -0.557 . . . . 71.0 110.886 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -87.63 13.13 2.71 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.0 2.467 . . . . 74.42 113.284 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -101.46 -54.85 2.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.591 0.234 . . . . 64.04 110.912 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.15 -0.66 11.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.062 0.458 . . . . 53.44 110.813 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 61.69 74.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.231 -0.895 . . . . 64.22 111.443 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.7 151.87 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.693 -0.685 . . . . 75.23 109.651 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 p -83.07 83.09 7.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.286 0.565 . . . . 74.42 110.737 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 26.9 m -101.5 8.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.469 0.652 . . . . 73.31 109.813 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.87 13.81 24.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.204 -0.907 . . . . 75.32 109.669 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 p -112.17 -64.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.613 -0.721 . . . . 73.11 111.659 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ptt85 -81.32 51.06 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.005 -0.543 . . . . 74.3 111.208 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -112.06 -110.55 3.1 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.78 -0.724 . . . . 64.34 112.253 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 62.2 mt -110.84 114.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.059 0.457 . . . . 74.31 110.346 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.54 110.87 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.748 -0.66 . . . . 51.51 109.454 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.89 116.8 32.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.559 -0.746 . . . . 51.14 111.085 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.89 121.21 38.5 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.361 -0.607 . . . . 61.45 109.361 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.15 76.68 1.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 72.5 109.189 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 66.01 -75.21 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.488 -0.778 . . . . 72.54 111.51 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -121.93 -22.75 5.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.128 0.49 . . . . 72.32 110.37 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 19.2 t0 -84.69 148.84 26.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 72.51 110.147 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 79' ' ' LEU . 68.1 mt -117.34 115.34 25.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.279 0.561 . . . . 65.2 111.055 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 38.0 m95 -117.19 163.39 16.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.371 -0.831 . . . . 73.32 110.17 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.545 ' HB ' HD21 ' A' ' 79' ' ' LEU . 13.3 p -137.56 137.39 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.09 -0.505 . . . . 70.25 110.387 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.17 132.22 56.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.982 -0.554 . . . . 54.35 110.452 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 43.3 t -67.89 133.37 92.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.898 -0.408 . . . . 73.33 109.898 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.7 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 39.7 Cg_endo -66.37 -32.24 41.33 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 122.341 2.027 . . . . 73.33 112.164 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -100.81 -56.84 2.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.845 -0.616 . . . . 73.32 111.111 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -79.56 -19.63 48.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 55.12 110.746 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 70' ' ' SER . 52.4 mtmt 57.37 34.8 25.21 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.505 -0.77 . . . . 74.22 112.841 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.6 mm-40 -82.82 139.65 33.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 53.21 108.908 169.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 8.7 m80 -116.17 115.83 26.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.103 -0.332 . . . . 75.31 110.103 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HZ ' ' HB2' ' A' ' 90' ' ' TYR . 77.6 m-85 -129.86 166.89 19.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.541 0.21 . . . . 73.11 110.631 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 61.4 mtt180 -81.26 146.53 30.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.407 . . . . 71.23 109.9 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 66' ' ' LEU . 96.0 mt -67.97 -27.47 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.896 0.332 . . . . 63.15 111.896 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.59 37.22 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.81 0.3 . . . . 71.24 111.81 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 20.2 t70 -148.88 -62.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.932 -0.307 . . . . 71.05 111.195 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.46 -12.22 23.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.181 -1.009 . . . . 22.33 113.697 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -75.32 160.03 30.79 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.193 0.52 . . . . 65.22 111.253 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . 61.8 m -87.86 151.99 22.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.453 -0.794 . . . . 60.44 111.481 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 64.5 tp -88.49 -58.86 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.484 . . . . 63.4 110.324 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 16.3 mm-40 -125.53 18.84 8.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 71.24 109.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 84' ' ' CYS . 2.1 m-20 -124.07 -180.0 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.414 -0.812 . . . . 62.4 111.037 -168.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.81 23.72 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.513 -0.767 . . . . 64.23 111.277 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.34 -59.52 2.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.748 0.277 . . . . 51.53 111.748 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.571 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 40.3 m-85 -90.4 -76.35 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.621 0.23 . . . . 73.33 111.621 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 m 66.27 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.84 0.712 . . . . 73.44 110.333 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.7 176.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.445 . . . . 72.25 111.697 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.08 167.64 9.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 51.33 110.916 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -127.34 112.39 14.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.087 0.47 . . . . 63.33 110.649 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -85.98 157.31 20.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.734 -0.666 . . . . 74.22 110.082 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 107' ' ' SER . 3.9 t0 -82.47 162.93 21.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.714 -0.476 . . . . 64.13 109.714 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.788 HG22 HG22 ' A' ' 106' ' ' ILE . 3.1 p -149.12 154.01 38.59 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.342 0.257 . . . . 72.33 110.831 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -154.45 153.87 32.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.239 0.542 . . . . 63.34 111.115 174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.08 83.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.735 -0.839 . . . . 73.04 108.735 173.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -97.25 -0.22 47.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.703 -0.68 . . . . 75.34 110.813 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -161.13 -164.75 1.22 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.785 -0.821 . . . . 73.22 108.785 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.01 -11.38 84.8 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.59 -0.604 . . . . 73.23 111.59 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.47 152.26 24.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.953 -0.388 . . . . 72.33 109.953 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.79 136.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 73.32 110.889 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -126.16 147.51 49.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 60.52 110.386 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.788 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -125.62 158.37 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.905 -0.589 . . . . 74.33 109.567 177.127 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 13.1 t -102.65 119.61 39.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.97 0.414 . . . . 51.33 109.973 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -120.85 117.36 52.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 70.24 110.446 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.33 17.67 15.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 73.43 111.133 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -172.67 141.91 1.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.44 -0.8 . . . . 64.13 109.353 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.585 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 50.0 m -121.19 -72.28 0.7 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.256 0.465 . . . . 42.42 112.256 -173.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' SER . 30.4 t70 73.43 112.73 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.059 0.849 . . . . 72.13 109.27 -166.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.47 116.61 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.393 0.616 . . . . 63.12 111.805 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.05 94.53 5.22 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.325 -0.852 . . . . 70.5 109.182 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.32 103.39 14.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.084 0.945 . . . . 63.41 112.053 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -132.2 122.93 26.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.363 -1.289 . . . . 54.11 108.228 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.91 124.52 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.544 0.688 . . . . 72.34 111.01 -173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 m -114.85 80.77 1.46 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.64 -0.709 . . . . 52.25 110.003 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.7 tp60 -72.55 117.2 57.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 73.31 109.594 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.67 111.11 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.653 2.236 . . . . 54.14 111.719 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 92.9 mt -75.91 121.65 85.44 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.213 -0.448 . . . . 74.24 110.562 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 35.1 Cg_exo -60.2 118.8 5.72 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.733 2.289 . . . . 74.41 111.455 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 tt -130.54 111.79 12.58 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.559 -0.534 . . . . 75.24 109.559 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -119.36 141.91 48.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.106 -0.497 . . . . 71.1 110.137 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -124.71 84.49 2.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.269 -0.641 . . . . 74.53 109.269 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -97.57 121.0 38.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 65.01 109.757 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -107.6 78.67 1.22 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.517 0.675 . . . . 62.51 109.466 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -118.89 86.68 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.227 -0.897 . . . . 74.23 109.43 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -132.14 133.11 43.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.476 . . . . 75.01 110.156 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.672 -0.68 . . . . 74.52 109.821 176.334 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.927 0.394 . . . . 70.22 110.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -75.02 -75.03 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 73.24 110.614 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 21.71 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.362 0.601 . . . . 70.43 110.545 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 91.8 m95 -74.44 111.14 9.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.45 110.096 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 106' ' ' ILE . 9.6 m -95.55 138.5 33.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 73.12 109.909 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -84.36 128.72 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.789 0.328 . . . . 54.42 110.837 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.92 -75.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.017 0.437 . . . . 53.2 110.081 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.0 m -151.64 -173.76 4.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 55.15 109.534 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.717 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 86.4 mttt -78.4 164.15 25.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 71.4 110.402 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 37' ' ' GLU . 65.6 tp -75.4 -19.45 59.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.682 0.753 . . . . 74.23 109.046 167.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.51 -25.38 19.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.926 -1.034 . . . . 72.43 110.761 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.717 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 35.6 t70 -75.93 -21.56 56.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.444 0.64 . . . . 71.53 109.97 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.528 HD13 HG11 ' A' ' 30' ' ' VAL . 26.8 mt -97.29 104.56 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 51.31 109.469 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.4 mt -71.84 148.88 92.53 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 75.45 111.938 -173.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 31.2 Cg_exo -60.79 119.8 7.17 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.981 2.454 . . . . 73.34 112.017 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.38 33.24 4.59 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.96 -0.564 . . . . 53.44 112.058 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -133.62 176.96 8.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.305 0.574 . . . . 54.23 111.53 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 177.14 91.83 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.272 -1.131 . . . . 74.12 110.272 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.659 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.1 m -121.0 151.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.659 0.614 . . . . 73.0 112.659 -172.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 3.4 p -77.63 99.12 5.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.743 -0.662 . . . . 53.45 111.073 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.93 127.36 32.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 53.04 109.836 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.9 112.24 17.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.051 0.453 . . . . 53.22 109.922 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.08 107.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 72.41 109.622 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 67.11 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.72 -0.673 . . . . 72.11 111.785 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -138.88 0.75 2.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.227 0.537 . . . . 75.33 110.162 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -116.02 129.83 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.886 -0.597 . . . . 75.53 111.276 -173.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 39.5 mt-30 -89.14 113.99 25.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.351 -0.611 . . . . 72.51 109.351 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.09 117.71 55.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.796 -0.638 . . . . 74.01 110.625 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -79.97 119.51 22.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 72.32 110.119 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.674 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 18.8 t -100.91 108.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.268 -0.424 . . . . 74.54 109.931 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HE1' ' HB3' ' A' ' 55' ' ' SER . 33.4 m-85 -79.48 117.98 20.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.296 -0.411 . . . . 75.24 110.598 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.609 HH11 ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -130.83 75.57 78.5 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 72.21 110.786 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.74 -34.89 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.037 2.491 . . . . 54.31 113.033 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.7 -179.67 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 70.5 111.296 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.28 18.88 18.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.757 -0.656 . . . . 72.11 109.852 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 23.3 t70 -83.13 -161.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 75.51 109.454 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 10' ' ' LEU . 50.3 mt-10 -118.25 2.43 11.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.122 -0.361 . . . . 75.12 111.255 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 153.79 41.41 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 110.164 -0.31 . . . . 70.11 110.164 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.7 148.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.106 0.479 . . . . 62.34 111.598 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -137.92 100.2 4.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.427 -0.806 . . . . 74.03 109.913 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -118.89 106.33 12.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.047 -0.524 . . . . 63.1 110.459 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.6 pt -132.35 164.58 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 72.45 109.757 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 56.1 m -78.41 65.72 3.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.49 . . . . 35.43 110.779 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.582 ' HA ' HG11 ' A' ' 92' ' ' VAL . 64.4 t30 -97.7 75.98 2.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 74.02 108.986 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.7 mm -125.18 137.65 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.628 -0.714 . . . . 64.5 111.128 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.91 117.98 69.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.417 -0.586 . . . . 70.31 109.417 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.86 -0.14 9.9 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.69 2.26 . . . . 73.43 113.276 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -88.85 -30.72 18.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.22 0.534 . . . . 74.23 109.737 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 -19.49 13.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.868 -0.605 . . . . 75.13 109.933 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 63.16 36.37 12.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.895 -1.048 . . . . 72.23 111.347 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -148.95 165.53 31.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 72.53 109.216 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.659 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 14.0 p -77.31 77.99 3.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.217 0.532 . . . . 53.31 111.302 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.68 -8.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 62.21 109.755 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.95 7.63 23.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.978 -1.01 . . . . 72.13 110.2 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 10.0 p -129.63 7.7 5.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.602 -0.726 . . . . 74.13 110.772 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -110.01 18.19 20.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 71.21 110.486 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -103.67 -158.93 24.71 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.527 -0.844 . . . . 71.31 112.428 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 74.1 mt -85.86 108.02 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.845 0.355 . . . . 70.23 110.389 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 68' ' ' VAL . 84.9 t -71.56 91.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.871 -0.789 . . . . 53.41 108.871 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.45 145.99 30.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.47 0.652 . . . . 53.35 111.744 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -90.41 98.2 11.64 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.305 -0.861 . . . . 74.41 108.725 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.544 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 77.5 t60 -91.64 -45.29 8.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.487 -1.233 . . . . 73.13 110.076 -169.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -123.68 -148.11 0.39 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.148 -1.427 . . . . 70.02 107.148 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.98 44.25 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.179 -0.675 . . . . 75.34 109.179 171.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 5.6 t70 -157.55 -175.44 5.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.669 -0.493 . . . . 54.24 109.669 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.85 114.8 24.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 54.22 110.312 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.614 ' CZ3' ' HB2' ' A' ' 78' ' ' ARG . 46.8 m95 -122.28 127.35 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.862 -0.608 . . . . 74.2 110.243 -176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 HG22 ' A' ' 59' ' ' VAL . 15.9 m -89.13 126.46 42.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.363 0.601 . . . . 71.41 111.036 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -88.83 99.38 12.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.663 -0.699 . . . . 62.01 109.231 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -58.47 128.41 82.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.726 -0.67 . . . . 71.12 111.035 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.1 Cg_endo -71.01 -36.38 7.59 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 62.13 112.324 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.9 tp -89.73 -44.25 10.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 72.43 110.705 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 27.0 mmmt -81.43 -28.68 34.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 74.02 110.638 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 63.06 22.31 13.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.572 -0.74 . . . . 74.14 112.29 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.39 161.63 19.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.884 -0.598 . . . . 71.2 109.612 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -92.64 140.33 29.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.553 -0.294 . . . . 74.41 110.879 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' A' ' 90' ' ' TYR . 53.5 m-85 -128.95 139.27 52.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.079 -0.341 . . . . 71.32 110.079 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 52.6 ttt180 -96.55 127.38 42.49 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.74 -0.466 . . . . 74.52 109.74 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.45 -60.59 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.66 0.6 . . . . 64.13 111.403 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.56 77.25 2.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 74.52 109.836 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 22.6 t70 -178.2 -58.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.197 -0.91 . . . . 72.43 109.881 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . 102.97 -16.35 54.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.672 -0.775 . . . . 71.1 113.395 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 81.8 m-85 -85.83 162.42 18.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.052 0.426 . . . . 74.24 111.452 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.17 40.57 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.648 -0.705 . . . . 61.42 111.27 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.914 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.4 tp 60.5 -83.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.02 0.528 . . . . 74.15 111.859 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.914 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 43.4 mt-10 -110.73 -17.83 13.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.337 -0.392 . . . . 63.44 110.575 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -93.02 172.24 8.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 74.32 110.472 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.01 60.24 0.5 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.001 -0.84 . . . . 70.12 111.001 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.25 -27.41 15.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.997 0.369 . . . . 72.5 111.997 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.423 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 22.3 m-85 -132.58 -68.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.337 0.495 . . . . 72.1 112.337 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 27.6 m 62.25 88.28 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 73.11 109.695 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 44' ' ' ASN . 30.1 m -85.86 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.587 -0.733 . . . . 62.34 112.566 -169.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -89.95 169.18 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 72.23 111.037 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 120.17 8.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.839 0.352 . . . . 65.15 110.342 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.48 153.87 27.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.057 -0.519 . . . . 72.51 110.714 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.15 119.89 21.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 65.0 110.186 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 106' ' ' ILE . 77.5 p -119.73 145.06 46.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.114 -0.494 . . . . 74.1 110.814 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -152.47 148.4 27.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 75.41 111.111 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 47.2 t -100.06 109.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.54 -0.755 . . . . 65.01 109.142 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.4 m -96.19 -63.26 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.176 0.512 . . . . 72.11 111.714 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -124.24 55.44 1.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.639 -0.709 . . . . 73.1 109.878 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.6 -1.31 62.15 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.031 -0.604 . . . . 72.25 112.233 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 29.9 p-10 -110.65 144.62 39.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 72.42 110.725 -177.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.1 113.31 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 70.45 110.058 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 21.5 mt-30 -106.52 135.66 47.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.171 -0.468 . . . . 73.05 110.529 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.845 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.42 150.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.328 -0.619 . . . . 62.53 109.328 174.019 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -89.08 101.88 14.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.919 0.39 . . . . 74.21 110.982 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.4 mm -95.18 96.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.25 0.548 . . . . 74.31 109.676 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.13 157.14 19.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.554 -0.748 . . . . 74.14 110.674 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.13 145.08 35.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.13 0.491 . . . . 63.15 110.774 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.4 m -150.63 -85.87 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.696 -0.684 . . . . 75.22 109.889 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -177.27 -146.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.036 -1.098 . . . . 53.41 108.036 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t 53.72 58.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.125 0.964 . . . . 62.41 110.928 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.1 83.57 1.8 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.098 -0.956 . . . . 60.15 110.24 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.07 167.27 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.004 -0.544 . . . . 70.12 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -124.23 110.34 14.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.942 -0.572 . . . . 72.15 109.674 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.23 158.73 42.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.81 -0.441 . . . . 70.22 109.81 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 m 65.69 95.66 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.935 0.772 . . . . 51.03 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 61.32 78.44 0.31 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.307 -0.861 . . . . 73.0 111.725 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.81 153.22 42.64 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.493 2.129 . . . . 74.23 111.975 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.59 92.74 48.75 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.748 0.309 . . . . 64.01 111.667 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.53 175.63 11.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.415 2.077 . . . . 73.2 111.459 172.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.41 -51.19 54.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.974 0.416 . . . . 55.33 110.93 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.9 136.58 32.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.207 0.527 . . . . 74.14 111.614 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 75.3 m80 -136.73 122.84 20.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.493 -0.776 . . . . 71.44 108.908 173.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -76.56 71.96 3.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.253 0.549 . . . . 72.24 110.813 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -103.22 153.93 19.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.991 -0.744 . . . . 75.33 108.991 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -145.53 113.68 6.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.296 0.569 . . . . 75.4 110.644 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -86.69 148.6 25.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.391 -0.822 . . . . 70.14 109.638 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.457 -0.783 . . . . 64.14 108.908 174.409 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.246 -0.65 . . . . 74.42 109.246 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -61.79 -60.97 2.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.671 0.619 . . . . 73.34 112.671 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' SER . 26.8 pt20 -89.48 -0.86 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 54.24 111.798 -173.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 98.5 m95 -118.27 95.02 4.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.909 -0.587 . . . . 75.13 109.733 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.3 m -92.81 135.1 34.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 72.12 110.84 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 103' ' ' ASN . 85.2 m -76.49 121.35 22.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.083 -0.508 . . . . 71.44 110.585 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 23' ' ' VAL . 54.1 t -80.61 -69.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.985 -0.552 . . . . 61.13 110.128 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 p -161.55 -179.46 7.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.702 -0.681 . . . . 64.31 110.172 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.12 137.6 40.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.951 0.405 . . . . 73.13 110.953 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' A' ' 37' ' ' GLU . 51.0 tp -70.94 -8.04 50.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.053 0.93 . . . . 74.44 109.354 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.33 -14.96 39.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.375 -1.284 . . . . 71.3 110.078 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -100.86 -25.4 14.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.924 -0.58 . . . . 72.5 110.513 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.22 113.5 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 52.51 110.674 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 93.3 mt -71.61 129.52 88.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 70.13 111.661 -175.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 17.0 Cg_exo -67.79 128.92 18.73 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.314 2.676 . . . . 73.15 112.48 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 27.7 15.57 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.963 -0.637 . . . . 74.43 112.098 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.73 19.86 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.574 0.226 . . . . 75.11 111.199 -176.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 130.35 2.16 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 74.03 111.445 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.51 174.72 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.963 0.382 . . . . 53.01 111.31 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -80.63 138.92 36.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.867 -0.606 . . . . 71.34 111.614 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.68 127.76 45.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.41 -0.814 . . . . 44.13 109.523 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tm? -84.66 100.6 11.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.431 -0.581 . . . . 64.2 109.431 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 7' ' ' VAL . 48.4 t -107.29 112.27 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 42.53 109.832 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 63.97 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.775 -0.648 . . . . 74.03 110.48 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.7 -6.51 3.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.281 0.562 . . . . 74.15 109.936 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.674 ' HB3' HD11 ' A' ' 28' ' ' ILE . 6.7 mm-40 -89.97 138.78 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.685 -0.689 . . . . 65.24 112.023 -171.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.772 ' HB3' HG13 ' A' ' 45' ' ' ILE . 51.7 mt-30 -100.59 103.44 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 74.0 109.554 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 26' ' ' GLN . 3.2 mp -119.21 142.15 35.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.246 -0.279 . . . . 64.02 110.246 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.47 131.63 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.473 -0.566 . . . . 73.12 109.473 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.96 99.75 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.024 0.44 . . . . 73.05 110.456 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 42.3 m-85 -75.78 125.12 28.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.725 . . . . 60.23 110.507 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -110.78 87.35 6.68 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.113 -1.069 . . . . 70.52 108.113 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.89 -13.32 13.0 Favored 'Trans proline' 0 CA--C 1.517 -0.349 0 C-N-CA 122.588 2.192 . . . . 63.33 112.933 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -117.21 163.37 16.4 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.864 -0.607 . . . . 73.31 110.213 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.811 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 m-20 -79.9 -1.92 41.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 73.12 109.562 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 37.5 t70 -92.76 178.56 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.073 -0.967 . . . . 74.52 109.534 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.774 ' HB3' HD21 ' A' ' 10' ' ' LEU . 41.9 mt-10 -86.14 46.55 1.34 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.127 0.489 . . . . 61.04 111.547 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -117.53 128.93 55.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.425 -0.583 . . . . 71.05 109.425 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.73 162.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 64.51 112.428 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 49.0 m-85 -132.66 106.73 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.245 -0.889 . . . . 75.05 110.38 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -97.14 101.59 13.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.894 0.378 . . . . 73.35 111.277 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -129.87 155.06 41.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 64.35 109.956 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 m -90.81 85.99 6.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 111.94 0.348 . . . . 75.05 111.94 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.789 ' HB3' HG11 ' A' ' 92' ' ' VAL . 21.7 p30 -135.39 65.5 1.55 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.855 0.836 . . . . 74.23 111.017 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.772 HG13 ' HB3' ' A' ' 27' ' ' GLN . 10.6 mm -84.04 -15.79 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.316 -0.856 . . . . 73.14 111.282 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.622 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 10.9 t70 66.62 121.13 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.939 -1.028 . . . . 74.31 110.714 -174.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.7 Cg_exo -75.01 -4.36 15.29 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.986 2.457 . . . . 64.24 113.523 -173.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.24 -31.91 11.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.744 0.307 . . . . 72.12 110.847 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.03 -31.65 7.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.825 0.345 . . . . 71.32 110.896 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 63.71 16.61 9.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.543 -0.753 . . . . 64.52 112.412 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.9 23.85 4.97 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.159 -0.338 . . . . 54.35 111.21 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 14.9 m 61.87 58.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 74.11 111.418 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 72' ' ' LEU . 20.6 m -79.62 -14.11 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.301 0.572 . . . . 55.11 109.901 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 49.4 mt -74.78 -23.52 58.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.749 -0.834 . . . . 71.0 108.749 172.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 1.1 m -90.59 -38.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.231 -0.895 . . . . 71.34 110.034 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -80.64 29.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.56 -0.745 . . . . 74.44 111.112 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.96 -147.2 21.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.381 -0.688 . . . . 73.24 111.381 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.45 102.18 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.143 0.497 . . . . 73.44 110.397 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.3 t -83.82 94.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.39 -0.823 . . . . 74.31 109.3 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 179.76 3.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.116 -0.493 . . . . 50.01 111.267 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG2' HD23 ' A' ' 66' ' ' LEU . 23.8 mt-10 -116.02 155.59 27.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.6 -0.727 . . . . 63.41 110.614 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -127.1 39.23 3.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.936 -1.135 . . . . 63.22 107.936 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 78.7 mt-30 69.28 103.2 0.06 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.128 -1.396 . . . . 75.43 110.6 -171.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 63' ' ' GLN . 29.3 t70 75.8 -53.05 0.63 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.863 -1.062 . . . . 62.1 111.55 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 78' ' ' ARG . 23.9 m-20 -76.2 143.88 40.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.208 0.527 . . . . 72.1 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 ' HG2' ' A' ' 61' ' ' GLU . 92.6 mt -103.52 120.25 40.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 65.12 109.768 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 58.5 m95 -124.49 117.1 23.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 65.12 110.423 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.08 130.3 42.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.018 0.437 . . . . 63.12 110.259 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.46 116.54 32.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.903 -0.59 . . . . 63.11 110.111 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.7 p -81.2 138.16 48.98 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.137 -0.483 . . . . 74.23 110.951 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.03 -29.84 26.68 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.413 2.075 . . . . 65.25 112.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 53' ' ' VAL . 74.8 mt -86.83 -52.21 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 74.12 111.405 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -32.48 29.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.426 -0.352 . . . . 74.12 110.854 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt 62.24 37.75 13.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.742 -0.663 . . . . 72.31 111.215 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -115.62 146.89 41.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 71.11 109.753 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 66.0 m80 -91.42 116.35 28.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.012 -0.54 . . . . 71.1 110.604 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -105.77 121.3 43.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.243 -0.435 . . . . 72.44 110.038 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.9 ttp180 -84.58 129.99 34.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.916 -0.401 . . . . 70.44 109.916 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.07 95.34 0.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.296 0.569 . . . . 63.42 111.032 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -161.31 -58.95 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.449 -0.945 . . . . 73.23 108.449 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 94' ' ' ALA . 7.3 m-20 -138.23 -83.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.835 -1.075 . . . . 44.42 108.985 170.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . -159.28 32.34 0.45 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.596 -0.729 . . . . 55.13 111.539 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -71.25 120.24 16.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.758 0.314 . . . . 64.41 110.731 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 8.6 m -100.83 141.74 33.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.734 -0.667 . . . . 73.33 110.099 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 53.9 tp -71.17 -64.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 73.51 111.818 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' CD ' ' H ' ' A' ' 86' ' ' GLU . 1.4 pm0 -85.73 -51.84 6.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.994 0.368 . . . . 71.03 111.994 -173.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 9.9 t70 -115.8 -151.92 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.832 -0.433 . . . . 75.15 109.832 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . -172.14 48.38 0.18 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.865 -0.894 . . . . 74.24 110.865 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.04 -25.32 67.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.112 0.412 . . . . 21.3 112.112 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -128.54 -57.98 1.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.886 -0.326 . . . . 74.42 111.332 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 49.3 m 57.05 83.01 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.479 0.657 . . . . 75.4 109.749 -173.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.789 HG11 ' HB3' ' A' ' 44' ' ' ASN . 23.3 m -70.99 166.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.019 -0.991 . . . . 74.23 112.605 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.49 146.39 25.81 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 53.44 110.714 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -124.79 107.86 11.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 64.31 110.532 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.556 ' HE1' ' HB3' ' A' ' 109' ' ' ALA . 91.2 m-85 -84.11 144.31 29.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.678 -0.692 . . . . 75.41 109.463 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.34 136.07 49.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.781 0.324 . . . . 63.22 110.353 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.801 HG22 HG22 ' A' ' 106' ' ' ILE . 79.2 p -127.77 144.46 51.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 64.31 110.512 -175.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 8.9 pt20 -140.11 141.8 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 74.25 110.93 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 10' ' ' LEU . 37.5 t -110.48 98.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.566 -0.743 . . . . 70.04 109.214 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -128.02 -1.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 63.12 111.42 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 103' ' ' ASN . 8.4 t-20 -136.36 24.99 3.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.374 0.607 . . . . 71.53 110.222 -175.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.89 -23.32 2.61 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.752 -0.737 . . . . 63.11 111.516 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.55 ' HB3' HG23 ' A' ' 6' ' ' THR . 41.6 m-80 -103.57 153.82 20.17 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.362 -0.607 . . . . 73.04 109.362 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' VAL . 45.0 t -90.08 120.11 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.947 -0.39 . . . . 74.34 109.947 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 68.8 mt-30 -114.14 127.06 55.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 62.41 109.892 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.801 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.21 152.98 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.15 110.977 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 25.4 t -82.69 107.31 15.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.166 -0.679 . . . . 64.02 109.166 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 108' ' ' ILE . 1.7 pp -81.51 121.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.705 0.764 . . . . 73.24 112.275 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . . . -110.29 24.41 13.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.396 -0.82 . . . . 74.34 108.875 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.57 141.93 44.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.423 -1.262 . . . . 74.0 111.212 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.7 m -123.75 -77.17 0.59 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.906 -0.588 . . . . 74.11 110.009 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -150.37 113.26 4.79 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.44 -0.346 . . . . 51.5 110.604 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.66 132.97 41.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.007 0.432 . . . . 74.05 110.104 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.16 95.98 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 63.11 110.333 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.3 m -78.74 168.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.657 -0.701 . . . . 73.1 111.103 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -84.47 -169.41 2.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.984 -0.747 . . . . 74.04 108.984 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -79.7 115.33 19.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.384 0.612 . . . . 64.41 110.337 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -68.97 -42.08 77.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.627 -0.715 . . . . 33.21 109.498 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.509 ' CD ' ' H ' ' A' ' 119' ' ' GLN . 5.1 pm0 -89.0 128.78 50.63 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.385 -0.825 . . . . 64.43 109.988 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 4.7 Cg_exo -75.73 176.77 9.57 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.976 2.451 . . . . 72.35 112.372 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.42 137.12 26.16 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.581 . . . . 75.03 109.935 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.44 117.77 4.72 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.534 2.156 . . . . 72.05 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.75 165.99 14.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.988 -0.551 . . . . 74.21 110.665 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -118.89 135.95 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 74.11 110.501 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -139.4 109.03 6.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.192 -0.669 . . . . 74.31 109.192 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -58.26 123.46 16.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.06 -0.518 . . . . 72.45 111.489 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -60.31 126.68 28.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.522 -0.763 . . . . 72.15 110.195 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -96.78 109.78 22.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.4 0.619 . . . . 65.55 111.221 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -147.13 142.1 26.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.033 -0.985 . . . . 63.23 108.948 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.633 -0.698 . . . . 73.53 109.786 177.927 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.97 0.414 . . . . 45.24 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -85.52 -158.31 0.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.006 -0.543 . . . . 73.11 110.168 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 15.6 mm-40 -70.56 77.42 0.58 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.18 0.514 . . . . 74.25 111.395 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 96.0 m95 -116.26 96.58 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.418 -0.81 . . . . 74.02 109.437 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.4 m -77.07 119.3 20.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.354 -0.384 . . . . 74.21 110.633 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.416 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 21.2 m -68.81 113.13 5.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.058 -0.519 . . . . 62.32 109.743 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.36 -65.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.169 0.509 . . . . 63.43 111.246 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.781 ' SG ' HG12 ' A' ' 13' ' ' ILE . 34.1 t -134.11 167.56 20.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.904 -0.589 . . . . 64.35 110.874 -172.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' ASP . 16.0 tptm -84.93 2.96 40.46 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.978 -0.555 . . . . 63.13 110.27 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 67.5 tp 71.77 -40.49 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.855 -1.066 . . . . 71.11 111.018 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' LYS . 28.8 t70 -74.25 -32.56 63.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.374 -0.83 . . . . 71.04 111.231 -175.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -84.67 9.9 12.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.911 -0.716 . . . . 55.22 111.342 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.781 HG12 ' SG ' ' A' ' 8' ' ' CYS . 37.2 mm -90.55 128.93 42.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.719 -0.474 . . . . 63.22 109.719 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.96 125.99 92.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 71.1 111.3 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.17 126.82 17.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.837 2.358 . . . . 45.42 112.459 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 30.86 29.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 70.3 111.553 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -150.54 173.98 13.48 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.308 . . . . 70.24 110.864 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.503 ' H ' HG22 ' A' ' 17' ' ' THR . . . -148.04 142.88 10.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.175 -1.17 . . . . 75.21 110.175 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 m -134.3 146.83 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 117.822 0.811 . . . . 73.11 112.605 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 3.5 p -75.54 111.94 11.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.729 -0.668 . . . . 62.31 110.713 174.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.07 109.55 20.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.931 -0.577 . . . . 61.1 109.878 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.15 103.15 3.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.298 -0.63 . . . . 75.31 109.298 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 26' ' ' GLN . 16.3 t -94.22 161.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.6 -0.889 . . . . 61.53 108.6 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.81 -53.16 10.07 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.52 0.512 . . . . 75.24 112.246 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 -130.36 23.02 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.614 0.245 . . . . 74.13 111.226 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 20.2 mm-40 -138.4 157.63 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.107 0.479 . . . . 74.24 112.064 -174.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.47 ' HB3' HG13 ' A' ' 45' ' ' ILE . 50.3 mt-30 -127.6 103.31 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.653 -0.703 . . . . 71.34 110.461 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 26' ' ' GLN . 2.8 mp -121.21 135.94 59.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.324 -0.398 . . . . 63.35 110.254 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -100.51 134.62 43.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.743 -0.465 . . . . 71.34 109.743 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 39.8 t -111.06 108.44 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.808 -0.357 . . . . 55.14 110.343 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.847 ' HZ ' ' HB3' ' A' ' 44' ' ' ASN . 2.8 m-85 -93.55 128.0 39.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.906 -0.588 . . . . 72.01 110.148 -178.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.522 ' HG3' HG12 ' A' ' 39' ' ' VAL . 55.3 ttt180 -119.74 86.67 35.92 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 108.765 -0.828 . . . . 62.34 108.765 172.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 -36.84 91.72 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.853 2.368 . . . . 73.45 112.166 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.5 mtm180 -133.24 163.96 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 62.4 109.551 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.97 56.47 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.624 0.726 . . . . 65.45 110.243 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.82 -171.61 2.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.503 -0.771 . . . . 71.43 109.72 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.6 0.04 56.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 73.54 111.09 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.99 99.33 12.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.979 0.419 . . . . 71.33 110.3 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.522 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.5 m -125.32 165.57 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 62.54 110.818 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -133.04 107.34 8.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.983 -0.553 . . . . 72.14 110.77 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -106.79 96.43 6.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.03 0.443 . . . . 74.41 110.714 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.3 164.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 74.21 109.6 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.8 m -76.89 53.83 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.043 0.449 . . . . 74.02 111.865 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.847 ' HB3' ' HZ ' ' A' ' 31' ' ' PHE . 53.8 t30 -100.93 67.03 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.625 0.726 . . . . 73.53 109.294 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 29' ' ' ALA . 30.8 mm -97.05 -21.05 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.107 -0.951 . . . . 75.54 111.555 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 32.1 t0 63.2 96.97 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.152 -0.931 . . . . 64.43 109.259 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 90' ' ' TYR . 32.2 Cg_exo -60.31 -1.05 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.622 2.881 . . . . 64.42 113.57 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -92.4 -15.04 27.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.557 0.218 . . . . 61.1 110.822 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -129.43 -31.02 2.08 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.817 0.673 . . . . 63.01 112.817 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.7 mp0 76.35 -14.14 0.84 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.017 0.747 . . . . 75.24 113.017 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -111.3 34.53 4.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.108 0.41 . . . . 72.31 112.108 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 53.0 p 47.55 56.4 7.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.282 0.563 . . . . 73.15 111.584 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 m -76.44 -2.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.497 0.665 . . . . 43.44 110.133 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 82.9 mt -92.58 23.36 4.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.086 -0.961 . . . . 74.43 109.583 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 77.2 p -145.12 -39.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 55.33 110.858 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -81.37 59.33 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 63.23 109.685 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.4 -110.38 0.44 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.401 -0.818 . . . . 63.22 111.524 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 50.5 mm -119.74 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.159 0.504 . . . . 73.24 110.694 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.78 101.7 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.141 -1.059 . . . . 75.41 108.141 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 116.19 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.913 -0.585 . . . . 73.33 112.497 -169.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.99 103.67 3.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.043 -1.095 . . . . 61.3 108.043 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -58.96 -57.24 13.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.869 -0.605 . . . . 54.12 110.656 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -141.64 -66.81 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.731 -0.668 . . . . 73.32 109.371 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.08 -7.63 8.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.181 -0.918 . . . . 65.12 110.331 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.594 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.5 t70 -122.54 171.63 8.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.4 110.115 -173.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.98 112.48 24.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.061 0.458 . . . . 73.53 110.955 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.715 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 9.3 m95 -124.65 168.14 13.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.577 -0.897 . . . . 75.31 108.577 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 14.4 p -131.94 144.75 36.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.769 0.318 . . . . 61.14 110.541 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -103.83 127.64 51.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.537 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 47.5 t -90.77 132.94 33.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 73.15 110.427 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.9 -17.3 37.03 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.648 2.232 . . . . 71.02 112.182 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.33 -52.85 4.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 52.21 109.868 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.1 pttm -125.9 103.38 7.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.601 -0.727 . . . . 74.44 109.147 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.7 77.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 64.34 112.178 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -130.72 151.37 51.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 64.31 109.022 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -88.92 93.26 9.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.555 0.217 . . . . 73.01 110.877 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 33.4 m-85 -78.81 121.87 25.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 71.01 109.656 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 49.4 ttt180 -80.04 122.65 27.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.867 -0.333 . . . . 74.21 110.583 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 62.11 111.353 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 49.4 t80 -106.84 16.46 24.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.329 0.585 . . . . 73.33 110.558 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.542 ' CB ' ' HD3' ' A' ' 78' ' ' ARG . 9.8 t70 -147.92 -65.21 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.1 111.191 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.04 -30.03 4.22 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.037 -0.601 . . . . 41.01 111.817 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.45 153.67 42.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 64.21 110.307 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.3 m -100.41 29.49 4.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 73.15 111.702 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 56.5 tp 53.89 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.452 0.908 . . . . 71.02 113.452 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -73.15 -21.71 60.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.695 . . . . 74.23 111.782 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 3.4 t70 -166.51 -160.68 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.777 -0.823 . . . . 74.32 108.777 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.08 -155.14 9.33 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 110.24 -1.144 . . . . 52.11 110.24 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 171.39 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.373 0.606 . . . . 75.4 110.018 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD2' ' HD2' ' A' ' 47' ' ' PRO . 94.9 m-85 -147.25 108.54 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.139 -0.937 . . . . 64.33 108.687 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 m -56.87 105.59 0.23 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 74.31 110.456 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.0 m -94.35 156.07 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.277 -0.419 . . . . 60.2 110.959 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.4 121.43 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.535 . . . . 63.45 111.51 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.36 94.72 8.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 70.3 110.057 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -75.46 164.56 26.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.557 -0.747 . . . . 72.12 111.381 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 21.6 t70 -86.04 132.24 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.342 -0.614 . . . . 73.04 109.342 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.762 HG22 HG22 ' A' ' 106' ' ' ILE . 51.7 p -128.06 144.49 51.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.342 -0.39 . . . . 53.24 111.081 -173.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -135.42 148.77 49.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.94 0.4 . . . . 45.01 110.653 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.48 103.11 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.915 -0.584 . . . . 71.02 109.504 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 m -83.32 77.99 9.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.153 -0.476 . . . . 74.4 110.832 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 71.83 -44.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.84 0.856 . . . . 64.33 112.348 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.06 -49.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.059 -0.591 . . . . 71.3 112.039 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -80.4 151.73 29.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.028 0.442 . . . . 73.42 110.855 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.94 127.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 42.51 110.457 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 90.4 mt-30 -120.47 137.22 54.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 74.1 110.483 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -113.82 149.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.107 -0.331 . . . . 74.44 110.107 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -84.99 105.05 15.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.62 . . . . 74.1 109.327 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 pt -82.85 147.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.089 0.471 . . . . 74.5 111.288 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.71 151.84 22.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 34.43 109.691 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.91 172.61 13.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.051 -0.351 . . . . 40.51 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 t -152.18 -60.34 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.748 -0.381 . . . . 75.21 111.327 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t70 65.54 100.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.257 0.551 . . . . 74.43 110.448 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 p -156.88 149.31 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.087 -0.506 . . . . 63.03 110.274 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 126.73 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.837 0.351 . . . . 41.13 110.538 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.18 155.25 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 75.53 111.493 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.03 125.24 29.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.577 -0.738 . . . . 74.24 109.954 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.84 128.09 34.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.336 0.588 . . . . 71.41 111.685 -178.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 t -118.16 -1.92 11.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.051 -0.522 . . . . 73.41 110.926 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.55 96.2 45.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 121.135 -0.226 . . . . 54.01 111.023 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.501 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 3.8 Cg_exo -77.67 125.33 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.583 2.189 . . . . 64.14 110.532 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.97 105.5 24.32 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.812 0.339 . . . . 75.55 110.935 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 95.3 Cg_endo -91.48 20.55 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.124 2.549 . . . . 45.53 112.18 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 123' ' ' LEU . 2.6 pp -77.42 145.77 36.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.308 -0.86 . . . . 74.34 109.437 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.21 168.38 18.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.454 0.645 . . . . 75.55 112.419 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -159.04 74.86 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.69 -1.141 . . . . 64.41 109.177 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -76.84 112.68 13.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.9 -0.591 . . . . 72.53 109.962 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -104.13 137.06 42.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.7 -0.682 . . . . 74.33 109.918 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -72.45 130.95 41.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.948 -0.39 . . . . 74.04 109.948 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -91.3 -48.47 6.9 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.117 -0.697 . . . . 71.4 109.117 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.298 -0.865 . . . . 52.12 108.689 174.149 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.57 ' N ' ' HB2' ' A' ' 4' ' ' TRP . 47.2 ttm . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.516 0.198 . . . . 54.44 110.828 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 67.6 -75.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.242 0.617 . . . . 74.02 112.181 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -85.9 14.34 6.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.39 0.615 . . . . 75.32 110.348 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 57.4 m95 -129.14 125.38 36.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.132 -0.94 . . . . 62.34 109.041 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -112.62 136.18 52.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 71.12 111.732 -177.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.53 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 25.9 m -67.55 114.37 6.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.656 -0.702 . . . . 73.31 110.873 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 106' ' ' ILE . 46.4 t -89.38 -78.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 75.42 111.171 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' HD11 ' A' ' 13' ' ' ILE . 86.0 m -143.44 177.8 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 71.25 110.677 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 13' ' ' ILE . 43.3 mtmt -84.29 117.68 23.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.582 -0.735 . . . . 72.3 110.384 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . 56.9 tp -66.34 -21.13 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.408 0.623 . . . . 61.21 110.429 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.97 -13.27 56.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.437 -0.801 . . . . 72.31 109.794 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.47 -29.94 10.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.172 -0.922 . . . . 73.32 110.412 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 9' ' ' LYS . 77.4 mt -68.67 122.03 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 74.2 110.741 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 6.3 mp -68.92 142.01 92.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 70.03 111.258 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.756 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 15.3 Cg_exo -69.16 142.01 49.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.872 2.382 . . . . 73.54 111.571 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.76 29.54 38.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.214 -0.517 . . . . 71.22 111.9 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 18' ' ' GLY . 2.0 m -139.54 177.81 7.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.057 -0.349 . . . . 64.12 110.057 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 17' ' ' THR . . . 178.0 118.97 0.57 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.657 -0.577 . . . . 40.22 111.657 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.545 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 28.1 m -129.45 156.0 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.926 0.363 . . . . 54.32 111.712 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 4.7 p -80.42 107.95 13.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 73.13 110.895 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 138.15 31.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.534 . . . . 75.43 110.058 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 22' ' ' LEU . 2.4 tm? -82.75 100.36 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 70.22 109.86 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.32 97.85 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.941 -0.572 . . . . 52.02 109.52 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 64.84 -76.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.817 0.698 . . . . 65.2 111.719 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -142.88 6.04 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.612 0.244 . . . . 74.55 111.132 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -115.73 145.46 42.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.464 -0.335 . . . . 75.2 111.155 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -105.47 126.63 52.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.532 . . . . 74.51 109.562 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 5.0 mp -130.96 130.35 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 43.44 109.189 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.83 113.95 21.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.246 -0.434 . . . . 63.12 110.03 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.557 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.1 t -97.16 98.44 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.045 -0.525 . . . . 63.22 110.416 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HZ ' HG21 ' A' ' 68' ' ' VAL . 18.6 m-85 -76.21 138.74 40.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.339 -0.846 . . . . 72.13 111.313 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -123.41 76.14 53.44 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 109.121 -0.696 . . . . 74.45 109.121 164.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.39 -24.37 19.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.735 2.29 . . . . 75.24 111.267 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 3.4 mmp_? -94.74 137.11 34.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.077 -0.965 . . . . 74.11 110.251 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 31.4 p-10 -86.94 14.04 8.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 73.24 109.982 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 3.4 p-10 -113.75 -93.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.457 -0.792 . . . . 72.41 111.352 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 49.0 mt-10 -121.27 -52.64 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.963 0.727 . . . . 73.23 112.963 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.419 ' HB3' ' HG3' ' A' ' 34' ' ' ARG . 57.8 tp60 -55.72 130.92 45.23 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.267 0.84 . . . . 71.44 113.267 -169.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.4 m -128.72 170.23 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.207 -0.906 . . . . 52.0 109.846 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -144.72 111.31 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.769 0.319 . . . . 72.13 111.686 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.19 103.61 15.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.873 0.368 . . . . 62.1 110.258 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.1 pt -122.39 161.85 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.788 0.328 . . . . 65.55 111.353 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -76.88 46.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 34.31 111.126 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 45' ' ' ILE . 65.9 t30 -95.5 61.43 2.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.619 0.724 . . . . 73.32 110.776 -171.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 45' ' ' ILE . 4.2 mp -123.12 129.64 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.299 -0.864 . . . . 72.23 110.024 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.3 t70 -87.6 123.91 68.59 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 74.32 109.691 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 25.4 Cg_exo -63.84 -22.22 69.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.299 2.666 . . . . 73.21 113.806 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.76 -22.22 37.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.333 0.587 . . . . 74.43 110.465 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.01 -20.14 13.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 71.21 109.851 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 59.2 28.65 18.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.82 -1.082 . . . . 62.43 109.99 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.775 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -150.83 165.52 33.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.136 -0.938 . . . . 75.31 109.864 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.946 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 3.8 p -80.75 56.93 2.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 63.35 111.258 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.12 -9.72 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.618 . . . . 74.42 110.368 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -95.0 -1.46 52.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.321 -0.854 . . . . 74.4 109.25 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.946 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 25.9 t -113.12 -52.46 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.205 -0.907 . . . . 55.34 110.862 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -83.78 59.97 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 64.43 109.696 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -131.65 -91.26 0.53 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 114.835 -1.075 . . . . 30.54 111.963 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.74 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 58.9 mt -129.09 132.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 74.43 110.247 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.23 121.22 58.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.215 -0.661 . . . . 72.05 109.215 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.77 162.51 34.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.08 0.466 . . . . 65.35 111.185 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -87.15 157.15 19.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.707 -0.679 . . . . 72.41 110.263 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 82.8 t60 -131.36 96.19 3.94 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.691 -0.485 . . . . 74.33 109.691 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 73.79 -55.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.857 -1.065 . . . . 70.23 111.792 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.88 -36.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.966 0.412 . . . . 73.35 110.828 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 1.3 m-20 -89.24 169.84 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 73.44 111.542 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.8 mt -108.93 123.79 49.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.492 -0.776 . . . . 73.11 109.898 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.507 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 11.8 m95 -130.84 174.94 9.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.204 -0.665 . . . . 63.41 109.204 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.4 p -120.09 145.28 26.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.955 -0.387 . . . . 51.22 109.955 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -110.02 103.54 12.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.173 0.511 . . . . 51.1 110.539 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -73.89 124.68 90.37 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 65.31 110.36 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 24.3 Cg_endo -61.0 -32.45 92.36 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.792 2.328 . . . . 65.14 112.874 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.3 -63.65 1.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.388 -0.369 . . . . 74.14 111.425 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.817 ' HE3' ' HE2' ' A' ' 90' ' ' TYR . 73.2 mmtt -71.87 -26.55 62.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.32 112.022 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 62.69 15.88 8.45 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.065 0.546 . . . . 73.43 111.733 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 79.6 mt-30 -80.3 141.81 35.12 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.959 -0.564 . . . . 74.31 109.625 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 29.1 m80 -104.57 96.44 6.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 51.22 110.246 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' HG12 ' A' ' 68' ' ' VAL . 58.9 m-85 -82.42 121.22 26.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.767 -0.457 . . . . 71.43 109.767 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 65' ' ' ASP . 23.8 ttp85 -71.5 127.59 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.747 -0.834 . . . . 54.44 108.747 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 68' ' ' VAL . 87.5 mt -72.72 67.46 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 44.31 113.059 -167.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 t80 168.68 -52.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.975 0.91 . . . . 63.31 109.592 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.95 -44.0 61.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 73.24 111.587 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.77 -15.37 44.97 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.474 -0.87 . . . . 23.43 113.183 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.26 135.65 57.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.108 -0.331 . . . . 72.13 110.108 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 2.5 m -90.54 22.59 3.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.022 -0.536 . . . . 72.11 111.476 -172.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp 59.41 -73.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.716 0.806 . . . . 62.32 112.277 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -81.6 -49.99 9.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.289 0.566 . . . . 74.11 110.724 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -105.51 -175.53 2.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.513 -0.767 . . . . 70.21 110.419 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.48 32.71 0.77 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.824 -0.91 . . . . 43.35 110.824 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.04 -48.25 18.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.039 0.447 . . . . 74.53 110.874 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.817 ' HE2' ' HE3' ' A' ' 73' ' ' LYS . 56.5 m-85 -102.58 79.56 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.265 0.555 . . . . 55.43 110.037 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -73.18 82.72 1.32 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.627 -0.715 . . . . 61.45 109.695 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -78.69 149.69 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.596 -0.729 . . . . 73.21 111.753 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.32 165.58 11.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.849 -0.614 . . . . 73.01 110.187 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -122.27 105.06 9.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.062 0.458 . . . . 61.11 110.343 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.66 129.83 34.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.865 -0.607 . . . . 62.21 110.201 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.9 153.89 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.766 -0.652 . . . . 74.13 110.76 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.813 HG22 HG22 ' A' ' 106' ' ' ILE . 30.8 p -133.54 133.66 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.293 -0.412 . . . . 73.12 110.931 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -114.86 150.67 35.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.388 . . . . 75.22 110.024 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 t -102.98 96.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.99 -0.55 . . . . 72.3 109.922 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.0 m -66.99 -63.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.994 -0.548 . . . . 74.32 111.014 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -173.75 95.67 0.1 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.607 -0.724 . . . . 73.21 109.781 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.13 -40.86 2.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.152 -0.547 . . . . 71.1 112.369 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -104.21 151.64 23.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 73.42 110.604 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 47.9 t -101.47 135.99 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 60.14 110.661 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 75.8 mt-30 -118.2 127.06 53.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 64.34 110.151 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.813 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -100.25 155.17 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 63.44 110.83 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -77.02 124.07 27.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.709 -0.678 . . . . 54.44 110.407 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 pt -116.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.259 0.552 . . . . 74.23 110.935 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.61 19.54 7.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.444 0.64 . . . . 74.15 110.481 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.6 150.92 21.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.145 -0.934 . . . . 63.52 108.644 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 t -137.13 17.2 2.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.116 0.26 . . . . 74.21 110.762 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 53.88 84.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.288 0.566 . . . . 64.43 109.637 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.8 m -67.49 133.56 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.656 -0.702 . . . . 72.3 112.437 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.33 -175.0 5.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.146 -0.934 . . . . 44.11 108.812 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.14 70.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 122.821 1.296 . . . . 43.03 110.683 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 117' ' ' ASN . 25.1 t70 55.03 -158.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.224 -1.807 . . . . 74.34 110.084 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 116' ' ' ASP . 6.9 p30 -165.59 167.96 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.053 -0.404 . . . . 54.32 110.467 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.2 t -117.25 79.45 1.34 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.099 -0.704 . . . . 65.45 109.099 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.8 114.82 13.49 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.584 -0.735 . . . . 64.11 111.061 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 3.8 Cg_endo -85.49 106.63 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.844 2.363 . . . . 71.43 110.457 173.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.56 107.6 2.4 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.384 -0.371 . . . . 74.35 111.106 -174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 93.1 Cg_endo -88.77 146.99 5.82 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.867 2.378 . . . . 65.45 111.84 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 pp -91.31 135.61 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.23 0.538 . . . . 71.33 110.178 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -100.05 176.81 5.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.376 -0.972 . . . . 75.05 108.376 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.459 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 41.4 m80 -72.01 76.94 0.92 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.31 -0.996 . . . . 71.53 108.31 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 50.5 t-80 -75.51 95.14 3.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 73.14 110.736 -171.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -86.03 85.02 7.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.768 -0.651 . . . . 71.03 110.757 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -98.02 89.94 4.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.91 -0.586 . . . . 74.33 109.774 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -95.01 -49.01 5.73 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.983 -0.747 . . . . 53.24 108.983 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.1 p80 . . . . . 0 C--O 1.244 0.794 0 CA-C-N 115.456 -0.793 . . . . 73.23 109.078 173.483 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.78 0.324 . . . . 73.32 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 t -89.14 -171.49 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.852 -0.613 . . . . 74.33 110.272 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -83.91 104.24 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.987 -0.551 . . . . 61.42 110.142 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.49 136.59 52.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.375 . . . . 75.22 110.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -118.74 128.47 54.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.222 -0.445 . . . . 63.3 110.353 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.611 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.6 m -78.14 113.7 16.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.175 -0.466 . . . . 54.21 110.77 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.11 -75.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.07 0.462 . . . . 75.24 109.848 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.3 m -144.34 168.44 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 72.12 109.189 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 9.8 mtmp? -91.17 165.81 13.28 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.992 -0.283 . . . . 64.14 110.578 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 tp -71.27 -7.59 47.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.496 0.665 . . . . 74.04 110.124 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.65 -20.29 21.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.216 -0.902 . . . . 72.11 110.002 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 18.4 m-20 -83.47 -27.18 29.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 73.54 110.694 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.87 136.99 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.87 -0.604 . . . . 73.24 110.572 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HB2' HG21 ' A' ' 17' ' ' THR . 5.2 mp -91.53 149.04 38.7 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.621 -0.263 . . . . 74.04 110.977 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.98 121.41 8.89 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.562 2.175 . . . . 74.42 111.696 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 45.72 6.24 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.93 -0.577 . . . . 73.03 112.198 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 14' ' ' LEU . 72.5 p -141.61 174.9 10.13 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.954 0.377 . . . . 63.53 111.073 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -164.22 110.83 0.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.266 -1.134 . . . . 74.05 110.266 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -125.78 135.8 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 117.265 0.533 . . . . 73.43 112.43 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 8.7 p -79.72 104.22 10.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.86 -0.609 . . . . 72.12 110.082 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.06 147.46 23.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.108 -0.496 . . . . 73.2 110.236 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.57 113.35 22.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.897 -0.779 . . . . 73.22 108.897 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.33 93.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.872 -0.603 . . . . 73.33 110.082 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 67.23 -75.57 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.238 -0.892 . . . . 72.41 111.854 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.589 ' HG2' HG12 ' A' ' 115' ' ' VAL . 88.3 mt-30 -132.26 -8.49 3.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.446 -0.343 . . . . 73.42 111.223 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.406 ' NE2' HG21 ' A' ' 113' ' ' VAL . 16.3 mm-40 -122.9 163.53 20.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 75.42 111.46 -175.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.21 128.84 51.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 54.33 109.912 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -127.13 119.04 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.765 -0.457 . . . . 64.33 109.765 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -88.96 125.47 34.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.933 -0.576 . . . . 43.43 110.262 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.528 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.1 t -107.87 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.166 -0.47 . . . . 73.2 110.081 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 63.1 t80 -91.8 130.25 37.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.716 -0.675 . . . . 71.34 110.352 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HG3' HG12 ' A' ' 39' ' ' VAL . 64.2 ttt180 -131.31 100.37 16.85 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.009 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.45 -32.76 6.0 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.672 2.248 . . . . 54.32 113.293 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -128.73 166.13 19.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.52 -0.309 . . . . 75.12 110.684 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.77 26.47 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 63.33 111.255 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 16.5 m-20 -113.56 -155.04 0.56 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.461 -0.336 . . . . 74.15 110.745 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 24.4 mt-10 -84.4 -13.04 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.916 -0.583 . . . . 74.55 111.61 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -73.07 100.23 2.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.097 0.475 . . . . 72.53 110.992 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 32' ' ' ARG . 27.0 m -129.95 156.4 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 60.51 110.159 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 80' ' ' TYR . 93.7 m-85 -131.36 102.84 6.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.698 0.285 . . . . 64.14 110.667 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.94 96.91 7.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.01 0.433 . . . . 62.33 110.682 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 44' ' ' ASN . 49.3 pt -134.56 -179.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.461 . . . . 51.12 110.083 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -79.29 60.73 3.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 73.32 109.911 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 42' ' ' ILE . 50.5 t30 -93.0 46.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.457 0.646 . . . . 54.44 110.644 -174.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.7 mp -103.05 131.25 51.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.512 -0.767 . . . . 65.33 110.04 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 10.0 t70 -82.52 120.94 77.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.101 -0.703 . . . . 73.22 109.101 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 43.4 Cg_exo -57.35 -23.71 56.39 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.227 2.618 . . . . 61.25 113.678 -175.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -84.14 -20.35 32.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 65.45 111.08 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.78 -20.57 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.99 -0.284 . . . . 71.24 111.195 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 64.49 19.19 11.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.692 -0.685 . . . . 71.41 111.096 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.687 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -137.1 169.7 17.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 42.23 109.927 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -81.42 50.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.682 -0.69 . . . . 74.53 111.291 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.66 -19.05 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.115 0.484 . . . . 31.23 109.91 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.23 -43.45 98.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.62 -0.718 . . . . 51.13 109.38 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -71.3 -23.15 61.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.441 -0.8 . . . . 71.54 111.09 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -98.37 20.23 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.267 0.556 . . . . 73.14 110.429 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.51 -149.29 24.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.745 -0.661 . . . . 61.02 111.636 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.6 mp -90.26 116.32 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 75.4 109.759 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 68' ' ' VAL . 60.2 t -112.37 112.93 42.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.672 -0.695 . . . . 71.51 110.301 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.6 159.07 30.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 53.11 110.237 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HG3' HD23 ' A' ' 66' ' ' LEU . 2.1 mp0 -76.07 163.32 27.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.992 0.425 . . . . 72.24 110.251 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -122.09 46.54 2.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.727 -0.67 . . . . 74.34 109.264 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 55.85 25.31 8.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.087 -0.961 . . . . 64.43 111.697 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -164.15 -55.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 55.31 110.777 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.566 ' HB3' ' NE1' ' A' ' 67' ' ' TRP . 2.3 t0 -135.83 -173.0 3.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.086 -0.506 . . . . 71.42 110.116 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 79.2 mt -107.34 110.02 21.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 73.14 109.98 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.566 ' NE1' ' HB3' ' A' ' 65' ' ' ASP . 61.3 m95 -122.89 128.69 50.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.38 . . . . 71.55 111.062 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG23 HG22 ' A' ' 59' ' ' VAL . 13.2 p -103.56 145.69 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.22 -0.445 . . . . 72.03 110.339 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.21 117.68 30.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.499 -0.318 . . . . 44.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 27.3 t -73.34 147.27 87.48 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 65.4 111.29 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.36 -20.53 24.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.437 2.091 . . . . 63.11 112.021 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 72' ' ' LEU . 4.0 mm? -98.33 -67.98 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 72.0 110.499 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -64.58 -39.23 93.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 73.01 111.416 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 70' ' ' SER . 70.6 tttt 62.06 11.94 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.635 -0.711 . . . . 64.34 111.374 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 87' ' ' ASP . 21.9 mm-40 -88.65 150.04 23.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.386 -0.598 . . . . 64.21 109.386 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.4 m80 -89.86 121.66 32.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.914 0.388 . . . . 72.0 110.737 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -117.54 143.42 46.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 73.23 110.002 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 46.6 mtm180 -79.61 119.68 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.732 -0.47 . . . . 75.41 109.732 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 68' ' ' VAL . 92.3 mt -52.1 -55.82 18.37 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.811 0.671 . . . . 62.21 112.811 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.407 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 46.9 p90 -90.22 15.94 9.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.735 0.302 . . . . 74.3 111.44 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.794 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 29.5 t70 -122.52 -60.69 1.52 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 45.02 111.365 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.26 -22.8 14.92 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.298 -0.954 . . . . 52.31 113.289 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.36 166.21 18.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.997 0.398 . . . . 74.22 110.924 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -112.7 166.2 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.853 -0.612 . . . . 71.15 111.634 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 62.1 tp -94.89 -69.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 44.41 110.276 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -87.1 -19.51 28.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 74.14 110.985 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 5.1 t70 -96.59 -152.37 0.38 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.931 -0.396 . . . . 52.22 109.931 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.27 -33.34 0.29 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.962 -0.855 . . . . 74.01 110.962 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.25 66.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.461 . . . . 54.43 110.803 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 94.7 m-85 -107.44 61.45 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 70.43 110.893 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.24 121.63 33.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.467 -0.788 . . . . 71.33 109.385 174.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.88 163.73 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 71.2 112.124 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.53 131.22 37.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.65 -0.704 . . . . 70.43 110.961 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.9 98.73 7.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.88 -0.6 . . . . 71.14 110.369 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.63 150.88 34.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 63.45 110.475 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.24 122.74 23.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.54 -0.541 . . . . 74.42 109.54 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.92 HG22 HG22 ' A' ' 106' ' ' ILE . 69.3 p -124.7 160.88 27.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.247 -0.433 . . . . 74.03 110.589 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -168.9 151.38 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 73.12 110.715 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 60.4 t -94.01 106.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.547 -0.751 . . . . 52.25 108.978 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.2 t -104.34 -34.24 8.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.228 0.455 . . . . 74.55 112.228 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -133.03 30.81 3.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 54.52 110.369 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.25 -0.25 85.51 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.113 -0.795 . . . . 70.12 111.113 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.0 p30 -115.09 151.47 34.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.568 . . . . 60.02 110.318 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 99' ' ' VAL . 46.0 t -94.66 113.2 28.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 74.21 109.963 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 23.7 mt-30 -115.3 140.77 48.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.091 -0.504 . . . . 52.13 110.746 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.92 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -111.32 151.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.691 -0.686 . . . . 74.34 109.815 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 t -87.67 104.02 16.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.597 -0.89 . . . . 70.14 108.597 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.3 pp -74.12 135.91 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.588 0.709 . . . . 71.12 112.439 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.92 87.64 2.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.098 -0.955 . . . . 74.51 109.037 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -76.76 136.78 39.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.682 -0.69 . . . . 74.52 111.174 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.7 m -104.96 -81.81 0.53 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 73.54 109.927 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.04 100.6 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.148 -0.315 . . . . 52.2 110.148 174.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.406 HG21 ' NE2' ' A' ' 26' ' ' GLN . 55.7 t -139.45 133.06 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 72.01 109.896 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.15 166.47 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.274 -0.421 . . . . 53.43 110.644 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 25' ' ' GLN . 12.1 m -88.33 111.91 23.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.274 0.559 . . . . 62.23 111.548 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -95.22 105.84 17.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.258 -0.428 . . . . 73.02 109.944 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -112.71 33.43 4.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 71.14 109.714 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.7 m -59.06 -34.11 71.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 44.33 110.05 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 5.5 mp0 -88.05 117.44 68.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.157 -0.683 . . . . 51.03 109.157 171.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 33.8 Cg_exo -60.03 146.69 95.45 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.844 2.363 . . . . 64.24 112.793 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 146.09 96.98 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.756 -0.656 . . . . 60.35 110.523 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.06 129.46 35.42 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.816 2.344 . . . . 73.14 112.478 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.44 -64.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.445 -0.576 . . . . 74.13 109.445 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.85 28.02 3.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.379 -0.828 . . . . 71.1 112.833 174.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -95.83 20.82 9.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.602 0.715 . . . . 74.53 109.219 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -59.21 -63.03 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.368 -1.287 . . . . 72.13 110.243 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.3 m170 64.0 177.7 0.17 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.493 -0.776 . . . . 41.43 112.106 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -100.95 122.01 42.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.031 -0.531 . . . . 74.21 110.689 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -86.62 84.34 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.464 -0.569 . . . . 75.52 109.464 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.722 -0.656 . . . . 54.42 109.689 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.127 -0.323 . . . . 62.54 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -137.23 -33.55 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.303 -0.408 . . . . 74.41 111.199 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -86.82 16.84 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.421 -0.354 . . . . 73.25 110.831 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.465 ' CZ3' ' HG3' ' A' ' 98' ' ' GLN . 59.7 m95 -109.14 109.78 20.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.49 -0.323 . . . . 75.32 110.858 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -99.01 141.49 31.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.5 -0.318 . . . . 63.33 110.858 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 m -80.32 122.87 27.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.541 -0.299 . . . . 72.41 110.276 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.5 -81.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.883 -0.414 . . . . 73.11 109.883 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -145.17 -84.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 60.33 109.796 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 60.3 mttp -151.35 151.44 31.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.018 0.437 . . . . 71.12 111.128 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.3 tp -84.39 -13.56 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.091 0.948 . . . . 65.52 109.138 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -88.39 -28.34 21.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.585 -1.188 . . . . 75.34 110.199 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 -18.75 43.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 73.13 111.3 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 32' ' ' ARG . 48.6 mm -76.1 118.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 62.21 110.898 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.66 163.72 42.93 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.57 . . . . 54.43 111.684 -175.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.79 125.19 16.04 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.165 2.577 . . . . 73.11 112.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.45 40.47 96.2 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.08 -0.509 . . . . 54.11 111.923 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.7 m -148.68 174.29 12.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.842 0.353 . . . . 74.13 110.422 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 30' ' ' VAL . . . 166.16 165.38 23.43 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.745 -0.942 . . . . 63.15 110.745 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.528 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 30.7 m -129.57 164.6 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 74.03 111.652 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD11 ' A' ' 45' ' ' ILE . 2.8 p -83.44 129.27 34.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.913 -0.585 . . . . 72.21 111.084 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.92 125.41 51.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.797 -0.638 . . . . 74.34 109.921 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.06 89.57 5.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 74.35 109.403 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.8 104.39 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.296 -0.411 . . . . 64.32 111.151 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 61.38 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.031 0.832 . . . . 65.12 112.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.73 3.69 3.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.743 0.306 . . . . 75.23 111.061 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' HG13 ' A' ' 28' ' ' ILE . 58.0 mm-40 -102.28 129.22 48.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 73.12 111.329 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -102.73 88.2 3.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.926 -0.768 . . . . 74.13 108.926 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 26' ' ' GLN . 60.3 mt -105.33 135.76 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.88 -0.6 . . . . 72.53 110.825 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -117.99 137.16 53.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.128 -0.323 . . . . 71.55 110.128 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 26.2 t -95.38 146.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.534 -0.543 . . . . 65.23 109.534 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -140.65 129.41 23.02 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 70.51 109.629 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' HG3' HG12 ' A' ' 39' ' ' VAL . 46.8 ttt180 -111.71 91.15 14.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.01 -0.276 . . . . 74.52 110.825 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.13 -55.09 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.452 2.102 . . . . 73.23 113.668 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.677 ' HB2' ' OD1' ' A' ' 36' ' ' ASP . 34.3 mtm180 -89.58 -0.15 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.65 0.262 . . . . 63.41 110.926 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 64.5 t30 62.12 28.14 16.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.545 0.688 . . . . 70.51 110.895 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.677 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 6.4 p-10 -111.81 -166.71 1.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.254 -0.43 . . . . 64.42 110.324 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.75 -28.3 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 71.23 111.633 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.33 104.24 11.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.371 0.605 . . . . 70.12 111.433 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG12 ' HG3' ' A' ' 32' ' ' ARG . 30.9 m -105.77 158.56 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.459 -0.791 . . . . 73.12 109.596 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -113.28 96.3 5.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 72.22 110.258 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 93.6 8.15 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.747 -0.661 . . . . 64.54 109.429 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.3 pt -126.43 -172.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.001 -0.545 . . . . 74.13 110.678 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.49 47.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 53.32 110.284 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 33.8 t30 -83.12 40.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.271 0.558 . . . . 62.15 111.175 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 20' ' ' CYS . 33.4 mm -114.38 123.5 70.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 62.32 111.037 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.97 120.85 71.75 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.011 -0.737 . . . . 75.0 109.011 173.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD2' ' HE2' ' A' ' 90' ' ' TYR . 52.4 Cg_exo -56.34 -26.03 60.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.18 2.587 . . . . 41.01 113.406 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -78.15 -13.79 59.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 73.11 110.666 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.44 -34.85 4.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.902 0.382 . . . . 65.23 110.494 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 50' ' ' GLN . 5.7 tp60 66.37 17.56 10.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.325 -0.852 . . . . 65.44 111.027 177.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.41 171.06 14.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 55.02 109.311 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 6.5 p -76.97 80.24 3.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.477 0.656 . . . . 55.12 111.282 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.0 m -90.97 -20.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 72.22 110.171 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.449 HD13 ' HZ ' ' A' ' 77' ' ' PHE . 61.0 mt -86.08 -17.74 34.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.45 -0.795 . . . . 52.42 110.222 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 49.6 m -81.56 10.66 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 53.5 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -149.5 31.97 0.72 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.291 0.567 . . . . 75.21 109.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.67 -145.58 19.25 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.293 -0.867 . . . . 75.1 112.485 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.5 mp -97.83 123.94 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.106 0.479 . . . . 64.25 110.992 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -88.85 102.2 12.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.699 -0.682 . . . . 70.13 109.905 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 109.02 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 64.11 110.952 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.16 116.87 23.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.998 -0.546 . . . . 70.03 110.196 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -102.96 90.25 3.71 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.851 -0.426 . . . . 72.2 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 63.8 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.465 -0.789 . . . . 73.13 111.787 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -114.19 -22.91 9.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.352 0.596 . . . . 73.52 110.301 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 5.9 m-20 -91.64 154.14 19.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 72.32 111.712 -173.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.22 116.2 29.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.595 -0.73 . . . . 70.02 110.486 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.539 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 16.2 m95 -119.81 151.14 39.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 73.0 109.7 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.94 129.17 66.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.347 0.594 . . . . 75.0 109.724 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -87.94 114.27 24.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.626 -0.716 . . . . 71.31 110.216 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.4 t -62.42 116.22 21.48 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 71.41 109.867 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HD2' HD23 ' A' ' 54' ' ' LEU . 45.8 Cg_endo -69.25 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.491 2.127 . . . . 71.24 112.16 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -112.82 -50.65 2.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 72.35 111.198 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -92.64 -4.61 53.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.485 -0.325 . . . . 75.1 111.447 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HE3' ' HB2' ' A' ' 74' ' ' LYS . 32.2 ttmt 66.09 11.12 7.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.849 -0.614 . . . . 70.22 112.278 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.747 HE22 ' HB3' ' A' ' 89' ' ' ALA . 3.3 pt20 -102.36 150.71 23.07 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.133 -0.355 . . . . 74.05 110.697 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.38 107.31 18.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 74.05 110.189 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 16.2 p90 -111.29 142.38 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.289 0.566 . . . . 75.42 110.981 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 38.6 ttp180 -85.82 123.56 31.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 62.35 110.315 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.8 mt -50.66 -57.07 9.14 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.821 0.7 . . . . 74.31 112.497 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -87.08 37.08 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 71.21 111.468 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 26.4 t0 -149.92 -50.84 0.14 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.346 . . . . 75.01 110.649 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.93 -25.83 25.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.944 -0.646 . . . . 75.33 113.146 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -85.51 147.74 26.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.774 0.321 . . . . 74.12 110.955 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.2 m -102.04 47.16 0.91 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.992 -0.549 . . . . 41.52 111.749 -171.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HG ' ' HG2' ' A' ' 86' ' ' GLU . 49.5 tp 57.41 -95.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 50.23 112.123 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 6.5 mm-40 -107.23 -27.87 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 74.22 111.386 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 39.0 t70 -111.16 75.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.203 -0.666 . . . . 73.32 109.203 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -89.06 63.55 3.45 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.407 -0.815 . . . . 74.34 113.283 -171.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' HE22 ' A' ' 75' ' ' GLN . . . -80.45 -59.03 2.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.893 0.378 . . . . 51.53 110.576 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HE2' ' HD2' ' A' ' 47' ' ' PRO . 29.3 m-85 -90.04 74.19 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 65.13 110.323 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 100.3 3.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.497 -0.774 . . . . 62.41 109.638 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.76 167.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 53.11 111.125 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 135.89 51.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 40.41 110.53 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -96.86 92.33 6.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.935 -0.575 . . . . 45.11 109.578 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -67.2 155.87 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.432 -0.804 . . . . 73.54 110.754 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.66 142.8 29.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.543 -0.54 . . . . 72.0 109.543 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 106' ' ' ILE . 26.0 p -134.47 138.08 44.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.404 . . . . 65.44 111.082 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 48.2 mt-30 -104.85 144.13 32.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.864 0.364 . . . . 63.04 110.561 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.1 t -99.6 76.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.206 -1.035 . . . . 74.1 108.206 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.5 p -75.46 -32.58 60.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.27 -0.877 . . . . 63.14 111.789 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 103' ' ' ASN . 7.2 t-20 -164.52 -146.99 0.1 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.145 . . . . 72.41 107.907 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.07 36.81 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 42.12 111.239 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 20.4 p30 -145.74 163.25 35.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.96 0.504 . . . . 74.15 110.092 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 72.14 110.464 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -117.27 117.64 30.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 74.33 110.218 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.4 152.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.342 -0.39 . . . . 44.14 110.235 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 4' ' ' TRP . 9.0 t -87.81 125.37 34.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.496 -0.557 . . . . 74.33 109.496 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.07 96.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.092 -0.503 . . . . 44.41 111.029 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.71 140.97 35.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.478 -0.934 . . . . 54.54 108.478 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.98 139.28 42.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.415 0.626 . . . . 72.55 109.947 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.0 m -151.87 91.73 1.66 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.305 -0.862 . . . . 73.54 108.895 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.21 100.18 0.59 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 65.04 109.605 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.6 t -47.87 128.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.397 -1.274 . . . . 73.24 111.946 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.65 116.78 18.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.537 -0.756 . . . . 64.31 109.014 175.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.6 m -88.47 120.95 38.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.572 0.701 . . . . 74.53 112.278 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -105.87 -153.3 0.49 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.326 -0.99 . . . . 70.31 108.326 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.5 p-10 -142.49 94.07 2.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 73.53 112.362 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m 68.17 111.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.919 -1.037 . . . . 55.32 113.414 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -115.13 102.44 54.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.025 -0.732 . . . . 75.51 109.025 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.37 143.31 47.54 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.784 2.322 . . . . 63.14 113.015 -174.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.7 mt -109.42 106.41 58.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.755 -0.657 . . . . 71.23 110.13 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.13 94.39 0.57 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.589 2.192 . . . . 72.43 112.227 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mp -115.86 93.05 4.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.264 -0.425 . . . . 61.42 111.134 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -120.02 129.48 54.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.133 -0.691 . . . . 70.03 109.133 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -132.84 94.69 3.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.737 0.304 . . . . 75.01 111.096 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -109.67 132.63 53.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.473 -0.566 . . . . 71.13 109.473 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -143.6 113.22 7.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.277 -0.42 . . . . 75.44 110.022 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -92.92 122.09 34.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.191 -0.459 . . . . 73.22 110.101 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -91.71 -57.69 2.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.212 -0.662 . . . . 73.53 109.212 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.1 p80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.358 -0.829 . . . . 74.14 109.96 172.343 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.538 0.208 . . . . 64.33 110.835 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p 176.4 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.545 0.738 . . . . 75.21 109.019 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -132.09 16.3 4.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.938 -0.764 . . . . 74.23 108.938 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.45 ' HH2' ' OD2' ' A' ' 96' ' ' ASP . 73.9 m95 -59.81 117.22 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.71 -1.132 . . . . 61.42 110.393 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -89.61 131.83 35.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.121 -0.491 . . . . 64.44 110.192 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.1 m -74.47 118.9 17.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 62.42 110.48 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 23' ' ' VAL . 40.7 t -87.98 -70.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.091 -0.504 . . . . 70.43 111.064 -177.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -161.29 -177.33 5.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.666 . . . . 74.43 109.212 -174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' ILE . 58.3 mtpt -86.65 143.89 27.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.557 0.218 . . . . 74.1 110.592 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -67.28 -12.71 60.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.561 0.696 . . . . 74.35 110.139 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.09 -17.02 53.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 75.3 110.998 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.96 -9.08 16.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.31 0.576 . . . . 63.34 110.471 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' LYS . 46.3 mm -75.59 126.9 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.541 . . . . 61.02 110.686 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.8 mt -70.14 137.48 86.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 64.32 111.604 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -79.46 127.78 7.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.241 2.627 . . . . 71.42 112.639 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.84 23.77 44.53 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.932 -0.576 . . . . 71.01 112.573 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.35 167.34 29.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.064 0.432 . . . . 63.15 111.624 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -127.56 142.1 13.21 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.333 -0.707 . . . . 43.24 111.333 177.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.502 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 21.3 m -127.41 139.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.049 0.425 . . . . 72.23 111.821 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.4 p -70.64 99.0 1.59 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 53.21 110.479 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 132.04 34.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.112 -0.495 . . . . 52.34 110.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -86.99 100.47 12.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.377 -0.601 . . . . 72.22 109.377 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 106' ' ' ILE . 34.3 t -120.76 112.79 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.823 -0.626 . . . . 54.25 110.103 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 31.1 mt-10 61.78 19.41 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.269 0.557 . . . . 71.13 111.892 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 73.8 mm-40 81.47 19.72 0.39 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.176 -1.375 . . . . 70.55 111.27 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 44.0 tp60 -113.47 137.99 50.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.845 -0.798 . . . . 62.42 108.845 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -99.33 108.88 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 74.14 111.151 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.53 130.5 64.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.735 -0.666 . . . . 71.1 109.298 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 113.63 21.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 74.03 110.192 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 29.1 t -95.77 102.34 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.093 -0.503 . . . . 72.33 110.307 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.81 128.51 33.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.639 -0.709 . . . . 62.11 110.077 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 70.6 ttt180 -112.8 84.21 6.48 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.874 -0.788 . . . . 75.43 108.874 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.21 -31.75 53.14 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.672 2.248 . . . . 73.2 112.108 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 99.9 mtt180 -109.39 164.47 12.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.754 -0.657 . . . . 73.44 109.997 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -91.59 10.3 28.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.093 0.949 . . . . 63.14 108.647 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.25 -109.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.657 -1.156 . . . . 72.4 112.008 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.25 -67.06 1.02 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.455 0.539 . . . . 74.51 112.455 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.15 131.27 50.3 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.078 0.77 . . . . 71.31 113.078 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.4 m -124.74 169.18 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.872 -1.058 . . . . 72.11 109.861 175.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -137.8 104.4 5.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.565 -0.289 . . . . 74.42 111.298 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -97.14 108.28 20.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.153 0.501 . . . . 61.14 110.928 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 92' ' ' VAL . 34.4 pt -129.34 161.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.667 -0.697 . . . . 74.22 109.625 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 62.2 m -74.56 75.75 1.98 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.478 . . . . 74.11 111.096 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.55 HD22 HG11 ' A' ' 92' ' ' VAL . 26.8 t-20 -110.49 72.71 0.8 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.69 0.757 . . . . 63.13 109.487 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -127.82 133.16 68.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.268 -0.878 . . . . 74.45 109.829 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.04 125.8 63.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.769 -0.456 . . . . 64.31 109.769 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.94 -11.08 25.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.2 2.6 . . . . 65.21 113.392 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -87.64 -16.22 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.002 -0.279 . . . . 63.14 111.0 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.47 -26.67 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.283 0.475 . . . . 61.32 112.283 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.53 34.84 17.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 71.13 111.153 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -143.9 169.81 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 53.25 109.263 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 13.6 p -80.81 51.09 1.46 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.248 0.547 . . . . 72.25 110.973 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -18.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 75.13 110.196 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.464 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 72.5 mt -83.74 -17.07 42.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.345 -0.843 . . . . 61.43 109.745 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 m -89.96 -13.21 36.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.751 . . . . 70.21 111.6 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -104.96 30.32 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 71.53 111.339 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -94.66 -129.25 5.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.485 -0.864 . . . . 64.14 111.974 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.1 mt -104.74 108.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.071 0.462 . . . . 75.24 110.215 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 59' ' ' VAL . 7.2 p -103.37 108.53 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.502 -0.772 . . . . 50.04 110.073 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.85 166.01 27.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 64.13 111.569 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.95 120.94 33.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.525 -0.761 . . . . 73.3 109.718 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 63.7 t-80 -62.43 -76.88 0.05 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.728 -0.669 . . . . 62.43 110.024 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -130.97 -44.95 1.04 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.412 -0.813 . . . . 55.31 108.93 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -132.36 -21.45 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.275 -0.875 . . . . 71.32 110.574 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 1.6 t70 -109.92 175.15 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 72.22 111.203 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.76 124.57 49.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 45.54 110.359 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.621 ' CD1' ' HB2' ' A' ' 62' ' ' HIS . 40.1 m95 -124.63 143.84 50.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.164 -0.471 . . . . 65.12 110.594 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.43 117.44 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.617 0.722 . . . . 72.31 110.118 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -90.69 116.2 28.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.797 -0.638 . . . . 73.12 110.17 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -60.09 136.59 91.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.492 -0.322 . . . . 72.01 110.653 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.01 -31.53 55.39 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.695 2.263 . . . . 74.32 112.765 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.89 -56.83 2.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.595 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -90.93 -13.81 32.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 73.53 111.671 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 mttm 64.02 8.56 4.04 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.161 0.8 . . . . 74.23 113.161 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.52 127.12 30.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.094 -0.706 . . . . 72.35 109.094 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.756 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 41.9 m80 -90.87 99.45 12.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.037 -0.528 . . . . 64.34 110.371 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -84.71 120.45 26.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.933 0.397 . . . . 65.13 110.158 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 61.4 ttt180 -78.71 121.28 24.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.986 -0.552 . . . . 72.55 109.805 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.63 -36.22 78.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.42 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -80.29 -20.09 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.404 -0.362 . . . . 72.15 111.575 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 10.0 t70 -115.15 -74.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.023 -0.271 . . . . 73.51 111.586 -170.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' HG22 ' A' ' 92' ' ' VAL . . . 140.36 -27.12 2.53 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.802 -0.713 . . . . 75.32 112.124 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -63.31 151.68 40.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.178 0.514 . . . . 72.42 111.258 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . 4.4 m -103.39 50.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.63 -0.714 . . . . 75.01 110.643 -174.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 76' ' ' HIS . 38.6 tp 66.74 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.954 0.502 . . . . 74.11 111.363 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 36.6 mt-10 -109.08 -4.57 16.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 73.23 110.341 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 84' ' ' CYS . 6.9 m-20 -115.82 160.03 20.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.555 . . . . 72.53 110.917 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.39 27.67 2.49 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.978 -0.849 . . . . 75.3 110.978 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.3 42.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 54.22 110.745 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -117.27 62.39 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.11 -0.496 . . . . 74.53 110.299 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 2.5 p -65.88 107.19 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 75.3 109.784 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG22 ' HA2' ' A' ' 82' ' ' GLY . 28.0 m -68.01 136.78 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 75.01 111.295 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . -71.59 106.42 4.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.006 -0.543 . . . . 43.32 109.907 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -79.26 88.21 4.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.796 -0.638 . . . . 60.31 110.854 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -80.19 175.92 10.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.755 . . . . 74.42 109.811 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 20.0 t70 -114.32 147.29 39.33 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.992 -0.373 . . . . 73.21 109.992 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.486 HG23 HG22 ' A' ' 106' ' ' ILE . 1.3 m -129.0 157.16 42.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.62 -0.718 . . . . 75.25 109.606 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -153.34 143.26 22.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 74.2 111.112 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.86 98.27 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.39 -0.823 . . . . 73.15 108.783 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.4 t -94.3 -34.58 12.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.54 0.571 . . . . 70.23 112.54 -170.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -136.99 31.61 2.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.047 0.451 . . . . 34.41 110.599 -179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.62 -11.91 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 62.15 111.387 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.89 150.65 22.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.536 . . . . 74.34 110.127 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -97.12 120.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.305 -0.861 . . . . 75.32 111.05 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 36.2 mt-30 -115.59 142.33 46.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.101 -0.333 . . . . 62.22 110.101 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.632 HD11 HG11 ' A' ' 23' ' ' VAL . 2.8 pp -122.13 154.48 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.459 . . . . 75.33 110.633 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 t -113.38 102.01 9.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.778 -0.453 . . . . 41.25 109.778 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 106' ' ' ILE . 16.4 pt -109.04 110.96 34.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.187 -0.461 . . . . 74.43 111.124 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.47 13.29 28.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.66 0.743 . . . . 71.33 110.485 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -153.21 134.47 14.19 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.858 -1.065 . . . . 75.41 109.535 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 m -113.02 19.43 17.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.958 -0.564 . . . . 71.1 110.733 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.71 -92.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.648 0.779 . . . . 61.54 110.999 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.36 119.75 14.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.732 -1.122 . . . . 74.02 108.136 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.08 123.4 22.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.0 -0.545 . . . . 54.44 111.814 -174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.13 124.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.683 -0.69 . . . . 65.22 109.229 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.41 ' HA ' ' CD ' ' A' ' 25' ' ' GLN . 13.5 t70 -89.05 130.74 35.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.241 0.543 . . . . 62.42 111.957 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -127.11 136.78 52.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.338 -0.846 . . . . 75.04 108.887 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.3 m -103.24 -12.62 17.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.658 0.614 . . . . 65.24 112.658 -172.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -87.16 117.24 68.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 74.42 111.504 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -93.22 178.97 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.203 2.602 . . . . 72.25 111.997 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -124.52 106.27 30.05 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.77 0.319 . . . . 64.02 110.628 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -91.4 -170.92 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.075 2.517 . . . . 62.54 112.63 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.5 165.74 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 73.11 109.597 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.42 124.75 41.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.317 0.58 . . . . 73.2 111.01 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -112.22 131.22 55.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.903 -0.59 . . . . 55.12 109.574 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -153.51 120.58 5.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.979 -0.555 . . . . 71.21 110.942 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -88.5 158.25 18.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 54.12 111.265 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -132.21 171.95 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.747 -0.661 . . . . 62.12 110.344 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -155.01 164.68 38.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.074 -0.512 . . . . 73.04 109.644 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.6 p80 . . . . . 0 C--O 1.246 0.885 0 N-CA-C 109.209 -0.663 . . . . 74.45 109.209 174.241 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 2.0 mpt? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.26 -0.274 . . . . 70.15 110.26 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 p -86.05 -70.45 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.956 -0.297 . . . . 64.13 111.139 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.11 8.25 42.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.176 0.513 . . . . 73.31 111.398 -176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 97.0 m95 -81.19 112.11 18.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.811 -0.631 . . . . 74.43 110.072 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.482 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.0 m -95.93 126.72 41.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.679 . . . . 74.44 110.184 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.554 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 27.4 m -73.61 132.26 42.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.894 0.378 . . . . 72.43 110.994 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.14 -67.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.562 . . . . 74.3 109.514 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -169.92 -167.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 62.52 108.991 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 95.1 mttt -76.92 154.49 33.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.732 -0.213 . . . . 74.44 110.471 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 37' ' ' GLU . 56.9 tp -75.41 -27.07 58.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.51 -0.922 . . . . 60.41 108.51 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.37 -32.07 69.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.13 -1.395 . . . . 72.45 110.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.12 -14.27 59.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.422 -0.808 . . . . 74.41 110.186 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.0 mt -93.08 116.34 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 65.25 110.236 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.63 128.84 93.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 70.23 111.45 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.26 124.16 12.16 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.857 2.371 . . . . 65.23 112.16 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.62 28.62 8.28 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.814 -0.63 . . . . 52.41 112.141 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.27 170.46 17.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.608 0.242 . . . . 72.04 111.41 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -138.11 144.69 16.0 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.218 -0.753 . . . . 72.11 111.218 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.07 145.91 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.205 0.503 . . . . 71.32 112.18 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.677 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.2 p -86.79 133.08 33.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.101 -0.5 . . . . 72.21 111.213 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.38 125.9 41.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.092 -0.503 . . . . 71.43 110.419 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.97 99.9 2.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.773 -0.825 . . . . 72.52 108.773 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 106' ' ' ILE . 46.0 t -109.52 103.08 14.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 73.13 110.738 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 70.26 -53.72 0.64 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.285 -0.87 . . . . 73.1 112.771 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -143.6 -50.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.603 0.594 . . . . 74.42 112.603 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.595 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 95.9 mt-30 -109.39 167.38 10.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.743 0.306 . . . . 74.14 110.84 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -95.49 127.04 41.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.906 -0.588 . . . . 62.2 109.832 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.86 134.53 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.367 -0.605 . . . . 75.03 109.367 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -94.14 122.04 36.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.665 -0.494 . . . . 74.42 109.665 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 26.1 t -105.41 104.36 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.082 0.468 . . . . 70.45 110.18 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 79.5 m-85 -79.91 134.68 36.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.396 -0.82 . . . . 65.12 111.342 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -119.71 82.12 26.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.871 -1.159 . . . . 70.14 107.871 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.92 -25.63 19.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.649 2.233 . . . . 63.43 112.791 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 34' ' ' ARG . 61.8 mtt180 -111.57 167.72 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.684 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -84.5 2.88 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.153 0.501 . . . . 73.24 110.212 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 19.3 t70 -98.68 -150.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.894 -0.594 . . . . 54.21 110.041 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.561 ' HA ' HD21 ' A' ' 10' ' ' LEU . 40.7 mt-10 -105.83 21.62 16.97 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.892 0.701 . . . . 65.43 112.892 -169.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.4 123.21 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.593 -0.443 . . . . 62.33 110.337 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.45 167.3 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.983 -0.553 . . . . 75.43 110.967 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.696 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 78.3 m-85 -138.95 105.57 5.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 72.33 110.107 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -102.1 101.93 12.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.062 0.458 . . . . 63.22 110.651 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.7 pt -131.63 173.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.979 -0.555 . . . . 72.14 110.352 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.9 p -83.09 67.82 9.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.347 0.594 . . . . 72.12 109.69 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.562 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.9 t-20 -98.27 35.96 1.68 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.228 1.013 . . . . 71.3 109.517 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 20' ' ' CYS . 35.6 mm -107.01 109.14 27.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 71.42 110.483 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.71 115.95 42.94 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.129 -0.693 . . . . 64.41 109.129 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 90' ' ' TYR . 47.5 Cg_exo -57.51 -17.19 26.75 Favored 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.358 2.705 . . . . 71.44 113.445 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.09 -15.53 59.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 64.21 110.553 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.92 -29.89 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 61.34 111.645 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.68 37.99 12.34 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.328 0.585 . . . . 53.41 111.663 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.677 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.26 170.52 21.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.318 -0.856 . . . . 75.12 108.868 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 73.4 m -77.02 61.84 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.436 0.636 . . . . 74.31 110.895 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -80.42 -22.36 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.59 -0.732 . . . . 64.51 110.373 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.562 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 32.2 mt -81.06 -20.01 42.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.245 -0.65 . . . . 65.24 109.245 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 11.2 m -79.82 -15.6 57.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.225 -0.898 . . . . 75.44 110.904 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 18.71 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 63.44 109.759 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.78 -156.67 20.99 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.877 -0.678 . . . . 62.2 112.379 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.7 mt -100.01 125.09 53.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.875 0.369 . . . . 71.23 110.413 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.49 101.14 2.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.264 0.554 . . . . 65.52 109.83 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.56 95.37 5.7 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.536 -0.756 . . . . 54.01 109.616 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.48 137.71 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.784 -0.644 . . . . 74.51 110.244 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 41.1 t-80 -79.17 -169.93 2.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.647 -0.706 . . . . 72.23 109.288 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.491 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 24.0 tm0? -54.99 -37.73 66.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.778 -0.823 . . . . 73.42 108.778 175.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.19 60.62 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.253 -0.885 . . . . 72.41 109.888 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.64 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 1.5 t70 -156.52 173.29 17.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 63.55 109.674 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB3' HD23 ' A' ' 79' ' ' LEU . 96.7 mt -119.16 118.11 30.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.554 0.216 . . . . 74.11 111.36 -171.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 39.5 m95 -136.25 125.52 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.817 -0.438 . . . . 72.41 109.817 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.87 130.64 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.974 0.416 . . . . 75.43 110.589 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.0 114.96 22.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.093 -0.503 . . . . 54.33 111.148 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.77 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . 29.1 t -62.08 126.8 88.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.563 -0.744 . . . . 65.55 111.086 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.2 -4.18 14.52 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.419 2.079 . . . . 73.23 112.079 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.7 mt -109.74 -55.93 2.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.119 -0.491 . . . . 61.31 111.207 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.593 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 48.3 mmtm -91.55 -16.26 27.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.171 -0.468 . . . . 55.34 110.951 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 54.76 70.01 0.67 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.68 0.753 . . . . 72.11 111.214 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -141.32 152.04 44.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.211 -0.904 . . . . 72.55 109.091 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 95.5 m-70 -93.97 100.43 12.57 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.236 0.335 . . . . 75.02 110.162 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.77 ' HE2' ' HB2' ' A' ' 70' ' ' SER . 96.9 m-85 -85.88 124.53 32.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.221 -0.445 . . . . 75.2 110.487 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HD3' ' HB3' ' A' ' 81' ' ' ASP . 33.4 ttt180 -73.81 122.58 22.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.657 -0.497 . . . . 71.54 109.657 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 66' ' ' LEU . 3.3 mm? -70.57 1.47 5.15 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.908 1.077 . . . . 55.45 113.908 -168.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -153.65 28.29 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.711 -0.396 . . . . 72.23 111.412 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 7.9 t70 -145.3 -71.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.026 -0.27 . . . . 71.51 111.327 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.82 -20.3 3.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.201 -0.999 . . . . 73.24 113.287 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.51 157.21 37.59 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.123 0.461 . . . . 63.23 111.569 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 8.8 m -109.87 20.88 17.53 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.415 -0.811 . . . . 75.21 110.516 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.7 tp 69.68 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.34 -0.845 . . . . 75.1 111.774 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.69 -63.02 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.725 0.298 . . . . 65.13 111.388 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.57 92.31 6.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.853 -0.425 . . . . 70.23 109.853 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.93 74.1 2.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.656 -0.783 . . . . 73.33 112.441 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.58 -1.13 13.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.617 0.246 . . . . 54.32 111.504 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.593 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -134.1 50.84 2.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 65.22 110.24 -176.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 m -64.75 116.63 6.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.818 -0.628 . . . . 75.31 111.546 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.87 168.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.52 . . . . 70.41 110.565 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.26 154.82 18.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 73.05 111.218 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -121.95 109.1 14.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.971 -0.559 . . . . 74.2 109.495 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -84.96 -177.79 6.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 64.33 110.718 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.58 137.17 51.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.407 -0.59 . . . . 75.4 109.407 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.706 HG23 HG22 ' A' ' 106' ' ' ILE . 3.2 m -134.5 161.26 35.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.709 0.29 . . . . 73.12 111.005 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.1 pt20 -138.56 153.21 48.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.237 0.542 . . . . 72.42 110.635 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.19 123.52 60.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 64.12 107.927 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 101' ' ' ASN . 3.7 t -131.59 -63.51 0.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.966 0.728 . . . . 61.41 112.966 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.524 ' H ' HG23 ' A' ' 100' ' ' THR . 92.0 m-20 -101.41 28.21 5.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.098 0.475 . . . . 74.41 110.774 -174.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.96 3.22 85.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.662 -0.78 . . . . 54.14 111.2 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 27.9 p-10 -113.31 158.33 20.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.32 109.797 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.92 122.75 65.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.013 -0.54 . . . . 70.13 110.545 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 16.5 mt-30 -127.02 136.19 51.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.643 -0.503 . . . . 74.43 109.643 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.706 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.39 153.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.079 0.466 . . . . 62.23 110.686 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -103.57 96.79 6.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.164 -0.68 . . . . 71.05 109.164 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.5 pt -112.12 78.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 63.11 110.735 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.91 -21.58 50.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.951 0.881 . . . . 74.34 109.921 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -148.04 132.07 17.23 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.993 -1.458 . . . . 74.45 110.863 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 m -158.2 -77.91 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.308 -0.997 . . . . 72.42 108.308 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -150.39 119.02 6.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.941 -1.133 . . . . 55.23 107.941 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 t -55.29 119.49 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.241 0.543 . . . . 72.2 111.553 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB2' ' HB3' ' A' ' 25' ' ' GLN . . . -85.08 87.53 7.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.412 -0.813 . . . . 63.43 111.176 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.17 94.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.734 -0.839 . . . . 73.23 108.734 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -153.11 -148.96 0.27 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.169 -0.923 . . . . 71.5 108.745 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -69.48 137.09 52.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.77 0.319 . . . . 74.44 110.999 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.8 t -64.71 -44.36 90.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.319 -0.623 . . . . 62.43 109.319 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 11.2 pt20 -122.22 126.67 26.18 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.587 -0.733 . . . . 73.44 109.48 172.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 16.6 Cg_exo -68.49 174.96 7.59 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.466 2.111 . . . . 44.02 111.799 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 154.85 76.48 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.169 -0.469 . . . . 53.22 109.771 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.03 106.3 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.012 2.475 . . . . 73.34 112.584 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 123' ' ' LEU . 3.8 pp -101.48 136.41 41.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.877 -0.601 . . . . 65.01 109.968 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.56 104.7 2.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.844 -0.616 . . . . 70.03 110.894 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -110.48 94.14 4.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.55 -0.75 . . . . 73.43 109.454 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -103.47 103.67 13.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.736 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -178.26 147.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.498 -0.927 . . . . 70.14 108.498 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -52.73 102.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.52 0.512 . . . . 72.13 110.445 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -89.04 135.73 33.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 73.43 111.359 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.645 -0.693 . . . . 71.22 109.58 172.625 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 110.116 -0.328 . . . . 75.13 110.116 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -126.44 -84.23 0.62 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 62.4 109.998 175.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -102.61 19.14 19.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.991 0.901 . . . . 73.24 108.6 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 1' ' ' MET . 21.5 m95 -117.07 117.46 29.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.28 -1.327 . . . . 75.41 109.402 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -88.54 138.13 31.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 71.24 109.619 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 13.4 m -79.59 122.79 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.031 -0.532 . . . . 73.01 110.858 -174.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 23' ' ' VAL . 36.3 t -85.6 -81.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.974 0.416 . . . . 74.01 110.707 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.6 m -155.43 -178.75 7.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 71.52 109.411 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -71.14 147.6 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 72.33 110.667 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 tp -66.48 -27.12 67.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.677 -0.692 . . . . 75.32 110.943 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -98.05 -8.05 28.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.685 . . . . 72.1 110.715 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 -29.72 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.864 -0.791 . . . . 74.33 108.864 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.45 127.22 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.77 -1.104 . . . . 55.12 109.97 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.56 144.98 30.39 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.288 -0.415 . . . . 74.41 111.176 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.648 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 Cg_exo -58.55 147.94 84.0 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.56 . . . . 75.42 112.389 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.71 26.34 56.58 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.002 -0.618 . . . . 72.11 111.854 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -141.22 178.55 7.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.135 -0.32 . . . . 74.31 110.135 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 17' ' ' THR . . . 175.25 105.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.839 -0.696 . . . . 60.22 111.865 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.09 170.77 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.691 0.281 . . . . 73.13 111.116 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD12 ' A' ' 45' ' ' ILE . 8.0 p -83.05 134.33 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 74.35 111.557 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.94 143.51 42.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 74.11 109.651 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.43 100.06 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.689 -0.486 . . . . 73.04 109.689 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 7' ' ' VAL . 21.7 t -101.31 81.3 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.092 -0.503 . . . . 35.03 109.938 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.77 -74.91 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.134 -0.939 . . . . 72.41 112.223 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -116.82 -35.43 4.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.597 0.237 . . . . 74.14 111.524 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -103.84 153.78 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.068 0.461 . . . . 71.41 111.833 -174.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.88 116.94 29.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.636 -0.711 . . . . 60.22 109.095 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mp -112.93 127.93 69.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.609 -0.515 . . . . 73.43 109.609 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -86.44 131.01 34.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.206 -0.452 . . . . 71.32 109.837 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 29.8 t -110.0 97.29 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.02 0.438 . . . . 72.02 110.042 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.857 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 89.7 m-85 -72.71 141.32 48.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.492 -0.776 . . . . 72.3 110.741 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.67 ' HE ' ' HA ' ' A' ' 36' ' ' ASP . 6.4 tpt180 -132.69 59.39 42.87 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.878 -0.601 . . . . 72.4 110.495 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 6.2 Cg_exo -79.39 -22.31 8.25 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.491 2.127 . . . . 65.33 111.011 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -82.06 150.74 27.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.986 -1.006 . . . . 64.11 109.81 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -75.49 77.13 2.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.095 0.474 . . . . 71.43 109.888 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.67 ' HA ' ' HE ' ' A' ' 32' ' ' ARG . 41.1 t0 63.16 179.6 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.753 -1.112 . . . . 70.32 111.409 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 66.46 -22.91 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.746 1.218 . . . . 73.2 114.006 176.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 36' ' ' ASP . 30.2 tp60 -134.62 114.14 12.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.02 0.438 . . . . 75.1 110.364 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG12 ' HD3' ' A' ' 32' ' ' ARG . 27.1 m -110.99 163.37 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.898 -0.592 . . . . 72.31 110.507 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.857 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 73.2 m-85 -127.28 86.69 2.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 75.01 110.132 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -91.15 98.35 11.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 94' ' ' ALA . 41.0 pt -131.95 175.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 72.21 111.118 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.452 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 15.1 m -83.94 75.46 10.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.163 -0.471 . . . . 60.21 110.178 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -130.8 85.88 2.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.461 0.648 . . . . 74.42 110.08 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.2 mm -120.42 -124.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.782 -0.822 . . . . 54.24 108.782 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.522 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.1 p30 -175.35 141.61 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.296 -1.001 . . . . 51.33 108.296 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -94.7 30.22 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.352 2.035 . . . . 74.53 112.802 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -117.56 -48.06 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 70.43 110.417 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.44 6.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.279 -0.418 . . . . 64.55 111.472 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 58.44 61.82 2.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.559 0.537 . . . . 71.24 111.167 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.69 16.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.583 0.216 . . . . 75.12 111.583 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 72.4 m 61.74 57.98 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.461 0.648 . . . . 62.45 110.8 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 46' ' ' ASP . 19.7 m -73.68 -9.67 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 64.42 110.309 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 94.3 mt -87.59 -9.69 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.468 -0.787 . . . . 64.04 110.25 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 5.1 m -103.03 -43.83 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.847 -0.615 . . . . 74.21 111.303 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -81.08 50.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 71.51 111.86 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.42 -115.52 2.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.491 -0.861 . . . . 53.41 112.92 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 83.2 mt -108.19 120.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.003 0.43 . . . . 74.2 110.853 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -85.34 96.58 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.35 -0.611 . . . . 65.52 109.35 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.18 118.14 35.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.153 0.501 . . . . 70.22 111.204 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -92.84 121.44 34.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.311 -0.626 . . . . 74.43 109.311 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -117.5 102.97 9.63 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.781 -0.451 . . . . 72.24 109.781 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.12 -81.95 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.352 -0.84 . . . . 73.52 111.222 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -124.39 -30.2 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.903 0.383 . . . . 75.53 110.72 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.688 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 35.1 m-20 -85.21 161.02 19.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.301 0.572 . . . . 74.4 111.206 -172.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 33' ' ' PRO . 94.6 mt -108.32 112.9 25.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.443 -0.799 . . . . 65.31 109.642 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.688 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 30.5 m95 -110.66 107.82 17.53 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.974 -0.38 . . . . 73.32 109.974 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 31' ' ' PHE . 14.4 p -78.1 133.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.699 -0.482 . . . . 71.45 109.699 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 75' ' ' GLN . . . -118.91 134.02 55.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.434 . . . . 74.03 110.532 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 1.2 p -74.86 145.14 80.96 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.176 -0.465 . . . . 70.55 110.338 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.86 -53.14 5.42 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.965 2.443 . . . . 72.03 113.214 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.97 -47.08 7.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 73.14 111.518 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 71.4 mmtt -65.71 -33.46 75.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.343 -0.39 . . . . 71.52 110.77 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 60.82 28.96 18.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.685 -0.688 . . . . 55.05 111.022 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 79.0 mt-30 -91.86 137.12 32.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.645 -0.707 . . . . 70.22 110.563 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.567 ' H ' ' CG ' ' A' ' 87' ' ' ASP . 26.5 m80 -101.91 126.11 48.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.658 -0.701 . . . . 60.12 110.885 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.15 125.09 45.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.486 -0.324 . . . . 70.32 110.158 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.55 111.22 8.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.048 0.451 . . . . 75.3 110.446 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.94 82.8 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.746 . . . . 74.11 110.784 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -172.52 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.442 -0.799 . . . . 74.03 108.944 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -121.98 -11.82 8.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.51 -0.768 . . . . 73.25 110.726 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.59 59.29 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.94 -0.648 . . . . 71.44 112.341 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -62.68 123.13 17.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 74.11 111.157 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.4 145.59 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.797 -0.816 . . . . 65.05 108.797 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.87 -62.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.369 -0.604 . . . . 74.02 109.369 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.66 13.99 1.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.913 -1.143 . . . . 75.22 107.913 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 76' ' ' HIS . 1.1 m-20 -95.38 31.29 2.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.619 -1.628 . . . . 74.5 110.892 -167.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.15 44.37 2.38 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.014 -0.612 . . . . 75.03 113.117 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.42 -21.62 27.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.268 0.556 . . . . 71.25 110.08 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.64 91.34 3.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.49 -0.777 . . . . 75.13 109.057 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -61.16 100.89 0.13 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.51 -0.768 . . . . 65.22 111.593 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.1 m -122.13 161.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 75.15 110.286 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.84 173.17 11.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 44.53 110.349 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.576 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -101.92 -158.84 0.7 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.984 0.421 . . . . 72.04 109.987 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -157.24 169.88 23.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.105 -0.952 . . . . 71.23 109.839 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 9.2 m-20 -88.68 126.7 35.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.989 -0.745 . . . . 63.24 108.989 170.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.595 HG22 HG22 ' A' ' 106' ' ' ILE . 80.6 p -128.75 131.98 47.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.568 0.223 . . . . 74.43 110.953 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -121.24 141.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 71.22 110.253 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.4 92.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.711 -0.677 . . . . 62.23 109.812 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.46 83.57 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.616 -0.72 . . . . 62.43 111.375 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 71.06 -82.4 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.181 -0.918 . . . . 54.13 111.831 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 8.17 7.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.802 -0.713 . . . . 63.42 112.931 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -138.53 152.07 47.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.973 0.387 . . . . 71.34 110.46 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.0 t -107.21 131.91 56.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.274 -0.421 . . . . 73.01 110.807 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 68.0 mt-30 -127.51 128.23 45.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.939 -0.393 . . . . 73.23 109.939 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.595 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -117.32 156.16 18.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 73.04 110.985 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 13.5 t -98.14 106.76 19.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.345 -0.613 . . . . 71.02 109.345 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 pt -80.6 142.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.037 0.446 . . . . 65.44 110.962 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.79 22.0 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.965 -0.562 . . . . 62.21 110.936 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.88 -178.08 5.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.712 -0.676 . . . . 72.1 109.972 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.3 m -137.86 -2.54 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 73.25 110.474 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.3 t70 61.34 95.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.543 -0.753 . . . . 74.34 111.146 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -101.36 112.6 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 70.24 109.463 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.67 158.59 43.96 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.969 -0.56 . . . . 72.33 110.386 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.83 140.97 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.226 -0.443 . . . . 53.53 110.232 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -73.29 147.72 44.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.236 -0.438 . . . . 74.01 110.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -85.73 92.65 8.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.91 0.862 . . . . 75.21 109.146 172.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 m -63.46 -21.0 66.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.753 -1.112 . . . . 71.23 111.686 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -122.54 93.22 48.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 71.01 110.091 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.4 167.19 23.27 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.176 2.584 . . . . 74.13 111.801 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 82.3 mt -97.68 138.42 21.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.232 -0.44 . . . . 71.21 110.108 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 31.6 Cg_exo -59.47 113.12 1.47 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.748 2.299 . . . . 73.52 112.145 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 pp -78.35 -12.07 59.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.108 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.94 132.31 37.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 72.53 111.458 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -86.83 99.63 11.95 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.276 -1.379 . . . . 63.43 107.276 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.75 -79.22 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 74.13 111.004 -168.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -166.07 143.86 5.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.399 -0.593 . . . . 75.24 109.399 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.73 131.49 46.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.523 -0.547 . . . . 73.2 109.523 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -70.58 -45.99 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 71.42 109.99 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 117.958 -1.02 . . . . 75.41 108.849 170.378 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 25.2 ttt . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.604 0.24 . . . . 64.14 110.637 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 p -130.12 -82.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.618 -0.512 . . . . 45.53 109.618 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 107' ' ' SER . 14.2 mm100 -106.55 -3.38 20.86 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.411 -0.959 . . . . 74.13 108.411 166.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 84.0 m95 -86.31 110.69 19.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.915 -1.493 . . . . 75.23 109.482 175.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.696 HG21 HG11 ' A' ' 23' ' ' VAL . 19.1 m -100.22 136.79 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.618 -0.512 . . . . 73.04 109.618 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 8' ' ' CYS . 8.5 m -81.12 126.67 31.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.975 0.417 . . . . 73.22 111.974 -173.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.71 -1.2 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.6 0.714 . . . . 64.11 109.476 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.839 ' H ' HG22 ' A' ' 6' ' ' THR . 61.1 m 87.49 -60.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.566 -1.197 . . . . 62.33 111.581 169.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.85 ' HE3' ' HB2' ' A' ' 12' ' ' ASP . 44.1 mtmt -145.34 146.41 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.974 0.416 . . . . 64.55 111.893 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 37' ' ' GLU . 35.6 tp -84.12 -25.92 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.717 -1.216 . . . . 74.54 107.717 165.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -60.61 -39.37 87.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.168 -1.378 . . . . 64.23 111.349 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.85 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -77.67 -10.16 59.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 72.0 110.175 -176.399 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.4 mt -93.78 113.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.839 -0.619 . . . . 71.43 109.782 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.5 mt -69.7 139.16 88.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.316 -0.402 . . . . 73.5 111.381 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 16.5 Cg_exo -68.2 128.17 17.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.096 2.531 . . . . 72.13 112.178 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.07 19.33 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.949 -0.569 . . . . 72.3 112.19 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 172.47 16.86 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.816 0.308 . . . . 72.12 111.41 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.16 138.01 5.05 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.734 -0.546 . . . . 52.24 111.734 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.09 167.59 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.937 0.368 . . . . 43.45 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.79 109.42 11.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.979 0.419 . . . . 43.24 111.401 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.34 106.84 6.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.831 -0.622 . . . . 74.15 109.342 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 27' ' ' GLN . 3.2 tm? -78.13 105.48 9.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.07 -0.514 . . . . 64.33 109.709 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 5' ' ' THR . 48.5 t -118.6 92.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.759 -0.655 . . . . 63.12 110.016 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 61.64 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.578 -0.737 . . . . 70.43 112.035 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -118.82 -2.14 10.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.16 -0.473 . . . . 73.33 110.807 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -109.29 139.45 44.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.399 -0.364 . . . . 75.11 111.222 -174.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HG2' HD23 ' A' ' 22' ' ' LEU . 52.7 mt-30 -128.92 113.16 14.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.934 -0.576 . . . . 75.14 109.805 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HA ' HD11 ' A' ' 45' ' ' ILE . 1.4 pp -132.71 142.82 41.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.935 0.398 . . . . 73.42 110.588 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.49 120.79 28.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 64.11 109.94 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.26 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 53.45 110.619 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 55.7 m-85 -72.45 134.62 45.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.623 -0.717 . . . . 75.45 111.156 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -120.43 81.53 31.01 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.103 -0.703 . . . . 71.41 109.103 165.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.01 -32.54 53.55 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.848 2.366 . . . . 74.4 112.733 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.92 -166.71 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 74.13 111.459 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -79.98 -18.88 49.2 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.202 0.816 . . . . 74.34 113.202 -165.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 38' ' ' GLN . 11.5 p-10 -110.81 -165.69 1.01 Allowed 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.335 0.495 . . . . 45.4 112.335 -168.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE1' HD22 ' A' ' 10' ' ' LEU . 6.5 mm-40 -69.52 6.62 1.03 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.152 0.797 . . . . 74.23 113.152 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 15.8 mm100 -74.42 83.27 1.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 70.13 110.757 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 HG21 ' A' ' 97' ' ' THR . 20.6 m -108.79 159.53 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.885 -0.598 . . . . 64.44 110.79 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 94.7 m-85 -135.67 109.16 7.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.464 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.87 95.78 7.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 71.22 110.623 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 44' ' ' ASN . 37.7 pt -121.85 168.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.016 -0.538 . . . . 63.14 111.255 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -78.87 48.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.223 -0.444 . . . . 73.22 111.4 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.527 ' HB2' HG13 ' A' ' 42' ' ' ILE . 53.9 t30 -98.35 46.42 1.0 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.357 0.599 . . . . 72.15 110.242 -173.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 20' ' ' CYS . 10.9 mm -83.52 -23.5 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.551 -0.749 . . . . 71.43 111.098 -175.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.861 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 7.5 t70 68.6 123.05 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 O-C-N 124.367 1.042 . . . . 72.34 111.631 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.6 Cg_endo -80.99 18.86 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.17 2.58 . . . . 75.24 112.951 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 85.0 t80 -111.28 -36.04 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.636 -0.256 . . . . 72.44 111.094 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.42 -20.98 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.108 0.41 . . . . 72.55 112.108 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 64.84 19.18 11.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.387 0.514 . . . . 74.13 112.387 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.55 22.98 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.889 0.329 . . . . 72.32 111.889 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 38.2 m 58.62 39.62 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.279 0.561 . . . . 62.32 110.785 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.54 -18.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 74.53 111.275 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 59.0 mt -75.11 -18.06 60.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 74.4 110.11 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -86.78 1.23 52.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.073 -0.512 . . . . 72.14 110.536 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -102.13 11.75 37.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.946 -0.761 . . . . 61.02 108.946 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.96 -151.31 12.08 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.353 -0.84 . . . . 71.5 112.825 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 mp -97.44 129.82 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 63.44 110.898 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.95 99.1 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.917 -0.772 . . . . 72.33 108.917 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.5 97.93 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.611 . . . . 75.02 110.843 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.52 110.93 19.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 74.12 109.49 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -89.89 92.24 8.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.534 -0.543 . . . . 61.12 109.534 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 66.52 -74.86 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.706 -0.679 . . . . 73.24 111.145 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -126.99 -24.86 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.828 -0.624 . . . . 65.24 110.185 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.9 t0 -81.4 165.41 21.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 73.21 110.556 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.5 mt -123.75 108.69 12.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.208 0.528 . . . . 63.14 111.12 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 37.0 m95 -117.56 144.49 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 74.4 109.88 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 7.1 p -102.12 125.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.158 0.504 . . . . 73.3 109.79 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -84.55 109.46 17.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.974 -0.557 . . . . 71.11 109.82 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.552 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 46.5 t -60.86 122.82 71.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.784 -0.643 . . . . 75.13 110.846 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 61.1 Cg_endo -73.34 -8.6 22.1 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.442 2.095 . . . . 65.21 112.138 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.22 -49.37 2.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 74.42 111.219 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 75' ' ' GLN . 29.6 mmtm -94.85 -6.62 42.35 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.197 0.443 . . . . 63.13 112.197 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 73.47 -35.89 0.33 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.241 0.616 . . . . 74.13 112.65 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.563 ' OE1' ' HB3' ' A' ' 87' ' ' ASP . 21.0 pt20 -59.29 159.14 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.626 0.727 . . . . 71.25 112.604 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 80.6 m80 -99.21 123.55 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.946 -1.024 . . . . 71.11 110.66 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 81.1 m-85 -99.12 124.67 44.32 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.755 -0.831 . . . . 71.24 108.755 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 10.3 ttp180 -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.28 -0.568 . . . . 73.44 109.508 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.69 -52.75 63.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.637 -0.71 . . . . 74.35 112.728 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.73 32.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 74.22 110.591 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 11.4 t70 -145.23 -56.79 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.324 -0.398 . . . . 73.4 111.322 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.23 -32.09 6.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.631 -0.795 . . . . 51.53 113.109 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -78.42 166.91 22.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.195 0.521 . . . . 63.35 111.335 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 20.2 m -106.03 159.5 16.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.56 -0.745 . . . . 74.24 110.487 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.469 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 63.3 tp -83.56 -65.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 45.33 111.72 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.1 pm0 -92.34 -11.22 35.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.331 -0.395 . . . . 72.33 111.711 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 9.2 t70 -135.64 -161.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.059 -0.719 . . . . 75.22 109.059 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.56 27.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.387 -0.911 . . . . 60.15 113.075 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 3.0 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.726 0.298 . . . . 54.41 111.432 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.86 -78.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.18 -0.208 . . . . 64.14 111.331 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 m 66.55 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.839 0.712 . . . . 73.03 110.949 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 42' ' ' ILE . 33.9 m -95.51 164.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 72.34 111.313 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 167.24 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 72.34 109.696 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -141.61 120.09 12.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.369 . . . . 40.51 110.065 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.44 148.44 24.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.812 -0.631 . . . . 74.43 111.171 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 m-20 -66.72 140.64 57.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 65.21 109.917 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.652 HG22 HG22 ' A' ' 106' ' ' ILE . 12.1 p -116.7 124.89 50.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.879 0.371 . . . . 74.12 110.637 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -106.4 139.43 40.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.404 0.621 . . . . 64.35 110.936 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.68 97.9 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.602 -1.181 . . . . 74.23 108.661 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.523 ' HB ' HE21 ' A' ' 105' ' ' GLN . 13.3 t -86.71 -17.05 34.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.117 -0.492 . . . . 51.1 111.645 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.41 -77.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.042 -0.725 . . . . 54.41 109.042 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.22 24.03 1.4 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.316 -1.514 . . . . 73.54 109.316 173.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -135.49 153.69 51.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.953 -1.124 . . . . 61.53 108.35 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.08 139.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 121.098 -0.241 . . . . 75.14 111.043 -171.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.523 HE21 ' HB ' ' A' ' 100' ' ' THR . 36.0 mt-30 -129.69 131.93 46.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.932 -0.396 . . . . 71.44 109.932 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.654 HD13 ' H ' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -112.34 144.5 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 71.11 110.85 178.088 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 49.7 m -78.47 106.82 10.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 63.41 110.208 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 pp -80.52 143.83 11.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.915 0.388 . . . . 75.54 110.409 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.3 -46.08 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.439 0.637 . . . . 40.43 110.275 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.6 t70 70.42 130.37 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.615 -1.63 . . . . 53.01 112.072 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.1 m -101.55 -84.48 0.44 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.416 -0.811 . . . . 64.33 109.978 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -146.52 104.45 3.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.305 -0.407 . . . . 73.41 110.756 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.6 t -113.36 142.82 24.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.814 -0.63 . . . . 72.25 109.484 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 120.96 18.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 62.2 110.385 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.99 138.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.031 -0.531 . . . . 54.41 110.17 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.11 167.63 11.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 74.21 110.993 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -121.57 87.77 2.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 64.24 110.115 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.1 t -79.6 63.96 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.619 . . . . 71.32 109.479 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -62.63 131.49 94.2 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 63.14 111.023 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.49 -175.11 2.41 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.827 2.351 . . . . 61.21 112.227 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.49 122.71 81.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 72.42 111.043 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.29 42.59 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.427 2.752 . . . . 72.31 111.569 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 1.7 pp -59.58 164.92 3.21 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.767 -0.651 . . . . 64.41 111.406 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.2 122.72 10.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.818 -0.628 . . . . 73.45 111.746 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.37 121.31 1.37 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.0 -1.0 . . . . 74.11 108.477 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -67.76 140.93 56.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.346 0.593 . . . . 54.22 111.683 -173.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -163.02 131.12 3.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.057 -0.974 . . . . 74.43 108.491 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -63.37 140.47 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.109 -0.33 . . . . 73.42 110.109 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -91.4 -174.05 3.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.331 -0.395 . . . . 74.53 110.055 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.3 p80 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.346 -0.835 . . . . 73.34 110.095 179.742 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.635 0.255 . . . . 75.41 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -86.78 173.91 9.14 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.03 -0.359 . . . . 51.24 110.03 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -80.63 81.38 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.569 0.223 . . . . 72.01 111.305 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -81.44 114.59 20.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.927 0.394 . . . . 72.34 110.225 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -122.98 136.17 54.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 75.04 110.638 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 40.8 m -81.99 137.55 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.354 . . . . 74.12 110.262 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.461 HG11 ' HB1' ' A' ' 21' ' ' ALA . 25.7 t -99.61 -75.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.099 0.475 . . . . 52.14 110.008 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.87 -173.39 4.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.81 -0.632 . . . . 64.13 109.495 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -70.05 139.75 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 63.11 110.709 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 ' O ' HD23 ' A' ' 10' ' ' LEU . 6.9 tt -83.65 -27.5 29.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.122 -1.066 . . . . 72.12 108.122 171.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -67.5 -25.32 65.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.526 -1.216 . . . . 71.41 110.563 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.9 -5.72 56.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 41.1 110.23 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 10' ' ' LEU . 71.2 mt -78.58 129.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 64.24 109.822 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mt -74.37 138.8 74.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.105 -0.498 . . . . 75.22 111.584 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 14.3 Cg_exo -69.35 123.62 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.878 2.385 . . . . 73.32 111.88 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.19 28.18 10.12 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.773 -0.649 . . . . 74.34 112.601 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.6 p -139.18 -178.81 5.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 117.207 0.503 . . . . 73.21 111.607 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -158.02 127.16 1.84 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.237 -1.145 . . . . 51.25 110.237 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.11 146.02 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.252 0.834 . . . . 70.41 113.252 -172.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.9 t -73.97 108.73 6.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.202 -0.908 . . . . 70.33 110.176 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 7' ' ' VAL . . . -103.86 128.27 51.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.119 -0.491 . . . . 70.4 110.548 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.14 106.19 17.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.861 -0.792 . . . . 74.11 108.861 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 108' ' ' ILE . 13.5 t -105.76 90.12 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.347 -0.388 . . . . 72.04 110.448 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 67.61 -67.14 0.19 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.214 -0.903 . . . . 72.04 112.103 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.9 tp60 -136.84 -18.15 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.792 0.293 . . . . 63.12 111.792 -175.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.52 ' HG3' HD11 ' A' ' 28' ' ' ILE . 3.6 pt20 -117.12 151.96 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 64.15 111.75 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -103.43 125.58 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.808 -0.633 . . . . 74.21 110.739 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 ' HG3' ' A' ' 26' ' ' GLN . 5.1 mp -129.17 143.45 41.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 53.31 110.056 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.1 36.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 73.2 109.584 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 45.6 t -105.93 104.97 17.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.895 0.379 . . . . 75.25 110.332 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.7 m-85 -81.88 131.02 35.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.734 . . . . 73.35 111.312 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB2' HG12 ' A' ' 39' ' ' VAL . 75.6 ttt180 -131.06 76.35 76.9 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.81 -0.811 . . . . 70.2 108.81 165.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.47 -19.37 13.17 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.574 2.182 . . . . 62.33 111.963 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -100.13 164.62 11.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 74.33 109.899 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 2.2 p-10 -80.92 -10.23 59.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 51.11 109.904 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.93 171.76 14.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.442 -0.799 . . . . 53.02 110.94 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HG2' HD22 ' A' ' 10' ' ' LEU . 29.2 mt-10 -85.52 30.89 0.6 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 70.45 111.253 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -100.57 103.33 14.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.144 -0.48 . . . . 74.44 109.755 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 32' ' ' ARG . 19.1 m -104.92 163.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.002 -0.544 . . . . 65.35 111.298 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.784 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 48.9 m-85 -124.19 102.77 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 73.25 109.951 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.01 95.23 9.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.16 0.505 . . . . 64.4 110.741 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.58 162.65 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.576 . . . . 72.01 110.057 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 92' ' ' VAL . 20.7 m -78.71 82.87 4.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.15 0.5 . . . . 72.55 110.589 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.26 17.96 21.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.066 0.936 . . . . 73.51 109.556 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.27 107.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.721 -1.127 . . . . 74.52 109.909 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.2 t70 -60.95 131.67 91.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.251 -0.431 . . . . 62.22 110.221 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 18.7 Cg_exo -67.39 -4.64 12.23 Favored 'Trans proline' 0 N--CA 1.472 0.26 0 C-N-CA 123.393 2.729 . . . . 64.12 113.482 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -113.16 3.96 16.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.296 0.57 . . . . 73.21 109.923 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.41 -35.83 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.31 111.91 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 64.66 21.52 12.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.941 0.401 . . . . 73.1 111.658 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -146.25 170.56 16.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.57 . . . . 63.43 110.082 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.8 m -81.61 59.91 4.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.53 0.681 . . . . 74.21 111.057 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -78.53 -23.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.65 -0.705 . . . . 70.21 110.312 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 70' ' ' SER . 57.8 mt -81.79 -21.79 37.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 73.45 109.948 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 m -74.56 -22.57 58.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.369 -0.832 . . . . 72.43 111.244 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -96.61 27.1 4.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.192 0.52 . . . . 75.43 110.675 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.47 -152.0 26.76 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 62.12 112.056 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.792 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 53.8 mt -86.44 103.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.043 0.449 . . . . 71.12 110.8 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -75.58 96.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.815 -0.63 . . . . 62.31 109.759 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.43 137.17 46.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.995 -0.548 . . . . 75.35 111.416 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 72.12 109.482 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.689 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 57.5 t-80 -107.52 114.43 28.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.208 -0.451 . . . . 74.2 110.113 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 69.76 -84.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.054 -0.975 . . . . 72.01 111.413 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.65 -9.31 2.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.511 . . . . 73.13 110.999 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' HB2' ' NE1' ' A' ' 67' ' ' TRP . 3.6 m-20 -115.16 -179.2 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.04 0.447 . . . . 65.12 110.873 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.0 mt -112.6 118.46 35.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 74.54 109.449 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 26.8 m95 -122.5 115.8 22.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.637 . . . . 64.44 109.991 -174.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.8 p -85.16 127.31 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.146 0.498 . . . . 60.05 110.605 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -89.9 101.94 14.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.917 -0.583 . . . . 71.45 109.463 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 54' ' ' LEU . 12.8 p -64.89 136.5 96.81 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.642 -0.708 . . . . 75.11 111.028 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 38.1 Cg_endo -67.7 -32.12 31.02 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.392 2.061 . . . . 71.14 112.51 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.78 -49.42 9.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 72.15 111.683 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 4.3 mmpt? -84.18 -27.14 28.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 72.32 110.157 -175.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 62.07 27.11 16.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.152 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.03 151.9 25.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 63.35 110.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 79.7 m80 -92.8 126.33 37.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.105 -0.498 . . . . 74.23 110.471 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HE1' ' HG ' ' A' ' 84' ' ' CYS . 85.3 m-85 -115.29 132.76 56.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.182 -0.463 . . . . 75.43 110.064 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 ttp180 -81.75 119.97 24.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.536 -0.542 . . . . 74.3 109.536 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' CG1' ' A' ' 68' ' ' VAL . 75.1 mt -78.81 23.92 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.679 0.622 . . . . 74.21 112.679 -170.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.49 24.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.257 -0.646 . . . . 61.43 109.257 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 25.2 t70 -136.65 -71.26 0.45 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.83 -0.623 . . . . 62.01 110.898 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.61 -26.78 4.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.759 -0.734 . . . . 45.41 112.225 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.63 169.49 12.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.312 0.577 . . . . 71.55 111.067 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 4.2 m -109.14 149.93 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.479 -0.782 . . . . 75.1 110.351 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.3 tp -98.73 20.26 13.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.247 0.546 . . . . 75.41 110.184 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -135.44 -68.11 0.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 74.01 110.618 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.33 136.27 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.548 -0.296 . . . . 63.41 110.348 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.35 49.04 3.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.031 -0.604 . . . . 74.31 112.801 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.15 -5.59 16.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 74.33 110.904 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' CE2' ' HD3' ' A' ' 73' ' ' LYS . 80.5 m-85 -136.14 32.38 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.134 -0.485 . . . . 74.02 110.816 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -78.27 117.35 19.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.159 -0.473 . . . . 51.3 110.045 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 43' ' ' SER . 30.3 m -116.05 -170.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 62.33 111.476 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.01 168.19 9.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 74.04 111.075 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.47 109.53 13.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.61 -0.723 . . . . 53.43 109.376 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -82.26 147.42 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.757 -0.656 . . . . 75.44 111.232 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 12.5 m-20 -66.24 122.11 16.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 73.22 110.068 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.537 HG23 HG13 ' A' ' 106' ' ' ILE . 1.6 m -117.51 153.77 32.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.85 -0.426 . . . . 72.53 109.85 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -144.41 153.01 41.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.445 -0.343 . . . . 64.45 110.261 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -124.9 105.39 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 72.5 109.138 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 101' ' ' ASN . 5.2 t -112.72 -63.6 1.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.986 0.736 . . . . 75.15 112.986 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.489 ' H ' HG23 ' A' ' 100' ' ' THR . 32.6 m-20 -106.33 29.2 7.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 71.54 110.403 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.13 90.28 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.875 -0.89 . . . . 73.24 110.875 -172.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -111.34 159.4 18.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.956 -0.622 . . . . 74.34 109.758 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 10' ' ' LEU . 22.0 t -103.69 125.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.256 -0.429 . . . . 63.12 110.565 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -124.52 131.41 53.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.42 . . . . 63.12 110.389 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 97' ' ' THR . 3.8 mp -113.71 142.04 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 63.1 110.005 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 47.0 t -80.53 99.21 7.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.285 -0.635 . . . . 71.41 109.285 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 23' ' ' VAL . 44.3 mm -77.0 94.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.668 -0.696 . . . . 64.34 111.142 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.0 134.6 34.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.248 -0.649 . . . . 73.21 109.248 173.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.8 121.83 18.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.662 0.744 . . . . 61.31 111.157 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 m -84.99 -69.71 0.63 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.013 -0.994 . . . . 73.32 109.356 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.48 97.61 3.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.369 -0.832 . . . . 64.43 109.396 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -111.69 135.84 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.888 -0.596 . . . . 75.52 110.517 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.05 175.13 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.919 -0.582 . . . . 72.3 109.592 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 m -67.52 104.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.384 0.611 . . . . 63.43 110.598 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.53 144.33 54.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 74.33 110.699 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -63.44 137.58 58.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 74.22 110.125 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 m -82.55 76.76 9.39 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.631 0.729 . . . . 74.35 111.359 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -82.54 151.84 65.88 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.071 -0.968 . . . . 74.24 109.662 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 119.81 7.18 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.3 2.0 . . . . 70.24 111.598 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.07 144.98 93.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 75.14 110.751 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.71 168.63 4.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.832 2.354 . . . . 73.31 112.063 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -80.35 45.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.337 0.495 . . . . 44.13 112.337 -174.618 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.72 139.6 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.93 -1.137 . . . . 74.25 107.93 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -67.05 -50.05 63.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.657 0.243 . . . . 73.21 111.657 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 53.9 m80 63.31 179.31 0.15 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 71.32 111.183 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -125.93 101.72 6.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.313 -0.995 . . . . 71.43 108.313 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -103.39 118.46 36.81 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.419 -0.512 . . . . 74.44 111.37 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.0 135.19 8.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 75.12 109.089 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.616 -0.707 . . . . 72.12 109.546 177.977 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.956 0.408 . . . . 75.13 110.592 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HB2' ' NE1' ' A' ' 4' ' ' TRP . 4.0 m -69.03 153.53 43.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 75.43 110.313 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -75.57 76.01 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.066 0.46 . . . . 70.23 110.861 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.422 ' NE1' ' HB2' ' A' ' 2' ' ' SER . 98.4 m95 -85.13 118.21 24.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 75.13 110.131 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -121.08 152.27 38.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 63.43 110.555 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.944 0.402 . . . . 75.2 111.543 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 30' ' ' VAL . 93.3 t -80.84 -68.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 61.32 109.498 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.1 t -179.22 -163.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.052 -1.092 . . . . 70.21 108.052 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 13.7 mtpt -79.15 136.24 37.06 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.896 -0.409 . . . . 72.41 109.896 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.71 -30.49 69.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.356 0.598 . . . . 73.21 110.104 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.57 -17.57 51.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.178 -0.919 . . . . 75.54 110.479 -176.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 t70 -84.81 -19.63 32.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.77 -0.65 . . . . 71.11 109.347 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.97 125.03 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.616 -0.72 . . . . 75.05 110.679 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 94.1 mt -77.13 133.47 68.76 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.205 -0.452 . . . . 64.3 111.665 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 12.7 Cg_exo -70.24 144.8 52.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.324 2.683 . . . . 74.44 112.555 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.61 56.1 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.935 -0.575 . . . . 12.52 112.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -156.48 158.06 36.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.779 0.323 . . . . 64.3 111.737 -172.676 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -122.58 138.74 12.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.797 -0.921 . . . . 72.14 110.797 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.78 142.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.459 0.54 . . . . 70.44 112.459 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.642 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -75.19 105.91 6.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.448 . . . . 64.22 111.44 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.72 132.92 35.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.86 -0.609 . . . . 71.41 109.911 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 118' ' ' SER . 2.9 tm? -100.17 98.14 8.88 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.48 -0.563 . . . . 73.42 109.48 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 106' ' ' ILE . 21.2 t -108.74 70.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.957 -0.565 . . . . 73.33 109.629 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 8.1 pt-20 42.2 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.938 1.295 . . . . 60.45 114.191 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.703 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 3.9 pt20 -80.87 -13.05 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.564 0.579 . . . . 72.22 112.564 -172.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.522 ' NE2' ' HB3' ' A' ' 110' ' ' ASP . 19.6 mt-30 -143.92 153.72 42.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.288 0.566 . . . . 64.32 111.951 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -115.33 117.86 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 65.11 109.054 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 106' ' ' ILE . 66.1 mt -122.01 132.32 71.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.838 0.351 . . . . 75.33 110.903 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 45' ' ' ILE . . . -88.65 125.6 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.292 -0.413 . . . . 53.34 110.641 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 7' ' ' VAL . 39.0 t -105.54 105.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.074 0.464 . . . . 74.14 110.126 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 74.7 m-85 -78.37 128.39 33.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.501 -0.772 . . . . 71.44 110.76 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 13.0 tpt180 -109.16 84.67 2.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.196 -1.038 . . . . 64.3 108.196 168.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' PHE . 16.9 Cg_exo -66.65 -48.03 2.46 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.621 2.214 . . . . 55.24 112.353 -174.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -116.92 166.75 11.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.048 -0.524 . . . . 63.13 110.111 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -81.77 72.65 8.82 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.092 -1.077 . . . . 75.21 108.092 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' A' ' 38' ' ' GLN . 19.0 t70 -150.19 179.04 8.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.896 -1.047 . . . . 75.14 109.082 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -79.27 -9.04 59.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.724 0.297 . . . . 74.53 111.33 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -78.08 129.27 35.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.6 . . . . 74.52 111.605 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.74 155.17 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.794 . . . . 53.35 110.021 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 55.3 m-85 -132.94 108.01 8.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.684 0.278 . . . . 71.41 111.005 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.24 108.29 19.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.878 0.37 . . . . 73.13 111.109 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.3 pt -132.16 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 71.32 110.146 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 55.0 m -81.82 89.91 6.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.796 0.332 . . . . 61.12 110.167 178.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -129.08 43.99 3.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.583 0.706 . . . . 75.13 109.223 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 20' ' ' CYS . 46.8 mm -107.98 128.98 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.585 -0.734 . . . . 62.1 110.532 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 t70 -85.91 118.07 69.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.259 -0.645 . . . . 74.21 109.259 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 19.2 Cg_exo -66.97 -12.18 35.12 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.225 2.617 . . . . 75.11 113.25 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -93.94 -18.69 21.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.951 0.405 . . . . 72.05 110.37 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.41 -22.27 13.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 70.21 109.639 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.22 28.81 9.93 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.909 -1.041 . . . . 61.31 111.782 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -159.17 173.74 15.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 72.33 110.561 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -79.65 52.27 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.919 -0.582 . . . . 62.52 110.94 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.75 -18.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.784 -0.644 . . . . 63.13 110.702 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.49 -6.43 49.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.624 -0.716 . . . . 73.13 109.666 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 5.1 m -100.61 -35.16 9.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.388 -0.824 . . . . 64.05 110.362 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HG3' HG22 ' A' ' 17' ' ' THR . 72.5 ttt180 -88.18 61.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.797 0.808 . . . . 73.52 109.665 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.72 -153.81 9.34 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.865 -1.061 . . . . 64.01 111.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.437 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.5 mp -94.75 120.69 44.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.892 0.377 . . . . 52.23 110.012 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.4 99.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.726 . . . . 64.32 109.832 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.73 119.98 31.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.474 -0.785 . . . . 41.2 110.454 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -95.45 132.48 40.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.078 -0.51 . . . . 63.54 110.639 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -94.76 -155.78 0.48 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.921 -1.14 . . . . 72.21 107.921 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -78.08 -30.91 49.86 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.878 -0.514 . . . . 72.31 110.275 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -128.59 -39.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.982 -0.554 . . . . 74.21 111.0 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 11.8 m-20 -93.74 158.94 15.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 73.1 112.289 -170.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.41 121.77 43.77 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.024 -0.989 . . . . 63.22 109.621 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.604 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 24.0 m95 -119.4 165.81 13.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.244 -0.434 . . . . 75.54 110.33 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -122.93 129.13 75.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.204 0.526 . . . . 73.32 110.08 173.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.19 107.99 19.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.868 -0.606 . . . . 74.35 110.012 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 21.1 p -74.55 134.69 75.87 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.979 -0.555 . . . . 72.44 110.448 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.38 -39.67 12.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.527 2.152 . . . . 64.43 112.562 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.61 -58.08 3.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 63.55 111.387 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.6 -31.42 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.436 -0.347 . . . . 73.21 110.965 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 70' ' ' SER . 56.2 mttm 65.78 17.78 10.96 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.514 -0.766 . . . . 60.32 110.782 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 73.5 mt-30 -85.99 138.46 31.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.436 -0.802 . . . . 75.05 108.948 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -97.12 105.98 18.23 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.857 0.36 . . . . 64.4 110.214 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -96.72 128.59 43.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.912 -0.585 . . . . 63.42 110.02 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 35.2 ttp180 -74.21 117.05 15.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.35 -0.611 . . . . 71.34 109.35 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.647 HD21 ' HB ' ' A' ' 68' ' ' VAL . 88.7 mt -48.13 -58.06 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.113 0.883 . . . . 75.45 113.306 -168.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' OH ' ' HA ' ' A' ' 65' ' ' ASP . 5.9 p90 -95.84 24.82 5.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.049 0.389 . . . . 75.13 112.049 -172.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 83' ' ' PHE . 8.1 t70 -142.03 -59.01 0.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.028 0.381 . . . . 75.33 112.028 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.28 -16.13 10.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.454 -0.879 . . . . 61.33 113.46 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.518 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 10.7 t80 -56.34 126.28 25.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.955 0.378 . . . . 75.21 110.068 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 22.5 m -97.08 37.15 1.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 72.1 111.029 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.762 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 52.3 tp 66.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.4 111.479 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.762 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 45.4 mt-10 -137.38 -33.13 0.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 54.24 110.599 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.43 93.17 5.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.606 . . . . 61.54 110.985 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.05 21.75 40.24 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.953 -0.567 . . . . 53.41 112.011 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.45 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.888 0.375 . . . . 74.11 111.384 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.26 -47.73 4.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.405 -0.361 . . . . 74.31 111.718 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.481 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 23.9 p 49.84 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.334 0.654 . . . . 64.42 112.188 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 43' ' ' SER . 34.1 m -76.21 161.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.932 -0.577 . . . . 71.33 111.316 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -103.25 154.51 19.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 64.44 110.861 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.09 106.01 8.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.923 0.392 . . . . 71.11 110.393 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.5 -177.61 3.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.089 -0.505 . . . . 73.41 110.875 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.39 158.18 17.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 73.34 111.166 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 106' ' ' ILE . 3.9 m -148.36 159.62 43.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.77 -0.65 . . . . 53.12 109.317 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 pt20 -161.71 155.69 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.024 0.44 . . . . 61.33 111.126 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 104' ' ' VAL . 29.2 t -132.19 127.35 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.607 -0.886 . . . . 60.04 108.607 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -135.67 -28.22 1.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.631 0.604 . . . . 64.3 112.631 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -139.55 32.62 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.051 0.453 . . . . 62.42 110.625 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.47 -37.31 3.35 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.593 -0.813 . . . . 73.34 111.865 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.0 140.34 34.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.975 0.417 . . . . 53.41 110.034 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 99' ' ' VAL . 41.3 t -96.53 131.57 42.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.829 -0.623 . . . . 63.4 110.211 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' THR . 40.0 mt-30 -116.61 141.77 47.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.77 -0.196 . . . . 71.03 110.596 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.689 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -123.9 161.93 25.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.292 -0.413 . . . . 72.31 110.271 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 37.3 m -101.88 101.07 11.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.375 -0.375 . . . . 61.01 110.982 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 pt -80.54 119.04 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.274 -0.421 . . . . 73.53 109.968 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.08 22.42 7.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 72.24 111.697 -174.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HB3' ' NE2' ' A' ' 26' ' ' GLN . 21.7 t70 -160.7 178.48 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.843 -0.617 . . . . 64.41 109.414 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.531 ' OG ' ' HB2' ' A' ' 25' ' ' GLN . 32.5 t -165.9 23.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.733 0.302 . . . . 65.34 110.591 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.83 82.88 3.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.53 0.681 . . . . 63.22 110.983 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.85 128.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.326 -0.852 . . . . 63.14 109.699 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.66 102.58 14.39 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.047 -0.524 . . . . 63.41 111.188 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t 70.32 125.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.454 -0.794 . . . . 74.53 112.216 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.18 157.39 23.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.48 -0.782 . . . . 74.34 110.16 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -132.9 19.06 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.016 0.436 . . . . 73.11 110.636 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.516 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 2.5 m -106.45 77.64 1.22 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 73.34 110.948 -173.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.433 ' CD ' ' H ' ' A' ' 119' ' ' GLN . 5.3 pm0 -66.33 137.65 95.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 75.13 110.503 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 24.6 Cg_exo -64.61 168.17 13.75 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.029 2.486 . . . . 52.42 112.985 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 121' ' ' LEU . 2.3 pt? -129.14 145.32 56.2 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 71.31 110.38 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 3.3 Cg_exo -80.35 179.88 5.78 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.937 2.424 . . . . 70.3 111.322 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.6 tp -134.94 93.77 3.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.858 0.361 . . . . 63.35 110.514 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.86 122.02 34.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.17 -0.468 . . . . 62.15 109.932 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -126.66 87.06 2.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.936 -0.394 . . . . 73.11 109.936 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -99.18 132.21 44.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 64.33 110.042 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -153.84 108.25 3.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 61.01 110.476 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -114.27 158.58 21.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.87 -0.605 . . . . 71.52 109.538 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.0 t60 72.33 132.41 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 124.046 0.841 . . . . 64.12 111.103 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.0 p80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.561 -0.733 . . . . 60.02 109.888 178.855 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 ttp . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.09 -0.337 . . . . 50.21 110.09 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.0 t -145.39 -46.18 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.365 -0.38 . . . . 72.03 111.261 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -83.95 27.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.114 0.413 . . . . 71.21 112.114 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -128.45 135.78 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.326 . . . . 71.21 110.474 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 m -119.79 132.04 55.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.102 -0.499 . . . . 72.35 110.203 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.813 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.7 m -71.49 117.52 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.098 0.475 . . . . 75.3 111.58 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG2' HD12 ' A' ' 106' ' ' ILE . 41.4 t -86.9 -67.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.293 0.568 . . . . 72.05 110.644 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.51 -177.6 6.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.781 . . . . 73.3 108.975 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 47.3 mtpt -84.2 157.16 21.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.85 0.357 . . . . 75.41 110.546 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.8 tp -79.16 -2.38 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.415 0.626 . . . . 55.12 110.142 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.48 -40.74 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.745 . . . . 62.33 112.202 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 p30 -88.6 -6.74 57.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 72.34 112.395 -172.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.38 129.85 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.882 0.372 . . . . 63.21 110.164 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 91.7 mt -61.22 124.52 80.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.153 -0.476 . . . . 74.11 111.708 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 14.8 Cg_exo -68.47 131.91 24.26 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 123.232 2.621 . . . . 43.53 112.646 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 84.55 18.51 61.88 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.792 -0.64 . . . . 55.41 112.77 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -153.13 162.32 41.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 117.096 0.448 . . . . 61.01 111.444 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -118.27 124.32 6.03 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.478 -0.649 . . . . 71.33 111.478 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -111.95 141.45 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.953 0.377 . . . . 70.23 111.482 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 6.9 p -82.32 92.91 7.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.086 0.47 . . . . 74.31 111.025 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -82.65 143.19 31.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 53.32 109.93 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 27' ' ' GLN . 3.2 tm? -80.02 97.44 6.8 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.28 -0.637 . . . . 73.14 109.28 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 HD11 ' A' ' 106' ' ' ILE . 19.2 t -91.24 79.65 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.894 -0.594 . . . . 72.35 109.997 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 65.15 -68.56 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 74.24 112.437 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 84.4 mt-30 -118.94 -19.41 8.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.903 0.334 . . . . 73.11 111.903 -173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -138.35 140.32 39.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.807 -0.357 . . . . 75.33 111.444 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 49.0 mt-30 -88.41 132.0 34.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.787 -0.449 . . . . 65.22 109.787 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 59.4 mt -130.37 136.44 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.186 -0.672 . . . . 33.42 109.186 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.24 108.41 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.385 -0.37 . . . . 64.02 110.225 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.6 t -101.0 110.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.91 -0.586 . . . . 65.33 109.907 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 89.8 m-85 -77.9 137.4 38.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.54 -0.755 . . . . 71.52 111.432 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -124.29 57.89 14.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.925 -0.768 . . . . 54.33 108.925 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.703 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 98.5 Cg_endo -77.65 -25.54 7.85 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.545 2.163 . . . . 75.23 112.871 -166.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -97.96 1.05 47.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.281 -0.418 . . . . 63.34 110.141 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.54 31.17 18.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 74.03 110.147 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.7 t70 -144.23 -158.71 0.91 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.191 -0.913 . . . . 74.44 109.674 -171.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.505 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 37.8 mt-10 -70.41 -25.82 63.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.226 0.454 . . . . 72.3 112.226 -172.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.58 91.38 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.102 0.477 . . . . 62.42 111.522 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.16 157.64 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.333 -0.849 . . . . 73.35 110.266 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -140.25 115.54 9.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 71.34 110.424 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 106.27 16.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.312 -0.404 . . . . 63.23 111.274 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 44' ' ' ASN . 38.5 pt -123.98 153.9 30.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 63.05 109.986 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 95' ' ' TYR . 44.9 m -77.23 59.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.128 0.49 . . . . 62.2 110.596 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 42' ' ' ILE . 64.9 t30 -105.1 63.54 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.621 0.724 . . . . 72.24 110.378 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mp -114.36 132.05 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.088 -0.96 . . . . 72.34 109.77 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.0 t70 -81.24 117.12 66.83 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 71.24 109.396 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 9.0 Cg_exo -72.32 -5.6 17.44 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.143 2.562 . . . . 73.41 113.576 -174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -89.46 -32.09 17.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.136 -0.32 . . . . 62.11 110.136 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -13.81 14.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.191 0.519 . . . . 55.52 110.066 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 57.98 59.68 3.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.862 -1.063 . . . . 73.44 110.914 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -167.32 158.44 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.028 -0.987 . . . . 51.55 109.587 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 16.7 p -81.34 50.29 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.862 -0.608 . . . . 72.13 110.515 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.59 -20.74 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.376 0.608 . . . . 63.44 110.058 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.4 mt -75.57 -14.6 60.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.3 -0.864 . . . . 73.35 109.848 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 19.5 m -117.05 4.93 12.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 61.14 110.749 -176.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -107.68 9.06 29.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.535 . . . . 61.0 110.198 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -90.79 -114.92 1.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.895 -0.669 . . . . 72.12 112.53 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.0 mt -121.24 113.81 40.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.917 0.389 . . . . 70.45 110.874 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.1 t -74.79 93.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.653 . . . . 54.14 109.287 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.72 157.29 16.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.718 -0.674 . . . . 62.42 111.426 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -117.88 122.99 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.738 -0.665 . . . . 75.4 110.061 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 50.2 t-80 -65.38 -59.67 3.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.653 -0.703 . . . . 75.01 110.169 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -173.34 -58.52 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.774 -1.103 . . . . 73.12 108.439 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -125.96 11.37 7.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.34 -0.846 . . . . 62.45 109.489 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.596 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.3 t0 -132.53 166.48 21.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.446 -0.797 . . . . 71.33 109.526 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.62 117.43 21.99 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.462 0.305 . . . . 63.2 110.663 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 20.4 m95 -130.01 112.58 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 72.1 110.376 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 13.8 p -79.85 141.39 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.847 -0.427 . . . . 72.5 109.847 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.46 54.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.971 0.415 . . . . 74.22 111.583 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 28.2 t -74.66 127.44 87.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 74.41 110.552 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 55.5 Cg_endo -70.86 -34.05 11.5 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.635 2.223 . . . . 73.42 113.021 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.62 -63.2 1.33 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.85 0.357 . . . . 60.05 111.825 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 90' ' ' TYR . 41.4 mmtm -73.69 -25.57 60.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 74.22 110.874 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.4 tttm 56.15 95.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 71.43 112.357 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.437 ' OE1' ' HB3' ' A' ' 89' ' ' ALA . 2.5 pt20 -166.64 155.41 10.6 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.006 -0.997 . . . . 74.14 109.454 170.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.783 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 75.5 m80 -90.35 143.57 26.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.709 -0.678 . . . . 72.05 110.183 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.444 ' HB2' ' CG1' ' A' ' 68' ' ' VAL . 86.2 m-85 -130.58 121.1 25.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.401 -0.592 . . . . 62.11 109.401 173.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.07 133.79 45.44 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.333 -0.547 . . . . 75.51 109.74 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.63 11.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.653 0.612 . . . . 72.14 112.653 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -128.06 4.9 5.88 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.675 -0.41 . . . . 74.44 111.075 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.87 -77.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.581 -0.281 . . . . 62.45 111.164 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.49 22.66 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.608 -0.806 . . . . 54.14 113.056 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -68.26 146.28 53.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.86 -0.422 . . . . 73.33 109.86 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 53.9 m -99.28 0.96 44.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.646 0.61 . . . . 52.32 112.646 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.0 tp 63.58 -74.73 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.241 0.617 . . . . 74.13 112.537 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 27.0 mt-10 -109.95 -40.71 4.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.474 0.654 . . . . 55.11 109.969 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' CG ' ' HA ' ' A' ' 75' ' ' GLN . 1.7 m-20 -82.31 -171.01 3.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.852 -1.067 . . . . 71.23 110.386 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.33 118.43 0.75 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.574 -0.822 . . . . 64.34 112.522 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . . . -168.01 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.524 0.202 . . . . 54.53 110.884 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.583 ' HE2' ' HG3' ' A' ' 73' ' ' LYS . 75.1 m-85 -83.91 80.44 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 63.54 110.756 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -74.83 97.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.004 -0.543 . . . . 70.22 109.581 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.51 -175.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.171 -0.468 . . . . 62.22 111.725 -172.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.09 173.52 8.66 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.964 -0.562 . . . . 74.13 110.403 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -134.11 116.4 15.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.806 0.336 . . . . 74.51 111.179 -173.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HE1' ' OG ' ' A' ' 43' ' ' SER . 80.0 m-85 -80.42 151.51 29.3 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.788 -0.642 . . . . 63.32 109.42 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -81.5 160.84 23.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.224 -0.658 . . . . 54.1 109.224 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.829 HG22 HG22 ' A' ' 106' ' ' ILE . 4.8 p -136.08 142.86 44.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.779 0.324 . . . . 74.34 111.366 -171.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -125.45 138.25 54.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.22 0.533 . . . . 75.43 110.116 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.92 103.72 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.597 -0.89 . . . . 53.51 108.597 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.4 m -89.62 -68.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.317 0.58 . . . . 73.23 110.69 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -116.35 -133.02 0.33 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.359 -0.978 . . . . 71.31 108.359 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.78 35.4 2.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.421 -0.895 . . . . 24.45 111.139 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.7 p30 -141.65 155.13 45.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.496 . . . . 73.32 110.958 -175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.59 128.06 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.627 -0.715 . . . . 74.23 110.322 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.813 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -121.76 127.0 50.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.33 -0.395 . . . . 53.12 110.23 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.829 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -101.72 165.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.08 -0.341 . . . . 73.41 110.08 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -92.09 96.82 10.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.041 0.448 . . . . 73.42 110.235 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mm -73.79 102.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.2 0.524 . . . . 64.43 110.073 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.95 100.85 4.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 64.42 110.148 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.501 ' HB2' HG23 ' A' ' 113' ' ' VAL . 6.2 p-10 -99.35 143.98 28.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.966 -0.561 . . . . 74.22 109.939 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.1 t -56.69 -63.49 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.348 -0.612 . . . . 71.34 109.348 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -170.97 80.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.618 -0.719 . . . . 71.44 109.586 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.501 HG23 ' HB2' ' A' ' 110' ' ' ASP . 40.4 t -97.84 124.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.675 -0.693 . . . . 72.22 110.065 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.55 111.95 3.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.707 . . . . 43.31 110.398 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.05 127.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.508 -0.552 . . . . 63.21 109.508 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -118.03 106.86 13.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.157 0.504 . . . . 70.1 111.173 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -145.46 -38.51 0.25 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.61 -0.723 . . . . 73.22 110.26 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.6 p -99.35 78.95 2.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.642 -0.708 . . . . 72.54 110.864 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.14 111.7 11.79 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.736 -0.665 . . . . 73.0 109.996 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.485 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 87.9 Cg_endo -93.23 173.51 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.917 2.411 . . . . 65.45 112.269 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.54 90.4 8.66 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.384 -0.598 . . . . 75.1 109.384 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 5.9 Cg_endo -85.88 125.94 2.83 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.98 2.453 . . . . 74.15 112.07 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 tp -83.64 94.79 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.179 0.514 . . . . 62.33 109.861 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.607 ' OE1' ' HA ' ' A' ' 127' ' ' HIS . 44.2 tt0 -97.74 103.65 15.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.518 -0.765 . . . . 44.22 109.191 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -64.8 -41.79 95.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.379 -0.373 . . . . 74.53 111.039 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -108.62 94.26 4.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.774 -0.824 . . . . 65.21 108.774 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.607 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 51.1 m80 -68.71 129.62 40.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.426 -0.806 . . . . 72.44 112.61 -172.011 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -79.89 125.03 29.2 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.723 -1.214 . . . . 75.41 107.723 169.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -127.21 142.88 51.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.112 0.482 . . . . 73.22 111.632 -165.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.298 -0.858 . . . . 74.14 109.651 176.046 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.876 0.37 . . . . 73.21 110.772 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -114.25 -75.96 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.198 -0.456 . . . . 64.11 110.537 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 107' ' ' SER . 51.3 mt-30 -91.38 80.51 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 72.34 110.611 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 85.0 m95 -133.7 100.24 4.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.417 -0.811 . . . . 71.3 110.03 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -88.45 135.44 33.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.509 -0.314 . . . . 64.24 111.21 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.2 m -72.41 111.85 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 75.11 110.165 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 30' ' ' VAL . 50.2 t -81.97 -73.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.827 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.2 m -150.44 175.91 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 63.31 109.688 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 2.8 mptp? -79.36 142.18 36.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.973 -0.381 . . . . 72.42 109.973 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 99' ' ' VAL . 7.9 tt -62.63 -23.47 67.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 53.12 109.61 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.87 -21.21 26.5 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 72.55 110.264 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.55 -24.96 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 71.51 110.723 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 32' ' ' ARG . 73.1 mt -77.59 116.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 75.12 111.161 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.05 132.83 90.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 60.11 111.474 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 44.1 Cg_endo -68.4 145.12 64.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.073 2.515 . . . . 63.21 113.153 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.04 64.41 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.676 -0.693 . . . . 74.34 112.856 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 166.73 32.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.084 0.442 . . . . 63.4 111.932 -175.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -146.17 142.7 10.77 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.578 -0.609 . . . . 40.14 111.578 177.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.549 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 26.2 m -127.21 144.5 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.07 0.435 . . . . 52.24 112.013 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.55 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.5 p -74.0 105.3 5.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.162 -0.472 . . . . 71.4 110.851 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 131.27 41.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.02 -0.536 . . . . 71.35 110.391 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.27 101.33 13.75 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.331 -0.618 . . . . 63.24 109.331 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -111.45 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.213 -0.449 . . . . 74.11 110.594 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 66.09 -72.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.351 -0.84 . . . . 72.42 111.697 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -155.2 11.32 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 74.05 110.973 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 72.8 mm-40 -119.08 137.73 53.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.245 -0.434 . . . . 64.44 111.014 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -99.6 112.8 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 62.42 109.878 173.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.3 mt -118.18 135.65 57.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.087 -0.506 . . . . 75.53 110.453 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -89.91 114.81 26.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 74.43 109.989 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.9 t -98.54 101.63 12.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.376 -0.374 . . . . 54.54 110.747 -176.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HE2' HG21 ' A' ' 68' ' ' VAL . 66.8 m-85 -80.05 141.99 35.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.659 . . . . 75.45 111.089 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 39' ' ' VAL . 14.0 tpt180 -112.7 80.72 3.9 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.302 -0.999 . . . . 72.43 108.302 165.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.716 ' HG2' HE22 ' A' ' 38' ' ' GLN . 18.2 Cg_exo -65.95 -43.32 9.49 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.568 2.179 . . . . 61.43 112.962 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -114.08 156.79 23.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.707 0.289 . . . . 74.54 110.284 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.18 71.09 3.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.816 -1.179 . . . . 33.14 107.816 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 26.7 t70 -160.07 -175.9 5.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.91 -1.041 . . . . 62.32 109.08 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.5 ' HA ' HD11 ' A' ' 10' ' ' LEU . 29.0 mt-10 -78.71 -10.75 59.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 35.44 110.236 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.716 HE22 ' HG2' ' A' ' 33' ' ' PRO . 22.2 tm0? -73.52 124.2 25.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.291 -0.868 . . . . 71.24 110.885 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' HD2' ' A' ' 32' ' ' ARG . 28.5 m -132.74 168.22 24.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 51.1 110.425 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.92 103.02 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.657 0.244 . . . . 62.23 111.657 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -103.95 109.64 21.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.857 0.361 . . . . 42.22 110.245 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 43.7 pt -130.51 179.16 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.976 0.417 . . . . 73.24 111.149 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.48 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 5.2 m -82.29 80.11 8.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.501 -0.555 . . . . 62.43 109.501 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.0 t-20 -123.84 70.57 1.08 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.713 0.768 . . . . 73.33 110.243 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' HB3' ' A' ' 20' ' ' CYS . 37.3 mm -126.69 131.97 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.166 -0.924 . . . . 71.33 109.368 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.1 t70 -83.72 121.74 76.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.764 -0.458 . . . . 54.12 109.764 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 29.1 Cg_exo -62.54 -17.62 59.18 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.13 2.553 . . . . 50.11 113.248 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.1 5.77 44.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 73.01 110.597 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.33 -29.84 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 62.03 111.645 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 69.0 19.85 7.99 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.345 0.593 . . . . 74.51 110.816 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -142.19 168.19 20.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.757 -0.656 . . . . 73.02 109.88 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 22.0 p -81.62 55.83 2.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.933 -0.576 . . . . 64.14 110.938 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.01 -21.5 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.494 0.664 . . . . 62.3 109.901 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 50.0 mt -77.47 -19.68 55.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.264 -0.88 . . . . 61.41 109.636 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 6.0 m -90.62 -19.43 23.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.667 -0.697 . . . . 70.3 111.503 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -98.8 27.4 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.603 0.716 . . . . 63.33 109.847 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -95.93 -122.94 4.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.575 -0.739 . . . . 74.11 111.971 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 61.5 mt -112.34 104.27 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.205 0.526 . . . . 62.24 110.606 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 33' ' ' PRO . 93.6 t -91.64 105.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.396 -0.82 . . . . 74.34 109.077 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.27 179.38 8.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.135 0.493 . . . . 73.43 111.344 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 166.52 10.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.851 -0.613 . . . . 74.2 109.9 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -126.37 77.35 1.69 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.22 -0.659 . . . . 64.2 109.22 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 68.02 -59.78 0.42 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.441 -0.8 . . . . 74.11 111.77 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -117.84 -57.77 2.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.217 -0.447 . . . . 61.53 111.458 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.626 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.3 t0 -90.61 179.01 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 62.01 110.989 -173.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.66 123.19 43.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 52.4 110.742 -173.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.626 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 46.4 m95 -137.83 128.26 26.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 73.31 110.893 -173.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG21 ' HE2' ' A' ' 31' ' ' PHE . 10.6 p -94.95 127.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.603 . . . . 55.3 110.029 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -97.41 120.04 37.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.908 -0.587 . . . . 62.1 110.918 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 41.1 t -64.55 141.32 98.22 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 53.45 110.391 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.512 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 61.1 Cg_endo -78.11 -41.18 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.163 1.909 . . . . 35.11 111.706 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -76.99 -69.09 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.601 -0.727 . . . . 73.1 110.986 -178.063 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.72 ' HD2' ' HB3' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -80.95 -19.11 44.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.36 -0.382 . . . . 73.43 111.181 -175.196 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.6 mttp 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.82 -0.627 . . . . 73.31 112.594 176.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -78.3 143.31 37.1 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 73.33 109.477 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -100.62 115.36 30.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.307 -0.406 . . . . 62.35 110.328 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 68' ' ' VAL . 70.3 m-85 -106.12 124.75 50.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.114 -0.328 . . . . 64.14 110.114 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 42.9 ttp180 -72.97 121.99 20.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.821 0.343 . . . . 75.22 110.436 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 99.0 mt -76.39 78.0 3.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 74.13 110.263 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -174.56 -63.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 65.54 109.752 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -111.81 -23.08 10.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.736 -0.665 . . . . 73.04 111.046 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 19.29 27.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.742 . . . . 72.34 112.391 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.77 134.22 48.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.603 0.24 . . . . 74.41 110.539 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 46.0 m -88.31 26.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.157 0.428 . . . . 72.15 112.157 -174.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.2 tp 63.2 -79.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 73.2 112.308 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -126.93 -7.27 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.039 0.447 . . . . 75.52 110.56 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.59 -176.52 3.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.153 -0.684 . . . . 63.32 109.153 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 22.54 0.15 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.789 -0.719 . . . . 64.43 112.169 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -58.06 6.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.077 0.465 . . . . 60.03 110.799 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -130.61 92.38 3.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.471 . . . . 73.2 110.729 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.4 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 20.4 m -74.44 130.13 39.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.587 . . . . 54.41 109.414 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' SER . 32.4 m -95.88 -176.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.509 -0.314 . . . . 60.23 111.291 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -129.63 179.55 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 72.2 110.728 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.77 124.63 15.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.0 0.429 . . . . 75.23 110.664 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -89.51 169.6 11.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.651 -0.704 . . . . 74.54 109.704 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -99.73 138.53 36.68 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.474 -0.565 . . . . 74.4 109.474 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.906 HG22 HG22 ' A' ' 106' ' ' ILE . 44.6 p -127.24 156.38 41.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.303 -0.408 . . . . 55.22 111.104 -173.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.446 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 11.0 pt20 -155.44 140.77 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.169 0.509 . . . . 65.44 110.851 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.654 HG21 HD12 ' A' ' 10' ' ' LEU . 39.8 t -109.29 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.79 -0.819 . . . . 71.12 108.79 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -113.64 -5.04 13.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.47 . . . . 73.14 111.396 -171.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -141.63 25.09 2.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 74.11 110.842 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.28 17.48 Favored Glycine 0 C--O 1.234 0.139 0 C-N-CA 120.843 -0.694 . . . . 52.22 111.544 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 40.5 m-80 -106.56 157.14 17.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.3 -0.63 . . . . 72.24 109.3 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 99' ' ' VAL . 44.8 t -94.76 117.22 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.994 0.426 . . . . 74.34 110.297 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 93.1 mt-30 -102.29 139.08 38.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.529 . . . . 71.54 110.095 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.906 HG22 HG22 ' A' ' 97' ' ' THR . 2.9 pp -114.47 149.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.105 -0.498 . . . . 72.51 110.012 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 8.5 t -85.8 128.0 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.714 -0.476 . . . . 65.4 109.714 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 3' ' ' GLN . 50.2 mm -65.43 105.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 74.21 110.923 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.66 150.77 37.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.636 -0.711 . . . . 73.01 110.08 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.94 149.43 41.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 72.32 111.273 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 m -149.05 -71.08 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.856 -0.611 . . . . 73.35 109.515 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -179.42 107.05 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.016 -0.538 . . . . 75.45 110.037 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 t -84.88 116.26 28.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.173 -0.677 . . . . 74.42 109.173 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.88 -174.29 2.79 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.833 -0.621 . . . . 64.54 110.577 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.72 106.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.846 0.831 . . . . 61.43 109.369 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.24 158.86 15.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.106 -0.952 . . . . 63.35 111.682 -170.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.83 104.53 7.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.924 -1.035 . . . . 74.43 108.727 171.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 p -64.18 -53.07 55.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 71.21 111.509 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 64.82 107.9 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.191 0 O-C-N 123.707 0.63 . . . . 75.21 111.317 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.64 104.98 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.341 2.028 . . . . 34.21 110.762 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.96 134.18 41.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 54.41 110.471 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.32 105.12 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.448 2.099 . . . . 71.4 111.089 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 123' ' ' LEU . 1.6 pp -68.35 134.93 51.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.18 0.514 . . . . 64.12 110.815 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.58 -170.92 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.611 -0.722 . . . . 74.33 109.91 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.5 125.97 54.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.379 . . . . 72.02 111.054 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.01 104.48 14.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.803 -0.814 . . . . 74.24 108.803 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -64.75 137.73 57.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.512 -0.313 . . . . 72.13 110.224 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -66.37 131.78 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 64.1 110.07 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -70.93 125.33 26.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 73.52 110.975 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.169 -0.92 . . . . 63.44 109.917 178.403 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.917 0.389 . . . . 61.03 110.732 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.82 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 15.0 p -133.91 -73.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.104 -0.498 . . . . 73.22 110.371 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -90.73 21.26 4.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 71.43 110.293 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.82 ' HD1' ' H ' ' A' ' 2' ' ' SER . 54.9 m95 -102.4 116.71 33.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 74.42 109.772 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 m -98.91 131.78 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.073 0.463 . . . . 74.4 111.226 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.781 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 5.2 m -67.47 119.42 12.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.478 -0.783 . . . . 75.32 111.036 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 t -95.53 -84.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.52 110.46 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.1 m -142.25 161.15 38.75 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.979 -0.378 . . . . 74.45 109.979 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 89.8 mttt -65.6 145.15 56.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.047 -0.353 . . . . 70.02 110.047 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 37' ' ' GLU . 10.4 tt -65.57 -28.19 68.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.532 0.682 . . . . 75.12 109.565 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.85 -25.44 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.277 -0.874 . . . . 74.32 110.848 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 26.6 t0 -72.67 -15.94 61.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 53.34 109.817 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.4 mt -96.02 133.57 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.463 -0.79 . . . . 51.45 109.983 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.92 150.35 88.17 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.988 0.423 . . . . 62.22 111.784 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.97 123.68 11.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.69 2.26 . . . . 72.54 111.803 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.51 11.35 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.64 -0.709 . . . . 44.13 112.484 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -136.3 179.44 6.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.387 0.594 . . . . 63.33 111.023 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -175.42 101.42 0.16 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.069 -0.812 . . . . 45.14 111.069 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.465 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -117.63 150.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.21 0.448 . . . . 74.4 112.21 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.686 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.0 p -78.6 128.68 33.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.73 -0.668 . . . . 74.42 111.65 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.05 137.42 50.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.417 -0.586 . . . . 72.33 109.417 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -83.71 107.65 16.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.565 -0.531 . . . . 72.24 109.565 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.99 92.48 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.094 -0.503 . . . . 71.11 110.084 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 65.45 -75.06 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.271 -0.877 . . . . 75.41 113.113 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.68 10.58 3.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.194 0.442 . . . . 73.33 112.194 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -142.24 144.22 33.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.937 0.399 . . . . 73.43 111.314 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.493 ' HB2' HG13 ' A' ' 45' ' ' ILE . 52.3 mt-30 -95.48 120.16 35.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.269 -0.641 . . . . 75.55 109.269 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.85 120.83 62.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 110.056 -0.349 . . . . 65.54 110.056 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.0 123.71 34.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.602 . . . . 64.35 109.373 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 15.0 t -107.87 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.952 0.406 . . . . 73.1 111.043 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.1 m-85 -77.34 136.17 38.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.567 -0.742 . . . . 72.12 110.726 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -127.77 73.99 78.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.131 -0.692 . . . . 72.52 109.131 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.53 -36.72 52.32 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.017 2.478 . . . . 71.13 112.215 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -111.92 149.77 31.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.56 -0.746 . . . . 71.4 109.807 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -81.26 56.8 2.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.311 1.053 . . . . 71.44 109.231 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -136.92 -176.1 4.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.564 -1.198 . . . . 44.21 108.448 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 10' ' ' LEU . 35.7 mt-10 -82.76 47.6 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.622 0.725 . . . . 63.53 110.274 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -126.7 99.04 5.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.107 -0.952 . . . . 71.24 109.413 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.56 162.19 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 63.13 111.078 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 99.7 m-85 -134.31 102.07 5.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.965 -0.562 . . . . 75.03 110.3 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.68 96.97 6.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.879 0.371 . . . . 70.51 111.045 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 pt -131.18 175.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.924 -0.58 . . . . 71.41 110.15 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.2 m -80.63 56.62 2.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.175 0.512 . . . . 64.03 110.793 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.592 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 20.2 t-20 -87.05 71.5 10.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.72 0.771 . . . . 73.5 109.675 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 20' ' ' CYS . 16.8 mm -124.55 142.96 39.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 61.32 109.992 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 9.9 t70 -90.55 116.65 66.87 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.022 -0.733 . . . . 63.42 109.022 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.19 -16.9 53.76 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 123.121 2.547 . . . . 75.14 113.108 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -101.36 -3.41 28.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.003 0.43 . . . . 73.34 110.509 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -117.96 -24.92 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 43.45 110.897 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 69.11 19.49 7.99 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.727 -0.669 . . . . 65.21 110.601 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -153.1 169.1 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 64.11 109.709 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -84.23 83.87 7.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 71.12 110.791 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -96.97 -10.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.41 0.624 . . . . 74.45 109.787 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 43.6 mt -70.26 -28.52 65.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.315 -0.857 . . . . 70.02 109.608 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 p -88.81 5.86 41.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.06 -0.973 . . . . 33.31 111.841 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.946 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -108.6 15.38 23.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.276 0.56 . . . . 72.03 110.481 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -96.55 -147.61 22.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.717 -0.754 . . . . 73.32 112.299 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.75 118.03 42.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.02 0.438 . . . . 74.04 110.472 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.37 101.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.743 . . . . 42.35 109.531 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.85 109.01 21.42 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.254 -0.884 . . . . 63.34 110.641 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.32 129.01 35.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.124 -0.489 . . . . 74.45 110.305 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -108.1 45.44 1.02 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.581 -0.736 . . . . 64.21 109.523 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 69.29 -67.03 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.131 -0.94 . . . . 71.22 111.117 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.34 -43.9 7.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.177 -0.465 . . . . 60.34 110.965 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.488 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 3.2 t70 -98.52 174.58 6.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.287 . . . . 73.21 110.39 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 79' ' ' LEU . 89.3 mt -132.28 118.7 19.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 71.34 109.883 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.488 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 35.8 m95 -124.14 165.53 17.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.93 0.395 . . . . 73.43 110.585 -175.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.7 p -135.06 132.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.207 -0.451 . . . . 74.41 110.191 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -94.35 106.03 18.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 73.53 109.985 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.6 t -68.85 133.68 90.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.127 -0.488 . . . . 54.02 111.124 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.8 Cg_endo -71.14 -30.02 16.7 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.486 2.124 . . . . 65.41 111.941 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.86 -37.65 14.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.978 -0.555 . . . . 62.21 111.099 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.813 ' HD3' ' HE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -88.41 -28.16 21.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.164 -0.471 . . . . 71.31 111.379 -175.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 65.19 22.95 12.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.534 0.521 . . . . 65.12 111.018 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.86 155.81 35.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.29 -0.413 . . . . 73.12 110.712 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 76.6 m80 -95.32 117.0 29.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 75.43 110.667 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -100.78 137.41 39.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.179 -0.464 . . . . 72.34 110.7 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -78.42 123.89 27.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.036 -0.529 . . . . 75.12 110.19 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 84.4 mt -74.31 -30.44 62.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.454 0.538 . . . . 72.23 112.454 -172.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HD1' ' HE1' ' A' ' 40' ' ' TYR . 48.6 t80 -81.73 -19.13 42.06 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.797 -0.361 . . . . 73.43 111.566 -174.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -140.52 -78.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 74.21 111.037 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.36 0.46 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.681 -0.771 . . . . 71.44 112.123 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -55.37 108.32 0.41 Allowed 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 109.83 -0.434 . . . . 65.13 109.83 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.2 m -76.16 155.92 34.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.003 0.43 . . . . 43.43 111.418 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 24.7 tp -86.59 -20.45 27.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 70.51 110.001 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -82.97 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.799 -0.637 . . . . 72.12 110.715 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -144.16 160.65 40.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.106 -0.497 . . . . 72.03 109.954 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.13 65.78 3.73 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.971 -0.851 . . . . 62.32 110.971 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.34 -66.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.77 0.285 . . . . 74.03 111.77 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.813 ' HE2' ' HD3' ' A' ' 73' ' ' LYS . 60.1 m-85 -100.04 -28.21 13.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.833 -0.347 . . . . 71.22 111.501 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m 59.73 84.53 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.744 0.653 . . . . 74.34 110.234 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.9 m -79.2 155.83 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 61.11 110.975 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.11 142.79 26.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.202 -0.454 . . . . 74.32 111.008 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.78 97.71 6.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.916 -0.584 . . . . 71.43 110.153 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -81.96 136.43 35.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.987 -0.551 . . . . 75.43 110.042 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -66.44 136.63 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 73.12 109.357 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.577 HG22 HG22 ' A' ' 106' ' ' ILE . 76.0 p -115.52 143.43 45.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 65.33 111.214 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -134.72 137.27 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.617 . . . . 75.35 110.413 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 t -111.03 62.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.527 -0.761 . . . . 64.44 109.037 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -85.12 -29.35 24.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.247 -0.888 . . . . 64.43 111.397 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -103.59 -6.73 21.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.499 0.666 . . . . 54.54 110.835 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.02 -33.14 6.36 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.692 -1.363 . . . . 63.52 109.692 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 46.7 m-80 -81.39 139.84 35.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.566 -0.901 . . . . 45.22 108.566 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -81.78 123.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.409 -0.589 . . . . 62.12 109.409 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 87.9 mt-30 -117.55 121.1 40.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.656 . . . . 73.33 110.591 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.577 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -96.38 153.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.813 -0.63 . . . . 71.52 111.345 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -81.4 114.74 20.36 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.128 -0.693 . . . . 45.21 109.128 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.69 109.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.344 0.592 . . . . 73.11 111.745 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.11 7.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.258 -1.015 . . . . 72.11 108.258 168.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.51 136.21 54.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 70.21 111.053 -173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -86.89 -12.78 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.791 -0.64 . . . . 71.31 111.076 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 54.4 78.37 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.852 0.72 . . . . 72.34 111.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.551 HG22 HG23 ' A' ' 115' ' ' VAL . 10.7 p -152.13 142.34 15.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.995 -0.548 . . . . 61.44 110.543 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.66 86.95 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 42.13 111.25 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.551 HG23 HG22 ' A' ' 113' ' ' VAL . 40.1 t -112.9 144.74 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 54.35 109.641 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.46 82.42 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.209 0.528 . . . . 64.02 111.652 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -161.3 173.87 14.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 75.44 108.553 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.4 m 56.31 38.96 30.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.154 0.502 . . . . 72.22 110.537 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 27.2 pt20 -61.23 140.74 94.36 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.515 -0.766 . . . . 71.03 111.448 -175.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 23.1 Cg_exo -64.63 118.81 5.75 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.834 2.356 . . . . 72.32 111.212 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.55 77.48 0.42 Allowed Pre-proline 0 N--CA 1.463 0.217 0 O-C-N 123.732 0.645 . . . . 53.13 111.251 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.02 106.62 2.06 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.832 2.355 . . . . 72.32 111.424 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 124' ' ' GLU . 2.5 tm? 66.74 103.02 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.907 0.755 . . . . 53.5 109.919 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -74.06 -166.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 53.43 111.278 -175.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.458 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 8.8 t-160 70.73 26.5 3.82 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.516 -0.92 . . . . 72.32 108.516 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -79.49 79.03 5.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.936 -1.029 . . . . 72.0 110.395 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -129.41 153.24 48.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.368 -0.604 . . . . 74.31 109.368 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -160.51 146.23 14.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.425 -0.352 . . . . 70.12 110.169 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.62 134.0 35.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 43.13 109.707 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 . . . . . 0 C--O 1.241 0.634 0 CA-C-O 118.553 -0.737 . . . . 74.32 109.921 178.87 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.947 0.403 . . . . 75.42 110.668 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.504 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 25.6 p -111.22 -72.05 0.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.373 -0.376 . . . . 62.54 110.029 175.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.85 61.57 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.228 0.537 . . . . 71.21 109.818 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.504 ' HD1' ' H ' ' A' ' 2' ' ' SER . 82.3 m95 -124.58 139.12 54.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.57 -0.741 . . . . 73.12 110.173 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.646 HG21 HG13 ' A' ' 23' ' ' VAL . 21.1 m -126.15 124.3 40.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.235 -0.439 . . . . 72.34 110.841 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.3 m -67.32 119.57 12.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.286 -0.416 . . . . 74.31 110.394 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 30' ' ' VAL . 61.6 t -68.27 -60.91 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 62.34 109.673 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 13' ' ' ILE . 5.0 p -172.33 -90.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.024 -0.989 . . . . 71.31 109.414 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.84 ' HD2' ' HB2' ' A' ' 12' ' ' ASP . 47.0 mttp -145.08 170.68 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.597 -0.52 . . . . 73.03 109.597 177.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 99' ' ' VAL . 53.8 tp -91.23 -49.96 6.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.203 0.525 . . . . 74.31 110.396 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.44 -30.08 53.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.717 -0.674 . . . . 75.35 110.701 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.84 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 29.3 t0 -72.48 -13.68 61.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.293 -0.867 . . . . 75.44 110.334 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 8' ' ' CYS . 34.7 mm -88.4 117.67 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 74.21 109.803 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.63 123.33 76.39 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 74.23 111.174 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 36.6 Cg_endo -65.54 146.15 84.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.572 2.181 . . . . 54.51 111.874 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.82 30.17 36.43 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.448 -0.661 . . . . 45.3 111.448 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.1 m -147.97 174.16 12.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.738 0.304 . . . . 74.1 110.95 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.42 107.9 0.33 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.706 -0.958 . . . . 75.35 110.706 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.3 m -124.7 153.96 31.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 112.427 0.529 . . . . 65.45 112.427 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.2 p -79.87 118.23 21.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.578 -0.737 . . . . 73.24 111.275 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.14 169.94 9.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 71.45 110.358 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.09 117.54 29.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.236 0.541 . . . . 72.11 110.828 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 26' ' ' GLN . 57.3 t -124.77 154.03 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.385 -0.969 . . . . 73.04 108.385 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -45.68 -48.18 15.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.333 0.864 . . . . 73.52 113.333 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HB2' HG21 ' A' ' 113' ' ' VAL . 10.0 pt20 -114.65 -4.68 12.76 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.266 0.839 . . . . 71.32 113.266 -167.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 62.6 tt0 -172.37 143.49 1.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.821 -0.352 . . . . 63.3 110.524 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -75.64 137.45 40.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.28 -0.637 . . . . 73.52 109.28 173.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 20.6 tt -115.8 138.05 47.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.628 0.251 . . . . 61.54 110.502 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -97.43 124.8 41.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 72.2 110.281 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.625 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 38.9 t -106.19 99.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.974 0.416 . . . . 74.32 110.949 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.806 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 57.6 m-85 -75.21 113.83 13.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 52.34 110.75 176.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -118.59 82.69 20.19 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.528 -0.916 . . . . 71.54 108.528 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 59' ' ' VAL . 10.4 Cg_exo -71.11 -31.75 14.24 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 122.72 2.28 . . . . 72.21 112.758 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -121.48 -179.74 4.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.48 -0.327 . . . . 75.13 110.278 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 15' ' ' PRO . 80.8 m-20 -93.24 23.9 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 74.41 110.881 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.77 -174.8 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.381 0.61 . . . . 71.44 111.429 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -98.66 31.64 2.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.308 -0.86 . . . . 71.24 110.712 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.94 153.23 52.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.09 -0.505 . . . . 62.55 111.028 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.82 165.98 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.114 -0.493 . . . . 61.3 110.488 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.806 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.3 m-85 -122.14 92.15 3.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.063 -0.517 . . . . 73.33 110.401 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -94.04 100.48 12.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.982 0.42 . . . . 43.15 110.323 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.71 173.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 72.33 110.795 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 m -78.51 87.08 4.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.08 0.467 . . . . 62.42 109.87 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 25.7 t-20 -133.5 67.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.678 0.751 . . . . 52.44 109.584 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.68 HD12 ' HB3' ' A' ' 20' ' ' CYS . 38.7 mm -118.79 143.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.431 -0.804 . . . . 75.13 109.384 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 48' ' ' PHE . 27.0 t70 -99.36 114.44 65.57 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.327 -0.397 . . . . 53.22 109.941 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.19 -12.99 35.3 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.187 2.591 . . . . 43.05 112.773 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 82.7 t80 -82.82 -22.13 34.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 75.14 110.983 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.7 -13.78 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 72.35 111.426 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 63.62 29.44 15.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.801 -0.636 . . . . 73.01 111.018 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -147.95 170.35 17.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 74.04 110.166 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 12.2 p -83.95 58.83 4.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.249 0.547 . . . . 64.42 110.702 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.482 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 31.2 m -79.73 3.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.704 . . . . 64.2 110.208 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 64.1 mt -104.78 -2.54 24.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.99 -1.004 . . . . 74.14 109.248 174.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.513 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 34.9 t -102.04 -48.7 4.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.648 -0.705 . . . . 71.0 111.362 -174.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -84.17 62.65 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.89 0.852 . . . . 72.41 109.892 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -114.51 -156.06 11.39 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.748 -1.115 . . . . 63.32 111.741 176.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mm -93.9 125.21 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.74 -0.467 . . . . 71.31 109.74 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.4 t -86.48 97.79 6.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.023 -0.535 . . . . 74.1 110.097 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 133.13 51.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.667 -0.697 . . . . 72.35 110.374 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.67 151.24 20.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.116 0.484 . . . . 73.04 110.78 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -134.54 103.77 5.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.008 -0.738 . . . . 64.43 109.008 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 70.38 -61.45 0.46 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.07 0.857 . . . . 75.31 110.532 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -157.19 -23.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 73.52 110.826 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.64 171.56 14.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.98 -0.378 . . . . 74.0 109.98 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.6 mt -127.58 117.78 22.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.054 0.454 . . . . 71.15 110.668 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' A' ' 78' ' ' ARG . 20.7 m95 -111.56 127.35 55.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.508 -0.769 . . . . 73.45 109.655 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 79' ' ' LEU . 8.5 p -92.25 129.19 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.983 0.421 . . . . 71.55 110.496 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -99.28 108.09 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 70.52 110.813 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 29.9 t -56.31 138.34 74.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 64.43 111.407 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 53' ' ' VAL . 60.9 Cg_endo -73.67 -25.6 14.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.566 2.177 . . . . 62.41 112.768 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.94 -49.56 3.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 62.35 111.364 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -19.18 28.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.359 . . . . 64.31 110.903 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 70' ' ' SER . 57.2 tttm 62.62 22.66 13.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.437 0.636 . . . . 74.23 111.278 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.64 ' HG3' ' HB2' ' A' ' 86' ' ' GLU . 8.2 tt0 -95.61 150.8 19.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.857 -0.611 . . . . 75.11 110.387 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.0 m80 -99.32 124.32 44.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.895 -0.593 . . . . 75.12 110.439 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -119.3 134.86 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.317 -0.401 . . . . 60.3 110.793 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 49.1 mmm-85 -63.18 131.52 48.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.691 -0.485 . . . . 73.3 109.691 170.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 68' ' ' VAL . 59.6 mt -70.42 -67.6 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.972 0.36 . . . . 75.23 111.972 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 34.0 p90 -101.08 25.68 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.433 . . . . 74.43 111.546 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.741 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 8.0 t70 -118.27 -67.57 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.106 -0.497 . . . . 53.03 110.454 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 78' ' ' ARG . . . 129.48 -21.69 5.07 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.131 -1.033 . . . . 54.0 113.511 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -74.08 162.97 28.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.331 0.586 . . . . 74.31 111.606 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 90' ' ' TYR . 21.3 m -124.89 153.83 42.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 44.35 109.76 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.94 -68.34 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.705 0.288 . . . . 52.41 110.555 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 30.3 mp0 -64.47 -51.75 61.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 74.01 111.925 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.27 102.08 6.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 73.12 110.99 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -82.48 25.99 4.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.985 -0.626 . . . . 44.52 112.985 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 -14.72 46.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.069 0.462 . . . . 54.45 110.871 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 99.6 m-85 -80.91 -59.72 2.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.987 -0.551 . . . . 75.02 110.859 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 p 45.55 73.72 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.606 0.717 . . . . 74.42 110.742 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.58 157.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 75.24 111.751 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.71 116.38 29.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.506 -0.77 . . . . 63.34 110.825 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.37 86.89 3.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 73.2 110.046 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -71.75 170.27 13.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.822 -0.626 . . . . 72.42 111.202 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -83.48 135.29 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.146 -0.479 . . . . 33.22 110.367 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.996 HG22 HG22 ' A' ' 106' ' ' ILE . 63.9 p -124.82 127.19 46.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.281 -0.872 . . . . 72.15 109.535 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 29.2 pt20 -118.5 139.19 51.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.524 0.678 . . . . 74.23 111.102 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 10' ' ' LEU . 45.4 t -108.6 88.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.027 -0.988 . . . . 73.02 109.133 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -88.31 -23.44 23.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 73.44 110.562 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.452 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 68.8 m-20 -145.71 -154.8 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.802 -0.814 . . . . 72.22 108.802 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 101' ' ' ASN . . . -74.03 -1.34 59.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.835 -0.698 . . . . 72.34 112.288 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 3.8 m-20 -113.61 158.82 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.087 -0.338 . . . . 74.51 110.087 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.57 128.44 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 64.31 111.698 -176.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . 18.7 mm-40 -106.19 127.57 53.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.745 -0.661 . . . . 64.42 110.414 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.996 HG22 HG22 ' A' ' 97' ' ' THR . 2.7 pp -115.49 146.47 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.473 -0.33 . . . . 72.21 110.203 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -91.25 125.63 36.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 60.42 110.799 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.6 pt -98.17 102.15 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.968 -0.56 . . . . 64.23 110.224 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.22 17.43 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 73.43 111.037 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.82 122.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.961 -1.018 . . . . 74.31 111.264 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 m -90.4 -75.07 0.47 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.083 -0.962 . . . . 72.13 109.958 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -173.83 35.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.924 -1.139 . . . . 64.41 107.924 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 25' ' ' GLN . 7.9 p -81.35 139.71 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.982 -1.008 . . . . 63.21 112.333 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.47 112.08 24.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.847 -1.168 . . . . 54.33 107.847 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.05 95.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.679 0.752 . . . . 73.03 111.771 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.15 -161.2 0.74 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.009 -1.478 . . . . 45.32 107.009 172.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.62 114.83 27.19 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.647 -0.821 . . . . 71.34 109.308 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' GLN . 17.6 m -93.01 11.86 26.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.959 -0.564 . . . . 72.15 110.332 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 118' ' ' SER . 30.0 mm-40 69.33 119.67 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.126 0 O-C-N 124.027 0.829 . . . . 62.12 111.177 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 15.8 Cg_exo -68.78 90.39 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.322 2.015 . . . . 55.23 110.366 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HB3' ' CD2' ' A' ' 123' ' ' LEU . 97.9 mt -96.88 108.41 43.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.931 -0.577 . . . . 62.25 111.075 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 57.4 Cg_endo -96.97 70.91 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.489 2.792 . . . . 72.51 111.955 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 3.7 mm? -73.52 113.84 11.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 71.33 109.291 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.25 127.0 31.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.092 0.473 . . . . 72.13 110.382 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -74.04 73.04 1.69 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.733 -0.667 . . . . 75.41 109.806 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 35.1 p-80 -78.51 83.87 4.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.544 -0.753 . . . . 73.4 111.207 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -97.97 93.22 6.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.919 -1.141 . . . . 73.03 107.919 171.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -59.81 125.08 22.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.475 -0.784 . . . . 63.23 110.889 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -135.7 -177.13 4.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.479 -0.782 . . . . 71.21 110.517 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 . . . . . 0 C--O 1.247 0.939 0 N-CA-C 108.816 -0.809 . . . . 63.11 108.816 173.773 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.747 -0.464 . . . . 75.15 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -114.39 93.16 4.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.965 -0.754 . . . . 74.23 108.965 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -71.03 114.42 9.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.638 -0.71 . . . . 73.31 111.165 -172.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -67.76 105.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 74.33 109.546 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 p -96.01 146.04 24.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.886 -0.597 . . . . 71.04 110.679 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.1 m -83.61 119.94 25.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.301 -0.409 . . . . 73.11 110.507 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 23' ' ' VAL . 46.6 t -84.91 -83.38 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 65.41 110.314 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.6 m -158.75 174.55 14.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 64.12 109.688 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -75.69 133.77 40.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.656 -0.498 . . . . 65.51 109.656 173.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.5 tp -66.74 -20.41 65.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.04 0.448 . . . . 62.05 110.994 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.1 -29.19 67.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 72.05 110.278 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.5 -25.78 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.545 -0.752 . . . . 72.24 109.8 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.77 107.89 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 72.33 110.147 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 95.3 mt -68.42 145.86 97.52 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.417 . . . . 73.33 111.8 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.1 Cg_exo -64.41 125.98 16.09 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.525 2.15 . . . . 74.21 111.656 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.72 42.86 4.98 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.864 -0.607 . . . . 71.31 112.139 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.8 p -137.95 -179.47 5.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.099 0.476 . . . . 51.25 111.632 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 31' ' ' PHE . . . -166.81 81.19 0.11 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.058 -1.217 . . . . 74.01 110.058 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 35.7 m -111.39 150.68 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.743 0.646 . . . . 63.34 112.743 -169.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.557 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.6 p -70.07 114.42 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.452 -0.795 . . . . 74.22 110.736 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.35 148.38 25.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 74.2 110.384 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -89.31 103.58 16.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 63.03 109.605 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 7' ' ' VAL . 14.5 t -116.24 99.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 71.42 110.269 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 62.72 -85.68 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.649 0.593 . . . . 75.53 111.059 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -130.13 2.66 4.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.148 0.499 . . . . 75.32 109.961 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 14.5 mm100 -105.49 137.13 43.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 73.13 111.478 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -105.07 97.83 7.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 53.22 109.679 171.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.495 HG21 ' HB1' ' A' ' 41' ' ' ALA . 1.7 mp -110.26 135.9 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 74.32 110.541 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.12 114.44 21.77 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.597 -0.52 . . . . 53.41 109.597 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.9 t -99.89 106.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.005 0.431 . . . . 73.43 110.179 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 96.6 m-85 -81.24 127.25 32.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.598 -0.728 . . . . 73.45 110.687 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -118.97 80.39 18.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.54 -0.911 . . . . 53.13 108.54 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 38' ' ' GLN . 92.7 Cg_endo -79.25 -10.72 14.89 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.77 2.313 . . . . 72.4 112.351 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -121.44 163.01 19.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.428 -0.806 . . . . 73.25 110.119 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.31 -15.56 61.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.209 0.528 . . . . 72.34 111.15 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 16.8 t70 -97.42 -156.99 0.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.348 -0.387 . . . . 75.13 110.263 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.497 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 23.7 mt-10 -89.34 13.15 14.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.599 0.36 . . . . 72.21 111.929 -171.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 36' ' ' ASP . 2.5 mp0 -74.31 94.25 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.882 -0.414 . . . . 73.44 109.882 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 27.5 m -113.74 151.92 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.99 -0.55 . . . . 73.21 111.65 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 89.4 m-85 -122.46 99.83 6.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 71.43 109.559 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -97.02 100.79 12.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.952 0.406 . . . . 64.23 110.816 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 92' ' ' VAL . 31.3 pt -132.16 156.08 42.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.894 -0.594 . . . . 64.42 110.195 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 m -76.06 52.24 0.71 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.512 -0.313 . . . . 52.52 111.622 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -90.17 78.86 6.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.514 0.673 . . . . 75.42 110.072 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -126.75 142.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.17 -0.923 . . . . 74.23 109.67 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 12.7 t70 -80.94 125.83 78.99 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.755 -0.461 . . . . 71.3 109.755 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 24.3 Cg_exo -64.1 -12.58 33.07 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.323 2.682 . . . . 53.43 113.27 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -113.44 15.07 19.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.491 0.186 . . . . 64.22 111.365 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -134.75 -33.94 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.85 0.315 . . . . 43.13 111.85 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 63.41 23.09 13.56 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.312 0.577 . . . . 54.02 110.772 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -139.31 159.32 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.131 -0.941 . . . . 65.23 108.843 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -80.83 65.44 5.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.309 0.576 . . . . 71.21 111.321 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.43 -10.61 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.524 0.678 . . . . 71.14 109.806 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 87.3 mt -86.37 6.2 31.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.968 -1.015 . . . . 70.33 108.989 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.764 ' HA ' HG21 ' A' ' 68' ' ' VAL . 4.5 m -138.94 30.3 2.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.807 -1.088 . . . . 63.22 108.302 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.602 ' HD3' ' HG3' ' A' ' 71' ' ' PRO . 18.7 ttt180 -77.85 61.07 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.421 -0.809 . . . . 75.53 111.284 -170.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.58 -44.95 3.42 Favored Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.654 -1.157 . . . . 75.14 114.311 167.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -69.14 103.36 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.319 0.58 . . . . 73.54 111.293 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.69 118.1 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 115.105 -0.952 . . . . 62.53 109.478 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.56 55.67 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.544 -0.753 . . . . 71.33 111.001 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.73 95.52 4.03 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.63 -0.878 . . . . 71.42 108.63 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.704 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 32.1 t60 -84.35 89.01 7.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.985 -0.552 . . . . 75.13 109.548 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.12 -64.17 0.34 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.766 -1.106 . . . . 74.24 112.749 176.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -121.3 -33.17 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.389 0.515 . . . . 73.13 112.389 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -128.78 -172.2 2.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.655 -0.418 . . . . 62.45 111.141 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.53 117.29 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 71.44 110.213 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TRP . . . . . 0.872 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 30.3 m95 -122.48 119.8 32.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.901 -0.59 . . . . 75.01 110.297 -176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 55' ' ' SER . 12.8 p -84.15 149.77 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.282 -0.417 . . . . 72.31 110.143 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 130.68 54.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 61.43 110.526 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 57.3 p -102.76 143.4 26.54 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.14 -0.482 . . . . 73.44 110.291 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HG3' ' HD3' ' A' ' 56' ' ' ARG . 60.3 Cg_endo -73.19 -2.91 12.76 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.442 2.095 . . . . 65.21 112.188 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.81 -55.82 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 73.53 110.928 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.48 -24.75 21.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.438 -0.346 . . . . 73.33 110.638 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 74.35 -31.77 0.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.252 0.834 . . . . 74.44 113.252 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -71.59 168.18 18.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 74.1 111.081 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.872 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 35.5 m80 -96.5 128.5 43.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 75.34 111.385 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 68' ' ' VAL . 54.6 m-85 -98.09 122.66 41.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.389 -0.597 . . . . 75.22 109.389 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -72.69 117.46 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.62 -0.511 . . . . 75.14 109.62 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 68' ' ' VAL . 50.1 mt -61.5 -25.33 67.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 71.42 112.149 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -89.43 -0.52 57.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.639 0.257 . . . . 73.14 111.525 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.05 -65.67 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.54 -0.464 . . . . 64.12 112.011 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 92' ' ' VAL . . . 132.62 -25.79 3.73 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.731 -0.747 . . . . 63.12 112.667 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -55.61 144.03 28.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.508 0.67 . . . . 75.14 111.784 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.8 65.04 1.8 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.0 -1.0 . . . . 73.44 110.89 -171.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 67' ' ' TRP . 35.5 tp 65.53 -87.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.719 -0.673 . . . . 74.41 111.477 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.74 -12.37 17.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 70.4 110.934 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -117.12 176.19 5.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.373 -0.376 . . . . 45.41 110.569 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.5 41.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.908 -0.877 . . . . 72.34 110.908 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.91 -45.8 78.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 53.32 111.22 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.61 80.24 1.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.167 0.508 . . . . 73.24 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -76.65 96.98 4.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.969 -0.559 . . . . 74.42 109.558 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 42' ' ' ILE . 20.0 m -82.82 165.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.719 -0.673 . . . . 64.35 110.782 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.69 125.6 45.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.706 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -94.21 96.57 9.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 61.11 109.783 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -82.91 152.0 25.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.554 -0.748 . . . . 73.24 109.681 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.74 128.75 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.236 0.541 . . . . 65.34 109.73 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.61 HG23 HG12 ' A' ' 106' ' ' ILE . 3.5 m -122.96 158.39 30.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.63 -0.714 . . . . 54.21 109.376 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -156.46 141.76 17.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.225 0.536 . . . . 74.1 110.591 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 104' ' ' VAL . 34.5 t -110.21 105.68 19.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.12 -0.945 . . . . 62.53 108.797 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.2 t -86.6 -76.31 0.36 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.371 -0.377 . . . . 72.42 111.568 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 100' ' ' THR . 4.1 m-20 -120.87 70.46 0.91 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.678 0.275 . . . . 60.43 110.638 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.67 -31.34 2.2 Favored Glycine 0 C--O 1.229 -0.184 0 C-N-CA 120.701 -0.762 . . . . 64.0 112.748 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -89.0 146.86 24.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.957 0.408 . . . . 55.13 110.123 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 99' ' ' VAL . 39.8 t -105.51 133.22 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.798 -0.637 . . . . 73.41 109.918 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -129.32 146.8 51.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.707 0.289 . . . . 72.51 111.072 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 97' ' ' THR . 70.9 mt -121.38 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 73.51 109.81 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.5 p -90.88 112.94 24.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.177 0.513 . . . . 31.22 110.224 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 pt -126.06 155.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.381 -0.372 . . . . 61.04 110.792 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.49 173.86 10.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.882 -0.599 . . . . 71.5 109.664 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -65.04 132.48 49.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.646 0.736 . . . . 73.13 110.993 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -117.31 33.14 5.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.04 -0.982 . . . . 74.21 108.786 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -73.1 84.49 1.32 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.866 -1.061 . . . . 72.33 110.758 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.07 152.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.734 -0.839 . . . . 73.03 108.734 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.87 82.71 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.19 0.519 . . . . 72.51 111.062 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.4 t -121.51 125.32 73.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.531 -0.759 . . . . 54.44 109.941 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -91.35 174.28 7.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.859 -0.423 . . . . 73.3 109.859 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.78 132.15 56.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.936 0.398 . . . . 73.32 110.268 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -100.58 -16.12 17.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.952 -0.567 . . . . 52.21 110.141 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 48.8 mt-30 -121.46 124.33 27.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 62.51 109.95 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 27.2 Cg_exo -62.53 138.02 67.96 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.898 2.398 . . . . 74.11 112.098 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 3.1 mm? -64.22 139.56 97.72 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 74.14 110.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 4.2 Cg_exo -74.3 97.95 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.829 2.353 . . . . 72.43 112.286 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -91.87 99.1 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.612 -0.884 . . . . 54.21 108.612 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.69 124.18 51.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.96 -0.564 . . . . 74.41 109.588 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -78.11 101.29 6.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.9 0.381 . . . . 74.55 111.095 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -75.24 132.19 40.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.715 -0.675 . . . . 73.23 110.799 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -56.08 132.28 49.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.271 -0.877 . . . . 75.54 111.984 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -142.37 112.88 7.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 70.44 110.361 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -94.73 136.98 34.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 74.44 111.215 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.431 -0.795 . . . . 71.34 109.551 179.202 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.681 0.753 . . . . 73.010000000000005 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -98.0 112.28 24.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.95 -1.023 . . . . 72.540000000000006 110.176 -176.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -99.1 137.88 36.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.174 -0.466 . . . . 73.329999999999998 110.719 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -71.13 131.64 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 62.43 110.771 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 106' ' ' ILE . 38.9 t -87.42 -70.52 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.911 -0.403 . . . . 62.119999999999997 109.911 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.9 m -154.41 178.54 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 73.400000000000006 109.782 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -78.08 144.16 36.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.521 -0.548 . . . . 75.340000000000003 109.521 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 71.310000000000002 110.724 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.36 -32.93 64.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.464 -0.789 . . . . 63.109999999999999 111.157 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.49 -16.76 63.52 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.265 -0.425 . . . . 72.239999999999995 110.497 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 mm -89.69 112.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.806 -0.442 . . . . 70.109999999999999 109.806 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.12 133.67 91.66 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.489 . . . . 74.340000000000003 111.14 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.72 133.36 57.62 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.815 2.343 . . . . 74.040000000000006 112.169 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.09 28.0 51.0 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.654 -0.703 . . . . 63.229999999999997 111.766 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -150.24 177.08 10.27 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 121.014 -0.274 . . . . 74.219999999999999 110.619 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 17' ' ' THR . . . 174.22 130.04 1.24 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.008 -0.615 . . . . 74.299999999999997 112.197 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.721 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 27.1 m -125.03 162.35 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.717 0.259 . . . . 72.319999999999993 110.975 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 14.7 p -87.5 144.56 26.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.171 0.51 . . . . 63.399999999999999 111.307 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 148.32 50.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.587 -0.733 . . . . 74.109999999999999 109.546 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.28 94.59 4.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.708 -0.849 . . . . 64.329999999999998 108.708 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 106' ' ' ILE . 44.9 t -95.11 94.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 70.209999999999994 110.438 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . 41.0 mm-40 64.19 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.243 -0.89 . . . . 54.520000000000003 112.28 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -120.26 -21.31 7.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 70.239999999999995 111.542 -176.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -127.41 146.38 50.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.557 0.217 . . . . 72.239999999999995 111.263 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.72 130.0 35.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 72.409999999999997 110.135 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.0 mt -127.74 133.3 67.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 62.240000000000002 110.331 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -103.78 140.83 37.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.118 -0.492 . . . . 70.150000000000006 109.741 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 101.58 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.87 -0.332 . . . . 74.019999999999996 111.534 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.811 ' HZ ' HD22 ' A' ' 44' ' ' ASN . 79.8 m-85 -73.43 118.06 15.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.018 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HG3' HG12 ' A' ' 39' ' ' VAL . 59.2 ttt180 -111.54 103.53 55.16 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 120.072 -0.651 . . . . 74.340000000000003 110.244 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.38 -55.08 0.17 Allowed 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.731 2.288 . . . . 74.25 112.233 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -122.97 -174.95 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.466 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -79.18 12.66 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.483 0.659 . . . . 73.519999999999996 110.463 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.1 178.62 6.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 71.409999999999997 109.425 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.66 -22.78 19.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.362 -0.381 . . . . 72.430000000000007 110.229 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -72.69 99.0 2.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 73.120000000000005 110.823 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' ARG . 28.3 m -114.99 178.92 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.324 -0.853 . . . . 61.43 110.097 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.669 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 98.0 m-85 -126.01 101.23 6.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.807 0.337 . . . . 65.430000000000007 110.495 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.81 96.51 6.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.087 -0.506 . . . . 70.340000000000003 110.412 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.34 171.7 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.069 -0.514 . . . . 61.439999999999998 110.562 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.555 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 69.3 m -88.62 87.22 7.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.821 0.343 . . . . 54.210000000000001 110.209 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.811 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 53.2 t30 -124.37 82.43 2.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.408 0.623 . . . . 61.439999999999998 109.885 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.11 141.57 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.423 -0.808 . . . . 62.009999999999998 109.962 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t70 -93.39 123.99 58.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.503 -0.555 . . . . 61.420000000000002 109.503 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 23.3 Cg_exo -64.37 -10.22 23.1 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.055 2.503 . . . . 63.509999999999998 113.488 -175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -95.08 -13.06 25.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 61.329999999999998 110.717 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.57 -26.45 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.703 0.261 . . . . 74.409999999999997 111.703 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 68.39 12.63 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.773 0.671 . . . . 52.310000000000002 111.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.635 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -133.23 177.01 8.0 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.137 -0.483 . . . . 71.0 110.696 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.721 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 27.0 p -81.62 47.69 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.6 -0.727 . . . . 35.240000000000002 111.594 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.22 -21.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.282 0.563 . . . . 73.030000000000001 109.899 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 91.0 mt -82.46 -9.15 59.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.149 -0.932 . . . . 72.319999999999993 110.116 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 14.2 m -102.62 -18.93 15.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.816 -0.629 . . . . 71.400000000000006 110.742 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -94.32 19.88 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.332 0.587 . . . . 44.0 109.967 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.99 -151.43 9.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.635 -0.712 . . . . 74.340000000000003 112.047 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 4.0 mp -90.4 103.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.213 0.53 . . . . 61.329999999999998 110.285 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -88.08 104.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.32 -0.855 . . . . 62.039999999999999 109.411 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.38 175.15 11.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.807 -0.633 . . . . 72.010000000000005 111.036 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.35 119.43 28.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.011 -0.541 . . . . 71.329999999999998 110.227 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 71.2 t60 -86.11 -33.42 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.989 0.423 . . . . 73.239999999999995 110.476 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -150.89 -65.09 0.19 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.261 0.553 . . . . 51.140000000000001 109.969 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.29 -22.84 1.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 74.219999999999999 110.917 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.68 -174.59 2.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.96 -0.563 . . . . 63.43 110.257 -171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.4 mt -94.09 120.09 33.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.439 . . . . 71.430000000000007 110.409 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 19.7 m95 -121.95 153.39 38.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.842 -0.617 . . . . 75.209999999999994 109.893 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 9.8 p -114.3 122.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.455 0.645 . . . . 73.439999999999998 110.078 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.52 114.37 22.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.74 -0.664 . . . . 71.340000000000003 109.976 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.521 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 48.2 t -63.48 128.03 92.05 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.099 -0.501 . . . . 33.530000000000001 110.541 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.74 -31.41 32.41 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.585 2.19 . . . . 62.539999999999999 112.221 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.86 -56.3 2.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 53.210000000000001 111.179 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -84.1 -19.88 33.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.382 -0.372 . . . . 64.120000000000005 111.449 -173.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 70' ' ' SER . 0.3 OUTLIER 72.73 -23.01 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.547 0.943 . . . . 75.420000000000002 113.547 172.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.648 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 28.1 mm-40 -50.04 145.88 5.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.619 0.247 . . . . 75.209999999999994 110.991 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 19.0 m170 -100.18 105.66 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 74.129999999999995 110.848 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 52.3 m-85 -89.55 122.29 32.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.215 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 29.3 ttp180 -76.42 122.23 24.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.018 -1.104 . . . . 75.150000000000006 108.018 171.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.41 -49.81 60.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.682 0.993 . . . . 73.209999999999994 113.682 -165.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.533 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 58.1 t80 -89.32 -2.61 58.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 74.209999999999994 111.208 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HB2' ' HE ' ' A' ' 78' ' ' ARG . 10.5 t70 -103.16 -60.86 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.861 -0.336 . . . . 64.129999999999995 110.696 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.68 -19.76 28.05 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.504 -0.855 . . . . 70.109999999999999 113.527 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.93 157.48 33.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.421 0.61 . . . . 73.530000000000001 110.36 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 10.8 m -108.65 94.67 5.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.248 0.462 . . . . 74.209999999999994 112.248 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp 62.23 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.514 0.726 . . . . 74.25 112.39 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 -55.8 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.967 -0.383 . . . . 72.310000000000002 109.967 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.34 113.74 26.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 74.439999999999998 110.618 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.11 69.45 3.37 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.722 -0.672 . . . . 73.340000000000003 112.914 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.43 7.36 45.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.464 . . . . 63.420000000000002 110.852 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -153.33 29.7 0.49 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 72.420000000000002 109.928 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 m -63.97 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.619 -0.719 . . . . 44.539999999999999 111.292 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.5 m -103.6 -178.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 74.430000000000007 111.246 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -101.2 130.87 47.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 50.32 111.165 -177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.02 105.29 11.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.092 -0.504 . . . . 71.219999999999999 110.524 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -94.86 158.27 15.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.677 -0.692 . . . . 73.209999999999994 109.987 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -82.94 151.22 26.01 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.797 0.332 . . . . 75.200000000000003 110.788 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 1.015 HG22 HG22 ' A' ' 106' ' ' ILE . 28.6 p -134.07 151.23 51.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 65.219999999999999 111.256 -172.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' A' ' 98' ' ' GLN . 1.7 pt20 -135.64 157.97 45.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.04 -0.355 . . . . 74.200000000000003 110.04 173.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.89 108.51 25.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.963 -0.384 . . . . 70.239999999999995 109.963 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.7 t -74.6 -75.98 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 71.519999999999996 111.294 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.798 ' H ' HG23 ' A' ' 100' ' ' THR . 53.3 m-80 -144.32 87.79 1.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.859 -0.423 . . . . 71.540000000000006 109.859 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.51 -1.1 45.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.046 -0.597 . . . . 73.239999999999995 112.907 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.0 140.86 52.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.873 -0.417 . . . . 44.119999999999997 109.873 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.88 133.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.327 -0.397 . . . . 72.519999999999996 110.716 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.38 151.59 42.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 55.020000000000003 110.053 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.015 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -122.29 155.44 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.66 0.267 . . . . 61.329999999999998 110.291 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -83.42 101.44 11.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.822 -0.807 . . . . 62.109999999999999 108.822 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . 24.6 pt -79.34 86.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.816 0.817 . . . . 64.329999999999998 112.471 -173.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.834 0 N-CA-C 108.582 -0.895 . . . . 53.539999999999999 108.582 170.137 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.839 0.352 . . . . 74.219999999999999 111.122 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.412 ' CZ3' ' HG2' ' A' ' 98' ' ' GLN . 96.5 m95 -94.88 116.15 28.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 71.140000000000001 110.277 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.0 m -105.13 129.05 53.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.318 -0.401 . . . . 74.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.809 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.5 m -70.33 115.16 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 53.200000000000003 110.423 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.36 -77.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 53.109999999999999 110.747 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -146.59 172.91 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.502 . . . . 70.299999999999997 110.059 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -84.12 141.99 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 74.120000000000005 110.004 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.641 HD12 ' HB ' ' A' ' 13' ' ' ILE . 50.5 tp -70.69 -21.53 62.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 64.150000000000006 110.841 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.95 -34.39 76.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 63.32 110.733 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.63 -12.35 42.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 72.510000000000005 110.268 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.641 ' HB ' HD12 ' A' ' 10' ' ' LEU . 65.5 mt -82.11 111.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 71.200000000000003 110.164 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD12 ' H ' ' A' ' 14' ' ' LEU . 5.6 mp -56.42 130.12 75.71 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.675 -0.693 . . . . 73.310000000000002 112.11 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 17.1 Cg_exo -67.59 121.43 8.51 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.72 2.28 . . . . 73.329999999999998 111.381 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 35.87 5.09 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.917 -0.659 . . . . 75.219999999999999 112.462 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -136.14 -171.25 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.167 0.484 . . . . 72.0 111.328 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 168.94 96.13 0.1 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.154 -0.545 . . . . 43.109999999999999 111.887 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -133.98 165.92 30.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.52 0.16 . . . . 73.409999999999997 110.969 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.6 p -80.02 120.09 23.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.917 0.389 . . . . 74.409999999999997 111.421 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -91.35 150.87 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.402 -0.592 . . . . 72.019999999999996 109.402 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.77 107.44 19.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.992 0.425 . . . . 65.400000000000006 110.532 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 106' ' ' ILE . 46.4 t -113.5 113.78 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.314 -0.624 . . . . 74.319999999999993 109.314 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 27.5 mm-40 65.81 -85.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.677 0.611 . . . . 71.109999999999999 109.753 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -154.0 18.81 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.624 0.726 . . . . 73.200000000000003 109.302 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.82 128.87 47.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.864 -1.062 . . . . 74.25 109.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 48.9 mt-30 -101.46 130.32 47.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.189 0.519 . . . . 34.509999999999998 111.243 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.426 ' O ' HD12 ' A' ' 28' ' ' ILE . 1.2 pp -127.63 129.85 70.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.599 . . . . 72.319999999999993 110.313 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -85.73 113.7 22.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.55 . . . . 74.310000000000002 109.916 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 37.9 t -97.16 98.29 7.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.228 0.537 . . . . 73.0 110.27 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 69.9 m-85 -81.6 126.5 31.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.185 -0.916 . . . . 72.209999999999994 110.59 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 10' ' ' LEU . 77.1 ttt180 -120.04 78.51 24.81 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.8 -0.815 . . . . 74.540000000000006 108.8 170.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.6 Cg_exo -76.85 -20.03 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.98 2.454 . . . . 73.299999999999997 112.165 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -104.22 153.7 20.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.567 -0.742 . . . . 52.329999999999998 109.641 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.19 5.74 9.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.551 0.691 . . . . 63.43 109.727 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 13.6 t70 -89.56 -159.9 0.63 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.038 -0.983 . . . . 72.230000000000004 108.88 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.6 ' HA ' HD21 ' A' ' 10' ' ' LEU . 28.2 mt-10 -108.36 2.53 22.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 71.219999999999999 111.329 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -75.34 103.04 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.329999999999998 110.0 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.4 164.04 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.01 -0.541 . . . . 71.219999999999999 111.327 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 96.5 m-85 -135.61 101.94 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.693 -0.685 . . . . 65.049999999999997 110.278 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -100.38 95.24 6.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 110.872 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -115.24 164.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.973 -0.558 . . . . 74.329999999999998 110.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 33.2 m -81.67 66.92 7.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.129 0.49 . . . . 74.099999999999994 110.629 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.645 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 38.1 t-20 -92.23 92.03 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.897 -0.779 . . . . 33.240000000000002 108.897 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.581 HD11 ' O ' ' A' ' 27' ' ' GLN . 14.5 mt -137.55 144.8 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 64.299999999999997 110.158 -174.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' HG22 ' A' ' 53' ' ' VAL . 2.4 p-10 -88.96 140.07 29.13 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.948 -0.76 . . . . 63.310000000000002 108.948 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 1.2 Cg_endo -83.91 15.13 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.477 2.118 . . . . 73.099999999999994 112.942 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -101.37 -56.54 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.729 0.3 . . . . 71.319999999999993 110.54 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -120.49 -2.23 10.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.287 -0.415 . . . . 75.239999999999995 110.643 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 19.5 mm-40 62.99 72.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.558 -0.747 . . . . 73.319999999999993 111.94 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.685 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -152.25 173.01 15.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.39 -0.823 . . . . 63.119999999999997 109.227 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -92.58 66.55 4.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.329 0.585 . . . . 73.109999999999999 109.903 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 46' ' ' ASP . 32.8 m -85.5 -10.57 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 63.219999999999999 110.273 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 90.0 mt -86.56 9.62 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.619 -0.719 . . . . 72.430000000000007 109.766 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 40.7 t -84.37 -63.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.347 -0.842 . . . . 33.329999999999998 110.11 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.565 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 58.8 ttt180 70.47 -11.67 0.59 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.185 0.594 . . . . 72.239999999999995 111.15 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' SER . . . 77.41 5.5 85.75 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.319 -0.467 . . . . 62.450000000000003 112.244 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.47 105.72 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.613 0.72 . . . . 65.310000000000002 110.688 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 33' ' ' PRO . 96.7 t -99.3 101.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.702 -1.135 . . . . 71.530000000000001 109.757 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.95 156.98 17.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.515 . . . . 62.450000000000003 110.436 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.14 127.04 40.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.015 -0.539 . . . . 71.319999999999993 110.053 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.6 -46.05 17.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 177.62 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.658 -1.155 . . . . 73.450000000000003 108.497 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.87 -15.14 16.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.478 -0.783 . . . . 74.400000000000006 109.898 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -109.99 149.67 29.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.649 -0.705 . . . . 73.219999999999999 110.034 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.16 131.02 57.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 73.219999999999999 110.329 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.845 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 35.7 m95 -127.74 119.12 25.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.398 -0.365 . . . . 64.129999999999995 110.791 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -73.89 138.39 21.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.656 -0.498 . . . . 62.439999999999998 109.656 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.09 109.67 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 73.420000000000002 111.123 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 m -72.85 154.02 91.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 61.340000000000003 111.239 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 56' ' ' ARG . 69.6 Cg_endo -74.46 -6.0 17.69 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.044 2.496 . . . . 54.210000000000001 113.626 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.09 -75.63 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.804 0.335 . . . . 72.109999999999999 111.163 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.62 24.61 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.455 -0.339 . . . . 75.299999999999997 110.254 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 55.24 34.65 23.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.03 0.919 . . . . 75.230000000000004 109.908 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.745 ' HG3' ' HE1' ' A' ' 77' ' ' PHE . 3.8 pt20 -81.29 141.13 34.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.592 -1.185 . . . . 74.239999999999995 110.693 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.845 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 61.6 m80 -93.13 121.55 34.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.478 -0.783 . . . . 71.5 110.42 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.745 ' HE1' ' HG3' ' A' ' 75' ' ' GLN . 7.3 m-85 -96.11 -16.83 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.478 0.547 . . . . 72.040000000000006 112.478 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 67' ' ' TRP . 5.7 ttt180 72.32 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.527 0.68 . . . . 70.329999999999998 111.18 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' A' ' 68' ' ' VAL . 97.4 mt -96.48 5.81 50.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 73.129999999999995 112.168 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.89 -26.6 19.26 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.635 -0.426 . . . . 63.329999999999998 111.13 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.36 -69.35 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.306 . . . . 63.32 111.382 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 92' ' ' VAL . . . 159.29 12.31 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.915 -0.66 . . . . 51.399999999999999 112.621 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -82.1 96.26 7.73 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.546 -0.539 . . . . 73.5 109.546 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 87' ' ' ASP . 6.8 m -79.95 161.38 25.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.273 -0.876 . . . . 70.430000000000007 111.504 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.5 tp -90.14 -66.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.999 -0.546 . . . . 74.109999999999999 110.424 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -86.36 -1.06 57.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.401 -0.363 . . . . 62.210000000000001 111.215 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 7.7 t70 -114.1 132.85 55.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 41.409999999999997 111.401 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.21 15.14 3.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.684 -0.966 . . . . 72.439999999999998 110.684 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -112.11 -37.38 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.598 0.237 . . . . 74.319999999999993 111.231 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -89.13 -71.72 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.51 -0.314 . . . . 74.420000000000002 110.555 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.0 m 60.14 99.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.685 0.616 . . . . 65.549999999999997 111.805 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 27.2 m -77.54 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 111.254 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -118.54 178.93 4.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 110.188 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.01 118.04 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.799 0.333 . . . . 72.030000000000001 110.965 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -101.0 153.54 19.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.64 -0.709 . . . . 72.409999999999997 110.442 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.09 139.31 54.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.087 0.47 . . . . 73.219999999999999 110.973 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 41' ' ' ALA . 2.9 m -134.4 158.85 42.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.566 -0.743 . . . . 70.239999999999995 109.324 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.1 pt20 -155.91 146.1 21.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.03 0.443 . . . . 74.400000000000006 110.422 174.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.0 102.06 13.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 72.239999999999995 110.126 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.2 m -82.11 85.06 6.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.349 -0.611 . . . . 63.140000000000001 109.349 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 72.45 -66.89 0.29 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.983 -1.008 . . . . 73.010000000000005 111.298 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.32 3.9 1.96 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.915 -0.659 . . . . 71.040000000000006 112.085 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -103.17 118.19 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.493 0.187 . . . . 62.439999999999998 110.715 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.68 115.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.829 -0.434 . . . . 71.219999999999999 109.829 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.809 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 24.2 mt-30 -123.09 134.79 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 73.420000000000002 111.113 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 23' ' ' VAL . 2.9 pp -117.7 167.18 11.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.851 -0.613 . . . . 73.540000000000006 110.665 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.0 m -101.58 125.27 48.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.296 -0.411 . . . . 73.209999999999994 110.447 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.17 107.02 19.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.293 0.568 . . . . 75.109999999999999 111.543 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 116.143 -0.48 . . . . 35.420000000000002 111.067 179.622 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 107' ' ' SER . 52.4 mt-30 . . . . . 0 CA--C 1.521 -0.165 0 CA-C-O 121.155 0.502 . . . . 70.409999999999997 111.039 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -116.95 121.84 42.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.507 -0.769 . . . . 72.349999999999994 109.777 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 m -103.15 134.24 46.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.245 -0.434 . . . . 61.240000000000002 109.861 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -79.53 116.78 19.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 75.219999999999999 110.3 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.44 -65.62 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.434 . . . . 34.200000000000003 110.282 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -176.68 -166.37 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.648 -0.706 . . . . 74.239999999999995 109.15 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HE2' ' HB3' ' A' ' 11' ' ' ASP . 50.2 mtpt -67.48 151.45 47.35 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.211 0.319 . . . . 75.209999999999994 111.294 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.38 -17.26 63.66 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.777 -0.824 . . . . 74.230000000000004 108.777 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.597 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 4.9 t70 -93.84 -24.28 17.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.562 -1.199 . . . . 74.239999999999995 111.014 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 25.3 t70 -84.17 -26.27 28.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.912 -0.586 . . . . 71.129999999999995 110.391 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.497 HD13 HG11 ' A' ' 30' ' ' VAL . 61.3 mt -82.25 111.64 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.839 -0.619 . . . . 72.140000000000001 109.467 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.49 145.87 99.02 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 54.240000000000002 112.31 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HB3' ' OD1' ' A' ' 35' ' ' ASN . 72.5 Cg_endo -77.4 153.15 30.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.878 2.385 . . . . 75.239999999999995 112.571 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 62.72 28.58 71.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.81 -0.632 . . . . 71.239999999999995 113.052 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 34.4 p -143.31 -177.27 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.047 0.424 . . . . 74.239999999999995 110.817 -176.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.99 104.72 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.55 -1.02 . . . . 62.350000000000001 110.55 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 31.3 m -105.27 142.14 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.488 . . . . 64.230000000000004 112.319 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.821 ' HB3' HD12 ' A' ' 45' ' ' ILE . 3.8 p -75.51 117.13 16.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.555 . . . . 64.540000000000006 110.812 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.32 143.27 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 110.429 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 25' ' ' GLN . 7.0 tt -84.93 92.71 8.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 64.329999999999998 108.964 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.68 131.09 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.309 -0.86 . . . . 73.439999999999998 109.267 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.16 16.73 10.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.895 0.855 . . . . 62.520000000000003 110.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.473 ' HA ' HD21 ' A' ' 22' ' ' LEU . 83.9 mm-40 76.3 25.91 0.97 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.258 -1.792 . . . . 74.230000000000004 111.054 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.19 167.21 21.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 75.510000000000005 109.849 177.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 45' ' ' ILE . 24.4 mm-40 -91.87 119.35 31.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.047 0.451 . . . . 54.119999999999997 111.147 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.1 mt -135.46 129.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.725 -0.67 . . . . 72.329999999999998 109.869 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.98 134.46 34.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.496 -0.32 . . . . 63.25 110.335 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 40.4 t -110.14 111.32 35.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.986 0.422 . . . . 53.530000000000001 110.512 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 8.8 m-85 -91.74 146.95 23.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.583 -0.735 . . . . 75.510000000000005 111.386 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 46.9 mtp85 -140.66 55.07 5.39 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.666 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HG2' HD13 ' A' ' 79' ' ' LEU . 23.5 Cg_exo -63.45 -46.38 9.66 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.914 2.41 . . . . 74.549999999999997 113.077 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.31 -29.67 67.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.599 -0.273 . . . . 63.229999999999997 111.623 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 62.5 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.41 0.624 . . . . 73.200000000000003 110.029 -170.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -177.9 -127.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.421 -0.955 . . . . 74.340000000000003 108.421 -174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -104.74 -9.02 18.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.929 0.395 . . . . 71.519999999999996 110.105 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -71.04 103.43 2.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.032 -0.531 . . . . 72.420000000000002 110.966 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 m -113.74 142.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.019999999999996 109.402 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.832 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 74.1 m-85 -128.6 104.32 7.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.948 -0.301 . . . . 70.230000000000004 110.637 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.69 103.85 13.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 74.299999999999997 110.898 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.829 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.4 pt -134.9 154.16 36.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.005 -0.543 . . . . 54.329999999999998 110.056 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.4 m -77.95 55.13 1.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.262 0.553 . . . . 62.439999999999998 111.18 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.612 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 63.4 t30 -91.29 68.88 5.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.865 -0.791 . . . . 53.240000000000002 108.865 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 20' ' ' CYS . 25.7 mm -122.89 138.06 54.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 72.140000000000001 110.619 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.25 130.5 94.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.975 -0.557 . . . . 71.0 110.886 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -87.63 13.13 2.71 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.0 2.467 . . . . 74.420000000000002 113.284 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -101.46 -54.85 2.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.591 0.234 . . . . 64.040000000000006 110.912 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.15 -0.66 11.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.062 0.458 . . . . 53.439999999999998 110.813 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 61.69 74.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.231 -0.895 . . . . 64.219999999999999 111.443 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.7 151.87 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.651 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 p -83.07 83.09 7.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.286 0.565 . . . . 74.420000000000002 110.737 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 26.9 m -101.5 8.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.469 0.652 . . . . 73.310000000000002 109.813 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.87 13.81 24.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.204 -0.907 . . . . 75.319999999999993 109.669 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 p -112.17 -64.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.613 -0.721 . . . . 73.109999999999999 111.659 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ptt85 -81.32 51.06 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.005 -0.543 . . . . 74.299999999999997 111.208 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -112.06 -110.55 3.1 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.78 -0.724 . . . . 64.340000000000003 112.253 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 62.2 mt -110.84 114.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.059 0.457 . . . . 74.310000000000002 110.346 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.54 110.87 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.748 -0.66 . . . . 51.509999999999998 109.454 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.89 116.8 32.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.559 -0.746 . . . . 51.140000000000001 111.085 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.89 121.21 38.5 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.361 -0.607 . . . . 61.450000000000003 109.361 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.15 76.68 1.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 72.5 109.189 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 66.01 -75.21 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.488 -0.778 . . . . 72.540000000000006 111.51 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -121.93 -22.75 5.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.128 0.49 . . . . 72.319999999999993 110.37 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 19.2 t0 -84.69 148.84 26.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 72.510000000000005 110.147 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 79' ' ' LEU . 68.1 mt -117.34 115.34 25.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.279 0.561 . . . . 65.200000000000003 111.055 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 38.0 m95 -117.19 163.39 16.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.371 -0.831 . . . . 73.319999999999993 110.17 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.545 ' HB ' HD21 ' A' ' 79' ' ' LEU . 13.3 p -137.56 137.39 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.09 -0.505 . . . . 70.25 110.387 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.17 132.22 56.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.982 -0.554 . . . . 54.350000000000001 110.452 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 43.3 t -67.89 133.37 92.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.898 -0.408 . . . . 73.329999999999998 109.898 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.7 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 39.7 Cg_endo -66.37 -32.24 41.33 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 122.341 2.027 . . . . 73.329999999999998 112.164 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -100.81 -56.84 2.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.845 -0.616 . . . . 73.319999999999993 111.111 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -79.56 -19.63 48.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 55.119999999999997 110.746 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 70' ' ' SER . 52.4 mtmt 57.37 34.8 25.21 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.505 -0.77 . . . . 74.219999999999999 112.841 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.6 mm-40 -82.82 139.65 33.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 53.210000000000001 108.908 169.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 8.7 m80 -116.17 115.83 26.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.103 -0.332 . . . . 75.310000000000002 110.103 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HZ ' ' HB2' ' A' ' 90' ' ' TYR . 77.6 m-85 -129.86 166.89 19.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.541 0.21 . . . . 73.109999999999999 110.631 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 61.4 mtt180 -81.26 146.53 30.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.407 . . . . 71.230000000000004 109.9 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 66' ' ' LEU . 96.0 mt -67.97 -27.47 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.896 0.332 . . . . 63.149999999999999 111.896 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.59 37.22 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.81 0.3 . . . . 71.239999999999995 111.81 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 20.2 t70 -148.88 -62.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.932 -0.307 . . . . 71.049999999999997 111.195 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.46 -12.22 23.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.181 -1.009 . . . . 22.329999999999998 113.697 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -75.32 160.03 30.79 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.193 0.52 . . . . 65.219999999999999 111.253 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . 61.8 m -87.86 151.99 22.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.453 -0.794 . . . . 60.439999999999998 111.481 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 64.5 tp -88.49 -58.86 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.484 . . . . 63.399999999999999 110.324 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 16.3 mm-40 -125.53 18.84 8.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 71.239999999999995 109.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 84' ' ' CYS . 2.1 m-20 -124.07 -180.0 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.414 -0.812 . . . . 62.399999999999999 111.037 -168.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.81 23.72 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.513 -0.767 . . . . 64.230000000000004 111.277 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.34 -59.52 2.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.748 0.277 . . . . 51.530000000000001 111.748 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.571 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 40.3 m-85 -90.4 -76.35 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.621 0.23 . . . . 73.329999999999998 111.621 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 m 66.27 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.84 0.712 . . . . 73.439999999999998 110.333 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.7 176.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.445 . . . . 72.25 111.697 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.08 167.64 9.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 51.329999999999998 110.916 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -127.34 112.39 14.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.087 0.47 . . . . 63.329999999999998 110.649 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -85.98 157.31 20.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.734 -0.666 . . . . 74.219999999999999 110.082 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 107' ' ' SER . 3.9 t0 -82.47 162.93 21.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.714 -0.476 . . . . 64.129999999999995 109.714 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.788 HG22 HG22 ' A' ' 106' ' ' ILE . 3.1 p -149.12 154.01 38.59 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.342 0.257 . . . . 72.329999999999998 110.831 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 98' ' ' GLN . 2.1 pt20 -154.45 153.87 32.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.239 0.542 . . . . 63.340000000000003 111.115 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.08 83.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.735 -0.839 . . . . 73.040000000000006 108.735 173.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -97.25 -0.22 47.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.703 -0.68 . . . . 75.340000000000003 110.813 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -161.13 -164.75 1.22 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.785 -0.821 . . . . 73.219999999999999 108.785 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.01 -11.38 84.8 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.59 -0.604 . . . . 73.230000000000004 111.59 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.47 152.26 24.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.953 -0.388 . . . . 72.329999999999998 109.953 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.79 136.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 73.319999999999993 110.889 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -126.16 147.51 49.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 60.520000000000003 110.386 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.788 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -125.62 158.37 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.905 -0.589 . . . . 74.329999999999998 109.567 177.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 13.1 t -102.65 119.61 39.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.97 0.414 . . . . 51.329999999999998 109.973 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -120.85 117.36 52.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 70.239999999999995 110.446 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 73.430000000000007 111.133 -179.657 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.362 0.601 . . . . 70.430000000000007 110.545 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 91.8 m95 -74.44 111.14 9.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.450000000000003 110.096 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 106' ' ' ILE . 9.6 m -95.55 138.5 33.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 73.120000000000005 109.909 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -84.36 128.72 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.789 0.328 . . . . 54.420000000000002 110.837 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.92 -75.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.017 0.437 . . . . 53.200000000000003 110.081 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.0 m -151.64 -173.76 4.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 55.149999999999999 109.534 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.717 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 86.4 mttt -78.4 164.15 25.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 71.400000000000006 110.402 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 37' ' ' GLU . 65.6 tp -75.4 -19.45 59.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.682 0.753 . . . . 74.230000000000004 109.046 167.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.51 -25.38 19.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.926 -1.034 . . . . 72.430000000000007 110.761 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.717 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 35.6 t70 -75.93 -21.56 56.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.444 0.64 . . . . 71.530000000000001 109.97 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.528 HD13 HG11 ' A' ' 30' ' ' VAL . 26.8 mt -97.29 104.56 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 51.310000000000002 109.469 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.4 mt -71.84 148.88 92.53 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 75.450000000000003 111.938 -173.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 31.2 Cg_exo -60.79 119.8 7.17 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.981 2.454 . . . . 73.340000000000003 112.017 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.38 33.24 4.59 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.96 -0.564 . . . . 53.439999999999998 112.058 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -133.62 176.96 8.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.305 0.574 . . . . 54.229999999999997 111.53 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 177.14 91.83 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.272 -1.131 . . . . 74.120000000000005 110.272 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.659 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.1 m -121.0 151.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.659 0.614 . . . . 73.0 112.659 -172.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 3.4 p -77.63 99.12 5.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.743 -0.662 . . . . 53.450000000000003 111.073 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.93 127.36 32.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 53.039999999999999 109.836 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.9 112.24 17.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.051 0.453 . . . . 53.219999999999999 109.922 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.08 107.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.622 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 67.11 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.72 -0.673 . . . . 72.109999999999999 111.785 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -138.88 0.75 2.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.227 0.537 . . . . 75.329999999999998 110.162 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -116.02 129.83 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.886 -0.597 . . . . 75.530000000000001 111.276 -173.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 39.5 mt-30 -89.14 113.99 25.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.351 -0.611 . . . . 72.510000000000005 109.351 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.09 117.71 55.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.796 -0.638 . . . . 74.010000000000005 110.625 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -79.97 119.51 22.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 72.319999999999993 110.119 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.674 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 18.8 t -100.91 108.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 109.931 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HE1' ' HB3' ' A' ' 55' ' ' SER . 33.4 m-85 -79.48 117.98 20.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.296 -0.411 . . . . 75.239999999999995 110.598 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.609 HH11 ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -130.83 75.57 78.5 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 72.209999999999994 110.786 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.74 -34.89 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.037 2.491 . . . . 54.310000000000002 113.033 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.7 -179.67 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 70.5 111.296 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.28 18.88 18.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.757 -0.656 . . . . 72.109999999999999 109.852 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 23.3 t70 -83.13 -161.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 75.510000000000005 109.454 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 10' ' ' LEU . 50.3 mt-10 -118.25 2.43 11.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.122 -0.361 . . . . 75.120000000000005 111.255 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 153.79 41.41 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 110.164 -0.31 . . . . 70.109999999999999 110.164 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.7 148.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.106 0.479 . . . . 62.340000000000003 111.598 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -137.92 100.2 4.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.427 -0.806 . . . . 74.030000000000001 109.913 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -118.89 106.33 12.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.047 -0.524 . . . . 63.100000000000001 110.459 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.6 pt -132.35 164.58 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 72.450000000000003 109.757 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 56.1 m -78.41 65.72 3.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.49 . . . . 35.43 110.779 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.582 ' HA ' HG11 ' A' ' 92' ' ' VAL . 64.4 t30 -97.7 75.98 2.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 74.019999999999996 108.986 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.7 mm -125.18 137.65 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.628 -0.714 . . . . 64.5 111.128 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.91 117.98 69.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.417 -0.586 . . . . 70.310000000000002 109.417 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.86 -0.14 9.9 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.69 2.26 . . . . 73.430000000000007 113.276 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -88.85 -30.72 18.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.22 0.534 . . . . 74.230000000000004 109.737 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 -19.49 13.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.868 -0.605 . . . . 75.129999999999995 109.933 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 63.16 36.37 12.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.895 -1.048 . . . . 72.230000000000004 111.347 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -148.95 165.53 31.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 72.530000000000001 109.216 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.659 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 14.0 p -77.31 77.99 3.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.217 0.532 . . . . 53.310000000000002 111.302 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.68 -8.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 62.210000000000001 109.755 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.95 7.63 23.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.978 -1.01 . . . . 72.129999999999995 110.2 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 10.0 p -129.63 7.7 5.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.602 -0.726 . . . . 74.129999999999995 110.772 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -110.01 18.19 20.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 71.209999999999994 110.486 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -103.67 -158.93 24.71 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.527 -0.844 . . . . 71.310000000000002 112.428 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 74.1 mt -85.86 108.02 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.845 0.355 . . . . 70.230000000000004 110.389 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 68' ' ' VAL . 84.9 t -71.56 91.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.871 -0.789 . . . . 53.409999999999997 108.871 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.45 145.99 30.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.47 0.652 . . . . 53.350000000000001 111.744 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -90.41 98.2 11.64 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.305 -0.861 . . . . 74.409999999999997 108.725 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.544 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 77.5 t60 -91.64 -45.29 8.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.487 -1.233 . . . . 73.129999999999995 110.076 -169.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -123.68 -148.11 0.39 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.148 -1.427 . . . . 70.019999999999996 107.148 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.98 44.25 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.179 -0.675 . . . . 75.340000000000003 109.179 171.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.461 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 5.6 t70 -157.55 -175.44 5.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.669 -0.493 . . . . 54.240000000000002 109.669 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.85 114.8 24.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 54.219999999999999 110.312 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.614 ' CZ3' ' HB2' ' A' ' 78' ' ' ARG . 46.8 m95 -122.28 127.35 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.862 -0.608 . . . . 74.200000000000003 110.243 -176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 HG22 ' A' ' 59' ' ' VAL . 15.9 m -89.13 126.46 42.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.363 0.601 . . . . 71.409999999999997 111.036 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -88.83 99.38 12.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.663 -0.699 . . . . 62.009999999999998 109.231 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -58.47 128.41 82.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.726 -0.67 . . . . 71.120000000000005 111.035 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.1 Cg_endo -71.01 -36.38 7.59 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 62.130000000000003 112.324 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.9 tp -89.73 -44.25 10.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 72.430000000000007 110.705 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 27.0 mmmt -81.43 -28.68 34.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 74.019999999999996 110.638 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 63.06 22.31 13.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.572 -0.74 . . . . 74.140000000000001 112.29 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.39 161.63 19.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.884 -0.598 . . . . 71.200000000000003 109.612 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -92.64 140.33 29.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.553 -0.294 . . . . 74.409999999999997 110.879 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' A' ' 90' ' ' TYR . 53.5 m-85 -128.95 139.27 52.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.079 -0.341 . . . . 71.319999999999993 110.079 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 52.6 ttt180 -96.55 127.38 42.49 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.74 -0.466 . . . . 74.519999999999996 109.74 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.45 -60.59 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.66 0.6 . . . . 64.129999999999995 111.403 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.56 77.25 2.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 74.519999999999996 109.836 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 22.6 t70 -178.2 -58.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.197 -0.91 . . . . 72.430000000000007 109.881 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . 102.97 -16.35 54.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.672 -0.775 . . . . 71.099999999999994 113.395 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 81.8 m-85 -85.83 162.42 18.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.052 0.426 . . . . 74.239999999999995 111.452 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.17 40.57 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.648 -0.705 . . . . 61.420000000000002 111.27 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.914 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.4 tp 60.5 -83.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.02 0.528 . . . . 74.150000000000006 111.859 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.914 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 43.4 mt-10 -110.73 -17.83 13.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.337 -0.392 . . . . 63.439999999999998 110.575 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -93.02 172.24 8.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 74.319999999999993 110.472 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.01 60.24 0.5 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.001 -0.84 . . . . 70.120000000000005 111.001 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.25 -27.41 15.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.997 0.369 . . . . 72.5 111.997 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.423 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 22.3 m-85 -132.58 -68.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.337 0.495 . . . . 72.099999999999994 112.337 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 27.6 m 62.25 88.28 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 73.109999999999999 109.695 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 44' ' ' ASN . 30.1 m -85.86 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.587 -0.733 . . . . 62.340000000000003 112.566 -169.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -89.95 169.18 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 72.230000000000004 111.037 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 120.17 8.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.839 0.352 . . . . 65.150000000000006 110.342 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.48 153.87 27.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.057 -0.519 . . . . 72.510000000000005 110.714 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.15 119.89 21.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 65.0 110.186 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 106' ' ' ILE . 77.5 p -119.73 145.06 46.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 110.814 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -152.47 148.4 27.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 75.409999999999997 111.111 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 47.2 t -100.06 109.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.54 -0.755 . . . . 65.010000000000005 109.142 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.4 m -96.19 -63.26 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.176 0.512 . . . . 72.109999999999999 111.714 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -124.24 55.44 1.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.639 -0.709 . . . . 73.099999999999994 109.878 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.6 -1.31 62.15 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.031 -0.604 . . . . 72.25 112.233 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 29.9 p-10 -110.65 144.62 39.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 72.420000000000002 110.725 -177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.1 113.31 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 70.450000000000003 110.058 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 21.5 mt-30 -106.52 135.66 47.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.529 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.845 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.42 150.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.328 -0.619 . . . . 62.530000000000001 109.328 174.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -89.08 101.88 14.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.919 0.39 . . . . 74.209999999999994 110.982 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.4 mm -95.18 96.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 109.676 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.554 -0.748 . . . . 74.140000000000001 110.674 -179.465 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' SER . 3.9 pt20 . . . . . 0 CA--C 1.521 -0.156 0 CA-C-O 120.942 0.401 . . . . 54.240000000000002 111.798 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CZ3' ' HG2' ' A' ' 98' ' ' GLN . 98.5 m95 -118.27 95.02 4.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.909 -0.587 . . . . 75.129999999999995 109.733 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.3 m -92.81 135.1 34.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 72.120000000000005 110.84 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 103' ' ' ASN . 85.2 m -76.49 121.35 22.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.083 -0.508 . . . . 71.439999999999998 110.585 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 23' ' ' VAL . 54.1 t -80.61 -69.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.985 -0.552 . . . . 61.130000000000003 110.128 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 p -161.55 -179.46 7.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.702 -0.681 . . . . 64.310000000000002 110.172 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.12 137.6 40.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.951 0.405 . . . . 73.129999999999995 110.953 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' A' ' 37' ' ' GLU . 51.0 tp -70.94 -8.04 50.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.053 0.93 . . . . 74.439999999999998 109.354 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.33 -14.96 39.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.375 -1.284 . . . . 71.299999999999997 110.078 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -100.86 -25.4 14.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.924 -0.58 . . . . 72.5 110.513 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.22 113.5 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 52.509999999999998 110.674 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 93.3 mt -71.61 129.52 88.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 70.129999999999995 111.661 -175.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 17.0 Cg_exo -67.79 128.92 18.73 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.314 2.676 . . . . 73.150000000000006 112.48 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 27.7 15.57 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.963 -0.637 . . . . 74.430000000000007 112.098 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.73 19.86 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.574 0.226 . . . . 75.109999999999999 111.199 -176.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 130.35 2.16 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 74.030000000000001 111.445 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.51 174.72 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.963 0.382 . . . . 53.009999999999998 111.31 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -80.63 138.92 36.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.867 -0.606 . . . . 71.340000000000003 111.614 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.68 127.76 45.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.41 -0.814 . . . . 44.130000000000003 109.523 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tm? -84.66 100.6 11.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.431 -0.581 . . . . 64.200000000000003 109.431 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 7' ' ' VAL . 48.4 t -107.29 112.27 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 42.530000000000001 109.832 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 63.97 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.775 -0.648 . . . . 74.030000000000001 110.48 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.7 -6.51 3.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.281 0.562 . . . . 74.150000000000006 109.936 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.674 ' HB3' HD11 ' A' ' 28' ' ' ILE . 1.7 mm100 -89.97 138.78 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.685 -0.689 . . . . 65.239999999999995 112.023 -171.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.772 ' HB3' HG13 ' A' ' 45' ' ' ILE . 51.7 mt-30 -100.59 103.44 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 74.0 109.554 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 26' ' ' GLN . 3.2 mp -119.21 142.15 35.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.246 -0.279 . . . . 64.019999999999996 110.246 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.47 131.63 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.473 -0.566 . . . . 73.120000000000005 109.473 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.96 99.75 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.024 0.44 . . . . 73.049999999999997 110.456 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 42.3 m-85 -75.78 125.12 28.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.725 . . . . 60.229999999999997 110.507 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -110.78 87.35 6.68 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.113 -1.069 . . . . 70.519999999999996 108.113 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.89 -13.32 13.0 Favored 'Trans proline' 0 CA--C 1.517 -0.349 0 C-N-CA 122.588 2.192 . . . . 63.329999999999998 112.933 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -117.21 163.37 16.4 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.864 -0.607 . . . . 73.310000000000002 110.213 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.811 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 m-20 -79.9 -1.92 41.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 73.120000000000005 109.562 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 37.5 t70 -92.76 178.56 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.073 -0.967 . . . . 74.519999999999996 109.534 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.774 ' HB3' HD21 ' A' ' 10' ' ' LEU . 41.9 mt-10 -86.14 46.55 1.34 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.127 0.489 . . . . 61.039999999999999 111.547 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -117.53 128.93 55.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.425 -0.583 . . . . 71.049999999999997 109.425 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.73 162.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 64.510000000000005 112.428 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 49.0 m-85 -132.66 106.73 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.245 -0.889 . . . . 75.049999999999997 110.38 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -97.14 101.59 13.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.894 0.378 . . . . 73.349999999999994 111.277 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -129.87 155.06 41.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 64.349999999999994 109.956 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 m -90.81 85.99 6.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 111.94 0.348 . . . . 75.049999999999997 111.94 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.789 ' HB3' HG11 ' A' ' 92' ' ' VAL . 21.7 p30 -135.39 65.5 1.55 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.855 0.836 . . . . 74.230000000000004 111.017 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.772 HG13 ' HB3' ' A' ' 27' ' ' GLN . 10.6 mm -84.04 -15.79 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.316 -0.856 . . . . 73.140000000000001 111.282 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.622 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 10.9 t70 66.62 121.13 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.939 -1.028 . . . . 74.310000000000002 110.714 -174.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.7 Cg_exo -75.01 -4.36 15.29 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.986 2.457 . . . . 64.239999999999995 113.523 -173.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.24 -31.91 11.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.744 0.307 . . . . 72.120000000000005 110.847 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.03 -31.65 7.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.825 0.345 . . . . 71.319999999999993 110.896 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 63.71 16.61 9.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.543 -0.753 . . . . 64.519999999999996 112.412 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.9 23.85 4.97 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.159 -0.338 . . . . 54.350000000000001 111.21 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 14.9 m 61.87 58.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 74.109999999999999 111.418 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 72' ' ' LEU . 20.6 m -79.62 -14.11 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.301 0.572 . . . . 55.109999999999999 109.901 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 49.4 mt -74.78 -23.52 58.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.749 -0.834 . . . . 71.0 108.749 172.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 1.1 m -90.59 -38.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.231 -0.895 . . . . 71.340000000000003 110.034 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -80.64 29.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.56 -0.745 . . . . 74.439999999999998 111.112 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.96 -147.2 21.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.381 -0.688 . . . . 73.239999999999995 111.381 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.45 102.18 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.143 0.497 . . . . 73.439999999999998 110.397 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.3 t -83.82 94.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.39 -0.823 . . . . 74.310000000000002 109.3 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 179.76 3.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.116 -0.493 . . . . 50.009999999999998 111.267 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG2' HD23 ' A' ' 66' ' ' LEU . 23.8 mt-10 -116.02 155.59 27.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.6 -0.727 . . . . 63.409999999999997 110.614 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -127.1 39.23 3.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.936 -1.135 . . . . 63.219999999999999 107.936 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 78.7 mt-30 69.28 103.2 0.06 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.128 -1.396 . . . . 75.430000000000007 110.6 -171.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 63' ' ' GLN . 29.3 t70 75.8 -53.05 0.63 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.863 -1.062 . . . . 62.100000000000001 111.55 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 78' ' ' ARG . 23.9 m-20 -76.2 143.88 40.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.208 0.527 . . . . 72.099999999999994 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 ' HG2' ' A' ' 61' ' ' GLU . 92.6 mt -103.52 120.25 40.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 65.120000000000005 109.768 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 58.5 m95 -124.49 117.1 23.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 65.120000000000005 110.423 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.08 130.3 42.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.018 0.437 . . . . 63.119999999999997 110.259 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.46 116.54 32.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.903 -0.59 . . . . 63.109999999999999 110.111 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.7 p -81.2 138.16 48.98 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.137 -0.483 . . . . 74.230000000000004 110.951 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.03 -29.84 26.68 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.413 2.075 . . . . 65.25 112.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 53' ' ' VAL . 74.8 mt -86.83 -52.21 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 74.120000000000005 111.405 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -32.48 29.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.426 -0.352 . . . . 74.120000000000005 110.854 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt 62.24 37.75 13.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.742 -0.663 . . . . 72.310000000000002 111.215 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -115.62 146.89 41.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 71.109999999999999 109.753 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 66.0 m80 -91.42 116.35 28.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.012 -0.54 . . . . 71.099999999999994 110.604 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -105.77 121.3 43.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 110.038 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.9 ttp180 -84.58 129.99 34.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.916 -0.401 . . . . 70.439999999999998 109.916 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.07 95.34 0.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.296 0.569 . . . . 63.420000000000002 111.032 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -161.31 -58.95 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.449 -0.945 . . . . 73.230000000000004 108.449 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 94' ' ' ALA . 7.3 m-20 -138.23 -83.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.835 -1.075 . . . . 44.420000000000002 108.985 170.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . -159.28 32.34 0.45 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.596 -0.729 . . . . 55.130000000000003 111.539 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -71.25 120.24 16.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.758 0.314 . . . . 64.409999999999997 110.731 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 8.6 m -100.83 141.74 33.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.734 -0.667 . . . . 73.329999999999998 110.099 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 53.9 tp -71.17 -64.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 73.510000000000005 111.818 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.4 pm0 -85.73 -51.84 6.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.994 0.368 . . . . 71.030000000000001 111.994 -173.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 9.9 t70 -115.8 -151.92 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.832 -0.433 . . . . 75.150000000000006 109.832 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . -172.14 48.38 0.18 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.865 -0.894 . . . . 74.239999999999995 110.865 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.04 -25.32 67.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.112 0.412 . . . . 21.300000000000001 112.112 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -128.54 -57.98 1.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.886 -0.326 . . . . 74.420000000000002 111.332 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 49.3 m 57.05 83.01 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.479 0.657 . . . . 75.400000000000006 109.749 -173.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.789 HG11 ' HB3' ' A' ' 44' ' ' ASN . 23.3 m -70.99 166.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.019 -0.991 . . . . 74.230000000000004 112.605 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.49 146.39 25.81 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 53.439999999999998 110.714 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -124.79 107.86 11.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 64.310000000000002 110.532 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.556 ' HE1' ' HB3' ' A' ' 109' ' ' ALA . 91.2 m-85 -84.11 144.31 29.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.678 -0.692 . . . . 75.409999999999997 109.463 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.34 136.07 49.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.781 0.324 . . . . 63.219999999999999 110.353 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.801 HG22 HG22 ' A' ' 106' ' ' ILE . 79.2 p -127.77 144.46 51.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 64.310000000000002 110.512 -175.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 8.9 pt20 -140.11 141.8 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 74.25 110.93 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 10' ' ' LEU . 37.5 t -110.48 98.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.566 -0.743 . . . . 70.040000000000006 109.214 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -128.02 -1.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 63.119999999999997 111.42 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 103' ' ' ASN . 8.4 t-20 -136.36 24.99 3.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.374 0.607 . . . . 71.530000000000001 110.222 -175.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.89 -23.32 2.61 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.752 -0.737 . . . . 63.109999999999999 111.516 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.55 ' HB3' HG23 ' A' ' 6' ' ' THR . 41.6 m-80 -103.57 153.82 20.17 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.362 -0.607 . . . . 73.040000000000006 109.362 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' VAL . 45.0 t -90.08 120.11 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.947 -0.39 . . . . 74.340000000000003 109.947 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -114.14 127.06 55.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 62.409999999999997 109.892 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.801 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.21 152.98 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.150000000000006 110.977 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 25.4 t -82.69 107.31 15.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.166 -0.679 . . . . 64.019999999999996 109.166 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 108' ' ' ILE . 1.7 pp -81.51 121.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.705 0.764 . . . . 73.239999999999995 112.275 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . . . . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.396 -0.82 . . . . 74.340000000000003 108.875 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 15.6 mm-40 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 121.18 0.514 . . . . 74.25 111.395 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 96.0 m95 -116.26 96.58 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.418 -0.81 . . . . 74.019999999999996 109.437 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.4 m -77.07 119.3 20.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.354 -0.384 . . . . 74.209999999999994 110.633 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.416 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 21.2 m -68.81 113.13 5.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.058 -0.519 . . . . 62.32 109.743 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.36 -65.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.169 0.509 . . . . 63.43 111.246 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.781 ' SG ' HG12 ' A' ' 13' ' ' ILE . 34.1 t -134.11 167.56 20.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.904 -0.589 . . . . 64.349999999999994 110.874 -172.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' ASP . 16.0 tptm -84.93 2.96 40.46 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.978 -0.555 . . . . 63.130000000000003 110.27 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 67.5 tp 71.77 -40.49 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.855 -1.066 . . . . 71.109999999999999 111.018 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' LYS . 28.8 t70 -74.25 -32.56 63.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.374 -0.83 . . . . 71.040000000000006 111.231 -175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -84.67 9.9 12.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.911 -0.716 . . . . 55.219999999999999 111.342 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.781 HG12 ' SG ' ' A' ' 8' ' ' CYS . 37.2 mm -90.55 128.93 42.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.719 -0.474 . . . . 63.219999999999999 109.719 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.96 125.99 92.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 71.099999999999994 111.3 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.17 126.82 17.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.837 2.358 . . . . 45.420000000000002 112.459 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 30.86 29.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 70.299999999999997 111.553 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -150.54 173.98 13.48 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.308 . . . . 70.239999999999995 110.864 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.503 ' H ' HG22 ' A' ' 17' ' ' THR . . . -148.04 142.88 10.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.175 -1.17 . . . . 75.209999999999994 110.175 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 m -134.3 146.83 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 117.822 0.811 . . . . 73.109999999999999 112.605 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 3.5 p -75.54 111.94 11.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.729 -0.668 . . . . 62.310000000000002 110.713 174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.07 109.55 20.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.931 -0.577 . . . . 61.100000000000001 109.878 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.15 103.15 3.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.298 -0.63 . . . . 75.310000000000002 109.298 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 26' ' ' GLN . 16.3 t -94.22 161.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.6 -0.889 . . . . 61.530000000000001 108.6 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.81 -53.16 10.07 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.52 0.512 . . . . 75.239999999999995 112.246 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -130.36 23.02 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.614 0.245 . . . . 74.129999999999995 111.226 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 20.2 mm-40 -138.4 157.63 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.107 0.479 . . . . 74.239999999999995 112.064 -174.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.47 ' HB3' HG13 ' A' ' 45' ' ' ILE . 50.3 mt-30 -127.6 103.31 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.653 -0.703 . . . . 71.340000000000003 110.461 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 26' ' ' GLN . 2.8 mp -121.21 135.94 59.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.324 -0.398 . . . . 63.350000000000001 110.254 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -100.51 134.62 43.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.743 -0.465 . . . . 71.340000000000003 109.743 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 39.8 t -111.06 108.44 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.808 -0.357 . . . . 55.140000000000001 110.343 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.847 ' HZ ' ' HB3' ' A' ' 44' ' ' ASN . 2.8 m-85 -93.55 128.0 39.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.906 -0.588 . . . . 72.010000000000005 110.148 -178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.522 ' HG3' HG12 ' A' ' 39' ' ' VAL . 55.3 ttt180 -119.74 86.67 35.92 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 108.765 -0.828 . . . . 62.340000000000003 108.765 172.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 -36.84 91.72 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.853 2.368 . . . . 73.450000000000003 112.166 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.5 mtm180 -133.24 163.96 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 62.399999999999999 109.551 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.97 56.47 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.624 0.726 . . . . 65.450000000000003 110.243 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.82 -171.61 2.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.503 -0.771 . . . . 71.430000000000007 109.72 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.6 0.04 56.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 73.540000000000006 111.09 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.99 99.33 12.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.979 0.419 . . . . 71.329999999999998 110.3 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.522 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.5 m -125.32 165.57 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 62.539999999999999 110.818 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -133.04 107.34 8.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.983 -0.553 . . . . 72.140000000000001 110.77 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -106.79 96.43 6.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.03 0.443 . . . . 74.409999999999997 110.714 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.3 164.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 74.209999999999994 109.6 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.8 m -76.89 53.83 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.043 0.449 . . . . 74.019999999999996 111.865 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.847 ' HB3' ' HZ ' ' A' ' 31' ' ' PHE . 53.8 t30 -100.93 67.03 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.625 0.726 . . . . 73.530000000000001 109.294 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 29' ' ' ALA . 30.8 mm -97.05 -21.05 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.107 -0.951 . . . . 75.540000000000006 111.555 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 32.1 t0 63.2 96.97 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.152 -0.931 . . . . 64.430000000000007 109.259 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 90' ' ' TYR . 32.2 Cg_exo -60.31 -1.05 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.622 2.881 . . . . 64.420000000000002 113.57 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -92.4 -15.04 27.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.557 0.218 . . . . 61.100000000000001 110.822 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -129.43 -31.02 2.08 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.817 0.673 . . . . 63.009999999999998 112.817 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.7 mp0 76.35 -14.14 0.84 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.017 0.747 . . . . 75.239999999999995 113.017 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -111.3 34.53 4.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.108 0.41 . . . . 72.310000000000002 112.108 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 53.0 p 47.55 56.4 7.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.282 0.563 . . . . 73.150000000000006 111.584 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 m -76.44 -2.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.497 0.665 . . . . 43.439999999999998 110.133 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 82.9 mt -92.58 23.36 4.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.086 -0.961 . . . . 74.430000000000007 109.583 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 77.2 p -145.12 -39.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 55.329999999999998 110.858 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -81.37 59.33 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 63.229999999999997 109.685 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.4 -110.38 0.44 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.401 -0.818 . . . . 63.219999999999999 111.524 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 50.5 mm -119.74 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.159 0.504 . . . . 73.239999999999995 110.694 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.78 101.7 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.141 -1.059 . . . . 75.409999999999997 108.141 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 116.19 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.913 -0.585 . . . . 73.329999999999998 112.497 -169.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.99 103.67 3.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.043 -1.095 . . . . 61.299999999999997 108.043 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -58.96 -57.24 13.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.869 -0.605 . . . . 54.119999999999997 110.656 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -141.64 -66.81 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.731 -0.668 . . . . 73.319999999999993 109.371 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.08 -7.63 8.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.181 -0.918 . . . . 65.120000000000005 110.331 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.594 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.5 t70 -122.54 171.63 8.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.400000000000006 110.115 -173.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.98 112.48 24.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.061 0.458 . . . . 73.530000000000001 110.955 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.715 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 9.3 m95 -124.65 168.14 13.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.577 -0.897 . . . . 75.310000000000002 108.577 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 14.4 p -131.94 144.75 36.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.769 0.318 . . . . 61.140000000000001 110.541 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -103.83 127.64 51.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 74.230000000000004 110.537 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 47.5 t -90.77 132.94 33.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 73.150000000000006 110.427 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.9 -17.3 37.03 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.648 2.232 . . . . 71.019999999999996 112.182 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.33 -52.85 4.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 52.210000000000001 109.868 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.1 pttm -125.9 103.38 7.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.601 -0.727 . . . . 74.439999999999998 109.147 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.7 77.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 64.340000000000003 112.178 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -130.72 151.37 51.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 64.310000000000002 109.022 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -88.92 93.26 9.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.555 0.217 . . . . 73.010000000000005 110.877 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 33.4 m-85 -78.81 121.87 25.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 71.010000000000005 109.656 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 49.4 ttt180 -80.04 122.65 27.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.867 -0.333 . . . . 74.209999999999994 110.583 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 62.109999999999999 111.353 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 49.4 t80 -106.84 16.46 24.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.329 0.585 . . . . 73.329999999999998 110.558 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.542 ' CB ' ' HD3' ' A' ' 78' ' ' ARG . 9.8 t70 -147.92 -65.21 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.099999999999994 111.191 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.04 -30.03 4.22 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.037 -0.601 . . . . 41.009999999999998 111.817 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.45 153.67 42.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 64.209999999999994 110.307 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.3 m -100.41 29.49 4.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 73.150000000000006 111.702 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 56.5 tp 53.89 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.452 0.908 . . . . 71.019999999999996 113.452 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -73.15 -21.71 60.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.695 . . . . 74.230000000000004 111.782 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 3.4 t70 -166.51 -160.68 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.777 -0.823 . . . . 74.319999999999993 108.777 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.08 -155.14 9.33 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 110.24 -1.144 . . . . 52.109999999999999 110.24 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 171.39 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.373 0.606 . . . . 75.400000000000006 110.018 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD2' ' HD2' ' A' ' 47' ' ' PRO . 94.9 m-85 -147.25 108.54 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.139 -0.937 . . . . 64.329999999999998 108.687 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 m -56.87 105.59 0.23 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 74.310000000000002 110.456 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.0 m -94.35 156.07 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.277 -0.419 . . . . 60.200000000000003 110.959 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.4 121.43 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.535 . . . . 63.450000000000003 111.51 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.36 94.72 8.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 70.299999999999997 110.057 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -75.46 164.56 26.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.557 -0.747 . . . . 72.120000000000005 111.381 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 21.6 t70 -86.04 132.24 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.342 -0.614 . . . . 73.040000000000006 109.342 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.762 HG22 HG22 ' A' ' 106' ' ' ILE . 51.7 p -128.06 144.49 51.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.342 -0.39 . . . . 53.240000000000002 111.081 -173.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.42 148.77 49.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.94 0.4 . . . . 45.009999999999998 110.653 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.48 103.11 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.915 -0.584 . . . . 71.019999999999996 109.504 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 m -83.32 77.99 9.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.832 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 71.83 -44.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.84 0.856 . . . . 64.329999999999998 112.348 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.06 -49.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.059 -0.591 . . . . 71.299999999999997 112.039 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -80.4 151.73 29.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.028 0.442 . . . . 73.420000000000002 110.855 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.94 127.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 42.509999999999998 110.457 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 23.6 mt-30 -120.47 137.22 54.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 74.099999999999994 110.483 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -113.82 149.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.107 -0.331 . . . . 74.439999999999998 110.107 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -84.99 105.05 15.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.62 . . . . 74.099999999999994 109.327 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 pt -82.85 147.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.089 0.471 . . . . 74.5 111.288 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 34.43 109.691 175.647 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.39 0.615 . . . . 75.319999999999993 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 57.4 m95 -129.14 125.38 36.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.132 -0.94 . . . . 62.340000000000003 109.041 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -112.62 136.18 52.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 71.120000000000005 111.732 -177.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.53 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 25.9 m -67.55 114.37 6.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.656 -0.702 . . . . 73.310000000000002 110.873 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 106' ' ' ILE . 46.4 t -89.38 -78.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 75.420000000000002 111.171 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' HD11 ' A' ' 13' ' ' ILE . 86.0 m -143.44 177.8 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 71.25 110.677 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 13' ' ' ILE . 43.3 mtmt -84.29 117.68 23.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.582 -0.735 . . . . 72.299999999999997 110.384 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . 56.9 tp -66.34 -21.13 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.408 0.623 . . . . 61.210000000000001 110.429 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.97 -13.27 56.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.437 -0.801 . . . . 72.310000000000002 109.794 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.47 -29.94 10.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.172 -0.922 . . . . 73.319999999999993 110.412 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 9' ' ' LYS . 77.4 mt -68.67 122.03 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 74.200000000000003 110.741 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 6.3 mp -68.92 142.01 92.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 70.030000000000001 111.258 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.756 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 15.3 Cg_exo -69.16 142.01 49.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.872 2.382 . . . . 73.540000000000006 111.571 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.76 29.54 38.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.214 -0.517 . . . . 71.219999999999999 111.9 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 18' ' ' GLY . 2.0 m -139.54 177.81 7.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.057 -0.349 . . . . 64.120000000000005 110.057 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 17' ' ' THR . . . 178.0 118.97 0.57 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.657 -0.577 . . . . 40.219999999999999 111.657 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.545 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 28.1 m -129.45 156.0 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.926 0.363 . . . . 54.32 111.712 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 4.7 p -80.42 107.95 13.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 73.129999999999995 110.895 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 138.15 31.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.534 . . . . 75.430000000000007 110.058 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 22' ' ' LEU . 2.4 tm? -82.75 100.36 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 70.219999999999999 109.86 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.32 97.85 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.941 -0.572 . . . . 52.020000000000003 109.52 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 64.84 -76.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.817 0.698 . . . . 65.200000000000003 111.719 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.88 6.04 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.612 0.244 . . . . 74.549999999999997 111.132 -178.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -115.73 145.46 42.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.464 -0.335 . . . . 75.200000000000003 111.155 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -105.47 126.63 52.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.532 . . . . 74.510000000000005 109.562 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 5.0 mp -130.96 130.35 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 43.439999999999998 109.189 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.83 113.95 21.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.246 -0.434 . . . . 63.119999999999997 110.03 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.557 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.1 t -97.16 98.44 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.045 -0.525 . . . . 63.219999999999999 110.416 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HZ ' HG21 ' A' ' 68' ' ' VAL . 18.6 m-85 -76.21 138.74 40.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.339 -0.846 . . . . 72.129999999999995 111.313 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -123.41 76.14 53.44 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 109.121 -0.696 . . . . 74.450000000000003 109.121 164.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.39 -24.37 19.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.735 2.29 . . . . 75.239999999999995 111.267 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 3.4 mmp_? -94.74 137.11 34.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.077 -0.965 . . . . 74.109999999999999 110.251 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 31.4 p-10 -86.94 14.04 8.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 73.239999999999995 109.982 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 3.4 p-10 -113.75 -93.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.457 -0.792 . . . . 72.409999999999997 111.352 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 49.0 mt-10 -121.27 -52.64 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.963 0.727 . . . . 73.230000000000004 112.963 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.419 ' HB3' ' HG3' ' A' ' 34' ' ' ARG . 57.8 tp60 -55.72 130.92 45.23 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.267 0.84 . . . . 71.439999999999998 113.267 -169.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.4 m -128.72 170.23 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.207 -0.906 . . . . 52.0 109.846 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -144.72 111.31 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.769 0.319 . . . . 72.129999999999995 111.686 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.19 103.61 15.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.873 0.368 . . . . 62.100000000000001 110.258 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.1 pt -122.39 161.85 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.788 0.328 . . . . 65.549999999999997 111.353 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -76.88 46.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 34.310000000000002 111.126 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 45' ' ' ILE . 65.9 t30 -95.5 61.43 2.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.619 0.724 . . . . 73.319999999999993 110.776 -171.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 45' ' ' ILE . 4.2 mp -123.12 129.64 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.299 -0.864 . . . . 72.230000000000004 110.024 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.3 t70 -87.6 123.91 68.59 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 74.319999999999993 109.691 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 25.4 Cg_exo -63.84 -22.22 69.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.299 2.666 . . . . 73.209999999999994 113.806 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.76 -22.22 37.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.333 0.587 . . . . 74.430000000000007 110.465 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.01 -20.14 13.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 71.209999999999994 109.851 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 59.2 28.65 18.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.82 -1.082 . . . . 62.43 109.99 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.775 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -150.83 165.52 33.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.136 -0.938 . . . . 75.310000000000002 109.864 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.946 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 3.8 p -80.75 56.93 2.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 63.350000000000001 111.258 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.12 -9.72 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.618 . . . . 74.420000000000002 110.368 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -95.0 -1.46 52.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.321 -0.854 . . . . 74.400000000000006 109.25 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.946 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 25.9 t -113.12 -52.46 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.205 -0.907 . . . . 55.340000000000003 110.862 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -83.78 59.97 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 64.430000000000007 109.696 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -131.65 -91.26 0.53 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 114.835 -1.075 . . . . 30.539999999999999 111.963 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.74 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 58.9 mt -129.09 132.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 74.430000000000007 110.247 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.23 121.22 58.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.215 -0.661 . . . . 72.049999999999997 109.215 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.77 162.51 34.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.08 0.466 . . . . 65.349999999999994 111.185 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -87.15 157.15 19.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.707 -0.679 . . . . 72.409999999999997 110.263 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 82.8 t60 -131.36 96.19 3.94 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.691 -0.485 . . . . 74.329999999999998 109.691 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 73.79 -55.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.857 -1.065 . . . . 70.230000000000004 111.792 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.88 -36.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.966 0.412 . . . . 73.349999999999994 110.828 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 1.3 m-20 -89.24 169.84 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 73.439999999999998 111.542 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.8 mt -108.93 123.79 49.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.492 -0.776 . . . . 73.109999999999999 109.898 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.507 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 11.8 m95 -130.84 174.94 9.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.204 -0.665 . . . . 63.409999999999997 109.204 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.4 p -120.09 145.28 26.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.955 -0.387 . . . . 51.219999999999999 109.955 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -110.02 103.54 12.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.173 0.511 . . . . 51.100000000000001 110.539 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -73.89 124.68 90.37 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 65.310000000000002 110.36 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 24.3 Cg_endo -61.0 -32.45 92.36 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.792 2.328 . . . . 65.140000000000001 112.874 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.3 -63.65 1.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.388 -0.369 . . . . 74.140000000000001 111.425 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.817 ' HE3' ' HE2' ' A' ' 90' ' ' TYR . 73.2 mmtt -71.87 -26.55 62.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.319999999999993 112.022 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 62.69 15.88 8.45 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.065 0.546 . . . . 73.430000000000007 111.733 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 79.6 mt-30 -80.3 141.81 35.12 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 109.625 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 29.1 m80 -104.57 96.44 6.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 51.219999999999999 110.246 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' HG12 ' A' ' 68' ' ' VAL . 58.9 m-85 -82.42 121.22 26.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.767 -0.457 . . . . 71.430000000000007 109.767 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 65' ' ' ASP . 23.8 ttp85 -71.5 127.59 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.747 -0.834 . . . . 54.439999999999998 108.747 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 68' ' ' VAL . 87.5 mt -72.72 67.46 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 44.310000000000002 113.059 -167.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 t80 168.68 -52.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.975 0.91 . . . . 63.310000000000002 109.592 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.95 -44.0 61.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 73.239999999999995 111.587 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.77 -15.37 44.97 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.474 -0.87 . . . . 23.43 113.183 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.26 135.65 57.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.108 -0.331 . . . . 72.129999999999995 110.108 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 2.5 m -90.54 22.59 3.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.022 -0.536 . . . . 72.109999999999999 111.476 -172.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp 59.41 -73.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.716 0.806 . . . . 62.32 112.277 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -81.6 -49.99 9.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.289 0.566 . . . . 74.109999999999999 110.724 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -105.51 -175.53 2.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.513 -0.767 . . . . 70.209999999999994 110.419 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.48 32.71 0.77 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.824 -0.91 . . . . 43.350000000000001 110.824 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.04 -48.25 18.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.039 0.447 . . . . 74.530000000000001 110.874 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.817 ' HE2' ' HE3' ' A' ' 73' ' ' LYS . 56.5 m-85 -102.58 79.56 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.265 0.555 . . . . 55.43 110.037 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -73.18 82.72 1.32 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.627 -0.715 . . . . 61.450000000000003 109.695 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -78.69 149.69 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.596 -0.729 . . . . 73.209999999999994 111.753 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.32 165.58 11.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.849 -0.614 . . . . 73.010000000000005 110.187 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -122.27 105.06 9.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.062 0.458 . . . . 61.109999999999999 110.343 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.66 129.83 34.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.865 -0.607 . . . . 62.210000000000001 110.201 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.9 153.89 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.766 -0.652 . . . . 74.129999999999995 110.76 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.813 HG22 HG22 ' A' ' 106' ' ' ILE . 30.8 p -133.54 133.66 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.293 -0.412 . . . . 73.120000000000005 110.931 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -114.86 150.67 35.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.388 . . . . 75.219999999999999 110.024 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 t -102.98 96.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 109.922 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.0 m -66.99 -63.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.994 -0.548 . . . . 74.319999999999993 111.014 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -173.75 95.67 0.1 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.607 -0.724 . . . . 73.209999999999994 109.781 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.13 -40.86 2.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.152 -0.547 . . . . 71.099999999999994 112.369 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -104.21 151.64 23.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 73.420000000000002 110.604 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 47.9 t -101.47 135.99 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 60.140000000000001 110.661 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 75.8 mt-30 -118.2 127.06 53.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 64.340000000000003 110.151 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.813 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -100.25 155.17 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 63.439999999999998 110.83 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -77.02 124.07 27.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.709 -0.678 . . . . 54.439999999999998 110.407 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 pt -116.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.259 0.552 . . . . 74.230000000000004 110.935 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.405 0 CA-C-O 121.444 0.64 . . . . 74.150000000000006 110.481 177.461 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.142 -0.318 . . . . 61.420000000000002 110.142 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.49 136.59 52.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.375 . . . . 75.219999999999999 110.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -118.74 128.47 54.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.222 -0.445 . . . . 63.299999999999997 110.353 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.611 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.6 m -78.14 113.7 16.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 110.77 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.11 -75.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.07 0.462 . . . . 75.239999999999995 109.848 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.3 m -144.34 168.44 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 72.120000000000005 109.189 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 9.8 mtmp? -91.17 165.81 13.28 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.992 -0.283 . . . . 64.140000000000001 110.578 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 tp -71.27 -7.59 47.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.496 0.665 . . . . 74.040000000000006 110.124 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.65 -20.29 21.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.216 -0.902 . . . . 72.109999999999999 110.002 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 18.4 m-20 -83.47 -27.18 29.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 73.540000000000006 110.694 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.87 136.99 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.87 -0.604 . . . . 73.239999999999995 110.572 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HB2' HG21 ' A' ' 17' ' ' THR . 5.2 mp -91.53 149.04 38.7 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.621 -0.263 . . . . 74.040000000000006 110.977 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.98 121.41 8.89 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.562 2.175 . . . . 74.420000000000002 111.696 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 45.72 6.24 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.93 -0.577 . . . . 73.030000000000001 112.198 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 14' ' ' LEU . 72.5 p -141.61 174.9 10.13 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.954 0.377 . . . . 63.530000000000001 111.073 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -164.22 110.83 0.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.266 -1.134 . . . . 74.049999999999997 110.266 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -125.78 135.8 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 117.265 0.533 . . . . 73.430000000000007 112.43 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 8.7 p -79.72 104.22 10.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.86 -0.609 . . . . 72.120000000000005 110.082 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.06 147.46 23.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.108 -0.496 . . . . 73.200000000000003 110.236 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.57 113.35 22.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.897 -0.779 . . . . 73.219999999999999 108.897 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.33 93.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.872 -0.603 . . . . 73.329999999999998 110.082 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 67.23 -75.57 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.238 -0.892 . . . . 72.409999999999997 111.854 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 18.7 mt-30 -132.26 -8.49 3.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.223 -174.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.888 HE21 ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -122.9 163.53 20.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 75.420000000000002 111.46 -175.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.21 128.84 51.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 54.329999999999998 109.912 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -127.13 119.04 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.765 -0.457 . . . . 64.329999999999998 109.765 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -88.96 125.47 34.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.933 -0.576 . . . . 43.43 110.262 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.528 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.1 t -107.87 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.166 -0.47 . . . . 73.200000000000003 110.081 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 63.1 t80 -91.8 130.25 37.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.716 -0.675 . . . . 71.340000000000003 110.352 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HG3' HG12 ' A' ' 39' ' ' VAL . 64.2 ttt180 -131.31 100.37 16.85 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.009 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.45 -32.76 6.0 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.672 2.248 . . . . 54.32 113.293 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -128.73 166.13 19.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.52 -0.309 . . . . 75.120000000000005 110.684 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.77 26.47 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 63.329999999999998 111.255 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 16.5 m-20 -113.56 -155.04 0.56 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.461 -0.336 . . . . 74.150000000000006 110.745 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 24.4 mt-10 -84.4 -13.04 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.916 -0.583 . . . . 74.549999999999997 111.61 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -73.07 100.23 2.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.097 0.475 . . . . 72.530000000000001 110.992 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 32' ' ' ARG . 27.0 m -129.95 156.4 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 60.509999999999998 110.159 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 80' ' ' TYR . 93.7 m-85 -131.36 102.84 6.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.698 0.285 . . . . 64.140000000000001 110.667 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.94 96.91 7.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.01 0.433 . . . . 62.329999999999998 110.682 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 44' ' ' ASN . 49.3 pt -134.56 -179.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.461 . . . . 51.119999999999997 110.083 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -79.29 60.73 3.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 73.319999999999993 109.911 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 42' ' ' ILE . 2.0 t-20 -93.0 46.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.457 0.646 . . . . 54.439999999999998 110.644 -174.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.7 mp -103.05 131.25 51.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.512 -0.767 . . . . 65.329999999999998 110.04 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 10.0 t70 -82.52 120.94 77.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.101 -0.703 . . . . 73.219999999999999 109.101 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 43.4 Cg_exo -57.35 -23.71 56.39 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.227 2.618 . . . . 61.25 113.678 -175.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -84.14 -20.35 32.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 65.450000000000003 111.08 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.78 -20.57 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.99 -0.284 . . . . 71.239999999999995 111.195 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 64.49 19.19 11.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.692 -0.685 . . . . 71.409999999999997 111.096 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.687 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -137.1 169.7 17.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 42.229999999999997 109.927 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -81.42 50.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.682 -0.69 . . . . 74.530000000000001 111.291 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.66 -19.05 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.115 0.484 . . . . 31.23 109.91 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.23 -43.45 98.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.62 -0.718 . . . . 51.130000000000003 109.38 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -71.3 -23.15 61.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.441 -0.8 . . . . 71.540000000000006 111.09 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -98.37 20.23 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.267 0.556 . . . . 73.140000000000001 110.429 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.51 -149.29 24.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.745 -0.661 . . . . 61.020000000000003 111.636 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.6 mp -90.26 116.32 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 75.400000000000006 109.759 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 68' ' ' VAL . 60.2 t -112.37 112.93 42.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.672 -0.695 . . . . 71.510000000000005 110.301 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.6 159.07 30.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 53.109999999999999 110.237 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HG3' HD23 ' A' ' 66' ' ' LEU . 2.1 mp0 -76.07 163.32 27.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.992 0.425 . . . . 72.239999999999995 110.251 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -122.09 46.54 2.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.727 -0.67 . . . . 74.340000000000003 109.264 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 55.85 25.31 8.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.087 -0.961 . . . . 64.430000000000007 111.697 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -164.15 -55.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 55.310000000000002 110.777 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.566 ' HB3' ' NE1' ' A' ' 67' ' ' TRP . 2.3 t0 -135.83 -173.0 3.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.086 -0.506 . . . . 71.420000000000002 110.116 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 79.2 mt -107.34 110.02 21.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 73.140000000000001 109.98 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 61.3 m95 -122.89 128.69 50.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.38 . . . . 71.549999999999997 111.062 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.596 HG23 HG22 ' A' ' 59' ' ' VAL . 13.2 p -103.56 145.69 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.22 -0.445 . . . . 72.030000000000001 110.339 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.21 117.68 30.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.499 -0.318 . . . . 44.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 27.3 t -73.34 147.27 87.48 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 65.400000000000006 111.29 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.36 -20.53 24.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.437 2.091 . . . . 63.109999999999999 112.021 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 72' ' ' LEU . 4.0 mm? -98.33 -67.98 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 72.0 110.499 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -64.58 -39.23 93.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 73.010000000000005 111.416 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 70' ' ' SER . 70.6 tttt 62.06 11.94 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.635 -0.711 . . . . 64.340000000000003 111.374 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 87' ' ' ASP . 21.9 mm-40 -88.65 150.04 23.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.386 -0.598 . . . . 64.209999999999994 109.386 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.4 m80 -89.86 121.66 32.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.914 0.388 . . . . 72.0 110.737 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -117.54 143.42 46.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 73.230000000000004 110.002 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 46.6 mtm180 -79.61 119.68 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.732 -0.47 . . . . 75.409999999999997 109.732 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 68' ' ' VAL . 92.3 mt -52.1 -55.82 18.37 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.811 0.671 . . . . 62.210000000000001 112.811 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.407 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 46.9 p90 -90.22 15.94 9.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.735 0.302 . . . . 74.299999999999997 111.44 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.794 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 29.5 t70 -122.52 -60.69 1.52 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 45.020000000000003 111.365 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.26 -22.8 14.92 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.298 -0.954 . . . . 52.310000000000002 113.289 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.36 166.21 18.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.997 0.398 . . . . 74.219999999999999 110.924 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -112.7 166.2 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.853 -0.612 . . . . 71.150000000000006 111.634 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 62.1 tp -94.89 -69.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 44.409999999999997 110.276 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -87.1 -19.51 28.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 74.140000000000001 110.985 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 5.1 t70 -96.59 -152.37 0.38 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.931 -0.396 . . . . 52.219999999999999 109.931 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.27 -33.34 0.29 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.962 -0.855 . . . . 74.010000000000005 110.962 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.25 66.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.461 . . . . 54.43 110.803 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 94.7 m-85 -107.44 61.45 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 70.430000000000007 110.893 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.24 121.63 33.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.467 -0.788 . . . . 71.329999999999998 109.385 174.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.88 163.73 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 71.200000000000003 112.124 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.53 131.22 37.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.65 -0.704 . . . . 70.430000000000007 110.961 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.9 98.73 7.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.88 -0.6 . . . . 71.140000000000001 110.369 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.63 150.88 34.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 63.450000000000003 110.475 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.24 122.74 23.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.54 -0.541 . . . . 74.420000000000002 109.54 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.92 HG22 HG22 ' A' ' 106' ' ' ILE . 69.3 p -124.7 160.88 27.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.247 -0.433 . . . . 74.030000000000001 110.589 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -168.9 151.38 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 73.120000000000005 110.715 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 60.4 t -94.01 106.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.547 -0.751 . . . . 52.25 108.978 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.2 t -104.34 -34.24 8.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.228 0.455 . . . . 74.549999999999997 112.228 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -133.03 30.81 3.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 54.520000000000003 110.369 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.25 -0.25 85.51 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.113 -0.795 . . . . 70.120000000000005 111.113 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.0 p30 -115.09 151.47 34.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.568 . . . . 60.020000000000003 110.318 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 99' ' ' VAL . 46.0 t -94.66 113.2 28.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 109.963 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 23.7 mt-30 -115.3 140.77 48.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.091 -0.504 . . . . 52.130000000000003 110.746 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.92 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -111.32 151.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.691 -0.686 . . . . 74.340000000000003 109.815 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 t -87.67 104.02 16.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.597 -0.89 . . . . 70.140000000000001 108.597 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.3 pp -74.12 135.91 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.588 0.709 . . . . 71.120000000000005 112.439 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.549 0 CA-C-N 115.098 -0.955 . . . . 74.510000000000005 109.037 173.527 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 . . . . . 0 CA--C 1.523 -0.063 0 CA-C-O 120.656 0.265 . . . . 73.25 110.831 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.465 ' CZ3' ' HG3' ' A' ' 98' ' ' GLN . 59.7 m95 -109.14 109.78 20.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.49 -0.323 . . . . 75.319999999999993 110.858 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -99.01 141.49 31.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.5 -0.318 . . . . 63.329999999999998 110.858 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 m -80.32 122.87 27.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.541 -0.299 . . . . 72.409999999999997 110.276 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.5 -81.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.883 -0.414 . . . . 73.109999999999999 109.883 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -145.17 -84.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 60.329999999999998 109.796 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 60.3 mttp -151.35 151.44 31.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.018 0.437 . . . . 71.120000000000005 111.128 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.3 tp -84.39 -13.56 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.091 0.948 . . . . 65.519999999999996 109.138 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -88.39 -28.34 21.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.585 -1.188 . . . . 75.340000000000003 110.199 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 -18.75 43.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 73.129999999999995 111.3 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 32' ' ' ARG . 48.6 mm -76.1 118.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 62.210000000000001 110.898 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.66 163.72 42.93 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.57 . . . . 54.43 111.684 -175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.79 125.19 16.04 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.165 2.577 . . . . 73.109999999999999 112.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.45 40.47 96.2 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.08 -0.509 . . . . 54.109999999999999 111.923 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.7 m -148.68 174.29 12.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.842 0.353 . . . . 74.129999999999995 110.422 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 30' ' ' VAL . . . 166.16 165.38 23.43 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.745 -0.942 . . . . 63.149999999999999 110.745 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.528 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 30.7 m -129.57 164.6 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 74.030000000000001 111.652 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD11 ' A' ' 45' ' ' ILE . 2.8 p -83.44 129.27 34.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 111.084 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.92 125.41 51.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.797 -0.638 . . . . 74.340000000000003 109.921 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.06 89.57 5.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 74.349999999999994 109.403 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.8 104.39 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.296 -0.411 . . . . 64.319999999999993 111.151 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 61.38 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.031 0.832 . . . . 65.120000000000005 112.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.73 3.69 3.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.743 0.306 . . . . 75.230000000000004 111.061 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' HG13 ' A' ' 28' ' ' ILE . 58.0 mm-40 -102.28 129.22 48.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 73.120000000000005 111.329 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -102.73 88.2 3.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.926 -0.768 . . . . 74.129999999999995 108.926 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 26' ' ' GLN . 60.3 mt -105.33 135.76 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.88 -0.6 . . . . 72.530000000000001 110.825 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -117.99 137.16 53.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.128 -0.323 . . . . 71.549999999999997 110.128 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.69 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 26.2 t -95.38 146.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.534 -0.543 . . . . 65.230000000000004 109.534 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -140.65 129.41 23.02 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 70.510000000000005 109.629 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' HG3' HG12 ' A' ' 39' ' ' VAL . 46.8 ttt180 -111.71 91.15 14.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.01 -0.276 . . . . 74.519999999999996 110.825 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.13 -55.09 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.452 2.102 . . . . 73.230000000000004 113.668 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.677 ' HB2' ' OD1' ' A' ' 36' ' ' ASP . 34.3 mtm180 -89.58 -0.15 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.65 0.262 . . . . 63.409999999999997 110.926 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 64.5 t30 62.12 28.14 16.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.545 0.688 . . . . 70.510000000000005 110.895 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.677 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 6.4 p-10 -111.81 -166.71 1.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.254 -0.43 . . . . 64.420000000000002 110.324 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.75 -28.3 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 71.230000000000004 111.633 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.33 104.24 11.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.371 0.605 . . . . 70.120000000000005 111.433 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.535 HG12 ' HG3' ' A' ' 32' ' ' ARG . 30.9 m -105.77 158.56 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.459 -0.791 . . . . 73.120000000000005 109.596 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -113.28 96.3 5.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 72.219999999999999 110.258 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 93.6 8.15 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.747 -0.661 . . . . 64.540000000000006 109.429 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.3 pt -126.43 -172.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.001 -0.545 . . . . 74.129999999999995 110.678 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.49 47.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 53.32 110.284 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 33.8 t30 -83.12 40.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.271 0.558 . . . . 62.149999999999999 111.175 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 20' ' ' CYS . 33.4 mm -114.38 123.5 70.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 62.32 111.037 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.97 120.85 71.75 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.011 -0.737 . . . . 75.0 109.011 173.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD2' ' HE2' ' A' ' 90' ' ' TYR . 52.4 Cg_exo -56.34 -26.03 60.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.18 2.587 . . . . 41.009999999999998 113.406 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -78.15 -13.79 59.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 73.109999999999999 110.666 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.44 -34.85 4.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.902 0.382 . . . . 65.230000000000004 110.494 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.896 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 66.37 17.56 10.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.325 -0.852 . . . . 65.439999999999998 111.027 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.41 171.06 14.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 55.020000000000003 109.311 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 6.5 p -76.97 80.24 3.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.477 0.656 . . . . 55.119999999999997 111.282 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.0 m -90.97 -20.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 72.219999999999999 110.171 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.449 HD13 ' HZ ' ' A' ' 77' ' ' PHE . 61.0 mt -86.08 -17.74 34.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.45 -0.795 . . . . 52.420000000000002 110.222 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 49.6 m -81.56 10.66 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 53.5 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -149.5 31.97 0.72 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.291 0.567 . . . . 75.209999999999994 109.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.67 -145.58 19.25 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.293 -0.867 . . . . 75.099999999999994 112.485 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.5 mp -97.83 123.94 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.106 0.479 . . . . 64.25 110.992 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -88.85 102.2 12.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.699 -0.682 . . . . 70.129999999999995 109.905 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 109.02 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 64.109999999999999 110.952 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.16 116.87 23.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.998 -0.546 . . . . 70.030000000000001 110.196 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -102.96 90.25 3.71 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.851 -0.426 . . . . 72.200000000000003 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 63.8 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.465 -0.789 . . . . 73.129999999999995 111.787 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -114.19 -22.91 9.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.352 0.596 . . . . 73.519999999999996 110.301 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 5.9 m-20 -91.64 154.14 19.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 72.319999999999993 111.712 -173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.22 116.2 29.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.595 -0.73 . . . . 70.019999999999996 110.486 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.539 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 16.2 m95 -119.81 151.14 39.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 73.0 109.7 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.94 129.17 66.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.347 0.594 . . . . 75.0 109.724 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -87.94 114.27 24.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.626 -0.716 . . . . 71.310000000000002 110.216 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.4 t -62.42 116.22 21.48 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 71.409999999999997 109.867 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HD2' HD23 ' A' ' 54' ' ' LEU . 45.8 Cg_endo -69.25 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.491 2.127 . . . . 71.239999999999995 112.16 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -112.82 -50.65 2.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 72.349999999999994 111.198 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -92.64 -4.61 53.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.485 -0.325 . . . . 75.099999999999994 111.447 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 74' ' ' LYS . 32.2 ttmt 66.09 11.12 7.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.849 -0.614 . . . . 70.219999999999999 112.278 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.747 HE22 ' HB3' ' A' ' 89' ' ' ALA . 3.3 pt20 -102.36 150.71 23.07 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.133 -0.355 . . . . 74.049999999999997 110.697 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.38 107.31 18.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 74.049999999999997 110.189 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 16.2 p90 -111.29 142.38 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.289 0.566 . . . . 75.420000000000002 110.981 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 38.6 ttp180 -85.82 123.56 31.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 62.350000000000001 110.315 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.8 mt -50.66 -57.07 9.14 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.821 0.7 . . . . 74.310000000000002 112.497 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -87.08 37.08 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 71.209999999999994 111.468 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 26.4 t0 -149.92 -50.84 0.14 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.346 . . . . 75.010000000000005 110.649 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.93 -25.83 25.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.944 -0.646 . . . . 75.329999999999998 113.146 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -85.51 147.74 26.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.774 0.321 . . . . 74.120000000000005 110.955 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.2 m -102.04 47.16 0.91 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.992 -0.549 . . . . 41.520000000000003 111.749 -171.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HG ' ' HG2' ' A' ' 86' ' ' GLU . 49.5 tp 57.41 -95.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 50.229999999999997 112.123 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 6.5 mm-40 -107.23 -27.87 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 74.219999999999999 111.386 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 39.0 t70 -111.16 75.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.203 -0.666 . . . . 73.319999999999993 109.203 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -89.06 63.55 3.45 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.407 -0.815 . . . . 74.340000000000003 113.283 -171.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' HE22 ' A' ' 75' ' ' GLN . . . -80.45 -59.03 2.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.893 0.378 . . . . 51.530000000000001 110.576 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HE2' ' HD2' ' A' ' 47' ' ' PRO . 29.3 m-85 -90.04 74.19 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 65.129999999999995 110.323 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 100.3 3.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.497 -0.774 . . . . 62.409999999999997 109.638 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.76 167.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 53.109999999999999 111.125 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 135.89 51.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 40.409999999999997 110.53 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -96.86 92.33 6.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.935 -0.575 . . . . 45.109999999999999 109.578 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -67.2 155.87 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.432 -0.804 . . . . 73.540000000000006 110.754 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.66 142.8 29.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.543 -0.54 . . . . 72.0 109.543 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 106' ' ' ILE . 26.0 p -134.47 138.08 44.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.404 . . . . 65.439999999999998 111.082 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 48.2 mt-30 -104.85 144.13 32.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.864 0.364 . . . . 63.039999999999999 110.561 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.1 t -99.6 76.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.206 -1.035 . . . . 74.099999999999994 108.206 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.5 p -75.46 -32.58 60.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.27 -0.877 . . . . 63.140000000000001 111.789 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 103' ' ' ASN . 7.2 t-20 -164.52 -146.99 0.1 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.145 . . . . 72.409999999999997 107.907 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.07 36.81 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 42.119999999999997 111.239 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 20.4 p30 -145.74 163.25 35.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.96 0.504 . . . . 74.150000000000006 110.092 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 72.140000000000001 110.464 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -117.27 117.64 30.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 74.329999999999998 110.218 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.4 152.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.342 -0.39 . . . . 44.140000000000001 110.235 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 4' ' ' TRP . 9.0 t -87.81 125.37 34.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.496 -0.557 . . . . 74.329999999999998 109.496 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.07 96.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.092 -0.503 . . . . 44.409999999999997 111.029 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.627 0 N-CA-C 108.478 -0.934 . . . . 54.539999999999999 108.478 169.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 . . . . . 0 N--CA 1.457 -0.093 0 N-CA-C 108.938 -0.764 . . . . 74.230000000000004 108.938 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.45 ' HH2' ' OD2' ' A' ' 96' ' ' ASP . 73.9 m95 -59.81 117.22 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.71 -1.132 . . . . 61.420000000000002 110.393 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -89.61 131.83 35.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.121 -0.491 . . . . 64.439999999999998 110.192 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.1 m -74.47 118.9 17.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 62.420000000000002 110.48 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 23' ' ' VAL . 40.7 t -87.98 -70.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.091 -0.504 . . . . 70.430000000000007 111.064 -177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -161.29 -177.33 5.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.666 . . . . 74.430000000000007 109.212 -174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' ILE . 58.3 mtpt -86.65 143.89 27.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.557 0.218 . . . . 74.099999999999994 110.592 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -67.28 -12.71 60.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.561 0.696 . . . . 74.349999999999994 110.139 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.09 -17.02 53.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 75.299999999999997 110.998 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.96 -9.08 16.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.31 0.576 . . . . 63.340000000000003 110.471 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' LYS . 46.3 mm -75.59 126.9 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.541 . . . . 61.020000000000003 110.686 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.8 mt -70.14 137.48 86.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 64.319999999999993 111.604 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -79.46 127.78 7.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.241 2.627 . . . . 71.420000000000002 112.639 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.84 23.77 44.53 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.932 -0.576 . . . . 71.010000000000005 112.573 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.35 167.34 29.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.064 0.432 . . . . 63.149999999999999 111.624 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -127.56 142.1 13.21 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.333 -0.707 . . . . 43.240000000000002 111.333 177.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.502 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 21.3 m -127.41 139.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.049 0.425 . . . . 72.230000000000004 111.821 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.4 p -70.64 99.0 1.59 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 53.210000000000001 110.479 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 132.04 34.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.112 -0.495 . . . . 52.340000000000003 110.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -86.99 100.47 12.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.377 -0.601 . . . . 72.219999999999999 109.377 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 106' ' ' ILE . 34.3 t -120.76 112.79 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.823 -0.626 . . . . 54.25 110.103 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 31.1 mt-10 61.78 19.41 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.269 0.557 . . . . 71.129999999999995 111.892 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 73.8 mm-40 81.47 19.72 0.39 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.176 -1.375 . . . . 70.549999999999997 111.27 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -113.47 137.99 50.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.845 -0.798 . . . . 62.420000000000002 108.845 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -99.33 108.88 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 74.140000000000001 111.151 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.53 130.5 64.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.735 -0.666 . . . . 71.099999999999994 109.298 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 113.63 21.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 74.030000000000001 110.192 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 29.1 t -95.77 102.34 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.307 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.81 128.51 33.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.639 -0.709 . . . . 62.109999999999999 110.077 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 70.6 ttt180 -112.8 84.21 6.48 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.874 -0.788 . . . . 75.430000000000007 108.874 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.21 -31.75 53.14 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.672 2.248 . . . . 73.200000000000003 112.108 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 99.9 mtt180 -109.39 164.47 12.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.754 -0.657 . . . . 73.439999999999998 109.997 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -91.59 10.3 28.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.093 0.949 . . . . 63.140000000000001 108.647 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.25 -109.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.657 -1.156 . . . . 72.400000000000006 112.008 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.25 -67.06 1.02 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.455 0.539 . . . . 74.510000000000005 112.455 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.15 131.27 50.3 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.078 0.77 . . . . 71.310000000000002 113.078 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.4 m -124.74 169.18 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.872 -1.058 . . . . 72.109999999999999 109.861 175.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -137.8 104.4 5.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.565 -0.289 . . . . 74.420000000000002 111.298 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -97.14 108.28 20.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.153 0.501 . . . . 61.140000000000001 110.928 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 92' ' ' VAL . 34.4 pt -129.34 161.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.667 -0.697 . . . . 74.219999999999999 109.625 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 62.2 m -74.56 75.75 1.98 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.478 . . . . 74.109999999999999 111.096 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.55 HD22 HG11 ' A' ' 92' ' ' VAL . 26.8 t-20 -110.49 72.71 0.8 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.69 0.757 . . . . 63.130000000000003 109.487 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -127.82 133.16 68.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.268 -0.878 . . . . 74.450000000000003 109.829 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.04 125.8 63.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.769 -0.456 . . . . 64.310000000000002 109.769 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.94 -11.08 25.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.2 2.6 . . . . 65.209999999999994 113.392 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -87.64 -16.22 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.002 -0.279 . . . . 63.140000000000001 111.0 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.47 -26.67 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.283 0.475 . . . . 61.32 112.283 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.53 34.84 17.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 71.129999999999995 111.153 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -143.9 169.81 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 53.25 109.263 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 13.6 p -80.81 51.09 1.46 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.248 0.547 . . . . 72.25 110.973 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -18.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 75.129999999999995 110.196 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.464 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 72.5 mt -83.74 -17.07 42.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.345 -0.843 . . . . 61.43 109.745 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 m -89.96 -13.21 36.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.751 . . . . 70.209999999999994 111.6 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -104.96 30.32 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 71.530000000000001 111.339 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -94.66 -129.25 5.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.485 -0.864 . . . . 64.140000000000001 111.974 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.1 mt -104.74 108.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.071 0.462 . . . . 75.239999999999995 110.215 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 59' ' ' VAL . 7.2 p -103.37 108.53 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.502 -0.772 . . . . 50.039999999999999 110.073 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.85 166.01 27.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 64.129999999999995 111.569 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.95 120.94 33.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.525 -0.761 . . . . 73.299999999999997 109.718 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 63.7 t-80 -62.43 -76.88 0.05 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.728 -0.669 . . . . 62.43 110.024 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -130.97 -44.95 1.04 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.412 -0.813 . . . . 55.310000000000002 108.93 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -132.36 -21.45 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.275 -0.875 . . . . 71.319999999999993 110.574 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.543 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 1.6 t70 -109.92 175.15 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 72.219999999999999 111.203 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.76 124.57 49.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 45.539999999999999 110.359 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.621 ' CD1' ' HB2' ' A' ' 62' ' ' HIS . 40.1 m95 -124.63 143.84 50.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.164 -0.471 . . . . 65.120000000000005 110.594 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.43 117.44 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.617 0.722 . . . . 72.310000000000002 110.118 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -90.69 116.2 28.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.797 -0.638 . . . . 73.120000000000005 110.17 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -60.09 136.59 91.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.492 -0.322 . . . . 72.010000000000005 110.653 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.01 -31.53 55.39 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.695 2.263 . . . . 74.319999999999993 112.765 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.89 -56.83 2.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 111.595 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -90.93 -13.81 32.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 73.530000000000001 111.671 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 mttm 64.02 8.56 4.04 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.161 0.8 . . . . 74.230000000000004 113.161 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.52 127.12 30.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.094 -0.706 . . . . 72.349999999999994 109.094 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.756 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 41.9 m80 -90.87 99.45 12.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.037 -0.528 . . . . 64.340000000000003 110.371 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -84.71 120.45 26.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.933 0.397 . . . . 65.129999999999995 110.158 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 61.4 ttt180 -78.71 121.28 24.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.986 -0.552 . . . . 72.549999999999997 109.805 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.63 -36.22 78.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -80.29 -20.09 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.404 -0.362 . . . . 72.150000000000006 111.575 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 10.0 t70 -115.15 -74.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.023 -0.271 . . . . 73.510000000000005 111.586 -170.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' HG22 ' A' ' 92' ' ' VAL . . . 140.36 -27.12 2.53 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.802 -0.713 . . . . 75.319999999999993 112.124 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -63.31 151.68 40.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.178 0.514 . . . . 72.420000000000002 111.258 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . 4.4 m -103.39 50.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.63 -0.714 . . . . 75.010000000000005 110.643 -174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 76' ' ' HIS . 38.6 tp 66.74 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.954 0.502 . . . . 74.109999999999999 111.363 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 36.6 mt-10 -109.08 -4.57 16.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 73.230000000000004 110.341 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 84' ' ' CYS . 6.9 m-20 -115.82 160.03 20.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.555 . . . . 72.530000000000001 110.917 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.39 27.67 2.49 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.978 -0.849 . . . . 75.299999999999997 110.978 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.3 42.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 54.219999999999999 110.745 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -117.27 62.39 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.11 -0.496 . . . . 74.530000000000001 110.299 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 2.5 p -65.88 107.19 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 75.299999999999997 109.784 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.67 HG22 ' HA2' ' A' ' 82' ' ' GLY . 28.0 m -68.01 136.78 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 75.010000000000005 111.295 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . -71.59 106.42 4.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.006 -0.543 . . . . 43.32 109.907 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -79.26 88.21 4.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.796 -0.638 . . . . 60.310000000000002 110.854 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -80.19 175.92 10.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.755 . . . . 74.420000000000002 109.811 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.45 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 20.0 t70 -114.32 147.29 39.33 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.992 -0.373 . . . . 73.209999999999994 109.992 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.486 HG23 HG22 ' A' ' 106' ' ' ILE . 1.3 m -129.0 157.16 42.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.62 -0.718 . . . . 75.25 109.606 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -153.34 143.26 22.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 74.200000000000003 111.112 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.86 98.27 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.39 -0.823 . . . . 73.150000000000006 108.783 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 HD22 ' A' ' 101' ' ' ASN . 7.4 t -94.3 -34.58 12.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.54 0.571 . . . . 70.230000000000004 112.54 -170.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 100' ' ' THR . 61.3 m-80 -136.99 31.61 2.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.047 0.451 . . . . 34.409999999999997 110.599 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.62 -11.91 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 62.149999999999999 111.387 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.89 150.65 22.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.536 . . . . 74.340000000000003 110.127 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -97.12 120.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.305 -0.861 . . . . 75.319999999999993 111.05 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 36.2 mt-30 -115.59 142.33 46.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.101 -0.333 . . . . 62.219999999999999 110.101 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.632 HD11 HG11 ' A' ' 23' ' ' VAL . 2.8 pp -122.13 154.48 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 110.633 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 t -113.38 102.01 9.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.778 -0.453 . . . . 41.25 109.778 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 106' ' ' ILE . 16.4 pt -109.04 110.96 34.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 111.124 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.378 0 CA-C-O 121.66 0.743 . . . . 71.329999999999998 110.485 175.911 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 . . . . . 0 C--O 1.233 0.191 0 CA-C-O 121.176 0.513 . . . . 73.310000000000002 111.398 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -81.19 112.11 18.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.811 -0.631 . . . . 74.430000000000007 110.072 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.482 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.0 m -95.93 126.72 41.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.679 . . . . 74.439999999999998 110.184 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.554 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 27.4 m -73.61 132.26 42.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.894 0.378 . . . . 72.430000000000007 110.994 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.14 -67.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.562 . . . . 74.299999999999997 109.514 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -169.92 -167.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 62.520000000000003 108.991 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 95.1 mttt -76.92 154.49 33.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.732 -0.213 . . . . 74.439999999999998 110.471 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 37' ' ' GLU . 56.9 tp -75.41 -27.07 58.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.51 -0.922 . . . . 60.409999999999997 108.51 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.37 -32.07 69.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.13 -1.395 . . . . 72.450000000000003 110.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.12 -14.27 59.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.186 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.0 mt -93.08 116.34 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 65.25 110.236 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.63 128.84 93.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 70.230000000000004 111.45 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.26 124.16 12.16 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.857 2.371 . . . . 65.230000000000004 112.16 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.62 28.62 8.28 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.814 -0.63 . . . . 52.409999999999997 112.141 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.27 170.46 17.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.608 0.242 . . . . 72.040000000000006 111.41 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -138.11 144.69 16.0 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.218 -0.753 . . . . 72.109999999999999 111.218 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.07 145.91 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.205 0.503 . . . . 71.319999999999993 112.18 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.677 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.2 p -86.79 133.08 33.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.101 -0.5 . . . . 72.209999999999994 111.213 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.38 125.9 41.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.092 -0.503 . . . . 71.430000000000007 110.419 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.97 99.9 2.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.773 -0.825 . . . . 72.519999999999996 108.773 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 106' ' ' ILE . 46.0 t -109.52 103.08 14.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 73.129999999999995 110.738 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 70.26 -53.72 0.64 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.285 -0.87 . . . . 73.099999999999994 112.771 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.595 ' NE2' ' H ' ' A' ' 26' ' ' GLN . 0.1 OUTLIER -143.6 -50.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.603 0.594 . . . . 74.420000000000002 112.603 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.595 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 27.8 mt-30 -109.39 167.38 10.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.743 0.306 . . . . 74.140000000000001 110.84 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -95.49 127.04 41.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.906 -0.588 . . . . 62.200000000000003 109.832 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.86 134.53 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.367 -0.605 . . . . 75.030000000000001 109.367 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -94.14 122.04 36.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.665 -0.494 . . . . 74.420000000000002 109.665 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 26.1 t -105.41 104.36 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.082 0.468 . . . . 70.450000000000003 110.18 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 79.5 m-85 -79.91 134.68 36.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.396 -0.82 . . . . 65.120000000000005 111.342 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -119.71 82.12 26.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.871 -1.159 . . . . 70.140000000000001 107.871 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.92 -25.63 19.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.649 2.233 . . . . 63.43 112.791 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 34' ' ' ARG . 61.8 mtt180 -111.57 167.72 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.684 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -84.5 2.88 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.153 0.501 . . . . 73.239999999999995 110.212 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 19.3 t70 -98.68 -150.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.894 -0.594 . . . . 54.210000000000001 110.041 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.561 ' HA ' HD21 ' A' ' 10' ' ' LEU . 40.7 mt-10 -105.83 21.62 16.97 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.892 0.701 . . . . 65.430000000000007 112.892 -169.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.4 123.21 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.593 -0.443 . . . . 62.329999999999998 110.337 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.45 167.3 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.983 -0.553 . . . . 75.430000000000007 110.967 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.696 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 78.3 m-85 -138.95 105.57 5.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 72.329999999999998 110.107 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -102.1 101.93 12.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.062 0.458 . . . . 63.219999999999999 110.651 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.7 pt -131.63 173.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.979 -0.555 . . . . 72.140000000000001 110.352 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.9 p -83.09 67.82 9.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.347 0.594 . . . . 72.120000000000005 109.69 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.562 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.9 t-20 -98.27 35.96 1.68 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.228 1.013 . . . . 71.299999999999997 109.517 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 20' ' ' CYS . 35.6 mm -107.01 109.14 27.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 71.420000000000002 110.483 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.71 115.95 42.94 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.129 -0.693 . . . . 64.409999999999997 109.129 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 90' ' ' TYR . 47.5 Cg_exo -57.51 -17.19 26.75 Favored 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.358 2.705 . . . . 71.439999999999998 113.445 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.09 -15.53 59.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 64.209999999999994 110.553 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.92 -29.89 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 61.340000000000003 111.645 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.68 37.99 12.34 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.328 0.585 . . . . 53.409999999999997 111.663 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.677 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.26 170.52 21.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.318 -0.856 . . . . 75.120000000000005 108.868 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 73.4 m -77.02 61.84 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.436 0.636 . . . . 74.310000000000002 110.895 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -80.42 -22.36 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.59 -0.732 . . . . 64.510000000000005 110.373 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.562 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 32.2 mt -81.06 -20.01 42.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.245 -0.65 . . . . 65.239999999999995 109.245 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 11.2 m -79.82 -15.6 57.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.225 -0.898 . . . . 75.439999999999998 110.904 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 18.71 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 63.439999999999998 109.759 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.78 -156.67 20.99 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.877 -0.678 . . . . 62.200000000000003 112.379 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.7 mt -100.01 125.09 53.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.875 0.369 . . . . 71.230000000000004 110.413 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.49 101.14 2.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.264 0.554 . . . . 65.519999999999996 109.83 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.56 95.37 5.7 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.536 -0.756 . . . . 54.009999999999998 109.616 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.48 137.71 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.784 -0.644 . . . . 74.510000000000005 110.244 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 41.1 t-80 -79.17 -169.93 2.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.647 -0.706 . . . . 72.230000000000004 109.288 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.491 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -54.99 -37.73 66.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.778 -0.823 . . . . 73.420000000000002 108.778 175.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.19 60.62 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.253 -0.885 . . . . 72.409999999999997 109.888 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.64 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 1.5 t70 -156.52 173.29 17.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 63.549999999999997 109.674 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB3' HD23 ' A' ' 79' ' ' LEU . 96.7 mt -119.16 118.11 30.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.554 0.216 . . . . 74.109999999999999 111.36 -171.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 39.5 m95 -136.25 125.52 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.817 -0.438 . . . . 72.409999999999997 109.817 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.87 130.64 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.974 0.416 . . . . 75.430000000000007 110.589 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.0 114.96 22.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.093 -0.503 . . . . 54.329999999999998 111.148 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.77 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . 29.1 t -62.08 126.8 88.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.563 -0.744 . . . . 65.549999999999997 111.086 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.2 -4.18 14.52 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.419 2.079 . . . . 73.230000000000004 112.079 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.7 mt -109.74 -55.93 2.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.119 -0.491 . . . . 61.310000000000002 111.207 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.593 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 48.3 mmtm -91.55 -16.26 27.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.171 -0.468 . . . . 55.340000000000003 110.951 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 54.76 70.01 0.67 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.68 0.753 . . . . 72.109999999999999 111.214 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -141.32 152.04 44.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.211 -0.904 . . . . 72.549999999999997 109.091 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 74.2 m80 -93.97 100.43 12.57 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.236 0.335 . . . . 75.019999999999996 110.162 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.77 ' HE2' ' HB2' ' A' ' 70' ' ' SER . 96.9 m-85 -85.88 124.53 32.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.487 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HD3' ' HB3' ' A' ' 81' ' ' ASP . 33.4 ttt180 -73.81 122.58 22.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.657 -0.497 . . . . 71.540000000000006 109.657 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 66' ' ' LEU . 3.3 mm? -70.57 1.47 5.15 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.908 1.077 . . . . 55.450000000000003 113.908 -168.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -153.65 28.29 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.711 -0.396 . . . . 72.230000000000004 111.412 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 7.9 t70 -145.3 -71.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.026 -0.27 . . . . 71.510000000000005 111.327 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.82 -20.3 3.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.201 -0.999 . . . . 73.239999999999995 113.287 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.51 157.21 37.59 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.123 0.461 . . . . 63.229999999999997 111.569 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 8.8 m -109.87 20.88 17.53 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.415 -0.811 . . . . 75.209999999999994 110.516 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.7 tp 69.68 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.34 -0.845 . . . . 75.099999999999994 111.774 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.69 -63.02 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.725 0.298 . . . . 65.129999999999995 111.388 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.57 92.31 6.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.853 -0.425 . . . . 70.230000000000004 109.853 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.93 74.1 2.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.656 -0.783 . . . . 73.329999999999998 112.441 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.58 -1.13 13.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.617 0.246 . . . . 54.32 111.504 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.593 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -134.1 50.84 2.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 65.219999999999999 110.24 -176.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 m -64.75 116.63 6.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.818 -0.628 . . . . 75.310000000000002 111.546 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.87 168.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.52 . . . . 70.409999999999997 110.565 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.26 154.82 18.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 73.049999999999997 111.218 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -121.95 109.1 14.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.971 -0.559 . . . . 74.200000000000003 109.495 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -84.96 -177.79 6.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 64.329999999999998 110.718 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.58 137.17 51.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.706 HG23 HG22 ' A' ' 106' ' ' ILE . 3.2 m -134.5 161.26 35.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.709 0.29 . . . . 73.120000000000005 111.005 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -138.56 153.21 48.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.237 0.542 . . . . 72.420000000000002 110.635 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.19 123.52 60.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 64.120000000000005 107.927 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 101' ' ' ASN . 3.7 t -131.59 -63.51 0.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.966 0.728 . . . . 61.409999999999997 112.966 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.524 ' H ' HG23 ' A' ' 100' ' ' THR . 92.0 m-20 -101.41 28.21 5.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.098 0.475 . . . . 74.409999999999997 110.774 -174.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.96 3.22 85.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.662 -0.78 . . . . 54.140000000000001 111.2 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 27.9 p-10 -113.31 158.33 20.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.319999999999993 109.797 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.92 122.75 65.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.013 -0.54 . . . . 70.129999999999995 110.545 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 16.5 mt-30 -127.02 136.19 51.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.643 -0.503 . . . . 74.430000000000007 109.643 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.706 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.39 153.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.079 0.466 . . . . 62.229999999999997 110.686 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -103.57 96.79 6.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.164 -0.68 . . . . 71.049999999999997 109.164 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.5 pt -112.12 78.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 63.109999999999999 110.735 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.616 0 CA-C-O 121.951 0.881 . . . . 74.340000000000003 109.921 178.31 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 C--O 1.233 0.235 0 CA-C-O 121.991 0.901 . . . . 73.239999999999995 108.6 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 21.5 m95 -117.07 117.46 29.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.28 -1.327 . . . . 75.409999999999997 109.402 -174.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -88.54 138.13 31.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 71.239999999999995 109.619 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 13.4 m -79.59 122.79 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.031 -0.532 . . . . 73.010000000000005 110.858 -174.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 23' ' ' VAL . 36.3 t -85.6 -81.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.974 0.416 . . . . 74.010000000000005 110.707 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.6 m -155.43 -178.75 7.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 71.519999999999996 109.411 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -71.14 147.6 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 72.329999999999998 110.667 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 tp -66.48 -27.12 67.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.677 -0.692 . . . . 75.319999999999993 110.943 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -98.05 -8.05 28.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.685 . . . . 72.099999999999994 110.715 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 -29.72 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.864 -0.791 . . . . 74.329999999999998 108.864 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.45 127.22 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.77 -1.104 . . . . 55.119999999999997 109.97 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.56 144.98 30.39 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.288 -0.415 . . . . 74.409999999999997 111.176 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.648 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 Cg_exo -58.55 147.94 84.0 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.56 . . . . 75.420000000000002 112.389 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.71 26.34 56.58 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.002 -0.618 . . . . 72.109999999999999 111.854 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -141.22 178.55 7.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.135 -0.32 . . . . 74.310000000000002 110.135 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 17' ' ' THR . . . 175.25 105.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.839 -0.696 . . . . 60.219999999999999 111.865 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.09 170.77 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.691 0.281 . . . . 73.129999999999995 111.116 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD12 ' A' ' 45' ' ' ILE . 8.0 p -83.05 134.33 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 74.349999999999994 111.557 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.94 143.51 42.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 74.109999999999999 109.651 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.43 100.06 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.689 -0.486 . . . . 73.040000000000006 109.689 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 7' ' ' VAL . 21.7 t -101.31 81.3 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.092 -0.503 . . . . 35.030000000000001 109.938 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.77 -74.91 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 112.223 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -116.82 -35.43 4.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.597 0.237 . . . . 74.140000000000001 111.524 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -103.84 153.78 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.068 0.461 . . . . 71.409999999999997 111.833 -174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.88 116.94 29.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.636 -0.711 . . . . 60.219999999999999 109.095 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mp -112.93 127.93 69.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.609 -0.515 . . . . 73.430000000000007 109.609 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -86.44 131.01 34.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.206 -0.452 . . . . 71.319999999999993 109.837 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 29.8 t -110.0 97.29 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.02 0.438 . . . . 72.019999999999996 110.042 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.857 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 89.7 m-85 -72.71 141.32 48.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.492 -0.776 . . . . 72.299999999999997 110.741 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.67 ' HE ' ' HA ' ' A' ' 36' ' ' ASP . 6.4 tpt180 -132.69 59.39 42.87 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.878 -0.601 . . . . 72.400000000000006 110.495 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 6.2 Cg_exo -79.39 -22.31 8.25 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.491 2.127 . . . . 65.329999999999998 111.011 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -82.06 150.74 27.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.986 -1.006 . . . . 64.109999999999999 109.81 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -75.49 77.13 2.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.095 0.474 . . . . 71.430000000000007 109.888 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.67 ' HA ' ' HE ' ' A' ' 32' ' ' ARG . 41.1 t0 63.16 179.6 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.753 -1.112 . . . . 70.319999999999993 111.409 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 66.46 -22.91 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.746 1.218 . . . . 73.200000000000003 114.006 176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 36' ' ' ASP . 30.2 tp60 -134.62 114.14 12.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.02 0.438 . . . . 75.099999999999994 110.364 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG12 ' HD3' ' A' ' 32' ' ' ARG . 27.1 m -110.99 163.37 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.898 -0.592 . . . . 72.310000000000002 110.507 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.857 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 73.2 m-85 -127.28 86.69 2.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 75.010000000000005 110.132 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -91.15 98.35 11.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 94' ' ' ALA . 41.0 pt -131.95 175.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 72.209999999999994 111.118 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.452 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 15.1 m -83.94 75.46 10.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.163 -0.471 . . . . 60.210000000000001 110.178 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -130.8 85.88 2.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.461 0.648 . . . . 74.420000000000002 110.08 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.2 mm -120.42 -124.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.782 -0.822 . . . . 54.240000000000002 108.782 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.522 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.1 p30 -175.35 141.61 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.296 -1.001 . . . . 51.329999999999998 108.296 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -94.7 30.22 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.352 2.035 . . . . 74.530000000000001 112.802 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -117.56 -48.06 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 70.430000000000007 110.417 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.44 6.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.279 -0.418 . . . . 64.549999999999997 111.472 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 58.44 61.82 2.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.559 0.537 . . . . 71.239999999999995 111.167 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.69 16.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.583 0.216 . . . . 75.120000000000005 111.583 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 72.4 m 61.74 57.98 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.461 0.648 . . . . 62.450000000000003 110.8 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 46' ' ' ASP . 19.7 m -73.68 -9.67 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 64.420000000000002 110.309 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 94.3 mt -87.59 -9.69 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.468 -0.787 . . . . 64.040000000000006 110.25 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 5.1 m -103.03 -43.83 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.303 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -81.08 50.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 71.510000000000005 111.86 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.42 -115.52 2.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.491 -0.861 . . . . 53.409999999999997 112.92 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 83.2 mt -108.19 120.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.003 0.43 . . . . 74.200000000000003 110.853 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -85.34 96.58 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.35 -0.611 . . . . 65.519999999999996 109.35 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.18 118.14 35.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.153 0.501 . . . . 70.219999999999999 111.204 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -92.84 121.44 34.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.311 -0.626 . . . . 74.430000000000007 109.311 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -117.5 102.97 9.63 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.781 -0.451 . . . . 72.239999999999995 109.781 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.12 -81.95 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.352 -0.84 . . . . 73.519999999999996 111.222 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -124.39 -30.2 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.903 0.383 . . . . 75.530000000000001 110.72 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.688 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 35.1 m-20 -85.21 161.02 19.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.301 0.572 . . . . 74.400000000000006 111.206 -172.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 33' ' ' PRO . 94.6 mt -108.32 112.9 25.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.443 -0.799 . . . . 65.310000000000002 109.642 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.688 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 30.5 m95 -110.66 107.82 17.53 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.974 -0.38 . . . . 73.319999999999993 109.974 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 31' ' ' PHE . 14.4 p -78.1 133.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.699 -0.482 . . . . 71.450000000000003 109.699 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 75' ' ' GLN . . . -118.91 134.02 55.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.434 . . . . 74.030000000000001 110.532 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 1.2 p -74.86 145.14 80.96 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.176 -0.465 . . . . 70.549999999999997 110.338 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.86 -53.14 5.42 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.965 2.443 . . . . 72.030000000000001 113.214 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.97 -47.08 7.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 73.140000000000001 111.518 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 71.4 mmtt -65.71 -33.46 75.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.343 -0.39 . . . . 71.519999999999996 110.77 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 60.82 28.96 18.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.685 -0.688 . . . . 55.049999999999997 111.022 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 79.0 mt-30 -91.86 137.12 32.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.645 -0.707 . . . . 70.219999999999999 110.563 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.567 ' H ' ' CG ' ' A' ' 87' ' ' ASP . 26.5 m80 -101.91 126.11 48.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.658 -0.701 . . . . 60.119999999999997 110.885 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.15 125.09 45.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.486 -0.324 . . . . 70.319999999999993 110.158 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.55 111.22 8.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.048 0.451 . . . . 75.299999999999997 110.446 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.94 82.8 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.746 . . . . 74.109999999999999 110.784 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -172.52 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.442 -0.799 . . . . 74.030000000000001 108.944 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -121.98 -11.82 8.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.51 -0.768 . . . . 73.25 110.726 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.59 59.29 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.94 -0.648 . . . . 71.439999999999998 112.341 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -62.68 123.13 17.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 74.109999999999999 111.157 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.4 145.59 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.797 -0.816 . . . . 65.049999999999997 108.797 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.87 -62.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.369 -0.604 . . . . 74.019999999999996 109.369 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.66 13.99 1.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.913 -1.143 . . . . 75.219999999999999 107.913 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 76' ' ' HIS . 1.1 m-20 -95.38 31.29 2.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.619 -1.628 . . . . 74.5 110.892 -167.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.15 44.37 2.38 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.014 -0.612 . . . . 75.030000000000001 113.117 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.42 -21.62 27.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.268 0.556 . . . . 71.25 110.08 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.64 91.34 3.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.49 -0.777 . . . . 75.129999999999995 109.057 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -61.16 100.89 0.13 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.51 -0.768 . . . . 65.219999999999999 111.593 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.1 m -122.13 161.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 75.150000000000006 110.286 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.84 173.17 11.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 44.530000000000001 110.349 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.576 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -101.92 -158.84 0.7 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.984 0.421 . . . . 72.040000000000006 109.987 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -157.24 169.88 23.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.105 -0.952 . . . . 71.230000000000004 109.839 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 9.2 m-20 -88.68 126.7 35.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.989 -0.745 . . . . 63.240000000000002 108.989 170.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.595 HG22 HG22 ' A' ' 106' ' ' ILE . 80.6 p -128.75 131.98 47.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.568 0.223 . . . . 74.430000000000007 110.953 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 141.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 71.219999999999999 110.253 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.4 92.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.711 -0.677 . . . . 62.229999999999997 109.812 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.46 83.57 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.616 -0.72 . . . . 62.43 111.375 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 71.06 -82.4 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.181 -0.918 . . . . 54.130000000000003 111.831 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 8.17 7.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.802 -0.713 . . . . 63.420000000000002 112.931 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -138.53 152.07 47.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.973 0.387 . . . . 71.340000000000003 110.46 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.0 t -107.21 131.91 56.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.274 -0.421 . . . . 73.010000000000005 110.807 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 68.0 mt-30 -127.51 128.23 45.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.939 -0.393 . . . . 73.230000000000004 109.939 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.595 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -117.32 156.16 18.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 73.040000000000006 110.985 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 13.5 t -98.14 106.76 19.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.345 -0.613 . . . . 71.019999999999996 109.345 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 pt -80.6 142.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.037 0.446 . . . . 65.439999999999998 110.962 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 115.965 -0.562 . . . . 62.210000000000001 110.936 -177.015 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 107' ' ' SER . 14.2 mm100 . . . . . 0 CA--C 1.512 -0.504 0 N-CA-C 108.411 -0.959 . . . . 74.129999999999995 108.411 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 84.0 m95 -86.31 110.69 19.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.915 -1.493 . . . . 75.230000000000004 109.482 175.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.696 HG21 HG11 ' A' ' 23' ' ' VAL . 19.1 m -100.22 136.79 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.618 -0.512 . . . . 73.040000000000006 109.618 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 8' ' ' CYS . 8.5 m -81.12 126.67 31.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.975 0.417 . . . . 73.219999999999999 111.974 -173.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.71 -1.2 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.6 0.714 . . . . 64.109999999999999 109.476 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.839 ' H ' HG22 ' A' ' 6' ' ' THR . 61.1 m 87.49 -60.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.566 -1.197 . . . . 62.329999999999998 111.581 169.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.85 ' HE3' ' HB2' ' A' ' 12' ' ' ASP . 44.1 mtmt -145.34 146.41 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.974 0.416 . . . . 64.549999999999997 111.893 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 37' ' ' GLU . 35.6 tp -84.12 -25.92 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.717 -1.216 . . . . 74.540000000000006 107.717 165.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -60.61 -39.37 87.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.168 -1.378 . . . . 64.230000000000004 111.349 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.85 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -77.67 -10.16 59.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 72.0 110.175 -176.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.4 mt -93.78 113.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.839 -0.619 . . . . 71.430000000000007 109.782 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.5 mt -69.7 139.16 88.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.316 -0.402 . . . . 73.5 111.381 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 16.5 Cg_exo -68.2 128.17 17.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.096 2.531 . . . . 72.129999999999995 112.178 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.07 19.33 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.949 -0.569 . . . . 72.299999999999997 112.19 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 172.47 16.86 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.816 0.308 . . . . 72.120000000000005 111.41 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.16 138.01 5.05 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.734 -0.546 . . . . 52.240000000000002 111.734 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.09 167.59 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.937 0.368 . . . . 43.450000000000003 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.79 109.42 11.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.979 0.419 . . . . 43.240000000000002 111.401 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.34 106.84 6.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.831 -0.622 . . . . 74.150000000000006 109.342 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 27' ' ' GLN . 3.2 tm? -78.13 105.48 9.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.07 -0.514 . . . . 64.329999999999998 109.709 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 5' ' ' THR . 48.5 t -118.6 92.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.759 -0.655 . . . . 63.119999999999997 110.016 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 61.64 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.578 -0.737 . . . . 70.430000000000007 112.035 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -118.82 -2.14 10.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 110.807 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -109.29 139.45 44.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.399 -0.364 . . . . 75.109999999999999 111.222 -174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HG2' HD23 ' A' ' 22' ' ' LEU . 52.7 mt-30 -128.92 113.16 14.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.934 -0.576 . . . . 75.140000000000001 109.805 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HA ' HD11 ' A' ' 45' ' ' ILE . 1.4 pp -132.71 142.82 41.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.935 0.398 . . . . 73.420000000000002 110.588 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.49 120.79 28.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 64.109999999999999 109.94 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.26 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 53.450000000000003 110.619 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 55.7 m-85 -72.45 134.62 45.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.623 -0.717 . . . . 75.450000000000003 111.156 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -120.43 81.53 31.01 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.103 -0.703 . . . . 71.409999999999997 109.103 165.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.01 -32.54 53.55 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.848 2.366 . . . . 74.400000000000006 112.733 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.92 -166.71 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 74.129999999999995 111.459 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -79.98 -18.88 49.2 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.202 0.816 . . . . 74.340000000000003 113.202 -165.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 38' ' ' GLN . 11.5 p-10 -110.81 -165.69 1.01 Allowed 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.335 0.495 . . . . 45.399999999999999 112.335 -168.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE1' HD22 ' A' ' 10' ' ' LEU . 6.5 mm-40 -69.52 6.62 1.03 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.152 0.797 . . . . 74.230000000000004 113.152 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 15.8 mm100 -74.42 83.27 1.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 70.129999999999995 110.757 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 HG21 ' A' ' 97' ' ' THR . 20.6 m -108.79 159.53 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.885 -0.598 . . . . 64.439999999999998 110.79 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 94.7 m-85 -135.67 109.16 7.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.464 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.87 95.78 7.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 71.219999999999999 110.623 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 44' ' ' ASN . 37.7 pt -121.85 168.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.016 -0.538 . . . . 63.140000000000001 111.255 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -78.87 48.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 111.4 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.527 ' HB2' HG13 ' A' ' 42' ' ' ILE . 53.9 t30 -98.35 46.42 1.0 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.357 0.599 . . . . 72.150000000000006 110.242 -173.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 20' ' ' CYS . 10.9 mm -83.52 -23.5 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.551 -0.749 . . . . 71.430000000000007 111.098 -175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.861 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 7.5 t70 68.6 123.05 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 O-C-N 124.367 1.042 . . . . 72.340000000000003 111.631 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.6 Cg_endo -80.99 18.86 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.17 2.58 . . . . 75.239999999999995 112.951 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 85.0 t80 -111.28 -36.04 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.636 -0.256 . . . . 72.439999999999998 111.094 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.42 -20.98 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.108 0.41 . . . . 72.549999999999997 112.108 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 64.84 19.18 11.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.387 0.514 . . . . 74.129999999999995 112.387 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.55 22.98 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.889 0.329 . . . . 72.319999999999993 111.889 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 38.2 m 58.62 39.62 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.279 0.561 . . . . 62.32 110.785 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.54 -18.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 74.530000000000001 111.275 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 59.0 mt -75.11 -18.06 60.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.11 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -86.78 1.23 52.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.073 -0.512 . . . . 72.140000000000001 110.536 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -102.13 11.75 37.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.946 -0.761 . . . . 61.020000000000003 108.946 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.96 -151.31 12.08 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.353 -0.84 . . . . 71.5 112.825 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 mp -97.44 129.82 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 63.439999999999998 110.898 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.95 99.1 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.917 -0.772 . . . . 72.329999999999998 108.917 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.5 97.93 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.611 . . . . 75.019999999999996 110.843 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.52 110.93 19.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 74.120000000000005 109.49 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -89.89 92.24 8.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.534 -0.543 . . . . 61.119999999999997 109.534 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 66.52 -74.86 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.706 -0.679 . . . . 73.239999999999995 111.145 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -126.99 -24.86 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.828 -0.624 . . . . 65.239999999999995 110.185 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.9 t0 -81.4 165.41 21.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 73.209999999999994 110.556 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.5 mt -123.75 108.69 12.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.208 0.528 . . . . 63.140000000000001 111.12 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 37.0 m95 -117.56 144.49 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 74.400000000000006 109.88 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 7.1 p -102.12 125.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.158 0.504 . . . . 73.299999999999997 109.79 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -84.55 109.46 17.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.974 -0.557 . . . . 71.109999999999999 109.82 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.552 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 46.5 t -60.86 122.82 71.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.784 -0.643 . . . . 75.129999999999995 110.846 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 61.1 Cg_endo -73.34 -8.6 22.1 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.442 2.095 . . . . 65.209999999999994 112.138 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.22 -49.37 2.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 111.219 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 75' ' ' GLN . 29.6 mmtm -94.85 -6.62 42.35 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.197 0.443 . . . . 63.130000000000003 112.197 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 73.47 -35.89 0.33 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.241 0.616 . . . . 74.129999999999995 112.65 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.563 ' OE1' ' HB3' ' A' ' 87' ' ' ASP . 21.0 pt20 -59.29 159.14 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.626 0.727 . . . . 71.25 112.604 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 80.6 m80 -99.21 123.55 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.946 -1.024 . . . . 71.109999999999999 110.66 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 81.1 m-85 -99.12 124.67 44.32 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.755 -0.831 . . . . 71.239999999999995 108.755 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 10.3 ttp180 -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.28 -0.568 . . . . 73.439999999999998 109.508 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.69 -52.75 63.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.637 -0.71 . . . . 74.349999999999994 112.728 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.73 32.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 74.219999999999999 110.591 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 11.4 t70 -145.23 -56.79 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.324 -0.398 . . . . 73.400000000000006 111.322 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.23 -32.09 6.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.631 -0.795 . . . . 51.530000000000001 113.109 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -78.42 166.91 22.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.195 0.521 . . . . 63.350000000000001 111.335 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 20.2 m -106.03 159.5 16.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.56 -0.745 . . . . 74.239999999999995 110.487 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.469 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 63.3 tp -83.56 -65.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 45.329999999999998 111.72 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.1 pm0 -92.34 -11.22 35.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.331 -0.395 . . . . 72.329999999999998 111.711 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 9.2 t70 -135.64 -161.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.059 -0.719 . . . . 75.219999999999999 109.059 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.56 27.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.387 -0.911 . . . . 60.149999999999999 113.075 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 3.0 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.726 0.298 . . . . 54.409999999999997 111.432 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.86 -78.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.18 -0.208 . . . . 64.140000000000001 111.331 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 m 66.55 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.839 0.712 . . . . 73.030000000000001 110.949 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 42' ' ' ILE . 33.9 m -95.51 164.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 111.313 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 167.24 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 72.340000000000003 109.696 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -141.61 120.09 12.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.369 . . . . 40.509999999999998 110.065 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.44 148.44 24.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.812 -0.631 . . . . 74.430000000000007 111.171 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 m-20 -66.72 140.64 57.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 65.209999999999994 109.917 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.652 HG22 HG22 ' A' ' 106' ' ' ILE . 12.1 p -116.7 124.89 50.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.879 0.371 . . . . 74.120000000000005 110.637 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -106.4 139.43 40.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.404 0.621 . . . . 64.349999999999994 110.936 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.68 97.9 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.602 -1.181 . . . . 74.230000000000004 108.661 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.523 ' HB ' HE21 ' A' ' 105' ' ' GLN . 13.3 t -86.71 -17.05 34.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.117 -0.492 . . . . 51.100000000000001 111.645 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.41 -77.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.042 -0.725 . . . . 54.409999999999997 109.042 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.22 24.03 1.4 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.316 -1.514 . . . . 73.540000000000006 109.316 173.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -135.49 153.69 51.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.953 -1.124 . . . . 61.530000000000001 108.35 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.08 139.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 121.098 -0.241 . . . . 75.140000000000001 111.043 -171.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.523 HE21 ' HB ' ' A' ' 100' ' ' THR . 36.0 mt-30 -129.69 131.93 46.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.932 -0.396 . . . . 71.439999999999998 109.932 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.654 ' H ' HD13 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -112.34 144.5 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 71.109999999999999 110.85 178.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 49.7 m -78.47 106.82 10.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 63.409999999999997 110.208 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 pp -80.52 143.83 11.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.915 0.388 . . . . 75.540000000000006 110.409 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.59 0 CA-C-O 121.439 0.637 . . . . 40.43 110.275 -179.654 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.458 -0.069 0 CA-C-O 120.569 0.223 . . . . 72.010000000000005 111.305 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -81.44 114.59 20.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.927 0.394 . . . . 72.340000000000003 110.225 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -122.98 136.17 54.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 75.040000000000006 110.638 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 40.8 m -81.99 137.55 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.354 . . . . 74.120000000000005 110.262 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.461 HG11 ' HB1' ' A' ' 21' ' ' ALA . 25.7 t -99.61 -75.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.099 0.475 . . . . 52.140000000000001 110.008 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.87 -173.39 4.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.81 -0.632 . . . . 64.129999999999995 109.495 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -70.05 139.75 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 63.109999999999999 110.709 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 10' ' ' LEU . 6.9 tt -83.65 -27.5 29.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.122 -1.066 . . . . 72.120000000000005 108.122 171.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -67.5 -25.32 65.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.526 -1.216 . . . . 71.409999999999997 110.563 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.9 -5.72 56.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 41.100000000000001 110.23 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 10' ' ' LEU . 71.2 mt -78.58 129.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 64.239999999999995 109.822 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mt -74.37 138.8 74.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.105 -0.498 . . . . 75.219999999999999 111.584 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 14.3 Cg_exo -69.35 123.62 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.878 2.385 . . . . 73.319999999999993 111.88 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.19 28.18 10.12 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.773 -0.649 . . . . 74.340000000000003 112.601 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.6 p -139.18 -178.81 5.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 117.207 0.503 . . . . 73.209999999999994 111.607 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -158.02 127.16 1.84 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.237 -1.145 . . . . 51.25 110.237 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.11 146.02 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.252 0.834 . . . . 70.409999999999997 113.252 -172.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.9 t -73.97 108.73 6.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.202 -0.908 . . . . 70.329999999999998 110.176 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 7' ' ' VAL . . . -103.86 128.27 51.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.119 -0.491 . . . . 70.400000000000006 110.548 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.14 106.19 17.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.861 -0.792 . . . . 74.109999999999999 108.861 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 108' ' ' ILE . 13.5 t -105.76 90.12 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.347 -0.388 . . . . 72.040000000000006 110.448 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 67.61 -67.14 0.19 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.214 -0.903 . . . . 72.040000000000006 112.103 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.633 HE21 ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -136.84 -18.15 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.792 0.293 . . . . 63.119999999999997 111.792 -175.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.52 ' HG3' HD11 ' A' ' 28' ' ' ILE . 3.6 pt20 -117.12 151.96 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 64.150000000000006 111.75 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -103.43 125.58 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.808 -0.633 . . . . 74.209999999999994 110.739 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 ' HG3' ' A' ' 26' ' ' GLN . 5.1 mp -129.17 143.45 41.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 53.310000000000002 110.056 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.1 36.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 73.200000000000003 109.584 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 45.6 t -105.93 104.97 17.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.895 0.379 . . . . 75.25 110.332 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.7 m-85 -81.88 131.02 35.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.734 . . . . 73.349999999999994 111.312 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB2' HG12 ' A' ' 39' ' ' VAL . 75.6 ttt180 -131.06 76.35 76.9 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.81 -0.811 . . . . 70.200000000000003 108.81 165.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.47 -19.37 13.17 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.574 2.182 . . . . 62.329999999999998 111.963 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -100.13 164.62 11.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 74.329999999999998 109.899 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 2.2 p-10 -80.92 -10.23 59.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 51.109999999999999 109.904 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.93 171.76 14.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.442 -0.799 . . . . 53.020000000000003 110.94 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HG2' HD22 ' A' ' 10' ' ' LEU . 29.2 mt-10 -85.52 30.89 0.6 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 70.450000000000003 111.253 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -100.57 103.33 14.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.144 -0.48 . . . . 74.439999999999998 109.755 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 32' ' ' ARG . 19.1 m -104.92 163.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.002 -0.544 . . . . 65.349999999999994 111.298 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.784 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 48.9 m-85 -124.19 102.77 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 73.25 109.951 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.01 95.23 9.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.16 0.505 . . . . 64.400000000000006 110.741 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.58 162.65 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.576 . . . . 72.010000000000005 110.057 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 92' ' ' VAL . 20.7 m -78.71 82.87 4.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.15 0.5 . . . . 72.549999999999997 110.589 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.26 17.96 21.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.066 0.936 . . . . 73.510000000000005 109.556 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.27 107.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.721 -1.127 . . . . 74.519999999999996 109.909 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.2 t70 -60.95 131.67 91.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.251 -0.431 . . . . 62.219999999999999 110.221 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 18.7 Cg_exo -67.39 -4.64 12.23 Favored 'Trans proline' 0 N--CA 1.472 0.26 0 C-N-CA 123.393 2.729 . . . . 64.120000000000005 113.482 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -113.16 3.96 16.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.296 0.57 . . . . 73.209999999999994 109.923 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.41 -35.83 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 111.91 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 64.66 21.52 12.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.941 0.401 . . . . 73.099999999999994 111.658 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -146.25 170.56 16.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.57 . . . . 63.43 110.082 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.8 m -81.61 59.91 4.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.53 0.681 . . . . 74.209999999999994 111.057 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -78.53 -23.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.65 -0.705 . . . . 70.209999999999994 110.312 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 70' ' ' SER . 57.8 mt -81.79 -21.79 37.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 73.450000000000003 109.948 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 m -74.56 -22.57 58.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.369 -0.832 . . . . 72.430000000000007 111.244 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -96.61 27.1 4.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.192 0.52 . . . . 75.430000000000007 110.675 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.47 -152.0 26.76 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 62.119999999999997 112.056 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.792 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 53.8 mt -86.44 103.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.043 0.449 . . . . 71.120000000000005 110.8 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -75.58 96.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.815 -0.63 . . . . 62.310000000000002 109.759 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.43 137.17 46.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.995 -0.548 . . . . 75.349999999999994 111.416 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 72.120000000000005 109.482 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.689 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 56.2 t60 -107.52 114.43 28.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.113 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 69.76 -84.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.054 -0.975 . . . . 72.010000000000005 111.413 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.65 -9.31 2.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.511 . . . . 73.129999999999995 110.999 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.541 ' HB2' ' NE1' ' A' ' 67' ' ' TRP . 3.6 m-20 -115.16 -179.2 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.04 0.447 . . . . 65.120000000000005 110.873 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.0 mt -112.6 118.46 35.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 74.540000000000006 109.449 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 26.8 m95 -122.5 115.8 22.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.637 . . . . 64.439999999999998 109.991 -174.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.8 p -85.16 127.31 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.146 0.498 . . . . 60.049999999999997 110.605 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -89.9 101.94 14.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.917 -0.583 . . . . 71.450000000000003 109.463 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 54' ' ' LEU . 12.8 p -64.89 136.5 96.81 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.642 -0.708 . . . . 75.109999999999999 111.028 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 38.1 Cg_endo -67.7 -32.12 31.02 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.392 2.061 . . . . 71.140000000000001 112.51 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.78 -49.42 9.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 72.150000000000006 111.683 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 4.3 mmpt? -84.18 -27.14 28.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 72.319999999999993 110.157 -175.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 62.07 27.11 16.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 110.152 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.03 151.9 25.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 63.350000000000001 110.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 79.7 m80 -92.8 126.33 37.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.105 -0.498 . . . . 74.230000000000004 110.471 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HE1' ' HG ' ' A' ' 84' ' ' CYS . 85.3 m-85 -115.29 132.76 56.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.182 -0.463 . . . . 75.430000000000007 110.064 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 ttp180 -81.75 119.97 24.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.536 -0.542 . . . . 74.299999999999997 109.536 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' CG1' ' A' ' 68' ' ' VAL . 75.1 mt -78.81 23.92 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.679 0.622 . . . . 74.209999999999994 112.679 -170.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.49 24.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.257 -0.646 . . . . 61.43 109.257 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 25.2 t70 -136.65 -71.26 0.45 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.83 -0.623 . . . . 62.009999999999998 110.898 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.61 -26.78 4.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.759 -0.734 . . . . 45.409999999999997 112.225 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.63 169.49 12.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.312 0.577 . . . . 71.549999999999997 111.067 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 4.2 m -109.14 149.93 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.479 -0.782 . . . . 75.099999999999994 110.351 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.3 tp -98.73 20.26 13.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.247 0.546 . . . . 75.409999999999997 110.184 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -135.44 -68.11 0.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 74.010000000000005 110.618 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.33 136.27 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.548 -0.296 . . . . 63.409999999999997 110.348 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.35 49.04 3.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.031 -0.604 . . . . 74.310000000000002 112.801 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.15 -5.59 16.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 74.329999999999998 110.904 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.515 ' CE2' ' HD3' ' A' ' 73' ' ' LYS . 80.5 m-85 -136.14 32.38 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.134 -0.485 . . . . 74.019999999999996 110.816 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -78.27 117.35 19.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.159 -0.473 . . . . 51.299999999999997 110.045 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 43' ' ' SER . 30.3 m -116.05 -170.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 62.329999999999998 111.476 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.01 168.19 9.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 111.075 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.47 109.53 13.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.61 -0.723 . . . . 53.43 109.376 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -82.26 147.42 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.757 -0.656 . . . . 75.439999999999998 111.232 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 12.5 m-20 -66.24 122.11 16.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 73.219999999999999 110.068 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.537 HG23 HG13 ' A' ' 106' ' ' ILE . 1.6 m -117.51 153.77 32.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.85 -0.426 . . . . 72.530000000000001 109.85 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -144.41 153.01 41.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.445 -0.343 . . . . 64.450000000000003 110.261 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -124.9 105.39 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 72.5 109.138 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 101' ' ' ASN . 5.2 t -112.72 -63.6 1.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.986 0.736 . . . . 75.150000000000006 112.986 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.489 ' H ' HG23 ' A' ' 100' ' ' THR . 32.6 m-20 -106.33 29.2 7.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 71.540000000000006 110.403 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.13 90.28 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.875 -0.89 . . . . 73.239999999999995 110.875 -172.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -111.34 159.4 18.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.956 -0.622 . . . . 74.340000000000003 109.758 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 10' ' ' LEU . 22.0 t -103.69 125.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.256 -0.429 . . . . 63.119999999999997 110.565 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -124.52 131.41 53.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.42 . . . . 63.119999999999997 110.389 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 97' ' ' THR . 3.8 mp -113.71 142.04 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 63.100000000000001 110.005 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 47.0 t -80.53 99.21 7.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.285 -0.635 . . . . 71.409999999999997 109.285 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 23' ' ' VAL . 44.3 mm -77.0 94.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.668 -0.696 . . . . 64.340000000000003 111.142 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 109.248 -0.649 . . . . 73.209999999999994 109.248 173.927 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 107' ' ' SER . 0.9 OUTLIER . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.066 0.46 . . . . 70.230000000000004 110.861 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.4 m95 -85.13 118.21 24.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 75.129999999999995 110.131 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -121.08 152.27 38.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 63.43 110.555 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.944 0.402 . . . . 75.200000000000003 111.543 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 30' ' ' VAL . 93.3 t -80.84 -68.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 61.32 109.498 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.1 t -179.22 -163.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.052 -1.092 . . . . 70.209999999999994 108.052 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 13.7 mtpt -79.15 136.24 37.06 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.896 -0.409 . . . . 72.409999999999997 109.896 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.71 -30.49 69.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.356 0.598 . . . . 73.209999999999994 110.104 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.57 -17.57 51.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 110.479 -176.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 t70 -84.81 -19.63 32.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.77 -0.65 . . . . 71.109999999999999 109.347 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.97 125.03 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.616 -0.72 . . . . 75.049999999999997 110.679 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 94.1 mt -77.13 133.47 68.76 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.205 -0.452 . . . . 64.299999999999997 111.665 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 12.7 Cg_exo -70.24 144.8 52.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.324 2.683 . . . . 74.439999999999998 112.555 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.61 56.1 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.935 -0.575 . . . . 12.52 112.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -156.48 158.06 36.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.779 0.323 . . . . 64.299999999999997 111.737 -172.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -122.58 138.74 12.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.797 -0.921 . . . . 72.140000000000001 110.797 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.78 142.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.459 0.54 . . . . 70.439999999999998 112.459 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -75.19 105.91 6.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.448 . . . . 64.219999999999999 111.44 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.72 132.92 35.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.86 -0.609 . . . . 71.409999999999997 109.911 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -100.17 98.14 8.88 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.48 -0.563 . . . . 73.420000000000002 109.48 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 106' ' ' ILE . 21.2 t -108.74 70.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.957 -0.565 . . . . 73.329999999999998 109.629 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 8.1 pt-20 42.2 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.938 1.295 . . . . 60.450000000000003 114.191 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.703 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 3.9 pt20 -80.87 -13.05 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.564 0.579 . . . . 72.219999999999999 112.564 -172.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -143.92 153.72 42.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.288 0.566 . . . . 64.319999999999993 111.951 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -115.33 117.86 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 65.109999999999999 109.054 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 106' ' ' ILE . 66.1 mt -122.01 132.32 71.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.903 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 45' ' ' ILE . . . -88.65 125.6 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.292 -0.413 . . . . 53.340000000000003 110.641 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 7' ' ' VAL . 39.0 t -105.54 105.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.074 0.464 . . . . 74.140000000000001 110.126 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 74.7 m-85 -78.37 128.39 33.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.501 -0.772 . . . . 71.439999999999998 110.76 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.463 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 13.0 tpt180 -109.16 84.67 2.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.196 -1.038 . . . . 64.299999999999997 108.196 168.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' PHE . 16.9 Cg_exo -66.65 -48.03 2.46 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.621 2.214 . . . . 55.240000000000002 112.353 -174.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -116.92 166.75 11.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.048 -0.524 . . . . 63.130000000000003 110.111 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -81.77 72.65 8.82 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.092 -1.077 . . . . 75.209999999999994 108.092 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' A' ' 38' ' ' GLN . 19.0 t70 -150.19 179.04 8.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.896 -1.047 . . . . 75.140000000000001 109.082 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -79.27 -9.04 59.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.724 0.297 . . . . 74.530000000000001 111.33 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -78.08 129.27 35.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.6 . . . . 74.519999999999996 111.605 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.74 155.17 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.794 . . . . 53.350000000000001 110.021 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 55.3 m-85 -132.94 108.01 8.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.684 0.278 . . . . 71.409999999999997 111.005 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.24 108.29 19.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.878 0.37 . . . . 73.129999999999995 111.109 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.3 pt -132.16 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 71.319999999999993 110.146 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 55.0 m -81.82 89.91 6.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.796 0.332 . . . . 61.119999999999997 110.167 178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -129.08 43.99 3.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.583 0.706 . . . . 75.129999999999995 109.223 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 20' ' ' CYS . 46.8 mm -107.98 128.98 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.585 -0.734 . . . . 62.100000000000001 110.532 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 t70 -85.91 118.07 69.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.259 -0.645 . . . . 74.209999999999994 109.259 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 19.2 Cg_exo -66.97 -12.18 35.12 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.225 2.617 . . . . 75.109999999999999 113.25 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -93.94 -18.69 21.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.951 0.405 . . . . 72.049999999999997 110.37 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.41 -22.27 13.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 70.209999999999994 109.639 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 66.22 28.81 9.93 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.909 -1.041 . . . . 61.310000000000002 111.782 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -159.17 173.74 15.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 72.329999999999998 110.561 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -79.65 52.27 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.919 -0.582 . . . . 62.520000000000003 110.94 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.75 -18.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.784 -0.644 . . . . 63.130000000000003 110.702 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.49 -6.43 49.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.624 -0.716 . . . . 73.129999999999995 109.666 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 5.1 m -100.61 -35.16 9.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.388 -0.824 . . . . 64.049999999999997 110.362 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HG3' HG22 ' A' ' 17' ' ' THR . 72.5 ttt180 -88.18 61.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.797 0.808 . . . . 73.519999999999996 109.665 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.72 -153.81 9.34 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.865 -1.061 . . . . 64.010000000000005 111.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 58' ' ' ILE . 3.5 mp -94.75 120.69 44.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.892 0.377 . . . . 52.229999999999997 110.012 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.4 99.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.726 . . . . 64.319999999999993 109.832 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.73 119.98 31.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.474 -0.785 . . . . 41.200000000000003 110.454 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -95.45 132.48 40.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.078 -0.51 . . . . 63.539999999999999 110.639 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -94.76 -155.78 0.48 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.921 -1.14 . . . . 72.209999999999994 107.921 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -78.08 -30.91 49.86 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.878 -0.514 . . . . 72.310000000000002 110.275 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -128.59 -39.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.982 -0.554 . . . . 74.209999999999994 111.0 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 11.8 m-20 -93.74 158.94 15.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 73.099999999999994 112.289 -170.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.41 121.77 43.77 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.024 -0.989 . . . . 63.219999999999999 109.621 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.604 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 24.0 m95 -119.4 165.81 13.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.244 -0.434 . . . . 75.540000000000006 110.33 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -122.93 129.13 75.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.204 0.526 . . . . 73.319999999999993 110.08 173.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.19 107.99 19.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.868 -0.606 . . . . 74.349999999999994 110.012 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 21.1 p -74.55 134.69 75.87 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.979 -0.555 . . . . 72.439999999999998 110.448 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.38 -39.67 12.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.527 2.152 . . . . 64.430000000000007 112.562 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.61 -58.08 3.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 63.549999999999997 111.387 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.6 -31.42 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.436 -0.347 . . . . 73.209999999999994 110.965 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 70' ' ' SER . 56.2 mttm 65.78 17.78 10.96 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.514 -0.766 . . . . 60.32 110.782 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -85.99 138.46 31.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.436 -0.802 . . . . 75.049999999999997 108.948 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -97.12 105.98 18.23 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.857 0.36 . . . . 64.400000000000006 110.214 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -96.72 128.59 43.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.912 -0.585 . . . . 63.420000000000002 110.02 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 35.2 ttp180 -74.21 117.05 15.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.35 -0.611 . . . . 71.340000000000003 109.35 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.647 HD21 ' HB ' ' A' ' 68' ' ' VAL . 88.7 mt -48.13 -58.06 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.113 0.883 . . . . 75.450000000000003 113.306 -168.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.486 ' OH ' ' HA ' ' A' ' 65' ' ' ASP . 5.9 p90 -95.84 24.82 5.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.049 0.389 . . . . 75.129999999999995 112.049 -172.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 83' ' ' PHE . 8.1 t70 -142.03 -59.01 0.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.028 0.381 . . . . 75.329999999999998 112.028 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.28 -16.13 10.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.454 -0.879 . . . . 61.329999999999998 113.46 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.518 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 10.7 t80 -56.34 126.28 25.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.955 0.378 . . . . 75.209999999999994 110.068 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 22.5 m -97.08 37.15 1.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 72.099999999999994 111.029 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.762 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 52.3 tp 66.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.400000000000006 111.479 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.762 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 45.4 mt-10 -137.38 -33.13 0.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 54.240000000000002 110.599 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.43 93.17 5.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.606 . . . . 61.539999999999999 110.985 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.05 21.75 40.24 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.953 -0.567 . . . . 53.409999999999997 112.011 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.45 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.888 0.375 . . . . 74.109999999999999 111.384 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.26 -47.73 4.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.405 -0.361 . . . . 74.310000000000002 111.718 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.481 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 23.9 p 49.84 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.334 0.654 . . . . 64.420000000000002 112.188 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 43' ' ' SER . 34.1 m -76.21 161.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.932 -0.577 . . . . 71.329999999999998 111.316 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -103.25 154.51 19.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 64.439999999999998 110.861 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.09 106.01 8.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.923 0.392 . . . . 71.109999999999999 110.393 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.5 -177.61 3.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 110.875 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.39 158.18 17.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 73.340000000000003 111.166 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 106' ' ' ILE . 3.9 m -148.36 159.62 43.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.77 -0.65 . . . . 53.119999999999997 109.317 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -161.71 155.69 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.024 0.44 . . . . 61.329999999999998 111.126 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 104' ' ' VAL . 29.2 t -132.19 127.35 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.607 -0.886 . . . . 60.039999999999999 108.607 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -135.67 -28.22 1.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.631 0.604 . . . . 64.299999999999997 112.631 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -139.55 32.62 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.051 0.453 . . . . 62.420000000000002 110.625 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.47 -37.31 3.35 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.593 -0.813 . . . . 73.340000000000003 111.865 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.0 140.34 34.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.975 0.417 . . . . 53.409999999999997 110.034 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 99' ' ' VAL . 41.3 t -96.53 131.57 42.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.829 -0.623 . . . . 63.399999999999999 110.211 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' THR . 40.0 mt-30 -116.61 141.77 47.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.77 -0.196 . . . . 71.030000000000001 110.596 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.689 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -123.9 161.93 25.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.292 -0.413 . . . . 72.310000000000002 110.271 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 37.3 m -101.88 101.07 11.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.375 -0.375 . . . . 61.009999999999998 110.982 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 pt -80.54 119.04 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.274 -0.421 . . . . 73.530000000000001 109.968 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 72.239999999999995 111.697 -174.56 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 . . . . . 0 CA--C 1.53 0.178 0 N-CA-C 112.114 0.413 . . . . 71.209999999999994 112.114 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -128.45 135.78 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.326 . . . . 71.209999999999994 110.474 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 m -119.79 132.04 55.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.102 -0.499 . . . . 72.349999999999994 110.203 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.813 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.7 m -71.49 117.52 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.098 0.475 . . . . 75.299999999999997 111.58 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG2' HD12 ' A' ' 106' ' ' ILE . 41.4 t -86.9 -67.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.293 0.568 . . . . 72.049999999999997 110.644 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.51 -177.6 6.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.781 . . . . 73.299999999999997 108.975 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 47.3 mtpt -84.2 157.16 21.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.85 0.357 . . . . 75.409999999999997 110.546 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.8 tp -79.16 -2.38 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.415 0.626 . . . . 55.119999999999997 110.142 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.48 -40.74 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.745 . . . . 62.329999999999998 112.202 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 p30 -88.6 -6.74 57.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 72.340000000000003 112.395 -172.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.38 129.85 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.882 0.372 . . . . 63.210000000000001 110.164 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 91.7 mt -61.22 124.52 80.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 111.708 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 14.8 Cg_exo -68.47 131.91 24.26 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 123.232 2.621 . . . . 43.530000000000001 112.646 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 84.55 18.51 61.88 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.792 -0.64 . . . . 55.409999999999997 112.77 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -153.13 162.32 41.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 117.096 0.448 . . . . 61.009999999999998 111.444 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -118.27 124.32 6.03 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.478 -0.649 . . . . 71.329999999999998 111.478 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -111.95 141.45 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.953 0.377 . . . . 70.230000000000004 111.482 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 6.9 p -82.32 92.91 7.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.086 0.47 . . . . 74.310000000000002 111.025 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -82.65 143.19 31.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 53.32 109.93 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 27' ' ' GLN . 3.2 tm? -80.02 97.44 6.8 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.28 -0.637 . . . . 73.140000000000001 109.28 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 HD11 ' A' ' 106' ' ' ILE . 19.2 t -91.24 79.65 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.894 -0.594 . . . . 72.349999999999994 109.997 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 65.15 -68.56 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 74.239999999999995 112.437 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.417 ' HB2' HE21 ' A' ' 25' ' ' GLN . 15.3 mt-30 -118.94 -19.41 8.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.903 0.334 . . . . 73.109999999999999 111.903 -173.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -138.35 140.32 39.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.807 -0.357 . . . . 75.329999999999998 111.444 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 49.0 mt-30 -88.41 132.0 34.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.787 -0.449 . . . . 65.219999999999999 109.787 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 59.4 mt -130.37 136.44 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.186 -0.672 . . . . 33.420000000000002 109.186 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.24 108.41 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.385 -0.37 . . . . 64.019999999999996 110.225 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.6 t -101.0 110.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.91 -0.586 . . . . 65.329999999999998 109.907 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 89.8 m-85 -77.9 137.4 38.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.54 -0.755 . . . . 71.519999999999996 111.432 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -124.29 57.89 14.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.925 -0.768 . . . . 54.329999999999998 108.925 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.703 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 98.5 Cg_endo -77.65 -25.54 7.85 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.545 2.163 . . . . 75.230000000000004 112.871 -166.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -97.96 1.05 47.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.281 -0.418 . . . . 63.340000000000003 110.141 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.54 31.17 18.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 74.030000000000001 110.147 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.7 t70 -144.23 -158.71 0.91 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.191 -0.913 . . . . 74.439999999999998 109.674 -171.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.505 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 37.8 mt-10 -70.41 -25.82 63.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.226 0.454 . . . . 72.299999999999997 112.226 -172.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.58 91.38 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.102 0.477 . . . . 62.420000000000002 111.522 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.16 157.64 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.333 -0.849 . . . . 73.349999999999994 110.266 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -140.25 115.54 9.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 71.340000000000003 110.424 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 106.27 16.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.312 -0.404 . . . . 63.229999999999997 111.274 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 44' ' ' ASN . 38.5 pt -123.98 153.9 30.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 63.049999999999997 109.986 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 95' ' ' TYR . 44.9 m -77.23 59.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.128 0.49 . . . . 62.200000000000003 110.596 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 42' ' ' ILE . 64.9 t30 -105.1 63.54 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.621 0.724 . . . . 72.239999999999995 110.378 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mp -114.36 132.05 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.088 -0.96 . . . . 72.340000000000003 109.77 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.0 t70 -81.24 117.12 66.83 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 71.239999999999995 109.396 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 9.0 Cg_exo -72.32 -5.6 17.44 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.143 2.562 . . . . 73.409999999999997 113.576 -174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -89.46 -32.09 17.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.136 -0.32 . . . . 62.109999999999999 110.136 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -13.81 14.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.191 0.519 . . . . 55.520000000000003 110.066 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 57.98 59.68 3.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.862 -1.063 . . . . 73.439999999999998 110.914 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -167.32 158.44 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.028 -0.987 . . . . 51.549999999999997 109.587 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 16.7 p -81.34 50.29 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.862 -0.608 . . . . 72.129999999999995 110.515 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.59 -20.74 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.376 0.608 . . . . 63.439999999999998 110.058 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.4 mt -75.57 -14.6 60.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.3 -0.864 . . . . 73.349999999999994 109.848 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 19.5 m -117.05 4.93 12.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 61.140000000000001 110.749 -176.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -107.68 9.06 29.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.535 . . . . 61.0 110.198 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -90.79 -114.92 1.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.895 -0.669 . . . . 72.120000000000005 112.53 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.0 mt -121.24 113.81 40.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.917 0.389 . . . . 70.450000000000003 110.874 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.1 t -74.79 93.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.653 . . . . 54.140000000000001 109.287 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.72 157.29 16.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.718 -0.674 . . . . 62.420000000000002 111.426 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -117.88 122.99 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.738 -0.665 . . . . 75.400000000000006 110.061 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 50.2 t-80 -65.38 -59.67 3.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.653 -0.703 . . . . 75.010000000000005 110.169 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -173.34 -58.52 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.774 -1.103 . . . . 73.120000000000005 108.439 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -125.96 11.37 7.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.34 -0.846 . . . . 62.450000000000003 109.489 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.596 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.3 t0 -132.53 166.48 21.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.446 -0.797 . . . . 71.329999999999998 109.526 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.62 117.43 21.99 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.462 0.305 . . . . 63.200000000000003 110.663 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 20.4 m95 -130.01 112.58 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 72.099999999999994 110.376 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 13.8 p -79.85 141.39 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.847 -0.427 . . . . 72.5 109.847 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.46 54.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.971 0.415 . . . . 74.219999999999999 111.583 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 28.2 t -74.66 127.44 87.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 74.409999999999997 110.552 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 55.5 Cg_endo -70.86 -34.05 11.5 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.635 2.223 . . . . 73.420000000000002 113.021 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.62 -63.2 1.33 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.85 0.357 . . . . 60.049999999999997 111.825 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 90' ' ' TYR . 41.4 mmtm -73.69 -25.57 60.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 74.219999999999999 110.874 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.4 tttm 56.15 95.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 71.430000000000007 112.357 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.437 ' OE1' ' HB3' ' A' ' 89' ' ' ALA . 2.5 pt20 -166.64 155.41 10.6 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.006 -0.997 . . . . 74.140000000000001 109.454 170.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.783 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 75.5 m80 -90.35 143.57 26.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.709 -0.678 . . . . 72.049999999999997 110.183 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.444 ' HB2' ' CG1' ' A' ' 68' ' ' VAL . 86.2 m-85 -130.58 121.1 25.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.401 -0.592 . . . . 62.109999999999999 109.401 173.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.07 133.79 45.44 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.333 -0.547 . . . . 75.510000000000005 109.74 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.63 11.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.653 0.612 . . . . 72.140000000000001 112.653 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -128.06 4.9 5.88 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.675 -0.41 . . . . 74.439999999999998 111.075 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.87 -77.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.581 -0.281 . . . . 62.450000000000003 111.164 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.49 22.66 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.608 -0.806 . . . . 54.140000000000001 113.056 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -68.26 146.28 53.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.86 -0.422 . . . . 73.329999999999998 109.86 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 53.9 m -99.28 0.96 44.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.646 0.61 . . . . 52.32 112.646 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.0 tp 63.58 -74.73 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.241 0.617 . . . . 74.129999999999995 112.537 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 27.0 mt-10 -109.95 -40.71 4.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.474 0.654 . . . . 55.109999999999999 109.969 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' CG ' ' HA ' ' A' ' 75' ' ' GLN . 1.7 m-20 -82.31 -171.01 3.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.852 -1.067 . . . . 71.230000000000004 110.386 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.33 118.43 0.75 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.574 -0.822 . . . . 64.340000000000003 112.522 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . . . -168.01 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.524 0.202 . . . . 54.530000000000001 110.884 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.583 ' HE2' ' HG3' ' A' ' 73' ' ' LYS . 75.1 m-85 -83.91 80.44 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 63.539999999999999 110.756 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -74.83 97.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.004 -0.543 . . . . 70.219999999999999 109.581 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.51 -175.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.171 -0.468 . . . . 62.219999999999999 111.725 -172.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.09 173.52 8.66 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.964 -0.562 . . . . 74.129999999999995 110.403 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -134.11 116.4 15.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 111.179 -173.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HE1' ' OG ' ' A' ' 43' ' ' SER . 80.0 m-85 -80.42 151.51 29.3 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.788 -0.642 . . . . 63.32 109.42 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -81.5 160.84 23.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.224 -0.658 . . . . 54.100000000000001 109.224 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.829 HG22 HG22 ' A' ' 106' ' ' ILE . 4.8 p -136.08 142.86 44.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.779 0.324 . . . . 74.340000000000003 111.366 -171.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -125.45 138.25 54.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.22 0.533 . . . . 75.430000000000007 110.116 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.92 103.72 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.597 -0.89 . . . . 53.509999999999998 108.597 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.4 m -89.62 -68.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 110.69 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -116.35 -133.02 0.33 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.359 -0.978 . . . . 71.310000000000002 108.359 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.78 35.4 2.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.421 -0.895 . . . . 24.449999999999999 111.139 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.7 p30 -141.65 155.13 45.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.496 . . . . 73.319999999999993 110.958 -175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.59 128.06 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.627 -0.715 . . . . 74.230000000000004 110.322 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.813 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -121.76 127.0 50.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.33 -0.395 . . . . 53.119999999999997 110.23 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.829 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -101.72 165.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.08 -0.341 . . . . 73.409999999999997 110.08 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -92.09 96.82 10.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.041 0.448 . . . . 73.420000000000002 110.235 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mm -73.79 102.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.2 0.524 . . . . 64.430000000000007 110.073 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 64.420000000000002 110.148 178.489 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 107' ' ' SER . 51.3 mt-30 . . . . . 0 C--O 1.233 0.234 0 CA-C-O 121.054 0.454 . . . . 72.340000000000003 110.611 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 85.0 m95 -133.7 100.24 4.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.417 -0.811 . . . . 71.299999999999997 110.03 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -88.45 135.44 33.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.509 -0.314 . . . . 64.239999999999995 111.21 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.2 m -72.41 111.85 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 75.109999999999999 110.165 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 30' ' ' VAL . 50.2 t -81.97 -73.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.827 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.2 m -150.44 175.91 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 63.310000000000002 109.688 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 2.8 mptp? -79.36 142.18 36.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.973 -0.381 . . . . 72.420000000000002 109.973 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 99' ' ' VAL . 7.9 tt -62.63 -23.47 67.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 53.119999999999997 109.61 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.87 -21.21 26.5 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 72.549999999999997 110.264 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.55 -24.96 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 71.510000000000005 110.723 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 32' ' ' ARG . 73.1 mt -77.59 116.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 75.120000000000005 111.161 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.05 132.83 90.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 60.109999999999999 111.474 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 44.1 Cg_endo -68.4 145.12 64.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.073 2.515 . . . . 63.210000000000001 113.153 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.04 64.41 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.676 -0.693 . . . . 74.340000000000003 112.856 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 166.73 32.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.084 0.442 . . . . 63.399999999999999 111.932 -175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -146.17 142.7 10.77 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.578 -0.609 . . . . 40.140000000000001 111.578 177.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.549 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 26.2 m -127.21 144.5 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.07 0.435 . . . . 52.240000000000002 112.013 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.55 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.5 p -74.0 105.3 5.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.162 -0.472 . . . . 71.400000000000006 110.851 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 131.27 41.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.02 -0.536 . . . . 71.349999999999994 110.391 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.27 101.33 13.75 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.331 -0.618 . . . . 63.240000000000002 109.331 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -111.45 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.594 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 66.09 -72.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.351 -0.84 . . . . 72.420000000000002 111.697 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' A' ' 25' ' ' GLN . 2.9 pt20 -155.2 11.32 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 74.049999999999997 110.973 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -119.08 137.73 53.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 111.014 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -99.6 112.8 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 62.420000000000002 109.878 173.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.3 mt -118.18 135.65 57.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.087 -0.506 . . . . 75.530000000000001 110.453 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -89.91 114.81 26.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 109.989 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.9 t -98.54 101.63 12.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.376 -0.374 . . . . 54.539999999999999 110.747 -176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HE2' HG21 ' A' ' 68' ' ' VAL . 66.8 m-85 -80.05 141.99 35.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.659 . . . . 75.450000000000003 111.089 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 39' ' ' VAL . 14.0 tpt180 -112.7 80.72 3.9 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.302 -0.999 . . . . 72.430000000000007 108.302 165.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.716 ' HG2' HE22 ' A' ' 38' ' ' GLN . 18.2 Cg_exo -65.95 -43.32 9.49 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.568 2.179 . . . . 61.43 112.962 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -114.08 156.79 23.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.707 0.289 . . . . 74.540000000000006 110.284 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.18 71.09 3.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.816 -1.179 . . . . 33.140000000000001 107.816 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 26.7 t70 -160.07 -175.9 5.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.91 -1.041 . . . . 62.32 109.08 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.5 ' HA ' HD11 ' A' ' 10' ' ' LEU . 29.0 mt-10 -78.71 -10.75 59.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 35.439999999999998 110.236 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.716 HE22 ' HG2' ' A' ' 33' ' ' PRO . 22.2 tm0? -73.52 124.2 25.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.291 -0.868 . . . . 71.239999999999995 110.885 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' HD2' ' A' ' 32' ' ' ARG . 28.5 m -132.74 168.22 24.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 51.100000000000001 110.425 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.92 103.02 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.657 0.244 . . . . 62.229999999999997 111.657 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -103.95 109.64 21.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.857 0.361 . . . . 42.219999999999999 110.245 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 43.7 pt -130.51 179.16 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.976 0.417 . . . . 73.239999999999995 111.149 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.48 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 5.2 m -82.29 80.11 8.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.501 -0.555 . . . . 62.43 109.501 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.0 t-20 -123.84 70.57 1.08 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.713 0.768 . . . . 73.329999999999998 110.243 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' HB3' ' A' ' 20' ' ' CYS . 37.3 mm -126.69 131.97 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.166 -0.924 . . . . 71.329999999999998 109.368 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.1 t70 -83.72 121.74 76.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.764 -0.458 . . . . 54.119999999999997 109.764 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 29.1 Cg_exo -62.54 -17.62 59.18 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.13 2.553 . . . . 50.109999999999999 113.248 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.1 5.77 44.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 73.010000000000005 110.597 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.33 -29.84 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 62.030000000000001 111.645 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 69.0 19.85 7.99 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.345 0.593 . . . . 74.510000000000005 110.816 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -142.19 168.19 20.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.757 -0.656 . . . . 73.019999999999996 109.88 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 22.0 p -81.62 55.83 2.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.933 -0.576 . . . . 64.140000000000001 110.938 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.01 -21.5 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.494 0.664 . . . . 62.299999999999997 109.901 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 50.0 mt -77.47 -19.68 55.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.264 -0.88 . . . . 61.409999999999997 109.636 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 6.0 m -90.62 -19.43 23.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.667 -0.697 . . . . 70.299999999999997 111.503 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -98.8 27.4 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.603 0.716 . . . . 63.329999999999998 109.847 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -95.93 -122.94 4.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.575 -0.739 . . . . 74.109999999999999 111.971 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 61.5 mt -112.34 104.27 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.205 0.526 . . . . 62.240000000000002 110.606 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 33' ' ' PRO . 93.6 t -91.64 105.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.396 -0.82 . . . . 74.340000000000003 109.077 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.27 179.38 8.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.135 0.493 . . . . 73.430000000000007 111.344 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 166.52 10.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.851 -0.613 . . . . 74.200000000000003 109.9 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -126.37 77.35 1.69 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.22 -0.659 . . . . 64.200000000000003 109.22 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 68.02 -59.78 0.42 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.441 -0.8 . . . . 74.109999999999999 111.77 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -117.84 -57.77 2.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.217 -0.447 . . . . 61.530000000000001 111.458 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.626 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.3 t0 -90.61 179.01 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 62.009999999999998 110.989 -173.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.66 123.19 43.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 52.399999999999999 110.742 -173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.626 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 46.4 m95 -137.83 128.26 26.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 73.310000000000002 110.893 -173.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.453 HG21 ' HE2' ' A' ' 31' ' ' PHE . 10.6 p -94.95 127.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.603 . . . . 55.299999999999997 110.029 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -97.41 120.04 37.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.908 -0.587 . . . . 62.100000000000001 110.918 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 41.1 t -64.55 141.32 98.22 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 53.450000000000003 110.391 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.512 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 61.1 Cg_endo -78.11 -41.18 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.163 1.909 . . . . 35.109999999999999 111.706 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -76.99 -69.09 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.601 -0.727 . . . . 73.099999999999994 110.986 -178.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.72 ' HD2' ' HB3' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -80.95 -19.11 44.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.36 -0.382 . . . . 73.430000000000007 111.181 -175.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.6 mttp 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.82 -0.627 . . . . 73.310000000000002 112.594 176.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -78.3 143.31 37.1 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 73.329999999999998 109.477 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -100.62 115.36 30.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.307 -0.406 . . . . 62.350000000000001 110.328 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 68' ' ' VAL . 70.3 m-85 -106.12 124.75 50.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.114 -0.328 . . . . 64.140000000000001 110.114 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 42.9 ttp180 -72.97 121.99 20.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.821 0.343 . . . . 75.219999999999999 110.436 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 99.0 mt -76.39 78.0 3.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 74.129999999999995 110.263 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -174.56 -63.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 65.540000000000006 109.752 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -111.81 -23.08 10.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.736 -0.665 . . . . 73.040000000000006 111.046 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 19.29 27.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.742 . . . . 72.340000000000003 112.391 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.77 134.22 48.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.603 0.24 . . . . 74.409999999999997 110.539 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 46.0 m -88.31 26.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.157 0.428 . . . . 72.150000000000006 112.157 -174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.2 tp 63.2 -79.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 73.200000000000003 112.308 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -126.93 -7.27 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.039 0.447 . . . . 75.519999999999996 110.56 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.59 -176.52 3.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.153 -0.684 . . . . 63.32 109.153 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 22.54 0.15 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.789 -0.719 . . . . 64.430000000000007 112.169 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -58.06 6.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.077 0.465 . . . . 60.030000000000001 110.799 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -130.61 92.38 3.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.471 . . . . 73.200000000000003 110.729 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.4 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 20.4 m -74.44 130.13 39.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.587 . . . . 54.409999999999997 109.414 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' SER . 32.4 m -95.88 -176.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.509 -0.314 . . . . 60.229999999999997 111.291 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -129.63 179.55 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 72.200000000000003 110.728 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.77 124.63 15.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.0 0.429 . . . . 75.230000000000004 110.664 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -89.51 169.6 11.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.651 -0.704 . . . . 74.540000000000006 109.704 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -99.73 138.53 36.68 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.474 -0.565 . . . . 74.400000000000006 109.474 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.906 HG22 HG22 ' A' ' 106' ' ' ILE . 44.6 p -127.24 156.38 41.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.303 -0.408 . . . . 55.219999999999999 111.104 -173.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.446 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.0 pt20 -155.44 140.77 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.169 0.509 . . . . 65.439999999999998 110.851 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.654 HG21 HD12 ' A' ' 10' ' ' LEU . 39.8 t -109.29 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.79 -0.819 . . . . 71.120000000000005 108.79 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -113.64 -5.04 13.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.396 -171.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -141.63 25.09 2.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 74.109999999999999 110.842 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.28 17.48 Favored Glycine 0 C--O 1.234 0.139 0 C-N-CA 120.843 -0.694 . . . . 52.219999999999999 111.544 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 40.5 m-80 -106.56 157.14 17.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.3 -0.63 . . . . 72.239999999999995 109.3 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 99' ' ' VAL . 44.8 t -94.76 117.22 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.994 0.426 . . . . 74.340000000000003 110.297 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 25.1 mt-30 -102.29 139.08 38.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.529 . . . . 71.540000000000006 110.095 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.906 HG22 HG22 ' A' ' 97' ' ' THR . 2.9 pp -114.47 149.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.105 -0.498 . . . . 72.510000000000005 110.012 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 8.5 t -85.8 128.0 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.714 -0.476 . . . . 65.400000000000006 109.714 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 3' ' ' GLN . 50.2 mm -65.43 105.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 74.209999999999994 110.923 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.557 0 CA-C-N 115.636 -0.711 . . . . 73.010000000000005 110.08 177.936 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 121.269 0.557 . . . . 71.430000000000007 110.293 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -102.4 116.71 33.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 74.420000000000002 109.772 -177.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 m -98.91 131.78 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.073 0.463 . . . . 74.400000000000006 111.226 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.781 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 5.2 m -67.47 119.42 12.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.478 -0.783 . . . . 75.319999999999993 111.036 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 t -95.53 -84.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.519999999999996 110.46 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.1 m -142.25 161.15 38.75 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.979 -0.378 . . . . 74.450000000000003 109.979 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 89.8 mttt -65.6 145.15 56.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.047 -0.353 . . . . 70.019999999999996 110.047 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 37' ' ' GLU . 10.4 tt -65.57 -28.19 68.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.532 0.682 . . . . 75.120000000000005 109.565 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.85 -25.44 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.277 -0.874 . . . . 74.319999999999993 110.848 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 26.6 t0 -72.67 -15.94 61.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 53.340000000000003 109.817 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.4 mt -96.02 133.57 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.463 -0.79 . . . . 51.450000000000003 109.983 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.92 150.35 88.17 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.988 0.423 . . . . 62.219999999999999 111.784 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.97 123.68 11.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.69 2.26 . . . . 72.540000000000006 111.803 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.51 11.35 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.64 -0.709 . . . . 44.130000000000003 112.484 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -136.3 179.44 6.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.387 0.594 . . . . 63.329999999999998 111.023 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -175.42 101.42 0.16 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.069 -0.812 . . . . 45.140000000000001 111.069 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.465 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -117.63 150.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.21 0.448 . . . . 74.400000000000006 112.21 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.686 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.0 p -78.6 128.68 33.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.73 -0.668 . . . . 74.420000000000002 111.65 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.05 137.42 50.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.417 -0.586 . . . . 72.329999999999998 109.417 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -83.71 107.65 16.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.565 -0.531 . . . . 72.239999999999995 109.565 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.99 92.48 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.094 -0.503 . . . . 71.109999999999999 110.084 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 65.45 -75.06 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.271 -0.877 . . . . 75.409999999999997 113.113 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.68 10.58 3.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.194 0.442 . . . . 73.329999999999998 112.194 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -142.24 144.22 33.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.937 0.399 . . . . 73.430000000000007 111.314 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.493 ' HB2' HG13 ' A' ' 45' ' ' ILE . 52.3 mt-30 -95.48 120.16 35.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.269 -0.641 . . . . 75.549999999999997 109.269 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.85 120.83 62.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 110.056 -0.349 . . . . 65.540000000000006 110.056 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.0 123.71 34.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.602 . . . . 64.349999999999994 109.373 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 15.0 t -107.87 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.952 0.406 . . . . 73.099999999999994 111.043 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.1 m-85 -77.34 136.17 38.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.567 -0.742 . . . . 72.120000000000005 110.726 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -127.77 73.99 78.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.131 -0.692 . . . . 72.519999999999996 109.131 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.53 -36.72 52.32 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.017 2.478 . . . . 71.129999999999995 112.215 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -111.92 149.77 31.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.56 -0.746 . . . . 71.400000000000006 109.807 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -81.26 56.8 2.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.311 1.053 . . . . 71.439999999999998 109.231 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -136.92 -176.1 4.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.564 -1.198 . . . . 44.210000000000001 108.448 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 10' ' ' LEU . 35.7 mt-10 -82.76 47.6 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.622 0.725 . . . . 63.530000000000001 110.274 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -126.7 99.04 5.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.107 -0.952 . . . . 71.239999999999995 109.413 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.56 162.19 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 63.130000000000003 111.078 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 99.7 m-85 -134.31 102.07 5.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.965 -0.562 . . . . 75.030000000000001 110.3 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.68 96.97 6.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.879 0.371 . . . . 70.510000000000005 111.045 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 pt -131.18 175.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.924 -0.58 . . . . 71.409999999999997 110.15 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.2 m -80.63 56.62 2.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.175 0.512 . . . . 64.030000000000001 110.793 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.592 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 20.2 t-20 -87.05 71.5 10.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.72 0.771 . . . . 73.5 109.675 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 20' ' ' CYS . 16.8 mm -124.55 142.96 39.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 61.32 109.992 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 9.9 t70 -90.55 116.65 66.87 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.022 -0.733 . . . . 63.420000000000002 109.022 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.19 -16.9 53.76 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 123.121 2.547 . . . . 75.140000000000001 113.108 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -101.36 -3.41 28.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.003 0.43 . . . . 73.340000000000003 110.509 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -117.96 -24.92 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 43.450000000000003 110.897 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 69.11 19.49 7.99 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.727 -0.669 . . . . 65.209999999999994 110.601 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -153.1 169.1 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 64.109999999999999 109.709 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -84.23 83.87 7.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 71.120000000000005 110.791 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -96.97 -10.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.41 0.624 . . . . 74.450000000000003 109.787 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 43.6 mt -70.26 -28.52 65.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.315 -0.857 . . . . 70.019999999999996 109.608 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 p -88.81 5.86 41.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.06 -0.973 . . . . 33.310000000000002 111.841 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.946 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -108.6 15.38 23.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.276 0.56 . . . . 72.030000000000001 110.481 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -96.55 -147.61 22.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.717 -0.754 . . . . 73.319999999999993 112.299 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.75 118.03 42.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.02 0.438 . . . . 74.040000000000006 110.472 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.37 101.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.743 . . . . 42.350000000000001 109.531 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.85 109.01 21.42 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.254 -0.884 . . . . 63.340000000000003 110.641 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.32 129.01 35.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.305 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -108.1 45.44 1.02 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.581 -0.736 . . . . 64.209999999999994 109.523 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 69.29 -67.03 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.131 -0.94 . . . . 71.219999999999999 111.117 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.34 -43.9 7.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.177 -0.465 . . . . 60.340000000000003 110.965 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.488 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 3.2 t70 -98.52 174.58 6.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.287 . . . . 73.209999999999994 110.39 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 79' ' ' LEU . 89.3 mt -132.28 118.7 19.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 71.340000000000003 109.883 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.488 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 35.8 m95 -124.14 165.53 17.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.93 0.395 . . . . 73.430000000000007 110.585 -175.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.7 p -135.06 132.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 110.191 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.48 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -94.35 106.03 18.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 73.530000000000001 109.985 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.6 t -68.85 133.68 90.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.127 -0.488 . . . . 54.020000000000003 111.124 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.8 Cg_endo -71.14 -30.02 16.7 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.486 2.124 . . . . 65.409999999999997 111.941 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.86 -37.65 14.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.978 -0.555 . . . . 62.210000000000001 111.099 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.813 ' HD3' ' HE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -88.41 -28.16 21.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 111.379 -175.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 65.19 22.95 12.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.534 0.521 . . . . 65.120000000000005 111.018 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.86 155.81 35.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.29 -0.413 . . . . 73.120000000000005 110.712 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 76.6 m80 -95.32 117.0 29.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 75.430000000000007 110.667 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -100.78 137.41 39.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.179 -0.464 . . . . 72.340000000000003 110.7 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -78.42 123.89 27.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.036 -0.529 . . . . 75.120000000000005 110.19 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 84.4 mt -74.31 -30.44 62.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.454 0.538 . . . . 72.230000000000004 112.454 -172.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HD1' ' HE1' ' A' ' 40' ' ' TYR . 48.6 t80 -81.73 -19.13 42.06 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.797 -0.361 . . . . 73.430000000000007 111.566 -174.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -140.52 -78.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 74.209999999999994 111.037 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.36 0.46 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.681 -0.771 . . . . 71.439999999999998 112.123 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -55.37 108.32 0.41 Allowed 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 109.83 -0.434 . . . . 65.129999999999995 109.83 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.2 m -76.16 155.92 34.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.003 0.43 . . . . 43.43 111.418 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 24.7 tp -86.59 -20.45 27.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 70.510000000000005 110.001 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -82.97 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.799 -0.637 . . . . 72.120000000000005 110.715 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -144.16 160.65 40.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.106 -0.497 . . . . 72.030000000000001 109.954 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.13 65.78 3.73 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.971 -0.851 . . . . 62.32 110.971 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.34 -66.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.77 0.285 . . . . 74.030000000000001 111.77 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.813 ' HE2' ' HD3' ' A' ' 73' ' ' LYS . 60.1 m-85 -100.04 -28.21 13.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.833 -0.347 . . . . 71.219999999999999 111.501 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m 59.73 84.53 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.744 0.653 . . . . 74.340000000000003 110.234 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.9 m -79.2 155.83 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 61.109999999999999 110.975 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.11 142.79 26.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.008 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.78 97.71 6.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.916 -0.584 . . . . 71.430000000000007 110.153 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -81.96 136.43 35.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.987 -0.551 . . . . 75.430000000000007 110.042 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -66.44 136.63 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 73.120000000000005 109.357 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.577 HG22 HG22 ' A' ' 106' ' ' ILE . 76.0 p -115.52 143.43 45.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 65.329999999999998 111.214 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -134.72 137.27 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.617 . . . . 75.349999999999994 110.413 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 t -111.03 62.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.527 -0.761 . . . . 64.439999999999998 109.037 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -85.12 -29.35 24.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.247 -0.888 . . . . 64.430000000000007 111.397 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -103.59 -6.73 21.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.499 0.666 . . . . 54.539999999999999 110.835 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.02 -33.14 6.36 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.692 -1.363 . . . . 63.520000000000003 109.692 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 46.7 m-80 -81.39 139.84 35.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.566 -0.901 . . . . 45.219999999999999 108.566 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -81.78 123.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.409 -0.589 . . . . 62.119999999999997 109.409 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 21.5 mt-30 -117.55 121.1 40.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.656 . . . . 73.329999999999998 110.591 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.577 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -96.38 153.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.813 -0.63 . . . . 71.519999999999996 111.345 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -81.4 114.74 20.36 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.128 -0.693 . . . . 45.210000000000001 109.128 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.69 109.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.344 0.592 . . . . 73.109999999999999 111.745 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 108.258 -1.015 . . . . 72.109999999999999 108.258 168.626 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 121.228 0.537 . . . . 71.209999999999994 109.818 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -124.58 139.12 54.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.57 -0.741 . . . . 73.120000000000005 110.173 -177.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.646 HG21 HG13 ' A' ' 23' ' ' VAL . 21.1 m -126.15 124.3 40.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.841 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.3 m -67.32 119.57 12.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.286 -0.416 . . . . 74.310000000000002 110.394 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 30' ' ' VAL . 61.6 t -68.27 -60.91 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 62.340000000000003 109.673 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 13' ' ' ILE . 5.0 p -172.33 -90.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.024 -0.989 . . . . 71.310000000000002 109.414 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.84 ' HD2' ' HB2' ' A' ' 12' ' ' ASP . 47.0 mttp -145.08 170.68 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.597 -0.52 . . . . 73.030000000000001 109.597 177.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 99' ' ' VAL . 53.8 tp -91.23 -49.96 6.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.203 0.525 . . . . 74.310000000000002 110.396 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.44 -30.08 53.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.717 -0.674 . . . . 75.349999999999994 110.701 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.84 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 29.3 t0 -72.48 -13.68 61.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.293 -0.867 . . . . 75.439999999999998 110.334 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 8' ' ' CYS . 34.7 mm -88.4 117.67 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 74.209999999999994 109.803 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.63 123.33 76.39 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 74.230000000000004 111.174 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 36.6 Cg_endo -65.54 146.15 84.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.572 2.181 . . . . 54.509999999999998 111.874 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.82 30.17 36.43 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.448 -0.661 . . . . 45.299999999999997 111.448 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.1 m -147.97 174.16 12.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.738 0.304 . . . . 74.099999999999994 110.95 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.42 107.9 0.33 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.706 -0.958 . . . . 75.349999999999994 110.706 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.3 m -124.7 153.96 31.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 112.427 0.529 . . . . 65.450000000000003 112.427 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.2 p -79.87 118.23 21.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.578 -0.737 . . . . 73.239999999999995 111.275 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.14 169.94 9.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 71.450000000000003 110.358 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.09 117.54 29.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.236 0.541 . . . . 72.109999999999999 110.828 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 26' ' ' GLN . 57.3 t -124.77 154.03 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.385 -0.969 . . . . 73.040000000000006 108.385 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -45.68 -48.18 15.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.333 0.864 . . . . 73.519999999999996 113.333 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -114.65 -4.68 12.76 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.266 0.839 . . . . 71.319999999999993 113.266 -167.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 10.3 tt0 -172.37 143.49 1.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.821 -0.352 . . . . 63.299999999999997 110.524 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -75.64 137.45 40.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.28 -0.637 . . . . 73.519999999999996 109.28 173.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 20.6 tt -115.8 138.05 47.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.628 0.251 . . . . 61.539999999999999 110.502 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -97.43 124.8 41.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 72.200000000000003 110.281 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.625 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 38.9 t -106.19 99.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 110.949 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.806 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 57.6 m-85 -75.21 113.83 13.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 52.340000000000003 110.75 176.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -118.59 82.69 20.19 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.528 -0.916 . . . . 71.540000000000006 108.528 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 59' ' ' VAL . 10.4 Cg_exo -71.11 -31.75 14.24 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 122.72 2.28 . . . . 72.209999999999994 112.758 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -121.48 -179.74 4.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.48 -0.327 . . . . 75.129999999999995 110.278 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 15' ' ' PRO . 80.8 m-20 -93.24 23.9 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 74.409999999999997 110.881 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.77 -174.8 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.381 0.61 . . . . 71.439999999999998 111.429 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -98.66 31.64 2.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.308 -0.86 . . . . 71.239999999999995 110.712 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.94 153.23 52.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.09 -0.505 . . . . 62.549999999999997 111.028 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.82 165.98 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.114 -0.493 . . . . 61.299999999999997 110.488 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.806 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.3 m-85 -122.14 92.15 3.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.063 -0.517 . . . . 73.329999999999998 110.401 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -94.04 100.48 12.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.982 0.42 . . . . 43.149999999999999 110.323 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.71 173.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 72.329999999999998 110.795 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 m -78.51 87.08 4.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.08 0.467 . . . . 62.420000000000002 109.87 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 25.7 t-20 -133.5 67.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.678 0.751 . . . . 52.439999999999998 109.584 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.68 HD12 ' HB3' ' A' ' 20' ' ' CYS . 38.7 mm -118.79 143.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.431 -0.804 . . . . 75.129999999999995 109.384 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 48' ' ' PHE . 27.0 t70 -99.36 114.44 65.57 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.327 -0.397 . . . . 53.219999999999999 109.941 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.19 -12.99 35.3 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.187 2.591 . . . . 43.049999999999997 112.773 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 82.7 t80 -82.82 -22.13 34.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 75.140000000000001 110.983 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.7 -13.78 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 72.349999999999994 111.426 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 63.62 29.44 15.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.801 -0.636 . . . . 73.010000000000005 111.018 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -147.95 170.35 17.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.166 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 12.2 p -83.95 58.83 4.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.249 0.547 . . . . 64.420000000000002 110.702 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.482 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 31.2 m -79.73 3.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.704 . . . . 64.200000000000003 110.208 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 64.1 mt -104.78 -2.54 24.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.99 -1.004 . . . . 74.140000000000001 109.248 174.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.513 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 34.9 t -102.04 -48.7 4.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.648 -0.705 . . . . 71.0 111.362 -174.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -84.17 62.65 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.89 0.852 . . . . 72.409999999999997 109.892 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -114.51 -156.06 11.39 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.748 -1.115 . . . . 63.32 111.741 176.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mm -93.9 125.21 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.74 -0.467 . . . . 71.310000000000002 109.74 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.4 t -86.48 97.79 6.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.023 -0.535 . . . . 74.099999999999994 110.097 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 133.13 51.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.667 -0.697 . . . . 72.349999999999994 110.374 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.67 151.24 20.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.116 0.484 . . . . 73.040000000000006 110.78 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -134.54 103.77 5.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.008 -0.738 . . . . 64.430000000000007 109.008 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 70.38 -61.45 0.46 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.07 0.857 . . . . 75.310000000000002 110.532 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -157.19 -23.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 73.519999999999996 110.826 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.64 171.56 14.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.98 -0.378 . . . . 74.0 109.98 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.6 mt -127.58 117.78 22.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.054 0.454 . . . . 71.150000000000006 110.668 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' A' ' 78' ' ' ARG . 20.7 m95 -111.56 127.35 55.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.508 -0.769 . . . . 73.450000000000003 109.655 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 79' ' ' LEU . 8.5 p -92.25 129.19 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.983 0.421 . . . . 71.549999999999997 110.496 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -99.28 108.09 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 70.519999999999996 110.813 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 29.9 t -56.31 138.34 74.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 64.430000000000007 111.407 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 53' ' ' VAL . 60.9 Cg_endo -73.67 -25.6 14.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.566 2.177 . . . . 62.409999999999997 112.768 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.94 -49.56 3.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 62.350000000000001 111.364 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -19.18 28.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.359 . . . . 64.310000000000002 110.903 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 70' ' ' SER . 57.2 tttm 62.62 22.66 13.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.437 0.636 . . . . 74.230000000000004 111.278 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.64 ' HG3' ' HB2' ' A' ' 86' ' ' GLU . 8.2 tt0 -95.61 150.8 19.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.857 -0.611 . . . . 75.109999999999999 110.387 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.0 m80 -99.32 124.32 44.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.895 -0.593 . . . . 75.120000000000005 110.439 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -119.3 134.86 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.317 -0.401 . . . . 60.299999999999997 110.793 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 49.1 mmm-85 -63.18 131.52 48.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.691 -0.485 . . . . 73.299999999999997 109.691 170.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 68' ' ' VAL . 59.6 mt -70.42 -67.6 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.972 0.36 . . . . 75.230000000000004 111.972 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 34.0 p90 -101.08 25.68 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.433 . . . . 74.430000000000007 111.546 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.741 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 8.0 t70 -118.27 -67.57 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.106 -0.497 . . . . 53.030000000000001 110.454 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 78' ' ' ARG . . . 129.48 -21.69 5.07 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.131 -1.033 . . . . 54.0 113.511 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -74.08 162.97 28.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.331 0.586 . . . . 74.310000000000002 111.606 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 90' ' ' TYR . 21.3 m -124.89 153.83 42.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 44.350000000000001 109.76 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.94 -68.34 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.705 0.288 . . . . 52.409999999999997 110.555 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 30.3 mp0 -64.47 -51.75 61.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 74.010000000000005 111.925 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.27 102.08 6.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 73.120000000000005 110.99 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -82.48 25.99 4.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.985 -0.626 . . . . 44.520000000000003 112.985 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 -14.72 46.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.069 0.462 . . . . 54.450000000000003 110.871 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 99.6 m-85 -80.91 -59.72 2.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.987 -0.551 . . . . 75.019999999999996 110.859 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 p 45.55 73.72 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.606 0.717 . . . . 74.420000000000002 110.742 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.58 157.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 75.239999999999995 111.751 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.71 116.38 29.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.506 -0.77 . . . . 63.340000000000003 110.825 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.37 86.89 3.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 73.200000000000003 110.046 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -71.75 170.27 13.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.822 -0.626 . . . . 72.420000000000002 111.202 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -83.48 135.29 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.146 -0.479 . . . . 33.219999999999999 110.367 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.996 HG22 HG22 ' A' ' 106' ' ' ILE . 63.9 p -124.82 127.19 46.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.281 -0.872 . . . . 72.150000000000006 109.535 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 4.5 pt20 -118.5 139.19 51.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.524 0.678 . . . . 74.230000000000004 111.102 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 10' ' ' LEU . 45.4 t -108.6 88.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.027 -0.988 . . . . 73.019999999999996 109.133 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -88.31 -23.44 23.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 73.439999999999998 110.562 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.452 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 68.8 m-20 -145.71 -154.8 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.802 -0.814 . . . . 72.219999999999999 108.802 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 101' ' ' ASN . . . -74.03 -1.34 59.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.835 -0.698 . . . . 72.340000000000003 112.288 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 3.8 m-20 -113.61 158.82 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.087 -0.338 . . . . 74.510000000000005 110.087 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.57 128.44 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 64.310000000000002 111.698 -176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . 18.7 mm-40 -106.19 127.57 53.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.745 -0.661 . . . . 64.420000000000002 110.414 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.996 HG22 HG22 ' A' ' 97' ' ' THR . 2.7 pp -115.49 146.47 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.473 -0.33 . . . . 72.209999999999994 110.203 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -91.25 125.63 36.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 60.420000000000002 110.799 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.6 pt -98.17 102.15 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.968 -0.56 . . . . 64.230000000000004 110.224 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 73.430000000000007 111.037 -178.621 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.987 0.422 . . . . 73.310000000000002 111.165 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -67.76 105.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 74.329999999999998 109.546 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 p -96.01 146.04 24.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.886 -0.597 . . . . 71.040000000000006 110.679 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.1 m -83.61 119.94 25.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.301 -0.409 . . . . 73.109999999999999 110.507 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 23' ' ' VAL . 46.6 t -84.91 -83.38 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 65.409999999999997 110.314 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.6 m -158.75 174.55 14.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 64.120000000000005 109.688 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -75.69 133.77 40.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.656 -0.498 . . . . 65.510000000000005 109.656 173.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.5 tp -66.74 -20.41 65.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.04 0.448 . . . . 62.049999999999997 110.994 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.1 -29.19 67.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 72.049999999999997 110.278 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.5 -25.78 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.545 -0.752 . . . . 72.239999999999995 109.8 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.77 107.89 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 72.329999999999998 110.147 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 95.3 mt -68.42 145.86 97.52 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.417 . . . . 73.329999999999998 111.8 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.1 Cg_exo -64.41 125.98 16.09 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.525 2.15 . . . . 74.209999999999994 111.656 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.72 42.86 4.98 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.864 -0.607 . . . . 71.310000000000002 112.139 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.8 p -137.95 -179.47 5.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.099 0.476 . . . . 51.25 111.632 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 31' ' ' PHE . . . -166.81 81.19 0.11 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.058 -1.217 . . . . 74.010000000000005 110.058 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 35.7 m -111.39 150.68 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.743 0.646 . . . . 63.340000000000003 112.743 -169.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.557 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.6 p -70.07 114.42 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.452 -0.795 . . . . 74.219999999999999 110.736 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.35 148.38 25.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 74.200000000000003 110.384 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -89.31 103.58 16.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 63.030000000000001 109.605 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 7' ' ' VAL . 14.5 t -116.24 99.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 71.420000000000002 110.269 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 62.72 -85.68 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.649 0.593 . . . . 75.530000000000001 111.059 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -130.13 2.66 4.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.148 0.499 . . . . 75.319999999999993 109.961 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 14.5 mm100 -105.49 137.13 43.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 73.129999999999995 111.478 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -105.07 97.83 7.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 53.219999999999999 109.679 171.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.495 HG21 ' HB1' ' A' ' 41' ' ' ALA . 1.7 mp -110.26 135.9 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 74.319999999999993 110.541 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.12 114.44 21.77 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.597 -0.52 . . . . 53.409999999999997 109.597 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.9 t -99.89 106.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.005 0.431 . . . . 73.430000000000007 110.179 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 96.6 m-85 -81.24 127.25 32.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.598 -0.728 . . . . 73.450000000000003 110.687 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -118.97 80.39 18.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.54 -0.911 . . . . 53.130000000000003 108.54 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 38' ' ' GLN . 92.7 Cg_endo -79.25 -10.72 14.89 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.77 2.313 . . . . 72.400000000000006 112.351 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -121.44 163.01 19.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.428 -0.806 . . . . 73.25 110.119 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.31 -15.56 61.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.209 0.528 . . . . 72.340000000000003 111.15 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 16.8 t70 -97.42 -156.99 0.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.348 -0.387 . . . . 75.129999999999995 110.263 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.497 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 23.7 mt-10 -89.34 13.15 14.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.599 0.36 . . . . 72.209999999999994 111.929 -171.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 36' ' ' ASP . 2.5 mp0 -74.31 94.25 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.882 -0.414 . . . . 73.439999999999998 109.882 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 27.5 m -113.74 151.92 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 111.65 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 89.4 m-85 -122.46 99.83 6.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 71.430000000000007 109.559 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -97.02 100.79 12.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.952 0.406 . . . . 64.230000000000004 110.816 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 92' ' ' VAL . 31.3 pt -132.16 156.08 42.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.894 -0.594 . . . . 64.420000000000002 110.195 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 m -76.06 52.24 0.71 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.512 -0.313 . . . . 52.520000000000003 111.622 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.489 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 65.8 t30 -90.17 78.86 6.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.514 0.673 . . . . 75.420000000000002 110.072 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -126.75 142.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.17 -0.923 . . . . 74.230000000000004 109.67 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 12.7 t70 -80.94 125.83 78.99 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.755 -0.461 . . . . 71.299999999999997 109.755 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 24.3 Cg_exo -64.1 -12.58 33.07 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.323 2.682 . . . . 53.43 113.27 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -113.44 15.07 19.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.491 0.186 . . . . 64.219999999999999 111.365 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -134.75 -33.94 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.85 0.315 . . . . 43.130000000000003 111.85 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 63.41 23.09 13.56 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.312 0.577 . . . . 54.020000000000003 110.772 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -139.31 159.32 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.131 -0.941 . . . . 65.230000000000004 108.843 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -80.83 65.44 5.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.309 0.576 . . . . 71.209999999999994 111.321 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.43 -10.61 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.524 0.678 . . . . 71.140000000000001 109.806 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 87.3 mt -86.37 6.2 31.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.968 -1.015 . . . . 70.329999999999998 108.989 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.764 ' HA ' HG21 ' A' ' 68' ' ' VAL . 4.5 m -138.94 30.3 2.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.807 -1.088 . . . . 63.219999999999999 108.302 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.602 ' HD3' ' HG3' ' A' ' 71' ' ' PRO . 18.7 ttt180 -77.85 61.07 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.421 -0.809 . . . . 75.530000000000001 111.284 -170.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.58 -44.95 3.42 Favored Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.654 -1.157 . . . . 75.140000000000001 114.311 167.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -69.14 103.36 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.319 0.58 . . . . 73.540000000000006 111.293 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.69 118.1 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 115.105 -0.952 . . . . 62.530000000000001 109.478 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.56 55.67 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.544 -0.753 . . . . 71.329999999999998 111.001 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.73 95.52 4.03 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.63 -0.878 . . . . 71.420000000000002 108.63 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' HIS . . . . . 0.704 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 32.1 t60 -84.35 89.01 7.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.985 -0.552 . . . . 75.129999999999995 109.548 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.12 -64.17 0.34 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.766 -1.106 . . . . 74.239999999999995 112.749 176.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -121.3 -33.17 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.389 0.515 . . . . 73.129999999999995 112.389 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -128.78 -172.2 2.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.655 -0.418 . . . . 62.450000000000003 111.141 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.53 117.29 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 71.439999999999998 110.213 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TRP . . . . . 0.872 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 30.3 m95 -122.48 119.8 32.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.901 -0.59 . . . . 75.010000000000005 110.297 -176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 55' ' ' SER . 12.8 p -84.15 149.77 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.282 -0.417 . . . . 72.310000000000002 110.143 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 130.68 54.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 61.43 110.526 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 57.3 p -102.76 143.4 26.54 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.14 -0.482 . . . . 73.439999999999998 110.291 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HG3' ' HD3' ' A' ' 56' ' ' ARG . 60.3 Cg_endo -73.19 -2.91 12.76 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.442 2.095 . . . . 65.209999999999994 112.188 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.81 -55.82 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 73.530000000000001 110.928 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.48 -24.75 21.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.438 -0.346 . . . . 73.329999999999998 110.638 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 74.35 -31.77 0.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.252 0.834 . . . . 74.439999999999998 113.252 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -71.59 168.18 18.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 74.099999999999994 111.081 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.872 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 35.5 m80 -96.5 128.5 43.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 75.340000000000003 111.385 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 68' ' ' VAL . 54.6 m-85 -98.09 122.66 41.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.389 -0.597 . . . . 75.219999999999999 109.389 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -72.69 117.46 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.62 -0.511 . . . . 75.140000000000001 109.62 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 68' ' ' VAL . 50.1 mt -61.5 -25.33 67.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 112.149 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -89.43 -0.52 57.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.639 0.257 . . . . 73.140000000000001 111.525 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.05 -65.67 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.54 -0.464 . . . . 64.120000000000005 112.011 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 92' ' ' VAL . . . 132.62 -25.79 3.73 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.731 -0.747 . . . . 63.119999999999997 112.667 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -55.61 144.03 28.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.508 0.67 . . . . 75.140000000000001 111.784 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.8 65.04 1.8 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.0 -1.0 . . . . 73.439999999999998 110.89 -171.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 67' ' ' TRP . 35.5 tp 65.53 -87.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.719 -0.673 . . . . 74.409999999999997 111.477 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.74 -12.37 17.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 70.400000000000006 110.934 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -117.12 176.19 5.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.373 -0.376 . . . . 45.409999999999997 110.569 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.5 41.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.908 -0.877 . . . . 72.340000000000003 110.908 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.91 -45.8 78.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 53.32 111.22 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.61 80.24 1.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.167 0.508 . . . . 73.239999999999995 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -76.65 96.98 4.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.969 -0.559 . . . . 74.420000000000002 109.558 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 42' ' ' ILE . 20.0 m -82.82 165.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.719 -0.673 . . . . 64.349999999999994 110.782 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.69 125.6 45.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.706 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -94.21 96.57 9.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 61.109999999999999 109.783 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -82.91 152.0 25.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.554 -0.748 . . . . 73.239999999999995 109.681 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.74 128.75 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.236 0.541 . . . . 65.340000000000003 109.73 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.61 HG23 HG12 ' A' ' 106' ' ' ILE . 3.5 m -122.96 158.39 30.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.63 -0.714 . . . . 54.210000000000001 109.376 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -156.46 141.76 17.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.225 0.536 . . . . 74.099999999999994 110.591 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 104' ' ' VAL . 34.5 t -110.21 105.68 19.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.12 -0.945 . . . . 62.530000000000001 108.797 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.2 t -86.6 -76.31 0.36 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.371 -0.377 . . . . 72.420000000000002 111.568 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 100' ' ' THR . 1.0 OUTLIER -120.87 70.46 0.91 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.678 0.275 . . . . 60.43 110.638 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.67 -31.34 2.2 Favored Glycine 0 C--O 1.229 -0.184 0 C-N-CA 120.701 -0.762 . . . . 64.0 112.748 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -89.0 146.86 24.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.957 0.408 . . . . 55.130000000000003 110.123 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 99' ' ' VAL . 39.8 t -105.51 133.22 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.798 -0.637 . . . . 73.409999999999997 109.918 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -129.32 146.8 51.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.707 0.289 . . . . 72.510000000000005 111.072 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 97' ' ' THR . 70.9 mt -121.38 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 73.510000000000005 109.81 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.5 p -90.88 112.94 24.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.177 0.513 . . . . 31.219999999999999 110.224 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 pt -126.06 155.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.381 -0.372 . . . . 61.039999999999999 110.792 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.526 0 CA-C-N 115.882 -0.599 . . . . 71.5 109.664 173.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.482 1.153 0 CA-C-O 120.828 0.347 . . . . 74.409999999999997 110.626 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.597 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 32.7 t -115.82 -71.35 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.051 0.453 . . . . 74.430000000000007 110.329 178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -106.06 22.02 16.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.681 0.753 . . . . 73.010000000000005 110.006 179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.597 ' HD1' ' H ' ' A' ' 2' ' ' SER . 71.6 m95 -98.0 112.28 24.28 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.95 -1.023 . . . . 72.540000000000006 110.176 -176.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -99.1 137.88 36.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.174 -0.466 . . . . 73.329999999999998 110.719 -178.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 3.9 m -71.13 131.64 43.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.335 -0.393 . . . . 62.43 110.771 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.419 HG22 HD12 ' A' ' 106' ' ' ILE . 38.9 t -87.42 -70.52 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 109.911 -0.403 . . . . 62.119999999999997 109.911 177.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 95.9 m -154.41 178.54 9.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.813 -0.63 . . . . 73.400000000000006 109.782 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 43.2 mttp -78.08 144.16 36.77 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.521 -0.548 . . . . 75.340000000000003 109.521 176.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.8 tp -63.84 -37.8 88.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.188 0.518 . . . . 71.310000000000002 110.724 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -73.36 -32.93 64.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.464 -0.789 . . . . 63.109999999999999 111.157 -173.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -69.49 -16.76 63.52 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.265 -0.425 . . . . 72.239999999999995 110.497 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 43.7 mm -89.69 112.35 24.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.806 -0.442 . . . . 70.109999999999999 109.806 177.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 97.2 mt -68.12 133.67 91.66 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.123 -0.489 . . . . 74.340000000000003 111.14 -178.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -55.72 133.36 57.62 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.815 2.343 . . . . 74.040000000000006 112.169 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.09 28.0 51.0 Favored Glycine 0 N--CA 1.447 -0.587 0 CA-C-N 115.654 -0.703 . . . . 63.229999999999997 111.766 -177.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.623 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -150.24 177.08 10.27 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 121.014 -0.274 . . . . 74.219999999999999 110.619 -172.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.623 ' H ' HG22 ' A' ' 17' ' ' THR . . . 174.22 130.04 1.24 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 121.008 -0.615 . . . . 74.299999999999997 112.197 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.721 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 27.1 m -125.03 162.35 27.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.717 0.259 . . . . 72.319999999999993 110.975 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.635 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 14.7 p -87.5 144.56 26.66 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 121.171 0.51 . . . . 63.399999999999999 111.307 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -128.42 148.32 50.7 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.587 -0.733 . . . . 74.109999999999999 109.546 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -77.28 94.59 4.18 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.708 -0.849 . . . . 64.329999999999998 108.708 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.621 HG11 HD11 ' A' ' 106' ' ' ILE . 44.9 t -95.11 94.36 4.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 70.209999999999994 110.438 -178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' HB3' ' NE2' ' A' ' 25' ' ' GLN . 41.0 mm-40 64.19 -79.21 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.243 -0.89 . . . . 54.520000000000003 112.28 176.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' NE2' ' HB3' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -120.26 -21.31 7.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.475 -0.33 . . . . 70.239999999999995 111.542 -176.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -127.41 146.38 50.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.557 0.217 . . . . 72.239999999999995 111.263 -170.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -82.72 130.0 35.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.921 0.391 . . . . 72.409999999999997 110.135 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.0 mt -127.74 133.3 67.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.102 -0.499 . . . . 62.240000000000002 110.331 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -103.78 140.83 37.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.118 -0.492 . . . . 70.150000000000006 109.741 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 44.5 t -114.25 101.58 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 120.87 -0.332 . . . . 74.019999999999996 111.534 -174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.811 ' HZ ' HD22 ' A' ' 44' ' ' ASN . 79.8 m-85 -73.43 118.06 15.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 110.018 176.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.48 ' HG3' HG12 ' A' ' 39' ' ' VAL . 59.2 ttt180 -111.54 103.53 55.16 Favored Pre-proline 0 C--N 1.322 -0.588 0 C-N-CA 120.072 -0.651 . . . . 74.340000000000003 110.244 171.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -70.38 -55.08 0.17 Allowed 'Trans proline' 0 CA--C 1.529 0.24 0 C-N-CA 122.731 2.288 . . . . 74.25 112.233 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 62.2 mtp180 -122.97 -174.95 3.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 110.466 -177.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -79.18 12.66 2.19 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.483 0.659 . . . . 73.519999999999996 110.463 177.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -76.1 178.62 6.22 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.871 -0.604 . . . . 71.409999999999997 109.425 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -92.66 -22.78 19.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.362 -0.381 . . . . 72.430000000000007 110.229 178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -72.69 99.0 2.48 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.926 -0.579 . . . . 73.120000000000005 110.823 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.48 HG12 ' HG3' ' A' ' 32' ' ' ARG . 28.3 m -114.99 178.92 1.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.324 -0.853 . . . . 61.43 110.097 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.669 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 98.0 m-85 -126.01 101.23 6.71 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.807 0.337 . . . . 65.430000000000007 110.495 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.485 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.81 96.51 6.89 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.087 -0.506 . . . . 70.340000000000003 110.412 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.5 pt -131.34 171.7 17.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.069 -0.514 . . . . 61.439999999999998 110.562 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.555 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 69.3 m -88.62 87.22 7.19 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.821 0.343 . . . . 54.210000000000001 110.209 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.811 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 53.2 t30 -124.37 82.43 2.04 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.408 0.623 . . . . 61.439999999999998 109.885 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 45.6 mm -122.11 141.57 41.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.423 -0.808 . . . . 62.009999999999998 109.962 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.531 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 12.2 t70 -93.39 123.99 58.82 Favored Pre-proline 0 C--N 1.323 -0.566 0 N-CA-C 109.503 -0.555 . . . . 61.420000000000002 109.503 176.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 23.3 Cg_exo -64.37 -10.22 23.1 Favored 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.055 2.503 . . . . 63.509999999999998 113.488 -175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -95.08 -13.06 25.49 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.791 0.329 . . . . 61.329999999999998 110.717 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -121.57 -26.45 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 111.703 0.261 . . . . 74.409999999999997 111.703 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 68.39 12.63 8.8 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 123.773 0.671 . . . . 52.310000000000002 111.559 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.635 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -133.23 177.01 8.0 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.137 -0.483 . . . . 71.0 110.696 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.721 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 27.0 p -81.62 47.69 1.1 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.6 -0.727 . . . . 35.240000000000002 111.594 -177.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.6 m -70.22 -21.47 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.282 0.563 . . . . 73.030000000000001 109.899 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 91.0 mt -82.46 -9.15 59.55 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.149 -0.932 . . . . 72.319999999999993 110.116 176.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.616 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 14.2 m -102.62 -18.93 15.02 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.816 -0.629 . . . . 71.400000000000006 110.742 -178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -94.32 19.88 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.332 0.587 . . . . 44.0 109.967 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -81.99 -151.43 9.13 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.635 -0.712 . . . . 74.340000000000003 112.047 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 4.0 mp -90.4 103.78 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.213 0.53 . . . . 61.329999999999998 110.285 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 93.1 t -88.08 104.13 14.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.32 -0.855 . . . . 62.039999999999999 109.411 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.38 175.15 11.35 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.807 -0.633 . . . . 72.010000000000005 111.036 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -88.35 119.43 28.77 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.011 -0.541 . . . . 71.329999999999998 110.227 178.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 71.2 t60 -86.11 -33.42 20.92 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.989 0.423 . . . . 73.239999999999995 110.476 -177.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -150.89 -65.09 0.19 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.261 0.553 . . . . 51.140000000000001 109.969 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -134.29 -22.84 1.73 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.482 -0.781 . . . . 74.219999999999999 110.917 -177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -119.68 -174.59 2.78 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.96 -0.563 . . . . 63.43 110.257 -171.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.4 mt -94.09 120.09 33.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.021 0.439 . . . . 71.430000000000007 110.409 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.437 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 19.7 m95 -121.95 153.39 38.56 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.842 -0.617 . . . . 75.209999999999994 109.893 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.431 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 9.8 p -114.3 122.51 68.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.455 0.645 . . . . 73.439999999999998 110.078 174.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.52 114.37 22.49 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.74 -0.664 . . . . 71.340000000000003 109.976 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.521 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 48.2 t -63.48 128.03 92.05 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 116.099 -0.501 . . . . 33.530000000000001 110.541 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.74 -31.41 32.41 Favored 'Trans proline' 0 N--CA 1.464 -0.22 0 C-N-CA 122.585 2.19 . . . . 62.539999999999999 112.221 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.4 mt -99.86 -56.3 2.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.126 -0.488 . . . . 53.210000000000001 111.179 -177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -84.1 -19.88 33.52 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.382 -0.372 . . . . 64.120000000000005 111.449 -173.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 70' ' ' SER . 0.3 OUTLIER 72.73 -23.01 0.21 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 113.547 0.943 . . . . 75.420000000000002 113.547 172.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.648 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 28.1 mm-40 -50.04 145.88 5.33 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.619 0.247 . . . . 75.209999999999994 110.991 176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 19.0 m170 -100.18 105.66 17.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.95 0.405 . . . . 74.129999999999995 110.848 -175.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.521 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 52.3 m-85 -89.55 122.29 32.57 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.238 -0.437 . . . . 72.540000000000006 110.215 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.502 ' HE ' ' HB2' ' A' ' 81' ' ' ASP . 29.3 ttp180 -76.42 122.23 24.2 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.018 -1.104 . . . . 75.150000000000006 108.018 171.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 74.2 mt -51.41 -49.81 60.88 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 113.682 0.993 . . . . 73.209999999999994 113.682 -165.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.533 ' HB2' ' HE1' ' A' ' 40' ' ' TYR . 58.1 t80 -89.32 -2.61 58.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.982 0.42 . . . . 74.209999999999994 111.208 -175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.502 ' HB2' ' HE ' ' A' ' 78' ' ' ARG . 10.5 t70 -103.16 -60.86 1.49 Allowed 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.861 -0.336 . . . . 64.129999999999995 110.696 -175.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.68 -19.76 28.05 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.504 -0.855 . . . . 70.109999999999999 113.527 178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -75.93 157.48 33.14 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.421 0.61 . . . . 73.530000000000001 110.36 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 10.8 m -108.65 94.67 5.18 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.248 0.462 . . . . 74.209999999999994 112.248 -171.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.7 tp 62.23 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.514 0.726 . . . . 74.25 112.39 172.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -131.52 -55.8 1.01 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.967 -0.383 . . . . 72.310000000000002 109.967 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -100.34 113.74 26.7 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.122 -0.49 . . . . 74.439999999999998 110.618 -177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -83.11 69.45 3.37 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.722 -0.672 . . . . 73.340000000000003 112.914 -177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.43 7.36 45.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.073 0.464 . . . . 63.420000000000002 110.852 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -153.33 29.7 0.49 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.875 -0.602 . . . . 72.420000000000002 109.928 -177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 13.4 m -63.97 141.11 58.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.619 -0.719 . . . . 44.539999999999999 111.292 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.5 m -103.6 -178.82 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.167 -0.469 . . . . 74.430000000000007 111.246 -178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -101.2 130.87 47.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.749 0.309 . . . . 50.32 111.165 -177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -118.02 105.29 11.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.092 -0.504 . . . . 71.219999999999999 110.524 -177.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -94.86 158.27 15.56 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.677 -0.692 . . . . 73.209999999999994 109.987 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -82.94 151.22 26.01 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.797 0.332 . . . . 75.200000000000003 110.788 -177.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 1.015 HG22 HG22 ' A' ' 106' ' ' ILE . 28.6 p -134.07 151.23 51.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.961 -0.563 . . . . 65.219999999999999 111.256 -172.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.42 HE21 ' HB2' ' A' ' 98' ' ' GLN . 1.7 pt20 -135.64 157.97 45.54 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 110.04 -0.355 . . . . 74.200000000000003 110.04 173.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.5 t -115.89 108.51 25.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.963 -0.384 . . . . 70.239999999999995 109.963 177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.798 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.7 t -74.6 -75.98 0.15 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.347 -0.388 . . . . 71.519999999999996 111.294 -178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.798 ' H ' HG23 ' A' ' 100' ' ' THR . 53.3 m-80 -144.32 87.79 1.9 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.859 -0.423 . . . . 71.540000000000006 109.859 177.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.51 -1.1 45.81 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.046 -0.597 . . . . 73.239999999999995 112.907 179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -126.0 140.86 52.27 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.873 -0.417 . . . . 44.119999999999997 109.873 -178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 40.8 t -100.88 133.19 44.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.327 -0.397 . . . . 72.519999999999996 110.716 -177.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -123.38 151.59 42.4 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.093 -0.503 . . . . 55.020000000000003 110.053 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.015 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -122.29 155.44 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.66 0.267 . . . . 61.329999999999998 110.291 178.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.2 t -83.42 101.44 11.37 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.822 -0.807 . . . . 62.109999999999999 108.822 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.406 ' O ' HG13 ' A' ' 108' ' ' ILE . 24.6 pt -79.34 86.26 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.816 0.817 . . . . 64.329999999999998 112.471 -173.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -98.67 93.76 6.28 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.582 -0.895 . . . . 53.539999999999999 108.582 170.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -63.29 122.86 17.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.374 0.607 . . . . 72.329999999999998 111.147 -175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.4 m -104.79 -54.46 2.5 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.411 -0.813 . . . . 62.329999999999998 110.643 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -136.42 108.57 7.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.22 -0.445 . . . . 73.420000000000002 109.865 179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 40.4 t -104.82 128.7 58.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.09 -0.505 . . . . 54.219999999999999 110.728 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -116.78 165.87 12.8 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.061 -0.518 . . . . 71.310000000000002 110.721 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 147.89 5.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.3 -0.409 . . . . 62.340000000000003 110.379 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -66.92 147.48 53.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.789 0.328 . . . . 74.120000000000005 110.664 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 119' ' ' GLN . 9.8 p30 -85.13 148.86 25.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.973 -0.558 . . . . 75.150000000000006 110.962 -173.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.4 t -107.04 74.72 0.99 Allowed 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.162 -0.681 . . . . 43.420000000000002 109.162 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.445 ' HB2' ' OD1' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -98.13 143.71 26.76 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.229 -0.896 . . . . 74.120000000000005 110.22 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 23.3 Cg_exo -63.78 121.89 9.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.265 1.977 . . . . 71.540000000000006 111.147 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 89.9 mt -65.04 162.06 42.21 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.416 . . . . 65.549999999999997 111.113 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -48.96 125.11 12.49 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.096 2.531 . . . . 70.530000000000001 112.577 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.5 tp -97.0 129.94 44.4 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.672 -0.695 . . . . 75.349999999999994 110.138 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -70.01 135.18 49.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 111.132 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.9 m-70 -85.01 97.63 9.93 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.936 -0.575 . . . . 75.299999999999997 109.701 175.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -70.12 127.96 34.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.845 0.355 . . . . 65.230000000000004 110.339 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -56.04 130.04 42.36 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.45 -0.795 . . . . 55.32 111.908 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -98.76 119.86 38.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.59 -0.732 . . . . 72.239999999999995 109.316 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 70.15 148.56 0.08 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.859 0.724 . . . . 72.120000000000005 111.244 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 . . . . . 0 C--O 1.247 0.944 0 CA-C-O 118.39 -0.814 . . . . 71.319999999999993 109.561 174.04 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.818 ' HA ' ' HD1' ' A' ' 4' ' ' TRP . 75.8 mtp . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 121.104 0.478 . . . . 75.049999999999997 111.152 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.3 t -102.14 -51.87 3.28 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.873 -0.603 . . . . 74.040000000000006 109.752 175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -109.39 22.56 15.64 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.073 -0.512 . . . . 74.219999999999999 111.122 -178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.818 ' HD1' ' HA ' ' A' ' 1' ' ' MET . 96.5 m95 -94.88 116.15 28.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.117 -0.492 . . . . 71.140000000000001 110.277 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 27.0 m -105.13 129.05 53.62 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.318 -0.401 . . . . 74.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.809 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.5 m -70.33 115.16 9.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.217 -0.447 . . . . 53.200000000000003 110.423 178.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 26.1 t -87.36 -77.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.921 0.391 . . . . 53.109999999999999 110.747 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 83.4 m -146.59 172.91 12.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.097 -0.502 . . . . 70.299999999999997 110.059 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -84.12 141.99 30.69 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.333 -0.394 . . . . 74.120000000000005 110.004 174.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.641 HD12 ' HB ' ' A' ' 13' ' ' ILE . 50.5 tp -70.69 -21.53 62.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.075 0.464 . . . . 64.150000000000006 110.841 -178.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -61.95 -34.39 76.02 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.666 -0.697 . . . . 63.32 110.733 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.63 -12.35 42.8 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.106 -0.497 . . . . 72.510000000000005 110.268 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.641 ' HB ' HD12 ' A' ' 10' ' ' LEU . 65.5 mt -82.11 111.15 18.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.193 -0.458 . . . . 71.200000000000003 110.164 178.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD12 ' H ' ' A' ' 14' ' ' LEU . 5.6 mp -56.42 130.12 75.71 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 115.675 -0.693 . . . . 73.310000000000002 112.11 -175.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 17.1 Cg_exo -67.59 121.43 8.51 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.72 2.28 . . . . 73.329999999999998 111.381 175.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.34 35.87 5.09 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.917 -0.659 . . . . 75.219999999999999 112.462 -177.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -136.14 -171.25 2.83 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 117.167 0.484 . . . . 72.0 111.328 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 168.94 96.13 0.1 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.154 -0.545 . . . . 43.109999999999999 111.887 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -133.98 165.92 30.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.52 0.16 . . . . 73.409999999999997 110.969 -179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.685 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.6 p -80.02 120.09 23.73 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.917 0.389 . . . . 74.409999999999997 111.421 -176.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -91.35 150.87 21.1 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.402 -0.592 . . . . 72.019999999999996 109.402 173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -99.77 107.44 19.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.992 0.425 . . . . 65.400000000000006 110.532 -175.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 106' ' ' ILE . 46.4 t -113.5 113.78 44.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.314 -0.624 . . . . 74.319999999999993 109.314 175.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 23' ' ' VAL . 27.5 mm-40 65.81 -85.2 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.677 0.611 . . . . 71.109999999999999 109.753 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -154.0 18.81 0.51 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.624 0.726 . . . . 73.200000000000003 109.302 167.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -101.82 128.87 47.99 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 114.864 -1.062 . . . . 74.25 109.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.658 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 48.9 mt-30 -101.46 130.32 47.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.189 0.519 . . . . 34.509999999999998 111.243 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.426 ' O ' HD12 ' A' ' 28' ' ' ILE . 1.2 pp -127.63 129.85 70.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.881 -0.599 . . . . 72.319999999999993 110.313 174.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -85.73 113.7 22.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.989 -0.55 . . . . 74.310000000000002 109.916 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.575 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 37.9 t -97.16 98.29 7.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.228 0.537 . . . . 73.0 110.27 -175.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 69.9 m-85 -81.6 126.5 31.81 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.185 -0.916 . . . . 72.209999999999994 110.59 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.59 ' HD2' HD11 ' A' ' 10' ' ' LEU . 77.1 ttt180 -120.04 78.51 24.81 Favored Pre-proline 0 C--N 1.318 -0.779 0 N-CA-C 108.8 -0.815 . . . . 74.540000000000006 108.8 170.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.725 ' HB3' HG21 ' A' ' 59' ' ' VAL . 3.6 Cg_exo -76.85 -20.03 13.64 Favored 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.98 2.454 . . . . 73.299999999999997 112.165 -174.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -104.22 153.7 20.66 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.567 -0.742 . . . . 52.329999999999998 109.641 177.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -78.19 5.74 9.59 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.551 0.691 . . . . 63.43 109.727 174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.464 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 13.6 t70 -89.56 -159.9 0.63 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.038 -0.983 . . . . 72.230000000000004 108.88 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.6 ' HA ' HD21 ' A' ' 10' ' ' LEU . 28.2 mt-10 -108.36 2.53 22.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 71.219999999999999 111.329 -175.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 28.2 tp60 -75.34 103.04 5.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 51.329999999999998 110.0 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -105.4 164.04 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.01 -0.541 . . . . 71.219999999999999 111.327 -178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 96.5 m-85 -135.61 101.94 4.95 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.693 -0.685 . . . . 65.049999999999997 110.278 177.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -100.38 95.24 6.62 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.107 0.48 . . . . 74.340000000000003 110.872 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.3 pt -115.24 164.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.973 -0.558 . . . . 74.329999999999998 110.163 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.401 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 33.2 m -81.67 66.92 7.43 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.129 0.49 . . . . 74.099999999999994 110.629 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.645 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 38.1 t-20 -92.23 92.03 8.0 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.897 -0.779 . . . . 33.240000000000002 108.897 177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.581 HD11 ' O ' ' A' ' 27' ' ' GLN . 14.5 mt -137.55 144.8 30.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.525 -0.761 . . . . 64.299999999999997 110.158 -174.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' HG22 ' A' ' 53' ' ' VAL . 2.4 p-10 -88.96 140.07 29.13 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 108.948 -0.76 . . . . 63.310000000000002 108.948 171.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 1.2 Cg_endo -83.91 15.13 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 122.477 2.118 . . . . 73.099999999999994 112.942 -177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -101.37 -56.54 2.28 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.729 0.3 . . . . 71.319999999999993 110.54 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -120.49 -2.23 10.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.287 -0.415 . . . . 75.239999999999995 110.643 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' HB3' ' OE1' ' A' ' 27' ' ' GLN . 19.5 mm-40 62.99 72.01 0.5 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.558 -0.747 . . . . 73.319999999999993 111.94 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.685 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -152.25 173.01 15.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.39 -0.823 . . . . 63.119999999999997 109.227 173.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.9 t -92.58 66.55 4.53 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.329 0.585 . . . . 73.109999999999999 109.903 -178.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.554 HG22 ' HB3' ' A' ' 46' ' ' ASP . 32.8 m -85.5 -10.57 11.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.033 -0.531 . . . . 63.219999999999999 110.273 178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 90.0 mt -86.56 9.62 17.9 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.619 -0.719 . . . . 72.430000000000007 109.766 177.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' C ' ' H ' ' A' ' 57' ' ' GLY . 40.7 t -84.37 -63.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.347 -0.842 . . . . 33.329999999999998 110.11 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.565 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 58.8 ttt180 70.47 -11.67 0.59 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.185 0.594 . . . . 72.239999999999995 111.15 178.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 55' ' ' SER . . . 77.41 5.5 85.75 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.319 -0.467 . . . . 62.450000000000003 112.244 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.7 mm -98.47 105.72 17.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.613 0.72 . . . . 65.310000000000002 110.688 -177.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.725 HG21 ' HB3' ' A' ' 33' ' ' PRO . 96.7 t -99.3 101.88 12.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 114.702 -1.135 . . . . 71.530000000000001 109.757 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -91.95 156.98 17.07 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.068 -0.515 . . . . 62.450000000000003 110.436 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -129.14 127.04 40.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.015 -0.539 . . . . 71.319999999999993 110.053 -177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -79.6 -46.05 17.98 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.583 -0.895 . . . . 72.230000000000004 108.583 176.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 177.62 -71.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.658 -1.155 . . . . 73.450000000000003 108.497 176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -101.87 -15.14 16.97 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.478 -0.783 . . . . 74.400000000000006 109.898 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -109.99 149.67 29.62 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.649 -0.705 . . . . 73.219999999999999 110.034 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.2 mt -115.16 131.02 57.06 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.847 0.356 . . . . 73.219999999999999 110.329 -175.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.845 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 35.7 m95 -127.74 119.12 25.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.398 -0.365 . . . . 64.129999999999995 110.791 -174.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.719 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -73.89 138.39 21.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.656 -0.498 . . . . 62.439999999999998 109.656 174.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.09 109.67 20.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.837 0.351 . . . . 73.420000000000002 111.123 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 39.1 m -72.85 154.02 91.11 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.095 -0.502 . . . . 61.340000000000003 111.239 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.565 ' HD3' ' HB2' ' A' ' 56' ' ' ARG . 69.6 Cg_endo -74.46 -6.0 17.69 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.044 2.496 . . . . 54.210000000000001 113.626 -176.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 9.0 mp -67.09 -75.63 0.09 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.804 0.335 . . . . 72.109999999999999 111.163 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -122.62 24.61 9.12 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.455 -0.339 . . . . 75.299999999999997 110.254 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 tttt 55.24 34.65 23.19 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.03 0.919 . . . . 75.230000000000004 109.908 -176.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.745 ' HG3' ' HE1' ' A' ' 77' ' ' PHE . 3.8 pt20 -81.29 141.13 34.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.592 -1.185 . . . . 74.239999999999995 110.693 -177.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.845 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 61.6 m80 -93.13 121.55 34.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.478 -0.783 . . . . 71.5 110.42 -176.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.745 ' HE1' ' HG3' ' A' ' 75' ' ' GLN . 7.3 m-85 -96.11 -16.83 21.31 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.478 0.547 . . . . 72.040000000000006 112.478 -177.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.734 ' HA ' ' HA ' ' A' ' 67' ' ' TRP . 5.7 ttt180 72.32 129.93 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.527 0.68 . . . . 70.329999999999998 111.18 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.719 HD21 ' HB ' ' A' ' 68' ' ' VAL . 97.4 mt -96.48 5.81 50.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.953 -0.567 . . . . 73.129999999999995 112.168 -173.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.8 t80 -90.89 -26.6 19.26 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.635 -0.426 . . . . 63.329999999999998 111.13 -175.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -160.36 -69.35 0.07 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.528 -0.306 . . . . 63.32 111.382 -178.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.494 ' HA3' ' O ' ' A' ' 92' ' ' VAL . . . 159.29 12.31 0.04 OUTLIER Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.915 -0.66 . . . . 51.399999999999999 112.621 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -82.1 96.26 7.73 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.546 -0.539 . . . . 73.5 109.546 174.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.503 ' CB ' ' HB3' ' A' ' 87' ' ' ASP . 6.8 m -79.95 161.38 25.53 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.273 -0.876 . . . . 70.430000000000007 111.504 -172.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.519 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.5 tp -90.14 -66.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.999 -0.546 . . . . 74.109999999999999 110.424 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 52.5 mp0 -86.36 -1.06 57.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.401 -0.363 . . . . 62.210000000000001 111.215 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.503 ' HB3' ' CB ' ' A' ' 84' ' ' CYS . 7.7 t70 -114.1 132.85 55.9 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.044 0.449 . . . . 41.409999999999997 111.401 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.21 15.14 3.72 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 110.684 -0.966 . . . . 72.439999999999998 110.684 172.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -112.11 -37.38 5.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.598 0.237 . . . . 74.319999999999993 111.231 -176.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -89.13 -71.72 0.59 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.51 -0.314 . . . . 74.420000000000002 110.555 179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.0 m 60.14 99.48 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 O-C-N 123.685 0.616 . . . . 65.549999999999997 111.805 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.494 ' O ' ' HA3' ' A' ' 82' ' ' GLY . 27.2 m -77.54 173.5 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 111.254 -178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -118.54 178.93 4.28 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.093 -0.503 . . . . 71.299999999999997 110.188 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.01 118.04 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.799 0.333 . . . . 72.030000000000001 110.965 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.2 m-85 -101.0 153.54 19.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.64 -0.709 . . . . 72.409999999999997 110.442 176.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.09 139.31 54.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.087 0.47 . . . . 73.219999999999999 110.973 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.492 ' OG1' ' HB3' ' A' ' 41' ' ' ALA . 2.9 m -134.4 158.85 42.8 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.566 -0.743 . . . . 70.239999999999995 109.324 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.412 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.1 pt20 -155.91 146.1 21.57 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.03 0.443 . . . . 74.400000000000006 110.422 174.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.3 t -107.0 102.06 13.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.733 -0.667 . . . . 72.239999999999995 110.126 177.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.2 m -82.11 85.06 6.83 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.349 -0.611 . . . . 63.140000000000001 109.349 175.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 72.45 -66.89 0.29 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 114.983 -1.008 . . . . 73.010000000000005 111.298 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.32 3.9 1.96 Allowed Glycine 0 C--N 1.318 -0.438 0 C-N-CA 120.915 -0.659 . . . . 71.040000000000006 112.085 178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -103.17 118.19 36.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.493 0.187 . . . . 62.439999999999998 110.715 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.5 t -84.68 115.48 26.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 109.829 -0.434 . . . . 71.219999999999999 109.829 177.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.809 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 24.2 mt-30 -123.09 134.79 54.22 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.962 -0.563 . . . . 73.420000000000002 111.113 -177.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.437 HD11 HG11 ' A' ' 23' ' ' VAL . 2.9 pp -117.7 167.18 11.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.851 -0.613 . . . . 73.540000000000006 110.665 179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.0 m -101.58 125.27 48.2 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.296 -0.411 . . . . 73.209999999999994 110.447 177.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 1.1 pp -96.17 107.02 19.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.293 0.568 . . . . 75.109999999999999 111.543 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -132.96 89.04 2.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.143 -0.48 . . . . 35.420000000000002 111.067 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -159.29 142.33 14.33 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.438 -0.578 . . . . 75.430000000000007 109.438 177.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.5 m -94.34 -10.59 32.2 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.157 -0.474 . . . . 53.329999999999998 111.34 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -90.58 93.3 9.22 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.996 0.427 . . . . 61.200000000000003 110.207 -176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.3 t -106.23 123.77 61.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.846 -0.616 . . . . 73.129999999999995 110.546 179.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -88.71 152.09 22.02 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.826 -0.625 . . . . 61.43 110.575 177.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.14 135.18 29.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.224 -0.444 . . . . 75.400000000000006 110.381 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -137.75 151.41 48.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.340000000000003 110.755 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -147.81 31.06 0.87 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.065 -0.516 . . . . 73.329999999999998 109.967 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.6 t -58.63 -53.66 55.82 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.781 -0.645 . . . . 41.310000000000002 111.601 -175.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -140.48 165.02 33.0 Favored Pre-proline 0 C--N 1.325 -0.475 0 C-N-CA 121.115 -0.234 . . . . 75.349999999999994 110.765 -177.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -70.1 137.57 34.77 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.169 1.913 . . . . 50.030000000000001 110.852 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 72.1 mt -68.47 151.36 97.28 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.466 -0.334 . . . . 42.399999999999999 110.323 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -48.0 135.8 23.64 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.834 2.356 . . . . 63.420000000000002 111.972 179.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.6 tp -75.03 97.81 3.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.111 0.481 . . . . 62.439999999999998 110.642 -175.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -101.57 125.44 48.22 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.933 -0.576 . . . . 74.349999999999994 110.129 176.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -130.18 36.27 4.02 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.152 0.501 . . . . 73.129999999999995 109.658 174.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 43.3 m170 -61.84 106.91 0.75 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 115.456 -0.793 . . . . 73.219999999999999 110.128 179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 25.2 t-80 -152.99 102.32 2.65 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.669 -0.696 . . . . 70.420000000000002 109.704 -176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 -103.55 147.87 26.65 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.974 -0.557 . . . . 71.319999999999993 111.799 -176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.2 m80 -103.32 -17.04 15.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.081 -1.081 . . . . 60.450000000000003 108.081 165.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 33.2 p-80 . . . . . 0 C--O 1.249 1.078 0 CA-C-N 114.53 -1.214 . . . . 64.329999999999998 109.02 174.72 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' ' HZ2' ' A' ' 4' ' ' TRP . 65.2 mtt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.934 -0.395 . . . . 45.109999999999999 109.934 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -122.34 -177.25 3.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.352 -0.386 . . . . 60.100000000000001 111.092 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.607 ' O ' ' HA ' ' A' ' 107' ' ' SER . 52.4 mt-30 64.36 71.53 0.47 Allowed 'General case' 0 CA--C 1.521 -0.165 0 CA-C-N 115.614 -0.721 . . . . 70.409999999999997 111.039 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.51 ' HZ2' ' HB3' ' A' ' 1' ' ' MET . 83.0 m95 -116.95 121.84 42.55 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.507 -0.769 . . . . 72.349999999999994 109.777 178.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.0 m -103.15 134.24 46.9 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.245 -0.434 . . . . 61.240000000000002 109.861 178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 44.8 m -79.53 116.78 19.94 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.788 0.328 . . . . 75.219999999999999 110.3 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.2 t -79.44 -65.62 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.246 -0.434 . . . . 34.200000000000003 110.282 -178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 8.8 t -176.68 -166.37 0.15 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.648 -0.706 . . . . 74.239999999999995 109.15 -178.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.597 ' HE2' ' HB3' ' A' ' 11' ' ' ASP . 50.2 mtpt -67.48 151.45 47.35 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.211 0.319 . . . . 75.209999999999994 111.294 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 28.9 tp -69.38 -17.26 63.66 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.777 -0.824 . . . . 74.230000000000004 108.777 169.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.597 ' HB3' ' HE2' ' A' ' 9' ' ' LYS . 4.9 t70 -93.84 -24.28 17.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.562 -1.199 . . . . 74.239999999999995 111.014 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.458 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 25.3 t70 -84.17 -26.27 28.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.912 -0.586 . . . . 71.129999999999995 110.391 -177.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.497 HD13 HG11 ' A' ' 30' ' ' VAL . 61.3 mt -82.25 111.64 18.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.839 -0.619 . . . . 72.140000000000001 109.467 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.3 mt -65.49 145.87 99.02 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.673 -0.694 . . . . 54.240000000000002 112.31 -173.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HB3' ' OD1' ' A' ' 35' ' ' ASN . 72.5 Cg_endo -77.4 153.15 30.84 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.878 2.385 . . . . 75.239999999999995 112.571 177.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 62.72 28.58 71.84 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.81 -0.632 . . . . 71.239999999999995 113.052 176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 34.4 p -143.31 -177.27 5.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 117.047 0.424 . . . . 74.239999999999995 110.817 -176.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.645 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.99 104.72 0.24 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 110.55 -1.02 . . . . 62.350000000000001 110.55 176.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 29' ' ' ALA . 31.3 m -105.27 142.14 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 112.319 0.488 . . . . 64.230000000000004 112.319 -174.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.821 ' HB3' HD12 ' A' ' 45' ' ' ILE . 3.8 p -75.51 117.13 16.96 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.98 -0.555 . . . . 64.540000000000006 110.812 175.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -115.32 143.27 45.52 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.063 -0.517 . . . . 72.319999999999993 110.429 177.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 25' ' ' GLN . 7.0 tt -84.93 92.71 8.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 64.329999999999998 108.964 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.9 t -119.68 131.09 73.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.309 -0.86 . . . . 73.439999999999998 109.267 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 67.16 16.73 10.28 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.895 0.855 . . . . 62.520000000000003 110.055 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.473 ' HA ' HD21 ' A' ' 22' ' ' LEU . 83.9 mm-40 76.3 25.91 0.97 Allowed 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.258 -1.792 . . . . 74.230000000000004 111.054 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 111' ' ' SER . 0.0 OUTLIER -136.19 167.21 21.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.083 -0.508 . . . . 75.510000000000005 109.849 177.054 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.551 ' HB3' HG13 ' A' ' 45' ' ' ILE . 24.4 mm-40 -91.87 119.35 31.57 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.047 0.451 . . . . 54.119999999999997 111.147 -178.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 73.1 mt -135.46 129.45 49.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.725 -0.67 . . . . 72.329999999999998 109.869 178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.98 134.46 34.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.496 -0.32 . . . . 63.25 110.335 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.645 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 40.4 t -110.14 111.32 35.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.986 0.422 . . . . 53.530000000000001 110.512 -179.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.832 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 8.8 m-85 -91.74 146.95 23.35 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.583 -0.735 . . . . 75.510000000000005 111.386 -176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' N ' ' HD3' ' A' ' 33' ' ' PRO . 46.9 mtp85 -140.66 55.07 5.39 Favored Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 116.045 -0.525 . . . . 74.430000000000007 111.666 169.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HG2' HD13 ' A' ' 79' ' ' LEU . 23.5 Cg_exo -63.45 -46.38 9.66 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.914 2.41 . . . . 74.549999999999997 113.077 -172.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -69.31 -29.67 67.57 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.599 -0.273 . . . . 63.229999999999997 111.623 -177.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 15' ' ' PRO . 10.6 t30 62.5 94.52 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.41 0.624 . . . . 73.200000000000003 110.029 -170.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -177.9 -127.71 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.421 -0.955 . . . . 74.340000000000003 108.421 -174.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -104.74 -9.02 18.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.929 0.395 . . . . 71.519999999999996 110.105 170.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -71.04 103.43 2.7 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.032 -0.531 . . . . 72.420000000000002 110.966 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.8 m -113.74 142.16 27.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.372 -0.831 . . . . 74.019999999999996 109.402 174.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.832 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 74.1 m-85 -128.6 104.32 7.6 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.948 -0.301 . . . . 70.230000000000004 110.637 -176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.69 103.85 13.8 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.135 0.493 . . . . 74.299999999999997 110.898 178.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.829 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.4 pt -134.9 154.16 36.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.005 -0.543 . . . . 54.329999999999998 110.056 178.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.4 m -77.95 55.13 1.39 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.262 0.553 . . . . 62.439999999999998 111.18 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.612 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 63.4 t30 -91.29 68.88 5.98 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.865 -0.791 . . . . 53.240000000000002 108.865 178.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.821 HD12 ' HB3' ' A' ' 20' ' ' CYS . 25.7 mm -122.89 138.06 54.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.105 -0.952 . . . . 72.140000000000001 110.619 -171.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.25 130.5 94.63 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.975 -0.557 . . . . 71.0 110.886 175.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -87.63 13.13 2.71 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 123.0 2.467 . . . . 74.420000000000002 113.284 -178.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -101.46 -54.85 2.67 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.591 0.234 . . . . 64.040000000000006 110.912 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -118.15 -0.66 11.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.062 0.458 . . . . 53.439999999999998 110.813 -177.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 61.69 74.48 0.44 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.231 -0.895 . . . . 64.219999999999999 111.443 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.683 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.7 151.87 27.9 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.693 -0.685 . . . . 75.230000000000004 109.651 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.8 p -83.07 83.09 7.97 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.286 0.565 . . . . 74.420000000000002 110.737 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.528 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 26.9 m -101.5 8.72 8.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.469 0.652 . . . . 73.310000000000002 109.813 176.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.5 mp -108.87 13.81 24.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.204 -0.907 . . . . 75.319999999999993 109.669 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 12.4 p -112.17 -64.67 1.26 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.613 -0.721 . . . . 73.109999999999999 111.659 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.5 ptt85 -81.32 51.06 1.55 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.005 -0.543 . . . . 74.299999999999997 111.208 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.7 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -112.06 -110.55 3.1 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.78 -0.724 . . . . 64.340000000000003 112.253 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 62.2 mt -110.84 114.04 45.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-O 121.059 0.457 . . . . 74.310000000000002 110.346 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 92.4 t -83.54 110.87 18.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.748 -0.66 . . . . 51.509999999999998 109.454 177.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.89 116.8 32.61 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.559 -0.746 . . . . 51.140000000000001 111.085 -177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -96.89 121.21 38.5 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.361 -0.607 . . . . 61.450000000000003 109.361 175.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -107.15 76.68 1.1 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.655 -0.702 . . . . 72.5 109.189 -177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 66.01 -75.21 0.05 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.488 -0.778 . . . . 72.540000000000006 111.51 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -121.93 -22.75 5.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.128 0.49 . . . . 72.319999999999993 110.37 -179.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.513 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 19.2 t0 -84.69 148.84 26.19 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.898 -0.592 . . . . 72.510000000000005 110.147 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.649 ' HB3' HD12 ' A' ' 79' ' ' LEU . 68.1 mt -117.34 115.34 25.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.279 0.561 . . . . 65.200000000000003 111.055 -175.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 38.0 m95 -117.19 163.39 16.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.371 -0.831 . . . . 73.319999999999993 110.17 -176.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.545 ' HB ' HD21 ' A' ' 79' ' ' LEU . 13.3 p -137.56 137.39 45.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 116.09 -0.505 . . . . 70.25 110.387 177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.604 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.17 132.22 56.7 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.982 -0.554 . . . . 54.350000000000001 110.452 178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 43.3 t -67.89 133.37 92.13 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.898 -0.408 . . . . 73.329999999999998 109.898 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.7 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 39.7 Cg_endo -66.37 -32.24 41.33 Favored 'Trans proline' 0 CA--C 1.527 0.147 0 C-N-CA 122.341 2.027 . . . . 73.329999999999998 112.164 -178.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 76.5 mt -100.81 -56.84 2.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.845 -0.616 . . . . 73.319999999999993 111.111 -176.25 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -79.56 -19.63 48.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.331 -0.395 . . . . 55.119999999999997 110.746 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 70' ' ' SER . 52.4 mtmt 57.37 34.8 25.21 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.505 -0.77 . . . . 74.219999999999999 112.841 175.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.435 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.6 mm-40 -82.82 139.65 33.4 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.908 -0.775 . . . . 53.210000000000001 108.908 169.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 8.7 m80 -116.17 115.83 26.73 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.103 -0.332 . . . . 75.310000000000002 110.103 -176.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.571 ' HZ ' ' HB2' ' A' ' 90' ' ' TYR . 77.6 m-85 -129.86 166.89 19.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.541 0.21 . . . . 73.109999999999999 110.631 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 61.4 mtt180 -81.26 146.53 30.38 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.9 -0.407 . . . . 71.230000000000004 109.9 171.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.649 HD12 ' HB3' ' A' ' 66' ' ' LEU . 96.0 mt -67.97 -27.47 66.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.896 0.332 . . . . 63.149999999999999 111.896 -178.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -132.59 37.22 3.5 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.81 0.3 . . . . 71.239999999999995 111.81 -174.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 20.2 t70 -148.88 -62.22 0.23 Allowed 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.932 -0.307 . . . . 71.049999999999997 111.195 -178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.46 -12.22 23.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.181 -1.009 . . . . 22.329999999999998 113.697 174.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 12.6 m-30 -75.32 160.03 30.79 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.193 0.52 . . . . 65.219999999999999 111.253 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.505 ' HB3' ' HB2' ' A' ' 87' ' ' ASP . 61.8 m -87.86 151.99 22.43 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.453 -0.794 . . . . 60.439999999999998 111.481 -174.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 64.5 tp -88.49 -58.86 2.4 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.134 -0.484 . . . . 63.399999999999999 110.324 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.562 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 16.3 mm-40 -125.53 18.84 8.09 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.742 -0.663 . . . . 71.239999999999995 109.346 -177.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.505 ' HB2' ' HB3' ' A' ' 84' ' ' CYS . 2.1 m-20 -124.07 -180.0 4.64 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.414 -0.812 . . . . 62.399999999999999 111.037 -168.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -167.81 23.72 0.11 Allowed Glycine 0 N--CA 1.446 -0.665 0 CA-C-N 115.513 -0.767 . . . . 64.230000000000004 111.277 174.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.34 -59.52 2.23 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 111.748 0.277 . . . . 51.530000000000001 111.748 -175.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.571 ' HB2' ' HZ ' ' A' ' 77' ' ' PHE . 40.3 m-85 -90.4 -76.35 0.43 Allowed 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.621 0.23 . . . . 73.329999999999998 111.621 -176.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 42.1 m 66.27 102.2 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.84 0.712 . . . . 73.439999999999998 110.333 -172.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.9 m -106.7 176.39 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.222 -0.445 . . . . 72.25 111.697 -173.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -103.08 167.64 9.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.938 -0.574 . . . . 51.329999999999998 110.916 -178.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.829 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -127.34 112.39 14.98 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-O 121.087 0.47 . . . . 63.329999999999998 110.649 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -85.98 157.31 20.15 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.734 -0.666 . . . . 74.219999999999999 110.082 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.637 ' HB3' ' HB3' ' A' ' 107' ' ' SER . 3.9 t0 -82.47 162.93 21.91 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.714 -0.476 . . . . 64.129999999999995 109.714 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.788 HG22 HG22 ' A' ' 106' ' ' ILE . 3.1 p -149.12 154.01 38.59 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 122.342 0.257 . . . . 72.329999999999998 110.831 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 98' ' ' GLN . 2.1 pt20 -154.45 153.87 32.26 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.239 0.542 . . . . 63.340000000000003 111.115 174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.6 t -123.08 83.46 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 108.735 -0.839 . . . . 73.040000000000006 108.735 173.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 t -97.25 -0.22 47.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.703 -0.68 . . . . 75.340000000000003 110.813 -174.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -161.13 -164.75 1.22 Allowed 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.785 -0.821 . . . . 73.219999999999999 108.785 -174.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -76.01 -11.38 84.8 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.59 -0.604 . . . . 73.230000000000004 111.59 175.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -108.47 152.26 24.95 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.953 -0.388 . . . . 72.329999999999998 109.953 176.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 60.6 t -99.79 136.79 29.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.005 -0.543 . . . . 73.319999999999993 110.889 -176.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -126.16 147.51 49.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 60.520000000000003 110.386 178.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.788 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -125.62 158.37 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.905 -0.589 . . . . 74.329999999999998 109.567 177.127 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.637 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 13.1 t -102.65 119.61 39.12 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.97 0.414 . . . . 51.329999999999998 109.973 -178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 67.8 mt -120.85 117.36 52.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 70.239999999999995 110.446 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.33 17.67 15.49 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.04 0.448 . . . . 73.430000000000007 111.133 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -172.67 141.91 1.14 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.44 -0.8 . . . . 64.129999999999995 109.353 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.585 ' O ' ' HG3' ' A' ' 26' ' ' GLN . 50.0 m -121.19 -72.28 0.7 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.256 0.465 . . . . 42.420000000000002 112.256 -173.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.463 ' HB3' ' O ' ' A' ' 111' ' ' SER . 30.4 t70 73.43 112.73 0.06 Allowed 'General case' 0 N--CA 1.466 0.342 0 O-C-N 124.059 0.849 . . . . 72.129999999999995 109.27 -166.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.4 t -62.47 116.61 2.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.393 0.616 . . . . 63.119999999999997 111.805 -172.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.05 94.53 5.22 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.325 -0.852 . . . . 70.5 109.182 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.8 p -92.32 103.39 14.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.084 0.945 . . . . 63.409999999999997 112.053 -173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -132.2 122.93 26.05 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.363 -1.289 . . . . 54.109999999999999 108.228 174.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -59.91 124.52 20.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.544 0.688 . . . . 72.340000000000003 111.01 -173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 50.9 m -114.85 80.77 1.46 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.64 -0.709 . . . . 52.25 110.003 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.682 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -72.55 117.2 57.02 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.43 -0.805 . . . . 73.310000000000002 109.594 178.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -62.67 111.11 1.25 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.653 2.236 . . . . 54.140000000000001 111.719 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 92.9 mt -75.91 121.65 85.44 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.213 -0.448 . . . . 74.239999999999995 110.562 -178.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 35.1 Cg_exo -60.2 118.8 5.72 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.733 2.289 . . . . 74.409999999999997 111.455 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 6.3 tt -130.54 111.79 12.58 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.559 -0.534 . . . . 75.239999999999995 109.559 -177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -119.36 141.91 48.62 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.106 -0.497 . . . . 71.099999999999994 110.137 176.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 11.7 t-160 -124.71 84.49 2.29 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.269 -0.641 . . . . 74.530000000000001 109.269 175.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -97.57 121.0 38.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.909 -0.587 . . . . 65.010000000000005 109.757 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -107.6 78.67 1.22 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.517 0.675 . . . . 62.509999999999998 109.466 175.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -118.89 86.68 2.59 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.227 -0.897 . . . . 74.230000000000004 109.43 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -132.14 133.11 43.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.154 -0.476 . . . . 75.010000000000005 110.156 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.672 -0.68 . . . . 74.519999999999996 109.821 176.334 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.6 ptm . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 120.927 0.394 . . . . 70.219999999999999 110.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m -75.02 -75.03 0.18 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.324 -0.398 . . . . 73.239999999999995 110.614 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 21.71 6.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.362 0.601 . . . . 70.430000000000007 110.545 176.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.501 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 91.8 m95 -74.44 111.14 9.32 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.51 -0.768 . . . . 74.450000000000003 110.096 176.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.423 ' O ' HD13 ' A' ' 106' ' ' ILE . 9.6 m -95.55 138.5 33.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.267 -0.424 . . . . 73.120000000000005 109.909 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.4 m -84.36 128.72 34.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.789 0.328 . . . . 54.420000000000002 110.837 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.7 t -95.92 -75.36 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.017 0.437 . . . . 53.200000000000003 110.081 176.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.0 m -151.64 -173.76 4.62 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.797 -0.638 . . . . 55.149999999999999 109.534 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.717 ' HB2' ' H ' ' A' ' 12' ' ' ASP . 86.4 mttt -78.4 164.15 25.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.752 0.311 . . . . 71.400000000000006 110.402 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.558 HD21 ' HA ' ' A' ' 37' ' ' GLU . 65.6 tp -75.4 -19.45 59.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.682 0.753 . . . . 74.230000000000004 109.046 167.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -91.51 -25.38 19.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.926 -1.034 . . . . 72.430000000000007 110.761 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.717 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 35.6 t70 -75.93 -21.56 56.94 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.444 0.64 . . . . 71.530000000000001 109.97 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.528 HD13 HG11 ' A' ' 30' ' ' VAL . 26.8 mt -97.29 104.56 16.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.378 -0.828 . . . . 51.310000000000002 109.469 176.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.4 mt -71.84 148.88 92.53 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.913 -0.585 . . . . 75.450000000000003 111.938 -173.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 31.2 Cg_exo -60.79 119.8 7.17 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.981 2.454 . . . . 73.340000000000003 112.017 175.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 102.38 33.24 4.59 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 115.96 -0.564 . . . . 53.439999999999998 112.058 -179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -133.62 176.96 8.08 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.305 0.574 . . . . 54.229999999999997 111.53 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.674 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . 177.14 91.83 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.272 -1.131 . . . . 74.120000000000005 110.272 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.659 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.1 m -121.0 151.93 24.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.659 0.614 . . . . 73.0 112.659 -172.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.694 ' HB2' ' HB3' ' A' ' 27' ' ' GLN . 3.4 p -77.63 99.12 5.66 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.743 -0.662 . . . . 53.450000000000003 111.073 176.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -80.93 127.36 32.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.896 -0.593 . . . . 53.039999999999999 109.836 176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -79.9 112.24 17.0 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.051 0.453 . . . . 53.219999999999999 109.922 -178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 61.1 t -121.08 107.55 20.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.621 -0.718 . . . . 72.409999999999997 109.622 176.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 67.11 -80.28 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.72 -0.673 . . . . 72.109999999999999 111.785 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -138.88 0.75 2.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.227 0.537 . . . . 75.329999999999998 110.162 -179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -116.02 129.83 56.54 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.886 -0.597 . . . . 75.530000000000001 111.276 -173.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.694 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 39.5 mt-30 -89.14 113.99 25.22 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.351 -0.611 . . . . 72.510000000000005 109.351 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 63.6 mt -110.09 117.71 55.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.796 -0.638 . . . . 74.010000000000005 110.625 -175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.414 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -79.97 119.51 22.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.02 -0.536 . . . . 72.319999999999993 110.119 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.674 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 18.8 t -100.91 108.16 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.268 -0.424 . . . . 74.540000000000006 109.931 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HE1' ' HB3' ' A' ' 55' ' ' SER . 33.4 m-85 -79.48 117.98 20.92 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.296 -0.411 . . . . 75.239999999999995 110.598 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.609 HH11 ' HA ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -130.83 75.57 78.5 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.578 -0.283 . . . . 72.209999999999994 110.786 177.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -86.74 -34.89 0.12 Allowed 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 123.037 2.491 . . . . 54.310000000000002 113.033 178.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -92.7 -179.67 5.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.968 0.413 . . . . 70.5 111.296 -176.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -111.28 18.88 18.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.757 -0.656 . . . . 72.109999999999999 109.852 175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.542 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 23.3 t70 -83.13 -161.73 0.53 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.099 -0.955 . . . . 75.510000000000005 109.454 -178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 10' ' ' LEU . 50.3 mt-10 -118.25 2.43 11.95 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.122 -0.361 . . . . 75.120000000000005 111.255 -179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.2 153.79 41.41 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 110.164 -0.31 . . . . 70.109999999999999 110.164 172.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 14.3 m -138.7 148.56 24.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.106 0.479 . . . . 62.340000000000003 111.598 179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -137.92 100.2 4.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.427 -0.806 . . . . 74.030000000000001 109.913 174.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.706 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -118.89 106.33 12.38 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.047 -0.524 . . . . 63.100000000000001 110.459 178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.54 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.6 pt -132.35 164.58 34.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.025 -0.534 . . . . 72.450000000000003 109.757 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' A' ' 93' ' ' ALA . 56.1 m -78.41 65.72 3.8 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.128 0.49 . . . . 35.43 110.779 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.582 ' HA ' HG11 ' A' ' 92' ' ' VAL . 64.4 t30 -97.7 75.98 2.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.427 -0.806 . . . . 74.019999999999996 108.986 178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.683 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.7 mm -125.18 137.65 56.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.628 -0.714 . . . . 64.5 111.128 -172.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -84.91 117.98 69.96 Favored Pre-proline 0 C--N 1.322 -0.595 0 N-CA-C 109.417 -0.586 . . . . 70.310000000000002 109.417 172.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.86 -0.14 9.9 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.69 2.26 . . . . 73.430000000000007 113.276 -176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -88.85 -30.72 18.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.22 0.534 . . . . 74.230000000000004 109.737 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -109.79 -19.49 13.13 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.868 -0.605 . . . . 75.129999999999995 109.933 176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 63.16 36.37 12.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 114.895 -1.048 . . . . 72.230000000000004 111.347 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -148.95 165.53 31.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 72.530000000000001 109.216 178.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.659 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 14.0 p -77.31 77.99 3.83 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.217 0.532 . . . . 53.310000000000002 111.302 -178.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -92.68 -8.3 10.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.43 0.633 . . . . 62.210000000000001 109.755 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.95 7.63 23.56 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 114.978 -1.01 . . . . 72.129999999999995 110.2 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB3' ' HE1' ' A' ' 31' ' ' PHE . 10.0 p -129.63 7.7 5.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.602 -0.726 . . . . 74.129999999999995 110.772 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 79.6 mtt180 -110.01 18.19 20.31 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.121 0.486 . . . . 71.209999999999994 110.486 -177.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.566 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -103.67 -158.93 24.71 Favored Glycine 0 N--CA 1.443 -0.877 0 C-N-CA 120.527 -0.844 . . . . 71.310000000000002 112.428 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.472 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 74.1 mt -85.86 108.02 16.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-O 120.845 0.355 . . . . 70.230000000000004 110.389 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG22 HG12 ' A' ' 68' ' ' VAL . 84.9 t -71.56 91.27 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 108.871 -0.789 . . . . 53.409999999999997 108.871 174.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.45 145.99 30.12 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.47 0.652 . . . . 53.350000000000001 111.744 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -90.41 98.2 11.64 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 115.305 -0.861 . . . . 74.409999999999997 108.725 173.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.544 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 77.5 t60 -91.64 -45.29 8.55 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.487 -1.233 . . . . 73.129999999999995 110.076 -169.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -123.68 -148.11 0.39 Allowed 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.148 -1.427 . . . . 70.019999999999996 107.148 173.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -81.98 44.25 0.83 Allowed 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.179 -0.675 . . . . 75.340000000000003 109.179 171.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.461 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 5.6 t70 -157.55 -175.44 5.39 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 109.669 -0.493 . . . . 54.240000000000002 109.669 -175.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -116.85 114.8 24.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.983 0.421 . . . . 54.219999999999999 110.312 -173.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.614 ' CZ3' ' HB2' ' A' ' 78' ' ' ARG . 46.8 m95 -122.28 127.35 49.77 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.862 -0.608 . . . . 74.200000000000003 110.243 -176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 HG22 ' A' ' 59' ' ' VAL . 15.9 m -89.13 126.46 42.13 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.363 0.601 . . . . 71.409999999999997 111.036 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.472 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -88.83 99.38 12.33 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.663 -0.699 . . . . 62.009999999999998 109.231 174.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.9 m -58.47 128.41 82.92 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.726 -0.67 . . . . 71.120000000000005 111.035 -177.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.566 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.1 Cg_endo -71.01 -36.38 7.59 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 62.130000000000003 112.324 -176.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 34.9 tp -89.73 -44.25 10.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.801 -0.636 . . . . 72.430000000000007 110.705 -177.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.423 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 27.0 mmmt -81.43 -28.68 34.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.937 -0.574 . . . . 74.019999999999996 110.638 -175.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 66.9 mttm 63.06 22.31 13.37 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.572 -0.74 . . . . 74.140000000000001 112.29 178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -117.39 161.63 19.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.884 -0.598 . . . . 71.200000000000003 109.612 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -92.64 140.33 29.65 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.553 -0.294 . . . . 74.409999999999997 110.879 -174.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.413 ' HZ ' ' HD2' ' A' ' 90' ' ' TYR . 53.5 m-85 -128.95 139.27 52.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.079 -0.341 . . . . 71.319999999999993 110.079 174.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.655 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 52.6 ttt180 -96.55 127.38 42.49 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.74 -0.466 . . . . 74.519999999999996 109.74 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 78.6 mt -57.45 -60.59 3.43 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.66 0.6 . . . . 64.129999999999995 111.403 -175.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.4 t80 -97.56 77.25 2.58 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.124 0.488 . . . . 74.519999999999996 109.836 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.655 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 22.6 t70 -178.2 -58.87 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.197 -0.91 . . . . 72.430000000000007 109.881 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . 102.97 -16.35 54.38 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.672 -0.775 . . . . 71.099999999999994 113.395 175.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.403 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 81.8 m-85 -85.83 162.42 18.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 117.052 0.426 . . . . 74.239999999999995 111.452 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -96.17 40.57 1.12 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.648 -0.705 . . . . 61.420000000000002 111.27 -174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.914 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.4 tp 60.5 -83.97 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.02 0.528 . . . . 74.150000000000006 111.859 -178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.914 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 43.4 mt-10 -110.73 -17.83 13.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.337 -0.392 . . . . 63.439999999999998 110.575 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -93.02 172.24 8.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.073 -0.512 . . . . 74.319999999999993 110.472 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -145.01 60.24 0.5 Allowed Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 111.001 -0.84 . . . . 70.120000000000005 111.001 177.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.25 -27.41 15.52 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.997 0.369 . . . . 72.5 111.997 -173.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.423 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 22.3 m-85 -132.58 -68.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.337 0.495 . . . . 72.099999999999994 112.337 -177.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 27.6 m 62.25 88.28 0.09 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.446 0.641 . . . . 73.109999999999999 109.695 -171.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.582 HG11 ' HA ' ' A' ' 44' ' ' ASN . 30.1 m -85.86 178.63 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.587 -0.733 . . . . 62.340000000000003 112.566 -169.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 43' ' ' SER . . . -89.95 169.18 11.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.735 -0.666 . . . . 72.230000000000004 111.037 -177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.74 120.17 8.46 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.839 0.352 . . . . 65.150000000000006 110.342 -176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -113.48 153.87 27.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.057 -0.519 . . . . 72.510000000000005 110.714 -178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -77.15 119.89 21.47 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.421 -0.354 . . . . 65.0 110.186 177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.845 HG22 HG22 ' A' ' 106' ' ' ILE . 77.5 p -119.73 145.06 46.88 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.114 -0.494 . . . . 74.099999999999994 110.814 -178.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -152.47 148.4 27.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.9 0.381 . . . . 75.409999999999997 111.111 178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 47.2 t -100.06 109.57 25.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.54 -0.755 . . . . 65.010000000000005 109.142 173.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.4 m -96.19 -63.26 1.16 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.176 0.512 . . . . 72.109999999999999 111.714 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -124.24 55.44 1.3 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.639 -0.709 . . . . 73.099999999999994 109.878 -177.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 76.6 -1.31 62.15 Favored Glycine 0 CA--C 1.517 0.218 0 C-N-CA 121.031 -0.604 . . . . 72.25 112.233 -176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 99' ' ' VAL . 29.9 p-10 -110.65 144.62 39.29 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.86 0.362 . . . . 72.420000000000002 110.725 -177.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 51.6 t -95.1 113.31 29.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.064 -0.516 . . . . 70.450000000000003 110.058 177.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.501 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 21.5 mt-30 -106.52 135.66 47.64 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.171 -0.468 . . . . 73.049999999999997 110.529 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.845 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -112.42 150.24 14.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.328 -0.619 . . . . 62.530000000000001 109.328 174.019 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 20.5 m -89.08 101.88 14.54 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 120.919 0.39 . . . . 74.209999999999994 110.982 -178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 47.4 mm -95.18 96.36 5.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.25 0.548 . . . . 74.310000000000002 109.676 176.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -87.13 157.14 19.45 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.554 -0.748 . . . . 74.140000000000001 110.674 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -78.13 145.08 35.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.13 0.491 . . . . 63.149999999999999 110.774 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 22.4 m -150.63 -85.87 0.08 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.696 -0.684 . . . . 75.219999999999999 109.889 -179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -177.27 -146.89 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.036 -1.098 . . . . 53.409999999999997 108.036 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.9 t 53.72 58.0 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 122.125 0.964 . . . . 62.409999999999997 110.928 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.1 83.57 1.8 Allowed 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.098 -0.956 . . . . 60.149999999999999 110.24 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.7 m -117.07 167.27 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 116.004 -0.544 . . . . 70.120000000000005 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -124.23 110.34 14.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.942 -0.572 . . . . 72.150000000000006 109.674 176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -153.23 158.73 42.14 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.81 -0.441 . . . . 70.219999999999999 109.81 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.8 m 65.69 95.66 0.05 Allowed 'General case' 0 CA--C 1.532 0.267 0 O-C-N 123.935 0.772 . . . . 51.030000000000001 111.467 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 61.32 78.44 0.31 Allowed Pre-proline 0 N--CA 1.465 0.308 0 CA-C-N 115.307 -0.861 . . . . 73.0 111.725 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -74.81 153.22 42.64 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.493 2.129 . . . . 74.230000000000004 111.975 178.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.8 mt -121.59 92.74 48.75 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.748 0.309 . . . . 64.010000000000005 111.667 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 125' ' ' HIS . 74.4 Cg_endo -76.53 175.63 11.12 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.415 2.077 . . . . 73.200000000000003 111.459 172.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 64.2 tp -67.41 -51.19 54.79 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.974 0.416 . . . . 55.329999999999998 110.93 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -90.9 136.58 32.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.207 0.527 . . . . 74.140000000000001 111.614 -175.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.44 ' CE1' ' HD2' ' A' ' 122' ' ' PRO . 92.8 m-70 -136.73 122.84 20.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.493 -0.776 . . . . 71.439999999999998 108.908 173.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -76.56 71.96 3.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.253 0.549 . . . . 72.239999999999995 110.813 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -103.22 153.93 19.87 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.991 -0.744 . . . . 75.329999999999998 108.991 173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 25.3 t-80 -145.53 113.68 6.57 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.296 0.569 . . . . 75.400000000000006 110.644 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -86.69 148.6 25.38 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.391 -0.822 . . . . 70.140000000000001 109.638 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.457 -0.783 . . . . 64.140000000000001 108.908 174.409 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.53 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 109.246 -0.65 . . . . 74.420000000000002 109.246 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.0 p -61.79 -60.97 2.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.671 0.619 . . . . 73.340000000000003 112.671 -173.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.574 ' O ' ' HA ' ' A' ' 107' ' ' SER . 3.9 pt20 -89.48 -0.86 57.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.942 0.401 . . . . 54.240000000000002 111.798 -173.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 98.5 m95 -118.27 95.02 4.7 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.909 -0.587 . . . . 75.129999999999995 109.733 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 28.3 m -92.81 135.1 34.42 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.655 -0.702 . . . . 72.120000000000005 110.84 -176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.55 HG23 ' HB3' ' A' ' 103' ' ' ASN . 85.2 m -76.49 121.35 22.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.083 -0.508 . . . . 71.439999999999998 110.585 178.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 23' ' ' VAL . 54.1 t -80.61 -69.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.985 -0.552 . . . . 61.130000000000003 110.128 178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 16.2 p -161.55 -179.46 7.33 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.702 -0.681 . . . . 64.310000000000002 110.172 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -76.12 137.6 40.21 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 120.951 0.405 . . . . 73.129999999999995 110.953 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' A' ' 37' ' ' GLU . 51.0 tp -70.94 -8.04 50.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 122.053 0.93 . . . . 74.439999999999998 109.354 174.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.33 -14.96 39.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.375 -1.284 . . . . 71.299999999999997 110.078 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -100.86 -25.4 14.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.924 -0.58 . . . . 72.5 110.513 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.22 113.5 4.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.98 -0.554 . . . . 52.509999999999998 110.674 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 93.3 mt -71.61 129.52 88.43 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 70.129999999999995 111.661 -175.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.811 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 17.0 Cg_exo -67.79 128.92 18.73 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.314 2.676 . . . . 73.150000000000006 112.48 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.03 27.7 15.57 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.963 -0.637 . . . . 74.430000000000007 112.098 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -163.45 168.73 19.86 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.574 0.226 . . . . 75.109999999999999 111.199 -176.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.87 130.35 2.16 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.445 -0.662 . . . . 74.030000000000001 111.445 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.6 m -132.51 174.72 12.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.963 0.382 . . . . 53.009999999999998 111.31 -177.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -80.63 138.92 36.45 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.867 -0.606 . . . . 71.340000000000003 111.614 -177.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -126.68 127.76 45.66 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.41 -0.814 . . . . 44.130000000000003 109.523 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 22' ' ' LEU . 1.4 tm? -84.66 100.6 11.56 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.431 -0.581 . . . . 64.200000000000003 109.431 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 7' ' ' VAL . 48.4 t -107.29 112.27 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.737 -0.665 . . . . 42.530000000000001 109.832 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 63.97 -87.11 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.775 -0.648 . . . . 74.030000000000001 110.48 -175.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -132.7 -6.51 3.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.281 0.562 . . . . 74.150000000000006 109.936 175.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.674 ' HB3' HD11 ' A' ' 28' ' ' ILE . 1.7 mm100 -89.97 138.78 31.21 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.685 -0.689 . . . . 65.239999999999995 112.023 -171.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.772 ' HB3' HG13 ' A' ' 45' ' ' ILE . 51.7 mt-30 -100.59 103.44 14.75 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.418 -0.81 . . . . 74.0 109.554 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.674 HD11 ' HB3' ' A' ' 26' ' ' GLN . 3.2 mp -119.21 142.15 35.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.246 -0.279 . . . . 64.019999999999996 110.246 -178.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -103.47 131.63 50.41 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.473 -0.566 . . . . 73.120000000000005 109.473 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 39.2 t -108.96 99.75 9.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.024 0.44 . . . . 73.049999999999997 110.456 -175.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 42.3 m-85 -75.78 125.12 28.46 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.606 -0.725 . . . . 60.229999999999997 110.507 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 66.8 ttt180 -110.78 87.35 6.68 Favored Pre-proline 0 C--N 1.316 -0.862 0 N-CA-C 108.113 -1.069 . . . . 70.519999999999996 108.113 164.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -79.89 -13.32 13.0 Favored 'Trans proline' 0 CA--C 1.517 -0.349 0 C-N-CA 122.588 2.192 . . . . 63.329999999999998 112.933 -171.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -117.21 163.37 16.4 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.864 -0.607 . . . . 73.310000000000002 110.213 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.811 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 5.5 m-20 -79.9 -1.92 41.41 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.667 0.746 . . . . 73.120000000000005 109.562 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.438 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 37.5 t70 -92.76 178.56 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.073 -0.967 . . . . 74.519999999999996 109.534 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.774 ' HB3' HD21 ' A' ' 10' ' ' LEU . 41.9 mt-10 -86.14 46.55 1.34 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.127 0.489 . . . . 61.039999999999999 111.547 -175.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -117.53 128.93 55.45 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.425 -0.583 . . . . 71.049999999999997 109.425 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.73 162.85 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.344 0.592 . . . . 64.510000000000005 112.428 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 49.0 m-85 -132.66 106.73 7.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.245 -0.889 . . . . 75.049999999999997 110.38 176.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.765 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -97.14 101.59 13.19 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.894 0.378 . . . . 73.349999999999994 111.277 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 27.6 pt -129.87 155.06 41.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.157 -0.474 . . . . 64.349999999999994 109.956 178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.2 m -90.81 85.99 6.19 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 111.94 0.348 . . . . 75.049999999999997 111.94 -172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.789 ' HB3' HG11 ' A' ' 92' ' ' VAL . 21.7 p30 -135.39 65.5 1.55 Allowed 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.855 0.836 . . . . 74.230000000000004 111.017 176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.772 HG13 ' HB3' ' A' ' 27' ' ' GLN . 10.6 mm -84.04 -15.79 11.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.316 -0.856 . . . . 73.140000000000001 111.282 -174.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.622 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 10.9 t70 66.62 121.13 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 114.939 -1.028 . . . . 74.310000000000002 110.714 -174.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.7 Cg_exo -75.01 -4.36 15.29 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.986 2.457 . . . . 64.239999999999995 113.523 -173.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.24 -31.91 11.48 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.744 0.307 . . . . 72.120000000000005 110.847 -178.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.03 -31.65 7.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.825 0.345 . . . . 71.319999999999993 110.896 -175.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 83.3 mm-40 63.71 16.61 9.86 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 115.543 -0.753 . . . . 64.519999999999996 112.412 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -130.9 23.85 4.97 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 122.159 -0.338 . . . . 54.350000000000001 111.21 -177.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.515 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 14.9 m 61.87 58.24 1.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.906 -0.588 . . . . 74.109999999999999 111.418 175.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.637 HG21 HD12 ' A' ' 72' ' ' LEU . 20.6 m -79.62 -14.11 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.301 0.572 . . . . 55.109999999999999 109.901 177.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 49.4 mt -74.78 -23.52 58.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.749 -0.834 . . . . 71.0 108.749 172.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.515 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 1.1 m -90.59 -38.27 13.26 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.231 -0.895 . . . . 71.340000000000003 110.034 178.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -80.64 29.37 0.31 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.56 -0.745 . . . . 74.439999999999998 111.112 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -98.96 -147.2 21.66 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.381 -0.688 . . . . 73.239999999999995 111.381 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.2 mm -99.45 102.18 13.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.143 0.497 . . . . 73.439999999999998 110.397 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 72.3 t -83.82 94.46 3.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.39 -0.823 . . . . 74.310000000000002 109.3 178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -113.27 179.76 3.87 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.116 -0.493 . . . . 50.009999999999998 111.267 -174.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.451 ' HG2' HD23 ' A' ' 66' ' ' LEU . 23.8 mt-10 -116.02 155.59 27.81 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.6 -0.727 . . . . 63.409999999999997 110.614 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -127.1 39.23 3.95 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.936 -1.135 . . . . 63.219999999999999 107.936 174.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.406 ' O ' ' HB3' ' A' ' 64' ' ' ASP . 78.7 mt-30 69.28 103.2 0.06 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 114.128 -1.396 . . . . 75.430000000000007 110.6 -171.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB3' ' O ' ' A' ' 63' ' ' GLN . 29.3 t70 75.8 -53.05 0.63 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 114.863 -1.062 . . . . 62.100000000000001 111.55 179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 78' ' ' ARG . 23.9 m-20 -76.2 143.88 40.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.208 0.527 . . . . 72.099999999999994 110.969 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD23 ' HG2' ' A' ' 61' ' ' GLU . 92.6 mt -103.52 120.25 40.49 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.396 -0.82 . . . . 65.120000000000005 109.768 179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.54 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 58.5 m95 -124.49 117.1 23.63 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.191 -0.459 . . . . 65.120000000000005 110.423 -177.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -93.08 130.3 42.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.018 0.437 . . . . 63.119999999999997 110.259 177.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.46 116.54 32.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.903 -0.59 . . . . 63.109999999999999 110.111 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.7 p -81.2 138.16 48.98 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.137 -0.483 . . . . 74.230000000000004 110.951 -178.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -69.03 -29.84 26.68 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.413 2.075 . . . . 65.25 112.958 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.637 HD12 HG21 ' A' ' 53' ' ' VAL . 74.8 mt -86.83 -52.21 5.62 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.877 0.37 . . . . 74.120000000000005 111.405 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -82.35 -32.48 29.29 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.426 -0.352 . . . . 74.120000000000005 110.854 -176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt 62.24 37.75 13.91 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.742 -0.663 . . . . 72.310000000000002 111.215 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.7 mt-30 -115.62 146.89 41.38 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.535 -0.757 . . . . 71.109999999999999 109.753 175.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.456 ' HB3' ' HE3' ' A' ' 67' ' ' TRP . 66.0 m80 -91.42 116.35 28.77 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.012 -0.54 . . . . 71.099999999999994 110.604 -178.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 47.9 m-85 -105.77 121.3 43.76 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.243 -0.435 . . . . 72.439999999999998 110.038 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.469 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.9 ttp180 -84.58 129.99 34.78 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.916 -0.401 . . . . 70.439999999999998 109.916 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 80.7 mt -70.07 95.34 0.96 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.296 0.569 . . . . 63.420000000000002 111.032 -178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 80.4 t80 -161.31 -58.95 0.05 Allowed 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.449 -0.945 . . . . 73.230000000000004 108.449 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' HA ' ' CB ' ' A' ' 94' ' ' ALA . 7.3 m-20 -138.23 -83.5 0.3 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.835 -1.075 . . . . 44.420000000000002 108.985 170.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 91' ' ' SER . . . -159.28 32.34 0.45 Allowed Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.596 -0.729 . . . . 55.130000000000003 111.539 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -71.25 120.24 16.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.758 0.314 . . . . 64.409999999999997 110.731 -176.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 8.6 m -100.83 141.74 33.29 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.734 -0.667 . . . . 73.329999999999998 110.099 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 53.9 tp -71.17 -64.93 0.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.307 -0.406 . . . . 73.510000000000005 111.818 -175.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.4 pm0 -85.73 -51.84 6.17 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.994 0.368 . . . . 71.030000000000001 111.994 -173.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 9.9 t70 -115.8 -151.92 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.832 -0.433 . . . . 75.150000000000006 109.832 -177.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.475 ' H ' ' CG ' ' A' ' 87' ' ' ASP . . . -172.14 48.38 0.18 Allowed Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.865 -0.894 . . . . 74.239999999999995 110.865 178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.04 -25.32 67.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.112 0.412 . . . . 21.300000000000001 112.112 -173.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -128.54 -57.98 1.19 Allowed 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 120.886 -0.326 . . . . 74.420000000000002 111.332 -178.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 49.3 m 57.05 83.01 0.11 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.479 0.657 . . . . 75.400000000000006 109.749 -173.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.789 HG11 ' HB3' ' A' ' 44' ' ' ASN . 23.3 m -70.99 166.42 2.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.019 -0.991 . . . . 74.230000000000004 112.605 -169.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.49 146.39 25.81 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 115.641 -0.709 . . . . 53.439999999999998 110.714 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.479 ' CB ' ' HA ' ' A' ' 81' ' ' ASP . . . -124.79 107.86 11.37 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.8 -0.636 . . . . 64.310000000000002 110.532 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.556 ' HE1' ' HB3' ' A' ' 109' ' ' ALA . 91.2 m-85 -84.11 144.31 29.11 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.678 -0.692 . . . . 75.409999999999997 109.463 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -70.34 136.07 49.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.781 0.324 . . . . 63.219999999999999 110.353 -178.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.801 HG22 HG22 ' A' ' 106' ' ' ILE . 79.2 p -127.77 144.46 51.08 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.169 -0.469 . . . . 64.310000000000002 110.512 -175.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.45 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 8.9 pt20 -140.11 141.8 36.11 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.193 0.52 . . . . 74.25 110.93 173.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.707 HG11 HD22 ' A' ' 10' ' ' LEU . 37.5 t -110.48 98.21 6.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.566 -0.743 . . . . 70.040000000000006 109.214 177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.0 t -128.02 -1.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 63.119999999999997 111.42 -173.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.47 ' C ' ' H ' ' A' ' 103' ' ' ASN . 8.4 t-20 -136.36 24.99 3.21 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.374 0.607 . . . . 71.530000000000001 110.222 -175.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.89 -23.32 2.61 Favored Glycine 0 C--N 1.329 0.177 0 C-N-CA 120.752 -0.737 . . . . 63.109999999999999 111.516 -175.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.55 ' HB3' HG23 ' A' ' 6' ' ' THR . 41.6 m-80 -103.57 153.82 20.17 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.362 -0.607 . . . . 73.040000000000006 109.362 176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.536 HG22 HG22 ' A' ' 99' ' ' VAL . 45.0 t -90.08 120.11 38.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.947 -0.39 . . . . 74.340000000000003 109.947 178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -114.14 127.06 55.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.2 -0.454 . . . . 62.409999999999997 109.892 -178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.801 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.21 152.98 9.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 75.150000000000006 110.977 -176.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 25.4 t -82.69 107.31 15.24 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.166 -0.679 . . . . 64.019999999999996 109.166 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.53 ' O ' HD12 ' A' ' 108' ' ' ILE . 1.7 pp -81.51 121.58 35.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.705 0.764 . . . . 73.239999999999995 112.275 -174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.556 ' HB3' ' HE1' ' A' ' 95' ' ' TYR . . . -110.29 24.41 13.03 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.396 -0.82 . . . . 74.340000000000003 108.875 173.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -74.57 141.93 44.73 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.423 -1.262 . . . . 74.0 111.212 -177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.7 m -123.75 -77.17 0.59 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.906 -0.588 . . . . 74.109999999999999 110.009 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -150.37 113.26 4.79 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 116.44 -0.346 . . . . 51.5 110.604 178.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 p -138.66 132.97 41.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.007 0.432 . . . . 74.049999999999997 110.104 176.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -99.16 95.98 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.182 -0.463 . . . . 63.109999999999999 110.333 -177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 27.3 m -78.74 168.81 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.657 -0.701 . . . . 73.099999999999994 111.103 -178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -84.47 -169.41 2.6 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.984 -0.747 . . . . 74.040000000000006 108.984 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -79.7 115.33 19.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.384 0.612 . . . . 64.409999999999997 110.337 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 t -68.97 -42.08 77.06 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.627 -0.715 . . . . 33.210000000000001 109.498 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.509 ' CD ' ' H ' ' A' ' 119' ' ' GLN . 5.1 pm0 -89.0 128.78 50.63 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.385 -0.825 . . . . 64.430000000000007 109.988 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 4.7 Cg_exo -75.73 176.77 9.57 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.976 2.451 . . . . 72.349999999999994 112.372 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -91.42 137.12 26.16 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.921 -0.581 . . . . 75.030000000000001 109.935 -179.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.44 117.77 4.72 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.534 2.156 . . . . 72.049999999999997 112.323 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 pp -87.75 165.99 14.95 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.988 -0.551 . . . . 74.209999999999994 110.665 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -118.89 135.95 54.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.887 0.375 . . . . 74.109999999999999 110.501 -179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -139.4 109.03 6.22 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.192 -0.669 . . . . 74.310000000000002 109.192 175.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -58.26 123.46 16.14 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.06 -0.518 . . . . 72.450000000000003 111.489 -176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -60.31 126.68 28.4 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.522 -0.763 . . . . 72.150000000000006 110.195 176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -96.78 109.78 22.39 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.4 0.619 . . . . 65.549999999999997 111.221 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 44.6 t-80 -147.13 142.1 26.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.033 -0.985 . . . . 63.229999999999997 108.948 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 56.9 t-80 . . . . . 0 C--O 1.245 0.846 0 CA-C-O 118.633 -0.698 . . . . 73.530000000000001 109.786 177.927 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.7 ttp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.97 0.414 . . . . 45.240000000000002 110.585 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -85.52 -158.31 0.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.006 -0.543 . . . . 73.109999999999999 110.168 176.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' OE1' ' A' ' 3' ' ' GLN . 15.6 mm-40 -70.56 77.42 0.58 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.18 0.514 . . . . 74.25 111.395 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.537 ' HB3' ' HB3' ' A' ' 105' ' ' GLN . 96.0 m95 -116.26 96.58 5.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.418 -0.81 . . . . 74.019999999999996 109.437 176.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 44.4 m -77.07 119.3 20.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.354 -0.384 . . . . 74.209999999999994 110.633 -177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.416 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 21.2 m -68.81 113.13 5.98 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.058 -0.519 . . . . 62.32 109.743 175.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.1 t -91.36 -65.25 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.169 0.509 . . . . 63.43 111.246 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.781 ' SG ' HG12 ' A' ' 13' ' ' ILE . 34.1 t -134.11 167.56 20.42 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.904 -0.589 . . . . 64.349999999999994 110.874 -172.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 11' ' ' ASP . 16.0 tptm -84.93 2.96 40.46 Favored 'General case' 0 CA--C 1.506 -0.715 0 CA-C-N 115.978 -0.555 . . . . 63.130000000000003 110.27 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.439 ' HB3' ' O ' ' A' ' 9' ' ' LYS . 67.5 tp 71.77 -40.49 0.48 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.855 -1.066 . . . . 71.109999999999999 111.018 -175.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.482 ' H ' ' C ' ' A' ' 9' ' ' LYS . 28.8 t70 -74.25 -32.56 63.0 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.374 -0.83 . . . . 71.040000000000006 111.231 -175.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -84.67 9.9 12.65 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 119.911 -0.716 . . . . 55.219999999999999 111.342 176.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.781 HG12 ' SG ' ' A' ' 8' ' ' CYS . 37.2 mm -90.55 128.93 42.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 109.719 -0.474 . . . . 63.219999999999999 109.719 170.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 83.9 mt -69.96 125.99 92.24 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 116.263 -0.426 . . . . 71.099999999999994 111.3 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -65.17 126.82 17.08 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.837 2.358 . . . . 45.420000000000002 112.459 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.19 30.86 29.82 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.798 -0.637 . . . . 70.299999999999997 111.553 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.503 HG22 ' H ' ' A' ' 18' ' ' GLY . 0.5 OUTLIER -150.54 173.98 13.48 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.929 -0.308 . . . . 70.239999999999995 110.864 -173.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.503 ' H ' HG22 ' A' ' 17' ' ' THR . . . -148.04 142.88 10.48 Favored Glycine 0 N--CA 1.45 -0.404 0 N-CA-C 110.175 -1.17 . . . . 75.209999999999994 110.175 176.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.8 m -134.3 146.83 30.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 117.822 0.811 . . . . 73.109999999999999 112.605 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 3.5 p -75.54 111.94 11.37 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.729 -0.668 . . . . 62.310000000000002 110.713 174.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.07 109.55 20.38 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.931 -0.577 . . . . 61.100000000000001 109.878 177.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -73.15 103.15 3.79 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.298 -0.63 . . . . 75.310000000000002 109.298 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 26' ' ' GLN . 16.3 t -94.22 161.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 108.6 -0.889 . . . . 61.530000000000001 108.6 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -45.81 -53.16 10.07 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.52 0.512 . . . . 75.239999999999995 112.246 -175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -130.36 23.02 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.614 0.245 . . . . 74.129999999999995 111.226 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.423 ' HB2' ' HB ' ' A' ' 23' ' ' VAL . 20.2 mm-40 -138.4 157.63 45.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.107 0.479 . . . . 74.239999999999995 112.064 -174.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.47 ' HB3' HG13 ' A' ' 45' ' ' ILE . 50.3 mt-30 -127.6 103.31 7.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.653 -0.703 . . . . 71.340000000000003 110.461 176.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.404 ' CD1' ' HB3' ' A' ' 26' ' ' GLN . 2.8 mp -121.21 135.94 59.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.324 -0.398 . . . . 63.350000000000001 110.254 -179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.747 ' HB2' HD13 ' A' ' 45' ' ' ILE . . . -100.51 134.62 43.18 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.743 -0.465 . . . . 71.340000000000003 109.743 177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.498 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 39.8 t -111.06 108.44 25.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 120.808 -0.357 . . . . 55.140000000000001 110.343 -176.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.847 ' HZ ' ' HB3' ' A' ' 44' ' ' ASN . 2.8 m-85 -93.55 128.0 39.48 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.906 -0.588 . . . . 72.010000000000005 110.148 -178.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.522 ' HG3' HG12 ' A' ' 39' ' ' VAL . 55.3 ttt180 -119.74 86.67 35.92 Favored Pre-proline 0 C--N 1.319 -0.753 0 N-CA-C 108.765 -0.828 . . . . 62.340000000000003 108.765 172.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -59.57 -36.84 91.72 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.853 2.368 . . . . 73.450000000000003 112.166 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.503 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 49.5 mtm180 -133.24 163.96 28.14 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.596 -0.729 . . . . 62.399999999999999 109.551 179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -77.97 56.47 1.59 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.624 0.726 . . . . 65.450000000000003 110.243 -179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -132.82 -171.61 2.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.503 -0.771 . . . . 71.430000000000007 109.72 -177.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -87.6 0.04 56.19 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.217 -0.447 . . . . 73.540000000000006 111.09 -177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.99 99.33 12.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.979 0.419 . . . . 71.329999999999998 110.3 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.522 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.5 m -125.32 165.57 22.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.875 -0.602 . . . . 62.539999999999999 110.818 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -133.04 107.34 8.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.983 -0.553 . . . . 72.140000000000001 110.77 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -106.79 96.43 6.44 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.03 0.443 . . . . 74.409999999999997 110.714 178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.0 pt -133.3 164.64 34.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.996 -0.547 . . . . 74.209999999999994 109.6 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.8 m -76.89 53.83 0.96 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.043 0.449 . . . . 74.019999999999996 111.865 -177.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.847 ' HB3' ' HZ ' ' A' ' 31' ' ' PHE . 53.8 t30 -100.93 67.03 1.19 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.625 0.726 . . . . 73.530000000000001 109.294 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.747 HD13 ' HB2' ' A' ' 29' ' ' ALA . 30.8 mm -97.05 -21.05 5.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.107 -0.951 . . . . 75.540000000000006 111.555 -172.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.728 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 32.1 t0 63.2 96.97 0.04 OUTLIER Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.152 -0.931 . . . . 64.430000000000007 109.259 -170.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 90' ' ' TYR . 32.2 Cg_exo -60.31 -1.05 1.18 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 123.622 2.881 . . . . 64.420000000000002 113.57 -178.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -92.4 -15.04 27.74 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.557 0.218 . . . . 61.100000000000001 110.822 178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.497 ' O ' ' HB2' ' A' ' 50' ' ' GLN . . . -129.43 -31.02 2.08 Favored 'General case' 0 CA--C 1.528 0.123 0 N-CA-C 112.817 0.673 . . . . 63.009999999999998 112.817 -173.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 2.7 mp0 76.35 -14.14 0.84 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.017 0.747 . . . . 75.239999999999995 113.017 177.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.484 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -111.3 34.53 4.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.108 0.41 . . . . 72.310000000000002 112.108 -173.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 53.0 p 47.55 56.4 7.1 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.282 0.563 . . . . 73.150000000000006 111.584 176.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.7 m -76.44 -2.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.497 0.665 . . . . 43.439999999999998 110.133 -177.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 82.9 mt -92.58 23.36 4.08 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 115.086 -0.961 . . . . 74.430000000000007 109.583 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.565 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 77.2 p -145.12 -39.22 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 55.329999999999998 110.858 175.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 31.8 mtm180 -81.37 59.33 3.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.213 0.53 . . . . 63.229999999999997 109.685 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -152.4 -110.38 0.44 Allowed Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.401 -0.818 . . . . 63.219999999999999 111.524 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 50.5 mm -119.74 104.75 16.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.159 0.504 . . . . 73.239999999999995 110.694 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.78 101.7 8.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.141 -1.059 . . . . 75.409999999999997 108.141 174.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.22 116.19 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.913 -0.585 . . . . 73.329999999999998 112.497 -169.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -71.99 103.67 3.3 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.043 -1.095 . . . . 61.299999999999997 108.043 169.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -58.96 -57.24 13.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.869 -0.605 . . . . 54.119999999999997 110.656 -170.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -141.64 -66.81 0.41 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.731 -0.668 . . . . 73.319999999999993 109.371 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -122.08 -7.63 8.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.181 -0.918 . . . . 65.120000000000005 110.331 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.594 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.5 t70 -122.54 171.63 8.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 73.400000000000006 110.115 -173.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.8 mt -110.98 112.48 24.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.061 0.458 . . . . 73.530000000000001 110.955 -171.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.715 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 9.3 m95 -124.65 168.14 13.56 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 108.577 -0.897 . . . . 75.310000000000002 108.577 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 14.4 p -131.94 144.75 36.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.769 0.318 . . . . 61.140000000000001 110.541 178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -103.83 127.64 51.31 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.118 -0.492 . . . . 74.230000000000004 110.537 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.575 ' HB3' ' O ' ' A' ' 73' ' ' LYS . 47.5 t -90.77 132.94 33.4 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.979 -0.555 . . . . 73.150000000000006 110.427 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.9 -17.3 37.03 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.648 2.232 . . . . 71.019999999999996 112.182 176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.0 mt -89.33 -52.85 4.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.118 0.485 . . . . 52.210000000000001 109.868 179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.575 ' O ' ' HB3' ' A' ' 70' ' ' SER . 14.1 pttm -125.9 103.38 7.74 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.601 -0.727 . . . . 74.439999999999998 109.147 178.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -66.7 77.91 0.11 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.932 -1.031 . . . . 64.340000000000003 112.178 -175.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -130.72 151.37 51.24 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.534 -0.757 . . . . 64.310000000000002 109.022 176.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -88.92 93.26 9.54 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.555 0.217 . . . . 73.010000000000005 110.877 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 33.4 m-85 -78.81 121.87 25.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.656 -0.498 . . . . 71.010000000000005 109.656 178.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 49.4 ttt180 -80.04 122.65 27.02 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.867 -0.333 . . . . 74.209999999999994 110.583 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.1 -16.25 60.56 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.021 -0.536 . . . . 62.109999999999999 111.353 -176.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' H ' ' HG2' ' A' ' 78' ' ' ARG . 49.4 t80 -106.84 16.46 24.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.329 0.585 . . . . 73.329999999999998 110.558 -177.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.542 ' CB ' ' HD3' ' A' ' 78' ' ' ARG . 9.8 t70 -147.92 -65.21 0.26 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.895 0.379 . . . . 73.099999999999994 111.191 -177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 127.04 -30.03 4.22 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.037 -0.601 . . . . 41.009999999999998 111.817 -177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -71.45 153.67 42.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 64.209999999999994 110.307 179.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.616 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.3 m -100.41 29.49 4.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.262 -0.426 . . . . 73.150000000000006 111.702 -171.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 56.5 tp 53.89 -79.45 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.452 0.908 . . . . 71.019999999999996 113.452 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -73.15 -21.71 60.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.672 -0.695 . . . . 74.230000000000004 111.782 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 3.4 t70 -166.51 -160.68 0.42 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.777 -0.823 . . . . 74.319999999999993 108.777 -177.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -122.08 -155.14 9.33 Favored Glycine 0 N--CA 1.434 -1.444 0 N-CA-C 110.24 -1.144 . . . . 52.109999999999999 110.24 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . 171.39 -69.01 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.373 0.606 . . . . 75.400000000000006 110.018 -178.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD2' ' HD2' ' A' ' 47' ' ' PRO . 94.9 m-85 -147.25 108.54 4.27 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.139 -0.937 . . . . 64.329999999999998 108.687 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.9 m -56.87 105.59 0.23 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.457 -0.338 . . . . 74.310000000000002 110.456 176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 36.0 m -94.35 156.07 3.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.277 -0.419 . . . . 60.200000000000003 110.959 -178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -101.4 121.43 41.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.022 -0.535 . . . . 63.450000000000003 111.51 -177.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -94.36 94.72 8.44 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.875 -0.602 . . . . 70.299999999999997 110.057 175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -75.46 164.56 26.25 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.557 -0.747 . . . . 72.120000000000005 111.381 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.447 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 21.6 t70 -86.04 132.24 34.09 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.342 -0.614 . . . . 73.040000000000006 109.342 177.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.762 HG22 HG22 ' A' ' 106' ' ' ILE . 51.7 p -128.06 144.49 51.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.342 -0.39 . . . . 53.240000000000002 111.081 -173.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -135.42 148.77 49.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.94 0.4 . . . . 45.009999999999998 110.653 175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.48 103.11 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.915 -0.584 . . . . 71.019999999999996 109.504 175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 6.5 m -83.32 77.99 9.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.153 -0.476 . . . . 74.400000000000006 110.832 -177.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 71.83 -44.21 0.58 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.84 0.856 . . . . 64.329999999999998 112.348 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -147.06 -49.28 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.059 -0.591 . . . . 71.299999999999997 112.039 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -80.4 151.73 29.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.028 0.442 . . . . 73.420000000000002 110.855 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 52.6 t -104.94 127.38 59.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.979 -0.555 . . . . 42.509999999999998 110.457 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 23.6 mt-30 -120.47 137.22 54.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.007 -0.542 . . . . 74.099999999999994 110.483 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.762 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -113.82 149.91 16.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 110.107 -0.331 . . . . 74.439999999999998 110.107 177.599 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.7 t -84.99 105.05 15.46 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.327 -0.62 . . . . 74.099999999999994 109.327 176.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 40.9 pt -82.85 147.13 6.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.089 0.471 . . . . 74.5 111.288 -177.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -103.71 151.84 22.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.628 -0.715 . . . . 34.43 109.691 175.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -80.91 172.61 13.52 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.051 -0.351 . . . . 40.509999999999998 110.051 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 17.0 t -152.18 -60.34 0.16 Allowed 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.748 -0.381 . . . . 75.209999999999994 111.327 -175.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.0 t70 65.54 100.68 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.257 0.551 . . . . 74.430000000000007 110.448 -174.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.8 p -156.88 149.31 10.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.087 -0.506 . . . . 63.030000000000001 110.274 -176.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.08 126.73 30.71 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.837 0.351 . . . . 41.130000000000003 110.538 178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 20.7 m -70.18 155.25 7.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.15 0.5 . . . . 75.530000000000001 111.493 -177.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -78.03 125.24 29.05 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.577 -0.738 . . . . 74.239999999999995 109.954 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -60.84 128.09 34.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.336 0.588 . . . . 71.409999999999997 111.685 -178.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 14.4 t -118.16 -1.92 11.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.051 -0.522 . . . . 73.409999999999997 110.926 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.55 96.2 45.45 Favored Pre-proline 0 C--N 1.33 -0.279 0 C-N-CA 121.135 -0.226 . . . . 54.009999999999998 111.023 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.501 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 3.8 Cg_exo -77.67 125.33 7.44 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.583 2.189 . . . . 64.140000000000001 110.532 171.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 93.3 mt -96.97 105.5 24.32 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-O 120.812 0.339 . . . . 75.549999999999997 110.935 -175.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.501 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 95.3 Cg_endo -91.48 20.55 0.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 123.124 2.549 . . . . 45.530000000000001 112.18 -178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.421 ' O ' HD12 ' A' ' 123' ' ' LEU . 2.6 pp -77.42 145.77 36.98 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.308 -0.86 . . . . 74.340000000000003 109.437 176.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.21 168.38 18.96 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.454 0.645 . . . . 75.549999999999997 112.419 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -159.04 74.86 0.67 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.69 -1.141 . . . . 64.409999999999997 109.177 171.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -76.84 112.68 13.7 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.9 -0.591 . . . . 72.530000000000001 109.962 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 39.1 t-80 -104.13 137.06 42.61 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.7 -0.682 . . . . 74.329999999999998 109.918 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 33.6 m170 -72.45 130.95 41.87 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.948 -0.39 . . . . 74.040000000000006 109.948 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -91.3 -48.47 6.9 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.117 -0.697 . . . . 71.400000000000006 109.117 -178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 . . . . . 0 C--O 1.242 0.701 0 CA-C-N 115.298 -0.865 . . . . 52.119999999999997 108.689 174.149 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.57 ' N ' ' HB2' ' A' ' 4' ' ' TRP . 47.2 ttm . . . . . 0 N--CA 1.482 1.142 0 CA-C-O 120.516 0.198 . . . . 54.439999999999998 110.828 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 67.6 -75.05 0.06 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.242 0.617 . . . . 74.019999999999996 112.181 176.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 84.3 mm-40 -85.9 14.34 6.19 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.39 0.615 . . . . 75.319999999999993 110.348 -178.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.575 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 57.4 m95 -129.14 125.38 36.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.132 -0.94 . . . . 62.340000000000003 109.041 -178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.6 OUTLIER -112.62 136.18 52.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.946 0.403 . . . . 71.120000000000005 111.732 -177.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.53 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 25.9 m -67.55 114.37 6.14 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.656 -0.702 . . . . 73.310000000000002 110.873 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 106' ' ' ILE . 46.4 t -89.38 -78.33 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.077 -0.511 . . . . 75.420000000000002 111.171 -178.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.45 ' HB2' HD11 ' A' ' 13' ' ' ILE . 86.0 m -143.44 177.8 8.2 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.318 -0.401 . . . . 71.25 110.677 -176.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 13' ' ' ILE . 43.3 mtmt -84.29 117.68 23.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.582 -0.735 . . . . 72.299999999999997 110.384 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.451 ' HB2' ' CG2' ' A' ' 104' ' ' VAL . 56.9 tp -66.34 -21.13 66.24 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.408 0.623 . . . . 61.210000000000001 110.429 -179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -82.97 -13.27 56.31 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.437 -0.801 . . . . 72.310000000000002 109.794 -178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.47 -29.94 10.37 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.172 -0.922 . . . . 73.319999999999993 110.412 -178.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 9' ' ' LYS . 77.4 mt -68.67 122.03 19.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 74.200000000000003 110.741 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 6.3 mp -68.92 142.01 92.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 70.030000000000001 111.258 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.756 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 15.3 Cg_exo -69.16 142.01 49.35 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.872 2.382 . . . . 73.540000000000006 111.571 174.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.76 29.54 38.61 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.214 -0.517 . . . . 71.219999999999999 111.9 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.665 HG22 ' H ' ' A' ' 18' ' ' GLY . 2.0 m -139.54 177.81 7.67 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 110.057 -0.349 . . . . 64.120000000000005 110.057 -175.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.665 ' H ' HG22 ' A' ' 17' ' ' THR . . . 178.0 118.97 0.57 Allowed Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.657 -0.577 . . . . 40.219999999999999 111.657 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.545 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 28.1 m -129.45 156.0 41.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.926 0.363 . . . . 54.32 111.712 -176.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.775 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 4.7 p -80.42 107.95 13.64 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 121.161 0.505 . . . . 73.129999999999995 110.895 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.88 138.15 31.67 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.026 -0.534 . . . . 75.430000000000007 110.058 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 22' ' ' LEU . 2.4 tm? -82.75 100.36 10.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.217 -0.447 . . . . 70.219999999999999 109.86 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.1 t -100.32 97.85 6.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.941 -0.572 . . . . 52.020000000000003 109.52 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 64.84 -76.27 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.278 0 O-C-N 123.817 0.698 . . . . 65.200000000000003 111.719 -176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.42 HE22 ' ND2' ' A' ' 117' ' ' ASN . 3.8 pt20 -142.88 6.04 1.57 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.612 0.244 . . . . 74.549999999999997 111.132 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -115.73 145.46 42.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.464 -0.335 . . . . 75.200000000000003 111.155 -178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -105.47 126.63 52.34 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.562 -0.532 . . . . 74.510000000000005 109.562 174.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 5.0 mp -130.96 130.35 63.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.189 -0.671 . . . . 43.439999999999998 109.189 177.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -83.83 113.95 21.29 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.246 -0.434 . . . . 63.119999999999997 110.03 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.557 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 43.1 t -97.16 98.44 7.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-N 116.045 -0.525 . . . . 63.219999999999999 110.416 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.466 ' HZ ' HG21 ' A' ' 68' ' ' VAL . 18.6 m-85 -76.21 138.74 40.83 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.339 -0.846 . . . . 72.129999999999995 111.313 178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 71.6 ttt180 -123.41 76.14 53.44 Favored Pre-proline 0 C--N 1.318 -0.801 0 N-CA-C 109.121 -0.696 . . . . 74.450000000000003 109.121 164.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.39 -24.37 19.45 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.735 2.29 . . . . 75.239999999999995 111.267 -178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 34' ' ' ARG . 3.4 mmp_? -94.74 137.11 34.25 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.077 -0.965 . . . . 74.109999999999999 110.251 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.756 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 31.4 p-10 -86.94 14.04 8.04 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.354 0.597 . . . . 73.239999999999995 109.982 178.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 3.4 p-10 -113.75 -93.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.457 -0.792 . . . . 72.409999999999997 111.352 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 49.0 mt-10 -121.27 -52.64 2.05 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.963 0.727 . . . . 73.230000000000004 112.963 -174.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.419 ' HB3' ' HG3' ' A' ' 34' ' ' ARG . 57.8 tp60 -55.72 130.92 45.23 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 113.267 0.84 . . . . 71.439999999999998 113.267 -169.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 22.4 m -128.72 170.23 18.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.207 -0.906 . . . . 52.0 109.846 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -144.72 111.31 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.769 0.319 . . . . 72.129999999999995 111.686 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -96.19 103.61 15.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.873 0.368 . . . . 62.100000000000001 110.258 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' ALA . 34.1 pt -122.39 161.85 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.788 0.328 . . . . 65.549999999999997 111.353 -177.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -76.88 46.91 0.49 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 34.310000000000002 111.126 -178.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.41 ' N ' HD12 ' A' ' 45' ' ' ILE . 65.9 t30 -95.5 61.43 2.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.619 0.724 . . . . 73.319999999999993 110.776 -171.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 45' ' ' ILE . 4.2 mp -123.12 129.64 74.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.299 -0.864 . . . . 72.230000000000004 110.024 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.428 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.3 t70 -87.6 123.91 68.59 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.691 -0.485 . . . . 74.319999999999993 109.691 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 25.4 Cg_exo -63.84 -22.22 69.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.299 2.666 . . . . 73.209999999999994 113.806 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -81.76 -22.22 37.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.333 0.587 . . . . 74.430000000000007 110.465 -177.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -107.01 -20.14 13.41 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.962 -0.563 . . . . 71.209999999999994 109.851 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 59.2 28.65 18.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.82 -1.082 . . . . 62.43 109.99 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.775 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -150.83 165.52 33.31 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.136 -0.938 . . . . 75.310000000000002 109.864 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.946 ' HB2' ' HB3' ' A' ' 55' ' ' SER . 3.8 p -80.75 56.93 2.82 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.733 -0.667 . . . . 63.350000000000001 111.258 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.3 m -74.12 -9.72 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.399 0.618 . . . . 74.420000000000002 110.368 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 56.8 mt -95.0 -1.46 52.36 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.321 -0.854 . . . . 74.400000000000006 109.25 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.946 ' HB3' ' HB2' ' A' ' 52' ' ' SER . 25.9 t -113.12 -52.46 2.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.205 -0.907 . . . . 55.340000000000003 110.862 -175.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 46.5 ttt-85 -83.78 59.97 5.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.676 0.75 . . . . 64.430000000000007 109.696 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -131.65 -91.26 0.53 Allowed Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 114.835 -1.075 . . . . 30.539999999999999 111.963 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.74 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 58.9 mt -129.09 132.93 66.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 74.430000000000007 110.247 178.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.4 p -126.23 121.22 58.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 109.215 -0.661 . . . . 72.049999999999997 109.215 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -159.77 162.51 34.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.08 0.466 . . . . 65.349999999999994 111.185 -174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 61' ' ' GLU . 0.6 OUTLIER -87.15 157.15 19.43 Favored 'General case' 0 N--CA 1.439 -0.992 0 CA-C-N 115.707 -0.679 . . . . 72.409999999999997 110.263 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.507 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 82.8 t60 -131.36 96.19 3.94 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.691 -0.485 . . . . 74.329999999999998 109.691 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 73.79 -55.73 0.66 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 114.857 -1.065 . . . . 70.230000000000004 111.792 177.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -150.88 -36.38 0.14 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.966 0.412 . . . . 73.349999999999994 110.828 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 1.3 m-20 -89.24 169.84 11.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 73.439999999999998 111.542 -179.008 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 83.8 mt -108.93 123.79 49.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.492 -0.776 . . . . 73.109999999999999 109.898 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.507 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 11.8 m95 -130.84 174.94 9.47 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.204 -0.665 . . . . 63.409999999999997 109.204 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.4 p -120.09 145.28 26.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.955 -0.387 . . . . 51.219999999999999 109.955 173.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.74 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -110.02 103.54 12.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.173 0.511 . . . . 51.100000000000001 110.539 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.3 m -73.89 124.68 90.37 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.739 -0.664 . . . . 65.310000000000002 110.36 177.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 24.3 Cg_endo -61.0 -32.45 92.36 Favored 'Trans proline' 0 CA--C 1.53 0.296 0 C-N-CA 122.792 2.328 . . . . 65.140000000000001 112.874 -177.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.3 mt -89.3 -63.65 1.26 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.388 -0.369 . . . . 74.140000000000001 111.425 -177.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.817 ' HE3' ' HE2' ' A' ' 90' ' ' TYR . 73.2 mmtt -71.87 -26.55 62.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 74.319999999999993 112.022 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 62.69 15.88 8.45 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.065 0.546 . . . . 73.430000000000007 111.733 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 84' ' ' CYS . 79.6 mt-30 -80.3 141.81 35.12 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.959 -0.564 . . . . 74.310000000000002 109.625 176.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.6 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 29.1 m80 -104.57 96.44 6.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.404 -0.362 . . . . 51.219999999999999 110.246 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.46 ' HB2' HG12 ' A' ' 68' ' ' VAL . 58.9 m-85 -82.42 121.22 26.45 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.767 -0.457 . . . . 71.430000000000007 109.767 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.411 ' HD2' ' OD2' ' A' ' 65' ' ' ASP . 23.8 ttp85 -71.5 127.59 33.05 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.747 -0.834 . . . . 54.439999999999998 108.747 175.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.448 HD21 ' HB ' ' A' ' 68' ' ' VAL . 87.5 mt -72.72 67.46 0.79 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 113.059 0.763 . . . . 44.310000000000002 113.059 -167.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 t80 168.68 -52.98 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 123.975 0.91 . . . . 63.310000000000002 109.592 174.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -72.95 -44.0 61.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.736 -0.665 . . . . 73.239999999999995 111.587 -175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 105.77 -15.37 44.97 Favored Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.474 -0.87 . . . . 23.43 113.183 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -63.26 135.65 57.2 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.108 -0.331 . . . . 72.129999999999995 110.108 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 75' ' ' GLN . 2.5 m -90.54 22.59 3.38 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.022 -0.536 . . . . 72.109999999999999 111.476 -172.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp 59.41 -73.28 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.716 0.806 . . . . 62.32 112.277 -175.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -81.6 -49.99 9.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.289 0.566 . . . . 74.109999999999999 110.724 -177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -105.51 -175.53 2.82 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.513 -0.767 . . . . 70.209999999999994 110.419 -171.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -153.48 32.71 0.77 Allowed Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.824 -0.91 . . . . 43.350000000000001 110.824 178.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.04 -48.25 18.41 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.039 0.447 . . . . 74.530000000000001 110.874 -179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.817 ' HE2' ' HE3' ' A' ' 73' ' ' LYS . 56.5 m-85 -102.58 79.56 1.82 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.265 0.555 . . . . 55.43 110.037 178.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.1 m -73.18 82.72 1.32 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.627 -0.715 . . . . 61.450000000000003 109.695 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -78.69 149.69 5.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.596 -0.729 . . . . 73.209999999999994 111.753 -173.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -98.32 165.58 11.79 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.849 -0.614 . . . . 73.010000000000005 110.187 177.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.59 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -122.27 105.06 9.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.062 0.458 . . . . 61.109999999999999 110.343 -179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -84.66 129.83 34.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.865 -0.607 . . . . 62.210000000000001 110.201 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -65.9 153.89 40.77 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.766 -0.652 . . . . 74.129999999999995 110.76 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.813 HG22 HG22 ' A' ' 106' ' ' ILE . 30.8 p -133.54 133.66 42.41 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.293 -0.412 . . . . 73.120000000000005 110.931 -178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.4 pt20 -114.86 150.67 35.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.916 0.388 . . . . 75.219999999999999 110.024 173.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 28.2 t -102.98 96.14 4.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.99 -0.55 . . . . 72.299999999999997 109.922 177.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.0 m -66.99 -63.56 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.994 -0.548 . . . . 74.319999999999993 111.014 -177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 -173.75 95.67 0.1 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.607 -0.724 . . . . 73.209999999999994 109.781 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.13 -40.86 2.57 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.152 -0.547 . . . . 71.099999999999994 112.369 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -104.21 151.64 23.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 73.420000000000002 110.604 -178.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.451 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 47.9 t -101.47 135.99 35.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.943 -0.571 . . . . 60.140000000000001 110.661 -179.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 75.8 mt-30 -118.2 127.06 53.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.309 -0.405 . . . . 64.340000000000003 110.151 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.813 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -100.25 155.17 4.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.951 0.405 . . . . 63.439999999999998 110.83 -179.638 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.9 t -77.02 124.07 27.26 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.709 -0.678 . . . . 54.439999999999998 110.407 178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.1 pt -116.35 75.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.259 0.552 . . . . 74.230000000000004 110.935 177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -92.61 19.54 7.29 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.444 0.64 . . . . 74.150000000000006 110.481 177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -158.6 150.92 21.66 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.145 -0.934 . . . . 63.520000000000003 108.644 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 25.3 t -137.13 17.2 2.99 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 123.116 0.26 . . . . 74.209999999999994 110.762 -175.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 20.2 t70 53.88 84.49 0.06 Allowed 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.288 0.566 . . . . 64.430000000000007 109.637 -175.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 25.8 m -67.49 133.56 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.656 -0.702 . . . . 72.299999999999997 112.437 -170.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -151.33 -175.0 5.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.146 -0.934 . . . . 44.109999999999999 108.812 176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 7.7 p -79.14 70.02 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 122.821 1.296 . . . . 43.030000000000001 110.683 178.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 117' ' ' ASN . 25.1 t70 55.03 -158.12 0.21 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 113.224 -1.807 . . . . 74.340000000000003 110.084 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' A' ' 116' ' ' ASP . 6.9 p30 -165.59 167.96 16.84 Favored 'General case' 0 C--N 1.329 -0.323 0 O-C-N 122.053 -0.404 . . . . 54.32 110.467 -178.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.2 t -117.25 79.45 1.34 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.099 -0.704 . . . . 65.450000000000003 109.099 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 4.4 tp-100 -62.8 114.82 13.49 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 115.584 -0.735 . . . . 64.109999999999999 111.061 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 3.8 Cg_endo -85.49 106.63 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.844 2.363 . . . . 71.430000000000007 110.457 173.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -69.56 107.6 2.4 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 116.384 -0.371 . . . . 74.349999999999994 111.106 -174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 93.1 Cg_endo -88.77 146.99 5.82 Favored 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.867 2.378 . . . . 65.450000000000003 111.84 -178.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 pp -91.31 135.61 33.69 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.23 0.538 . . . . 71.329999999999998 110.178 177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 125' ' ' HIS . 0.2 OUTLIER -100.05 176.81 5.28 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.376 -0.972 . . . . 75.049999999999997 108.376 178.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.459 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 41.4 m80 -72.01 76.94 0.92 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.31 -0.996 . . . . 71.530000000000001 108.31 172.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -75.51 95.14 3.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.794 . . . . 73.140000000000001 110.736 -171.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -86.03 85.02 7.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.768 -0.651 . . . . 71.030000000000001 110.757 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -98.02 89.94 4.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.91 -0.586 . . . . 74.329999999999998 109.774 178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.2 t-160 -95.01 -49.01 5.73 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.983 -0.747 . . . . 53.240000000000002 108.983 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.1 p80 . . . . . 0 C--O 1.244 0.794 0 CA-C-N 115.456 -0.793 . . . . 73.230000000000004 109.078 173.483 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.477 0.922 0 CA-C-O 120.78 0.324 . . . . 73.319999999999993 110.189 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.7 t -89.14 -171.49 3.29 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.852 -0.613 . . . . 74.329999999999998 110.272 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -83.91 104.24 13.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.987 -0.551 . . . . 61.420000000000002 110.142 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 94.9 m95 -114.49 136.59 52.85 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.374 -0.375 . . . . 75.219999999999999 110.316 179.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.6 m -118.74 128.47 54.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.222 -0.445 . . . . 63.299999999999997 110.353 178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.611 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 6.6 m -78.14 113.7 16.33 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.175 -0.466 . . . . 54.210000000000001 110.77 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.9 t -82.11 -75.35 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.07 0.462 . . . . 75.239999999999995 109.848 177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 81.3 m -144.34 168.44 20.08 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.666 -0.697 . . . . 72.120000000000005 109.189 178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 9.8 mtmp? -91.17 165.81 13.28 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.992 -0.283 . . . . 64.140000000000001 110.578 178.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.8 tp -71.27 -7.59 47.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.496 0.665 . . . . 74.040000000000006 110.124 -178.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -92.65 -20.29 21.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.216 -0.902 . . . . 72.109999999999999 110.002 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 18.4 m-20 -83.47 -27.18 29.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.634 -0.712 . . . . 73.540000000000006 110.694 -178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 22.5 mt -91.87 136.99 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.87 -0.604 . . . . 73.239999999999995 110.572 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.44 ' HB2' HG21 ' A' ' 17' ' ' THR . 5.2 mp -91.53 149.04 38.7 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.621 -0.263 . . . . 74.040000000000006 110.977 -177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.98 121.41 8.89 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.562 2.175 . . . . 74.420000000000002 111.696 174.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.88 45.72 6.24 Favored Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.93 -0.577 . . . . 73.030000000000001 112.198 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.44 HG21 ' HB2' ' A' ' 14' ' ' LEU . 72.5 p -141.61 174.9 10.13 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-N 116.954 0.377 . . . . 63.530000000000001 111.073 -178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -164.22 110.83 0.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 110.266 -1.134 . . . . 74.049999999999997 110.266 176.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.0 m -125.78 135.8 62.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 117.265 0.533 . . . . 73.430000000000007 112.43 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.687 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 8.7 p -79.72 104.22 10.16 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-N 115.86 -0.609 . . . . 72.120000000000005 110.082 174.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -90.06 147.46 23.63 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.108 -0.496 . . . . 73.200000000000003 110.236 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -86.57 113.35 22.4 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.897 -0.779 . . . . 73.219999999999999 108.897 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.33 93.12 2.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.872 -0.603 . . . . 73.329999999999998 110.082 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 67.23 -75.57 0.06 Allowed 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 115.238 -0.892 . . . . 72.409999999999997 111.854 178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.589 ' HG2' HG12 ' A' ' 115' ' ' VAL . 18.7 mt-30 -132.26 -8.49 3.36 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.446 -0.343 . . . . 73.420000000000002 111.223 -174.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.888 HE21 ' HA ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -122.9 163.53 20.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.845 0.355 . . . . 75.420000000000002 111.46 -175.523 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -104.21 128.84 51.97 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.048 -0.524 . . . . 54.329999999999998 109.912 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 67.5 mt -127.13 119.04 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.765 -0.457 . . . . 64.329999999999998 109.765 177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.65 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -88.96 125.47 34.99 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.933 -0.576 . . . . 43.43 110.262 -178.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.528 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.1 t -107.87 105.37 18.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.166 -0.47 . . . . 73.200000000000003 110.081 -177.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' CZ ' HG21 ' A' ' 59' ' ' VAL . 63.1 t80 -91.8 130.25 37.62 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.716 -0.675 . . . . 71.340000000000003 110.352 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' HG3' HG12 ' A' ' 39' ' ' VAL . 64.2 ttt180 -131.31 100.37 16.85 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.009 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -74.45 -32.76 6.0 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.672 2.248 . . . . 54.32 113.293 -176.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -128.73 166.13 19.57 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.52 -0.309 . . . . 75.120000000000005 110.684 -176.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.4 p-10 -83.77 26.47 0.7 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.935 0.398 . . . . 63.329999999999998 111.255 -175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 37' ' ' GLU . 16.5 m-20 -113.56 -155.04 0.56 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.461 -0.336 . . . . 74.150000000000006 110.745 -178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 36' ' ' ASP . 24.4 mt-10 -84.4 -13.04 53.3 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.916 -0.583 . . . . 74.549999999999997 111.61 -172.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -73.07 100.23 2.96 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.097 0.475 . . . . 72.530000000000001 110.992 -177.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.582 HG12 ' HG3' ' A' ' 32' ' ' ARG . 27.0 m -129.95 156.4 42.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 60.509999999999998 110.159 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 80' ' ' TYR . 93.7 m-85 -131.36 102.84 6.13 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.698 0.285 . . . . 64.140000000000001 110.667 178.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.679 ' HB3' HG21 ' A' ' 97' ' ' THR . . . -102.94 96.91 7.13 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.01 0.433 . . . . 62.329999999999998 110.682 178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.596 HG13 ' HB2' ' A' ' 44' ' ' ASN . 49.3 pt -134.56 -179.63 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.187 -0.461 . . . . 51.119999999999997 110.083 -177.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 51.1 m -79.29 60.73 3.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.211 0.529 . . . . 73.319999999999993 109.911 175.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.596 ' HB2' HG13 ' A' ' 42' ' ' ILE . 2.0 t-20 -93.0 46.69 1.23 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.457 0.646 . . . . 54.439999999999998 110.644 -174.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.428 ' N ' HD12 ' A' ' 45' ' ' ILE . 3.7 mp -103.05 131.25 51.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.512 -0.767 . . . . 65.329999999999998 110.04 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 10.0 t70 -82.52 120.94 77.74 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 109.101 -0.703 . . . . 73.219999999999999 109.101 176.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.462 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 43.4 Cg_exo -57.35 -23.71 56.39 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.227 2.618 . . . . 61.25 113.678 -175.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -84.14 -20.35 32.61 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.881 0.372 . . . . 65.450000000000003 111.08 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.78 -20.57 10.56 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.99 -0.284 . . . . 71.239999999999995 111.195 -175.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 64.49 19.19 11.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.692 -0.685 . . . . 71.409999999999997 111.096 -178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.687 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -137.1 169.7 17.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.5 -0.773 . . . . 42.229999999999997 109.927 -178.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.1 p -81.42 50.66 1.5 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.682 -0.69 . . . . 74.530000000000001 111.291 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.9 m -70.66 -19.05 21.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.115 0.484 . . . . 31.23 109.91 179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 70.6 mt -62.23 -43.45 98.8 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.62 -0.718 . . . . 51.130000000000003 109.38 173.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.9 m -71.3 -23.15 61.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.441 -0.8 . . . . 71.540000000000006 111.09 -178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.1 ttt180 -98.37 20.23 12.99 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.267 0.556 . . . . 73.140000000000001 110.429 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -93.51 -149.29 24.98 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.745 -0.661 . . . . 61.020000000000003 111.636 176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.6 mp -90.26 116.32 31.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.141 0.496 . . . . 75.400000000000006 109.759 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.596 HG22 HG23 ' A' ' 68' ' ' VAL . 60.2 t -112.37 112.93 42.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.672 -0.695 . . . . 71.510000000000005 110.301 -177.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -160.6 159.07 30.07 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.974 -0.557 . . . . 53.109999999999999 110.237 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HG3' HD23 ' A' ' 66' ' ' LEU . 2.1 mp0 -76.07 163.32 27.24 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.992 0.425 . . . . 72.239999999999995 110.251 176.005 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -122.09 46.54 2.09 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.727 -0.67 . . . . 74.340000000000003 109.264 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 55.85 25.31 8.36 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.087 -0.961 . . . . 64.430000000000007 111.697 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -164.15 -55.07 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.043 -0.526 . . . . 55.310000000000002 110.777 -177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.566 ' HB3' ' NE1' ' A' ' 67' ' ' TRP . 2.3 t0 -135.83 -173.0 3.25 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.086 -0.506 . . . . 71.420000000000002 110.116 -176.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.44 ' O ' ' HA ' ' A' ' 78' ' ' ARG . 79.2 mt -107.34 110.02 21.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.149 -0.478 . . . . 73.140000000000001 109.98 -177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.566 ' CZ3' ' HB2' ' A' ' 85' ' ' LEU . 61.3 m95 -122.89 128.69 50.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.897 0.38 . . . . 71.549999999999997 111.062 -174.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.596 HG23 HG22 ' A' ' 59' ' ' VAL . 13.2 p -103.56 145.69 12.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.22 -0.445 . . . . 72.030000000000001 110.339 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.415 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -117.21 117.68 30.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.499 -0.318 . . . . 44.0 110.771 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.568 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 27.3 t -73.34 147.27 87.48 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.889 -0.596 . . . . 65.400000000000006 111.29 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.36 -20.53 24.08 Favored 'Trans proline' 0 CA--C 1.531 0.361 0 C-N-CA 122.437 2.091 . . . . 63.109999999999999 112.021 172.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 72' ' ' LEU . 4.0 mm? -98.33 -67.98 0.82 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 72.0 110.499 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -64.58 -39.23 93.35 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.036 -0.529 . . . . 73.010000000000005 111.416 178.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HA ' ' O ' ' A' ' 70' ' ' SER . 70.6 tttt 62.06 11.94 4.63 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.635 -0.711 . . . . 64.340000000000003 111.374 -179.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.486 ' HG3' ' HB2' ' A' ' 87' ' ' ASP . 21.9 mm-40 -88.65 150.04 23.22 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.386 -0.598 . . . . 64.209999999999994 109.386 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.4 m80 -89.86 121.66 32.19 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.914 0.388 . . . . 72.0 110.737 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -117.54 143.42 46.1 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 73.230000000000004 110.002 179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.794 ' HB2' ' HB3' ' A' ' 81' ' ' ASP . 46.6 mtm180 -79.61 119.68 22.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.732 -0.47 . . . . 75.409999999999997 109.732 173.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.533 HD21 ' HB ' ' A' ' 68' ' ' VAL . 92.3 mt -52.1 -55.82 18.37 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 112.811 0.671 . . . . 62.210000000000001 112.811 -173.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.407 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 46.9 p90 -90.22 15.94 9.48 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.735 0.302 . . . . 74.299999999999997 111.44 -173.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.794 ' HB3' ' HB2' ' A' ' 78' ' ' ARG . 29.5 t70 -122.52 -60.69 1.52 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.846 0.355 . . . . 45.020000000000003 111.365 -173.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.26 -22.8 14.92 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.298 -0.954 . . . . 52.310000000000002 113.289 177.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -83.36 166.21 18.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.997 0.398 . . . . 74.219999999999999 110.924 -178.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 2.8 m -112.7 166.2 11.57 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.853 -0.612 . . . . 71.150000000000006 111.634 -169.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 62.1 tp -94.89 -69.8 0.74 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.903 -0.589 . . . . 44.409999999999997 110.276 173.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -87.1 -19.51 28.44 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.314 -0.403 . . . . 74.140000000000001 110.985 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.486 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 5.1 t70 -96.59 -152.37 0.38 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.931 -0.396 . . . . 52.219999999999999 109.931 -177.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 163.27 -33.34 0.29 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.962 -0.855 . . . . 74.010000000000005 110.962 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.78 -30.25 66.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.279 -0.461 . . . . 54.43 110.803 177.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' CE1' ' HG2' ' A' ' 47' ' ' PRO . 94.7 m-85 -107.44 61.45 0.62 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.309 0.576 . . . . 70.430000000000007 110.893 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.24 121.63 33.16 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.467 -0.788 . . . . 71.329999999999998 109.385 174.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -93.88 163.73 2.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.157 0.503 . . . . 71.200000000000003 112.124 -170.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -91.53 131.22 37.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.65 -0.704 . . . . 70.430000000000007 110.961 -179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -110.9 98.73 7.78 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.88 -0.6 . . . . 71.140000000000001 110.369 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -77.63 150.88 34.56 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.591 -0.731 . . . . 63.450000000000003 110.475 178.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -74.24 122.74 23.3 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.54 -0.541 . . . . 74.420000000000002 109.54 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.92 HG22 HG22 ' A' ' 106' ' ' ILE . 69.3 p -124.7 160.88 27.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.247 -0.433 . . . . 74.030000000000001 110.589 -175.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -168.9 151.38 4.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 73.120000000000005 110.715 173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.578 ' HA ' ' O ' ' A' ' 103' ' ' ASN . 60.4 t -94.01 106.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.547 -0.751 . . . . 52.25 108.978 173.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.2 t -104.34 -34.24 8.37 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.228 0.455 . . . . 74.549999999999997 112.228 -171.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -133.03 30.81 3.93 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.235 0.541 . . . . 54.520000000000003 110.369 -178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 87.25 -0.25 85.51 Favored Glycine 0 N--CA 1.451 -0.325 0 N-CA-C 111.113 -0.795 . . . . 70.120000000000005 111.113 -174.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.0 p30 -115.09 151.47 34.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.065 -0.568 . . . . 60.020000000000003 110.318 178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.458 HG22 HG22 ' A' ' 99' ' ' VAL . 46.0 t -94.66 113.2 28.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.22 -0.446 . . . . 74.209999999999994 109.963 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 23.7 mt-30 -115.3 140.77 48.82 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.091 -0.504 . . . . 52.130000000000003 110.746 -178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.92 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -111.32 151.86 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.691 -0.686 . . . . 74.340000000000003 109.815 177.038 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.1 t -87.67 104.02 16.13 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.597 -0.89 . . . . 70.140000000000001 108.597 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.497 ' O ' HD12 ' A' ' 108' ' ' ILE . 2.3 pp -74.12 135.91 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.588 0.709 . . . . 71.120000000000005 112.439 -171.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -124.92 87.64 2.75 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.098 -0.955 . . . . 74.510000000000005 109.037 173.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -76.76 136.78 39.02 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.682 -0.69 . . . . 74.519999999999996 111.174 -175.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 16.7 m -104.96 -81.81 0.53 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.64 . . . . 73.540000000000006 109.927 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -176.04 100.6 0.07 Allowed 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 110.148 -0.315 . . . . 52.200000000000003 110.148 174.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 55.7 t -139.45 133.06 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.106 -0.497 . . . . 72.010000000000005 109.896 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.15 166.47 23.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.274 -0.421 . . . . 53.43 110.644 177.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.589 HG12 ' HG2' ' A' ' 25' ' ' GLN . 12.1 m -88.33 111.91 23.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.274 0.559 . . . . 62.229999999999997 111.548 -178.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -95.22 105.84 17.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.258 -0.428 . . . . 73.019999999999996 109.944 175.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -112.71 33.43 4.99 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.255 0.55 . . . . 71.140000000000001 109.714 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 36.7 m -59.06 -34.11 71.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.634 -0.712 . . . . 44.329999999999998 110.05 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.404 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 5.5 mp0 -88.05 117.44 68.44 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.157 -0.683 . . . . 51.030000000000001 109.157 171.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 33.8 Cg_exo -60.03 146.69 95.45 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.844 2.363 . . . . 64.239999999999995 112.793 -177.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.66 146.09 96.98 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.756 -0.656 . . . . 60.350000000000001 110.523 178.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.06 129.46 35.42 Favored 'Trans proline' 0 C--O 1.236 0.387 0 C-N-CA 122.816 2.344 . . . . 73.140000000000001 112.478 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 61.1 tp -80.44 -64.24 1.23 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.445 -0.576 . . . . 74.129999999999995 109.445 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.85 28.02 3.46 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.379 -0.828 . . . . 71.099999999999994 112.833 174.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -95.83 20.82 9.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.602 0.715 . . . . 74.530000000000001 109.219 172.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -59.21 -63.03 1.45 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 114.368 -1.287 . . . . 72.129999999999995 110.243 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 10.3 m170 64.0 177.7 0.17 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.493 -0.776 . . . . 41.43 112.106 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 58.2 m80 -100.95 122.01 42.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.031 -0.531 . . . . 74.209999999999994 110.689 -176.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -86.62 84.34 7.42 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.464 -0.569 . . . . 75.519999999999996 109.464 172.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 . . . . . 0 C--O 1.246 0.91 0 CA-C-O 118.722 -0.656 . . . . 54.420000000000002 109.689 -177.727 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 110.127 -0.323 . . . . 62.539999999999999 110.127 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.1 p -137.23 -33.55 0.74 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.303 -0.408 . . . . 74.409999999999997 111.199 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -86.82 16.84 4.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.421 -0.354 . . . . 73.25 110.831 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.465 ' CZ3' ' HG3' ' A' ' 98' ' ' GLN . 59.7 m95 -109.14 109.78 20.84 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.49 -0.323 . . . . 75.319999999999993 110.858 -175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 p -99.01 141.49 31.69 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.5 -0.318 . . . . 63.329999999999998 110.858 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 7.9 m -80.32 122.87 27.45 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.541 -0.299 . . . . 72.409999999999997 110.276 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 50.6 t -69.5 -81.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 109.883 -0.414 . . . . 73.109999999999999 109.883 178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 80.6 m -145.17 -84.17 0.13 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.112 -0.495 . . . . 60.329999999999998 109.796 174.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 60.3 mttp -151.35 151.44 31.75 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.018 0.437 . . . . 71.120000000000005 111.128 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.3 tp -84.39 -13.56 51.89 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.091 0.948 . . . . 65.519999999999996 109.138 174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -88.39 -28.34 21.01 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.585 -1.188 . . . . 75.340000000000003 110.199 -176.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -81.56 -18.75 43.8 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.72 -0.673 . . . . 73.129999999999995 111.3 -176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.451 ' CG2' ' HB2' ' A' ' 32' ' ' ARG . 48.6 mm -76.1 118.43 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.986 0.422 . . . . 62.210000000000001 110.898 -177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.7 mt -85.66 163.72 42.93 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.945 -0.57 . . . . 54.43 111.684 -175.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -61.79 125.19 16.04 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.165 2.577 . . . . 73.109999999999999 112.266 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 59.45 40.47 96.2 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 116.08 -0.509 . . . . 54.109999999999999 111.923 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.7 m -148.68 174.29 12.31 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.842 0.353 . . . . 74.129999999999995 110.422 -176.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 30' ' ' VAL . . . 166.16 165.38 23.43 Favored Glycine 0 N--CA 1.444 -0.775 0 N-CA-C 110.745 -0.942 . . . . 63.149999999999999 110.745 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.528 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 30.7 m -129.57 164.6 31.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.42 0.61 . . . . 74.030000000000001 111.652 -177.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.769 ' HB3' HD11 ' A' ' 45' ' ' ILE . 2.8 p -83.44 129.27 34.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 111.084 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -108.92 125.41 51.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.797 -0.638 . . . . 74.340000000000003 109.921 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.06 89.57 5.61 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.403 -0.591 . . . . 74.349999999999994 109.403 -177.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 47.9 t -110.8 104.39 16.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.296 -0.411 . . . . 64.319999999999993 111.151 -176.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 61.38 -83.45 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.031 0.832 . . . . 65.120000000000005 112.15 176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.73 3.69 3.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.743 0.306 . . . . 75.230000000000004 111.061 -178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.471 ' HB3' HG13 ' A' ' 28' ' ' ILE . 58.0 mm-40 -102.28 129.22 48.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.171 -0.468 . . . . 73.120000000000005 111.329 -177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 -102.73 88.2 3.15 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.926 -0.768 . . . . 74.129999999999995 108.926 172.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG13 ' HB3' ' A' ' 26' ' ' GLN . 60.3 mt -105.33 135.76 42.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.88 -0.6 . . . . 72.530000000000001 110.825 -173.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.704 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -117.99 137.16 53.06 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 110.128 -0.323 . . . . 71.549999999999997 110.128 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.69 ' O ' ' HA3' ' A' ' 18' ' ' GLY . 26.2 t -95.38 146.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.534 -0.543 . . . . 65.230000000000004 109.534 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -140.65 129.41 23.02 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.629 -0.508 . . . . 70.510000000000005 109.629 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' HG3' HG12 ' A' ' 39' ' ' VAL . 46.8 ttt180 -111.71 91.15 14.09 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 121.01 -0.276 . . . . 74.519999999999996 110.825 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.13 -55.09 0.1 Allowed 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 122.452 2.102 . . . . 73.230000000000004 113.668 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.677 ' HB2' ' OD1' ' A' ' 36' ' ' ASP . 34.3 mtm180 -89.58 -0.15 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.65 0.262 . . . . 63.409999999999997 110.926 -173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.449 ' HA ' ' HG2' ' A' ' 32' ' ' ARG . 64.5 t30 62.12 28.14 16.95 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.545 0.688 . . . . 70.510000000000005 110.895 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.677 ' OD1' ' HB2' ' A' ' 34' ' ' ARG . 6.4 p-10 -111.81 -166.71 1.1 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.254 -0.43 . . . . 64.420000000000002 110.324 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.7 mp0 -63.75 -28.3 69.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.254 -0.43 . . . . 71.230000000000004 111.633 -178.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -81.33 104.24 11.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.371 0.605 . . . . 70.120000000000005 111.433 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.535 HG12 ' HG3' ' A' ' 32' ' ' ARG . 30.9 m -105.77 158.56 6.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.459 -0.791 . . . . 73.120000000000005 109.596 173.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 72.0 m-85 -113.28 96.3 5.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.02 0.438 . . . . 72.219999999999999 110.258 -179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -93.6 93.6 8.15 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.747 -0.661 . . . . 64.540000000000006 109.429 175.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.792 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.3 pt -126.43 -172.78 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.001 -0.545 . . . . 74.129999999999995 110.678 -174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.49 47.69 0.5 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.257 -0.429 . . . . 53.32 110.284 177.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.704 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 33.8 t30 -83.12 40.3 0.69 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.271 0.558 . . . . 62.149999999999999 111.175 -170.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.769 HD11 ' HB3' ' A' ' 20' ' ' CYS . 33.4 mm -114.38 123.5 70.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.974 -0.557 . . . . 62.32 111.037 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -86.97 120.85 71.75 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.011 -0.737 . . . . 75.0 109.011 173.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.426 ' HD2' ' HE2' ' A' ' 90' ' ' TYR . 52.4 Cg_exo -56.34 -26.03 60.06 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 123.18 2.587 . . . . 41.009999999999998 113.406 -177.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -78.15 -13.79 59.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.992 0.425 . . . . 73.109999999999999 110.666 -176.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -117.44 -34.85 4.16 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.902 0.382 . . . . 65.230000000000004 110.494 -178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.896 HE21 ' HA ' ' A' ' 50' ' ' GLN . 0.0 OUTLIER 66.37 17.56 10.71 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.325 -0.852 . . . . 65.439999999999998 111.027 177.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -139.41 171.06 14.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.64 -0.709 . . . . 55.020000000000003 109.311 178.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.528 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 6.5 p -76.97 80.24 3.51 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.477 0.656 . . . . 55.119999999999997 111.282 -178.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.0 m -90.97 -20.6 6.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.864 -0.607 . . . . 72.219999999999999 110.171 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.449 HD13 ' HZ ' ' A' ' 77' ' ' PHE . 61.0 mt -86.08 -17.74 34.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.45 -0.795 . . . . 52.420000000000002 110.222 179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 49.6 m -81.56 10.66 5.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 53.5 111.093 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -149.5 31.97 0.72 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.291 0.567 . . . . 75.209999999999994 109.74 178.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -97.67 -145.58 19.25 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.293 -0.867 . . . . 75.099999999999994 112.485 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.785 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.5 mp -97.83 123.94 50.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.106 0.479 . . . . 64.25 110.992 -175.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 96.9 t -88.85 102.2 12.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.699 -0.682 . . . . 70.129999999999995 109.905 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -103.15 109.02 20.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 64.109999999999999 110.952 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -85.16 116.87 23.78 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.998 -0.546 . . . . 70.030000000000001 110.196 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 69.7 t60 -102.96 90.25 3.71 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.851 -0.426 . . . . 72.200000000000003 109.851 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 63.8 -82.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.465 -0.789 . . . . 73.129999999999995 111.787 178.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -114.19 -22.91 9.74 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.352 0.596 . . . . 73.519999999999996 110.301 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 5.9 m-20 -91.64 154.14 19.22 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.545 -0.752 . . . . 72.319999999999993 111.712 -173.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.9 mt -113.22 116.2 29.4 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.595 -0.73 . . . . 70.019999999999996 110.486 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.539 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 16.2 m95 -119.81 151.14 39.29 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.893 -0.594 . . . . 73.0 109.7 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.9 p -110.94 129.17 66.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.347 0.594 . . . . 75.0 109.724 175.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.785 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -87.94 114.27 24.39 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.626 -0.716 . . . . 71.310000000000002 110.216 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 45.4 t -62.42 116.22 21.48 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 116.058 -0.519 . . . . 71.409999999999997 109.867 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.437 ' HD2' HD23 ' A' ' 54' ' ' LEU . 45.8 Cg_endo -69.25 -8.52 23.82 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.491 2.127 . . . . 71.239999999999995 112.16 -178.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.8 mt -112.82 -50.65 2.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 72.349999999999994 111.198 -178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 22.6 mmtp -92.64 -4.61 53.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.485 -0.325 . . . . 75.099999999999994 111.447 -174.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 74' ' ' LYS . 32.2 ttmt 66.09 11.12 7.57 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.849 -0.614 . . . . 70.219999999999999 112.278 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.747 HE22 ' HB3' ' A' ' 89' ' ' ALA . 3.3 pt20 -102.36 150.71 23.07 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 122.133 -0.355 . . . . 74.049999999999997 110.697 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 76.9 m80 -106.38 107.31 18.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.28 -0.418 . . . . 74.049999999999997 110.189 -178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.772 ' HA ' ' HA ' ' A' ' 84' ' ' CYS . 16.2 p90 -111.29 142.38 43.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.289 0.566 . . . . 75.420000000000002 110.981 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.437 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 38.6 ttp180 -85.82 123.56 31.32 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.437 -0.801 . . . . 62.350000000000001 110.315 -175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 79.8 mt -50.66 -57.07 9.14 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.821 0.7 . . . . 74.310000000000002 112.497 -174.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -87.08 37.08 0.75 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.148 -0.478 . . . . 71.209999999999994 111.468 -176.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.437 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 26.4 t0 -149.92 -50.84 0.14 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.828 0.346 . . . . 75.010000000000005 110.649 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 103.93 -25.83 25.15 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.944 -0.646 . . . . 75.329999999999998 113.146 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -85.51 147.74 26.29 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.774 0.321 . . . . 74.120000000000005 110.955 -176.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.772 ' HA ' ' HA ' ' A' ' 77' ' ' PHE . 3.2 m -102.04 47.16 0.91 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.992 -0.549 . . . . 41.520000000000003 111.749 -171.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HG ' ' HG2' ' A' ' 86' ' ' GLU . 49.5 tp 57.41 -95.99 0.06 Allowed 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.062 -0.517 . . . . 50.229999999999997 112.123 177.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.597 ' HG2' ' HG ' ' A' ' 85' ' ' LEU . 6.5 mm-40 -107.23 -27.87 10.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.576 -0.284 . . . . 74.219999999999999 111.386 -174.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' CYS . 39.0 t70 -111.16 75.45 0.92 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.203 -0.666 . . . . 73.319999999999993 109.203 179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.562 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -89.06 63.55 3.45 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.407 -0.815 . . . . 74.340000000000003 113.283 -171.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.747 ' HB3' HE22 ' A' ' 75' ' ' GLN . . . -80.45 -59.03 2.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.893 0.378 . . . . 51.530000000000001 110.576 178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.426 ' HE2' ' HD2' ' A' ' 47' ' ' PRO . 29.3 m-85 -90.04 74.19 7.25 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.168 0.509 . . . . 65.129999999999995 110.323 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 100.3 3.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.497 -0.774 . . . . 62.409999999999997 109.638 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 26.7 m -88.76 167.43 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.166 -0.47 . . . . 53.109999999999999 111.125 -175.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.16 135.89 51.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.904 0.383 . . . . 40.409999999999997 110.53 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.792 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -96.86 92.33 6.08 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.935 -0.575 . . . . 45.109999999999999 109.578 179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -67.2 155.87 37.71 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.432 -0.804 . . . . 73.540000000000006 110.754 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -84.66 142.8 29.65 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.543 -0.54 . . . . 72.0 109.543 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.859 HG22 HG22 ' A' ' 106' ' ' ILE . 26.0 p -134.47 138.08 44.44 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.312 -0.404 . . . . 65.439999999999998 111.082 -174.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.465 ' HG3' ' CZ3' ' A' ' 4' ' ' TRP . 48.2 mt-30 -104.85 144.13 32.19 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.864 0.364 . . . . 63.039999999999999 110.561 173.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 34.1 t -99.6 76.9 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 108.206 -1.035 . . . . 74.099999999999994 108.206 172.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.5 p -75.46 -32.58 60.67 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.27 -0.877 . . . . 63.140000000000001 111.789 -173.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 103' ' ' ASN . 7.2 t-20 -164.52 -146.99 0.1 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 107.907 -1.145 . . . . 72.409999999999997 107.907 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -78.07 36.81 1.71 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.72 -0.752 . . . . 42.119999999999997 111.239 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 20.4 p30 -145.74 163.25 35.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.96 0.504 . . . . 74.150000000000006 110.092 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 46.2 t -116.56 125.51 73.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.419 -0.355 . . . . 72.140000000000001 110.464 -178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -117.27 117.64 30.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 74.329999999999998 110.218 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.859 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.4 152.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.342 -0.39 . . . . 44.140000000000001 110.235 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.406 ' HB2' ' CZ3' ' A' ' 4' ' ' TRP . 9.0 t -87.81 125.37 34.41 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.496 -0.557 . . . . 74.329999999999998 109.496 176.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 58.9 mt -69.07 96.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 116.092 -0.503 . . . . 44.409999999999997 111.029 -178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -80.71 140.97 35.31 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.478 -0.934 . . . . 54.539999999999999 108.478 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.98 139.28 42.83 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.415 0.626 . . . . 72.549999999999997 109.947 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.0 m -151.87 91.73 1.66 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.305 -0.862 . . . . 73.540000000000006 108.895 179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -66.21 100.18 0.59 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.647 -0.706 . . . . 65.040000000000006 109.605 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.6 t -47.87 128.41 3.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 114.397 -1.274 . . . . 73.239999999999995 111.946 -175.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.65 116.78 18.46 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.537 -0.756 . . . . 64.310000000000002 109.014 175.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 17.6 m -88.47 120.95 38.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.572 0.701 . . . . 74.530000000000001 112.278 -172.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -105.87 -153.3 0.49 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.326 -0.99 . . . . 70.310000000000002 108.326 174.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.482 HD22 ' N ' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -142.49 94.07 2.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.34 0.59 . . . . 73.530000000000001 112.362 -178.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 30.7 m 68.17 111.1 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 114.919 -1.037 . . . . 55.32 113.414 169.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -115.13 102.44 54.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 109.025 -0.732 . . . . 75.510000000000005 109.025 170.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.37 143.31 47.54 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.784 2.322 . . . . 63.140000000000001 113.015 -174.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.7 mt -109.42 106.41 58.51 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.755 -0.657 . . . . 71.230000000000004 110.13 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -86.13 94.39 0.57 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.589 2.192 . . . . 72.430000000000007 112.227 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 10.2 mp -115.86 93.05 4.09 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.264 -0.425 . . . . 61.420000000000002 111.134 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -120.02 129.48 54.28 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.133 -0.691 . . . . 70.030000000000001 109.133 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -132.84 94.69 3.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.737 0.304 . . . . 75.010000000000005 111.096 -174.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -109.67 132.63 53.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.473 -0.566 . . . . 71.129999999999995 109.473 172.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -143.6 113.22 7.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.277 -0.42 . . . . 75.439999999999998 110.022 -177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 15.5 t-80 -92.92 122.09 34.94 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.191 -0.459 . . . . 73.219999999999999 110.101 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 -91.71 -57.69 2.67 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.212 -0.662 . . . . 73.530000000000001 109.212 178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.1 p80 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.358 -0.829 . . . . 74.140000000000001 109.96 172.343 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.483 1.198 0 CA-C-O 120.538 0.208 . . . . 64.329999999999998 110.835 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 59.5 p 176.4 -68.32 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.545 0.738 . . . . 75.209999999999994 109.019 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -132.09 16.3 4.63 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.938 -0.764 . . . . 74.230000000000004 108.938 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.45 ' HH2' ' OD2' ' A' ' 96' ' ' ASP . 73.9 m95 -59.81 117.22 4.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.71 -1.132 . . . . 61.420000000000002 110.393 178.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -89.61 131.83 35.42 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.121 -0.491 . . . . 64.439999999999998 110.192 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 16.1 m -74.47 118.9 17.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 62.420000000000002 110.48 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.415 HG22 HG21 ' A' ' 23' ' ' VAL . 40.7 t -87.98 -70.23 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.091 -0.504 . . . . 70.430000000000007 111.064 -177.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 36.3 t -161.29 -177.33 5.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.734 -0.666 . . . . 74.430000000000007 109.212 -174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.403 ' O ' HG12 ' A' ' 13' ' ' ILE . 58.3 mtpt -86.65 143.89 27.4 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.557 0.218 . . . . 74.099999999999994 110.592 178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.3 tp -67.28 -12.71 60.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.561 0.696 . . . . 74.349999999999994 110.139 177.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -80.09 -17.02 53.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.194 -0.912 . . . . 75.299999999999997 110.998 -175.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -106.96 -9.08 16.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.31 0.576 . . . . 63.340000000000003 110.471 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 9' ' ' LYS . 46.3 mm -75.59 126.9 36.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.011 -0.541 . . . . 61.020000000000003 110.686 -179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.519 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 82.8 mt -70.14 137.48 86.97 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.12 -0.491 . . . . 64.319999999999993 111.604 -176.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 4.8 Cg_exo -79.46 127.78 7.54 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 123.241 2.627 . . . . 71.420000000000002 112.639 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 85.84 23.77 44.53 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.932 -0.576 . . . . 71.010000000000005 112.573 176.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -153.35 167.34 29.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.064 0.432 . . . . 63.149999999999999 111.624 -173.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.564 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -127.56 142.1 13.21 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 111.333 -0.707 . . . . 43.240000000000002 111.333 177.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.502 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 21.3 m -127.41 139.26 52.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 117.049 0.425 . . . . 72.230000000000004 111.821 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.4 p -70.64 99.0 1.59 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.947 0.403 . . . . 53.210000000000001 110.479 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -86.21 132.04 34.1 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.112 -0.495 . . . . 52.340000000000003 110.464 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -86.99 100.47 12.63 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.377 -0.601 . . . . 72.219999999999999 109.377 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.632 HG11 HD11 ' A' ' 106' ' ' ILE . 34.3 t -120.76 112.79 37.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.823 -0.626 . . . . 54.25 110.103 -179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.495 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 31.1 mt-10 61.78 19.41 10.55 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.269 0.557 . . . . 71.129999999999995 111.892 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 73.8 mm-40 81.47 19.72 0.39 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.176 -1.375 . . . . 70.549999999999997 111.27 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -113.47 137.99 50.75 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.845 -0.798 . . . . 62.420000000000002 108.845 169.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -99.33 108.88 21.51 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.113 0.482 . . . . 74.140000000000001 111.151 -178.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.4 mp -111.53 130.5 64.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.735 -0.666 . . . . 71.099999999999994 109.298 178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.74 113.63 21.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.912 0.387 . . . . 74.030000000000001 110.192 -178.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.564 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 29.1 t -95.77 102.34 13.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 116.093 -0.503 . . . . 72.329999999999998 110.307 -176.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -78.81 128.51 33.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.639 -0.709 . . . . 62.109999999999999 110.077 177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.635 ' HG2' ' O ' ' A' ' 34' ' ' ARG . 70.6 ttt180 -112.8 84.21 6.48 Favored Pre-proline 0 C--N 1.315 -0.925 0 N-CA-C 108.874 -0.788 . . . . 75.430000000000007 108.874 169.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -65.21 -31.75 53.14 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.672 2.248 . . . . 73.200000000000003 112.108 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.635 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 99.9 mtt180 -109.39 164.47 12.46 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.754 -0.657 . . . . 73.439999999999998 109.997 177.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -91.59 10.3 28.6 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 122.093 0.949 . . . . 63.140000000000001 108.647 174.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -95.25 -109.28 0.14 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 114.657 -1.156 . . . . 72.400000000000006 112.008 -173.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -116.25 -67.06 1.02 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.455 0.539 . . . . 74.510000000000005 112.455 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -60.15 131.27 50.3 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 113.078 0.77 . . . . 71.310000000000002 113.078 -171.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.592 HG12 ' HG3' ' A' ' 32' ' ' ARG . 24.4 m -124.74 169.18 16.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 114.872 -1.058 . . . . 72.109999999999999 109.861 175.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 76.3 m-85 -137.8 104.4 5.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.565 -0.289 . . . . 74.420000000000002 111.298 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -97.14 108.28 20.98 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.153 0.501 . . . . 61.140000000000001 110.928 177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.585 HD12 HG21 ' A' ' 92' ' ' VAL . 34.4 pt -129.34 161.47 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.667 -0.697 . . . . 74.219999999999999 109.625 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.431 ' HB2' ' H ' ' A' ' 93' ' ' ALA . 62.2 m -74.56 75.75 1.98 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.103 0.478 . . . . 74.109999999999999 111.096 178.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.55 HD22 HG11 ' A' ' 92' ' ' VAL . 26.8 t-20 -110.49 72.71 0.8 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.69 0.757 . . . . 63.130000000000003 109.487 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -127.82 133.16 68.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.268 -0.878 . . . . 74.450000000000003 109.829 -176.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -88.04 125.8 63.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.769 -0.456 . . . . 64.310000000000002 109.769 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -63.94 -11.08 25.36 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.2 2.6 . . . . 65.209999999999994 113.392 -176.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -87.64 -16.22 35.05 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 121.002 -0.279 . . . . 63.140000000000001 111.0 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -128.47 -26.67 2.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.283 0.475 . . . . 61.32 112.283 -174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 61.53 34.84 17.72 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.28 0.562 . . . . 71.129999999999995 111.153 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.439 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -143.9 169.81 17.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.305 -0.861 . . . . 53.25 109.263 178.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.502 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 13.6 p -80.81 51.09 1.46 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.248 0.547 . . . . 72.25 110.973 -177.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.6 m -73.72 -18.81 17.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.374 0.607 . . . . 75.129999999999995 110.196 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.464 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 72.5 mt -83.74 -17.07 42.48 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.345 -0.843 . . . . 61.43 109.745 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.8 m -89.96 -13.21 36.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.547 -0.751 . . . . 70.209999999999994 111.6 -174.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 65.9 mtp180 -104.96 30.32 5.62 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.911 0.386 . . . . 71.530000000000001 111.339 -177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.507 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -94.66 -129.25 5.57 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.485 -0.864 . . . . 64.140000000000001 111.974 177.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.421 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.1 mt -104.74 108.1 24.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.071 0.462 . . . . 75.239999999999995 110.215 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 59' ' ' VAL . 7.2 p -103.37 108.53 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.502 -0.772 . . . . 50.039999999999999 110.073 -179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -146.85 166.01 27.99 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.853 -0.612 . . . . 64.129999999999995 111.569 -175.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -92.95 120.94 33.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.525 -0.761 . . . . 73.299999999999997 109.718 178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.621 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 63.7 t-80 -62.43 -76.88 0.05 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.728 -0.669 . . . . 62.43 110.024 -178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 84.1 mm-40 -130.97 -44.95 1.04 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.412 -0.813 . . . . 55.310000000000002 108.93 172.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -132.36 -21.45 2.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.275 -0.875 . . . . 71.319999999999993 110.574 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.543 ' CG ' ' HE ' ' A' ' 78' ' ' ARG . 1.6 t70 -109.92 175.15 5.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.985 -0.552 . . . . 72.219999999999999 111.203 -173.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 94.2 mt -116.76 124.57 49.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.377 -0.374 . . . . 45.539999999999999 110.359 -174.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.621 ' CD1' ' HB2' ' A' ' 62' ' ' HIS . 40.1 m95 -124.63 143.84 50.5 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.164 -0.471 . . . . 65.120000000000005 110.594 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.43 117.44 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.617 0.722 . . . . 72.310000000000002 110.118 173.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -90.69 116.2 28.37 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.797 -0.638 . . . . 73.120000000000005 110.17 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.0 p -60.09 136.59 91.0 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.492 -0.322 . . . . 72.010000000000005 110.653 178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.01 -31.53 55.39 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.695 2.263 . . . . 74.319999999999993 112.765 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.1 mt -92.89 -56.83 2.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.14 -0.482 . . . . 72.319999999999993 111.595 -175.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -90.93 -13.81 32.81 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 73.530000000000001 111.671 -172.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 52.8 mttm 64.02 8.56 4.04 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.161 0.8 . . . . 74.230000000000004 113.161 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -65.52 127.12 30.58 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.094 -0.706 . . . . 72.349999999999994 109.094 174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.756 ' HB2' ' HB2' ' A' ' 85' ' ' LEU . 41.9 m80 -90.87 99.45 12.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.037 -0.528 . . . . 64.340000000000003 110.371 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -84.71 120.45 26.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.933 0.397 . . . . 65.129999999999995 110.158 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.543 ' HE ' ' CG ' ' A' ' 65' ' ' ASP . 61.4 ttt180 -78.71 121.28 24.53 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.986 -0.552 . . . . 72.549999999999997 109.805 178.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.3 mt -68.63 -36.22 78.33 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 73.420000000000002 111.915 -172.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -80.29 -20.09 45.17 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.404 -0.362 . . . . 72.150000000000006 111.575 -176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.484 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 10.0 t70 -115.15 -74.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 121.023 -0.271 . . . . 73.510000000000005 111.586 -170.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.67 ' HA2' HG22 ' A' ' 92' ' ' VAL . . . 140.36 -27.12 2.53 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.802 -0.713 . . . . 75.319999999999993 112.124 -177.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -63.31 151.68 40.03 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.178 0.514 . . . . 72.420000000000002 111.258 178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 87' ' ' ASP . 4.4 m -103.39 50.06 0.82 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.63 -0.714 . . . . 75.010000000000005 110.643 -174.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 76' ' ' HIS . 38.6 tp 66.74 -83.57 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.954 0.502 . . . . 74.109999999999999 111.363 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.428 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 36.6 mt-10 -109.08 -4.57 16.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.926 0.393 . . . . 73.230000000000004 110.341 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.422 ' HB2' ' HB2' ' A' ' 84' ' ' CYS . 6.9 m-20 -115.82 160.03 20.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.555 . . . . 72.530000000000001 110.917 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.39 27.67 2.49 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.978 -0.849 . . . . 75.299999999999997 110.978 175.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.66 -42.3 42.42 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.918 0.39 . . . . 54.219999999999999 110.745 -178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -117.27 62.39 0.74 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.11 -0.496 . . . . 74.530000000000001 110.299 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' GLY . 2.5 p -65.88 107.19 1.75 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.906 -0.588 . . . . 75.299999999999997 109.784 176.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.67 HG22 ' HA2' ' A' ' 82' ' ' GLY . 28.0 m -68.01 136.78 25.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.866 -0.606 . . . . 75.010000000000005 111.295 -174.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.431 ' H ' ' HB2' ' A' ' 43' ' ' SER . . . -71.59 106.42 4.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.006 -0.543 . . . . 43.32 109.907 176.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.55 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -79.26 88.21 4.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.796 -0.638 . . . . 60.310000000000002 110.854 -178.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -80.19 175.92 10.21 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.54 -0.755 . . . . 74.420000000000002 109.811 174.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.45 ' OD2' ' HH2' ' A' ' 4' ' ' TRP . 20.0 t70 -114.32 147.29 39.33 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.992 -0.373 . . . . 73.209999999999994 109.992 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.486 HG23 HG22 ' A' ' 106' ' ' ILE . 1.3 m -129.0 157.16 42.45 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.62 -0.718 . . . . 75.25 109.606 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -153.34 143.26 22.1 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.182 0.515 . . . . 74.200000000000003 111.112 175.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 48.9 t -107.86 98.27 6.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.39 -0.823 . . . . 73.150000000000006 108.783 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.47 HG23 HD22 ' A' ' 101' ' ' ASN . 7.4 t -94.3 -34.58 12.78 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 112.54 0.571 . . . . 70.230000000000004 112.54 -170.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.47 HD22 HG23 ' A' ' 100' ' ' THR . 61.3 m-80 -136.99 31.61 2.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.047 0.451 . . . . 34.409999999999997 110.599 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.62 -11.91 68.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.773 -0.727 . . . . 62.149999999999999 111.387 -175.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -101.89 150.65 22.97 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.129 -0.536 . . . . 74.340000000000003 110.127 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 85.0 t -97.12 120.32 46.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.305 -0.861 . . . . 75.319999999999993 111.05 -174.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 36.2 mt-30 -115.59 142.33 46.87 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.101 -0.333 . . . . 62.219999999999999 110.101 175.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.632 HD11 HG11 ' A' ' 23' ' ' VAL . 2.8 pp -122.13 154.48 26.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.189 -0.459 . . . . 75.329999999999998 110.633 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 16.8 t -113.38 102.01 9.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.778 -0.453 . . . . 41.25 109.778 177.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.578 HG23 HD13 ' A' ' 106' ' ' ILE . 16.4 pt -109.04 110.96 34.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.187 -0.461 . . . . 74.430000000000007 111.124 179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -96.47 13.29 28.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.66 0.743 . . . . 71.329999999999998 110.485 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -153.21 134.47 14.19 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.858 -1.065 . . . . 75.409999999999997 109.535 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 7.0 m -113.02 19.43 17.24 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.958 -0.564 . . . . 71.099999999999994 110.733 -177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.6 t70 53.71 -92.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.648 0.779 . . . . 61.539999999999999 110.999 -177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.36 119.75 14.51 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-N 114.732 -1.122 . . . . 74.019999999999996 108.136 173.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.08 123.4 22.75 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.0 -0.545 . . . . 54.439999999999998 111.814 -174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 4.2 p -143.13 124.19 11.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.683 -0.69 . . . . 65.219999999999999 109.229 174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.41 ' HA ' ' CD ' ' A' ' 25' ' ' GLN . 13.5 t70 -89.05 130.74 35.45 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.241 0.543 . . . . 62.420000000000002 111.957 -171.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -127.11 136.78 52.61 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.338 -0.846 . . . . 75.040000000000006 108.887 169.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 40.3 m -103.24 -12.62 17.17 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.658 0.614 . . . . 65.239999999999995 112.658 -172.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -87.16 117.24 68.33 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 120.905 0.383 . . . . 74.420000000000002 111.504 -174.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -93.22 178.97 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 123.203 2.602 . . . . 72.25 111.997 174.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 96.5 mt -124.52 106.27 30.05 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-O 120.77 0.319 . . . . 64.019999999999996 110.628 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -91.4 -170.92 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 123.075 2.517 . . . . 62.539999999999999 112.63 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 pp -145.5 165.74 27.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.005 -0.543 . . . . 73.109999999999999 109.597 177.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.42 124.75 41.71 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.317 0.58 . . . . 73.200000000000003 111.01 -178.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 18.0 p80 -112.22 131.22 55.61 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.903 -0.59 . . . . 55.119999999999997 109.574 176.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -153.51 120.58 5.75 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.979 -0.555 . . . . 71.209999999999994 110.942 -172.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -88.5 158.25 18.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 54.119999999999997 111.265 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 9.5 m-70 -132.21 171.95 13.03 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.747 -0.661 . . . . 62.119999999999997 110.344 177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -155.01 164.68 38.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.074 -0.512 . . . . 73.040000000000006 109.644 176.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 25.6 p80 . . . . . 0 C--O 1.246 0.885 0 N-CA-C 109.209 -0.663 . . . . 74.450000000000003 109.209 174.241 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.762 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 2.0 mpt? . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 110.26 -0.274 . . . . 70.150000000000006 110.26 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.6 p -86.05 -70.45 0.6 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 120.956 -0.297 . . . . 64.129999999999995 111.139 -179.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -101.11 8.25 42.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.176 0.513 . . . . 73.310000000000002 111.398 -176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 97.0 m95 -81.19 112.11 18.23 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.811 -0.631 . . . . 74.430000000000007 110.072 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.482 ' O ' HD13 ' A' ' 106' ' ' ILE . 6.0 m -95.93 126.72 41.37 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.705 -0.679 . . . . 74.439999999999998 110.184 -176.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.554 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 27.4 m -73.61 132.26 42.59 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.894 0.378 . . . . 72.430000000000007 110.994 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 53.7 t -93.14 -67.53 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.965 -0.562 . . . . 74.299999999999997 109.514 175.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.7 t -169.92 -167.83 0.69 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.476 -0.784 . . . . 62.520000000000003 108.991 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 95.1 mttt -76.92 154.49 33.61 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.732 -0.213 . . . . 74.439999999999998 110.471 178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 37' ' ' GLU . 56.9 tp -75.41 -27.07 58.88 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.51 -0.922 . . . . 60.409999999999997 108.51 169.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.37 -32.07 69.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.13 -1.395 . . . . 72.450000000000003 110.481 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -79.12 -14.27 59.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.422 -0.808 . . . . 74.409999999999997 110.186 -179.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 76.0 mt -93.08 116.34 33.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.012 -0.54 . . . . 65.25 110.236 178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.3 mt -64.63 128.84 93.91 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.051 -0.522 . . . . 70.230000000000004 111.45 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.26 124.16 12.16 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.857 2.371 . . . . 65.230000000000004 112.16 177.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 97.62 28.62 8.28 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.814 -0.63 . . . . 52.409999999999997 112.141 -178.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -163.27 170.46 17.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.608 0.242 . . . . 72.040000000000006 111.41 -176.322 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.426 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -138.11 144.69 16.0 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.218 -0.753 . . . . 72.109999999999999 111.218 177.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 28.8 m -128.07 145.91 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 117.205 0.503 . . . . 71.319999999999993 112.18 -176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.677 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 21.2 p -86.79 133.08 33.68 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.101 -0.5 . . . . 72.209999999999994 111.213 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -127.38 125.9 41.5 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.092 -0.503 . . . . 71.430000000000007 110.419 174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -72.97 99.9 2.83 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.773 -0.825 . . . . 72.519999999999996 108.773 174.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.559 HG11 HD11 ' A' ' 106' ' ' ILE . 46.0 t -109.52 103.08 14.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.069 -0.514 . . . . 73.129999999999995 110.738 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 70.26 -53.72 0.64 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.285 -0.87 . . . . 73.099999999999994 112.771 175.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -143.6 -50.42 0.32 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.603 0.594 . . . . 74.420000000000002 112.603 -175.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.595 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 27.8 mt-30 -109.39 167.38 10.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.743 0.306 . . . . 74.140000000000001 110.84 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -95.49 127.04 41.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.906 -0.588 . . . . 62.200000000000003 109.832 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 4.0 mp -109.86 134.53 51.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.367 -0.605 . . . . 75.030000000000001 109.367 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -94.14 122.04 36.25 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.665 -0.494 . . . . 74.420000000000002 109.665 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.426 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 26.1 t -105.41 104.36 16.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.082 0.468 . . . . 70.450000000000003 110.18 -177.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.696 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 79.5 m-85 -79.91 134.68 36.3 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.396 -0.82 . . . . 65.120000000000005 111.342 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -119.71 82.12 26.25 Favored Pre-proline 0 C--N 1.314 -0.945 0 N-CA-C 107.871 -1.159 . . . . 70.140000000000001 107.871 164.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.92 -25.63 19.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.649 2.233 . . . . 63.43 112.791 -172.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 34' ' ' ARG . 61.8 mtt180 -111.57 167.72 10.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.821 -0.627 . . . . 74.25 109.684 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -84.5 2.88 39.01 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.153 0.501 . . . . 73.239999999999995 110.212 179.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.488 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 19.3 t70 -98.68 -150.91 0.37 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.894 -0.594 . . . . 54.210000000000001 110.041 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.561 ' HA ' HD21 ' A' ' 10' ' ' LEU . 40.7 mt-10 -105.83 21.62 16.97 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 112.892 0.701 . . . . 65.430000000000007 112.892 -169.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -96.4 123.21 39.97 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.593 -0.443 . . . . 62.329999999999998 110.337 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 29.9 m -122.45 167.3 16.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.983 -0.553 . . . . 75.430000000000007 110.967 -179.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.696 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 78.3 m-85 -138.95 105.57 5.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.703 -0.68 . . . . 72.329999999999998 110.107 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' HB3' ' OG1' ' A' ' 97' ' ' THR . . . -102.1 101.93 12.34 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.062 0.458 . . . . 63.219999999999999 110.651 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 94' ' ' ALA . 38.7 pt -131.63 173.68 14.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.979 -0.555 . . . . 72.140000000000001 110.352 -179.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 89.9 p -83.09 67.82 9.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.347 0.594 . . . . 72.120000000000005 109.69 178.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.562 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.9 t-20 -98.27 35.96 1.68 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 122.228 1.013 . . . . 71.299999999999997 109.517 -175.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.535 HD12 ' HB3' ' A' ' 20' ' ' CYS . 35.6 mm -107.01 109.14 27.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 114.98 -1.009 . . . . 71.420000000000002 110.483 -176.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.71 115.95 42.94 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 109.129 -0.693 . . . . 64.409999999999997 109.129 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HD2' ' OH ' ' A' ' 90' ' ' TYR . 47.5 Cg_exo -57.51 -17.19 26.75 Favored 'Trans proline' 0 N--CA 1.473 0.286 0 C-N-CA 123.358 2.705 . . . . 71.439999999999998 113.445 -176.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -77.09 -15.53 59.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 64.209999999999994 110.553 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -125.92 -29.89 3.05 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.356 -0.384 . . . . 61.340000000000003 111.645 -178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 62.68 37.99 12.34 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.328 0.585 . . . . 53.409999999999997 111.663 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.677 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -155.26 170.52 21.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.318 -0.856 . . . . 75.120000000000005 108.868 177.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.414 ' HB3' ' OG ' ' A' ' 55' ' ' SER . 73.4 m -77.02 61.84 2.05 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.436 0.636 . . . . 74.310000000000002 110.895 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.0 m -80.42 -22.36 11.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.59 -0.732 . . . . 64.510000000000005 110.373 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.562 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 32.2 mt -81.06 -20.01 42.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.245 -0.65 . . . . 65.239999999999995 109.245 177.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.414 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 11.2 m -79.82 -15.6 57.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.225 -0.898 . . . . 75.439999999999998 110.904 -178.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 29.9 ttp180 -100.77 18.71 18.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.116 -0.493 . . . . 63.439999999999998 109.759 -179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -82.78 -156.67 20.99 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.877 -0.678 . . . . 62.200000000000003 112.379 -178.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 57.7 mt -100.01 125.09 53.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 120.875 0.369 . . . . 71.230000000000004 110.413 -178.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 99.2 t -76.49 101.14 2.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.264 0.554 . . . . 65.519999999999996 109.83 178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.56 95.37 5.7 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.536 -0.756 . . . . 54.009999999999998 109.616 -179.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -74.48 137.71 42.73 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.784 -0.644 . . . . 74.510000000000005 110.244 -175.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.614 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 41.1 t-80 -79.17 -169.93 2.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.647 -0.706 . . . . 72.230000000000004 109.288 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.491 ' H ' ' CG ' ' A' ' 62' ' ' HIS . 0.9 OUTLIER -54.99 -37.73 66.93 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.778 -0.823 . . . . 73.420000000000002 108.778 175.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -164.19 60.62 0.15 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.253 -0.885 . . . . 72.409999999999997 109.888 169.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.64 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 1.5 t70 -156.52 173.29 17.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.89 -0.595 . . . . 63.549999999999997 109.674 178.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.437 ' HB3' HD23 ' A' ' 79' ' ' LEU . 96.7 mt -119.16 118.11 30.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.554 0.216 . . . . 74.109999999999999 111.36 -171.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.788 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 39.5 m95 -136.25 125.52 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.817 -0.438 . . . . 72.409999999999997 109.817 -178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.4 p -101.87 130.64 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.974 0.416 . . . . 75.430000000000007 110.589 179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -85.0 114.96 22.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.093 -0.503 . . . . 54.329999999999998 111.148 -178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.77 ' HB2' ' HE2' ' A' ' 77' ' ' PHE . 29.1 t -62.08 126.8 88.31 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.563 -0.744 . . . . 65.549999999999997 111.086 176.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -77.2 -4.18 14.52 Favored 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.419 2.079 . . . . 73.230000000000004 112.079 176.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.7 mt -109.74 -55.93 2.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.119 -0.491 . . . . 61.310000000000002 111.207 -178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.593 ' HE2' ' HE2' ' A' ' 90' ' ' TYR . 48.3 mmtm -91.55 -16.26 27.44 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.171 -0.468 . . . . 55.340000000000003 110.951 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 85.7 tttt 54.76 70.01 0.67 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.68 0.753 . . . . 72.109999999999999 111.214 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -141.32 152.04 44.11 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.211 -0.904 . . . . 72.549999999999997 109.091 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.788 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 74.2 m80 -93.97 100.43 12.57 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 123.236 0.335 . . . . 75.019999999999996 110.162 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.77 ' HE2' ' HB2' ' A' ' 70' ' ' SER . 96.9 m-85 -85.88 124.53 32.46 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.221 -0.445 . . . . 75.200000000000003 110.487 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.599 ' HD3' ' HB3' ' A' ' 81' ' ' ASP . 33.4 ttt180 -73.81 122.58 22.67 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.657 -0.497 . . . . 71.540000000000006 109.657 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 66' ' ' LEU . 3.3 mm? -70.57 1.47 5.15 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 113.908 1.077 . . . . 55.450000000000003 113.908 -168.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -153.65 28.29 0.49 Allowed 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.711 -0.396 . . . . 72.230000000000004 111.412 -178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.599 ' HB3' ' HD3' ' A' ' 78' ' ' ARG . 7.9 t70 -145.3 -71.91 0.26 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 121.026 -0.27 . . . . 71.510000000000005 111.327 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 137.82 -20.3 3.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.201 -0.999 . . . . 73.239999999999995 113.287 178.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -69.51 157.21 37.59 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 117.123 0.461 . . . . 63.229999999999997 111.569 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 8.8 m -109.87 20.88 17.53 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.415 -0.811 . . . . 75.209999999999994 110.516 -177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.7 tp 69.68 -84.25 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 115.34 -0.845 . . . . 75.099999999999994 111.774 178.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -94.69 -63.02 1.22 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.725 0.298 . . . . 65.129999999999995 111.388 -175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -95.57 92.31 6.57 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.853 -0.425 . . . . 70.230000000000004 109.853 -178.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -85.93 74.1 2.46 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.656 -0.783 . . . . 73.329999999999998 112.441 -175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -114.58 -1.13 13.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.617 0.246 . . . . 54.32 111.504 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.593 ' HE2' ' HE2' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -134.1 50.84 2.16 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.11 0.481 . . . . 65.219999999999999 110.24 -176.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 16.5 m -64.75 116.63 6.48 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.818 -0.628 . . . . 75.310000000000002 111.546 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.87 168.12 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.057 -0.52 . . . . 70.409999999999997 110.565 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -100.26 154.82 18.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.798 0.332 . . . . 73.049999999999997 111.218 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.642 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -121.95 109.1 14.19 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.971 -0.559 . . . . 74.200000000000003 109.495 -179.087 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -84.96 -177.79 6.66 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.867 -0.606 . . . . 64.329999999999998 110.718 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -112.58 137.17 51.21 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.407 -0.59 . . . . 75.400000000000006 109.407 176.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.706 HG23 HG22 ' A' ' 106' ' ' ILE . 3.2 m -134.5 161.26 35.55 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.709 0.29 . . . . 73.120000000000005 111.005 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -138.56 153.21 48.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.237 0.542 . . . . 72.420000000000002 110.635 176.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 59.6 t -128.19 123.52 60.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.927 -1.138 . . . . 64.120000000000005 107.927 172.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.524 HG23 ' H ' ' A' ' 101' ' ' ASN . 3.7 t -131.59 -63.51 0.83 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.966 0.728 . . . . 61.409999999999997 112.966 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.524 ' H ' HG23 ' A' ' 100' ' ' THR . 92.0 m-20 -101.41 28.21 5.65 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.098 0.475 . . . . 74.409999999999997 110.774 -174.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 85.96 3.22 85.65 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.662 -0.78 . . . . 54.140000000000001 111.2 -175.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 27.9 p-10 -113.31 158.33 20.68 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.797 -0.445 . . . . 74.319999999999993 109.797 178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.92 122.75 65.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.013 -0.54 . . . . 70.129999999999995 110.545 -178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.554 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 16.5 mt-30 -127.02 136.19 51.88 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.643 -0.503 . . . . 74.430000000000007 109.643 179.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.706 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -108.39 153.73 9.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.079 0.466 . . . . 62.229999999999997 110.686 -179.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 32.3 t -103.57 96.79 6.96 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.164 -0.68 . . . . 71.049999999999997 109.164 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.5 pt -112.12 78.82 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-O 121.326 0.584 . . . . 63.109999999999999 110.735 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -77.91 -21.58 50.97 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.951 0.881 . . . . 74.340000000000003 109.921 178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -148.04 132.07 17.23 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 113.993 -1.458 . . . . 74.450000000000003 110.863 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 m -158.2 -77.91 0.07 Allowed 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.308 -0.997 . . . . 72.420000000000002 108.308 175.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -150.39 119.02 6.52 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.941 -1.133 . . . . 55.229999999999997 107.941 170.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 32.8 t -55.29 119.49 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.241 0.543 . . . . 72.200000000000003 111.553 -172.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.622 ' HB2' ' HB3' ' A' ' 25' ' ' GLN . . . -85.08 87.53 7.38 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.412 -0.813 . . . . 63.43 111.176 -178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.17 94.96 5.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.734 -0.839 . . . . 73.230000000000004 108.734 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -153.11 -148.96 0.27 Allowed 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.169 -0.923 . . . . 71.5 108.745 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -69.48 137.09 52.3 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.77 0.319 . . . . 74.439999999999998 110.999 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 32.8 t -64.71 -44.36 90.47 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 109.319 -0.623 . . . . 62.43 109.319 176.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.448 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 11.2 pt20 -122.22 126.67 26.18 Favored Pre-proline 0 N--CA 1.446 -0.636 0 CA-C-N 115.587 -0.733 . . . . 73.439999999999998 109.48 172.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 16.6 Cg_exo -68.49 174.96 7.59 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.466 2.111 . . . . 44.020000000000003 111.799 176.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 154.85 76.48 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.169 -0.469 . . . . 53.219999999999999 109.771 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -52.03 106.3 0.14 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.012 2.475 . . . . 73.340000000000003 112.584 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.404 ' O ' HD12 ' A' ' 123' ' ' LEU . 3.8 pp -101.48 136.41 41.36 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.877 -0.601 . . . . 65.010000000000005 109.968 178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -70.56 104.7 2.87 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.844 -0.616 . . . . 70.030000000000001 110.894 -177.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -110.48 94.14 4.85 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.55 -0.75 . . . . 73.430000000000007 109.454 177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 72.8 t60 -103.47 103.67 13.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.314 -0.857 . . . . 74.5 110.736 -175.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -178.26 147.05 0.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.498 -0.927 . . . . 70.140000000000001 108.498 179.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.4 t60 -52.73 102.33 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 O-C-N 123.52 0.512 . . . . 72.129999999999995 110.445 177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -89.04 135.73 33.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.944 -0.571 . . . . 73.430000000000007 111.359 -173.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 m80 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.645 -0.693 . . . . 71.219999999999999 109.58 172.625 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.495 ' HG2' ' O ' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 N--CA 1.478 0.948 0 N-CA-C 110.116 -0.328 . . . . 75.129999999999995 110.116 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -126.44 -84.23 0.62 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.986 0.422 . . . . 62.399999999999999 109.998 175.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -102.61 19.14 19.64 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.991 0.901 . . . . 73.239999999999995 108.6 172.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.495 ' O ' ' HG2' ' A' ' 1' ' ' MET . 21.5 m95 -117.07 117.46 29.69 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 114.28 -1.327 . . . . 75.409999999999997 109.402 -174.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 t -88.54 138.13 31.7 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.619 -0.511 . . . . 71.239999999999995 109.619 178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.44 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 13.4 m -79.59 122.79 26.95 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.031 -0.532 . . . . 73.010000000000005 110.858 -174.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.406 HG13 HG22 ' A' ' 23' ' ' VAL . 36.3 t -85.6 -81.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.974 0.416 . . . . 74.010000000000005 110.707 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 73.6 m -155.43 -178.75 7.49 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.707 -0.679 . . . . 71.519999999999996 109.411 -178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -71.14 147.6 48.24 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.076 0.465 . . . . 72.329999999999998 110.667 177.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.0 tp -66.48 -27.12 67.54 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.677 -0.692 . . . . 75.319999999999993 110.943 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -98.05 -8.05 28.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.694 -0.685 . . . . 72.099999999999994 110.715 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -66.63 -29.72 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.864 -0.791 . . . . 74.329999999999998 108.864 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 69.0 mt -102.45 127.22 56.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 114.77 -1.104 . . . . 55.119999999999997 109.97 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.7 mt -91.56 144.98 30.39 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.288 -0.415 . . . . 74.409999999999997 111.176 -175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.648 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 37.6 Cg_exo -58.55 147.94 84.0 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.139 2.56 . . . . 75.420000000000002 112.389 177.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.71 26.34 56.58 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.002 -0.618 . . . . 72.109999999999999 111.854 -178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.2 m -141.22 178.55 7.32 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.135 -0.32 . . . . 74.310000000000002 110.135 -176.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.605 ' H ' HG22 ' A' ' 17' ' ' THR . . . 175.25 105.58 0.19 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.839 -0.696 . . . . 60.219999999999999 111.865 178.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 m -136.09 170.77 18.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.37 0 CA-C-O 120.691 0.281 . . . . 73.129999999999995 111.116 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.671 ' HB3' HD12 ' A' ' 45' ' ' ILE . 8.0 p -83.05 134.33 35.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.986 -0.552 . . . . 74.349999999999994 111.557 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -111.94 143.51 42.8 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.842 -0.617 . . . . 74.109999999999999 109.651 174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.43 100.06 6.67 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.689 -0.486 . . . . 73.040000000000006 109.689 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.406 HG22 HG13 ' A' ' 7' ' ' VAL . 21.7 t -101.31 81.3 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.092 -0.503 . . . . 35.030000000000001 109.938 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 64.77 -74.91 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.134 -0.939 . . . . 72.409999999999997 112.223 179.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -116.82 -35.43 4.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.597 0.237 . . . . 74.140000000000001 111.524 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 -103.84 153.78 20.36 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.068 0.461 . . . . 71.409999999999997 111.833 -174.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -93.88 116.94 29.44 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.636 -0.711 . . . . 60.219999999999999 109.095 170.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.405 HD13 ' HB ' ' A' ' 23' ' ' VAL . 2.8 mp -112.93 127.93 69.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.609 -0.515 . . . . 73.430000000000007 109.609 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . . . -86.44 131.01 34.3 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.206 -0.452 . . . . 71.319999999999993 109.837 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 41' ' ' ALA . 29.8 t -110.0 97.29 5.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.02 0.438 . . . . 72.019999999999996 110.042 -177.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.857 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 89.7 m-85 -72.71 141.32 48.2 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.492 -0.776 . . . . 72.299999999999997 110.741 179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.67 ' HE ' ' HA ' ' A' ' 36' ' ' ASP . 6.4 tpt180 -132.69 59.39 42.87 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 115.878 -0.601 . . . . 72.400000000000006 110.495 176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.506 ' HD3' ' N ' ' A' ' 32' ' ' ARG . 6.2 Cg_exo -79.39 -22.31 8.25 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.491 2.127 . . . . 65.329999999999998 111.011 179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.4 mmt85 -82.06 150.74 27.39 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.986 -1.006 . . . . 64.109999999999999 109.81 175.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -75.49 77.13 2.53 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.095 0.474 . . . . 71.430000000000007 109.888 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.67 ' HA ' ' HE ' ' A' ' 32' ' ' ARG . 41.1 t0 63.16 179.6 0.15 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 114.753 -1.112 . . . . 70.319999999999993 111.409 178.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 66.46 -22.91 0.1 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.746 1.218 . . . . 73.200000000000003 114.006 176.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' C ' ' A' ' 36' ' ' ASP . 30.2 tp60 -134.62 114.14 12.45 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.02 0.438 . . . . 75.099999999999994 110.364 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.608 HG12 ' HD3' ' A' ' 32' ' ' ARG . 27.1 m -110.99 163.37 7.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.898 -0.592 . . . . 72.310000000000002 110.507 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.857 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 73.2 m-85 -127.28 86.69 2.53 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.096 -0.502 . . . . 75.010000000000005 110.132 174.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -91.15 98.35 11.69 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.214 -0.448 . . . . 72.0 110.116 179.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.576 ' HB ' ' HA ' ' A' ' 94' ' ' ALA . 41.0 pt -131.95 175.45 11.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.162 -0.472 . . . . 72.209999999999994 111.118 -175.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.452 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 15.1 m -83.94 75.46 10.12 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.163 -0.471 . . . . 60.210000000000001 110.178 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -130.8 85.88 2.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.461 0.648 . . . . 74.420000000000002 110.08 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.671 HD12 ' HB3' ' A' ' 20' ' ' CYS . 5.2 mm -120.42 -124.14 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.782 -0.822 . . . . 54.240000000000002 108.782 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.522 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.1 p30 -175.35 141.61 0.65 Allowed Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 108.296 -1.001 . . . . 51.329999999999998 108.296 176.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -94.7 30.22 0.23 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.352 2.035 . . . . 74.530000000000001 112.802 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.5 t80 -117.56 -48.06 2.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.287 -0.415 . . . . 70.430000000000007 110.417 179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -123.84 -16.44 6.63 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.279 -0.418 . . . . 64.549999999999997 111.472 -177.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 81.1 mm-40 58.44 61.82 2.15 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.559 0.537 . . . . 71.239999999999995 111.167 -177.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -149.69 16.44 0.88 Allowed 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.583 0.216 . . . . 75.120000000000005 111.583 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 72.4 m 61.74 57.98 2.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.461 0.648 . . . . 62.450000000000003 110.8 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 46' ' ' ASP . 19.7 m -73.68 -9.67 13.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.017 -0.538 . . . . 64.420000000000002 110.309 178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 94.3 mt -87.59 -9.69 53.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.468 -0.787 . . . . 64.040000000000006 110.25 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.425 ' OG ' ' HB3' ' A' ' 52' ' ' SER . 5.1 m -103.03 -43.83 5.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.847 -0.615 . . . . 74.209999999999994 111.303 -176.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.8 ptm180 -81.08 50.19 1.36 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.028 -0.533 . . . . 71.510000000000005 111.86 -173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -125.42 -115.52 2.06 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.491 -0.861 . . . . 53.409999999999997 112.92 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.497 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 83.2 mt -108.19 120.55 59.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.003 0.43 . . . . 74.200000000000003 110.853 -176.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -85.34 96.58 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.35 -0.611 . . . . 65.519999999999996 109.35 174.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -104.18 118.14 35.93 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.153 0.501 . . . . 70.219999999999999 111.204 -177.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -92.84 121.44 34.21 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.311 -0.626 . . . . 74.430000000000007 109.311 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 40.1 t60 -117.5 102.97 9.63 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.781 -0.451 . . . . 72.239999999999995 109.781 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 67.12 -81.95 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.352 -0.84 . . . . 73.519999999999996 111.222 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -124.39 -30.2 3.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.903 0.383 . . . . 75.530000000000001 110.72 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.688 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 35.1 m-20 -85.21 161.02 19.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.301 0.572 . . . . 74.400000000000006 111.206 -172.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 HD13 ' HB2' ' A' ' 33' ' ' PRO . 94.6 mt -108.32 112.9 25.59 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.443 -0.799 . . . . 65.310000000000002 109.642 177.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.688 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 30.5 m95 -110.66 107.82 17.53 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.974 -0.38 . . . . 73.319999999999993 109.974 -176.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.476 HG21 ' HE2' ' A' ' 31' ' ' PHE . 14.4 p -78.1 133.98 29.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.699 -0.482 . . . . 71.450000000000003 109.699 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 75' ' ' GLN . . . -118.91 134.02 55.45 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.244 -0.434 . . . . 74.030000000000001 110.532 179.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.656 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 1.2 p -74.86 145.14 80.96 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 116.176 -0.465 . . . . 70.549999999999997 110.338 177.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_endo -56.86 -53.14 5.42 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.965 2.443 . . . . 72.030000000000001 113.214 -176.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.0 mt -91.97 -47.08 7.48 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.368 -0.378 . . . . 73.140000000000001 111.518 -177.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 71.4 mmtt -65.71 -33.46 75.92 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.343 -0.39 . . . . 71.519999999999996 110.77 -178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 71.7 tttt 60.82 28.96 18.69 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.685 -0.688 . . . . 55.049999999999997 111.022 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 69' ' ' ALA . 79.0 mt-30 -91.86 137.12 32.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.645 -0.707 . . . . 70.219999999999999 110.563 -179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.567 ' H ' ' CG ' ' A' ' 87' ' ' ASP . 26.5 m80 -101.91 126.11 48.74 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.658 -0.701 . . . . 60.119999999999997 110.885 -173.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -122.15 125.09 45.39 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.486 -0.324 . . . . 70.319999999999993 110.158 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -73.55 111.22 8.47 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.048 0.451 . . . . 75.299999999999997 110.446 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 85.2 mt -74.94 82.8 2.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.56 -0.746 . . . . 74.109999999999999 110.784 -178.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -172.52 -57.88 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.442 -0.799 . . . . 74.030000000000001 108.944 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 16.6 p-10 -121.98 -11.82 8.45 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.51 -0.768 . . . . 73.25 110.726 178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 94.74 8.59 59.29 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.94 -0.648 . . . . 71.439999999999998 112.341 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -62.68 123.13 17.59 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.197 0.522 . . . . 74.109999999999999 111.157 -178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 12.5 m -93.4 145.59 24.37 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.797 -0.816 . . . . 65.049999999999997 108.797 174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.5 tp -65.87 -62.46 1.49 Allowed 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.369 -0.604 . . . . 74.019999999999996 109.369 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -145.66 13.99 1.37 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.913 -1.143 . . . . 75.219999999999999 107.913 171.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.567 ' CG ' ' H ' ' A' ' 76' ' ' HIS . 1.1 m-20 -95.38 31.29 2.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 113.619 -1.628 . . . . 74.5 110.892 -167.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -78.15 44.37 2.38 Favored Glycine 0 CA--C 1.518 0.233 0 C-N-CA 121.014 -0.612 . . . . 75.030000000000001 113.117 -176.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.42 -21.62 27.02 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.268 0.556 . . . . 71.25 110.08 178.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -125.64 91.34 3.38 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.49 -0.777 . . . . 75.129999999999995 109.057 175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -61.16 100.89 0.13 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.51 -0.768 . . . . 65.219999999999999 111.593 -178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.452 ' HB ' ' O ' ' A' ' 43' ' ' SER . 27.1 m -122.13 161.99 22.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.639 -0.709 . . . . 75.150000000000006 110.286 178.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -136.84 173.17 11.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.329 -0.396 . . . . 44.530000000000001 110.349 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.576 ' HA ' ' HB ' ' A' ' 42' ' ' ILE . . . -101.92 -158.84 0.7 Allowed 'General case' 0 N--CA 1.436 -1.165 0 CA-C-O 120.984 0.421 . . . . 72.040000000000006 109.987 -179.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -157.24 169.88 23.75 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.105 -0.952 . . . . 71.230000000000004 109.839 -178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 9.2 m-20 -88.68 126.7 35.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.989 -0.745 . . . . 63.240000000000002 108.989 170.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.595 HG22 HG22 ' A' ' 106' ' ' ILE . 80.6 p -128.75 131.98 47.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.568 0.223 . . . . 74.430000000000007 110.953 -175.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -121.24 141.12 51.18 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.985 0.421 . . . . 71.219999999999999 110.253 173.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 47.0 t -104.4 92.1 2.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.711 -0.677 . . . . 62.229999999999997 109.812 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -83.46 83.57 7.84 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.616 -0.72 . . . . 62.43 111.375 -178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 71.06 -82.4 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.181 -0.918 . . . . 54.130000000000003 111.831 172.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 8.17 7.77 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.802 -0.713 . . . . 63.420000000000002 112.931 -175.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -138.53 152.07 47.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.973 0.387 . . . . 71.340000000000003 110.46 178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 47.0 t -107.21 131.91 56.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.274 -0.421 . . . . 73.010000000000005 110.807 -177.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 68.0 mt-30 -127.51 128.23 45.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.939 -0.393 . . . . 73.230000000000004 109.939 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.595 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -117.32 156.16 18.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.05 0.452 . . . . 73.040000000000006 110.985 -178.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.402 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 13.5 t -98.14 106.76 19.1 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.345 -0.613 . . . . 71.019999999999996 109.345 178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.3 pt -80.6 142.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.037 0.446 . . . . 65.439999999999998 110.962 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.79 22.0 6.89 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.965 -0.562 . . . . 62.210000000000001 110.936 -177.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -162.88 -178.08 5.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.712 -0.676 . . . . 72.099999999999994 109.972 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 15.3 m -137.86 -2.54 1.9 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.395 -0.366 . . . . 73.25 110.474 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 27.3 t70 61.34 95.01 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.543 -0.753 . . . . 74.340000000000003 111.146 -175.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.1 t -101.36 112.6 34.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.782 -0.645 . . . . 70.239999999999995 109.463 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.67 158.59 43.96 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.969 -0.56 . . . . 72.329999999999998 110.386 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 29.8 m -84.83 140.97 15.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.226 -0.443 . . . . 53.530000000000001 110.232 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -73.29 147.72 44.25 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.236 -0.438 . . . . 74.010000000000005 110.839 -177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -85.73 92.65 8.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.91 0.862 . . . . 75.209999999999994 109.146 172.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.8 m -63.46 -21.0 66.06 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.753 -1.112 . . . . 71.230000000000004 111.686 -174.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -122.54 93.22 48.63 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 121.056 0.455 . . . . 71.010000000000005 110.091 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.4 167.19 23.27 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.176 2.584 . . . . 74.129999999999995 111.801 176.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 82.3 mt -97.68 138.42 21.06 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.232 -0.44 . . . . 71.209999999999994 110.108 177.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 31.6 Cg_exo -59.47 113.12 1.47 Allowed 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.748 2.299 . . . . 73.519999999999996 112.145 179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.8 pp -78.35 -12.07 59.98 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.915 -0.584 . . . . 72.329999999999998 111.108 -179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -77.94 132.31 37.83 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.868 -0.605 . . . . 72.530000000000001 111.458 -177.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 59.1 t-80 -86.83 99.63 11.95 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.276 -1.379 . . . . 63.43 107.276 167.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -72.75 -79.22 0.08 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 74.129999999999995 111.004 -168.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 18.3 t-80 -166.07 143.86 5.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.399 -0.593 . . . . 75.239999999999995 109.399 -176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.73 131.49 46.06 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.523 -0.547 . . . . 73.200000000000003 109.523 178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -70.58 -45.99 64.31 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.977 0.418 . . . . 71.420000000000002 109.99 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 . . . . . 0 C--O 1.247 0.924 0 CA-C-O 117.958 -1.02 . . . . 75.409999999999997 108.849 170.378 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.529 ' HB3' ' HB2' ' A' ' 4' ' ' TRP . 25.2 ttt . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.604 0.24 . . . . 64.140000000000001 110.637 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 p -130.12 -82.59 0.55 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.618 -0.512 . . . . 45.530000000000001 109.618 177.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 107' ' ' SER . 14.2 mm100 -106.55 -3.38 20.86 Favored 'General case' 0 CA--C 1.512 -0.504 0 N-CA-C 108.411 -0.959 . . . . 74.129999999999995 108.411 166.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 84.0 m95 -86.31 110.69 19.83 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.915 -1.493 . . . . 75.230000000000004 109.482 175.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.696 HG21 HG11 ' A' ' 23' ' ' VAL . 19.1 m -100.22 136.79 39.57 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.618 -0.512 . . . . 73.040000000000006 109.618 176.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.839 HG22 ' H ' ' A' ' 8' ' ' CYS . 8.5 m -81.12 126.67 31.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.975 0.417 . . . . 73.219999999999999 111.974 -173.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.2 t -79.71 -1.2 4.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 121.6 0.714 . . . . 64.109999999999999 109.476 176.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.839 ' H ' HG22 ' A' ' 6' ' ' THR . 61.1 m 87.49 -60.47 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.566 -1.197 . . . . 62.329999999999998 111.581 169.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.85 ' HE3' ' HB2' ' A' ' 12' ' ' ASP . 44.1 mtmt -145.34 146.41 31.59 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.974 0.416 . . . . 64.549999999999997 111.893 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.459 HD22 ' OE1' ' A' ' 37' ' ' GLU . 35.6 tp -84.12 -25.92 29.33 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.717 -1.216 . . . . 74.540000000000006 107.717 165.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -60.61 -39.37 87.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.168 -1.378 . . . . 64.230000000000004 111.349 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.85 ' HB2' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -77.67 -10.16 59.37 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.698 -0.683 . . . . 72.0 110.175 -176.399 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.4 mt -93.78 113.47 28.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.839 -0.619 . . . . 71.430000000000007 109.782 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 89.5 mt -69.7 139.16 88.5 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.316 -0.402 . . . . 73.5 111.381 -178.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 16.5 Cg_exo -68.2 128.17 17.07 Favored 'Trans proline' 0 C--N 1.343 0.28 0 C-N-CA 123.096 2.531 . . . . 72.129999999999995 112.178 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 87.72 30.07 19.33 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.949 -0.569 . . . . 72.299999999999997 112.19 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.96 172.47 16.86 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 116.816 0.308 . . . . 72.120000000000005 111.41 -175.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.16 138.01 5.05 Favored Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 111.734 -0.546 . . . . 52.240000000000002 111.734 177.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.2 m -132.09 167.59 26.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.937 0.368 . . . . 43.450000000000003 110.828 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.75 ' HB3' HD12 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.79 109.42 11.79 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.979 0.419 . . . . 43.240000000000002 111.401 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.34 106.84 6.15 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.831 -0.622 . . . . 74.150000000000006 109.342 174.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.406 HD23 ' HG2' ' A' ' 27' ' ' GLN . 3.2 tm? -78.13 105.48 9.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.07 -0.514 . . . . 64.329999999999998 109.709 -178.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.696 HG11 HG21 ' A' ' 5' ' ' THR . 48.5 t -118.6 92.11 2.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.759 -0.655 . . . . 63.119999999999997 110.016 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 61.64 -84.95 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.578 -0.737 . . . . 70.430000000000007 112.035 178.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -118.82 -2.14 10.94 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.16 -0.473 . . . . 73.329999999999998 110.807 -175.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -109.29 139.45 44.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.399 -0.364 . . . . 75.109999999999999 111.222 -174.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.406 ' HG2' HD23 ' A' ' 22' ' ' LEU . 52.7 mt-30 -128.92 113.16 14.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.934 -0.576 . . . . 75.140000000000001 109.805 173.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.505 ' HA ' HD11 ' A' ' 45' ' ' ILE . 1.4 pp -132.71 142.82 41.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 120.935 0.398 . . . . 73.420000000000002 110.588 176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -86.49 120.79 28.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.753 -0.658 . . . . 64.109999999999999 109.94 -178.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 38.4 t -101.26 100.05 9.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.04 0.448 . . . . 53.450000000000003 110.619 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 55.7 m-85 -72.45 134.62 45.45 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.623 -0.717 . . . . 75.450000000000003 111.156 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -120.43 81.53 31.01 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 109.103 -0.703 . . . . 71.409999999999997 109.103 165.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.01 -32.54 53.55 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.848 2.366 . . . . 74.400000000000006 112.733 -174.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -133.92 -166.71 1.83 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.873 0.368 . . . . 74.129999999999995 111.459 -176.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -79.98 -18.88 49.2 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.202 0.816 . . . . 74.340000000000003 113.202 -165.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.476 ' OD2' ' HG2' ' A' ' 38' ' ' GLN . 11.5 p-10 -110.81 -165.69 1.01 Allowed 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 112.335 0.495 . . . . 45.399999999999999 112.335 -168.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' OE1' HD22 ' A' ' 10' ' ' LEU . 6.5 mm-40 -69.52 6.62 1.03 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.152 0.797 . . . . 74.230000000000004 113.152 -171.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.476 ' HG2' ' OD2' ' A' ' 36' ' ' ASP . 15.8 mm100 -74.42 83.27 1.95 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.008 0.433 . . . . 70.129999999999995 110.757 178.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.443 HG23 HG21 ' A' ' 97' ' ' THR . 20.6 m -108.79 159.53 8.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.885 -0.598 . . . . 64.439999999999998 110.79 178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 94.7 m-85 -135.67 109.16 7.91 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.27 -0.423 . . . . 74.0 110.464 -179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -98.87 95.78 7.41 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.26 -0.427 . . . . 71.219999999999999 110.623 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.527 HG13 ' HB2' ' A' ' 44' ' ' ASN . 37.7 pt -121.85 168.49 14.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.016 -0.538 . . . . 63.140000000000001 111.255 -177.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.8 m -78.87 48.96 0.87 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 111.4 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.527 ' HB2' HG13 ' A' ' 42' ' ' ILE . 53.9 t30 -98.35 46.42 1.0 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.357 0.599 . . . . 72.150000000000006 110.242 -173.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.75 HD12 ' HB3' ' A' ' 20' ' ' CYS . 10.9 mm -83.52 -23.5 8.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.551 -0.749 . . . . 71.430000000000007 111.098 -175.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.861 ' HB2' ' HG ' ' A' ' 54' ' ' LEU . 7.5 t70 68.6 123.05 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.538 0 O-C-N 124.367 1.042 . . . . 72.340000000000003 111.631 -178.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 2.6 Cg_endo -80.99 18.86 1.23 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.17 2.58 . . . . 75.239999999999995 112.951 -177.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.421 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 85.0 t80 -111.28 -36.04 5.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.636 -0.256 . . . . 72.439999999999998 111.094 178.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.42 -20.98 5.91 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.108 0.41 . . . . 72.549999999999997 112.108 -176.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 64.84 19.18 11.77 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.387 0.514 . . . . 74.129999999999995 112.387 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -125.55 22.98 7.55 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.889 0.329 . . . . 72.319999999999993 111.889 -175.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 45' ' ' ILE . 38.2 m 58.62 39.62 24.41 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.279 0.561 . . . . 62.32 110.785 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.4 m -67.54 -18.88 24.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.453 -0.794 . . . . 74.530000000000001 111.275 -175.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 46' ' ' ASP . 59.0 mt -75.11 -18.06 60.32 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.11 177.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 20.1 m -86.78 1.23 52.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.073 -0.512 . . . . 72.140000000000001 110.536 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.4 ttt180 -102.13 11.75 37.84 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.946 -0.761 . . . . 61.020000000000003 108.946 176.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -83.96 -151.31 12.08 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.353 -0.84 . . . . 71.5 112.825 -177.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.641 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 3.7 mp -97.44 129.82 46.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 63.439999999999998 110.898 -175.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 86.3 t -77.95 99.1 2.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.917 -0.772 . . . . 72.329999999999998 108.917 173.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -101.5 97.93 8.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.855 -0.611 . . . . 75.019999999999996 110.843 -175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -84.52 110.93 19.05 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.782 -0.644 . . . . 74.120000000000005 109.49 177.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.5 t60 -89.89 92.24 8.93 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.534 -0.543 . . . . 61.119999999999997 109.534 179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 66.52 -74.86 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.706 -0.679 . . . . 73.239999999999995 111.145 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -126.99 -24.86 3.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.828 -0.624 . . . . 65.239999999999995 110.185 -178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.9 t0 -81.4 165.41 21.33 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.777 -0.647 . . . . 73.209999999999994 110.556 -174.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.5 mt -123.75 108.69 12.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.208 0.528 . . . . 63.140000000000001 111.12 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.532 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 37.0 m95 -117.56 144.49 45.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.722 -0.672 . . . . 74.400000000000006 109.88 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.448 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 7.1 p -102.12 125.38 56.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.158 0.504 . . . . 73.299999999999997 109.79 173.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -84.55 109.46 17.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.974 -0.557 . . . . 71.109999999999999 109.82 178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.552 ' HB2' ' HE1' ' A' ' 77' ' ' PHE . 46.5 t -60.86 122.82 71.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.784 -0.643 . . . . 75.129999999999995 110.846 -179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.471 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 61.1 Cg_endo -73.34 -8.6 22.1 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.442 2.095 . . . . 65.209999999999994 112.138 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 84.8 mt -113.22 -49.37 2.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.332 -0.395 . . . . 74.420000000000002 111.219 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.51 ' HB3' ' HG2' ' A' ' 75' ' ' GLN . 29.6 mmtm -94.85 -6.62 42.35 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.197 0.443 . . . . 63.130000000000003 112.197 -176.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.1 tptm 73.47 -35.89 0.33 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.241 0.616 . . . . 74.129999999999995 112.65 175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.563 ' OE1' ' HB3' ' A' ' 87' ' ' ASP . 21.0 pt20 -59.29 159.14 8.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.626 0.727 . . . . 71.25 112.604 -177.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.532 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 80.6 m80 -99.21 123.55 43.58 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.946 -1.024 . . . . 71.109999999999999 110.66 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 70' ' ' SER . 81.1 m-85 -99.12 124.67 44.32 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.755 -0.831 . . . . 71.239999999999995 108.755 172.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 10.3 ttp180 -79.76 117.22 20.45 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.28 -0.568 . . . . 73.439999999999998 109.508 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 92.9 mt -56.69 -52.75 63.73 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.637 -0.71 . . . . 74.349999999999994 112.728 -169.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -91.73 32.09 1.14 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.144 0.497 . . . . 74.219999999999999 110.591 -174.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 11.4 t70 -145.23 -56.79 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.324 -0.398 . . . . 73.400000000000006 111.322 -175.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 113.23 -32.09 6.32 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.631 -0.795 . . . . 51.530000000000001 113.109 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -78.42 166.91 22.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.195 0.521 . . . . 63.350000000000001 111.335 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 87' ' ' ASP . 20.2 m -106.03 159.5 16.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.56 -0.745 . . . . 74.239999999999995 110.487 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.469 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 63.3 tp -83.56 -65.2 1.04 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.364 . . . . 45.329999999999998 111.72 -175.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' H ' ' CD ' ' A' ' 86' ' ' GLU . 1.1 pm0 -92.34 -11.22 35.61 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.331 -0.395 . . . . 72.329999999999998 111.711 -174.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.563 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . 9.2 t70 -135.64 -161.43 1.15 Allowed 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.059 -0.719 . . . . 75.219999999999999 109.059 178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 173.56 27.25 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.387 -0.911 . . . . 60.149999999999999 113.075 179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.35 3.0 33.56 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.726 0.298 . . . . 54.409999999999997 111.432 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -120.86 -78.2 0.59 Allowed 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 121.18 -0.208 . . . . 64.140000000000001 111.331 -179.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 m 66.55 108.98 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.35 0 O-C-N 123.839 0.712 . . . . 73.030000000000001 110.949 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.428 HG21 HD12 ' A' ' 42' ' ' ILE . 33.9 m -95.51 164.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.111 -0.495 . . . . 72.340000000000003 111.313 -176.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.26 167.24 10.79 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.696 -0.483 . . . . 72.340000000000003 109.696 174.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -141.61 120.09 12.4 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.876 0.369 . . . . 40.509999999999998 110.065 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -87.44 148.44 24.97 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.812 -0.631 . . . . 74.430000000000007 111.171 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.614 ' O ' ' HA ' ' A' ' 106' ' ' ILE . 8.9 m-20 -66.72 140.64 57.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.885 -0.598 . . . . 65.209999999999994 109.917 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.652 HG22 HG22 ' A' ' 106' ' ' ILE . 12.1 p -116.7 124.89 50.78 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.879 0.371 . . . . 74.120000000000005 110.637 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -106.4 139.43 40.88 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.404 0.621 . . . . 64.349999999999994 110.936 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 54.5 t -93.68 97.9 7.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.077 0 CA-C-N 114.602 -1.181 . . . . 74.230000000000004 108.661 174.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.523 ' HB ' HE21 ' A' ' 105' ' ' GLN . 13.3 t -86.71 -17.05 34.63 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.117 -0.492 . . . . 51.100000000000001 111.645 -173.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 178.41 -77.56 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.042 -0.725 . . . . 54.409999999999997 109.042 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -148.22 24.03 1.4 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 109.316 -1.514 . . . . 73.540000000000006 109.316 173.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -135.49 153.69 51.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 113.953 -1.124 . . . . 61.530000000000001 108.35 -176.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 43.9 t -100.08 139.74 20.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 C-N-CA 121.098 -0.241 . . . . 75.140000000000001 111.043 -171.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.523 HE21 ' HB ' ' A' ' 100' ' ' THR . 36.0 mt-30 -129.69 131.93 46.51 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.932 -0.396 . . . . 71.439999999999998 109.932 172.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.654 ' H ' HD13 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -112.34 144.5 19.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 120.615 0.245 . . . . 71.109999999999999 110.85 178.088 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 49.7 m -78.47 106.82 10.68 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.285 -0.416 . . . . 63.409999999999997 110.208 176.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.7 pp -80.52 143.83 11.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.915 0.388 . . . . 75.540000000000006 110.409 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.3 -46.08 0.42 Allowed 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 121.439 0.637 . . . . 40.43 110.275 -179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 38.6 t70 70.42 130.37 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.615 -1.63 . . . . 53.009999999999998 112.072 177.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.1 m -101.55 -84.48 0.44 Allowed 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.416 -0.811 . . . . 64.329999999999998 109.978 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -146.52 104.45 3.76 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.305 -0.407 . . . . 73.409999999999997 110.756 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.6 t -113.36 142.82 24.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.814 -0.63 . . . . 72.25 109.484 177.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.51 120.96 18.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.844 0.354 . . . . 62.200000000000003 110.385 -179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.1 t -82.99 138.64 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.031 -0.531 . . . . 54.409999999999997 110.17 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -67.11 167.63 11.65 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.087 -0.506 . . . . 74.209999999999994 110.993 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -121.57 87.77 2.81 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.825 -0.625 . . . . 64.239999999999995 110.115 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 6.1 t -79.6 63.96 4.33 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.399 0.619 . . . . 71.319999999999993 109.479 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -62.63 131.49 94.2 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.392 -0.822 . . . . 63.140000000000001 111.023 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -76.49 -175.11 2.41 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.827 2.351 . . . . 61.210000000000001 112.227 179.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.5 mt -65.49 122.71 81.73 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.09 -0.505 . . . . 72.420000000000002 111.043 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -79.29 42.59 1.32 Allowed 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 123.427 2.752 . . . . 72.310000000000002 111.569 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.43 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 1.7 pp -59.58 164.92 3.21 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 115.767 -0.651 . . . . 64.409999999999997 111.406 -179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -53.2 122.72 10.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.818 -0.628 . . . . 73.450000000000003 111.746 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -165.37 121.31 1.37 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.0 -1.0 . . . . 74.109999999999999 108.477 175.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -67.76 140.93 56.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.346 0.593 . . . . 54.219999999999999 111.683 -173.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -163.02 131.12 3.77 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.057 -0.974 . . . . 74.430000000000007 108.491 178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -63.37 140.47 58.88 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 110.109 -0.33 . . . . 73.420000000000002 110.109 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 32.5 m170 -91.4 -174.05 3.79 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.331 -0.395 . . . . 74.530000000000001 110.055 -179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 17.3 p80 . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.346 -0.835 . . . . 73.340000000000003 110.095 179.742 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 N--CA 1.481 1.091 0 CA-C-O 120.635 0.255 . . . . 75.409999999999997 110.322 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 p -86.78 173.91 9.14 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 110.03 -0.359 . . . . 51.240000000000002 110.03 175.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -80.63 81.38 6.9 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.569 0.223 . . . . 72.010000000000005 111.305 -175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -81.44 114.59 20.28 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.927 0.394 . . . . 72.340000000000003 110.225 177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -122.98 136.17 54.75 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.135 -0.484 . . . . 75.040000000000006 110.638 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 40.8 m -81.99 137.55 35.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.422 -0.354 . . . . 74.120000000000005 110.262 178.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.461 HG11 ' HB1' ' A' ' 21' ' ' ALA . 25.7 t -99.61 -75.17 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.099 0.475 . . . . 52.140000000000001 110.008 175.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 72.2 m -152.87 -173.39 4.55 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.81 -0.632 . . . . 64.129999999999995 109.495 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -70.05 139.75 52.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.804 0.335 . . . . 63.109999999999999 110.709 175.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 ' O ' ' A' ' 10' ' ' LEU . 6.9 tt -83.65 -27.5 29.05 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.122 -1.066 . . . . 72.120000000000005 108.122 171.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -67.5 -25.32 65.79 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.526 -1.216 . . . . 71.409999999999997 110.563 -177.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -89.9 -5.72 56.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.882 -0.599 . . . . 41.100000000000001 110.23 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.426 HD12 ' HA ' ' A' ' 10' ' ' LEU . 71.2 mt -78.58 129.68 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.848 -0.614 . . . . 64.239999999999995 109.822 176.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 81.8 mt -74.37 138.8 74.82 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.105 -0.498 . . . . 75.219999999999999 111.584 -176.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HB3' ' HA ' ' A' ' 35' ' ' ASN . 14.3 Cg_exo -69.35 123.62 10.42 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.878 2.385 . . . . 73.319999999999993 111.88 177.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.19 28.18 10.12 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.773 -0.649 . . . . 74.340000000000003 112.601 178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.6 p -139.18 -178.81 5.52 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 117.207 0.503 . . . . 73.209999999999994 111.607 -175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.496 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -158.02 127.16 1.84 Allowed Glycine 0 N--CA 1.448 -0.555 0 N-CA-C 110.237 -1.145 . . . . 51.25 110.237 176.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.11 146.02 29.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 113.252 0.834 . . . . 70.409999999999997 113.252 -172.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 50.9 t -73.97 108.73 6.96 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.202 -0.908 . . . . 70.329999999999998 110.176 173.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 7' ' ' VAL . . . -103.86 128.27 51.34 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.119 -0.491 . . . . 70.400000000000006 110.548 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -87.14 106.19 17.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.861 -0.792 . . . . 74.109999999999999 108.861 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 HG11 HD11 ' A' ' 108' ' ' ILE . 13.5 t -105.76 90.12 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.347 -0.388 . . . . 72.040000000000006 110.448 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 28.7 mm-40 67.61 -67.14 0.19 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.214 -0.903 . . . . 72.040000000000006 112.103 176.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.633 HE21 ' HA ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -136.84 -18.15 1.39 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.792 0.293 . . . . 63.119999999999997 111.792 -175.442 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.52 ' HG3' HD11 ' A' ' 28' ' ' ILE . 3.6 pt20 -117.12 151.96 35.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.967 0.413 . . . . 64.150000000000006 111.75 -176.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -103.43 125.58 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.808 -0.633 . . . . 74.209999999999994 110.739 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.52 HD11 ' HG3' ' A' ' 26' ' ' GLN . 5.1 mp -129.17 143.45 41.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.077 -0.511 . . . . 53.310000000000002 110.056 -178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.1 36.82 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.584 -0.524 . . . . 73.200000000000003 109.584 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.496 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 45.6 t -105.93 104.97 17.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.895 0.379 . . . . 75.25 110.332 -177.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.784 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.7 m-85 -81.88 131.02 35.25 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.586 -0.734 . . . . 73.349999999999994 111.312 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.415 ' HB2' HG12 ' A' ' 39' ' ' VAL . 75.6 ttt180 -131.06 76.35 76.9 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 108.81 -0.811 . . . . 70.200000000000003 108.81 165.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.47 -19.37 13.17 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.574 2.182 . . . . 62.329999999999998 111.963 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 78.4 mtp180 -100.13 164.62 11.89 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.429 -0.805 . . . . 74.329999999999998 109.899 179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 15' ' ' PRO . 2.2 p-10 -80.92 -10.23 59.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.302 0.572 . . . . 51.109999999999999 109.904 177.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -79.93 171.76 14.68 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.442 -0.799 . . . . 53.020000000000003 110.94 -178.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.513 ' HG2' HD22 ' A' ' 10' ' ' LEU . 29.2 mt-10 -85.52 30.89 0.6 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.85 -0.614 . . . . 70.450000000000003 111.253 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 26.6 tp60 -100.57 103.33 14.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.144 -0.48 . . . . 74.439999999999998 109.755 176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.415 HG12 ' HB2' ' A' ' 32' ' ' ARG . 19.1 m -104.92 163.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.002 -0.544 . . . . 65.349999999999994 111.298 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.784 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 48.9 m-85 -124.19 102.77 7.88 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.554 -0.748 . . . . 73.25 109.951 177.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.01 95.23 9.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.16 0.505 . . . . 64.400000000000006 110.741 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.9 pt -131.58 162.65 39.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.932 -0.576 . . . . 72.010000000000005 110.057 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HB2' ' HB ' ' A' ' 92' ' ' VAL . 20.7 m -78.71 82.87 4.91 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.15 0.5 . . . . 72.549999999999997 110.589 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -108.26 17.96 21.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.066 0.936 . . . . 73.510000000000005 109.556 178.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 43.7 mm -82.27 107.76 14.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 114.721 -1.127 . . . . 74.519999999999996 109.909 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.2 t70 -60.95 131.67 91.8 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.251 -0.431 . . . . 62.219999999999999 110.221 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 18.7 Cg_exo -67.39 -4.64 12.23 Favored 'Trans proline' 0 N--CA 1.472 0.26 0 C-N-CA 123.393 2.729 . . . . 64.120000000000005 113.482 -175.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -113.16 3.96 16.32 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.296 0.57 . . . . 73.209999999999994 109.923 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -129.41 -35.83 1.73 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 111.91 -174.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 64.66 21.52 12.42 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.941 0.401 . . . . 73.099999999999994 111.658 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.402 ' HA ' ' HB2' ' A' ' 20' ' ' CYS . . . -146.25 170.56 16.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.947 -0.57 . . . . 63.43 110.082 179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.8 m -81.61 59.91 4.35 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.53 0.681 . . . . 74.209999999999994 111.057 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 31.2 m -78.53 -23.56 13.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.65 -0.705 . . . . 70.209999999999994 110.312 -179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 70' ' ' SER . 57.8 mt -81.79 -21.79 37.51 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.607 -0.724 . . . . 73.450000000000003 109.948 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 11.4 m -74.56 -22.57 58.92 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.369 -0.832 . . . . 72.430000000000007 111.244 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -96.61 27.1 4.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.192 0.52 . . . . 75.430000000000007 110.675 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -90.47 -152.0 26.76 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.848 -0.691 . . . . 62.119999999999997 112.056 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.792 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 53.8 mt -86.44 103.28 12.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.043 0.449 . . . . 71.120000000000005 110.8 -177.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 83.0 t -75.58 96.8 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.815 -0.63 . . . . 62.310000000000002 109.759 177.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.43 137.17 46.82 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.995 -0.548 . . . . 75.349999999999994 111.416 -176.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -90.79 103.07 15.82 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.869 -0.605 . . . . 72.120000000000005 109.482 176.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.689 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 56.2 t60 -107.52 114.43 28.43 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.208 -0.451 . . . . 74.200000000000003 110.113 -175.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 69.76 -84.69 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.054 -0.975 . . . . 72.010000000000005 111.413 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -135.65 -9.31 2.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.172 0.511 . . . . 73.129999999999995 110.999 -177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.541 ' HB2' ' NE1' ' A' ' 67' ' ' TRP . 3.6 m-20 -115.16 -179.2 3.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.04 0.447 . . . . 65.120000000000005 110.873 -173.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 98.0 mt -112.6 118.46 35.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.759 -0.655 . . . . 74.540000000000006 109.449 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.689 ' CD1' ' HB3' ' A' ' 62' ' ' HIS . 26.8 m95 -122.5 115.8 22.83 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.8 -0.637 . . . . 64.439999999999998 109.991 -174.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.8 p -85.16 127.31 40.05 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-O 121.146 0.498 . . . . 60.049999999999997 110.605 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.792 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -89.9 101.94 14.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.917 -0.583 . . . . 71.450000000000003 109.463 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.695 ' HB2' HD22 ' A' ' 54' ' ' LEU . 12.8 p -64.89 136.5 96.81 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.642 -0.708 . . . . 75.109999999999999 111.028 -177.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 54' ' ' LEU . 38.1 Cg_endo -67.7 -32.12 31.02 Favored 'Trans proline' 0 CA--C 1.528 0.224 0 C-N-CA 122.392 2.061 . . . . 71.140000000000001 112.51 -179.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 71.2 mt -83.78 -49.42 9.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.196 -0.457 . . . . 72.150000000000006 111.683 -177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HD3' ' CE2' ' A' ' 90' ' ' TYR . 4.3 mmpt? -84.18 -27.14 28.27 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.882 0.372 . . . . 72.319999999999993 110.157 -175.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 48.7 tttm 62.07 27.11 16.37 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 110.152 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -109.03 151.9 25.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.205 -0.907 . . . . 63.350000000000001 110.446 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.537 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 79.7 m80 -92.8 126.33 37.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.105 -0.498 . . . . 74.230000000000004 110.471 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' HE1' ' HG ' ' A' ' 84' ' ' CYS . 85.3 m-85 -115.29 132.76 56.51 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.182 -0.463 . . . . 75.430000000000007 110.064 177.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.494 ' HD3' ' CZ2' ' A' ' 67' ' ' TRP . 18.6 ttp180 -81.75 119.97 24.54 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.536 -0.542 . . . . 74.299999999999997 109.536 176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD21 ' CG1' ' A' ' 68' ' ' VAL . 75.1 mt -78.81 23.92 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.679 0.622 . . . . 74.209999999999994 112.679 -170.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 12.6 t80 -154.49 24.45 0.46 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.257 -0.646 . . . . 61.43 109.257 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 25.2 t70 -136.65 -71.26 0.45 Allowed 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.83 -0.623 . . . . 62.009999999999998 110.898 -174.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 128.61 -26.78 4.53 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.759 -0.734 . . . . 45.409999999999997 112.225 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.63 169.49 12.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.312 0.577 . . . . 71.549999999999997 111.067 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.475 ' HG ' ' HE1' ' A' ' 77' ' ' PHE . 4.2 m -109.14 149.93 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.479 -0.782 . . . . 75.099999999999994 110.351 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 32.3 tp -98.73 20.26 13.33 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.247 0.546 . . . . 75.409999999999997 110.184 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -135.44 -68.11 0.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.16 -0.473 . . . . 74.010000000000005 110.618 -177.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -139.33 136.27 34.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.548 -0.296 . . . . 63.409999999999997 110.348 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.35 49.04 3.74 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.031 -0.604 . . . . 74.310000000000002 112.801 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -108.15 -5.59 16.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 74.329999999999998 110.904 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' CE2' ' HD3' ' A' ' 73' ' ' LYS . 80.5 m-85 -136.14 32.38 2.89 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.134 -0.485 . . . . 74.019999999999996 110.816 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.9 m -78.27 117.35 19.43 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.159 -0.473 . . . . 51.299999999999997 110.045 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.427 ' HB ' ' HB2' ' A' ' 43' ' ' SER . 30.3 m -116.05 -170.03 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 62.329999999999998 111.476 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -111.01 168.19 9.68 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.122 -0.49 . . . . 74.040000000000006 111.075 -179.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -124.47 109.53 13.38 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.61 -0.723 . . . . 53.43 109.376 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -82.26 147.42 28.93 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.757 -0.656 . . . . 75.439999999999998 111.232 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 107' ' ' SER . 12.5 m-20 -66.24 122.11 16.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.04 -0.527 . . . . 73.219999999999999 110.068 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.537 HG23 HG13 ' A' ' 106' ' ' ILE . 1.6 m -117.51 153.77 32.61 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.85 -0.426 . . . . 72.530000000000001 109.85 178.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -144.41 153.01 41.48 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.445 -0.343 . . . . 64.450000000000003 110.261 178.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -124.9 105.39 15.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.595 -0.73 . . . . 72.5 109.138 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.489 HG23 ' H ' ' A' ' 101' ' ' ASN . 5.2 t -112.72 -63.6 1.42 Allowed 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 112.986 0.736 . . . . 75.150000000000006 112.986 -173.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.489 ' H ' HG23 ' A' ' 100' ' ' THR . 32.6 m-20 -106.33 29.2 7.03 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.906 0.384 . . . . 71.540000000000006 110.403 -172.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 81.22 5.13 90.28 Favored Glycine 0 N--CA 1.451 -0.363 0 N-CA-C 110.875 -0.89 . . . . 73.239999999999995 110.875 -172.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -111.34 159.4 18.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.956 -0.622 . . . . 74.340000000000003 109.758 178.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 10' ' ' LEU . 22.0 t -103.69 125.9 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 116.256 -0.429 . . . . 63.119999999999997 110.565 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.405 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -124.52 131.41 53.49 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.983 0.42 . . . . 63.119999999999997 110.389 176.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.537 HG13 HG23 ' A' ' 97' ' ' THR . 3.8 mp -113.71 142.04 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.592 -0.731 . . . . 63.100000000000001 110.005 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.639 ' HB3' ' HB2' ' A' ' 96' ' ' ASP . 47.0 t -80.53 99.21 7.95 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.285 -0.635 . . . . 71.409999999999997 109.285 173.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.556 HD11 HG11 ' A' ' 23' ' ' VAL . 44.3 mm -77.0 94.97 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.668 -0.696 . . . . 64.340000000000003 111.142 -174.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -84.0 134.6 34.63 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.248 -0.649 . . . . 73.209999999999994 109.248 173.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -70.8 121.83 18.74 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.662 0.744 . . . . 61.310000000000002 111.157 -176.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.6 m -84.99 -69.71 0.63 Allowed 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.013 -0.994 . . . . 73.319999999999993 109.356 177.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -140.48 97.61 3.25 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.369 -0.832 . . . . 64.430000000000007 109.396 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.3 t -111.69 135.84 49.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.888 -0.596 . . . . 75.519999999999996 110.517 -178.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -106.05 175.13 5.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.919 -0.582 . . . . 72.299999999999997 109.592 175.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.9 m -67.52 104.97 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 121.384 0.611 . . . . 63.43 110.598 177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -68.53 144.33 54.63 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.674 -0.694 . . . . 74.329999999999998 110.699 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -63.44 137.58 58.2 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 74.219999999999999 110.125 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.4 m -82.55 76.76 9.39 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-O 121.631 0.729 . . . . 74.349999999999994 111.359 -169.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -82.54 151.84 65.88 Favored Pre-proline 0 C--N 1.315 -0.916 0 CA-C-N 115.071 -0.968 . . . . 74.239999999999995 109.662 170.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -60.98 119.81 7.18 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.3 2.0 . . . . 70.239999999999995 111.598 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -62.07 144.98 93.81 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.98 -0.554 . . . . 75.140000000000001 110.751 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.71 168.63 4.0 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.832 2.354 . . . . 73.310000000000002 112.063 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.431 ' H ' ' HG ' ' A' ' 123' ' ' LEU . 1.0 OUTLIER -80.35 45.46 0.76 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.337 0.495 . . . . 44.130000000000003 112.337 -174.618 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.72 139.6 53.39 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 107.93 -1.137 . . . . 74.25 107.93 173.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -67.05 -50.05 63.17 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 111.657 0.243 . . . . 73.209999999999994 111.657 -170.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 63.31 179.31 0.15 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.308 0.575 . . . . 71.319999999999993 111.183 -176.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 22.5 m170 -125.93 101.72 6.95 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.313 -0.995 . . . . 71.430000000000007 108.313 171.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -103.39 118.46 36.81 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 120.419 -0.512 . . . . 74.439999999999998 111.37 -175.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -160.0 135.19 8.04 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.411 -0.813 . . . . 75.120000000000005 109.089 176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 61.9 t-80 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.616 -0.707 . . . . 72.120000000000005 109.546 177.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.956 0.408 . . . . 75.129999999999995 110.592 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.422 ' HB2' ' NE1' ' A' ' 4' ' ' TRP . 4.0 m -69.03 153.53 43.63 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 75.430000000000007 110.313 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 107' ' ' SER . 0.9 OUTLIER -75.57 76.01 2.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.066 0.46 . . . . 70.230000000000004 110.861 179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.422 ' NE1' ' HB2' ' A' ' 2' ' ' SER . 98.4 m95 -85.13 118.21 24.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.847 -0.615 . . . . 75.129999999999995 110.131 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 0.8 OUTLIER -121.08 152.27 38.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.904 -0.589 . . . . 63.43 110.555 179.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 32.7 m -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.944 0.402 . . . . 75.200000000000003 111.543 -175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.496 HG11 HG21 ' A' ' 30' ' ' VAL . 93.3 t -80.84 -68.35 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.561 . . . . 61.32 109.498 172.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 28.1 t -179.22 -163.78 0.06 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.052 -1.092 . . . . 70.209999999999994 108.052 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB2' ' HB2' ' A' ' 12' ' ' ASP . 13.7 mtpt -79.15 136.24 37.06 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.896 -0.409 . . . . 72.409999999999997 109.896 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.7 tt -60.71 -30.49 69.99 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.356 0.598 . . . . 73.209999999999994 110.104 174.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -80.57 -17.57 51.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.178 -0.919 . . . . 75.540000000000006 110.479 -176.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.716 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 t70 -84.81 -19.63 32.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.77 -0.65 . . . . 71.109999999999999 109.347 -179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.97 125.03 40.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.616 -0.72 . . . . 75.049999999999997 110.679 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 94.1 mt -77.13 133.47 68.76 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.205 -0.452 . . . . 64.299999999999997 111.665 -177.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 12.7 Cg_exo -70.24 144.8 52.55 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.324 2.683 . . . . 74.439999999999998 112.555 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 91.96 14.61 56.1 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.935 -0.575 . . . . 12.52 112.338 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' HG3' ' A' ' 56' ' ' ARG . 0.6 OUTLIER -156.48 158.06 36.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.779 0.323 . . . . 64.299999999999997 111.737 -172.676 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -122.58 138.74 12.07 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.797 -0.921 . . . . 72.140000000000001 110.797 175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.8 m -120.78 142.87 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.459 0.54 . . . . 70.439999999999998 112.459 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.642 ' HB3' HD12 ' A' ' 45' ' ' ILE . 2.1 p -75.19 105.91 6.44 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.042 0.448 . . . . 64.219999999999999 111.44 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -82.72 132.92 35.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.86 -0.609 . . . . 71.409999999999997 109.911 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 118' ' ' SER . 2.9 tm? -100.17 98.14 8.88 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.48 -0.563 . . . . 73.420000000000002 109.48 -177.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.561 HG21 HD11 ' A' ' 106' ' ' ILE . 21.2 t -108.74 70.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.957 -0.565 . . . . 73.329999999999998 109.629 178.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HG3' ' H ' ' A' ' 25' ' ' GLN . 8.1 pt-20 42.2 -82.66 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.938 1.295 . . . . 60.450000000000003 114.191 178.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.703 ' H ' ' HG3' ' A' ' 24' ' ' GLU . 3.9 pt20 -80.87 -13.05 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.564 0.579 . . . . 72.219999999999999 112.564 -172.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.522 ' NE2' ' HB3' ' A' ' 110' ' ' ASP . 19.6 mt-30 -143.92 153.72 42.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.288 0.566 . . . . 64.319999999999993 111.951 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -115.33 117.86 31.62 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.316 -0.856 . . . . 65.109999999999999 109.054 174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.598 HD12 HG13 ' A' ' 106' ' ' ILE . 66.1 mt -122.01 132.32 71.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.838 0.351 . . . . 75.329999999999998 110.903 -174.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 45' ' ' ILE . . . -88.65 125.6 34.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.292 -0.413 . . . . 53.340000000000003 110.641 -178.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.496 HG21 HG11 ' A' ' 7' ' ' VAL . 39.0 t -105.54 105.37 18.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.074 0.464 . . . . 74.140000000000001 110.126 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' O ' ' HD3' ' A' ' 33' ' ' PRO . 74.7 m-85 -78.37 128.39 33.58 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.501 -0.772 . . . . 71.439999999999998 110.76 179.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' CG ' ' HA ' ' A' ' 15' ' ' PRO . 13.0 tpt180 -109.16 84.67 2.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.196 -1.038 . . . . 64.299999999999997 108.196 168.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 31' ' ' PHE . 16.9 Cg_exo -66.65 -48.03 2.46 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.621 2.214 . . . . 55.240000000000002 112.353 -174.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -116.92 166.75 11.8 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.048 -0.524 . . . . 63.130000000000003 110.111 -179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -81.77 72.65 8.82 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.092 -1.077 . . . . 75.209999999999994 108.092 169.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' A' ' 38' ' ' GLN . 19.0 t70 -150.19 179.04 8.42 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.896 -1.047 . . . . 75.140000000000001 109.082 -174.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -79.27 -9.04 59.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.724 0.297 . . . . 74.530000000000001 111.33 -176.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.412 ' H ' ' HG3' ' A' ' 38' ' ' GLN . 0.0 OUTLIER -78.08 129.27 35.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.359 0.6 . . . . 74.519999999999996 111.605 179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.6 m -135.74 155.17 35.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.454 -0.794 . . . . 53.350000000000001 110.021 178.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.421 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 55.3 m-85 -132.94 108.01 8.65 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.684 0.278 . . . . 71.409999999999997 111.005 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -103.24 108.29 19.45 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.878 0.37 . . . . 73.129999999999995 111.109 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.402 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 46.3 pt -132.16 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 71.319999999999993 110.146 178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.608 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 55.0 m -81.82 89.91 6.36 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 120.796 0.332 . . . . 61.119999999999997 110.167 178.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -129.08 43.99 3.05 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.583 0.706 . . . . 75.129999999999995 109.223 -177.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' A' ' 20' ' ' CYS . 46.8 mm -107.98 128.98 62.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.585 -0.734 . . . . 62.100000000000001 110.532 -176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 20.1 t70 -85.91 118.07 69.86 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.259 -0.645 . . . . 74.209999999999994 109.259 174.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 19.2 Cg_exo -66.97 -12.18 35.12 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 123.225 2.617 . . . . 75.109999999999999 113.25 -174.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -93.94 -18.69 21.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.951 0.405 . . . . 72.049999999999997 110.37 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -105.41 -22.27 13.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.803 -0.635 . . . . 70.209999999999994 109.639 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 66.22 28.81 9.93 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 114.909 -1.041 . . . . 61.310000000000002 111.782 172.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -159.17 173.74 15.91 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.433 -0.349 . . . . 72.329999999999998 110.561 -178.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -79.65 52.27 1.4 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.919 -0.582 . . . . 62.520000000000003 110.94 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 27.8 m -71.75 -18.59 19.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.784 -0.644 . . . . 63.130000000000003 110.702 -176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 42.2 mt -92.49 -6.43 49.81 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.624 -0.716 . . . . 73.129999999999995 109.666 177.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.674 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 5.1 m -100.61 -35.16 9.6 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.388 -0.824 . . . . 64.049999999999997 110.362 -178.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.556 ' HG3' HG22 ' A' ' 17' ' ' THR . 72.5 ttt180 -88.18 61.74 6.41 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-O 121.797 0.808 . . . . 73.519999999999996 109.665 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -119.72 -153.81 9.34 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-N 114.865 -1.061 . . . . 64.010000000000005 111.64 175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.437 HD12 ' N ' ' A' ' 58' ' ' ILE . 3.5 mp -94.75 120.69 44.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.892 0.377 . . . . 52.229999999999997 110.012 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 90.5 t -71.4 99.41 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.602 -0.726 . . . . 64.319999999999993 109.832 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -90.73 119.98 31.4 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.474 -0.785 . . . . 41.200000000000003 110.454 -178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -95.45 132.48 40.48 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.078 -0.51 . . . . 63.539999999999999 110.639 -178.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -94.76 -155.78 0.48 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.921 -1.14 . . . . 72.209999999999994 107.921 175.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -78.08 -30.91 49.86 Favored 'General case' 0 C--N 1.32 -0.716 0 O-C-N 121.878 -0.514 . . . . 72.310000000000002 110.275 178.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -128.59 -39.64 1.63 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.982 -0.554 . . . . 74.209999999999994 111.0 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB2' ' HE1' ' A' ' 67' ' ' TRP . 11.8 m-20 -93.74 158.94 15.43 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.391 0.615 . . . . 73.099999999999994 112.289 -170.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.7 mt -115.41 121.77 43.77 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.024 -0.989 . . . . 63.219999999999999 109.621 177.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.604 ' HE1' ' HB2' ' A' ' 65' ' ' ASP . 24.0 m95 -119.4 165.81 13.86 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.244 -0.434 . . . . 75.540000000000006 110.33 -175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.647 ' HB ' HD21 ' A' ' 79' ' ' LEU . 11.3 p -122.93 129.13 75.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.204 0.526 . . . . 73.319999999999993 110.08 173.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -93.19 107.99 19.69 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.868 -0.606 . . . . 74.349999999999994 110.012 176.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 21.1 p -74.55 134.69 75.87 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.979 -0.555 . . . . 72.439999999999998 110.448 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.38 -39.67 12.28 Favored 'Trans proline' 0 CA--C 1.527 0.166 0 C-N-CA 122.527 2.152 . . . . 64.430000000000007 112.562 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.0 mt -80.61 -58.08 3.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.193 -0.458 . . . . 63.549999999999997 111.387 -174.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 69.4 mmtt -78.6 -31.42 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.436 -0.347 . . . . 73.209999999999994 110.965 -175.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 70' ' ' SER . 56.2 mttm 65.78 17.78 10.96 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 115.514 -0.766 . . . . 60.32 110.782 -175.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -85.99 138.46 31.97 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.436 -0.802 . . . . 75.049999999999997 108.948 175.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -97.12 105.98 18.23 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.857 0.36 . . . . 64.400000000000006 110.214 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -96.72 128.59 43.81 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.912 -0.585 . . . . 63.420000000000002 110.02 -178.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.404 ' HG2' ' HB3' ' A' ' 81' ' ' ASP . 35.2 ttp180 -74.21 117.05 15.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.35 -0.611 . . . . 71.340000000000003 109.35 174.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.647 HD21 ' HB ' ' A' ' 68' ' ' VAL . 88.7 mt -48.13 -58.06 5.01 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.113 0.883 . . . . 75.450000000000003 113.306 -168.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.486 ' OH ' ' HA ' ' A' ' 65' ' ' ASP . 5.9 p90 -95.84 24.82 5.1 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 112.049 0.389 . . . . 75.129999999999995 112.049 -172.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.518 ' OD2' ' HB2' ' A' ' 83' ' ' PHE . 8.1 t70 -142.03 -59.01 0.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.028 0.381 . . . . 75.329999999999998 112.028 -176.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 119.28 -16.13 10.73 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.454 -0.879 . . . . 61.329999999999998 113.46 179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.518 ' HB2' ' OD2' ' A' ' 81' ' ' ASP . 10.7 t80 -56.34 126.28 25.6 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.955 0.378 . . . . 75.209999999999994 110.068 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 22.5 m -97.08 37.15 1.34 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.992 -0.549 . . . . 72.099999999999994 111.029 -174.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.762 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 52.3 tp 66.68 -78.6 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.423 -0.808 . . . . 74.400000000000006 111.479 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.762 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 45.4 mt-10 -137.38 -33.13 0.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.911 0.386 . . . . 54.240000000000002 110.599 -179.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -79.43 93.17 5.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.866 -0.606 . . . . 61.539999999999999 110.985 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.05 21.75 40.24 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.953 -0.567 . . . . 53.409999999999997 112.011 -178.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.45 85.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.888 0.375 . . . . 74.109999999999999 111.384 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -101.26 -47.73 4.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.405 -0.361 . . . . 74.310000000000002 111.718 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.481 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 23.9 p 49.84 95.3 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.334 0.654 . . . . 64.420000000000002 112.188 -178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 43' ' ' SER . 34.1 m -76.21 161.31 4.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.932 -0.577 . . . . 71.329999999999998 111.316 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.402 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -103.25 154.51 19.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.06 -0.518 . . . . 64.439999999999998 110.861 -177.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -131.09 106.01 8.08 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.923 0.392 . . . . 71.109999999999999 110.393 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -97.5 -177.61 3.86 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.089 -0.505 . . . . 73.409999999999997 110.875 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -89.39 158.18 17.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 73.340000000000003 111.166 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.689 HG23 HG22 ' A' ' 106' ' ' ILE . 3.9 m -148.36 159.62 43.83 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.77 -0.65 . . . . 53.119999999999997 109.317 -177.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -161.71 155.69 21.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.024 0.44 . . . . 61.329999999999998 111.126 178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 104' ' ' VAL . 29.2 t -132.19 127.35 57.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 108.607 -0.886 . . . . 60.039999999999999 108.607 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 9.4 t -135.67 -28.22 1.12 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.631 0.604 . . . . 64.299999999999997 112.631 -174.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -139.55 32.62 2.06 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.051 0.453 . . . . 62.420000000000002 110.625 -175.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 89.47 -37.31 3.35 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.593 -0.813 . . . . 73.340000000000003 111.865 -177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -82.0 140.34 34.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.975 0.417 . . . . 53.409999999999997 110.034 177.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG22 HG22 ' A' ' 99' ' ' VAL . 41.3 t -96.53 131.57 42.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.829 -0.623 . . . . 63.399999999999999 110.211 -179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 5' ' ' THR . 40.0 mt-30 -116.61 141.77 47.76 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.77 -0.196 . . . . 71.030000000000001 110.596 178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.689 HG22 HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -123.9 161.93 25.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.292 -0.413 . . . . 72.310000000000002 110.271 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 37.3 m -101.88 101.07 11.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.375 -0.375 . . . . 61.009999999999998 110.982 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 18.1 pt -80.54 119.04 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.274 -0.421 . . . . 73.530000000000001 109.968 175.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -126.08 22.42 7.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.947 0.403 . . . . 72.239999999999995 111.697 -174.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.522 ' HB3' ' NE2' ' A' ' 26' ' ' GLN . 21.7 t70 -160.7 178.48 9.43 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.843 -0.617 . . . . 64.409999999999997 109.414 179.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.531 ' OG ' ' HB2' ' A' ' 25' ' ' GLN . 32.5 t -165.9 23.15 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.733 0.302 . . . . 65.340000000000003 110.591 -175.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -76.83 82.88 3.41 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.53 0.681 . . . . 63.219999999999999 110.983 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.85 128.72 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.326 -0.852 . . . . 63.140000000000001 109.699 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.66 102.58 14.39 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.047 -0.524 . . . . 63.409999999999997 111.188 -175.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 60.2 t 70.32 125.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.454 -0.794 . . . . 74.530000000000001 112.216 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -115.18 157.39 23.73 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.48 -0.782 . . . . 74.340000000000003 110.16 176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -132.9 19.06 4.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.016 0.436 . . . . 73.109999999999999 110.636 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.516 ' O ' ' HG ' ' A' ' 22' ' ' LEU . 2.5 m -106.45 77.64 1.22 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.114 0.483 . . . . 73.340000000000003 110.948 -173.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.433 ' CD ' ' H ' ' A' ' 119' ' ' GLN . 5.3 pm0 -66.33 137.65 95.57 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.191 -0.459 . . . . 75.129999999999995 110.503 176.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 24.6 Cg_exo -64.61 168.17 13.75 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 123.029 2.486 . . . . 52.420000000000002 112.985 -178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 121' ' ' LEU . 2.3 pt? -129.14 145.32 56.2 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.724 -0.671 . . . . 71.310000000000002 110.38 -177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 3.3 Cg_exo -80.35 179.88 5.78 Favored 'Trans proline' 0 N--CA 1.458 -0.587 0 C-N-CA 122.937 2.424 . . . . 70.299999999999997 111.322 176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.6 tp -134.94 93.77 3.06 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.858 0.361 . . . . 63.350000000000001 110.514 178.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -91.86 122.02 34.01 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.17 -0.468 . . . . 62.149999999999999 109.932 178.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 14.0 t60 -126.66 87.06 2.6 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.936 -0.394 . . . . 73.109999999999999 109.936 178.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 11.7 p-80 -99.18 132.21 44.66 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.861 0.362 . . . . 64.329999999999998 110.042 178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 49.8 t-80 -153.84 108.25 3.07 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.265 -0.425 . . . . 61.009999999999998 110.476 -178.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -114.27 158.58 21.23 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.87 -0.605 . . . . 71.519999999999996 109.538 175.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.0 t60 72.33 132.41 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.228 0 O-C-N 124.046 0.841 . . . . 64.120000000000005 111.103 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.0 p80 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.561 -0.733 . . . . 60.020000000000003 109.888 178.855 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.0 ttp . . . . . 0 N--CA 1.478 0.936 0 N-CA-C 110.09 -0.337 . . . . 50.210000000000001 110.09 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.0 t -145.39 -46.18 0.22 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.365 -0.38 . . . . 72.030000000000001 111.261 -176.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -83.95 27.56 0.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.114 0.413 . . . . 71.209999999999994 112.114 -173.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -128.45 135.78 49.94 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.784 0.326 . . . . 71.209999999999994 110.474 -177.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.9 m -119.79 132.04 55.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.102 -0.499 . . . . 72.349999999999994 110.203 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.813 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 3.7 m -71.49 117.52 13.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.098 0.475 . . . . 75.299999999999997 111.58 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.52 ' CG2' HD12 ' A' ' 106' ' ' ILE . 41.4 t -86.9 -67.9 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.293 0.568 . . . . 72.049999999999997 110.644 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.51 -177.6 6.32 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.481 -0.781 . . . . 73.299999999999997 108.975 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 47.3 mtpt -84.2 157.16 21.72 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.85 0.357 . . . . 75.409999999999997 110.546 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.8 tp -79.16 -2.38 40.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.415 0.626 . . . . 55.119999999999997 110.142 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -97.48 -40.74 8.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.56 -0.745 . . . . 62.329999999999998 112.202 -174.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.477 ' OD2' ' HB2' ' A' ' 9' ' ' LYS . 3.5 p30 -88.6 -6.74 57.33 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.395 0.517 . . . . 72.340000000000003 112.395 -172.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 67.2 mt -73.38 129.85 36.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.882 0.372 . . . . 63.210000000000001 110.164 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.502 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 91.7 mt -61.22 124.52 80.85 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 111.708 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.502 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 14.8 Cg_exo -68.47 131.91 24.26 Favored 'Trans proline' 0 CA--C 1.528 0.205 0 C-N-CA 123.232 2.621 . . . . 43.530000000000001 112.646 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.703 ' HA2' ' HA ' ' A' ' 33' ' ' PRO . . . 84.55 18.51 61.88 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.792 -0.64 . . . . 55.409999999999997 112.77 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.4 p -153.13 162.32 41.45 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 117.096 0.448 . . . . 61.009999999999998 111.444 -174.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -118.27 124.32 6.03 Favored Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 111.478 -0.649 . . . . 71.329999999999998 111.478 174.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.434 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -111.95 141.45 27.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.953 0.377 . . . . 70.230000000000004 111.482 -177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.731 ' SG ' ' HA ' ' A' ' 51' ' ' ALA . 6.9 p -82.32 92.91 7.05 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-O 121.086 0.47 . . . . 74.310000000000002 111.025 178.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.49 ' O ' ' HA ' ' A' ' 27' ' ' GLN . . . -82.65 143.19 31.14 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.021 -0.536 . . . . 53.32 109.93 177.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.405 HD23 ' HG3' ' A' ' 27' ' ' GLN . 3.2 tm? -80.02 97.44 6.8 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.28 -0.637 . . . . 73.140000000000001 109.28 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.53 HG11 HD11 ' A' ' 106' ' ' ILE . 19.2 t -91.24 79.65 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.894 -0.594 . . . . 72.349999999999994 109.997 -179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 65.15 -68.56 0.11 Allowed 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 74.239999999999995 112.437 178.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.417 ' HB2' HE21 ' A' ' 25' ' ' GLN . 15.3 mt-30 -118.94 -19.41 8.53 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.903 0.334 . . . . 73.109999999999999 111.903 -173.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -138.35 140.32 39.41 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.807 -0.357 . . . . 75.329999999999998 111.444 -173.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 20' ' ' CYS . 49.0 mt-30 -88.41 132.0 34.63 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.787 -0.449 . . . . 65.219999999999999 109.787 172.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 59.4 mt -130.37 136.44 58.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.186 -0.672 . . . . 33.420000000000002 109.186 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -81.24 108.41 14.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.385 -0.37 . . . . 64.019999999999996 110.225 -178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.48 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.6 t -101.0 110.18 27.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.91 -0.586 . . . . 65.329999999999998 109.907 -178.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.612 ' HB3' ' HD3' ' A' ' 33' ' ' PRO . 89.8 m-85 -77.9 137.4 38.33 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.54 -0.755 . . . . 71.519999999999996 111.432 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.3 ttt180 -124.29 57.89 14.93 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.925 -0.768 . . . . 54.329999999999998 108.925 167.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.703 ' HA ' ' HA2' ' A' ' 16' ' ' GLY . 98.5 Cg_endo -77.65 -25.54 7.85 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.545 2.163 . . . . 75.230000000000004 112.871 -166.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 21.4 mtp180 -97.96 1.05 47.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.281 -0.418 . . . . 63.340000000000003 110.141 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 60.5 t30 56.54 31.17 18.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.995 0.902 . . . . 74.030000000000001 110.147 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.505 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 16.7 t70 -144.23 -158.71 0.91 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.191 -0.913 . . . . 74.439999999999998 109.674 -171.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.505 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 37.8 mt-10 -70.41 -25.82 63.4 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.226 0.454 . . . . 72.299999999999997 112.226 -172.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -75.58 91.38 2.83 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.102 0.477 . . . . 62.420000000000002 111.522 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 26.8 m -103.16 157.64 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.333 -0.849 . . . . 73.349999999999994 110.266 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -140.25 115.54 9.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.682 0.277 . . . . 71.340000000000003 110.424 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.26 106.27 16.64 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.312 -0.404 . . . . 63.229999999999997 111.274 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.467 HG13 ' HB2' ' A' ' 44' ' ' ASN . 38.5 pt -123.98 153.9 30.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.209 -0.45 . . . . 63.049999999999997 109.986 177.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.477 ' OG ' ' HE1' ' A' ' 95' ' ' TYR . 44.9 m -77.23 59.48 1.78 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.128 0.49 . . . . 62.200000000000003 110.596 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.467 ' HB2' HG13 ' A' ' 42' ' ' ILE . 64.9 t30 -105.1 63.54 0.7 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.621 0.724 . . . . 72.239999999999995 110.378 -173.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.486 HG13 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mp -114.36 132.05 64.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.088 -0.96 . . . . 72.340000000000003 109.77 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.417 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 11.0 t70 -81.24 117.12 66.83 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.396 -0.594 . . . . 71.239999999999995 109.396 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 9.0 Cg_exo -72.32 -5.6 17.44 Favored 'Trans proline' 0 CA--C 1.528 0.187 0 C-N-CA 123.143 2.562 . . . . 73.409999999999997 113.576 -174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -89.46 -32.09 17.39 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 110.136 -0.32 . . . . 62.109999999999999 110.136 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.42 -13.81 14.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.191 0.519 . . . . 55.520000000000003 110.066 179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 57.98 59.68 3.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.862 -1.063 . . . . 73.439999999999998 110.914 -179.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.731 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -167.32 158.44 11.78 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.028 -0.987 . . . . 51.549999999999997 109.587 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 16.7 p -81.34 50.29 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.862 -0.608 . . . . 72.129999999999995 110.515 179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.4 m -65.59 -20.74 27.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.376 0.608 . . . . 63.439999999999998 110.058 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 77' ' ' PHE . 25.4 mt -75.57 -14.6 60.4 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.3 -0.864 . . . . 73.349999999999994 109.848 176.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.504 ' HB2' ' HB2' ' A' ' 52' ' ' SER . 19.5 m -117.05 4.93 12.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.552 -0.749 . . . . 61.140000000000001 110.749 -176.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 24.9 ttt180 -107.68 9.06 29.29 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.022 -0.535 . . . . 61.0 110.198 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.521 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -90.79 -114.92 1.78 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.895 -0.669 . . . . 72.120000000000005 112.53 -177.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 61.0 mt -121.24 113.81 40.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.917 0.389 . . . . 70.450000000000003 110.874 -177.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.415 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.1 t -74.79 93.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.762 -0.653 . . . . 54.140000000000001 109.287 173.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -94.72 157.29 16.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.718 -0.674 . . . . 62.420000000000002 111.426 -174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -117.88 122.99 44.76 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.738 -0.665 . . . . 75.400000000000006 110.061 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 67' ' ' TRP . 50.2 t-80 -65.38 -59.67 3.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.653 -0.703 . . . . 75.010000000000005 110.169 178.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -173.34 -58.52 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.774 -1.103 . . . . 73.120000000000005 108.439 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -125.96 11.37 7.7 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.34 -0.846 . . . . 62.450000000000003 109.489 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.596 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 4.3 t0 -132.53 166.48 21.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.446 -0.797 . . . . 71.329999999999998 109.526 -178.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.9 mt -127.62 117.43 21.99 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 122.462 0.305 . . . . 63.200000000000003 110.663 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.596 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 20.4 m95 -130.01 112.58 13.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.265 -0.425 . . . . 72.099999999999994 110.376 -175.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.444 ' CG1' ' HB2' ' A' ' 77' ' ' PHE . 13.8 p -79.85 141.39 15.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.847 -0.427 . . . . 72.5 109.847 177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.11 127.46 54.89 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.971 0.415 . . . . 74.219999999999999 111.583 -178.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.578 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 28.2 t -74.66 127.44 87.25 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.546 -0.752 . . . . 74.409999999999997 110.552 174.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.521 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 55.5 Cg_endo -70.86 -34.05 11.5 Favored 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.635 2.223 . . . . 73.420000000000002 113.021 176.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -88.62 -63.2 1.33 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.85 0.357 . . . . 60.049999999999997 111.825 -175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.583 ' HG3' ' HE2' ' A' ' 90' ' ' TYR . 41.4 mmtm -73.69 -25.57 60.3 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.417 -0.356 . . . . 74.219999999999999 110.874 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.4 tttm 56.15 95.01 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.38 -0.827 . . . . 71.430000000000007 112.357 -174.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.437 ' OE1' ' HB3' ' A' ' 89' ' ' ALA . 2.5 pt20 -166.64 155.41 10.6 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.006 -0.997 . . . . 74.140000000000001 109.454 170.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.783 ' O ' ' HA ' ' A' ' 84' ' ' CYS . 75.5 m80 -90.35 143.57 26.64 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.709 -0.678 . . . . 72.049999999999997 110.183 -179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.444 ' HB2' ' CG1' ' A' ' 68' ' ' VAL . 86.2 m-85 -130.58 121.1 25.05 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.401 -0.592 . . . . 62.109999999999999 109.401 173.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.07 133.79 45.44 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.333 -0.547 . . . . 75.510000000000005 109.74 174.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 67.5 mt -74.63 11.45 1.03 Allowed 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.653 0.612 . . . . 72.140000000000001 112.653 -171.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.401 ' HD1' ' HA ' ' A' ' 80' ' ' TYR . 0.5 OUTLIER -128.06 4.9 5.88 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.675 -0.41 . . . . 74.439999999999998 111.075 -179.0 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.87 -77.83 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.581 -0.281 . . . . 62.450000000000003 111.164 176.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.49 22.66 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.608 -0.806 . . . . 54.140000000000001 113.056 -179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -68.26 146.28 53.48 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.86 -0.422 . . . . 73.329999999999998 109.86 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 76' ' ' HIS . 53.9 m -99.28 0.96 44.15 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.646 0.61 . . . . 52.32 112.646 -170.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.538 ' HG ' ' HG3' ' A' ' 86' ' ' GLU . 58.0 tp 63.58 -74.73 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.241 0.617 . . . . 74.129999999999995 112.537 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HG3' ' HG ' ' A' ' 85' ' ' LEU . 27.0 mt-10 -109.95 -40.71 4.68 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.474 0.654 . . . . 55.109999999999999 109.969 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' CG ' ' HA ' ' A' ' 75' ' ' GLN . 1.7 m-20 -82.31 -171.01 3.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.852 -1.067 . . . . 71.230000000000004 110.386 -173.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.33 118.43 0.75 Allowed Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.574 -0.822 . . . . 64.340000000000003 112.522 176.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.437 ' HB3' ' OE1' ' A' ' 75' ' ' GLN . . . -168.01 -83.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.524 0.202 . . . . 54.530000000000001 110.884 177.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.583 ' HE2' ' HG3' ' A' ' 73' ' ' LYS . 75.1 m-85 -83.91 80.44 9.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.137 0.494 . . . . 63.539999999999999 110.756 -179.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.7 m -74.83 97.0 3.19 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.004 -0.543 . . . . 70.219999999999999 109.581 171.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 33.5 m -101.51 -175.51 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.171 -0.468 . . . . 62.219999999999999 111.725 -172.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -125.09 173.52 8.66 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 115.964 -0.562 . . . . 74.129999999999995 110.403 179.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.447 ' CB ' HG22 ' A' ' 42' ' ' ILE . . . -134.11 116.4 15.39 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 120.806 0.336 . . . . 74.510000000000005 111.179 -173.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.477 ' HE1' ' OG ' ' A' ' 43' ' ' SER . 80.0 m-85 -80.42 151.51 29.3 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.788 -0.642 . . . . 63.32 109.42 174.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -81.5 160.84 23.84 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.224 -0.658 . . . . 54.100000000000001 109.224 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.829 HG22 HG22 ' A' ' 106' ' ' ILE . 4.8 p -136.08 142.86 44.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.779 0.324 . . . . 74.340000000000003 111.366 -171.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -125.45 138.25 54.0 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.22 0.533 . . . . 75.430000000000007 110.116 175.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 31.3 t -103.92 103.72 15.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 N-CA-C 108.597 -0.89 . . . . 53.509999999999998 108.597 177.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.4 m -89.62 -68.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.317 0.58 . . . . 73.230000000000004 110.69 -173.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -116.35 -133.02 0.33 Allowed 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.359 -0.978 . . . . 71.310000000000002 108.359 175.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -82.78 35.4 2.7 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.421 -0.895 . . . . 24.449999999999999 111.139 172.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 17.7 p30 -141.65 155.13 45.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.496 . . . . 73.319999999999993 110.958 -175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.59 128.06 65.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.627 -0.715 . . . . 74.230000000000004 110.322 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.813 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 38.2 mt-30 -121.76 127.0 50.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.33 -0.395 . . . . 53.119999999999997 110.23 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.829 HG22 HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -101.72 165.88 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.08 -0.341 . . . . 73.409999999999997 110.08 178.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.0 t -92.09 96.82 10.56 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.041 0.448 . . . . 73.420000000000002 110.235 178.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 36.1 mm -73.79 102.33 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.2 0.524 . . . . 64.430000000000007 110.073 176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.95 100.85 4.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.732 -0.667 . . . . 64.420000000000002 110.148 178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.501 ' HB2' HG23 ' A' ' 113' ' ' VAL . 6.2 p-10 -99.35 143.98 28.98 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.966 -0.561 . . . . 74.219999999999999 109.939 179.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.1 t -56.69 -63.49 1.18 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.348 -0.612 . . . . 71.340000000000003 109.348 176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -170.97 80.79 0.08 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.618 -0.719 . . . . 71.439999999999998 109.586 169.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.501 HG23 ' HB2' ' A' ' 110' ' ' ASP . 40.4 t -97.84 124.36 50.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.675 -0.693 . . . . 72.219999999999999 110.065 -179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -155.55 111.95 3.16 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.644 -0.707 . . . . 43.310000000000002 110.398 -178.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 6.2 p -151.05 127.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 109.508 -0.552 . . . . 63.210000000000001 109.508 176.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -118.03 106.86 13.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.157 0.504 . . . . 70.099999999999994 111.173 -174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -145.46 -38.51 0.25 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.61 -0.723 . . . . 73.219999999999999 110.26 177.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 28.6 p -99.35 78.95 2.25 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.642 -0.708 . . . . 72.540000000000006 110.864 -175.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -72.14 111.7 11.79 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.736 -0.665 . . . . 73.0 109.996 174.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.485 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 87.9 Cg_endo -93.23 173.51 1.85 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.917 2.411 . . . . 65.450000000000003 112.269 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 91.5 mt -109.54 90.4 8.66 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.384 -0.598 . . . . 75.099999999999994 109.384 174.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 5.9 Cg_endo -85.88 125.94 2.83 Favored 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.98 2.453 . . . . 74.150000000000006 112.07 -176.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.4 tp -83.64 94.79 8.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.179 0.514 . . . . 62.329999999999998 109.861 177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.607 ' OE1' ' HA ' ' A' ' 127' ' ' HIS . 44.2 tt0 -97.74 103.65 15.61 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.518 -0.765 . . . . 44.219999999999999 109.191 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -64.8 -41.79 95.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.379 -0.373 . . . . 74.530000000000001 111.039 -175.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -108.62 94.26 4.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.774 -0.824 . . . . 65.209999999999994 108.774 174.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.607 ' HA ' ' OE1' ' A' ' 124' ' ' GLU . 51.1 m80 -68.71 129.62 40.46 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.426 -0.806 . . . . 72.439999999999998 112.61 -172.011 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -79.89 125.03 29.2 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.723 -1.214 . . . . 75.409999999999997 107.723 169.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -127.21 142.88 51.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.112 0.482 . . . . 73.219999999999999 111.632 -165.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 10.9 p-80 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.298 -0.858 . . . . 74.140000000000001 109.651 176.046 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttp . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.876 0.37 . . . . 73.209999999999994 110.772 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.1 m -114.25 -75.96 0.59 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.198 -0.456 . . . . 64.109999999999999 110.537 176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 107' ' ' SER . 51.3 mt-30 -91.38 80.51 5.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.054 0.454 . . . . 72.340000000000003 110.611 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.497 ' HA ' ' O ' ' A' ' 106' ' ' ILE . 85.0 m95 -133.7 100.24 4.72 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.417 -0.811 . . . . 71.299999999999997 110.03 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.6 p -88.45 135.44 33.47 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.509 -0.314 . . . . 64.239999999999995 111.21 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.2 m -72.41 111.85 7.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.017 -0.538 . . . . 75.109999999999999 110.165 178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.483 HG11 HG21 ' A' ' 30' ' ' VAL . 50.2 t -81.97 -73.34 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.19 -0.459 . . . . 74.25 110.827 -178.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 74.2 m -150.44 175.91 11.42 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.091 -0.504 . . . . 63.310000000000002 109.688 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' OD1' ' A' ' 103' ' ' ASN . 2.8 mptp? -79.36 142.18 36.27 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.973 -0.381 . . . . 72.420000000000002 109.973 179.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.654 HD12 HG21 ' A' ' 99' ' ' VAL . 7.9 tt -62.63 -23.47 67.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.662 0.744 . . . . 53.119999999999997 109.61 175.179 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.87 -21.21 26.5 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.835 -1.075 . . . . 72.549999999999997 110.264 -177.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -89.55 -24.96 21.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.522 -0.763 . . . . 71.510000000000005 110.723 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.503 HG22 ' HB2' ' A' ' 32' ' ' ARG . 73.1 mt -77.59 116.2 20.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.016 -0.538 . . . . 75.120000000000005 111.161 -178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.7 mt -69.05 132.83 90.07 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 60.109999999999999 111.474 -178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.512 ' HA ' ' CG ' ' A' ' 32' ' ' ARG . 44.1 Cg_endo -68.4 145.12 64.18 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.073 2.515 . . . . 63.210000000000001 113.153 -178.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.79 18.04 64.41 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.676 -0.693 . . . . 74.340000000000003 112.856 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -154.62 166.73 32.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 117.084 0.442 . . . . 63.399999999999999 111.932 -175.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.561 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -146.17 142.7 10.77 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.578 -0.609 . . . . 40.140000000000001 111.578 177.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.549 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 26.2 m -127.21 144.5 37.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 117.07 0.435 . . . . 52.240000000000002 112.013 -177.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.55 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.5 p -74.0 105.3 5.18 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.162 -0.472 . . . . 71.400000000000006 110.851 175.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -95.33 131.27 41.61 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.02 -0.536 . . . . 71.349999999999994 110.391 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -88.27 101.33 13.75 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.331 -0.618 . . . . 63.240000000000002 109.331 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.9 m -111.45 111.55 36.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.213 -0.449 . . . . 74.109999999999999 110.594 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 66.09 -72.6 0.08 Allowed 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.351 -0.84 . . . . 72.420000000000002 111.697 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.4 ' HB3' HE21 ' A' ' 25' ' ' GLN . 2.9 pt20 -155.2 11.32 0.34 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.906 0.384 . . . . 74.049999999999997 110.973 -179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -119.08 137.73 53.37 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.245 -0.434 . . . . 64.439999999999998 111.014 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -99.6 112.8 24.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 62.420000000000002 109.878 173.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 61.3 mt -118.18 135.65 57.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 116.087 -0.506 . . . . 75.530000000000001 110.453 -177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB3' ' A' ' 44' ' ' ASN . . . -89.91 114.81 26.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 109.989 179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.561 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 21.9 t -98.54 101.63 12.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.376 -0.374 . . . . 54.539999999999999 110.747 -176.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.453 ' HE2' HG21 ' A' ' 68' ' ' VAL . 66.8 m-85 -80.05 141.99 35.35 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.659 . . . . 75.450000000000003 111.089 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' HD2' HG12 ' A' ' 39' ' ' VAL . 14.0 tpt180 -112.7 80.72 3.9 Favored Pre-proline 0 C--N 1.318 -0.782 0 N-CA-C 108.302 -0.999 . . . . 72.430000000000007 108.302 165.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.716 ' HG2' HE22 ' A' ' 38' ' ' GLN . 18.2 Cg_exo -65.95 -43.32 9.49 Favored 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.568 2.179 . . . . 61.43 112.962 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -114.08 156.79 23.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.707 0.289 . . . . 74.540000000000006 110.284 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -77.18 71.09 3.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.816 -1.179 . . . . 33.140000000000001 107.816 167.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' CG ' ' H ' ' A' ' 37' ' ' GLU . 26.7 t70 -160.07 -175.9 5.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.91 -1.041 . . . . 62.32 109.08 -170.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.5 ' HA ' HD11 ' A' ' 10' ' ' LEU . 29.0 mt-10 -78.71 -10.75 59.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 35.439999999999998 110.236 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.716 HE22 ' HG2' ' A' ' 33' ' ' PRO . 22.2 tm0? -73.52 124.2 25.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.291 -0.868 . . . . 71.239999999999995 110.885 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.531 HG12 ' HD2' ' A' ' 32' ' ' ARG . 28.5 m -132.74 168.22 24.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 51.100000000000001 110.425 179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.92 103.02 3.03 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.657 0.244 . . . . 62.229999999999997 111.657 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 30' ' ' VAL . . . -103.95 109.64 21.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.857 0.361 . . . . 42.219999999999999 110.245 175.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 93' ' ' ALA . 43.7 pt -130.51 179.16 4.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 120.976 0.417 . . . . 73.239999999999995 111.149 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.48 ' O ' ' HB ' ' A' ' 92' ' ' VAL . 5.2 m -82.29 80.11 8.58 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.501 -0.555 . . . . 62.43 109.501 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.578 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 16.0 t-20 -123.84 70.57 1.08 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.713 0.768 . . . . 73.329999999999998 110.243 -176.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.55 HD12 ' HB3' ' A' ' 20' ' ' CYS . 37.3 mm -126.69 131.97 70.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.166 -0.924 . . . . 71.329999999999998 109.368 -178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.461 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 15.1 t70 -83.72 121.74 76.28 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 109.764 -0.458 . . . . 54.119999999999997 109.764 177.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 29.1 Cg_exo -62.54 -17.62 59.18 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.13 2.553 . . . . 50.109999999999999 113.248 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -100.1 5.77 44.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.887 0.375 . . . . 73.010000000000005 110.597 -177.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -132.33 -29.84 1.56 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.037 -0.529 . . . . 62.030000000000001 111.645 179.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.6 tp60 69.0 19.85 7.99 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.345 0.593 . . . . 74.510000000000005 110.816 178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -142.19 168.19 20.33 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.757 -0.656 . . . . 73.019999999999996 109.88 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 22.0 p -81.62 55.83 2.8 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.933 -0.576 . . . . 64.140000000000001 110.938 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 28.6 m -71.01 -21.5 22.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.494 0.664 . . . . 62.299999999999997 109.901 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 50.0 mt -77.47 -19.68 55.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.264 -0.88 . . . . 61.409999999999997 109.636 177.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.411 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 6.0 m -90.62 -19.43 23.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.667 -0.697 . . . . 70.299999999999997 111.503 -175.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -98.8 27.4 4.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.603 0.716 . . . . 63.329999999999998 109.847 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.512 ' HA3' ' HD3' ' A' ' 71' ' ' PRO . . . -95.93 -122.94 4.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.575 -0.739 . . . . 74.109999999999999 111.971 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.681 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 61.5 mt -112.34 104.27 16.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.205 0.526 . . . . 62.240000000000002 110.606 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.535 HG11 ' HA ' ' A' ' 33' ' ' PRO . 93.6 t -91.64 105.23 16.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 115.396 -0.82 . . . . 74.340000000000003 109.077 176.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -150.27 179.38 8.16 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.135 0.493 . . . . 73.430000000000007 111.344 -177.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -107.26 166.52 10.58 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 115.851 -0.613 . . . . 74.200000000000003 109.9 175.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -126.37 77.35 1.69 Allowed 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.22 -0.659 . . . . 64.200000000000003 109.22 177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 68.02 -59.78 0.42 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.441 -0.8 . . . . 74.109999999999999 111.77 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -117.84 -57.77 2.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.217 -0.447 . . . . 61.530000000000001 111.458 -176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.626 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 2.3 t0 -90.61 179.01 5.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.401 -0.363 . . . . 62.009999999999998 110.989 -173.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 54.6 mt -119.66 123.19 43.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.46 -0.336 . . . . 52.399999999999999 110.742 -173.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.626 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 46.4 m95 -137.83 128.26 26.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.704 0.288 . . . . 73.310000000000002 110.893 -173.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG21 ' HE2' ' A' ' 31' ' ' PHE . 10.6 p -94.95 127.39 46.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.365 0.603 . . . . 55.299999999999997 110.029 175.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.681 ' HB3' ' HB ' ' A' ' 58' ' ' ILE . . . -97.41 120.04 37.04 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.908 -0.587 . . . . 62.100000000000001 110.918 -179.39 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.684 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 41.1 t -64.55 141.32 98.22 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.957 -0.565 . . . . 53.450000000000003 110.391 176.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.512 ' HD3' ' HA3' ' A' ' 57' ' ' GLY . 61.1 Cg_endo -78.11 -41.18 0.3 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.163 1.909 . . . . 35.109999999999999 111.706 174.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.72 ' HB3' ' HD2' ' A' ' 73' ' ' LYS . 0.7 OUTLIER -76.99 -69.09 0.55 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.601 -0.727 . . . . 73.099999999999994 110.986 -178.063 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.72 ' HD2' ' HB3' ' A' ' 72' ' ' LEU . 0.3 OUTLIER -80.95 -19.11 44.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.36 -0.382 . . . . 73.430000000000007 111.181 -175.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 70' ' ' SER . 60.6 mttp 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.82 -0.627 . . . . 73.310000000000002 112.594 176.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -78.3 143.31 37.1 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.477 -0.564 . . . . 73.329999999999998 109.477 173.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -100.62 115.36 30.0 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.307 -0.406 . . . . 62.350000000000001 110.328 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.445 ' O ' HG12 ' A' ' 68' ' ' VAL . 70.3 m-85 -106.12 124.75 50.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 110.114 -0.328 . . . . 64.140000000000001 110.114 -178.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 67' ' ' TRP . 42.9 ttp180 -72.97 121.99 20.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.821 0.343 . . . . 75.219999999999999 110.436 177.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 99.0 mt -76.39 78.0 3.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.896 -0.593 . . . . 74.129999999999995 110.263 178.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -174.56 -63.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.724 -0.671 . . . . 65.540000000000006 109.752 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -111.81 -23.08 10.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.736 -0.665 . . . . 73.040000000000006 111.046 -178.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 96.89 19.29 27.13 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.742 . . . . 72.340000000000003 112.391 179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -69.77 134.22 48.33 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.603 0.24 . . . . 74.409999999999997 110.539 179.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.4 ' SG ' ' HA ' ' A' ' 91' ' ' SER . 46.0 m -88.31 26.3 1.46 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.157 0.428 . . . . 72.150000000000006 112.157 -174.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.2 tp 63.2 -79.14 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.487 0.715 . . . . 73.200000000000003 112.308 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -126.93 -7.27 6.07 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.039 0.447 . . . . 75.519999999999996 110.56 -175.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -102.59 -176.52 3.12 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.153 -0.684 . . . . 63.32 109.153 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.89 22.54 0.15 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.789 -0.719 . . . . 64.430000000000007 112.169 -179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -58.06 6.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.077 0.465 . . . . 60.030000000000001 110.799 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 22.4 m-85 -130.61 92.38 3.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.165 -0.471 . . . . 73.200000000000003 110.729 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.4 ' HA ' ' SG ' ' A' ' 84' ' ' CYS . 20.4 m -74.44 130.13 39.06 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.414 -0.587 . . . . 54.409999999999997 109.414 173.114 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 43' ' ' SER . 32.4 m -95.88 -176.68 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.509 -0.314 . . . . 60.229999999999997 111.291 -174.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.56 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -129.63 179.55 5.76 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.234 -0.439 . . . . 72.200000000000003 110.728 -178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -142.77 124.63 15.13 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-O 121.0 0.429 . . . . 75.230000000000004 110.664 -174.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -89.51 169.6 11.22 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.651 -0.704 . . . . 74.540000000000006 109.704 175.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 42.0 t0 -99.73 138.53 36.68 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.474 -0.565 . . . . 74.400000000000006 109.474 176.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.906 HG22 HG22 ' A' ' 106' ' ' ILE . 44.6 p -127.24 156.38 41.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.303 -0.408 . . . . 55.219999999999999 111.104 -173.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.446 ' HG2' ' CZ3' ' A' ' 4' ' ' TRP . 4.0 pt20 -155.44 140.77 17.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.169 0.509 . . . . 65.439999999999998 110.851 172.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.654 HG21 HD12 ' A' ' 10' ' ' LEU . 39.8 t -109.29 91.0 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 108.79 -0.819 . . . . 71.120000000000005 108.79 175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 t -113.64 -5.04 13.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.165 -0.47 . . . . 73.140000000000001 111.396 -171.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 28.2 p-10 -141.63 25.09 2.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.894 0.378 . . . . 74.109999999999999 110.842 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 83.02 -18.28 17.48 Favored Glycine 0 C--O 1.234 0.139 0 C-N-CA 120.843 -0.694 . . . . 52.219999999999999 111.544 -175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.488 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 40.5 m-80 -106.56 157.14 17.89 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 109.3 -0.63 . . . . 72.239999999999995 109.3 178.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.581 HG22 HG22 ' A' ' 99' ' ' VAL . 44.8 t -94.76 117.22 38.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-O 120.994 0.426 . . . . 74.340000000000003 110.297 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 4' ' ' TRP . 25.1 mt-30 -102.29 139.08 38.37 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.035 -0.529 . . . . 71.540000000000006 110.095 177.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.906 HG22 HG22 ' A' ' 97' ' ' THR . 2.9 pp -114.47 149.94 16.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.105 -0.498 . . . . 72.510000000000005 110.012 176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 3' ' ' GLN . 8.5 t -85.8 128.0 34.7 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.714 -0.476 . . . . 65.400000000000006 109.714 177.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 3' ' ' GLN . 50.2 mm -65.43 105.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 74.209999999999994 110.923 -179.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -116.66 150.77 37.58 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.636 -0.711 . . . . 73.010000000000005 110.08 177.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -73.94 149.43 41.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 72.319999999999993 111.273 -177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 48.0 m -149.05 -71.08 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.856 -0.611 . . . . 73.349999999999994 109.515 176.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -179.42 107.05 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 116.016 -0.538 . . . . 75.450000000000003 110.037 175.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.9 t -84.88 116.26 28.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.173 -0.677 . . . . 74.420000000000002 109.173 175.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -120.88 -174.29 2.79 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.833 -0.621 . . . . 64.540000000000006 110.577 -174.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.6 p -66.72 106.47 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 CA-C-O 121.846 0.831 . . . . 61.43 109.369 172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -98.24 158.86 15.31 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.106 -0.952 . . . . 63.350000000000001 111.682 -170.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -128.83 104.53 7.67 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.924 -1.035 . . . . 74.430000000000007 108.727 171.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.7 p -64.18 -53.07 55.04 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.787 -0.642 . . . . 71.209999999999994 111.509 -174.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 64.82 107.9 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.191 0 O-C-N 123.707 0.63 . . . . 75.209999999999994 111.317 -176.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.64 104.98 0.39 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.341 2.028 . . . . 34.210000000000001 110.762 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 92.9 mt -84.96 134.18 41.83 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 54.409999999999997 110.471 -176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.32 105.12 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.448 2.099 . . . . 71.400000000000006 111.089 174.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.501 ' O ' HD12 ' A' ' 123' ' ' LEU . 1.6 pp -68.35 134.93 51.04 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.18 0.514 . . . . 64.120000000000005 110.815 -179.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -93.58 -170.92 2.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.611 -0.722 . . . . 74.329999999999998 109.91 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.5 125.97 54.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.897 0.379 . . . . 72.019999999999996 111.054 -177.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -106.01 104.48 14.19 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.803 -0.814 . . . . 74.239999999999995 108.803 174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -64.75 137.73 57.97 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.512 -0.313 . . . . 72.129999999999995 110.224 -178.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.7 p-80 -66.37 131.78 46.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.839 0.352 . . . . 64.099999999999994 110.07 -178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -70.93 125.33 26.56 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.161 -0.472 . . . . 73.519999999999996 110.975 -174.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.169 -0.92 . . . . 63.439999999999998 109.917 178.403 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ttt . . . . . 0 N--CA 1.48 1.073 0 CA-C-O 120.917 0.389 . . . . 61.030000000000001 110.732 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.82 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 15.0 p -133.91 -73.01 0.49 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.104 -0.498 . . . . 73.219999999999999 110.371 177.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -90.73 21.26 4.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.948 -0.569 . . . . 71.430000000000007 110.293 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.82 ' HD1' ' H ' ' A' ' 2' ' ' SER . 54.9 m95 -102.4 116.71 33.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.398 -0.819 . . . . 74.420000000000002 109.772 -177.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 73.1 m -98.91 131.78 44.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.073 0.463 . . . . 74.400000000000006 111.226 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.781 ' HA ' ' HG2' ' A' ' 105' ' ' GLN . 5.2 m -67.47 119.42 12.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.478 -0.783 . . . . 75.319999999999993 111.036 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 35.3 t -95.53 -84.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.757 0.313 . . . . 70.519999999999996 110.46 178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 82.1 m -142.25 161.15 38.75 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.979 -0.378 . . . . 74.450000000000003 109.979 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.734 ' HA ' ' HA ' ' A' ' 103' ' ' ASN . 89.8 mttt -65.6 145.15 56.42 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.047 -0.353 . . . . 70.019999999999996 110.047 177.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.492 HD11 ' HA ' ' A' ' 37' ' ' GLU . 10.4 tt -65.57 -28.19 68.97 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.532 0.682 . . . . 75.120000000000005 109.565 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -87.85 -25.44 23.29 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.277 -0.874 . . . . 74.319999999999993 110.848 -177.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 9' ' ' LYS . 26.6 t0 -72.67 -15.94 61.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.706 -0.679 . . . . 53.340000000000003 109.817 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 70.4 mt -96.02 133.57 36.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.463 -0.79 . . . . 51.450000000000003 109.983 177.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.92 150.35 88.17 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.988 0.423 . . . . 62.219999999999999 111.784 -174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.97 123.68 11.62 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.69 2.26 . . . . 72.540000000000006 111.803 176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.72 34.51 11.35 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.64 -0.709 . . . . 44.130000000000003 112.484 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 64.5 p -136.3 179.44 6.35 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 117.387 0.594 . . . . 63.329999999999998 111.023 -177.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -175.42 101.42 0.16 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.069 -0.812 . . . . 45.140000000000001 111.069 179.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.465 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 29.1 m -117.63 150.54 19.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 112.21 0.448 . . . . 74.400000000000006 112.21 -174.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.686 ' HB3' HD12 ' A' ' 45' ' ' ILE . 7.0 p -78.6 128.68 33.84 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.73 -0.668 . . . . 74.420000000000002 111.65 178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -112.05 137.42 50.11 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.417 -0.586 . . . . 72.329999999999998 109.417 172.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -83.71 107.65 16.27 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.565 -0.531 . . . . 72.239999999999995 109.565 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.7 t -111.99 92.48 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.094 -0.503 . . . . 71.109999999999999 110.084 179.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.5 mm-40 65.45 -75.06 0.05 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.271 -0.877 . . . . 75.409999999999997 113.113 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.68 10.58 3.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.194 0.442 . . . . 73.329999999999998 112.194 -173.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -142.24 144.22 33.24 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.937 0.399 . . . . 73.430000000000007 111.314 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.493 ' HB2' HG13 ' A' ' 45' ' ' ILE . 52.3 mt-30 -95.48 120.16 35.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.269 -0.641 . . . . 75.549999999999997 109.269 173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.85 120.83 62.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 110.056 -0.349 . . . . 65.540000000000006 110.056 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 19' ' ' VAL . . . -91.0 123.71 34.68 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.373 -0.602 . . . . 64.349999999999994 109.373 176.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.64 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 15.0 t -107.87 107.07 21.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.952 0.406 . . . . 73.099999999999994 111.043 -175.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.636 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 65.1 m-85 -77.34 136.17 38.43 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.567 -0.742 . . . . 72.120000000000005 110.726 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -127.77 73.99 78.52 Favored Pre-proline 0 C--N 1.322 -0.599 0 N-CA-C 109.131 -0.692 . . . . 72.519999999999996 109.131 166.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.53 -36.72 52.32 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.017 2.478 . . . . 71.129999999999995 112.215 -174.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.8 mtp180 -111.92 149.77 31.43 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.56 -0.746 . . . . 71.400000000000006 109.807 178.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -81.26 56.8 2.98 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 122.311 1.053 . . . . 71.439999999999998 109.231 175.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -136.92 -176.1 4.25 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.564 -1.198 . . . . 44.210000000000001 108.448 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.492 ' HA ' HD11 ' A' ' 10' ' ' LEU . 35.7 mt-10 -82.76 47.6 1.22 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.622 0.725 . . . . 63.530000000000001 110.274 176.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 53.8 tp60 -126.7 99.04 5.61 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.107 -0.952 . . . . 71.239999999999995 109.413 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 24.9 m -124.56 162.19 26.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.191 -0.459 . . . . 63.130000000000003 111.078 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.636 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 99.7 m-85 -134.31 102.07 5.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.965 -0.562 . . . . 75.030000000000001 110.3 179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.68 96.97 6.94 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.879 0.371 . . . . 70.510000000000005 111.045 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 pt -131.18 175.94 10.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.924 -0.58 . . . . 71.409999999999997 110.15 -179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.2 m -80.63 56.62 2.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.175 0.512 . . . . 64.030000000000001 110.793 179.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.592 ' OD1' ' HB2' ' A' ' 54' ' ' LEU . 20.2 t-20 -87.05 71.5 10.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.72 0.771 . . . . 73.5 109.675 -179.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.686 HD12 ' HB3' ' A' ' 20' ' ' CYS . 16.8 mm -124.55 142.96 39.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.183 -0.917 . . . . 61.32 109.992 -174.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 9.9 t70 -90.55 116.65 66.87 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.022 -0.733 . . . . 63.420000000000002 109.022 173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.19 -16.9 53.76 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 123.121 2.547 . . . . 75.140000000000001 113.108 -176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.4 t80 -101.36 -3.41 28.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.003 0.43 . . . . 73.340000000000003 110.509 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -117.96 -24.92 6.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.152 -0.476 . . . . 43.450000000000003 110.897 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 69.11 19.49 7.99 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.727 -0.669 . . . . 65.209999999999994 110.601 177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.605 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -153.1 169.1 23.79 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.783 -0.644 . . . . 64.109999999999999 109.709 -178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 8.2 p -84.23 83.87 7.82 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.446 0.641 . . . . 71.120000000000005 110.791 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.3 m -96.97 -10.98 8.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 121.41 0.624 . . . . 74.450000000000003 109.787 175.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 43.6 mt -70.26 -28.52 65.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.315 -0.857 . . . . 70.019999999999996 109.608 177.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.1 p -88.81 5.86 41.64 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.06 -0.973 . . . . 33.310000000000002 111.841 -176.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.946 ' HA ' ' HE ' ' A' ' 56' ' ' ARG . 0.1 OUTLIER -108.6 15.38 23.82 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.276 0.56 . . . . 72.030000000000001 110.481 -177.099 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.484 ' CA ' ' HD3' ' A' ' 71' ' ' PRO . . . -96.55 -147.61 22.92 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.717 -0.754 . . . . 73.319999999999993 112.299 179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.2 mm -96.75 118.03 42.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.02 0.438 . . . . 74.040000000000006 110.472 -179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 88.3 t -70.37 101.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.564 -0.743 . . . . 42.350000000000001 109.531 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -95.85 109.01 21.42 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.254 -0.884 . . . . 63.340000000000003 110.641 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -88.32 129.01 35.5 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 116.124 -0.489 . . . . 74.450000000000003 110.305 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 33.6 t60 -108.1 45.44 1.02 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.581 -0.736 . . . . 64.209999999999994 109.523 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 69.29 -67.03 0.23 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.131 -0.94 . . . . 71.219999999999999 111.117 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -96.34 -43.9 7.47 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.177 -0.465 . . . . 60.340000000000003 110.965 -176.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.488 ' HB3' ' HE1' ' A' ' 67' ' ' TRP . 3.2 t70 -98.52 174.58 6.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.704 0.287 . . . . 73.209999999999994 110.39 -177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.511 ' HB3' HD12 ' A' ' 79' ' ' LEU . 89.3 mt -132.28 118.7 19.81 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.228 -0.442 . . . . 71.340000000000003 109.883 -174.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.488 ' HE1' ' HB3' ' A' ' 65' ' ' ASP . 35.8 m95 -124.14 165.53 17.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.93 0.395 . . . . 73.430000000000007 110.585 -175.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 76' ' ' HIS . 14.7 p -135.06 132.79 53.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.207 -0.451 . . . . 74.409999999999997 110.191 173.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.48 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -94.35 106.03 18.01 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.077 -0.51 . . . . 73.530000000000001 109.985 177.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.6 t -68.85 133.68 90.23 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.127 -0.488 . . . . 54.020000000000003 111.124 -177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.484 ' HD3' ' CA ' ' A' ' 57' ' ' GLY . 56.8 Cg_endo -71.14 -30.02 16.7 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.486 2.124 . . . . 65.409999999999997 111.941 178.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -89.86 -37.65 14.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.978 -0.555 . . . . 62.210000000000001 111.099 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.813 ' HD3' ' HE2' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -88.41 -28.16 21.1 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 111.379 -175.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mttm 65.19 22.95 12.25 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.534 0.521 . . . . 65.120000000000005 111.018 -177.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -122.86 155.81 35.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.29 -0.413 . . . . 73.120000000000005 110.712 -178.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 85' ' ' LEU . 76.6 m80 -95.32 117.0 29.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.274 -0.421 . . . . 75.430000000000007 110.667 179.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -100.78 137.41 39.2 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.179 -0.464 . . . . 72.340000000000003 110.7 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.5 ttt180 -78.42 123.89 27.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.036 -0.529 . . . . 75.120000000000005 110.19 177.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 66' ' ' LEU . 84.4 mt -74.31 -30.44 62.06 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.454 0.538 . . . . 72.230000000000004 112.454 -172.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' HD1' ' HE1' ' A' ' 40' ' ' TYR . 48.6 t80 -81.73 -19.13 42.06 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.797 -0.361 . . . . 73.430000000000007 111.566 -174.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -140.52 -78.41 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.184 0.516 . . . . 74.209999999999994 111.037 -176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 155.37 -14.36 0.46 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.681 -0.771 . . . . 71.439999999999998 112.123 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -55.37 108.32 0.41 Allowed 'General case' 0 C--O 1.227 -0.128 0 N-CA-C 109.83 -0.434 . . . . 65.129999999999995 109.83 175.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 26.2 m -76.16 155.92 34.16 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.003 0.43 . . . . 43.43 111.418 -173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 76' ' ' HIS . 24.7 tp -86.59 -20.45 27.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 70.510000000000005 110.001 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -87.57 -82.97 0.21 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.799 -0.637 . . . . 72.120000000000005 110.715 176.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -144.16 160.65 40.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.106 -0.497 . . . . 72.030000000000001 109.954 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -80.13 65.78 3.73 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.971 -0.851 . . . . 62.32 110.971 175.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -61.34 -66.09 0.59 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 111.77 0.285 . . . . 74.030000000000001 111.77 -175.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.813 ' HE2' ' HD3' ' A' ' 73' ' ' LYS . 60.1 m-85 -100.04 -28.21 13.17 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.833 -0.347 . . . . 71.219999999999999 111.501 -176.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 19.5 m 59.73 84.53 0.12 Allowed 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.744 0.653 . . . . 74.340000000000003 110.234 -173.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.9 m -79.2 155.83 4.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.12 -0.491 . . . . 61.109999999999999 110.975 -176.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -93.11 142.79 26.91 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.202 -0.454 . . . . 74.319999999999993 111.008 -178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -115.78 97.71 6.27 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.916 -0.584 . . . . 71.430000000000007 110.153 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -81.96 136.43 35.28 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.987 -0.551 . . . . 75.430000000000007 110.042 179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -66.44 136.63 56.0 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.357 -0.608 . . . . 73.120000000000005 109.357 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.577 HG22 HG22 ' A' ' 106' ' ' ILE . 76.0 p -115.52 143.43 45.33 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.414 -0.357 . . . . 65.329999999999998 111.214 -173.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -134.72 137.27 43.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.397 0.617 . . . . 75.349999999999994 110.413 170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 t -111.03 62.86 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-N 115.527 -0.761 . . . . 64.439999999999998 109.037 178.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.4 m -85.12 -29.35 24.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.247 -0.888 . . . . 64.430000000000007 111.397 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -103.59 -6.73 21.39 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.499 0.666 . . . . 54.539999999999999 110.835 -175.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 99.02 -33.14 6.36 Favored Glycine 0 CA--C 1.506 -0.483 0 N-CA-C 109.692 -1.363 . . . . 63.520000000000003 109.692 -169.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.734 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 46.7 m-80 -81.39 139.84 35.06 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.566 -0.901 . . . . 45.219999999999999 108.566 167.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.2 t -81.78 123.29 37.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 N-CA-C 109.409 -0.589 . . . . 62.119999999999997 109.409 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HG2' ' HA ' ' A' ' 6' ' ' THR . 21.5 mt-30 -117.55 121.1 40.06 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.758 -0.656 . . . . 73.329999999999998 110.591 -176.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.577 HG22 HG22 ' A' ' 97' ' ' THR . 2.1 pp -96.38 153.31 3.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 115.813 -0.63 . . . . 71.519999999999996 111.345 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 8.0 t -81.4 114.74 20.36 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.128 -0.693 . . . . 45.210000000000001 109.128 176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 16.6 mm -72.69 109.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.344 0.592 . . . . 73.109999999999999 111.745 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -107.89 98.11 7.74 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.258 -1.015 . . . . 72.109999999999999 108.258 168.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -56.51 136.21 54.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.865 -0.607 . . . . 70.209999999999994 111.053 -173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 50.9 m -86.89 -12.78 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.791 -0.64 . . . . 71.310000000000002 111.076 -176.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 4.6 t70 54.4 78.37 0.17 Allowed 'General case' 0 C--O 1.234 0.242 0 O-C-N 123.852 0.72 . . . . 72.340000000000003 111.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.551 HG22 HG23 ' A' ' 115' ' ' VAL . 10.7 p -152.13 142.34 15.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.995 -0.548 . . . . 61.439999999999998 110.543 -177.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -125.66 86.95 2.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.2 0.524 . . . . 42.130000000000003 111.25 -177.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.551 HG23 HG22 ' A' ' 113' ' ' VAL . 40.1 t -112.9 144.74 19.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.887 -0.597 . . . . 54.350000000000001 109.641 179.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.46 82.42 7.27 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.209 0.528 . . . . 64.019999999999996 111.652 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -161.3 173.87 14.38 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.553 -0.906 . . . . 75.439999999999998 108.553 172.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 39.4 m 56.31 38.96 30.25 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.154 0.502 . . . . 72.219999999999999 110.537 -177.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 27.2 pt20 -61.23 140.74 94.36 Favored Pre-proline 0 C--O 1.234 0.266 0 CA-C-N 115.515 -0.766 . . . . 71.030000000000001 111.448 -175.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 23.1 Cg_exo -64.63 118.81 5.75 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.834 2.356 . . . . 72.319999999999993 111.212 176.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 3.6 mm? 56.55 77.48 0.42 Allowed Pre-proline 0 N--CA 1.463 0.217 0 O-C-N 123.732 0.645 . . . . 53.130000000000003 111.251 -176.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.02 106.62 2.06 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 122.832 2.355 . . . . 72.319999999999993 111.424 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.455 HD13 ' O ' ' A' ' 124' ' ' GLU . 2.5 tm? 66.74 103.02 0.04 OUTLIER 'General case' 0 C--O 1.234 0.25 0 O-C-N 123.907 0.755 . . . . 53.5 109.919 -177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.458 ' CD ' ' H ' ' A' ' 125' ' ' HIS . 0.0 OUTLIER -74.06 -166.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.786 -0.643 . . . . 53.43 111.278 -175.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.458 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 8.8 t-160 70.73 26.5 3.82 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 108.516 -0.92 . . . . 72.319999999999993 108.516 -173.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -79.49 79.03 5.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 114.936 -1.029 . . . . 72.0 110.395 -177.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -129.41 153.24 48.11 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.368 -0.604 . . . . 74.310000000000002 109.368 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -160.51 146.23 14.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.425 -0.352 . . . . 70.120000000000005 110.169 -178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -82.62 134.0 35.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 43.130000000000003 109.707 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 50.0 t-80 . . . . . 0 C--O 1.241 0.634 0 CA-C-O 118.553 -0.737 . . . . 74.319999999999993 109.921 178.87 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.947 0.403 . . . . 75.420000000000002 110.668 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.504 ' H ' ' HD1' ' A' ' 4' ' ' TRP . 25.6 p -111.22 -72.05 0.73 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.373 -0.376 . . . . 62.539999999999999 110.029 175.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.85 61.57 0.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.228 0.537 . . . . 71.209999999999994 109.818 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.504 ' HD1' ' H ' ' A' ' 2' ' ' SER . 82.3 m95 -124.58 139.12 54.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.57 -0.741 . . . . 73.120000000000005 110.173 -177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.646 HG21 HG13 ' A' ' 23' ' ' VAL . 21.1 m -126.15 124.3 40.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.841 -178.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.3 m -67.32 119.57 12.41 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 116.286 -0.416 . . . . 74.310000000000002 110.394 176.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.467 HG11 HG21 ' A' ' 30' ' ' VAL . 61.6 t -68.27 -60.91 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.002 -0.544 . . . . 62.340000000000003 109.673 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' HD11 ' A' ' 13' ' ' ILE . 5.0 p -172.33 -90.57 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.024 -0.989 . . . . 71.310000000000002 109.414 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.84 ' HD2' ' HB2' ' A' ' 12' ' ' ASP . 47.0 mttp -145.08 170.68 15.73 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.597 -0.52 . . . . 73.030000000000001 109.597 177.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.671 HD22 HG11 ' A' ' 99' ' ' VAL . 53.8 tp -91.23 -49.96 6.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.203 0.525 . . . . 74.310000000000002 110.396 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -77.44 -30.08 53.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.717 -0.674 . . . . 75.349999999999994 110.701 -174.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.84 ' HB2' ' HD2' ' A' ' 9' ' ' LYS . 29.3 t0 -72.48 -13.68 61.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.293 -0.867 . . . . 75.439999999999998 110.334 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.507 HD11 ' SG ' ' A' ' 8' ' ' CYS . 34.7 mm -88.4 117.67 32.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 74.209999999999994 109.803 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.63 123.33 76.39 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 74.230000000000004 111.174 -177.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HB2' ' OD1' ' A' ' 35' ' ' ASN . 36.6 Cg_endo -65.54 146.15 84.09 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.572 2.181 . . . . 54.509999999999998 111.874 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 81.82 30.17 36.43 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.448 -0.661 . . . . 45.299999999999997 111.448 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.59 HG22 ' H ' ' A' ' 18' ' ' GLY . 1.1 m -147.97 174.16 12.17 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.738 0.304 . . . . 74.099999999999994 110.95 -174.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 30' ' ' VAL . . . -161.42 107.9 0.33 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.706 -0.958 . . . . 75.349999999999994 110.706 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.512 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 31.3 m -124.7 153.96 31.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 N-CA-C 112.427 0.529 . . . . 65.450000000000003 112.427 -174.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.68 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.2 p -79.87 118.23 21.44 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 115.578 -0.737 . . . . 73.239999999999995 111.275 176.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.14 169.94 9.04 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.144 -0.48 . . . . 71.450000000000003 110.358 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -92.09 117.54 29.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.236 0.541 . . . . 72.109999999999999 110.828 -175.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.698 ' HB ' ' O ' ' A' ' 26' ' ' GLN . 57.3 t -124.77 154.03 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.385 -0.969 . . . . 73.040000000000006 108.385 173.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -45.68 -48.18 15.03 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.333 0.864 . . . . 73.519999999999996 113.333 -172.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.455 ' HB2' HG21 ' A' ' 113' ' ' VAL . 10.0 pt20 -114.65 -4.68 12.76 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.266 0.839 . . . . 71.319999999999993 113.266 -167.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.698 ' O ' ' HB ' ' A' ' 23' ' ' VAL . 10.3 tt0 -172.37 143.49 1.42 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.821 -0.352 . . . . 63.299999999999997 110.524 -173.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -75.64 137.45 40.72 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.28 -0.637 . . . . 73.519999999999996 109.28 173.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 20' ' ' CYS . 20.6 tt -115.8 138.05 47.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 120.628 0.251 . . . . 61.539999999999999 110.502 -177.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 41' ' ' ALA . . . -97.43 124.8 41.74 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.417 -0.356 . . . . 72.200000000000003 110.281 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.625 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 38.9 t -106.19 99.38 8.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 110.949 -176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.806 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 57.6 m-85 -75.21 113.83 13.01 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.6 -0.727 . . . . 52.340000000000003 110.75 176.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 65.7 ttt180 -118.59 82.69 20.19 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.528 -0.916 . . . . 71.540000000000006 108.528 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.537 ' HB3' HG21 ' A' ' 59' ' ' VAL . 10.4 Cg_exo -71.11 -31.75 14.24 Favored 'Trans proline' 0 CA--C 1.519 -0.275 0 C-N-CA 122.72 2.28 . . . . 72.209999999999994 112.758 -172.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 17.7 mtm180 -121.48 -179.74 4.18 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.48 -0.327 . . . . 75.129999999999995 110.278 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.407 ' OD1' ' HB2' ' A' ' 15' ' ' PRO . 80.8 m-20 -93.24 23.9 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.314 -0.403 . . . . 74.409999999999997 110.881 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -87.77 -174.8 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.381 0.61 . . . . 71.439999999999998 111.429 -176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -98.66 31.64 2.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.308 -0.86 . . . . 71.239999999999995 110.712 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.94 153.23 52.15 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.09 -0.505 . . . . 62.549999999999997 111.028 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.5 m -143.82 165.98 13.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.114 -0.493 . . . . 61.299999999999997 110.488 -179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.806 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 76.3 m-85 -122.14 92.15 3.66 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.063 -0.517 . . . . 73.329999999999998 110.401 175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' O ' ' A' ' 29' ' ' ALA . . . -94.04 100.48 12.6 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.982 0.42 . . . . 43.149999999999999 110.323 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 42.6 pt -130.71 173.78 13.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.017 -0.538 . . . . 72.329999999999998 110.795 -175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 m -78.51 87.08 4.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.08 0.467 . . . . 62.420000000000002 109.87 175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' A' ' 29' ' ' ALA . 25.7 t-20 -133.5 67.23 1.53 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.678 0.751 . . . . 52.439999999999998 109.584 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.68 HD12 ' HB3' ' A' ' 20' ' ' CYS . 38.7 mm -118.79 143.09 30.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.431 -0.804 . . . . 75.129999999999995 109.384 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.496 ' OD2' ' HB3' ' A' ' 48' ' ' PHE . 27.0 t70 -99.36 114.44 65.57 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.327 -0.397 . . . . 53.219999999999999 109.941 177.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.19 -12.99 35.3 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 123.187 2.591 . . . . 43.049999999999997 112.773 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HB3' ' OD2' ' A' ' 46' ' ' ASP . 82.7 t80 -82.82 -22.13 34.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.041 -0.527 . . . . 75.140000000000001 110.983 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -122.7 -13.78 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.709 0.29 . . . . 72.349999999999994 111.426 -178.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 63.62 29.44 15.12 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.801 -0.636 . . . . 73.010000000000005 111.018 -178.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -147.95 170.35 17.9 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.232 -0.44 . . . . 74.040000000000006 110.166 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.512 ' OG ' ' HA ' ' A' ' 19' ' ' VAL . 12.2 p -83.95 58.83 4.91 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.249 0.547 . . . . 64.420000000000002 110.702 -179.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.482 ' O ' ' HD2' ' A' ' 71' ' ' PRO . 31.2 m -79.73 3.84 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.577 0.704 . . . . 64.200000000000003 110.208 -179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.416 ' HB2' ' OD1' ' A' ' 44' ' ' ASN . 64.1 mt -104.78 -2.54 24.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.99 -1.004 . . . . 74.140000000000001 109.248 174.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.513 ' HA ' ' CE2' ' A' ' 31' ' ' PHE . 34.9 t -102.04 -48.7 4.15 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.648 -0.705 . . . . 71.0 111.362 -174.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 51.1 ttp180 -84.17 62.65 7.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.89 0.852 . . . . 72.409999999999997 109.892 -178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 69' ' ' ALA . . . -114.51 -156.06 11.39 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 114.748 -1.115 . . . . 63.32 111.741 176.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.3 mm -93.9 125.21 46.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.74 -0.467 . . . . 71.310000000000002 109.74 178.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 33' ' ' PRO . 93.4 t -86.48 97.79 6.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.023 -0.535 . . . . 74.099999999999994 110.097 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.58 133.13 51.73 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.667 -0.697 . . . . 72.349999999999994 110.374 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -92.67 151.24 20.2 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 121.116 0.484 . . . . 73.040000000000006 110.78 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 75.7 t60 -134.54 103.77 5.82 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.008 -0.738 . . . . 64.430000000000007 109.008 175.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 70.38 -61.45 0.46 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 124.07 0.857 . . . . 75.310000000000002 110.532 -175.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -157.19 -23.18 0.09 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 73.519999999999996 110.826 178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -78.64 171.56 14.97 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.98 -0.378 . . . . 74.0 109.98 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.6 mt -127.58 117.78 22.68 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.054 0.454 . . . . 71.150000000000006 110.668 -172.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.453 ' CZ2' ' HD3' ' A' ' 78' ' ' ARG . 20.7 m95 -111.56 127.35 55.7 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.508 -0.769 . . . . 73.450000000000003 109.655 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.497 ' HB ' HD21 ' A' ' 79' ' ' LEU . 8.5 p -92.25 129.19 43.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-O 120.983 0.421 . . . . 71.549999999999997 110.496 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' O ' ' HA3' ' A' ' 57' ' ' GLY . . . -99.28 108.09 20.55 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.254 -0.43 . . . . 70.519999999999996 110.813 178.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.548 ' O ' ' HA ' ' A' ' 74' ' ' LYS . 29.9 t -56.31 138.34 74.56 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.006 -0.543 . . . . 64.430000000000007 111.407 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 53' ' ' VAL . 60.9 Cg_endo -73.67 -25.6 14.61 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.566 2.177 . . . . 62.409999999999997 112.768 176.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 80.9 mt -102.94 -49.56 3.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.931 0.396 . . . . 62.350000000000001 111.364 -175.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.06 -19.18 28.98 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.801 -0.359 . . . . 64.310000000000002 110.903 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 70' ' ' SER . 57.2 tttm 62.62 22.66 13.46 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.437 0.636 . . . . 74.230000000000004 111.278 176.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.64 ' HG3' ' HB2' ' A' ' 86' ' ' GLU . 8.2 tt0 -95.61 150.8 19.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.857 -0.611 . . . . 75.109999999999999 110.387 -179.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.479 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 73.0 m80 -99.32 124.32 44.32 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.895 -0.593 . . . . 75.120000000000005 110.439 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -119.3 134.86 54.99 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.317 -0.401 . . . . 60.299999999999997 110.793 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.741 ' HB3' ' HB3' ' A' ' 81' ' ' ASP . 49.1 mmm-85 -63.18 131.52 48.72 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.691 -0.485 . . . . 73.299999999999997 109.691 170.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.497 HD21 ' HB ' ' A' ' 68' ' ' VAL . 59.6 mt -70.42 -67.6 0.49 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.972 0.36 . . . . 75.230000000000004 111.972 -177.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.492 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 34.0 p90 -101.08 25.68 7.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.01 0.433 . . . . 74.430000000000007 111.546 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.741 ' HB3' ' HB3' ' A' ' 78' ' ' ARG . 8.0 t70 -118.27 -67.57 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.106 -0.497 . . . . 53.030000000000001 110.454 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.464 ' H ' ' HB2' ' A' ' 78' ' ' ARG . . . 129.48 -21.69 5.07 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.131 -1.033 . . . . 54.0 113.511 175.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -74.08 162.97 28.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.331 0.586 . . . . 74.310000000000002 111.606 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.515 ' SG ' ' HB2' ' A' ' 90' ' ' TYR . 21.3 m -124.89 153.83 42.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 44.350000000000001 109.76 -177.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 4.7 tt -87.94 -68.34 0.77 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.705 0.288 . . . . 52.409999999999997 110.555 -177.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HB2' ' HG3' ' A' ' 75' ' ' GLN . 30.3 mp0 -64.47 -51.75 61.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.262 -0.426 . . . . 74.010000000000005 111.925 -174.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -129.27 102.08 6.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.932 0.396 . . . . 73.120000000000005 110.99 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 84' ' ' CYS . . . -82.48 25.99 4.21 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.985 -0.626 . . . . 44.520000000000003 112.985 -177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.13 -14.72 46.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.069 0.462 . . . . 54.450000000000003 110.871 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.515 ' HB2' ' SG ' ' A' ' 84' ' ' CYS . 99.6 m-85 -80.91 -59.72 2.57 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.987 -0.551 . . . . 75.019999999999996 110.859 -179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 28.3 p 45.55 73.72 0.16 Allowed 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.606 0.717 . . . . 74.420000000000002 110.742 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.7 m -73.58 157.78 6.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.4 -0.818 . . . . 75.239999999999995 111.751 -171.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -96.71 116.38 29.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.506 -0.77 . . . . 63.340000000000003 110.825 -179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -99.37 86.89 3.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.882 -0.599 . . . . 73.200000000000003 110.046 178.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -71.75 170.27 13.93 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.822 -0.626 . . . . 72.420000000000002 111.202 -177.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -83.48 135.29 34.72 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.146 -0.479 . . . . 33.219999999999999 110.367 -179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.996 HG22 HG22 ' A' ' 106' ' ' ILE . 63.9 p -124.82 127.19 46.79 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.281 -0.872 . . . . 72.150000000000006 109.535 -177.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.442 ' HG3' ' HB2' ' A' ' 105' ' ' GLN . 4.5 pt20 -118.5 139.19 51.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.524 0.678 . . . . 74.230000000000004 111.102 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.671 HG11 HD22 ' A' ' 10' ' ' LEU . 45.4 t -108.6 88.85 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-N 115.027 -0.988 . . . . 73.019999999999996 109.133 176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.6 t -88.31 -23.44 23.44 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.124 -0.489 . . . . 73.439999999999998 110.562 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.452 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 68.8 m-20 -145.71 -154.8 0.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.802 -0.814 . . . . 72.219999999999999 108.802 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.452 ' H ' ' HB3' ' A' ' 101' ' ' ASN . . . -74.03 -1.34 59.38 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.835 -0.698 . . . . 72.340000000000003 112.288 177.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.735 ' HA ' ' HA ' ' A' ' 9' ' ' LYS . 3.8 m-20 -113.61 158.82 20.32 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.087 -0.338 . . . . 74.510000000000005 110.087 179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.57 128.44 64.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.835 0.35 . . . . 64.310000000000002 111.698 -176.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.442 ' HB2' ' HG3' ' A' ' 98' ' ' GLN . 18.7 mm-40 -106.19 127.57 53.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.745 -0.661 . . . . 64.420000000000002 110.414 177.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.996 HG22 HG22 ' A' ' 97' ' ' THR . 2.7 pp -115.49 146.47 19.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.473 -0.33 . . . . 72.209999999999994 110.203 176.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.7 t -91.25 125.63 36.07 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.11 0.481 . . . . 60.420000000000002 110.799 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 13.6 pt -98.17 102.15 13.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.968 -0.56 . . . . 64.230000000000004 110.224 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -100.22 17.43 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.138 -0.483 . . . . 73.430000000000007 111.037 -178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 11.7 t0 66.82 122.57 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.961 -1.018 . . . . 74.310000000000002 111.264 -177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.3 m -90.4 -75.07 0.47 Allowed 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.083 -0.962 . . . . 72.129999999999995 109.958 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -173.83 35.58 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.924 -1.139 . . . . 64.409999999999997 107.924 177.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 25' ' ' GLN . 7.9 p -81.35 139.71 17.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 114.982 -1.008 . . . . 63.210000000000001 112.333 -169.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -108.47 112.08 24.28 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.847 -1.168 . . . . 54.329999999999998 107.847 167.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 22.0 t -68.05 95.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.679 0.752 . . . . 73.030000000000001 111.771 -170.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -110.15 -161.2 0.74 Allowed 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 107.009 -1.478 . . . . 45.32 107.009 172.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -90.62 114.83 27.19 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 119.647 -0.821 . . . . 71.340000000000003 109.308 177.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 119' ' ' GLN . 17.6 m -93.01 11.86 26.0 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.959 -0.564 . . . . 72.150000000000006 110.332 179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 118' ' ' SER . 30.0 mm-40 69.33 119.67 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.126 0 O-C-N 124.027 0.829 . . . . 62.119999999999997 111.177 -178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.477 ' O ' ' HD3' ' A' ' 122' ' ' PRO . 15.8 Cg_exo -68.78 90.39 0.42 Allowed 'Trans proline' 0 N--CA 1.461 -0.397 0 C-N-CA 122.322 2.015 . . . . 55.229999999999997 110.366 173.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.407 ' HB3' ' CD2' ' A' ' 123' ' ' LEU . 97.9 mt -96.88 108.41 43.18 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.931 -0.577 . . . . 62.25 111.075 -174.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 120' ' ' PRO . 57.4 Cg_endo -96.97 70.91 0.11 Allowed 'Trans proline' 0 N--CA 1.446 -1.268 0 C-N-CA 123.489 2.792 . . . . 72.510000000000005 111.955 176.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.407 ' CD2' ' HB3' ' A' ' 121' ' ' LEU . 3.7 mm? -73.52 113.84 11.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.291 -0.633 . . . . 71.329999999999998 109.291 176.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -73.25 127.0 31.38 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.092 0.473 . . . . 72.129999999999995 110.382 -177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -74.04 73.04 1.69 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.733 -0.667 . . . . 75.409999999999997 109.806 178.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -78.51 83.87 4.68 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.544 -0.753 . . . . 73.400000000000006 111.207 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -97.97 93.22 6.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 107.919 -1.141 . . . . 73.030000000000001 107.919 171.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -59.81 125.08 22.25 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.475 -0.784 . . . . 63.229999999999997 110.889 -170.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.1 p80 -135.7 -177.13 4.54 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.479 -0.782 . . . . 71.209999999999994 110.517 -177.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 . . . . . 0 C--O 1.247 0.939 0 N-CA-C 108.816 -0.809 . . . . 63.109999999999999 108.816 173.773 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.0 ttt . . . . . 0 N--CA 1.481 1.113 0 N-CA-C 109.747 -0.464 . . . . 75.150000000000006 109.747 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.2 m -114.39 93.16 4.22 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.965 -0.754 . . . . 74.230000000000004 108.965 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -71.03 114.42 9.06 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.638 -0.71 . . . . 73.310000000000002 111.165 -172.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 98.3 m95 -67.76 105.63 1.99 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.699 -0.682 . . . . 74.329999999999998 109.546 172.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.3 p -96.01 146.04 24.95 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 115.886 -0.597 . . . . 71.040000000000006 110.679 -178.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.1 m -83.61 119.94 25.36 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.301 -0.409 . . . . 73.109999999999999 110.507 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 23' ' ' VAL . 46.6 t -84.91 -83.38 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.878 -0.601 . . . . 65.409999999999997 110.314 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 75.6 m -158.75 174.55 14.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.983 -0.553 . . . . 64.120000000000005 109.688 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -75.69 133.77 40.72 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.656 -0.498 . . . . 65.510000000000005 109.656 173.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.5 tp -66.74 -20.41 65.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.04 0.448 . . . . 62.049999999999997 110.994 -178.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -69.1 -29.19 67.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.372 0.606 . . . . 72.049999999999997 110.278 179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -77.5 -25.78 50.65 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.545 -0.752 . . . . 72.239999999999995 109.8 178.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 61.3 mt -86.77 107.89 17.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.716 -0.675 . . . . 72.329999999999998 110.147 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 95.3 mt -68.42 145.86 97.52 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.284 -0.417 . . . . 73.329999999999998 111.8 -174.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 14' ' ' LEU . 24.1 Cg_exo -64.41 125.98 16.09 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.525 2.15 . . . . 74.209999999999994 111.656 175.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 90.72 42.86 4.98 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.864 -0.607 . . . . 71.310000000000002 112.139 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 77.8 p -137.95 -179.47 5.79 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.099 0.476 . . . . 51.25 111.632 -178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 31' ' ' PHE . . . -166.81 81.19 0.11 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.058 -1.217 . . . . 74.010000000000005 110.058 176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HA ' ' OG ' ' A' ' 52' ' ' SER . 35.7 m -111.39 150.68 13.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 112.743 0.646 . . . . 63.340000000000003 112.743 -169.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.557 ' HB3' HD12 ' A' ' 45' ' ' ILE . 5.6 p -70.07 114.42 8.21 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.452 -0.795 . . . . 74.219999999999999 110.736 175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -101.35 148.38 25.22 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.053 -0.522 . . . . 74.200000000000003 110.384 178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -89.31 103.58 16.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.005 -0.543 . . . . 63.030000000000001 109.605 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 7' ' ' VAL . 14.5 t -116.24 99.12 7.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.978 -0.555 . . . . 71.420000000000002 110.269 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 62.72 -85.68 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 123.649 0.593 . . . . 75.530000000000001 111.059 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -130.13 2.66 4.75 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.148 0.499 . . . . 75.319999999999993 109.961 178.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.426 ' HB3' ' CD1' ' A' ' 28' ' ' ILE . 14.5 mm100 -105.49 137.13 43.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.839 -0.619 . . . . 73.129999999999995 111.478 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -105.07 97.83 7.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.115 -0.493 . . . . 53.219999999999999 109.679 171.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.495 HG21 ' HB1' ' A' ' 41' ' ' ALA . 1.7 mp -110.26 135.9 47.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.077 -0.51 . . . . 74.319999999999993 110.541 -178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -84.12 114.44 21.77 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.597 -0.52 . . . . 53.409999999999997 109.597 176.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 18' ' ' GLY . 42.9 t -99.89 106.2 18.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.005 0.431 . . . . 73.430000000000007 110.179 -176.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.763 ' HB2' ' HB2' ' A' ' 40' ' ' TYR . 96.6 m-85 -81.24 127.25 32.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.598 -0.728 . . . . 73.450000000000003 110.687 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -118.97 80.39 18.26 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 108.54 -0.911 . . . . 53.130000000000003 108.54 169.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 38' ' ' GLN . 92.7 Cg_endo -79.25 -10.72 14.89 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.77 2.313 . . . . 72.400000000000006 112.351 -174.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 70.8 mtp180 -121.44 163.01 19.44 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.428 -0.806 . . . . 73.25 110.119 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -73.31 -15.56 61.4 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.209 0.528 . . . . 72.340000000000003 111.15 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.502 ' HB3' ' OE1' ' A' ' 38' ' ' GLN . 16.8 t70 -97.42 -156.99 0.56 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.348 -0.387 . . . . 75.129999999999995 110.263 -176.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.497 ' H ' ' CG ' ' A' ' 36' ' ' ASP . 23.7 mt-10 -89.34 13.15 14.23 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 122.599 0.36 . . . . 72.209999999999994 111.929 -171.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.502 ' OE1' ' HB3' ' A' ' 36' ' ' ASP . 2.5 mp0 -74.31 94.25 2.49 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.882 -0.414 . . . . 73.439999999999998 109.882 178.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 27.5 m -113.74 151.92 15.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 111.65 -177.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.763 ' HB2' ' HB2' ' A' ' 31' ' ' PHE . 89.4 m-85 -122.46 99.83 6.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.368 -0.833 . . . . 71.430000000000007 109.559 176.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.495 ' HB1' HG21 ' A' ' 28' ' ' ILE . . . -97.02 100.79 12.28 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.952 0.406 . . . . 64.230000000000004 110.816 -179.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.586 HD12 HG21 ' A' ' 92' ' ' VAL . 31.3 pt -132.16 156.08 42.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.894 -0.594 . . . . 64.420000000000002 110.195 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 11.7 m -76.06 52.24 0.71 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.512 -0.313 . . . . 52.520000000000003 111.622 -178.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.489 HD22 ' HZ ' ' A' ' 31' ' ' PHE . 65.8 t30 -90.17 78.86 6.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.514 0.673 . . . . 75.420000000000002 110.072 -178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.557 HD12 ' HB3' ' A' ' 20' ' ' CYS . 43.9 mm -126.75 142.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.17 -0.923 . . . . 74.230000000000004 109.67 -176.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.534 ' HB3' ' HB3' ' A' ' 49' ' ' ALA . 12.7 t70 -80.94 125.83 78.99 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 109.755 -0.461 . . . . 71.299999999999997 109.755 177.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 46' ' ' ASP . 24.3 Cg_exo -64.1 -12.58 33.07 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.323 2.682 . . . . 53.43 113.27 -176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -113.44 15.07 19.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.491 0.186 . . . . 64.219999999999999 111.365 179.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 46' ' ' ASP . . . -134.75 -33.94 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.85 0.315 . . . . 43.130000000000003 111.85 -179.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 63.41 23.09 13.56 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.312 0.577 . . . . 54.020000000000003 110.772 -174.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.504 ' HA ' ' SG ' ' A' ' 20' ' ' CYS . . . -139.31 159.32 42.42 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.131 -0.941 . . . . 65.230000000000004 108.843 177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.631 ' HB2' ' HB2' ' A' ' 55' ' ' SER . 4.9 p -80.83 65.44 5.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-O 121.309 0.576 . . . . 71.209999999999994 111.321 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.43 -10.61 12.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.524 0.678 . . . . 71.140000000000001 109.806 176.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.72 ' HA ' ' HB3' ' A' ' 70' ' ' SER . 87.3 mt -86.37 6.2 31.17 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.968 -1.015 . . . . 70.329999999999998 108.989 172.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.764 ' HA ' HG21 ' A' ' 68' ' ' VAL . 4.5 m -138.94 30.3 2.25 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.807 -1.088 . . . . 63.219999999999999 108.302 -176.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.602 ' HD3' ' HG3' ' A' ' 71' ' ' PRO . 18.7 ttt180 -77.85 61.07 2.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.421 -0.809 . . . . 75.530000000000001 111.284 -170.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 84.58 -44.95 3.42 Favored Glycine 0 C--N 1.318 -0.467 0 CA-C-N 114.654 -1.157 . . . . 75.140000000000001 114.311 167.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 48.9 mt -69.14 103.36 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.319 0.58 . . . . 73.540000000000006 111.293 -172.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 12.6 p -119.69 118.1 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 CA-C-N 115.105 -0.952 . . . . 62.530000000000001 109.478 178.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.34 133.56 55.67 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.544 -0.753 . . . . 71.329999999999998 111.001 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -76.73 95.52 4.03 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.63 -0.878 . . . . 71.420000000000002 108.63 173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.704 ' HB3' ' CD1' ' A' ' 67' ' ' TRP . 32.1 t60 -84.35 89.01 7.29 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.985 -0.552 . . . . 75.129999999999995 109.548 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.8 mm100 69.12 -64.17 0.34 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 114.766 -1.106 . . . . 74.239999999999995 112.749 176.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -121.3 -33.17 3.73 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.389 0.515 . . . . 73.129999999999995 112.389 -171.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -128.78 -172.2 2.66 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.655 -0.418 . . . . 62.450000000000003 111.141 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt -101.53 117.29 34.62 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.02 0.438 . . . . 71.439999999999998 110.213 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TRP . . . . . 0.872 ' HB3' ' HB3' ' A' ' 76' ' ' HIS . 30.3 m95 -122.48 119.8 32.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.901 -0.59 . . . . 75.010000000000005 110.297 -176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.764 HG21 ' HA ' ' A' ' 55' ' ' SER . 12.8 p -84.15 149.77 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.282 -0.417 . . . . 72.310000000000002 110.143 -179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.89 130.68 54.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.933 0.397 . . . . 61.43 110.526 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.72 ' HB3' ' HA ' ' A' ' 54' ' ' LEU . 57.3 p -102.76 143.4 26.54 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.14 -0.482 . . . . 73.439999999999998 110.291 178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.602 ' HG3' ' HD3' ' A' ' 56' ' ' ARG . 60.3 Cg_endo -73.19 -2.91 12.76 Favored 'Trans proline' 0 CA--C 1.528 0.189 0 C-N-CA 122.442 2.095 . . . . 65.209999999999994 112.188 178.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 81.1 mt -104.81 -55.82 2.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.113 -0.494 . . . . 73.530000000000001 110.928 -177.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -89.48 -24.75 21.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.438 -0.346 . . . . 73.329999999999998 110.638 -177.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.5 tttt 74.35 -31.77 0.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.252 0.834 . . . . 74.439999999999998 113.252 169.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -71.59 168.18 18.18 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.949 0.404 . . . . 74.099999999999994 111.081 177.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.872 ' HB3' ' HB3' ' A' ' 67' ' ' TRP . 35.5 m80 -96.5 128.5 43.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.005 -0.543 . . . . 75.340000000000003 111.385 -173.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.516 ' HB2' HG12 ' A' ' 68' ' ' VAL . 54.6 m-85 -98.09 122.66 41.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.389 -0.597 . . . . 75.219999999999999 109.389 176.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -72.69 117.46 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.62 -0.511 . . . . 75.140000000000001 109.62 178.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.635 HD21 ' HB ' ' A' ' 68' ' ' VAL . 50.1 mt -61.5 -25.33 67.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.256 -0.429 . . . . 71.420000000000002 112.149 -173.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 36.1 t80 -89.43 -0.52 57.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.639 0.257 . . . . 73.140000000000001 111.525 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -141.05 -65.67 0.44 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.54 -0.464 . . . . 64.120000000000005 112.011 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.501 ' HA3' HG22 ' A' ' 92' ' ' VAL . . . 132.62 -25.79 3.73 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.731 -0.747 . . . . 63.119999999999997 112.667 -178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -55.61 144.03 28.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.508 0.67 . . . . 75.140000000000001 111.784 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 3.9 m -97.8 65.04 1.8 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.0 -1.0 . . . . 73.439999999999998 110.89 -171.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.501 ' HA ' ' CZ3' ' A' ' 67' ' ' TRP . 35.5 tp 65.53 -87.47 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.719 -0.673 . . . . 74.409999999999997 111.477 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -102.74 -12.37 17.69 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.814 0.34 . . . . 70.400000000000006 110.934 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -117.12 176.19 5.25 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.373 -0.376 . . . . 45.409999999999997 110.569 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.5 41.32 1.4 Allowed Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 110.908 -0.877 . . . . 72.340000000000003 110.908 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.91 -45.8 78.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.761 0.315 . . . . 53.32 111.22 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -117.61 80.24 1.47 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.167 0.508 . . . . 73.239999999999995 110.922 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.6 m -76.65 96.98 4.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.969 -0.559 . . . . 74.420000000000002 109.558 173.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.586 HG21 HD12 ' A' ' 42' ' ' ILE . 20.0 m -82.82 165.8 2.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.719 -0.673 . . . . 64.349999999999994 110.782 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -99.69 125.6 45.58 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.148 -0.478 . . . . 72.5 110.706 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.552 ' HA ' HG22 ' A' ' 42' ' ' ILE . . . -94.21 96.57 9.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.886 -0.597 . . . . 61.109999999999999 109.783 178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.6 m-85 -82.91 152.0 25.71 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.554 -0.748 . . . . 73.239999999999995 109.681 177.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -74.74 128.75 36.32 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.236 0.541 . . . . 65.340000000000003 109.73 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.61 HG23 HG12 ' A' ' 106' ' ' ILE . 3.5 m -122.96 158.39 30.55 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.63 -0.714 . . . . 54.210000000000001 109.376 -176.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -156.46 141.76 17.46 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.225 0.536 . . . . 74.099999999999994 110.591 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 104' ' ' VAL . 34.5 t -110.21 105.68 19.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.12 -0.945 . . . . 62.530000000000001 108.797 175.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.709 HG23 ' H ' ' A' ' 101' ' ' ASN . 1.2 t -86.6 -76.31 0.36 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.371 -0.377 . . . . 72.420000000000002 111.568 -175.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.709 ' H ' HG23 ' A' ' 100' ' ' THR . 1.0 OUTLIER -120.87 70.46 0.91 Allowed 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.678 0.275 . . . . 60.43 110.638 -178.952 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 79.67 -31.34 2.2 Favored Glycine 0 C--O 1.229 -0.184 0 C-N-CA 120.701 -0.762 . . . . 64.0 112.748 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -89.0 146.86 24.6 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.957 0.408 . . . . 55.130000000000003 110.123 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.529 HG22 HG22 ' A' ' 99' ' ' VAL . 39.8 t -105.51 133.22 50.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.798 -0.637 . . . . 73.409999999999997 109.918 -179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -129.32 146.8 51.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.707 0.289 . . . . 72.510000000000005 111.072 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.61 HG12 HG23 ' A' ' 97' ' ' THR . 70.9 mt -121.38 136.94 56.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.986 -0.552 . . . . 73.510000000000005 109.81 178.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 30.5 p -90.88 112.94 24.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.177 0.513 . . . . 31.219999999999999 110.224 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 29.8 pt -126.06 155.78 35.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 116.381 -0.372 . . . . 61.039999999999999 110.792 179.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -75.49 173.86 10.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.882 -0.599 . . . . 71.5 109.664 173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -65.04 132.48 49.32 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.646 0.736 . . . . 73.129999999999995 110.993 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 23.2 t -117.31 33.14 5.77 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.04 -0.982 . . . . 74.209999999999994 108.786 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -73.1 84.49 1.32 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.866 -1.061 . . . . 72.329999999999998 110.758 -177.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 26.4 t -126.07 152.5 33.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 108.734 -0.839 . . . . 73.030000000000001 108.734 177.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -71.87 82.71 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.19 0.519 . . . . 72.510000000000005 111.062 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.4 t -121.51 125.32 73.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.531 -0.759 . . . . 54.439999999999998 109.941 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -91.35 174.28 7.46 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.859 -0.423 . . . . 73.299999999999997 109.859 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -116.78 132.15 56.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.936 0.398 . . . . 73.319999999999993 110.268 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 16.6 m -100.58 -16.12 17.58 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.952 -0.567 . . . . 52.210000000000001 110.141 178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.459 ' HA ' ' HD3' ' A' ' 120' ' ' PRO . 48.8 mt-30 -121.46 124.33 27.27 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.582 -0.736 . . . . 62.509999999999998 109.95 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 119' ' ' GLN . 27.2 Cg_exo -62.53 138.02 67.96 Favored 'Trans proline' 0 C--O 1.233 0.251 0 C-N-CA 122.898 2.398 . . . . 74.109999999999999 112.098 178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 3.1 mm? -64.22 139.56 97.72 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.222 -0.445 . . . . 74.140000000000001 110.601 -179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 121' ' ' LEU . 4.2 Cg_exo -74.3 97.95 1.06 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.829 2.353 . . . . 72.430000000000007 112.286 -178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.3 tt -91.87 99.1 12.02 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.612 -0.884 . . . . 54.210000000000001 108.612 176.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -112.69 124.18 51.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.96 -0.564 . . . . 74.409999999999997 109.588 -176.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -78.11 101.29 6.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.9 0.381 . . . . 74.549999999999997 111.095 -176.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -75.24 132.19 40.9 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.715 -0.675 . . . . 73.230000000000004 110.799 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -56.08 132.28 49.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.271 -0.877 . . . . 75.540000000000006 111.984 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -142.37 112.88 7.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.964 -0.562 . . . . 70.439999999999998 110.361 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -94.73 136.98 34.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.168 -0.469 . . . . 74.439999999999998 111.215 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.431 -0.795 . . . . 71.340000000000003 109.551 179.202 . . . . . . . . 0 0 . 1 stop_ save_